Citrus Sinensis ID: 036419
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 754 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.984 | 0.947 | 0.436 | 1e-173 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.950 | 0.846 | 0.425 | 1e-173 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.933 | 0.845 | 0.405 | 1e-161 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.932 | 0.831 | 0.392 | 1e-154 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.978 | 0.861 | 0.388 | 1e-150 | |
| Q9SYA0 | 804 | G-type lectin S-receptor- | no | no | 0.970 | 0.910 | 0.392 | 1e-148 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.923 | 0.848 | 0.385 | 1e-146 | |
| O64781 | 831 | G-type lectin S-receptor- | no | no | 0.964 | 0.874 | 0.392 | 1e-146 | |
| Q9SXB5 | 820 | G-type lectin S-receptor- | no | no | 0.965 | 0.887 | 0.361 | 1e-146 | |
| O64783 | 814 | G-type lectin S-receptor- | no | no | 0.965 | 0.894 | 0.386 | 1e-144 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 608 bits (1567), Expect = e-173, Method: Compositional matrix adjust.
Identities = 347/795 (43%), Positives = 475/795 (59%), Gaps = 53/795 (6%)
Query: 1 MEKLTVFNIFSSFVFLFSIQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRY 60
ME V ++ + LFS L A I A+ ++DG+ VS FE+GFFSP SR
Sbjct: 1 MEATNVLHLL--IISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRN 58
Query: 61 RYLGIWYKQIP-DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAE 119
RYLGIWYK+I TVVWVANR+SP+ + + L +S NG+L + N N IWSS++S ++
Sbjct: 59 RYLGIWYKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQ 118
Query: 120 -----NPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVER 174
NP+ Q+LDTGNL+VR+ S + +WQS DYP D L GMK G + G+ R
Sbjct: 119 KASLRNPIVQILDTGNLVVRN----SGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNR 174
Query: 175 YLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSYASILSE 234
+LTSWR+ DDPS GN TN++D + +P+ L S + R+GPWNG+ F P+ +
Sbjct: 175 FLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPN---LKPN 231
Query: 235 PIL----VDNEDEIYYSYESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPTLFC 290
PI V E+E+YY+Y+ N ++ + +NP+G +QR W + W A C
Sbjct: 232 PIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSC 291
Query: 291 QFYGHCGGNRVCSYEKTPNCECLKGFKPKSQHNQTRPG---SCVRSESADCKSG-DRFIM 346
Y CG C+ ++P C CLKGF K+ CVR DC G D F+
Sbjct: 292 DQYTLCGSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLK 351
Query: 347 VDDIKLPDLLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDTTK 406
+ +KLPD +K+M+L EC+ CL+N TC AY+ ++ G GC++W+GDLID +
Sbjct: 352 ISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE 411
Query: 407 AKFHNGQPMAREAILVICPSFSSGGASYYFMHILSMETKTQGKSLASVSAATNNFGVENK 466
NGQ + + + + + L +VS AT+ F NK
Sbjct: 412 YN-ENGQDLYVRLASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNK 470
Query: 467 LGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509
LG+GGFGPVYK S QG+EEFKNEIKL AKLQHRNLV++LG CV+
Sbjct: 471 LGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVD 530
Query: 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRD 569
+ E +LIYEY PNKSLDSF+FD + L W R+ II+GIA+G+LYLH+ SRLR+IHRD
Sbjct: 531 EEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRD 590
Query: 570 LKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDV 629
LK SN+LLDS+M KISDFGLAR GGDE ++NT R+VGTYGYMSPEY I G+FS+KSDV
Sbjct: 591 LKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDV 650
Query: 630 FSFGVLLLETLSSKRSTRFFN-TNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPI--V 686
FSFGVL+LE +S +R+ F N + L LLGHAW + +D+++E++D + E+ I V
Sbjct: 651 FSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVN-ESCTDISEV 709
Query: 687 KRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKK-------SVETV 739
R I++ LLCVQ++ DRP MS V+ ++ + + L P+QPGF + + S+
Sbjct: 710 LRVIHIGLLCVQQDPKDRPNMS-VVVLMLSSEMLLLDPRQPGFFNERNLLFSDTVSINLE 768
Query: 740 ARSMNRLTLSVMDAR 754
S N T+SV+D R
Sbjct: 769 IPSNNFQTMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 607 bits (1566), Expect = e-173, Method: Compositional matrix adjust.
Identities = 346/813 (42%), Positives = 463/813 (56%), Gaps = 96/813 (11%)
Query: 35 IRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIP-DTVVWVANRNSPIIEPNAALTI 93
I + +S S+ FELGFF+P S YLGIWYK IP T VWVANR++P+ N L I
Sbjct: 38 ISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLKI 97
Query: 94 SNNGNLVILNLTNGAIWSSN-TSRKAENPVA-QLLDTGNLIVRDNFSRSASEGSCLWQSF 151
S+N NLVI + ++ +WS+N T +PVA +LLD GN ++RD S++ LWQSF
Sbjct: 98 SDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD--SKNNKPSGFLWQSF 154
Query: 152 DYPSDTLLAGMKLGWDLKNG-VERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQK 210
D+P+DTLL+ MK+GWD K+G R L SW++ DDPS G+ + +L PE +YN
Sbjct: 155 DFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKESI 214
Query: 211 LSRSGPWNGIFFGAAPSYASI-LSEPILVDNEDEIYYSYESYNNPIIAILTVNPSGTVQR 269
RSGPW G F + P + + +N ++ YSY I +IL+++ +G +QR
Sbjct: 215 TYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLLQR 274
Query: 270 LIWHERSNGWAAVHLAPTLFCQFYGHCGGNRVCSYEKTPNCECLKGFKPKSQHNQTRPGS 329
L W E + W + +P C Y CG C +P C C+KGF+P ++ R S
Sbjct: 275 LTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMNEQAALRDDS 334
Query: 330 --CVRSESADCKSGDRFIMVDDIKLPDLLNVSLNKSMNLKECEAECLKNRTCRAYANSEV 387
CVR C D F+ + ++LPD S++K + LKECE CLK C A+AN+++
Sbjct: 335 VGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDI 394
Query: 388 TGRGSGCLMWYGDLIDT-----------------------TKAK---------------- 408
GSGC++W G L D K+K
Sbjct: 395 RNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIKSKKIIGSSIGVSILLLLS 454
Query: 409 ---FHNGQPMAREAILVICPSFSSGGASYYFMHIL--------SMETKTQGKSL-----A 452
FH + + +I + P + M+ L S E KT L
Sbjct: 455 FIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWK 514
Query: 453 SVSAATNNFGVENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKL 495
+++ ATNNF +NKLG+GGFG VYK S QG +EF NE++L AKL
Sbjct: 515 ALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKL 574
Query: 496 QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLL 555
QH NLVRLLGCCV++GE +LIYEYL N SLDS LFD T+ L W R II GIA+GLL
Sbjct: 575 QHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLL 634
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSP 615
YLHQ SR R+IHRDLK SN+LLD NM PKISDFG+AR+FG +E ++NT+R+VGTYGYMSP
Sbjct: 635 YLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSP 694
Query: 616 EYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN-SLTLLGHAWNLWKDDRSWELMD 674
EYA+ G FS+KSDVFSFGVLLLE +S KR+ F+N+N L LLG W WK+ + E++D
Sbjct: 695 EYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVD 754
Query: 675 P----KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFS 730
P L E + R I + LLCVQE A DRP MS V+ ML +E +P P++PGF
Sbjct: 755 PINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFC 814
Query: 731 SLKKSVETVAR---------SMNRLTLSVMDAR 754
+ S+E + ++N++TLSV+DAR
Sbjct: 815 VGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 568 bits (1464), Expect = e-161, Method: Compositional matrix adjust.
Identities = 322/795 (40%), Positives = 448/795 (56%), Gaps = 91/795 (11%)
Query: 24 AADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPD-TVVWVANRNS 82
+ DTI S +RDGE +S+ +RF GFFS S RY+GIWY QI T+VWVANR+
Sbjct: 18 SVDTIMRRQS-LRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 83 PIIEPNAALTISNNGNLVILNLTNGA--IWSSNTSRKAENP--VAQLLDTGNLIVRDNFS 138
PI + + + SN GNL + N IWS+N S P VA L D GNL++ D +
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136
Query: 139 RSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPSPGNITNRLDIHV 198
G W+SFD+P+DT L M+LG+ K+G++R LTSW+S DP G++ R++
Sbjct: 137 -----GRSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRG 191
Query: 199 LPELGLYNGSQKLSRSGPWNGIFFGAAPSYA-SILSEPILVDNEDEIYYSYESYNNPIIA 257
P+L LY G R G W G + P + V+NEDE+ ++Y + +I
Sbjct: 192 FPQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVIT 251
Query: 258 ILTVNPSGTVQRLIWHERSNGWAAVHLAPTLFCQFYGHCGGNRVCS--YEKTPNCECLKG 315
VN +GT+ R W R W P C Y HCG N C KT C CL G
Sbjct: 252 RTMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPG 311
Query: 316 FKPKSQHN---QTRPGSCVRSESAD-CKSGDRFIMVDDIKLPDLLNVSLNKSMNLKECEA 371
F+PK + + G C + + A C D F+ + +K+PD + S++ ++ LKEC+
Sbjct: 312 FEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQ 371
Query: 372 ECLKNRTCRAYANS-EVTGRGS-GCLMWYGDLIDT-----TKAKFH-------------N 411
CLKN +C AYA++ + RG+ GCL W+G ++D + F+ N
Sbjct: 372 RCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRN 431
Query: 412 GQPMAREAILVICPSFSSGGASYYFMHILSMETKTQGKSLAS------------------ 453
G R +L++ ++ + + E + + +S
Sbjct: 432 GLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFE 491
Query: 454 ----------------VSAATNNFGVENKLGEGGFGPVYK-----------------SGQ 480
+ AATNNF +NKLG GGFGPVYK SGQ
Sbjct: 492 QDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQ 551
Query: 481 GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGW 540
G+EEFKNE+KL +KLQHRNLVR+LGCCVE E +L+YEYLPNKSLD F+F + L W
Sbjct: 552 GMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDW 611
Query: 541 GARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600
R+ I+ GIA+G+LYLHQ SRLR+IHRDLK SNILLDS MIPKISDFG+AR+FGG++++
Sbjct: 612 PKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQME 671
Query: 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA 660
T R+VGT+GYM+PEYA+ G FSIKSDV+SFGVL+LE ++ K+++ F +S L+GH
Sbjct: 672 GCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHEESS-NLVGHI 730
Query: 661 WNLWKDDRSWELMDPKLQCEA-SYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719
W+LW++ + E++D + E V + I + LLCVQENA+DR MS V+ ML +
Sbjct: 731 WDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNAT 790
Query: 720 NLPSPQQPGFSSLKK 734
NLP+P+ P F+S ++
Sbjct: 791 NLPNPKHPAFTSARR 805
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 546 bits (1408), Expect = e-154, Method: Compositional matrix adjust.
Identities = 314/800 (39%), Positives = 456/800 (57%), Gaps = 97/800 (12%)
Query: 25 ADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPD-TVVWVANRNSP 83
+D S ++DG+ S +RF GFFS S+ RY+GIWY Q+ + T+VWVANR+ P
Sbjct: 21 SDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHP 80
Query: 84 IIEPNAALTISNNGNLVILNLTNGA--IWSSNTSRKAENP--VAQLLDTGNLIVRDNFSR 139
I + + + S GNL + NG IWS++ + P VA+L D GNL++ D +
Sbjct: 81 INDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVT- 139
Query: 140 SASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPSPGNITNRLDIHVL 199
G W+SF++P++TLL MK G+ ++GV+R +TSWRS DP GNIT R++
Sbjct: 140 ----GKSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGF 195
Query: 200 PELGLYNGSQKLSRSGPWNGIFFGAAPSYASILSEPI-LVDNEDEIYYSYESYNNPIIAI 258
P++ +Y G R+G W G + P + I V+N DE+ +Y + +
Sbjct: 196 PQMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTR 255
Query: 259 LTVNPSGTVQRLIWHERSNGWAAVHLAPTLFCQFYGHCGGNRVCSYEKTPN--CECLKGF 316
+ +N +GT+QR W+ R W AP C Y HCG N C T C CL G+
Sbjct: 256 MVLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGY 315
Query: 317 KPKSQHN---QTRPGSCVRSESAD-CKSGDRFIMVDDIKLPDLLNVSLNKSMNLKECEAE 372
+PK+ + + C R ++ C + F + +K+P+ V+++ ++ LKECE
Sbjct: 316 EPKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQR 375
Query: 373 CLKNRTCRAYANS--EVTGRGSGCLMWYGDL----------------IDTTKAKFHNGQP 414
CLKN +C AYA++ E GCL W+G++ +D ++ NG
Sbjct: 376 CLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNG 435
Query: 415 MAREAILVIC-----------------------------------PSFSSGGASYYFMHI 439
+ + LV+ SF+ I
Sbjct: 436 ASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFI 495
Query: 440 LS-METKTQGKSL-----ASVSAATNNFGVENKLGEGGFGPVYK---------------- 477
L +E K++ + L ++++ ATNNF +NKLG GGFGPVYK
Sbjct: 496 LEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSK 555
Query: 478 -SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEG 536
SGQG+EEFKNE+KL +KLQHRNLVR+LGCCVE E +L+YEYLPNKSLD F+F +
Sbjct: 556 SSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRA 615
Query: 537 LLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596
L W R+ II GI +G+LYLHQ SRLR+IHRDLK SN+LLD+ MIPKI+DFGLAR+FGG
Sbjct: 616 ELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGG 675
Query: 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL 656
++++ +T R+VGTYGYMSPEYA+ G FSIKSDV+SFGVL+LE ++ KR++ F+ SL L
Sbjct: 676 NQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFYE-ESLNL 734
Query: 657 LGHAWNLWKDDRSWELMDPKLQCEASYP--IVKRYINVALLCVQENAADRPTMSEVISML 714
+ H W+ W++ + E++D KL E +Y V + +++ LLCVQEN++DRP MS V+ ML
Sbjct: 735 VKHIWDRWENGEAIEIID-KLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFML 793
Query: 715 TNEFVNLPSPQQPGFSSLKK 734
+ ++LPSP+ P F++ ++
Sbjct: 794 GHNAIDLPSPKHPAFTAGRR 813
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 532 bits (1370), Expect = e-150, Method: Compositional matrix adjust.
Identities = 331/853 (38%), Positives = 464/853 (54%), Gaps = 115/853 (13%)
Query: 10 FSSFVFLFSIQ------LSKAADTITPASSF-IRDGEKFVSSSERFELGFFSPRKSRYRY 62
+ SF+ +F + LS +T++ S I + VS FE+GFF R + Y
Sbjct: 12 YMSFLLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF--RTNSRWY 69
Query: 63 LGIWYKQIPD-TVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENP 121
LG+WYK++ D T VWVANR++P+ L IS N NLV+L+ +N +W +N +R E
Sbjct: 70 LGMWYKKVSDRTYVWVANRDNPLSNAIGTLKISGN-NLVLLDHSNKPVWWTNLTRGNERS 128
Query: 122 --VAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSW 179
VA+LL GN ++RD+ + ASE LWQSFDYP+DTLL MKLG++LK G+ R+LTSW
Sbjct: 129 PVVAELLANGNFVMRDSSNNDASE--YLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSW 186
Query: 180 RSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSYASILSEPI--L 237
RS+DDPS GN + +L+ LPE L + + RSGPWNGI F P LS +
Sbjct: 187 RSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQK-LSYMVYNF 245
Query: 238 VDNEDEIYYSYESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPT-LFCQFYGHC 296
++N +E+ Y++ NN + LT+ G QRL W+ W +P C Y C
Sbjct: 246 IENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMC 305
Query: 297 GGNRVCSYEKTPNCECLKGFKPKS--QHNQ-TRPGSCVRSESADCKSGDRFIMVDDIKLP 353
G C +P C C++GF P++ Q +Q G C+R C SGD F + +KLP
Sbjct: 306 GPYAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSC-SGDGFTRMKKMKLP 364
Query: 354 DLLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDTTKAKFH--N 411
+ ++++S+ +KEC+ C+ + C A+AN+++ GSGC++W L D +
Sbjct: 365 ETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAID 424
Query: 412 GQPM-AREAILVICP---------SFSSGGASYYFMHILSMETKTQGKSLASVSAATNN- 460
GQ + R A I S + G + + + + + Q ++ AS + N
Sbjct: 425 GQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQ 484
Query: 461 -----------------FGVENKLGE--------------------------GGFGPVYK 477
F E K E GGFG VYK
Sbjct: 485 RNQNLPMNEMVLSSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIVYK 544
Query: 478 -----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520
S QG +EF NE+ L A+LQH NLV++LGCC+E E +LIYEYL
Sbjct: 545 GRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYL 604
Query: 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN 580
N SLDS+LF T+ L W R I G+A+GLLYLHQ SR R+IHRDLK SNILLD N
Sbjct: 605 ENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKN 664
Query: 581 MIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
MIPKISDFG+AR+F DE ++NT ++VGTYGYMSPEYA++G FS KSDVFSFGV++LE +
Sbjct: 665 MIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIV 724
Query: 641 SSKRSTRFFNTN-SLTLLGHAWNLWKDDRSWELMDPKL-QCEASYPI------VKRYINV 692
S K++ F+N + LL + W+ WK+ R+ E++DP + +S P V + I +
Sbjct: 725 SGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQEVLKCIQI 784
Query: 693 ALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGF-----------SSLKKSVETVAR 741
LLCVQE A RP MS V+ M +E +P P+ PG+ SS + E +
Sbjct: 785 GLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGYCVRRSPYELDPSSSWQCDENESW 844
Query: 742 SMNRLTLSVMDAR 754
++N+ T SV+DAR
Sbjct: 845 TVNQYTCSVIDAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYA0|Y1150_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61500 OS=Arabidopsis thaliana GN=At1g61500 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 525 bits (1353), Expect = e-148, Method: Compositional matrix adjust.
Identities = 324/825 (39%), Positives = 455/825 (55%), Gaps = 93/825 (11%)
Query: 1 MEKLTVFNIFSSFVFLFSIQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRY 60
M + ++F+ F+F LS ++ + S + G+ S++E +ELGFFSP ++
Sbjct: 2 MTRFACLHLFTMFLFTL---LSGSSSAVITTESPLSMGQTLSSANEVYELGFFSPNNTQD 58
Query: 61 RYLGIWYKQ-IPDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAE 119
+Y+GIW+K IP VVWVANR P+ + A L IS++G+L++LN +G +WSS + +
Sbjct: 59 QYVGIWFKDTIPRVVVWVANREKPVTDSTAYLAISSSGSLLLLNGKHGTVWSSGVTFSSS 118
Query: 120 NPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSW 179
A+L D+GNL V DN S A LWQSFD+ DTLL L ++L +R LTSW
Sbjct: 119 GCRAELSDSGNLKVIDNVSERA-----LWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSW 173
Query: 180 RSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAP----SYASILSEP 235
+S DPSPG+ ++ V + + GS RSGPW F P SY +
Sbjct: 174 KSYTDPSPGDFLGQITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGPFTLH 233
Query: 236 ILVDNEDEIYYSYESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPTLFCQFYGH 295
V+ + Y Y ++ +T+ G+++ ++ + GW + AP C FYG
Sbjct: 234 QDVNGSGYLTYFQRDYK---LSRITLTSEGSIK--MFRDNGMGWELYYEAPKKLCDFYGA 288
Query: 296 CGGNRVCSYEKTPNCECLKGFKPKSQHNQTR---PGSCVRSESADC------KSGDRFIM 346
CG +C +P C+C +GF PKS R G CVR DC + D F
Sbjct: 289 CGPFGLCVMSPSPMCKCFRGFVPKSVEEWKRGNWTGGCVRHTELDCLGNSTGEDADDFHQ 348
Query: 347 VDDIKLPDLLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDTTK 406
+ +IK PD + S+N +EC C+ N +C A+A +G GCL+W DL+D +
Sbjct: 349 IANIKPPDFYEFA--SSVNAEECHQRCVHNCSCLAFAYI----KGIGCLVWNQDLMDAVQ 402
Query: 407 AKFHNGQ----PMAREAI-----------------LVICPSFSSGGA----SYYFMHILS 441
G+ +AR + L + F++ G + HI
Sbjct: 403 FS-ATGELLSIRLARSELDGNKRKKTIVASIVSLTLFMILGFTAFGVWRCRVEHIAHISK 461
Query: 442 METKTQGK----------SLASVSAATNNFGVENKLGEGGFGPVYK-------------- 477
K K + ++ ATNNF + NKLG+GGFG VYK
Sbjct: 462 DAWKNDLKPQDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRL 521
Query: 478 ---SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK 534
SGQG EEF NEI L +KLQHRNLVR+LGCC+E+ E +LIYE++ NKSLD+FLFD+ K
Sbjct: 522 SSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRK 581
Query: 535 EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594
+ W R II+GIA+GLLYLH SRLRVIHRDLK SNILLD M PKISDFGLARM+
Sbjct: 582 RLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMY 641
Query: 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRF-FNTNS 653
G E Q NT+R+VGT GYMSPEYA G FS KSD++SFGVL+LE +S ++ +RF +
Sbjct: 642 QGTEYQDNTRRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEG 701
Query: 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPI-VKRYINVALLCVQENAADRPTMSEVIS 712
TL+ +AW W + R +L+D L ++ +P+ V R I + LLCVQ ADRP E+++
Sbjct: 702 KTLIAYAWESWSEYRGIDLLDQDL-ADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLA 760
Query: 713 MLTNEFVNLPSPQQPGFSSLKKSVETVAR---SMNRLTLSVMDAR 754
MLT +LPSP+QP F+ + E+++ ++N +T SV+ R
Sbjct: 761 MLTTT-SDLPSPKQPTFAFHTRDDESLSNDLITVNGMTQSVILGR 804
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 521 bits (1341), Expect = e-146, Method: Compositional matrix adjust.
Identities = 306/793 (38%), Positives = 436/793 (54%), Gaps = 97/793 (12%)
Query: 15 FLFSIQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIP-DT 73
F S+ L++ S + D E VSS F GFFSP S RY GIWY + T
Sbjct: 19 FFLSVSLAQERAFF---SGKLNDSETIVSSFRTFRFGFFSPVNSTSRYAGIWYNSVSVQT 75
Query: 74 VVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAE--NPVAQLLDTGNL 131
V+WVAN++ PI + + +++S +GNLV+ + +WS+N S +A + VA+LLD+GNL
Sbjct: 76 VIWVANKDKPINDSSGVISVSQDGNLVVTDGQRRVLWSTNVSTQASANSTVAELLDSGNL 135
Query: 132 IVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLK-NGVERYLTSWRSADDPSPGNI 190
++++ AS + LW+SF YP+D+ L M +G + + G +TSW+S DPSPG+
Sbjct: 136 VLKE-----ASSDAYLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSDPSPGSY 190
Query: 191 TNRLDIHVLPELGLYNGSQKLS---RSGPWNGIFFGAAPS-YASILSEPILVDNEDEIYY 246
T L + PEL + N + S RSGPWNG F P YA + +V+++
Sbjct: 191 TAALVLAAYPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDVYAGVFLYRFIVNDDTNGSV 250
Query: 247 SYESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPTLFCQFYGHCGGNRVCSYEK 306
+ N+ + ++ G+V R W E W P C Y CG C+ K
Sbjct: 251 TMSYANDSTLRYFYMDYRGSVIRRDWSETRRNWTVGLQVPATECDNYRRCGEFATCNPRK 310
Query: 307 TPNCECLKGFKPKSQ---HNQTRPGSCVRSESADCK------SGDRFIMVDDIKLPDLLN 357
P C C++GF+P++ +N G C R C+ S D F+ + +KLPD
Sbjct: 311 NPLCSCIRGFRPRNLIEWNNGNWSGGCTRRVPLQCERQNNNGSADGFLRLRRMKLPDFAR 370
Query: 358 VSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDT------------- 404
S + EC CL+ +C A A+ G G GC++W G L+D+
Sbjct: 371 RS---EASEPECLRTCLQTCSCIAAAH----GLGYGCMIWNGSLVDSQELSASGLDLYIR 423
Query: 405 ---TKAKFHNGQP-------------------MAREAILVICPSFSSGGASYYFMHILSM 442
++ K + +P +AR ++ A F + ++
Sbjct: 424 LAHSEIKTKDKRPILIGTILAGGIFVVAACVLLARRIVMKKRAKKKGRDAEQIFERVEAL 483
Query: 443 ETKTQGK-------SLASVSAATNNFGVENKLGEGGFGPVYK-----------------S 478
+GK ++AATNNF + NKLG+GGFGPVYK S
Sbjct: 484 AGGNKGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRAS 543
Query: 479 GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLL 538
GQGLEE NE+ + +KLQHRNLV+LLGCC+ E +L+YE++P KSLD +LFD+ + LL
Sbjct: 544 GQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKLL 603
Query: 539 GWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598
W R II GI +GLLYLH+ SRLR+IHRDLK SNILLD N+IPKISDFGLAR+F G+E
Sbjct: 604 DWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNE 663
Query: 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLG 658
++NT+R+VGTYGYM+PEYA+ G FS KSDVFS GV+LLE +S +R N+NS TLL
Sbjct: 664 DEANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRR-----NSNS-TLLA 717
Query: 659 HAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718
+ W++W + L+DP++ + + I++ LLCVQE A DRP++S V SML++E
Sbjct: 718 YVWSIWNEGEINSLVDPEIFDLLFEKEIHKCIHIGLLCVQEAANDRPSVSTVCSMLSSEI 777
Query: 719 VNLPSPQQPGFSS 731
++P P+QP F S
Sbjct: 778 ADIPEPKQPAFIS 790
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64781|Y1639_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61390 OS=Arabidopsis thaliana GN=At1g61390 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1339), Expect = e-146, Method: Compositional matrix adjust.
Identities = 324/825 (39%), Positives = 448/825 (54%), Gaps = 98/825 (11%)
Query: 9 IFSSFVFLFSIQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYK 68
IF+ + L AD T SS + G+ S +ELGFFSP SR +Y+GIW+K
Sbjct: 26 IFACLLLLIIFPTFGYADINT--SSPLSIGQTLSSPDGVYELGFFSPNNSRKQYVGIWFK 83
Query: 69 QI-PDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLD 127
I P VVWVANR+ P+ + A LTIS+NG+L++L+ T IWS+ + + A+LLD
Sbjct: 84 NIAPQVVVWVANRDKPVTKTAANLTISSNGSLILLDGTQDVIWSTGEAFTSNKCHAELLD 143
Query: 128 TGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPSP 187
TGNL+V D+ S G LW+SF+ +T+L + +D+ G R LTSWRS DPSP
Sbjct: 144 TGNLVVIDDVS-----GKTLWKSFENLGNTMLPQSSVMYDIPRGKNRVLTSWRSNSDPSP 198
Query: 188 GNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSYASILSEPILVDNE---DEI 244
G T V P+ + GS RSGPW F P + P V +
Sbjct: 199 GEFTLEFTPQVPPQGLIRRGSSPYWRSGPWAKTRFSGIPGIDASYVSPFTVLQDVAKGTA 258
Query: 245 YYSYESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPTLFCQFYGHCGGNRVCSY 304
+SY N ++ +T+ G + +++W++ W APT C Y CG +C
Sbjct: 259 SFSYSMLRNYKLSYVTLTSEGKM-KILWND-GKSWKLHFEAPTSSCDLYRACGPFGLCVR 316
Query: 305 EKTPNCECLKGFKPKSQHNQTR---PGSCVRSESADC----------KSGDRFIMVDDIK 351
+ P C CLKGF PKS + CVR C K D F + +K
Sbjct: 317 SRNPKCICLKGFVPKSDDEWKKGNWTSGCVRRTQLSCHTNSSTKTQGKETDSFYHMTRVK 376
Query: 352 LPDLLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDTTKAKFHN 411
PDL L +N ++C +CL N +C A+A G GCL+W +L+DT + +
Sbjct: 377 TPDLYQ--LAGFLNAEQCYQDCLGNCSCTAFAYIS----GIGCLVWNRELVDTVQF-LSD 429
Query: 412 GQPMA------------REAILV---------ICPSFSSGGASYY----------FMH-- 438
G+ ++ R I++ + F++ + Y F+H
Sbjct: 430 GESLSLRLASSELAGSNRTKIILGTTVSLSIFVILVFAAYKSWRYRTKQNEPNPMFIHSS 489
Query: 439 --ILSMETKTQGKS------LASVSAATNNFGVENKLGEGGFGPVYK------------- 477
+ + + Q S + ++ ATNNF NKLG+GGFGPVYK
Sbjct: 490 QDAWAKDMEPQDVSGVNLFDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKR 549
Query: 478 ----SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTT 533
SGQG +EF NEI+L +KLQH+NLVRLLGCC++ E +LIYEYL NKSLD FLFD+T
Sbjct: 550 LSSSSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDST 609
Query: 534 KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593
+ + W R II+G+A+GLLYLH+ SRLRVIHRDLK SNILLD MIPKISDFGLARM
Sbjct: 610 LKFEIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARM 669
Query: 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS 653
G + Q NT+R+VGT GYM+PEYA G FS KSD++SFGVLLLE + ++ +R F+
Sbjct: 670 SQGTQYQDNTRRVVGTLGYMAPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISR-FSEEG 728
Query: 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPI-VKRYINVALLCVQENAADRPTMSEVIS 712
TLL +AW W + + +L+D L ++S+P V R + + LLCVQ ADRP E++S
Sbjct: 729 KTLLAYAWESWCETKGVDLLDQAL-ADSSHPAEVGRCVQIGLLCVQHQPADRPNTLELMS 787
Query: 713 MLTNEFVNLPSPQQPGFSSLKKSVETVAR---SMNRLTLSVMDAR 754
MLT LPSP+QP F+ + ++ + ++N +T SV+ R
Sbjct: 788 MLTT-ISELPSPKQPTFTVHSRDDDSTSNDLITVNEITQSVIQGR 831
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 518 bits (1334), Expect = e-146, Method: Compositional matrix adjust.
Identities = 301/832 (36%), Positives = 452/832 (54%), Gaps = 104/832 (12%)
Query: 6 VFNIFSSFVFLFSIQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGI 65
+ ++ S F S+ L+ S + D E VSS F GFFSP S RY GI
Sbjct: 10 IVHVLSLSCFFLSVSLAHERALF---SGTLNDSETIVSSFRTFRFGFFSPVNSTNRYAGI 66
Query: 66 WYKQIP-DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAE--NPV 122
WY IP TV+WVAN+++PI + + ++IS +GNLV+ + +WS+N S +A + V
Sbjct: 67 WYNSIPVQTVIWVANKDTPINDSSGVISISEDGNLVVTDGQRRVLWSTNVSTRASANSTV 126
Query: 123 AQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERY-LTSWRS 181
A+LL++GNL+++D A+ + LW+SF YP+D+ L M +G + + G +TSW +
Sbjct: 127 AELLESGNLVLKD-----ANTDAYLWESFKYPTDSWLPNMLVGTNARTGGGNITITSWTN 181
Query: 182 ADDPSPGNITNRLDIHVLPELGLYNGSQK---LSRSGPWNGIFFGAAPS-YASILSEPIL 237
DPSPG+ T L + PEL ++N + + RSGPWNG+ F P Y +
Sbjct: 182 PSDPSPGSYTAALVLAPYPELFIFNNNDNNATVWRSGPWNGLMFNGLPDVYPGLFLYRFK 241
Query: 238 VDNEDEIYYSYESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPTLFCQFYGHCG 297
V+++ + N+ + L ++ G R W E W P C Y CG
Sbjct: 242 VNDDTNGSATMSYANDSTLRHLYLDYRGFAIRRDWSEARRNWTLGSQVPATECDIYSRCG 301
Query: 298 GNRVCSYEKTPNCECLKGFKPKSQ---HNQTRPGSCVRSESADCK------SGDRFIMVD 348
C+ K P+C C+KGF+P++ +N G C+R C+ S DRF+ +
Sbjct: 302 QYTTCNPRKNPHCSCIKGFRPRNLIEWNNGNWSGGCIRKLPLQCERQNNKGSADRFLKLQ 361
Query: 349 DIKLPDLLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDT---- 404
+K+PD S + EC CL++ +C A+A+ G G GC++W L+D+
Sbjct: 362 RMKMPDFARRS---EASEPECFMTCLQSCSCIAFAH----GLGYGCMIWNRSLVDSQVLS 414
Query: 405 ------------TKAKFHNGQP-------------------MAREAILVICPSFSSGGAS 433
++ K + +P +AR ++ A
Sbjct: 415 ASGMDLSIRLAHSEFKTQDRRPILIGTSLAGGIFVVATCVLLARRIVMKKRAKKKGTDAE 474
Query: 434 YYFMHILSMETKTQGK-------SLASVSAATNNFGVENKLGEGGFGPVYK--------- 477
F + ++ ++ K ++ AT+NF + NKLG+GGFGPVYK
Sbjct: 475 QIFKRVEALAGGSREKLKELPLFEFQVLATATDNFSLSNKLGQGGFGPVYKGMLLEGQEI 534
Query: 478 --------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL 529
SGQGLEE E+ + +KLQHRNLV+L GCC+ E +L+YE++P KSLD ++
Sbjct: 535 AVKRLSQASGQGLEELVTEVVVISKLQHRNLVKLFGCCIAGEERMLVYEFMPKKSLDFYI 594
Query: 530 FDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589
FD + LL W R II GI +GLLYLH+ SRLR+IHRDLK SNILLD N+IPKISDFG
Sbjct: 595 FDPREAKLLDWNTRFEIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFG 654
Query: 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFF 649
LAR+F G+E ++NT+R+VGTYGYM+PEYA+ G FS KSDVFS GV+LLE +S +R
Sbjct: 655 LARIFPGNEDEANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRR----- 709
Query: 650 NTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSE 709
N++S TLL H W++W + ++DP++ + +++ +++ALLCVQ+ A DRP++S
Sbjct: 710 NSHS-TLLAHVWSIWNEGEINGMVDPEIFDQLFEKEIRKCVHIALLCVQDAANDRPSVST 768
Query: 710 VISMLTNEFVNLPSPQQPGFSSLKKSVE-------TVARSMNRLTLSVMDAR 754
V ML++E ++P P+QP F +E + S+N +T++ + R
Sbjct: 769 VCMMLSSEVADIPEPKQPAFMPRNVGLEAEFSESIALKASINNVTITDVSGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64783|Y1137_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61370 OS=Arabidopsis thaliana GN=At1g61370 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 513 bits (1322), Expect = e-144, Method: Compositional matrix adjust.
Identities = 318/823 (38%), Positives = 454/823 (55%), Gaps = 95/823 (11%)
Query: 10 FSSFVFLFSIQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQ 69
F+S +FL I S A IT AS + G+ S + +ELGFFSP SR +Y+GIW+K
Sbjct: 9 FASLLFLLIIFPSCAFAAITRASP-LSIGQTLSSPNGTYELGFFSPNNSRNQYVGIWFKN 67
Query: 70 I-PDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDT 128
I P VVWVANR+ P+ A LTI++NG+L+++ +WS + + A+LL+
Sbjct: 68 ITPRVVVWVANRDKPVTNNAANLTINSNGSLILVEREQNVVWSIGETFSSNELRAELLEN 127
Query: 129 GNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPSPG 188
GNL++ D S LW+SF++ DT+L + +D+ N +R L+SW++ DPSPG
Sbjct: 128 GNLVLIDGVSERN-----LWESFEHLGDTMLLESSVMYDVPNNKKRVLSSWKNPTDPSPG 182
Query: 189 NITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAP----SYASILS-EPILVDNEDE 243
L V P+ + GS+ R GPW + F P S+ S +
Sbjct: 183 EFVAELTTQVPPQGFIMRGSRPYWRGGPWARVRFTGIPEMDGSHVSKFDISQDVAAGTGS 242
Query: 244 IYYSYESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPTLFCQFYGHCGGNRVCS 303
+ YS E N+ + + T+ +G++ ++IW+ S GW AP C Y CG +C
Sbjct: 243 LTYSLERRNSNL-SYTTLTSAGSL-KIIWNNGS-GWVTDLEAPVSSCDVYNTCGPFGLCI 299
Query: 304 YEKTPNCECLKGFKPKSQHNQTR---PGSCVR----------SESADCKSGDRFIMVDDI 350
P CECLKGF PKS + G C+R S +A +GD F +V ++
Sbjct: 300 RSNPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNGDIFDIVANV 359
Query: 351 KLPDLLN-VSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLID------ 403
K PD +SL +N ++C+ CL N +C A++ E G CL+W +L+D
Sbjct: 360 KPPDFYEYLSL---INEEDCQQRCLGNCSCTAFSYIEQIG----CLVWNRELVDVMQFVA 412
Query: 404 ---TTKAKFHNGQPMAREAILVICPSFSSGG-------ASYYFMHI---------LSMET 444
T + + + + +I S S ASY++ + +ET
Sbjct: 413 GGETLSIRLASSELAGSNRVKIIVASIVSISVFMILVFASYWYWRYKAKQNDSNPIPLET 472
Query: 445 -----KTQGK-------SLASVSAATNNFGVENKLGEGGFGPVYK--------------- 477
+ Q K + ++ TNNF +ENKLG+GGFGPVYK
Sbjct: 473 SQDAWREQLKPQDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQDGKEIAIKRLS 532
Query: 478 --SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKE 535
SGQGLEEF NEI L +KLQHRNLVRLLGCC+E E +LIYE++ NKSL++F+FD+TK+
Sbjct: 533 STSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKK 592
Query: 536 GLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595
L W R II+GIA GLLYLH+ S LRV+HRD+K SNILLD M PKISDFGLARMF
Sbjct: 593 LELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQ 652
Query: 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRF-FNTNSL 654
G + Q+NT+R+VGT GYMSPEYA G FS KSD+++FGVLLLE ++ KR + F
Sbjct: 653 GTQHQANTRRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIITGKRISSFTIGEEGK 712
Query: 655 TLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714
TLL AW+ W + +L+D + S V R + + LLC+Q+ A DRP +++V+SML
Sbjct: 713 TLLEFAWDSWCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQQQAGDRPNIAQVMSML 772
Query: 715 TNEFVNLPSPQQPGFSSLKKSVETVARSM---NRLTLSVMDAR 754
T ++LP P+QP F+ + ++ +++M N +T + + R
Sbjct: 773 TTT-MDLPKPKQPVFAMQVQESDSESKTMYSVNNITQTAIVGR 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 754 | ||||||
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.996 | 0.936 | 0.503 | 0.0 | |
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.964 | 0.672 | 0.482 | 0.0 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.954 | 0.917 | 0.467 | 0.0 | |
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.974 | 0.935 | 0.475 | 0.0 | |
| 359493730 | 770 | PREDICTED: G-type lectin S-receptor-like | 0.972 | 0.951 | 0.467 | 0.0 | |
| 147856585 | 741 | hypothetical protein VITISV_033399 [Viti | 0.935 | 0.951 | 0.480 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.973 | 0.883 | 0.461 | 0.0 | |
| 255555123 | 825 | S-locus-specific glycoprotein S6 precurs | 0.992 | 0.906 | 0.442 | 0.0 | |
| 224115102 | 784 | predicted protein [Populus trichocarpa] | 0.929 | 0.894 | 0.468 | 0.0 | |
| 356514907 | 778 | PREDICTED: G-type lectin S-receptor-like | 0.954 | 0.925 | 0.459 | 0.0 |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1914), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/805 (50%), Positives = 530/805 (65%), Gaps = 54/805 (6%)
Query: 1 MEKLTVFNIFSSFVFLFSIQ-LSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSR 59
ME L F IF S +F+ S+ LS +AD ITP ++DG+ +S S+ FELGFFSP S+
Sbjct: 1 MESLPFF-IFFSTLFIQSLHFLSFSADIITPDLP-VKDGQTLISVSQSFELGFFSPGTSK 58
Query: 60 YRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAE 119
YRY+GIWYK+ P+TVVWVANRN+P+ + LTI N GNLV+L+ IWSSN+S
Sbjct: 59 YRYVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIA 118
Query: 120 NPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSW 179
PVAQLLD+GNL+VRDN S +E S WQSFD PSDTLL GMKLGW+LK G ERYL +W
Sbjct: 119 GPVAQLLDSGNLVVRDNGSSRNTE-SYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITW 177
Query: 180 RSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSYASILSEPILVD 239
RS DPSPG+ T RLDIH LP+L + GS K RSGPWNGIFFG P + + EPILV
Sbjct: 178 RSISDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVR 237
Query: 240 NEDEIYYSYESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPTLFCQFYGHCGGN 299
NEDEIYY+Y NN + + LT+N SG V+RL+ + +++GW ++ P C+ YG CG N
Sbjct: 238 NEDEIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGAN 297
Query: 300 RVCSYEKTPNCECLKGFK--PKSQHN-QTRPGS--CVRSESADCKSGDRFIMVDDIKLPD 354
+C +P CECLKGFK P+ + + Q GS C + DC+SG+ F+ + +KLPD
Sbjct: 298 GICRTRTSPICECLKGFKSIPEEELDIQNFYGSRKCETRLTLDCQSGEGFLKLPGVKLPD 357
Query: 355 LLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTG--RGSGCLMWYGDLID-------TT 405
LL LN+SMNLKECEAEC KN +C A+A + ++G GSGCLMW+G+LID T
Sbjct: 358 LLEFRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTI 417
Query: 406 KAKFHNGQP-----MAREAIL--VICPSFSSGGASYYFMHILSMETKTQGKS-----LAS 453
H P MAR + ++ + + ++ + + M+ + +G L +
Sbjct: 418 GQDIHIRVPASELEMARSSKRKKMLKTALVASMSALLGIFVSGMDRRKEGMEAPLFDLDT 477
Query: 454 VSAATNNFGVENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQ 496
++ ATNNF ++ +G GGFG VYK SGQG+EEF+NE+ L AKLQ
Sbjct: 478 IATATNNFAPDSIIGAGGFGSVYKGKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQ 537
Query: 497 HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLY 556
HRNLV LLG C+ + E +LIYEY+PNKSLD F+FD + LLGW R II GIA+GLLY
Sbjct: 538 HRNLVGLLGSCIHREERMLIYEYMPNKSLDYFIFDHERSALLGWKERFVIILGIARGLLY 597
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
LHQ S+L+++HRDLKPSN+LLDSN+IPKISDFGLAR+ G D ++ T+R++GTYGYM+PE
Sbjct: 598 LHQDSKLQIVHRDLKPSNVLLDSNLIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPE 657
Query: 617 YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN-SLTLLGHAWNLWKDDRSWELMDP 675
YAI G FS+KSDVFS GVLLLE +S K++ F + + LLGHAW +W + R+ EL+D
Sbjct: 658 YAIDGKFSVKSDVFSLGVLLLEIISGKKNRGFVHPDHHHHLLGHAWLMWNEGRASELIDT 717
Query: 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKKS 735
L+ + + R I V LLCVQ+ DRP MS V+ ML NE LP P+QPGF + S
Sbjct: 718 GLEDTSGKSQLLRCIQVGLLCVQKLPEDRPVMSTVVFMLANEGAVLPQPKQPGFFIERGS 777
Query: 736 V-ETVAR-----SMNRLTLSVMDAR 754
V E +R S N +++++AR
Sbjct: 778 VSEATSRNEDSYSTNEANITILEAR 802
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1809), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/793 (48%), Positives = 494/793 (62%), Gaps = 66/793 (8%)
Query: 23 KAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNS 82
+ AD+I S I D E VSS + FELGFFSP S+ RYLGIWYK P T VWVANRN+
Sbjct: 294 QRADSIRMDQS-ISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNN 352
Query: 83 PIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSAS 142
PI + LTI NNG LV+LN + IWS N SR ENPVAQLL+TGNL++RD + ++
Sbjct: 353 PIADSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDGSNETSK 412
Query: 143 EGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPSPGNITNRLDIHVLPEL 202
S +WQSFD PSDT+L GMK+GW+LK G++R LTSW+S+DDPS G+ + DI+VLP L
Sbjct: 413 --SYIWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYL 470
Query: 203 GLYNGSQKLSRSGPWNGIFFGAAPSYASILSEPILVDNEDEIYYSYESYNNPIIAILTVN 262
L GS K+ RSGPWNG+ F + + + + V N DE+Y YES NN II+ LT+N
Sbjct: 471 VLGVGSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLN 530
Query: 263 PSGTVQRLIWHERSNGWAAVHLAPTLFCQFYGHCGGNRVCSYEKTPNCECLKGFKPKSQH 322
SG +QRL+ + S+ W ++ P+ C+ YGHCG N +C K CECL GF PKSQ
Sbjct: 531 HSGFLQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQE 590
Query: 323 N----QTRPGSCVRSESADCKSGDRFIMVDDIKLPDLLNVSLNKSMNLKECEAECLKNRT 378
T G C R DC+ + F+ V +KLPDL++ + ++L+EC+ CL N +
Sbjct: 591 EWDMFNTSSG-CTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCS 649
Query: 379 CRAYANSEVTGRGSGCLMWYGDLID------------------TTKAKFHNGQPMAREAI 420
C AYA + G G GCLMW GDLID T++ + Q + I
Sbjct: 650 CTAYAYTNPNGSG-GCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVI 708
Query: 421 LVICPSFS---SGGASYYFM--HILSMETKTQGK---------SLASVSAATNNFGVENK 466
+++ +FS + G S++F +M T + K L +++ ATNNF NK
Sbjct: 709 ILVISTFSGILTLGLSFWFRFWKKRTMGTDQESKKENLELPLFDLPTIATATNNFSNTNK 768
Query: 467 LGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509
+G GGFG VYK S QG++EFKNE L AKLQH+NLVRLLGCC++
Sbjct: 769 IGAGGFGSVYKGNLPEGVAVAVKRLSKNSAQGVQEFKNEAVLIAKLQHKNLVRLLGCCIQ 828
Query: 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRD 569
E +L+YEY+PNKSLD F+FD + LL W R I+ GIA+GLLYLHQ SR ++IHRD
Sbjct: 829 GEERILLYEYMPNKSLDYFIFDQNRRALLAWDKRCEIVMGIARGLLYLHQDSRFQIIHRD 888
Query: 570 LKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDV 629
LK SNILLD N+ PKISDFGLAR+FG +E+++ TKRIVGTYGYMSPEY I G FSIK DV
Sbjct: 889 LKTSNILLDDNLNPKISDFGLARIFGENEMETRTKRIVGTYGYMSPEYVIDGHFSIKLDV 948
Query: 630 FSFGVLLLETLSSKRSTRFFNTN-SLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKR 688
FSFGVLLLE +S +++ F + + LLGHAW LW+ +R+ ELMD L+ V R
Sbjct: 949 FSFGVLLLEIVSGEKNRGFSHPDHHHNLLGHAWLLWEQNRALELMDACLEDSCVASQVLR 1008
Query: 689 YINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKKSVETVA-------R 741
I V LLCVQ ADRP MS VI ML NE LP P+ PGF + + SV+T
Sbjct: 1009 CIQVGLLCVQNLPADRPAMSSVIFMLGNEGATLPQPKHPGFFTERSSVDTDTMSGKIELH 1068
Query: 742 SMNRLTLSVMDAR 754
S N +T+S++ R
Sbjct: 1069 SENAVTISMLKGR 1081
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 677 bits (1747), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/802 (46%), Positives = 496/802 (61%), Gaps = 82/802 (10%)
Query: 4 LTVFNIFSSFVFLFSIQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYL 63
LT+FN +SF+ +F ++ S A DTI P+ S + DG+ VS FELGFFSP S+ RYL
Sbjct: 15 LTLFN--TSFL-IFQLKFSTALDTIAPSQS-LSDGKTLVSREGSFELGFFSPGISKNRYL 70
Query: 64 GIWYKQIP-DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPV 122
GIWYK IP TV+WVANR +PI + + LTI N NL++++ N +WSSN++ A++P+
Sbjct: 71 GIWYKNIPLRTVLWVANRRNPIEDSSGLLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPI 130
Query: 123 A-QLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRS 181
QLLD+GNL++RD S S G LWQSFD+PSDTL+ GMKLGWDL+ G+ER L+SWRS
Sbjct: 131 VLQLLDSGNLVLRDEKSDS---GRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRS 187
Query: 182 ADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSYASILSEPIL---- 237
+DDPSPG++T + + PE ++ GSQ+ RSGPW GI F AP ++ P+
Sbjct: 188 SDDPSPGDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPE---LVQNPVFKLNF 244
Query: 238 VDNEDEIYYSYESYNNPIIAILTVNPSGTVQR-LIWHERSNGWAAVHLAPTLFCQFYGHC 296
V +EDE+Y SY N + + VN + + W+E + W P C Y C
Sbjct: 245 VSSEDEVYLSYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASC 304
Query: 297 GGNRVCSYEKTPNCECLKGFKPKSQHN---QTRPGSCVRSESADCKSGDRFIMVDDIKLP 353
G N C P C CLK FKPKS CVR++ +C+ GD F+ +K P
Sbjct: 305 GANGNCIINDLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWP 364
Query: 354 DLLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDTTKAKFHNGQ 413
D + LNKSMNL EC A+CL+N +C AY+NS+V G GSGC++WYG LID +
Sbjct: 365 DATHSWLNKSMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGGLIDIRQ------- 417
Query: 414 PMAREAILVICPSFSSGGASYYF-MHILSMETKTQGKSL---------------ASVSAA 457
F +GG Y M+ E Q + A + A
Sbjct: 418 -------------FPAGGQELYIRMNPSESEMDQQNDQITDGENEDLELPQFEFAKIVNA 464
Query: 458 TNNFGVENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNL 500
TNNF +ENKLG+GGFGPVYK SGQG +EFKNE+ L KLQHRNL
Sbjct: 465 TNNFSIENKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSGQGSKEFKNEVILINKLQHRNL 524
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
V+LLGC +++ E +L+YEY+PNKSLDSFLFD TK LL W R II GIA+GLLYLHQ
Sbjct: 525 VKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNIICGIARGLLYLHQD 584
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH 620
SRLR+IHRDLK SN+LLD +M PKISDFGLAR FGGD+ + NT R+VGTYGYM+PEYA
Sbjct: 585 SRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVVGTYGYMAPEYATD 644
Query: 621 GFFSIKSDVFSFGVLLLETLSSKRSTRFFN-TNSLTLLGHAWNLWKDDRSWELMDPKLQC 679
G FS+KSDVFSFG++LLE ++ K+S F++ NSL+L+G+AW LWK+ + EL+D +
Sbjct: 645 GLFSVKSDVFSFGIMLLEIVTGKKSRGFYHPDNSLSLIGYAWRLWKEGKPLELVDGLAEE 704
Query: 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKKSVET- 738
+ V + I+++LLCVQ+ DRP+M+ V+ ML E LP P++PGF + VE
Sbjct: 705 SWNLSEVMKCIHISLLCVQQYPEDRPSMASVVLMLGGERT-LPKPKEPGFFKDRGPVEAY 763
Query: 739 ------VARSMNRLTLSVMDAR 754
+ S N ++ SV++ R
Sbjct: 764 SSSSKVESSSTNEISTSVLEPR 785
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 677 bits (1747), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/788 (47%), Positives = 500/788 (63%), Gaps = 53/788 (6%)
Query: 4 LTVFNIFSSFVFLFSIQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYL 63
LT+FNI SF+ +F ++ S A DTI P+ S I DG+ VS FELGFFSP S+ RYL
Sbjct: 15 LTLFNI--SFL-IFQLKFSTALDTIAPSQSLI-DGKTLVSREGSFELGFFSPGISKNRYL 70
Query: 64 GIWYKQIP-DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPV 122
GIWYK IP TV+WVANR +PI + + LTI N NL++++ N +WSSN++ A++P+
Sbjct: 71 GIWYKNIPVRTVLWVANRRNPIEDSSGFLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPI 130
Query: 123 A-QLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRS 181
QLLD+GNL++RD S S G LWQSFD+PSDTL+ GMKLGWDL+ G+ER L+SWRS
Sbjct: 131 VLQLLDSGNLVLRDEKSDS---GRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRS 187
Query: 182 ADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSYASILSEPI----L 237
+DDPSPG++T + + PE ++ GSQ+ RSGPW GI F AP ++ P+
Sbjct: 188 SDDPSPGDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAP---ELVQNPVFKLNF 244
Query: 238 VDNEDEIYYSYESYNNPIIAILTVNPSGTVQR-LIWHERSNGWAAVHLAPTLFCQFYGHC 296
V +EDE+Y SY N + + VN + + W+E + W P C Y C
Sbjct: 245 VSSEDEVYLSYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASC 304
Query: 297 GGNRVCSYEKTPNCECLKGFKPKSQHN---QTRPGSCVRSESADCKSGDRFIMVDDIKLP 353
G N C P C CLK FKPKS CVR++ +C+ GD F+ +K P
Sbjct: 305 GANGNCIINDLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWP 364
Query: 354 DLLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDTTKAKFHNGQ 413
D + LNKSMNL EC A+CL+N +C AY+NS+V G GSGC++WYGDLID +F G
Sbjct: 365 DATHSWLNKSMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGDLIDIR--QFPAG- 421
Query: 414 PMAREAILVICPSFSS--GGASYYFMHILSMETKTQGKSLASVSAATNNFGVENKLGEGG 471
+E + + PS S+ + + + + A + ATNNF ++NKLG+GG
Sbjct: 422 --GQELYIRMNPSESAEMDQQNDQITDGENEDLELPQFEFAKIVNATNNFSIKNKLGQGG 479
Query: 472 FGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514
FGPVYK S QG +EFKNE+ L KLQHRNLV+LLGC +++ E +
Sbjct: 480 FGPVYKGTLEDGQEIAVKRLSMSSRQGSKEFKNEVILINKLQHRNLVKLLGCSIQREERL 539
Query: 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSN 574
L+YEY+PNKSLDSFLFD TK LL W R II GIA+GLLYLHQ SRLR+IHRDLK SN
Sbjct: 540 LVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNIICGIARGLLYLHQDSRLRIIHRDLKSSN 599
Query: 575 ILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGV 634
+LLD +M PKISDFGLAR FGGD+ + NT R+VGTYGYM+PEYA G FS+KSDVFSFG+
Sbjct: 600 VLLDKDMNPKISDFGLARTFGGDQTEGNTSRVVGTYGYMAPEYATDGLFSVKSDVFSFGI 659
Query: 635 LLLETLSSKRSTRFFN-TNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVA 693
+LLE ++ K+S F++ NSL+L+G+AW LWK+ + EL+D + + V + I+++
Sbjct: 660 MLLEIVTGKKSRGFYHPDNSLSLIGYAWRLWKEGKPLELVDGLAEESWNLSEVMKCIHIS 719
Query: 694 LLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKKSVET-------VARSMNRL 746
LLCVQ+ DRP+M+ V+ ML E LP P++PGF + VE + S N +
Sbjct: 720 LLCVQQYPEDRPSMASVVLMLGGERT-LPKPKEPGFFKDRGPVEAYSSSSKVESSSTNEI 778
Query: 747 TLSVMDAR 754
+ SV++ R
Sbjct: 779 STSVLEPR 786
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493730|ref|XP_003634656.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 675 bits (1741), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/785 (46%), Positives = 484/785 (61%), Gaps = 52/785 (6%)
Query: 7 FNIFSSFVFLFS-----IQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYR 61
+ ++ VF+FS +++S A DTI + IRDGE S+ F+LGFFSP S+ R
Sbjct: 1 MDALATVVFIFSYVFSLLRISTAVDTIN-VNQHIRDGETITSAGGTFQLGFFSPGDSKNR 59
Query: 62 YLGIWYKQI-PDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAEN 120
YLGIWYK++ P TVVWVANR SP+ + + L ++ G LV+++ TNG +W+SN+SR A++
Sbjct: 60 YLGIWYKKVAPQTVVWVANRESPLTDSSGVLKVTQQGTLVVVSGTNGILWNSNSSRSAQD 119
Query: 121 PVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWR 180
P AQLL++GNL++R+ + + LWQSFDYP DTLL GMK GW+ G++RYL+SW+
Sbjct: 120 PNAQLLESGNLVMRN--GNDSDPENFLWQSFDYPCDTLLPGMKFGWNRVTGLDRYLSSWK 177
Query: 181 SADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSYAS-ILSEPILVD 239
SADDPS GN T +D+ P+ L NG R+GPWNG+ FG P + L V
Sbjct: 178 SADDPSKGNFTYGIDLSGFPQPFLRNGLTVKFRAGPWNGVRFGGIPQLTNNSLFTFDYVS 237
Query: 240 NEDEIYYSYESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPTLFCQFYGHCGGN 299
NE EIY+ Y N+ + + P G +R W ++ N W A C Y CG
Sbjct: 238 NEKEIYFIYYLVNSSVFVRRVLTPDGYSRRFTWTDKKNEWTLYSTAQRDDCDNYAICGVY 297
Query: 300 RVCSYEKTPNCECLKGFKPKSQHNQTRPG---SCVRSESADCKSGDRFIMVDDIKLPDLL 356
+C +++P CEC+KGF+PK Q N CVRS DC+ GD F+ +KLPD
Sbjct: 298 GICKIDESPKCECMKGFRPKFQSNWDMADWSKGCVRSTPLDCQKGDGFVKYSGVKLPDTR 357
Query: 357 NVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDTTKAKFHNGQPM- 415
N ++SMNLKEC + CL+N +C AYANS++ G GSGCL+W+ DLID NGQ
Sbjct: 358 NSWFDESMNLKECASLCLRNCSCTAYANSDIRGGGSGCLLWFDDLIDIRDFT-QNGQEFY 416
Query: 416 AREAILVICPSFSSGGASYYFMHILSMETKTQGK--------SLASVSAATNNFGVENKL 467
AR A S Y H +G+ +LA++ ATNNF ENKL
Sbjct: 417 ARMA----------ASESGYMDHKSKEGENNEGQEHLDLPLFNLATLLNATNNFSEENKL 466
Query: 468 GEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ 510
GEGGFGPVYK S QGL+EFKNE++ KLQHRNLV+LLGCC+
Sbjct: 467 GEGGFGPVYKGILQEGQEIAVKMMSKTSRQGLKEFKNEVESITKLQHRNLVKLLGCCIHG 526
Query: 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDL 570
E +LIYEY+PNKSLD ++FD + +L W R II GIA+GLLYLHQ SRLR+IHRDL
Sbjct: 527 RERLLIYEYMPNKSLDLYIFDHMRSRVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDL 586
Query: 571 KPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVF 630
K NILLD+ M PKISDFG+AR FGG+E ++NT R+VGT GYMSPEYA G +S KSDVF
Sbjct: 587 KAENILLDNEMTPKISDFGIARSFGGNETEANTTRVVGTLGYMSPEYASEGLYSTKSDVF 646
Query: 631 SFGVLLLETLSSKRSTRFFNTN-SLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRY 689
SFGVLLLE +S KR+ RF + + L LLGHAW L+ + S E +D + + V R
Sbjct: 647 SFGVLLLEIVSGKRNRRFSHPDHDLNLLGHAWTLYIEGGSLEFIDTSIVNTCNLIEVLRS 706
Query: 690 INVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKKSVETVARSMNRLTLS 749
INV LLCVQ DRP+M VI ML +E P P++P F + + +E + S + T++
Sbjct: 707 INVGLLCVQRFPDDRPSMHSVILMLGSEGAP-PRPKEPCFFTDRNMMEANSSSGIQPTIT 765
Query: 750 VMDAR 754
+++AR
Sbjct: 766 LLEAR 770
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147856585|emb|CAN80325.1| hypothetical protein VITISV_033399 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/783 (48%), Positives = 474/783 (60%), Gaps = 78/783 (9%)
Query: 1 MEKLTVFNIFSSFVFL-FSIQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSR 59
ME F F +++ L ++ AAD+I S I +GE VSS + FELGFFSP S
Sbjct: 1 METHLFFAFFCAWICLSVPLEFCIAADSIRMHQS-ISNGETLVSSGQSFELGFFSPGNSN 59
Query: 60 YRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAE 119
YLGIWYK P TVVWVANRN+PI + LTI NNG LV+LN T IWS N SR E
Sbjct: 60 NWYLGIWYKNTPQTVVWVANRNNPITDSYRVLTIINNG-LVLLNRTKSVIWSPNLSRVPE 118
Query: 120 NPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSW 179
NPVAQLL+TGNL++RDN + S+ S +WQSFD+PSDTLL GMK+G +LK GV+R LTSW
Sbjct: 119 NPVAQLLETGNLVLRDNSNESSK--SYIWQSFDHPSDTLLPGMKMGRNLKTGVQRNLTSW 176
Query: 180 RSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSYASILSEPILVD 239
RSADDPS G+ + R+DI VLP L GS K RSGPWNGI F P+ + + + + V
Sbjct: 177 RSADDPSLGDFSLRIDISVLPYFVLGTGSSKKVRSGPWNGIEFNGLPALKNEVFKSVFVY 236
Query: 240 NEDEIYYSYESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPTLFCQFYGHCGGN 299
EDE+Y YES+NN + LT+N SG VQRL+ + S+ W ++ P C+ YG CG N
Sbjct: 237 KEDEVYAFYESHNNAVFTKLTLNHSGFVQRLLLKKGSSEWDELYSIPNELCENYGRCGAN 296
Query: 300 RVCSYEKTPNCECLKGFKPKSQHNQ---TRPGSCVRSESADCKSGDRFIMVDDIKLPDLL 356
+C K CECL GF P S+ G C R C+S + F+ V +KLPDL+
Sbjct: 297 SICRMGKLQICECLTGFTPXSEEEWNMFNTSGGCTRRMPLXCQSEEGFVKVTGVKLPDLI 356
Query: 357 NVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDTTKAKFHNGQPMA 416
+ + S++L EC+A CL N +C AYA S + G SGCLMW G+LID
Sbjct: 357 DFHVIMSVSLGECKALCLNNCSCTAYAYSNLNG-SSGCLMWSGNLIDI------------ 403
Query: 417 REAILVICPSFSSGGASYYFMHILSMETKTQGKSLASVSAATNNFGVENKLGEGGFGPVY 476
RE LS ET + + ++ GGFGPVY
Sbjct: 404 RE---------------------LSTETNKEDIYIRGHTSEP-----------GGFGPVY 431
Query: 477 K-----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519
K S QG++EF NE+ L AKLQH+NLVRLLGCCV+ E +L+YE
Sbjct: 432 KGNLXEGVAVAVKRLSKNSAQGVQEFNNEVVLMAKLQHKNLVRLLGCCVQGEERILLYEX 491
Query: 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS 579
+PNKSLD F+FD + LL W R I+ GIA+GLLYLHQ SR ++IHRDLK SNILLD
Sbjct: 492 MPNKSLDYFIFDQNRXALLAWDKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDD 551
Query: 580 NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLET 639
N+ PKISDFGLAR+FG +E+++ TKRI+GT+GYMSPEY I G FS KSDVFSFGVLLLE
Sbjct: 552 NLNPKISDFGLARIFGENEMETRTKRIIGTHGYMSPEYVIDGXFSXKSDVFSFGVLLLEI 611
Query: 640 LSSKRSTRFFNT-NSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQ 698
+S K++ F + + LLGHAW LW+ +++ ELMD L+ V R I V LLCV+
Sbjct: 612 VSGKKNRGFSHPYHHHNLLGHAWLLWEQNKALELMDACLEDSCVASQVLRCIQVGLLCVK 671
Query: 699 ENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKKSVETVA-------RSMNRLTLSVM 751
ADRP MS VI ML NE LP P+ GF + + SV+T S N +T+S +
Sbjct: 672 NLPADRPAMSSVIFMLGNEGATLPQPKHXGFFTERCSVDTDTMSGKIELHSENEVTISKL 731
Query: 752 DAR 754
R
Sbjct: 732 KGR 734
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/823 (46%), Positives = 486/823 (59%), Gaps = 89/823 (10%)
Query: 12 SFVFLFSIQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIP 71
S VF SI S A ++I S + DG+ VSS FELGFFSP SR RY+GIWYK+I
Sbjct: 18 SIVFFLSIP-STAIESINATQS-LEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKIS 75
Query: 72 D-TVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGN 130
TVVWVANRN+P+ + + L ++GNL +N TNG IWSSN SR A NPVAQLLDTGN
Sbjct: 76 SFTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTGN 135
Query: 131 LIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPSPGNI 190
L+VR + LWQSFDYP D+ L GMK G G+ RYLTSW+S DPS G
Sbjct: 136 LVVRAENDNDPE--NFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKY 193
Query: 191 TNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSYASILSEPI----LVDNEDEIYY 246
TN+LD + LP+ L GS RSGPWNG+ F ++ PI V N++EIYY
Sbjct: 194 TNKLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGM---INLKPNPIYTFEFVFNQEEIYY 250
Query: 247 SYESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPTLFCQFYGHCGGNRVCSYEK 306
Y+ N+ +++ + ++P G +QR W +R+ W A C + CG + VC+
Sbjct: 251 KYQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINN 310
Query: 307 TPNCECLKGFKPKSQHNQTRPG---SCVRSESADCKSGDRFIMVDDIKLPDLLNVSLNKS 363
+P C+CLK F+PKS T CVR DC +G+ FI IK+PD NK+
Sbjct: 311 SPACDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKT 370
Query: 364 MNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDTTKAKFHNGQPM-AREAILV 422
+NL+ECE CLKN +C AYAN +V GSGC++W+GDLID + NGQ + R A V
Sbjct: 371 INLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQYN-ENGQDIYIRIAASV 429
Query: 423 ICPSFSSGG-------------------ASYYFMHILSMETKTQGK-------------- 449
I S G A F+ L + Q
Sbjct: 430 IDKPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNPEQDRT 489
Query: 450 -------------SLASVSAATNNFGVENKLGEGGFGPVYK-----------------SG 479
LA+++ ATN F + NKLG+GGFGPVYK S
Sbjct: 490 KESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGILQDGQEIAVKRLSKRSR 549
Query: 480 QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLG 539
QG+ EF+NE+ AKLQHRNLV+LLGCC+E E +LIYEY+PNKSLDSF+FD + LL
Sbjct: 550 QGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKSLDSFIFDKRRNMLLD 609
Query: 540 WGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599
W R II GIA+GLLYLHQ SRLR+IHRDLK SNILLD M PKISDFG+AR FGGDE
Sbjct: 610 WTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPKISDFGMARSFGGDET 669
Query: 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNT-NSLTLLG 658
+NT RIVGTYGYMSPEYAI G FS+KSDVFSFGVL+LE +S +++ F + + L LLG
Sbjct: 670 SANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGRKNRGFRHAEHKLNLLG 729
Query: 659 HAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718
HAW L K+ R +L+D + V R I VALLCVQ++ DRP MS V+ ML+++
Sbjct: 730 HAWMLHKEGRPLDLIDESIVDTCIISEVLRSIEVALLCVQKSPEDRPKMSIVVLMLSSDI 789
Query: 719 VNLPSPQQPGFSSLKK-------SVETVARSMNRLTLSVMDAR 754
V LP P++PGF + + +++ S+N LT ++++AR
Sbjct: 790 V-LPQPKEPGFFTERDLSNDSSSTIKHEISSVNELTSTLLEAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555123|ref|XP_002518599.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223542444|gb|EEF43986.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 661 bits (1706), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/831 (44%), Positives = 497/831 (59%), Gaps = 83/831 (9%)
Query: 1 MEKLTV-----FNIFSSFVFLFSIQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSP 55
MEKL + + + FSI S ADTI S + D + VS +FELGFF+P
Sbjct: 1 MEKLKANTSLYLAVCCTLILFFSIN-SFGADTIGAGQS-LNDSQTLVSPGRKFELGFFNP 58
Query: 56 RKSRYRYLGIWYKQIP-DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNT 114
S RYLGIWY+ IP TVVWVANR++ +I LT ++G +++LN T +WSS++
Sbjct: 59 ANSNVRYLGIWYRNIPVRTVVWVANRDNLLINSTGLLTFDDDGMIILLNQTGSIMWSSDS 118
Query: 115 SRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVER 174
A PVAQLLDTGN I++D + S +C+WQSFDYPSDTLL GMKLGW+ K G+ R
Sbjct: 119 LYAARAPVAQLLDTGNFILKD--TADGSSRNCIWQSFDYPSDTLLPGMKLGWNRKTGLNR 176
Query: 175 YLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSY-ASILS 233
YLTSW+S DPS GN T LD LP+L L GS + R+GPW G F P+ A+ +
Sbjct: 177 YLTSWKSPTDPSSGNCTYALDPGGLPQLVLRKGSTRQFRTGPWYGTQFSGLPALLANPVF 236
Query: 234 EPILVDNEDEIYYSYESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPTLFCQFY 293
+P V N+DE YYS+ + N II+ ++ SG Q W++R + W + C Y
Sbjct: 237 QPKFVSNDDEEYYSFITTGN-IISRFVLSQSGFAQHFSWNDRRSSWNLMFTVQRDRCDNY 295
Query: 294 GHCGGNRVCSYEK-TPNCECLKGFKPKSQHNQTR---PGSCVRSESADCKSGDRFIMVDD 349
G CG +C+ T CEC+KGFKP+S+++ G C + C++G+ F+
Sbjct: 296 GLCGAYGICNISNSTTVCECMKGFKPRSRNDWEMLDWSGGCTPKDMHVCRNGEGFVKFTG 355
Query: 350 IKLPDLLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDTTKAKF 409
+K+PD +N S ++K+C+ +CLKN +C AYA ++ G GSGC++W G+LIDT +
Sbjct: 356 MKMPDASEFLVNVSESVKDCKTKCLKNCSCMAYAKLDINGTGSGCVIWTGELIDTREVGE 415
Query: 410 HNGQPM----------------AREAILVICPSFSSGGASYYFMHILS------------ 441
+ GQ + A++ + I + S+ A I S
Sbjct: 416 Y-GQDIYVRVAATELESNAVMDAKQKNIAITAAISAFSAVIIIALISSFMIWMKRSRMAD 474
Query: 442 ------METKTQGK---------SLASVSAATNNFGVENKLGEGGFGPVYK--------- 477
++++ +G+ AS+ ATNNF + NK+GEGGFGPVYK
Sbjct: 475 QTDNEVIDSRVEGQRDDLELPLYEFASIQVATNNFALANKIGEGGFGPVYKGELQCGQEV 534
Query: 478 --------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL 529
SGQGL EFKNE+ L +KLQHRNLV+LLGCC++ E +LIYEY+ N+SLDS +
Sbjct: 535 AVKRLGQNSGQGLREFKNEVILISKLQHRNLVKLLGCCIQGEERMLIYEYMLNRSLDSLI 594
Query: 530 FDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589
FD T +L W R+ II GIA+GLLYLH+ SRLR+IHRDLK SN+LLD+ + PKISDFG
Sbjct: 595 FDETTRPMLNWQKRLDIIIGIARGLLYLHRDSRLRIIHRDLKASNVLLDNQLNPKISDFG 654
Query: 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFF 649
+ARMFGGD+ + NTKRIVGTYGYM PEYAI G FSIKSD FSFGV+LLE +S KR+ FF
Sbjct: 655 MARMFGGDQTEGNTKRIVGTYGYMPPEYAIDGNFSIKSDAFSFGVILLEIVSGKRNRGFF 714
Query: 650 N-TNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMS 708
+ L LLGHAW LW + ++ EL+D L+ E V R I V LLCVQ +RPTM+
Sbjct: 715 RPEHKLNLLGHAWKLWSEAKALELVDELLENEFPVSEVLRCIQVGLLCVQHRPEERPTMA 774
Query: 709 EVISMLTNEFVNLPSPQQPGFSSLKKSVETVARSM-----NRLTLSVMDAR 754
V+ ML E LP P PGF + + ET + S+ N +T+++++ R
Sbjct: 775 TVLLMLDTESTFLPQPGHPGFYAERCLSETDSSSIGNLISNEMTVTLLEGR 825
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 658 bits (1697), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/753 (46%), Positives = 472/753 (62%), Gaps = 52/753 (6%)
Query: 13 FVFLF---SIQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQ 69
FV+ F +I++S A D I+P FI DG+ VS+ + FELGFFSP S RYLGIWYK+
Sbjct: 16 FVYSFLLSTIRVSNAPDIISPGQ-FIGDGDTIVSAGQNFELGFFSPGSSTRRYLGIWYKK 74
Query: 70 IPD-TVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDT 128
TVVWVANR +PI + + L +N G L++LN T +WSSN + NPVAQLL++
Sbjct: 75 FSTGTVVWVANRENPIFDHSGVLYFTNQGTLLLLNGTKDVVWSSNRTTPKNNPVAQLLES 134
Query: 129 GNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPSPG 188
GNL+V+D ++ S LWQSFDYP DT L MKLG +L G++ ++SW+S DDP+ G
Sbjct: 135 GNLVVKD--GNDSNPESFLWQSFDYPGDTNLPDMKLGRNLVTGLDWSISSWKSLDDPARG 192
Query: 189 NITNRLDIHVLPELGLYNGSQKLSRSGPWNGI-FFGAAPSYASILSEPILVDNEDEIYYS 247
+ +D +L G R+G WNGI F GA + + V N+ E+Y++
Sbjct: 193 EYSLGIDPRGYQQLVYKKGRAIQFRAGSWNGIRFTGATRLRPNPVYRYEFVLNDKEVYFN 252
Query: 248 YESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPTLFCQFYGHCGGNRVCSYEKT 307
+E N+ + + VN SG V+RL W + + W C Y CG N C+ +K+
Sbjct: 253 FELLNSSVASRFVVNASGVVERLTWISQMHRWTRYFAVGEDQCDAYSFCGSNAKCNIDKS 312
Query: 308 PNCECLKGFKPKSQHN---QTRPGSCVRSESADCKSGDRFIMVDDIKLPDLLNVSLNKSM 364
P C CL GF+PKS + Q G CVR + C G+ F+ +KLPD + N S+
Sbjct: 313 PVCACLDGFEPKSARDWSFQDWSGGCVRRTTLTCNRGEGFVKHTGMKLPDTSSSWYNTSI 372
Query: 365 NLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDTTKAKFHNGQPMAREAILVIC 424
+LKEC+ CLK +C AYAN++V G GSGCL+W+GDLID + + GQ +
Sbjct: 373 SLKECQELCLKKCSCMAYANTDVRGGGSGCLLWFGDLIDM-REFVNTGQDL--------- 422
Query: 425 PSFSSGGASYY--FMHILSMETKTQGK---------SLASVSAATNNFGVENKLGEGGFG 473
+ ASY +IL M+ + + L++++ AT NF KLGEGGFG
Sbjct: 423 --YIRMAASYLGKMKNILEMDYDSHSRKEELELPIIDLSTIAKATGNFSSNKKLGEGGFG 480
Query: 474 PVYK----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517
VYK SGQG+EEFKNE+ L AKLQHRNLV+LLGCC+E E +LIY
Sbjct: 481 LVYKGTLYGQDIAVKRLSMYSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCIEGDERMLIY 540
Query: 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL 577
EY+PNKSLD F+FD ++ LL W RI II+GIA+GLLYLHQ SRLR+IHRDLK SN+LL
Sbjct: 541 EYMPNKSLDYFIFDQSRSKLLDWPTRISIIDGIARGLLYLHQDSRLRIIHRDLKASNVLL 600
Query: 578 DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLL 637
D++M PKISDFG+AR+FGG++ ++NTKR+VGTYGYM+PEYA+ G FS+KSD+FSFGVL+L
Sbjct: 601 DTDMNPKISDFGMARIFGGNQTEANTKRVVGTYGYMAPEYAVEGLFSVKSDIFSFGVLVL 660
Query: 638 ETLSSKRSTRFFNTN-SLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLC 696
E +S +++ FF+ N L L+GHAW LW ++RS EL D L + + RYI+V LLC
Sbjct: 661 EIVSGRKNRGFFSHNHHLNLVGHAWKLWMEERSLELTDNTLGASHALSEIIRYIHVGLLC 720
Query: 697 VQENAADRPTMSEVISMLTNEFVNLPSPQQPGF 729
VQ+ DRP MS + ML E +LP P+QPGF
Sbjct: 721 VQQQPDDRPNMSTAVLMLGGE-SSLPQPKQPGF 752
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514907|ref|XP_003526143.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 656 bits (1692), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/796 (45%), Positives = 492/796 (61%), Gaps = 76/796 (9%)
Query: 9 IFSSFVFLFSIQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYK 68
+FS+ + FS Q+S A DTIT + + DG VS FELGFF+P S Y+GIW+K
Sbjct: 9 VFSNPLVFFS-QISYATDTITQSQPLL-DGSTLVSKEGTFELGFFTPGNSPNHYVGIWFK 66
Query: 69 QIP-DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLD 127
IP TVVWVANR++P + + L++S +GNL++L IWS+N + NPV QLLD
Sbjct: 67 NIPMRTVVWVANRDNPAKDKSNMLSLSKDGNLILLGKNRSLIWSTNATIAVSNPVVQLLD 126
Query: 128 TGNLIVRDNFSRSA-SEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPS 186
GNL++R+ + +E + +WQSFDYP DT L GMKLGW+LK G+ RYLT+W++ +DPS
Sbjct: 127 NGNLVIREEKDDNMDNEENFVWQSFDYPCDTQLQGMKLGWNLKTGLNRYLTAWKNWEDPS 186
Query: 187 PGNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIF----FGAAPSYASILSEPILVDNED 242
G+ T+ L + PEL + GS + RSGPWNGIF FG +P+ L E V NED
Sbjct: 187 SGDFTSGLKLGTNPELVISKGSNEYYRSGPWNGIFSSGVFGFSPN---PLFEYKYVQNED 243
Query: 243 EIYYSYESYNNPIIAILTVNPSGTV-QRLIWHERSNGWAAVHLAPTLFCQFYGHCGGNRV 301
E+Y Y N+ +I+I+ +N + + QR+ W + W+ P C Y CG
Sbjct: 244 EVYVRYTLKNSSVISIIVLNQTLFLRQRITWIPHTRTWSVYQSLPQDSCDVYNVCGAYGN 303
Query: 302 CSYEKTPNCECLKGFKPKSQHNQTR---PGSCVRSESADC--KSGDRFIMVDDIKLPDLL 356
C +P C+CL+GFKPKS + + CVRSE C K+ D F ++ +K+PD
Sbjct: 304 CMINASPVCQCLEGFKPKSPQDWNQMDWTKGCVRSEPWSCGVKNKDGFRLIAGMKMPDTT 363
Query: 357 NVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDTTKAKFHNGQPMA 416
+ +N+SM L++C+A+CLKN +C A+AN + G GSGC +W+GDL+D ++
Sbjct: 364 HSWINRSMTLEDCKAKCLKNCSCTAFANMDTGGGGSGCSIWFGDLVDLRISE-------- 415
Query: 417 REAILVICPSFSSGGASYYFMHILSMETKTQGKS-------------LASVSAATNNFGV 463
SG Y M I T T+ K LA++ ATNNF +
Sbjct: 416 ------------SGQDLYVRMAISENGTWTEEKDDGGQENLELPFFDLATIINATNNFSI 463
Query: 464 ENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGC 506
+NKLGEGGFGPVYK SGQGL+EFKNE+ L AKLQHRNLV++LGC
Sbjct: 464 DNKLGEGGFGPVYKGTMLDGHEIAVKRLSKSSGQGLKEFKNEVILCAKLQHRNLVKVLGC 523
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVI 566
CVE E +L+YEY+PN+SLDSF+FD + LL W R I+ IA+GLLYLHQ SRLR+I
Sbjct: 524 CVEGEEKMLLYEYMPNRSLDSFIFDPAQSKLLDWPTRFNILCAIARGLLYLHQDSRLRII 583
Query: 567 HRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIK 626
HRDLK SNILLD+NM PKISDFGLA+M GGD+++ NT RIVGTYGYM+PEYAI G FSIK
Sbjct: 584 HRDLKASNILLDNNMNPKISDFGLAKMCGGDQVEGNTNRIVGTYGYMAPEYAIDGLFSIK 643
Query: 627 SDVFSFGVLLLETLSSKRS-TRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPI 685
SDVFSFGVLLLE +S K++ T + +S L+GHAW LWK+ +L+D L +
Sbjct: 644 SDVFSFGVLLLEIISGKKNRTVTYEEHSDNLIGHAWRLWKEGIPEQLIDASLVDSCNISE 703
Query: 686 VKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKKSVE-------T 738
+ R I V LLC+Q + DRP M+ V+ ML++E +L P+ PGF S+E
Sbjct: 704 LVRCIQVGLLCLQHHPEDRPNMTTVVVMLSSE-NSLSQPKVPGFLIKNISIEGEQPCGRQ 762
Query: 739 VARSMNRLTLSVMDAR 754
+ S N +T+S+++AR
Sbjct: 763 ESCSTNEVTVSLLNAR 778
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 754 | ||||||
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.367 | 0.327 | 0.570 | 1.5e-169 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.366 | 0.324 | 0.565 | 9.5e-168 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.367 | 0.328 | 0.567 | 7.5e-166 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.364 | 0.337 | 0.552 | 4.7e-158 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.343 | 0.305 | 0.606 | 2.3e-150 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.343 | 0.307 | 0.559 | 3.4e-145 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.366 | 0.339 | 0.526 | 6.3e-140 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.346 | 0.307 | 0.587 | 1.3e-139 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.367 | 0.333 | 0.512 | 4.4e-139 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.423 | 0.396 | 0.495 | 5.1e-138 |
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 818 (293.0 bits), Expect = 1.5e-169, Sum P(3) = 1.5e-169
Identities = 166/291 (57%), Positives = 210/291 (72%)
Query: 478 SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL 537
S QG +EF NE++L AKLQH NLVRLLGCCV++GE +LIYEYL N SLDS LFD T+
Sbjct: 557 SSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN 616
Query: 538 LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597
L W R II GIA+GLLYLHQ SR R+IHRDLK SN+LLD NM PKISDFG+AR+FG +
Sbjct: 617 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 676
Query: 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN-SLTL 656
E ++NT+R+VGTYGYMSPEYA+ G FS+KSDVFSFGVLLLE +S KR+ F+N+N L L
Sbjct: 677 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 736
Query: 657 LGHAWNLWKDDRSWELMDP-KLQCEAS-YPI--VKRYINVALLCVQENAADRPTMSEVIS 712
LG W WK+ + E++DP + +S +P + R I + LLCVQE A DRP MS V+
Sbjct: 737 LGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMV 796
Query: 713 MLTNEFVNLPSPQQPGFSSLKKSVETVARS---------MNRLTLSVMDAR 754
ML +E +P P++PGF + S+E + S +N++TLSV+DAR
Sbjct: 797 MLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 9.5e-168, Sum P(3) = 9.5e-168
Identities = 165/292 (56%), Positives = 209/292 (71%)
Query: 478 SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL 537
S QG +EFKNE+KL A+LQH NLVRLL CCV+ GE +LIYEYL N SLDS LFD ++
Sbjct: 560 SVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSK 619
Query: 538 LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597
L W R II GIA+GLLYLHQ SR R+IHRDLK SNILLD M PKISDFG+AR+FG D
Sbjct: 620 LNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRD 679
Query: 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN-SLTL 656
E ++NT+++VGTYGYMSPEYA+ G FS+KSDVFSFGVLLLE +SSKR+ F+N++ L L
Sbjct: 680 ETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNL 739
Query: 657 LGHAWNLWKDDRSWELMDPKLQCEAS----YPIVKRYINVALLCVQENAADRPTMSEVIS 712
LG W WK+ + E++DP + +S + I+ R I + LLCVQE A DRPTMS VI
Sbjct: 740 LGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAEDRPTMSLVIL 798
Query: 713 MLTNEFVNLPSPQQPGF----------SSLKKSVETVARSMNRLTLSVMDAR 754
ML +E +P P+ PG+ SS K + + ++N++T+SV+DAR
Sbjct: 799 MLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 811 (290.5 bits), Expect = 7.5e-166, Sum P(3) = 7.5e-166
Identities = 165/291 (56%), Positives = 208/291 (71%)
Query: 478 SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL 537
S QG +EF NE++L AKLQH NLVRLLGCCV++GE +LIYEYL N SLDS LFD T+
Sbjct: 553 SSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN 612
Query: 538 LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597
L W R II GIA+GLLYLHQ SR R+IHRDLK SN+LLD NM PKISDFG+AR+FG +
Sbjct: 613 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 672
Query: 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN-SLTL 656
E ++NT+R+VGTYGYMSPEYA+ G FS+KSDVFSFGVLLLE +S KR+ F+N+N L L
Sbjct: 673 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 732
Query: 657 LGHAWNLWKDDRSWELMDP-KLQCEAS-YPI--VKRYINVALLCVQENAADRPTMSEVIS 712
LG W WK+ E++DP + +S +P + R I + LLCVQE A DRP MS V+
Sbjct: 733 LGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMV 792
Query: 713 MLTNEFVNLPSPQQPGFSSLKKSVETVARS---------MNRLTLSVMDAR 754
ML +E +P P++PGF + +E + S +N++TLSV+DAR
Sbjct: 793 MLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 792 (283.9 bits), Expect = 4.7e-158, Sum P(3) = 4.7e-158
Identities = 157/284 (55%), Positives = 208/284 (73%)
Query: 478 SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL 537
SGQG+EEFKNE+KL AKLQHRNLVRLLGCC++ E +LIYEY+PNKSLD F+FD +
Sbjct: 534 SGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTE 593
Query: 538 LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597
L W R+ II G+A+G+LYLHQ SRLR+IHRDLK N+LLD++M PKISDFGLA+ FGGD
Sbjct: 594 LDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGD 653
Query: 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN-SLTL 656
+ +S+T R+VGTYGYM PEYAI G FS+KSDVFSFGVL+LE ++ K + F + + L L
Sbjct: 654 QSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNL 713
Query: 657 LGHAWNLWKDDRSWELMDPKLQCEASY-PIVKRYINVALLCVQENAADRPTMSEVISMLT 715
LGH W +W +DR E+ + + E S P V R I+VALLCVQ+ DRPTM+ V+ M
Sbjct: 714 LGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFG 773
Query: 716 NEFVNLPSPQQPGFSSLKKSVETVA-----RSMNRLTLSVMDAR 754
++ +LP P QPGF + ++V ++ RS N ++++++ R
Sbjct: 774 SDS-SLPHPTQPGFFT-NRNVPDISSSLSLRSQNEVSITMLQGR 815
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 825 (295.5 bits), Expect = 2.3e-150, Sum P(3) = 2.3e-150
Identities = 157/259 (60%), Positives = 205/259 (79%)
Query: 477 KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEG 536
KSGQG++EFKNEI L AKLQHRNLVRLLGCC E E +L+YEY+PNKSLD FLFD TK+
Sbjct: 562 KSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQA 621
Query: 537 LLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596
L+ W R IIEGIA+GLLYLH+ SRLR+IHRDLK SN+LLD+ M PKISDFG+AR+FGG
Sbjct: 622 LIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGG 681
Query: 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL 656
++ ++NT R+VGTYGYMSPEYA+ G FS+KSDV+SFGVLLLE +S KR+T ++ +L
Sbjct: 682 NQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSL 741
Query: 657 LGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
+G+AW L+ RS EL+DPK++ S R I+VA+LCVQ++AA+RP M+ V+ ML +
Sbjct: 742 IGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLES 801
Query: 717 EFVNLPSPQQPGFSSLKKS 735
+ L +P+QP F+S +++
Sbjct: 802 DTATLAAPRQPTFTSTRRN 820
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 757 (271.5 bits), Expect = 3.4e-145, Sum P(3) = 3.4e-145
Identities = 145/259 (55%), Positives = 189/259 (72%)
Query: 477 KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEG 536
KS QGLEEFKNEI L AKLQHRNLVRLLGCC+E E +L+YEY+PNKSLD FLFD +K+G
Sbjct: 558 KSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQG 617
Query: 537 LLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596
L W R +I GIA+GLLYLH+ SRL++IHRDLK SNILLD+ M PKISDFG+AR+F
Sbjct: 618 SLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNY 677
Query: 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL 656
+ +NT R+VGTYGYM+PEYA+ G FS KSDV+SFGVL+LE +S +++ F T+ +L
Sbjct: 678 RQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSL 737
Query: 657 LGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
+G+AW+LW ++ E++DP ++ R I+V +LC Q++ RP M V+ ML +
Sbjct: 738 IGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLES 797
Query: 717 EFVNLPSPQQPGFSSLKKS 735
+ LP P+QP F S S
Sbjct: 798 QTSQLPPPRQPTFHSFLNS 816
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 731 (262.4 bits), Expect = 6.3e-140, Sum P(3) = 6.3e-140
Identities = 148/281 (52%), Positives = 198/281 (70%)
Query: 478 SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL 537
SGQGLEEF NEI L +KLQHRNLVRLLGCC+E E +LIYE++ NKSL++F+FD+TK+
Sbjct: 535 SGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLE 594
Query: 538 LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597
L W R II+GIA GLLYLH+ S LRV+HRD+K SNILLD M PKISDFGLARMF G
Sbjct: 595 LDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQGT 654
Query: 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRF-FNTNSLTL 656
+ Q+NT+R+VGT GYMSPEYA G FS KSD+++FGVLLLE ++ KR + F TL
Sbjct: 655 QHQANTRRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIITGKRISSFTIGEEGKTL 714
Query: 657 LGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
L AW+ W + +L+D + S V R + + LLC+Q+ A DRP +++V+SMLT
Sbjct: 715 LEFAWDSWCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQQQAGDRPNIAQVMSMLTT 774
Query: 717 EFVNLPSPQQPGFSSLKKSVETVARSM---NRLTLSVMDAR 754
++LP P+QP F+ + ++ +++M N +T + + R
Sbjct: 775 T-MDLPKPKQPVFAMQVQESDSESKTMYSVNNITQTAIVGR 814
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 815 (292.0 bits), Expect = 1.3e-139, Sum P(3) = 1.3e-139
Identities = 154/262 (58%), Positives = 202/262 (77%)
Query: 478 SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL 537
SGQGLEEFKNE+ L AKLQHRNLVRLLGCC+ + E +L+YEY+PNKSLD+FLF+ K+ L
Sbjct: 564 SGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRL 623
Query: 538 LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597
L W R IIEGIA+GLLYLH+ SRLRV+HRDLK SNILLD++M PKISDFG+ARMFGGD
Sbjct: 624 LDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGD 683
Query: 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFF-NTNSLTL 656
+ Q NT R+VGT+GYMSPEYA+ G FS+KSDV+ FGVL+LE ++ KR+ F + +SL +
Sbjct: 684 QNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNI 743
Query: 657 LGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
G+AW W +D + EL+DP ++ S V R I++ALLCVQ++A +RP + VI ML+N
Sbjct: 744 AGYAWRQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSN 803
Query: 717 EFVNLPSPQQPGFSSLKKSVET 738
+ +LP+P+ P + +E+
Sbjct: 804 DSSSLPNPRPPTLMLRGREIES 825
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 729 (261.7 bits), Expect = 4.4e-139, Sum P(3) = 4.4e-139
Identities = 146/285 (51%), Positives = 203/285 (71%)
Query: 478 SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL 537
SGQG+EEF NE+ + +KLQHRNLVRLLG C+E E +L+YE++P LD++LFD K+ L
Sbjct: 546 SGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRL 605
Query: 538 LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597
L W R II+GI +GL+YLH+ SRL++IHRDLK SNILLD N+ PKISDFGLAR+F G+
Sbjct: 606 LDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGN 665
Query: 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN-SLTL 656
E + +T R+VGTYGYM+PEYA+ G FS KSDVFS GV+LLE +S +R++ F+N + L
Sbjct: 666 EDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNL 725
Query: 657 LGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
+AW LW L+DP + E ++R ++V LLCVQ++A DRP+++ VI ML++
Sbjct: 726 SAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSS 785
Query: 717 EFVNLPSPQQPGF------SSLKKSVETVAR-SMNRLTLSVMDAR 754
E NLP P+QP F S ++ S ++ R S+N ++L+ + R
Sbjct: 786 ENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 758 (271.9 bits), Expect = 5.1e-138, Sum P(2) = 5.1e-138
Identities = 166/335 (49%), Positives = 222/335 (66%)
Query: 431 GASYYFMHILSMETKTQGKSLASVSAATNNFG--VENKLGEGGFGPVYK----SGQGLEE 484
G ++ MH +++ T SL++ FG + KL +G V + SGQG EE
Sbjct: 475 GLDFFDMH--TIQNATNNFSLSN-KLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEE 531
Query: 485 FKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI 544
F NEI L +KLQHRNLVR+LGCC+E+ E +LIYE++ NKSLD+FLFD+ K + W R
Sbjct: 532 FMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRF 591
Query: 545 RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTK 604
II+GIA+GLLYLH SRLRVIHRDLK SNILLD M PKISDFGLARM+ G E Q NT+
Sbjct: 592 DIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTR 651
Query: 605 RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRF-FNTNSLTLLGHAWNL 663
R+VGT GYMSPEYA G FS KSD++SFGVL+LE +S ++ +RF + TL+ +AW
Sbjct: 652 RVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWES 711
Query: 664 WKDDRSWELMDPKLQCEASYPI-VKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLP 722
W + R +L+D L ++ +P+ V R I + LLCVQ ADRP E+++MLT +LP
Sbjct: 712 WSEYRGIDLLDQDL-ADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTTTS-DLP 769
Query: 723 SPQQPGFSSLKKSVETVARSM---NRLTLSVMDAR 754
SP+QP F+ + E+++ + N +T SV+ R
Sbjct: 770 SPKQPTFAFHTRDDESLSNDLITVNGMTQSVILGR 804
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4364 | 0.9840 | 0.9476 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 754 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-42 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 5e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-35 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 5e-35 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-25 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 4e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-23 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 1e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-15 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 3e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.003 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 85/286 (29%), Positives = 122/286 (42%), Gaps = 66/286 (23%)
Query: 464 ENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNL 500
KLGEG FG VYK S Q +EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
V+LLG C E+ +++ EY+P L +L + L + IA+G+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDELQSNTKRIVGTYGYMSPEYAI 619
IHRDL N L+ N++ KISDFGL+R ++ D + ++ +M+PE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLK 177
Query: 620 HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK--- 676
G F+ KSDV+SFGVLL E + LG + + M
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT---------------LG--------EEPYPGMSNAEVL 214
Query: 677 --------LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714
L + P + L C E+ DRPT SE++ +L
Sbjct: 215 EYLKKGYRLPKPPNCP--PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 6e-47
Identities = 83/281 (29%), Positives = 127/281 (45%), Gaps = 49/281 (17%)
Query: 465 NKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
KLGEG FG VYK S + ++F E ++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFL------FDTTKEGLLGWGARIRIIEGIAQGLLY 556
LLG C E+ L+ EY+ L +L F + ++ L + IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDELQSNTKRIVGTYGYMSP 615
L + +HRDL N L+ +++ KISDFGL+R ++ D + T + +M+P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 616 EYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675
E G F+ KSDV+SFGVLL E + + +T + ++ +L + L
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWE-IFTLGATPYPGLSNEEVLEY------------LRKG 223
Query: 676 -KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715
+L P + L C Q + DRPT SE++ L
Sbjct: 224 YRLPKPEYCP--DELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 8e-47
Identities = 86/287 (29%), Positives = 122/287 (42%), Gaps = 69/287 (24%)
Query: 464 ENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNL 500
KLGEG FG VYK S Q +EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
V+LLG C E+ ++ EY+ L S+L L + IA+G+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL--QSNTKRIVGTYGYMSPEYA 618
IHRDL N L+ N++ KISDFGL+R D+ + K + +M+PE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESL 175
Query: 619 IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK-- 676
G F+ KSDV+SFGVLL E + LG ++ + M +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFT---------------LG--------EQPYPGMSNEEV 212
Query: 677 ---------LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714
L + P ++ L C E+ DRPT SE++ +L
Sbjct: 213 LEYLKNGYRLPQPPNCP--PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 3e-45
Identities = 78/193 (40%), Positives = 103/193 (53%), Gaps = 28/193 (14%)
Query: 467 LGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCC 507
LGEGGFG VY S LEE EI++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 508 VEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIH 567
++ L+ EY SL L + EG L +RI+ I +GL YLH +IH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 568 RDLKPSNILLDS-NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSI 625
RDLKP NILLDS N K++DFGL+++ D+ T IVGT YM+PE + G++S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 626 KSDVFSFGVLLLE 638
KSD++S GV+L E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 6e-45
Identities = 81/272 (29%), Positives = 115/272 (42%), Gaps = 50/272 (18%)
Query: 466 KLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLG 505
KLG G FG VYK + + + EI++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
++ L+ EY L +L ++ G L +I I +GL YLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE-YAIHGFFS 624
IHRDLKP NILLD N + KI+DFGLA+ S+ VGT YM+PE +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 625 IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYP 684
K DV+S GV+L E L+ K F N L L +L+ L +
Sbjct: 178 PKVDVWSLGVILYELLTGK--PPFSGENILDQL-------------QLIRRILGPPLEFD 222
Query: 685 IVKRYINVALL------CVQENAADRPTMSEV 710
K C+ ++ + RPT E+
Sbjct: 223 EPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 84/287 (29%), Positives = 118/287 (41%), Gaps = 72/287 (25%)
Query: 466 KLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
KLGEG FG VYK S + EEF E + KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
LLG C + ++ EY+P L FL L +++ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG---YMSPEYAI 619
+HRDL N L+ N++ KISDFGL+R D+ ++ G +M+PE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWMAPESLK 177
Query: 620 HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679
G F+ KSDV+SFGVLL E + LG ++ + M +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFT---------------LG--------EQPYPGMSNEEVL 214
Query: 680 EASYPIVKRYI------------NVALLCVQENAADRPTMSEVISML 714
E + Y + L C + DRPT SE++ L
Sbjct: 215 EL---LEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 5e-41
Identities = 55/116 (47%), Positives = 72/116 (62%), Gaps = 7/116 (6%)
Query: 71 PDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGN 130
TVVWVANR +P+ + + L + ++GNLV+ + +WSSNTS K VA L D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 131 LIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPS 186
L++ DN G LWQSFD+P+DTLL G K G ++ G R LTSW+S DPS
Sbjct: 61 LVLYDN------SGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 66/195 (33%), Positives = 88/195 (45%), Gaps = 28/195 (14%)
Query: 463 VENKLGEGGFGPVYK-----SGQ--------------GLEEFKNEIKLTAKLQHRNLVRL 503
+ KLGEG FG VY +G+ E EIK+ KL+H N+VRL
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 504 LGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRL 563
++ + L+ EY L L K G L + I L YLH
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS---K 116
Query: 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFF 623
++HRDLKP NILLD + K++DFGLAR E VGT YM+PE + +
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGKGY 173
Query: 624 SIKSDVFSFGVLLLE 638
D++S GV+L E
Sbjct: 174 GKAVDIWSLGVILYE 188
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 2e-35
Identities = 76/269 (28%), Positives = 121/269 (44%), Gaps = 45/269 (16%)
Query: 465 NKLGEGGFGPVY--------------------KSGQGLEEFKNEIKLTAKLQHRNLVRLL 504
LG G FG VY S + LE + EI++ + LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 505 GCCVEQGENVL-IY-EYLPNKSLDSFL--FDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
G ++ +N L I+ EY+ SL S L F E ++ R + I +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI----RKYTRQ-ILEGLAYLH-- 118
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH 620
++HRD+K +NIL+DS+ + K++DFG A+ G E T + GT +M+PE
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 621 GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680
+ +D++S G ++E + K + + L+K S E P++
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP--WSELGN-----PMAALYKIGSSGEP--PEIPEH 228
Query: 681 ASYPIVKRYINVALLCVQENAADRPTMSE 709
S K ++ C++ + RPT E
Sbjct: 229 LS-EEAKDFL---RKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 54/123 (43%), Positives = 70/123 (56%), Gaps = 7/123 (5%)
Query: 32 SSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAAL 91
S+ + G+ VSS FELGFF Y I YK TVVWVANR++P + L
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTL 59
Query: 92 TISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSF 151
T+ ++GNLVI + + +WSSNT+R N V LLD GNL++ D+ LWQSF
Sbjct: 60 TLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNF------LWQSF 113
Query: 152 DYP 154
DYP
Sbjct: 114 DYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 52/122 (42%), Positives = 74/122 (60%), Gaps = 8/122 (6%)
Query: 32 SSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAAL 91
S+ + G+ VS + FELGFF+ + Y I YK TVVWVANR++P+ + + L
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTL-IMQNDYNLILYKSSSRTVVWVANRDNPVSD-SCTL 58
Query: 92 TISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSF 151
T+ ++GNLV+ + +WSSNT+ N V LLD GNL++ D S+G+ LWQSF
Sbjct: 59 TLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD------SDGNFLWQSF 112
Query: 152 DY 153
DY
Sbjct: 113 DY 114
|
Length = 114 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 79/285 (27%), Positives = 119/285 (41%), Gaps = 47/285 (16%)
Query: 465 NKLGEGGFGPVYK-------SGQGLE----------------EFKNEIKLTAKLQHRNLV 501
+LGEG FG V G + +F+ EI++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 502 RLLGCCVEQGENV--LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
+ G C + G LI EYLP+ SL +L + + + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLGS 127
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF--GGDELQSNTKRIVGTYGYMSPEY 617
R IHRDL NIL++S + KISDFGLA++ D + Y +PE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP-- 675
FS SDV+SFGV L E + ++ L ++G A R EL+
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 676 KLQCEASYP-----IVKRYINVALLCVQENAADRPTMSEVISMLT 715
+L S P ++K C + DRP+ +++I ++
Sbjct: 244 RLPRPPSCPDEVYDLMKL-------CWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (308), Expect = 3e-30
Identities = 78/320 (24%), Positives = 132/320 (41%), Gaps = 36/320 (11%)
Query: 460 NFGVENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQH-RNL 500
++ + KLGEG FG VY + +E F EI++ A L H N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
V+L ++G L+ EY+ SL+ L ++G L + I+ I L YLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH-- 118
Query: 561 SRLRVIHRDLKPSNILLDSN-MIPKISDFGLARMFGGD----ELQSNTKRIVGTYGYMSP 615
+IHRD+KP NILLD + + K+ DFGLA++ + + VGT GYM+P
Sbjct: 119 -SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 616 EYAIHGFF---SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672
E + S SD++S G+ L E L+ +S T + +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK-IILELPTPS-- 234
Query: 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSL 732
+ L I K ++ + ++ +R + S +S ++ + ++ S L
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS---HDLLAHLKLKESDLSDL 291
Query: 733 KKSVETVARSMNRLTLSVMD 752
K ++ ++
Sbjct: 292 LKPDDSAPLRLSLPPSLEAL 311
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 71/200 (35%), Positives = 107/200 (53%), Gaps = 27/200 (13%)
Query: 461 FGVENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLVRL 503
F +E KLG G FG V++ ++F+ E++ +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 504 LGCCVEQGENVLIYEYLPNK-SLDSFLFDTTKEG-LLGWGARIRIIEGIAQGLLYLHQYS 561
C GE V I L K SL +FL + EG +L + I + +A+G+ YL +
Sbjct: 68 FAVCSV-GEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEEQ- 123
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG 621
IHRDL NIL+ +++ K++DFGLAR+ D S+ K+I Y + +PE A HG
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHG 179
Query: 622 FFSIKSDVFSFGVLLLETLS 641
FS KSDV+SFG+LL E +
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 74/238 (31%), Positives = 112/238 (47%), Gaps = 30/238 (12%)
Query: 483 EEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGA 542
++F E K+ KL H NLV+L G C +Q ++ EY+ N L ++L ++G LG
Sbjct: 44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEW 101
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602
+ + + + + YL IHRDL N L+ + + K+SDFGLAR D+ S+
Sbjct: 102 LLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158
Query: 603 TKRIVGT---YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS--TRFFNTNSLTLL 657
GT + PE + FS KSDV+SFGVL+ E S + RF N+ + +
Sbjct: 159 Q----GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214
Query: 658 GHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715
+ L++ PKL Y I+ C E DRP +++S LT
Sbjct: 215 SAGYRLYR---------PKLAPTEVYTIMY-------SCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 72/205 (35%), Positives = 101/205 (49%), Gaps = 39/205 (19%)
Query: 459 NNFGVENKLGEGGFGPVY---------------KSGQ-GLEEFKNEIKLTAKLQHRNLVR 502
+ +E KLG G FG V+ K G E F E ++ KL+H LV+
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQ 65
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEG-------LLGWGARIRIIEGIAQGLL 555
L C E+ ++ EY+ SL FL + EG L+ A+I A+G+
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFL--KSGEGKKLRLPQLVDMAAQI------AEGMA 117
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL--QSNTKRIVGTYGYM 613
YL IHRDL NIL+ N++ KI+DFGLAR+ DE + K + +
Sbjct: 118 YLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI---KWT 171
Query: 614 SPEYAIHGFFSIKSDVFSFGVLLLE 638
+PE A +G F+IKSDV+SFG+LL E
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 80/283 (28%), Positives = 126/283 (44%), Gaps = 58/283 (20%)
Query: 466 KLGEGGFGPVYK-----SGQ--------------GLEEFKNEIKLTAKLQHRNLVRLLGC 506
LG+G G VYK +G+ ++ E+K + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTK--EGLLGWGARIRIIEGIAQGLLYLHQYSRLR 564
++GE ++ EY+ SL L K E +L + AR I +GL YLH +
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR-----QILKGLDYLHT--KRH 120
Query: 565 VIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFS 624
+IHRD+KPSN+L++S KI+DFG++++ Q NT VGT YMSPE +S
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPERIQGESYS 178
Query: 625 IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD-------PKL 677
+D++S G+ LLE K F + +ELM P L
Sbjct: 179 YAADIWSLGLTLLECALGKFP--FLPPGQPSF-------------FELMQAICDGPPPSL 223
Query: 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVN 720
E P + +I+ C+Q++ RP+ +E +L + F+
Sbjct: 224 PAEEFSPEFRDFIS---ACLQKDPKKRPSAAE---LLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 73/291 (25%)
Query: 460 NFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRN 499
+ + ++G+G FG VY S + E+ NE+K+ KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEG-------LLGWGARIRIIEGIAQ 552
+++ E+G+ ++ EY L + KEG +L W ++ +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW-----FVQ-LCL 114
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
L YLH SR +++HRD+KP NI L SN + K+ DFG++++ + T +VGT Y
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYY 169
Query: 613 MSPE------YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD 666
+SPE Y + KSD++S G +L E + K F +L
Sbjct: 170 LSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP---FEGENLL----------- 209
Query: 667 DRSWELMDPKLQCEASYPIVKRY----INVALLCVQENAADRPTMSEVISM 713
EL L+ + PI +Y N+ +Q++ +RP++++++
Sbjct: 210 ----ELALKILKGQYP-PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 42/213 (19%)
Query: 467 LGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
LGEG FG VYK + +EF+ E +L + LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLF-------------DTTKEGLLGWGARIRIIEG 549
LLG C ++ +++EYL + L FL D T + L + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDELQSNTKRIVG 608
IA G+ YL S +HRDL N L+ + KISDFGL+R ++ D + +K ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 609 TYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+M PE ++G F+ +SD++SFGV+L E S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 32/206 (15%)
Query: 460 NFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRN 499
N+ + + +G G FG VYK + L+ EI L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFL--FDTTKEGLLGWGARIRIIEGIAQGLLYL 557
+V+ +G +I EY N SL + F E L+ + + QGL YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-----AVYVYQVLQGLAYL 115
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
H+ VIHRD+K +NIL + + K++DFG+A + +VGT +M+PE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSK 643
S SD++S G ++E L+
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 32/199 (16%)
Query: 461 FGVENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
F + K+G+GGFG VYK S + E+ NEI++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 503 LLGCCVEQGENVLIYEYLPNKSLD---SFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
G +++ E ++ E+ SL T E + + + + + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-----VCKELLKGLEYLHS 116
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI 619
+IHRD+K +NILL S+ K+ DFGL+ +VGT +M+PE
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVIN 170
Query: 620 HGFFSIKSDVFSFGVLLLE 638
+ K+D++S G+ +E
Sbjct: 171 GKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 74/271 (27%), Positives = 122/271 (45%), Gaps = 46/271 (16%)
Query: 466 KLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509
++G G FG V+ E+F E ++ KL H LV+L G C E
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRD 569
+ L++E++ + L +L + G + + + +G+ YL + VIHRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 570 LKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT---YGYMSPEYAIHGFFSIK 626
L N L+ N + K+SDFG+ R D+ S+T GT + SPE +S K
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSK 181
Query: 627 SDVFSFGVLLLETLSSKRSTRFFNTNSLTL--LGHAWNLWKDDRSWELMDPKLQCEASYP 684
SDV+SFGVL+ E S ++ +NS + + + L+K P+L ++ Y
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---------PRLASQSVYE 232
Query: 685 IVKRYINVALLCVQENAADRPTMSEVISMLT 715
+++ C +E DRP+ S ++ L
Sbjct: 233 LMQH-------CWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 46/226 (20%)
Query: 467 LGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
LGEG FG V+ S ++F+ E +L QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFL-----------FDTTKEGLLGWGARIRIIEGIA 551
G C E ++++EY+ + L+ FL + G L ++I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT-- 609
G++YL + +HRDL N L+ +++ KI DFG++R D ++ R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 610 --YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS 653
+M PE ++ F+ +SDV+SFGV+L E + + + +N
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-25
Identities = 41/111 (36%), Positives = 56/111 (50%), Gaps = 5/111 (4%)
Query: 213 RSGPWNGIFFGAAP---SYASILSEPILVDNEDEIYYSYESYNNPIIAILTVNPSGTVQR 269
RSGPWNGI F P + + +N +E+YY+Y NN I + LT++ G+++R
Sbjct: 2 RSGPWNGIRFSGIPEMQKLSYYVYN--FTENNEEVYYTYRMTNNSIYSRLTLSSEGSLER 59
Query: 270 LIWHERSNGWAAVHLAPTLFCQFYGHCGGNRVCSYEKTPNCECLKGFKPKS 320
W S W AP C YG CG C +P C C+KGF PK+
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 88/279 (31%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 459 NNFGVENKLGEGGFGPV----YKSGQGL------------EEFKNEIKLTAKLQHRNLVR 502
+ KLG G FG V Y + E F E L +LQH LVR
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVR 65
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL-LGWGARIRIIEGIAQGLLYLHQYS 561
L V Q +I EY+ N SL FL T EG+ L I + IA+G+ ++
Sbjct: 66 LYAV-VTQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIE--- 119
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL--QSNTKRIVGTYGYMSPEYAI 619
R IHRDL+ +NIL+ + KI+DFGLAR+ +E + K + + +PE
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAIN 176
Query: 620 HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679
+G F+IKSDV+SFG+LL E ++ R TN + NL +R + + P
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ----NL---ERGYRMPRPDNCP 229
Query: 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718
E Y +++ C +E +RPT + S+L +F
Sbjct: 230 EELYELMRL-------CWKEKPEERPTFEYLRSVL-EDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 39/203 (19%)
Query: 467 LGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNLVRL 503
LG G FG VYK S + +E +E + A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 504 LGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKE----GLLGWGARIRIIEGIAQGLLYLH 558
LG C+ V LI + +P L ++ + LL W IA+G+ YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGMSYLE 126
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA 618
+ R++HRDL N+L+ + KI+DFGLA++ DE + + + +M+ E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 619 IHGFFSIKSDVFSFGVLLLETLS 641
+H ++ KSDV+S+GV + E ++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 33/208 (15%)
Query: 459 NNFGVENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQ 496
+ +E +G G FG V + S + +F E + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 497 HRNLVRLLGCCVEQGENVLIY-EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLL 555
H N++RL G V + V+I EY+ N SLD FL +G G + ++ GIA G+
Sbjct: 64 HPNIIRLEGV-VTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMK 120
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTK--RIVGTYGYM 613
YL S + +HRDL NIL++SN++ K+SDFGL+R E TK +I +
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWT 175
Query: 614 SPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+PE + F+ SDV+SFG+++ E +S
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 61/196 (31%), Positives = 91/196 (46%), Gaps = 33/196 (16%)
Query: 465 NKLGEGGFGPVYK-----SGQ-----------GLEEFKN---EIKLTAKLQHRNLVRLLG 505
+LG G G V K +G+ K E+ + K +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 506 CCVEQGENVLIYEYLPNKSLDSFL---FDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
G+ + EY+ SLD L E +LG +I + +GL YLH +
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH--EK 119
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF 622
++IHRD+KPSNIL++S K+ DFG++ G + S K VGT YM+PE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQGND 175
Query: 623 FSIKSDVFSFGVLLLE 638
+S+KSD++S G+ L+E
Sbjct: 176 YSVKSDIWSLGLSLIE 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 463 VENKLGEGGFGPVYKS-----------------GQGLEEFKNEIKLTAKLQHRNLVRLLG 505
+++KLG G +G VY+ +EEF E + +++H NLV+LLG
Sbjct: 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
C + +I E++ +L +L + ++ + + + I+ + YL + +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL--QSNTKRIVGTYGYMSPEYAIHGFF 623
IHRDL N L+ N + K++DFGL+R+ GD + K + + +PE + F
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKF 182
Query: 624 SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASY 683
SIKSDV++FGVLL E +T + L + L + E + E
Sbjct: 183 SIKSDVWAFGVLLWEI-----ATYGMSPYPGIDLSQVYELLEKGYRME------RPEGCP 231
Query: 684 PIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718
P V + C Q N +DRP+ +E+ F
Sbjct: 232 PKVYELM---RACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 77/260 (29%), Positives = 118/260 (45%), Gaps = 41/260 (15%)
Query: 466 KLGEGGFGPVY---------------KSG-QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509
KLG G FG V+ K G ++F E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRD 569
+ ++ E + SL +L L I + +A G+ YL + IHRD
Sbjct: 73 EEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 570 LKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT---YGYMSPEYAIHGFFSIK 626
L N+L+ N I K++DFGLAR+ D ++ G + +PE A++ FSIK
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSIK 184
Query: 627 SDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIV 686
SDV+SFG+LL E ++ R TN A L + D+ + ++ C P
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMTN-------AEVLQQVDQGY-----RMPCPPGCP-- 230
Query: 687 KRYINVALLCVQENAADRPT 706
K ++ L C +E+ DRPT
Sbjct: 231 KELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-23
Identities = 31/67 (46%), Positives = 46/67 (68%), Gaps = 1/67 (1%)
Query: 338 CKSGDRFIMVDDIKLPDLLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMW 397
C GD F+ + ++KLPD +++S+ LKECE CL N +C AYA +++ G GSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRG-GSGCLIW 59
Query: 398 YGDLIDT 404
G+L+D
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 81/270 (30%), Positives = 123/270 (45%), Gaps = 50/270 (18%)
Query: 466 KLGEGGFGPV-YKSGQGL---------------EEFKNEIKLTAKLQHRNLVRLLGCCVE 509
+LG G FG V Y +G +EF E K+ KL H LV+L G C +
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL--HQYSRLRVIH 567
Q ++ EY+ N L ++L + K + + + + +G+ YL Q+ IH
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESKQF-----IH 123
Query: 568 RDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT---YGYMSPEYAIHGFFS 624
RDL N L+D K+SDFGL+R DE S+ VG+ + PE ++ FS
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFS 179
Query: 625 IKSDVFSFGVLLLE--TLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682
KSDV++FGVL+ E +L RF N+ ++ + L++ P L E
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---------PHLASEKV 230
Query: 683 YPIVKRYINVALLCVQENAADRPTMSEVIS 712
Y I+ C E A +RPT +++S
Sbjct: 231 YAIMYS-------CWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 4e-23
Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 36/240 (15%)
Query: 483 EEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGA 542
E + EI+L A+L H +++R+LG E L E++ S+ L +K G
Sbjct: 48 EALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAV 104
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGLA-----RMFGG 596
I E + +GL YLH+ ++IHRD+K +N+L+DS +I+DFG A + G
Sbjct: 105 IINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161
Query: 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL 656
E Q +++GT +M+PE + DV+S G +++E ++K
Sbjct: 162 GEFQG---QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP------------ 206
Query: 657 LGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYIN-----VALLCVQENAADRPTMSEVI 711
WN K L+ K+ + P + +++ V L C++ DRP E++
Sbjct: 207 ---PWNAEKHSNHLALIF-KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 29/202 (14%)
Query: 463 VENKLGEGGFGPVYK-----SGQGL---------------EEFKNEIKLTAKLQHRNLVR 502
V +G+G FG V K G+ L ++ +E+ + +L+H N+VR
Sbjct: 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 503 LLGCCVEQGENVLIY---EYLPNKSLDSFLFDTTKEGL-LGWGARIRIIEGIAQGLLYLH 558
+++ N +Y EY L + KE + RI+ + L H
Sbjct: 64 YYDRIIDR-SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 559 --QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
V+HRDLKP+NI LD+N K+ DFGLA++ G D S K VGT YMSPE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYYMSPE 180
Query: 617 YAIHGFFSIKSDVFSFGVLLLE 638
H + KSD++S G L+ E
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 6e-23
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 37/208 (17%)
Query: 461 FGVENKLGEGGFGPVYK-----SGQ--GLEEFKN-------------EIKLTAKLQHRNL 500
+ KLGEG +G VYK +G+ L++ + EI L +L+H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIA----QGLLY 556
V+LL + + L++EY + L +L D L +I+ I +GL Y
Sbjct: 61 VKLLDVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPL-----SPNLIKSIMYQLLRGLAY 113
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
H + R++HRDLKP NIL++ + + K++DFGLAR F G L++ T +V T Y +PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPE 168
Query: 617 YAIHG-FFSIKSDVFSFGVLLLETLSSK 643
+ +S D++S G + E ++ K
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 66/210 (31%), Positives = 98/210 (46%), Gaps = 39/210 (18%)
Query: 467 LGEGGFGPVY----------------------KSGQGLEEFKN---EIKLTAKLQHRNLV 501
LG G FG VY + G +E K E L + H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEG----LLGWGARIRIIEGIAQGLLYL 557
+LLG C+ +I E + L S+L D E LL + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 558 HQYSRLRVIHRDLKPSNILL-----DSNMIPKISDFGLAR-MFGGDELQSNTKRIVGTYG 611
Q + IHRDL N L+ D++ + KI DFGLAR ++ D + + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 612 YMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+M+PE + G F+ +SDV+SFGVL+ E L+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 33/198 (16%)
Query: 467 LGEGGFGPVYK-----SGQ----------------GLEEFKNEIKLTAKLQHRNLVRLLG 505
LG+G FG V +G+ +E E + +++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 506 CCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWG-ARIRIIEGIAQGLLYLHQYSRL 563
+ E + L+ EY P L S L +KEG AR E I L YLH L
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAE-IVLALEYLH---SL 112
Query: 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFF 623
+I+RDLKP NILLD++ K++DFGLA+ + ++NT GT Y++PE + +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGY 170
Query: 624 SIKSDVFSFGVLLLETLS 641
D +S GVLL E L+
Sbjct: 171 GKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 56/193 (29%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 466 KLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCV 508
K+GEG G VYK Q E NEI + +H N+V +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 509 EQGENVLIYEYLPNKSLD---SFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
E ++ EY+ SL + F E + + + QGL YLH V
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA-----YVCREVLQGLEYLHS---QNV 137
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSI 625
IHRD+K NILL + K++DFG A + +S +VGT +M+PE +
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 626 KSDVFSFGVLLLE 638
K D++S G++ +E
Sbjct: 196 KVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 46/210 (21%)
Query: 465 NKLGEGGFGPVYKS----------------GQGLEEF----KNEIKLTAKLQHRNLVRLL 504
++GEG +G VYK+ E F EIKL KL+H N+VRL
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 505 GCCVEQGEN--VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
+G+ +++EY+ + L L + E ++ + +GL YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH-DLTGLL--DSPEVKFTESQIKCYMKQLLEGLQYLHSN-- 119
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE------ 616
++HRD+K SNIL++++ + K++DFGLAR + T R++ T Y PE
Sbjct: 120 -GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGAT 177
Query: 617 ---YAIHGFFSIKSDVFSFGVLLLETLSSK 643
+ D++S G +L E K
Sbjct: 178 RYGPEV--------DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 53/159 (33%), Positives = 81/159 (50%), Gaps = 20/159 (12%)
Query: 488 EIKLTAKLQHRNLVRLLGCCVEQGENVL--IYEYLPNKSLDSFLFDTTKEGLLGWGARI- 544
E+++ + +V+ G +++ + + EY SLDS K+ + G RI
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY----KK-VKKRGGRIG 103
Query: 545 -----RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599
+I E + +GL YLH ++IHRD+KPSNILL K+ DFG++ G+ +
Sbjct: 104 EKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELV 156
Query: 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLE 638
S GT YM+PE +SI SDV+S G+ LLE
Sbjct: 157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 28/237 (11%)
Query: 483 EEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGA 542
E+F E K+ KL H LV+L G C +Q ++ E++ N L ++L ++G L
Sbjct: 44 EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDM 101
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602
+ + + + +G+ YL + S IHRDL N L+ S + K+SDFG+ R DE S+
Sbjct: 102 LLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158
Query: 603 T--KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS--TRFFNTNSLTLLG 658
+ K V + PE +S KSDV+SFGVL+ E + + + N + ++
Sbjct: 159 SGAKFPV---KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215
Query: 659 HAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715
+ L++ PKL Y V C E RPT +E++ +T
Sbjct: 216 RGFRLYR---------PKLASMTVY-------EVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 75/273 (27%), Positives = 126/273 (46%), Gaps = 47/273 (17%)
Query: 466 KLGEGGFGPVYKS---GQGL---------------EEFKNEIKLTAKLQHRNLVRLLGCC 507
K+G+G FG VYK G +F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 508 VEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIH 567
V++ ++ E +P SL +FL K+ L +++ A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 568 RDLKPSNILLDSNMIPKISDFGLARMFGGD--ELQSNTKRIVGTYGYMSPEYAIHGFFSI 625
RDL N L+ N + KISDFG++R G + K+I + +PE +G ++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174
Query: 626 KSDVFSFGVLLLETLSSKRSTRFFN-TNSLTLLGHAWNLWKD--DRSWELMDPKLQCEAS 682
+SDV+S+G+LL ET S T + +N T ++ + + + P+L E
Sbjct: 175 ESDVWSYGILLWETF-SLGDTPYPGMSNQQT---------RERIESGYRMPAPQLCPEEI 224
Query: 683 YPIVKRYINVALLCVQENAADRPTMSEVISMLT 715
Y ++ L C + +RP+ SE+ + L
Sbjct: 225 YRLM-------LQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 28/195 (14%)
Query: 467 LGEGGFGPVYKS---------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG 511
+G+G FG V + F E + L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73
Query: 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLK 571
++ EY+ SL +L + ++ ++ + +G+ YL + +HRDL
Sbjct: 74 PLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLA 129
Query: 572 PSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY--GYMSPEYAIHGFFSIKSDV 629
N+L+ +++ K+SDFGLA+ +++ + G + +PE FS KSDV
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 630 FSFGVLLLETLSSKR 644
+SFG+LL E S R
Sbjct: 183 WSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 82/276 (29%), Positives = 113/276 (40%), Gaps = 37/276 (13%)
Query: 467 LGEGGFGPV--------------------YKSGQGL---EEFKNEIKLTAKLQHRNLVRL 503
LGEG FG V K G +K EI + L H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 504 LGCCVEQGENV--LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
GCC EQG LI EY+P SL +L + L + + I +G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMF-GGDELQSNTKRIVGTYGYMSPEYAIH 620
IHRDL N+LLD++ + KI DFGLA+ G E + + + E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 621 GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK--LQ 678
FS SDV+SFGV L E L+ S + ++G R EL++ L
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP 244
Query: 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714
C + P + C + A RPT +I +L
Sbjct: 245 CPKNCPQEVYILMKN--CWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 7e-22
Identities = 82/297 (27%), Positives = 130/297 (43%), Gaps = 60/297 (20%)
Query: 466 KLGEGGFGPVYK-SGQGLEEFKN----------------------------------EIK 490
KLGEG FG V+ +G+E+F + EIK
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 491 LTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEG--------LLGWGA 542
+ ++L+ N++RLL C+ +I EY+ N L+ FL + + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGD--EL 599
I + IA G+ YL S L +HRDL N L+ N KI+DFG++R ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH 659
Q R V +MS E + G F+ SDV++FGV L E L+ + + + ++ +
Sbjct: 189 QG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245
Query: 660 AWNLWKDD-RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715
++D R L P L C S + L C + NA +RP+ E+ + L
Sbjct: 246 TGEFFRDQGRQVYLPKPAL-CPDS------LYKLMLSCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 60/282 (21%)
Query: 467 LGEGGFGPVY-----------------------KSGQGLEEFKNEIKLTAKLQHRNLVRL 503
LG G FG VY + +++ + EI L +KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 504 LGCCVEQGENVLIY-EYLPNKSLDSFL--FDTTKEGLLGWGARIRI-IEGIAQGLLYLHQ 559
LG + +N+ I+ E +P SL L + + E + IR+ I GL YLH
Sbjct: 68 LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV------IRLYTRQILLGLEYLH- 119
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY-A 618
R +HRD+K +NIL+D+N + K++DFG+A+ S K G+ +M+PE A
Sbjct: 120 -DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIA 174
Query: 619 IHGFFSIKSDVFSFGVLLLETLSSKRS-TRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677
G + + +D++S G +LE + K ++ + ++K RS EL P +
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA---------VFKIGRSKEL--PPI 223
Query: 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719
S K +I L C+Q + + RPT +E +L + FV
Sbjct: 224 PDHLS-DEAKDFI---LKCLQRDPSLRPTAAE---LLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 71/251 (28%), Positives = 111/251 (44%), Gaps = 31/251 (12%)
Query: 481 GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL------FDTTK 534
E+F E+K+ ++L N+ RLLG C +I EY+ N L+ FL
Sbjct: 62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121
Query: 535 EGL--LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592
L + + + IA G+ YL L +HRDL N L+ N KI+DFG++R
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 593 -MFGGD--ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFF 649
++ D +Q R +M+ E + G F+ KSDV++FGV L E L+ R +
Sbjct: 179 NLYSSDYYRVQG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY- 234
Query: 650 NTNSLT---LLGHAWNLWKDDRSWELMDPKLQCEAS-YPIVKRYINVALLCVQENAADRP 705
LT ++ +A + ++DD + C Y + L C + + DRP
Sbjct: 235 --EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIY-------ELMLECWRRDEEDRP 285
Query: 706 TMSEVISMLTN 716
T E+ L
Sbjct: 286 TFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 458 TNNFGVENKLGEGGFGPVYKSGQGLEEFKN----------------------EIKLTAKL 495
NF +E K+G+G F VYK L + + EI L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYK-AICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL 59
Query: 496 QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI-RIIEGIAQGL 554
H N+++ L +E E ++ E L + K+ L I + + L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 555 LYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMS 614
++H R++HRD+KP+N+ + + + K+ D GL R F +++ VGT YMS
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMS 174
Query: 615 PEYAIHGF-FSIKSDVFSFGVLLLE 638
PE IH ++ KSD++S G LL E
Sbjct: 175 PE-RIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 48/227 (21%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAK 494
NN +G+G FG V++ S +F+ E L A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 495 LQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFD---TTKEGLLGWGARIR------ 545
H N+V+LLG C L++EY+ L+ FL + L + R
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 546 ----------IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MF 594
I + +A G+ YL S + +HRDL N L+ NM+ KI+DFGL+R ++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
D +++ + +M PE + ++ +SDV+++GV+L E S
Sbjct: 182 SADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-21
Identities = 79/274 (28%), Positives = 131/274 (47%), Gaps = 40/274 (14%)
Query: 463 VENKLGEGGFGPVY---------------KSG-QGLEEFKNEIKLTAKLQHRNLVRLLGC 506
+E KLG+G FG V+ K G E F E ++ KL+H LV+L
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVI 566
E+ ++ EY+ SL FL + L + + IA G+ Y+ R+ +
Sbjct: 70 VSEE-PIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYV 124
Query: 567 HRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY--GYMSPEYAIHGFFS 624
HRDL+ +NIL+ N++ K++DFGLAR+ +E T R + + +PE A++G F+
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFT 181
Query: 625 IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYP 684
IKSDV+SFG+LL E L++K + + +L +R + + P +C S
Sbjct: 182 IKSDVWSFGILLTE-LTTKGRVPYPGMVNREVLDQV------ERGYRMPCPP-ECPESLH 233
Query: 685 IVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718
++ C ++ +RPT + + L + F
Sbjct: 234 ------DLMCQCWRKEPEERPTFEYLQAFLEDYF 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 81/272 (29%), Positives = 128/272 (47%), Gaps = 40/272 (14%)
Query: 463 VENKLGEGGFGPVY---------------KSG-QGLEEFKNEIKLTAKLQHRNLVRLLGC 506
+ KLG G FG V+ K G E F E ++ KL+H LV+L
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVI 566
E+ ++ EY+ SL FL D L + + +A G+ Y+ R+ I
Sbjct: 70 VSEE-PIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE---RMNYI 124
Query: 567 HRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY--GYMSPEYAIHGFFS 624
HRDL+ +NIL+ ++ KI+DFGLAR+ +E T R + + +PE A++G F+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFT 181
Query: 625 IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYP 684
IKSDV+SFG+LL E L +K + N+ +L +R + ++ C P
Sbjct: 182 IKSDVWSFGILLTE-LVTKGRVPYPGMNNREVLEQV------ERGY-----RMPCPQDCP 229
Query: 685 IVKRYINVALLCVQENAADRPTMSEVISMLTN 716
I + L C +++ +RPT + S L +
Sbjct: 230 ISLH--ELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 67/194 (34%), Positives = 100/194 (51%), Gaps = 24/194 (12%)
Query: 466 KLGEGGFGPVYKS---GQGL-----------EEFKNEIKLTAKLQHRNLVRLLGCCVEQG 511
+GEG FG V + GQ + + F E + KL H+NLVRLLG + G
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG 72
Query: 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLK 571
+++ E + +L +FL T L+ ++ +A+G+ YL +++HRDL
Sbjct: 73 LYIVM-ELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLA 127
Query: 572 PSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFS 631
NIL+ + + K+SDFGLAR+ G N+K V + +PE H FS KSDV+S
Sbjct: 128 ARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAPEALKHKKFSSKSDVWS 182
Query: 632 FGVLLLETLSSKRS 645
+GVLL E S R+
Sbjct: 183 YGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 39/267 (14%)
Query: 466 KLGEGGFGPVY---------------KSG-QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509
KLG G FG V+ K G ++ F E L LQH LVRL +
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRD 569
+ +I EY+ SL FL + + G + I IA+G+ Y+ R IHRD
Sbjct: 73 EEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128
Query: 570 LKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY--GYMSPEYAIHGFFSIKS 627
L+ +N+L+ +++ KI+DFGLAR+ +E T R + + +PE G F+IKS
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 628 DVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVK 687
DV+SFG+LL E ++ + +NS + R + + + + Y I+K
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-------RGYRMPRMENCPDELYDIMK 238
Query: 688 RYINVALLCVQENAADRPTMSEVISML 714
C +E A +RPT + S+L
Sbjct: 239 -------TCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 78/277 (28%), Positives = 104/277 (37%), Gaps = 51/277 (18%)
Query: 466 KLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRL 503
KLG+G FG V + +++F E + L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 504 LGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRII----EGIAQGLLYLHQ 559
G V +++ E P SL L L I + IA G+ YL
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFL-----ISTLCDYAVQIANGMRYLES 115
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF--GGDELQSNTKRIVGTYGYMSPEY 617
R IHRDL NILL S+ KI DFGL R D V + + +PE
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPES 171
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677
FS SDV+ FGV L E + + L + L K D+ E ++
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKKIDKEGERLERPE 224
Query: 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714
C + NV L C N ADRPT + + L
Sbjct: 225 ACP------QDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-20
Identities = 83/275 (30%), Positives = 134/275 (48%), Gaps = 46/275 (16%)
Query: 463 VENKLGEGGFGPVY---------------KSGQGL-EEFKNEIKLTAKLQHRNLVRLLGC 506
++ KLG+G FG V+ K G + E F E ++ KL+H LV L
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEG---LLGWGARIRIIEGIAQGLLYLHQYSRL 563
E+ ++ E++ SL FL KEG L + + IA G+ Y+ R+
Sbjct: 70 VSEE-PIYIVTEFMGKGSLLDFL----KEGDGKYLKLPQLVDMAAQIADGMAYIE---RM 121
Query: 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY--GYMSPEYAIHG 621
IHRDL+ +NIL+ N++ KI+DFGLAR+ +E T R + + +PE A++G
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYG 178
Query: 622 FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681
F+IKSDV+SFG+LL E ++ R N L + +R + + P+ E+
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-------LEQVERGYRMPCPQGCPES 231
Query: 682 SYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
+ ++K LC +++ +RPT + S L +
Sbjct: 232 LHELMK-------LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 32/202 (15%)
Query: 460 NFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRN 499
+F + NK+G+G FG V+K + + EE +E ++ AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL---LGWGARIRIIEGIAQGLLY 556
++R +++G+ ++ EY N L L L W I+I+ G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
LH +++HRD+K N+ LD+ KI D G+A++ + +NT IVGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 617 YAIHGFFSIKSDVFSFGVLLLE 638
++ KSDV++ GV+L E
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 64/237 (27%), Positives = 116/237 (48%), Gaps = 30/237 (12%)
Query: 484 EFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGAR 543
+F +E + + H N++ L G + +++ EY+ N SLD+FL +G
Sbjct: 51 DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQL 108
Query: 544 IRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT 603
+ ++ GIA G+ YL S + +HRDL NIL++SN++ K+SDFGL+R+ D + T
Sbjct: 109 VGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
Query: 604 KRIVGTYG------YMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLL 657
R G + +PE + F+ SDV+S+G+++ E +S + +N +
Sbjct: 166 TR-----GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK 220
Query: 658 GHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714
+ + L P + C A+ + L C Q++ +RP +++S+L
Sbjct: 221 A-------IEEGYRLPAP-MDCPAALH------QLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 70/286 (24%), Positives = 110/286 (38%), Gaps = 56/286 (19%)
Query: 465 NKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKLQHRNL 500
LG G FG VY+ S Q +F E + +K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDT----TKEGLLGWGARIRIIEGIAQGLLY 556
VRL+G E+ ++ E + L SFL + + L + +A+G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 557 LHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLAR-MFGGDELQSNTKRIVGTYGY 612
L + IHRD+ N LL + KI+DFG+AR ++ + + ++ +
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML-PIKW 187
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS--TRFFNTNSLTLLGHAWNLWKDDRSW 670
M PE + G F+ K+DV+SFGVLL E S N + +
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV----------TGG 237
Query: 671 ELMDPKLQCEAS-YPIVKRYINVALLCVQENAADRPTMSEVISMLT 715
+DP C Y I+ C Q DRP + ++ +
Sbjct: 238 GRLDPPKGCPGPVYRIMTD-------CWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 27/243 (11%)
Query: 482 LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL------FDTTKE 535
EF+ E+ + KL H+N+VRLLG C E + +I EY L FL + K
Sbjct: 52 QSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKP 111
Query: 536 GLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595
L ++ + IA G+ +L S R +HRDL N L+ S K+S L++
Sbjct: 112 PPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168
Query: 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKR--STRFFNTNS 653
E ++ +++PE FS KSDV+SFGVL+ E + +
Sbjct: 169 NSEYYKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227
Query: 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713
L L EL P+ Y ++ R C N DRP+ SE++S
Sbjct: 228 LNRLQ--------AGKLELPVPEGCPSRLYKLMTR-------CWAVNPKDRPSFSELVSA 272
Query: 714 LTN 716
L
Sbjct: 273 LGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 63/239 (26%), Positives = 111/239 (46%), Gaps = 43/239 (17%)
Query: 487 NEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSL-------DSFLFDTTKEGLLG 539
NEI + + LQH N++ ++ ++ EY +L LF+ E ++
Sbjct: 48 NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE---EEMVL 104
Query: 540 WGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599
W + I + Y+H+ ++HRD+K NI L + K+ DFG++++ G +
Sbjct: 105 W-----YLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156
Query: 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH 659
+ T +VGT YMSPE ++ KSD+++ G +L E L+ KR+ F TN L L+
Sbjct: 157 MAET--VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT--FDATNPLNLV-- 210
Query: 660 AWNLWKDDRSWELMDPKLQCEASYPIVKRY----INVALLCVQENAADRPTMSEVISML 714
+++ Q + P+V Y I++ +Q++ RPT EV+
Sbjct: 211 ----------VKIV----QGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 60/282 (21%)
Query: 463 VENKLGEGGFGPVY---------------KSGQ-GLEEFKNEIKLTAKLQHRNLVRLLGC 506
+E KLG G FG V+ K G +E F E + LQH LV+L
Sbjct: 10 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL-HA 68
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEG-------LLGWGARIRIIEGIAQGLLYLHQ 559
V + +I E++ SL FL + EG L+ + A+I A+G+ ++ Q
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQI------AEGMAFIEQ 120
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY--GYMSPEY 617
+ IHRDL+ +NIL+ ++++ KI+DFGLAR+ +E T R + + +PE
Sbjct: 121 RN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEA 174
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSKRSTR--FFNTNSLTLLGHAWNLWKDDR-SWELMD 674
G F+IKSDV+SFG+LL+E ++ R N + L + + + + EL +
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234
Query: 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
++C + P +RPT + S+L +
Sbjct: 235 IMMRCWKNRP-----------------EERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 77/284 (27%), Positives = 112/284 (39%), Gaps = 62/284 (21%)
Query: 465 NKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
+LG G FG V K G +EF E + A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFD---TTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
L+G C + +L+ E P L +L L ++ A G+ YL
Sbjct: 61 LIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES 113
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM--FGGDELQSNT--KRIVGTYGYMSP 615
+HRDL N+LL + KISDFG++R G D ++ T + + Y +P
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---AP 167
Query: 616 EYAIHGFFSIKSDVFSFGVLLLETLS--SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673
E +G FS KSDV+S+GV L E S +K + +L L + +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEE----- 222
Query: 674 DPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
C + Y I+ L C + DRPT SE+ S
Sbjct: 223 -----CPQEIYSIM-------LSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 84/289 (29%), Positives = 121/289 (41%), Gaps = 67/289 (23%)
Query: 467 LGEGGFGPV----------------------YKSGQGLEEFKNEIKLTAKLQHRNLVRLL 504
LG+G FG V + + + L +F+ EI++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 505 GCCVEQGEN--VLIYEYLPNKSLDSFL------FDTTKEGLLGWGARIRIIEGIAQGLLY 556
G C G L+ EYLP SL +L D K L I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVG---TYGYM 613
L R +HRDL NIL++S KI DFGL ++ D+ + R G + Y
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY- 178
Query: 614 SPEYAIHGFFSIKSDVFSFGVLLLE--TLSSKRST--RFF------NTNSLTLLGHAWNL 663
+PE FS+ SDV+SFGV+L E T S K + F + ++ H L
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238
Query: 664 WKDDRSWELMDPKLQCEAS-YPIVKRYINVALLCVQENAADRPTMSEVI 711
K+ + L P C A Y I+K C + + RP+ SE+
Sbjct: 239 LKN--NGRLPAP-PGCPAEIYAIMK-------ECWNNDPSQRPSFSELA 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 36/209 (17%)
Query: 460 NFGVENKLGEGGFGPVYK-----SGQ--GLEEFK-------------NEIKLTAKLQHRN 499
NF K+GEG +G VYK +G+ L++ + EI L +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG----IAQGLL 555
+V+LL + + L++E+L ++ L F+ + G+ + +I+ + QGL
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGI-----PLPLIKSYLFQLLQGLA 114
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSP 615
+ H + RV+HRDLKP N+L+++ K++DFGLAR F G +++ T +V T Y +P
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAP 169
Query: 616 EYAIHG-FFSIKSDVFSFGVLLLETLSSK 643
E + ++S D++S G + E ++ +
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 30/200 (15%)
Query: 467 LGEGGFGPVY------------------KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCV 508
LG+G +G VY + + ++ EI L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 509 EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG--IAQGLLYLHQYSRLRVI 566
E G + E +P SL + L +K G L + I I +GL YLH +++
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130
Query: 567 HRDLKPSNILLDS-NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF--F 623
HRD+K N+L+++ + + KISDFG ++ G + T+ GT YM+PE G +
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 624 SIKSDVFSFGVLLLETLSSK 643
+D++S G ++E + K
Sbjct: 189 GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 16/216 (7%)
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFL--FDTTKEGLLGWGARIRIIEGIAQGLLYL 557
+V G + + + E++ SLD +LG +I + +GL YL
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL 119
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
Y+ R++HRD+KPSNIL++S K+ DFG++ G+ + S VGT YMSPE
Sbjct: 120 --YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPER 173
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677
G +++KSDV+S G+ ++E K F N + L + + P+L
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL 233
Query: 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713
++ +++ C+ ++ +RPT ++ +M
Sbjct: 234 PSSDFPEDLRDFVD---ACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 9e-20
Identities = 66/202 (32%), Positives = 99/202 (49%), Gaps = 33/202 (16%)
Query: 466 KLGEGGFGPVYK-----SGQGLEEFK---------------NEIKLTAKLQHRNLVRLLG 505
K+GEG +G VYK +GQ + K EI L +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 506 CCVEQGENVLIYEYLP---NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
+++ LI+E+L K LDS + L +I++GI L+ H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LFCH---S 119
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG- 621
RV+HRDLKP N+L+D+ + K++DFGLAR F G ++ T +V T Y +PE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSP 177
Query: 622 FFSIKSDVFSFGVLLLETLSSK 643
+S D++S G + E + K
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 466 KLGEGGFGPVY-----------------------KSGQGLEEFKNEIKLTAKLQHRNLVR 502
+LGEG FG V+ S ++F+ E +L LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFL---------FDTTKE---GLLGWGARIRIIEGI 550
G C E ++++EY+ + L+ FL ++ G L G + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 551 AQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY 610
A G++YL + L +HRDL N L+ ++ KI DFG++R + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 611 GYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+M PE ++ F+ +SD++SFGV+L E +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 61/234 (26%), Positives = 108/234 (46%), Gaps = 47/234 (20%)
Query: 463 VENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRN 499
++ +LGEG FG V+ + ++F+ E +L LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLF-------------DTTKEGLLGWGARIRI 546
+V+ G C + ++++EY+ + L+ FL +G LG + I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 547 IEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI 606
IA G++YL + +HRDL N L+ +N++ KI DFG++R D ++ R+
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV 181
Query: 607 VG----TYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL 656
G +M PE ++ F+ +SDV+SFGV+L E + + F +N+ +
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 70/250 (28%), Positives = 119/250 (47%), Gaps = 29/250 (11%)
Query: 484 EFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSF-----LFDTTKEGLL 538
+F E+K+ ++L+ N++RLLG CV++ +I EY+ N L+ F L D + G
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 539 GWG-----------ARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISD 587
+ + + IA G+ YL S L +HRDL N L+ N+ KI+D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 588 FGLAR-MFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRST 646
FG++R ++ GD + R V +M+ E + G F+ SDV++FGV L E L +
Sbjct: 182 FGMSRNLYAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240
Query: 647 RFFNTNSLTLLGHAWNLWKDD-RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRP 705
+ ++ +A ++D R L P + Y ++ L C + +RP
Sbjct: 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM-------LQCWSRDCRERP 293
Query: 706 TMSEVISMLT 715
+ S++ + LT
Sbjct: 294 SFSDIHAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 60/215 (27%)
Query: 464 ENKLGEGGFGPVYK-----SGQ-------GLEEFKN-----------EIKLTAKLQHRNL 500
KLGEG + VYK +G+ L E K EIKL +L+H N+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG--------IAQ 552
+ LL + L++E++ +T E ++ I + +
Sbjct: 65 IGLLDVFGHKSNINLVFEFM----------ETDLEKVIK-DKSIVLTPADIKSYMLMTLR 113
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG--GDELQSNTKRIVGTY 610
GL YLH ++HRDLKP+N+L+ S+ + K++DFGLAR FG ++ V T
Sbjct: 114 GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ----VVTR 166
Query: 611 GYMSPEYAIHGFFSIKS-----DVFSFGVLLLETL 640
Y +PE F + D++S G + E L
Sbjct: 167 WYRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 461 FGVENKLGEGGFGPVYK-----SGQ-----------GLEEFKNEIKLTAKLQHRNLVRLL 504
F + KLGEG +G VYK +GQ L+E EI + + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYY 64
Query: 505 GCCVEQGENVLIYEY-----------LPNKSLDSFLFDTTKEGLLGWGARIRII-EGIAQ 552
G + + ++ EY + NK+L I I +
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTE--------------EEIAAILYQTLK 110
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
GL YLH + IHRD+K NILL+ K++DFG++ + NT ++GT +
Sbjct: 111 GLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFW 165
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLE 638
M+PE ++ K+D++S G+ +E
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 75/293 (25%), Positives = 117/293 (39%), Gaps = 79/293 (26%)
Query: 467 LGEGGFGPVY-----KSGQGL------------------EEFKNEIKLTAKLQHRNLVRL 503
LG+G FG VY +G+ L + EI+L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 504 LGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG-----IAQGLLYLH 558
GC + + EY+P S+ K+ L +GA + I +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSV--------KDQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ-SNTKRIVGTYGYMSPEY 617
++HRD+K +NIL DS K+ DFG ++ + K + GT +MSPE
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM---- 673
+ K+DV+S G ++E L+ K W + +E M
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP------------------WAE---FEAMAAIF 217
Query: 674 -------DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719
+P+L S P + ++ ENA RP+ E +L + FV
Sbjct: 218 KIATQPTNPQLPSHVS-PDARNFLR---RTFVENAKKRPSAEE---LLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 72/293 (24%), Positives = 113/293 (38%), Gaps = 69/293 (23%)
Query: 467 LGEGGFGPVYKS-GQGLEEFKNEIKLTAKL------------------------QHRNLV 501
LGEG FG V K+ GL+ + K+ +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG------------ 549
LLG C ++G ++ EY + +L FL G R E
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 550 -IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVG 608
+A+G+ +L + IHRDL N+L+ + + KI+DFGLAR + T
Sbjct: 140 QVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 609 TYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH------AWN 662
+M+PE ++ +SDV+SFGVLL E TL G
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEI--------------FTLGGSPYPGIPVEE 242
Query: 663 LWKDDRSWELMDPKLQCEAS-YPIVKRYINVALLCVQENAADRPTMSEVISML 714
L+K + M+ C Y +++ C E + RPT +++ L
Sbjct: 243 LFKLLKEGYRMEKPQNCTQELYHLMRD-------CWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 33/199 (16%)
Query: 466 KLGEGGFGPVYK-----SGQ--GLEEFK-------------NEIKLTAKLQHRNLVRLLG 505
K+GEG +G VYK +G+ +++ K EIKL +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWG-ARIR-IIEGIAQGLLYLHQYSRL 563
+G+ L++E++ D+ L+ K+ G + I+ + + QGL + H +
Sbjct: 66 VFRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH-GF 622
++HRDLKP N+L+++ + K++DFGLAR FG V T Y +PE +
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKG 175
Query: 623 FSIKSDVFSFGVLLLETLS 641
+S D++S G + E LS
Sbjct: 176 YSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 28/199 (14%)
Query: 463 VENKLGEGGFGPVY-------KSGQGLEEFKN----------------EIKLTAKLQHRN 499
++ +LG+G FG VY + + L+ K E +L +KL H
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
+V+ +E+ +I EY + LD L + G + ++ E Q LL +H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL--SENQVCEWFIQLLLGVHY 121
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI 619
+ R++HRDLK NI L +N++ KI DFG++R+ G + T GT YMSPE
Sbjct: 122 MHQRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALK 178
Query: 620 HGFFSIKSDVFSFGVLLLE 638
H + KSD++S G +L E
Sbjct: 179 HQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 54/165 (32%), Positives = 90/165 (54%), Gaps = 16/165 (9%)
Query: 483 EEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGA 542
++F +E + + H N++RL G + ++I EY+ N +LD +L D +G
Sbjct: 51 QDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQ 108
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602
+ ++ GIA G+ YL S + +HRDL NIL++SN+ K+SDFGL+R+ D +
Sbjct: 109 LVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY 165
Query: 603 TKRIVGTYG------YMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
T T G + +PE + F+ SDV+SFG+++ E +S
Sbjct: 166 T-----TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 83/290 (28%), Positives = 125/290 (43%), Gaps = 67/290 (23%)
Query: 466 KLGEGGFGPVY-----------------KSG-QGLEEFKN---EIKLTAKLQHRNLVRLL 504
++G G FG VY SG Q E++++ E++ +L+H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 505 GCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL--LGWGARIRIIEGIAQGLLYLHQYSR 562
GC + + L+ EY + D + + K+ L + A I G QGL YLH + R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEIAA---ICHGALQGLAYLHSHER 136
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI--- 619
IHRD+K NILL K++DFG A L S VGT +M+PE +
Sbjct: 137 ---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVILAMD 187
Query: 620 HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH-AWN----LWKDDRSWELMD 674
G + K DV+S G+ +E ++R FN N+++ L H A N L +D S
Sbjct: 188 EGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDY--- 242
Query: 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSP 724
+ N C+Q+ DRP+ E +L + FV P
Sbjct: 243 --------------FRNFVDSCLQKIPQDRPSSEE---LLKHRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 53/172 (30%), Positives = 85/172 (49%), Gaps = 8/172 (4%)
Query: 486 KNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR 545
+NE ++ L H N++ +E +++ EY P +L ++ L
Sbjct: 47 QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLL----DEDT 102
Query: 546 IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGLARMFGGDELQSNTK 604
I+ Q LL LH ++HRDLK NILLD + M+ KI DFG++++ +S
Sbjct: 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAY 159
Query: 605 RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL 656
+VGT Y+SPE ++ KSD+++ G +L E S KR+ N +L L
Sbjct: 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 69/240 (28%), Positives = 115/240 (47%), Gaps = 24/240 (10%)
Query: 477 KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEG 536
K ++E + E++ ++ H N+V+ V E L+ YL SL + + G
Sbjct: 38 KCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRG 97
Query: 537 LLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF-- 594
L +++ + +GL YLH + IHRD+K NILL + KI+DFG++
Sbjct: 98 GLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLAD 154
Query: 595 GGDELQSNTKRIVGTYGYMSPE--YAIHGFFSIKSDVFSFGVLLLETLSSKRS--TRFFN 650
GGD + K VGT +M+PE +HG + K+D++SFG+ +E L++ + +++
Sbjct: 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHG-YDFKADIWSFGITAIE-LATGAAPYSKYPP 212
Query: 651 TNSLTLLGHAWNLWKDDRSWELMDPKLQCEASY-PIVKRYINVALLCVQENAADRPTMSE 709
L L L D P L+ A Y K + + LC+Q++ + RPT E
Sbjct: 213 MKVLMLT-----LQND-------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 84/299 (28%)
Query: 465 NKLGEGGFGPVYK-----SG---------------QGLEEFKNEIKLTAKLQHRNLVRLL 504
NK+G G FG VY +G + ++E +E+K+ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 505 GCCVEQGENVLIY-EYLPNKSLDSFLFDTTKEGLLGWGARIR-----IIEGIAQGLLYLH 558
G V + E V I+ EY +L+ L + G + IR ++EG+A YLH
Sbjct: 66 GVEVHR-EKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLA----YLH 116
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI-------VGTYG 611
+ ++HRD+KP+NI LD N + K+ DFG A L++NT + GT
Sbjct: 117 SH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVK-----LKNNTTTMGEEVQSLAGTPA 168
Query: 612 YMSPEYAIHGFFSIK---SDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR 668
YM+PE G +D++S G ++LE + KR +
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---------------- 212
Query: 669 SWELM-------DPKL-QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719
+++M P + P K +++ C++ + RPT SE +L + FV
Sbjct: 213 -FQIMFHVGAGHKPPIPDSLQLSPEGKDFLD---RCLESDPKKRPTASE---LLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 55/168 (32%), Positives = 93/168 (55%), Gaps = 14/168 (8%)
Query: 482 LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL--FDTTKEGLLG 539
L+ EI L +LQH N+V+ LG ++ + EY+P S+ + L + +E L+
Sbjct: 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR 109
Query: 540 WGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599
+ I +GL YLH +R +IHRD+K +NIL+D+ KISDFG+++ + L
Sbjct: 110 -----NFVRQILKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161
Query: 600 QS--NTKR--IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
+ N R + G+ +M+PE ++ K+D++S G L++E L+ K
Sbjct: 162 STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 44/220 (20%)
Query: 459 NNFGVENKLGEGGFGPVY-----------------------KSGQGLEEFKNEIKLTAKL 495
+N ++ +LGEG FG V+ S ++F E +L L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 496 QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL----------LGWGARIR 545
QH ++V+ G CVE ++++EY+ + L+ FL + + L +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 546 IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR 605
I + IA G++YL + +HRDL N L+ N++ KI DFG++R D ++ R
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYR 177
Query: 606 IVG----TYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+ G +M PE ++ F+ +SDV+S GV+L E +
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 30/204 (14%)
Query: 463 VENKLGEGGFGPVY-------------------KSG---QGLEEFKNEIKLTAKLQHRNL 500
+E +G G FG V KSG + +F +E + + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
+ L G + ++I E++ N +LDSFL +G + ++ GIA G+ YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVG---TYGYMSPEY 617
S + +HRDL NIL++SN++ K+SDFGL+R D +G + +PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 618 AIHGFFSIKSDVFSFGVLLLETLS 641
+ F+ SDV+S+G+++ E +S
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 36/198 (18%)
Query: 466 KLGEGGFGPVYK-----SGQ-------GLEEFKN--------EIKLTAKLQHRNLVRLLG 505
K+GEG +G VYK +G+ LE EI L +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG----IAQGLLYLHQYS 561
+ + L++E+L + L ++ D++ L +I+ + QG+ Y H +
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLD----PPLIKSYLYQLLQGIAYCHSH- 118
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG 621
RV+HRDLKP N+L+D K++DFGLAR F G +++ T +V T Y +PE +
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGS 174
Query: 622 -FFSIKSDVFSFGVLLLE 638
+S D++S G + E
Sbjct: 175 RQYSTPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 68/216 (31%), Positives = 101/216 (46%), Gaps = 46/216 (21%)
Query: 466 KLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+LGE FG VYK G EEFK+E + ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLF-------------DTTKEGLLGWGARIRIIE 548
LLG ++ +I+ Y + L FL D T + L + I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 549 GIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGD--ELQSNTKR 605
IA G+ +L S V+H+DL N+L+ + KISD GL R ++ D +L N+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 606 IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+ +MSPE ++G FSI SD++S+GV+L E S
Sbjct: 189 PI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 76/283 (26%), Positives = 119/283 (42%), Gaps = 63/283 (22%)
Query: 460 NFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRN 499
+F V KLG+G +G VYK S + E+ NEI++ A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 500 LVR-----LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEG-LLGWGARIRIIEGIAQG 553
++ L G + ++ EY P L + K+ L+ RI + +G
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 554 LLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN-TKRIVGTYGY 612
L LH+ +++HRDLK +NILL +N + KI D G++++ L+ N K +GT Y
Sbjct: 116 LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV-----LKKNMAKTQIGTPHY 167
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672
M+PE +S KSD++S G LL E + F RS +
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP---FEA----------------RSMQD 208
Query: 673 MDPKLQCEASYPIVKRY----INVALLCVQENAADRPTMSEVI 711
+ K+Q PI Y N +Q RP +++
Sbjct: 209 LRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 79/315 (25%), Positives = 126/315 (40%), Gaps = 80/315 (25%)
Query: 460 NFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKL 495
N + LGEG FG V K S L + +E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 496 QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGAR------------ 543
H ++++L G C + G +LI EY SL SFL ++ K G G+
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 544 ---------IRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594
I I++G+ YL + ++++HRDL N+L+ KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 595 GGDELQSNTKRIVG--TYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN 652
++ S KR G +M+ E ++ +SDV+SFGVLL E
Sbjct: 178 YEED--SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI------------- 222
Query: 653 SLTLLGHAW------NLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRP 705
+TL G+ + L+ ++ M+ C E Y ++ C ++ RP
Sbjct: 223 -VTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLT-------CWKQEPDKRP 274
Query: 706 TMSEVISMLTNEFVN 720
T +++ L V
Sbjct: 275 TFADISKELEKMMVK 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 66/214 (30%), Positives = 97/214 (45%), Gaps = 42/214 (19%)
Query: 466 KLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
+LGE FG +YK + Q EF+ E L A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLF--------------DTTKEGLLGWGARIRIIE 548
LLG ++ +++EYL L FL D T + L G + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 549 GIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDELQSNTKRIV 607
IA G+ YL + +H+DL NIL+ + KISD GL+R ++ D + K ++
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+M PE ++G FS SD++SFGV+L E S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 67/226 (29%), Positives = 102/226 (45%), Gaps = 47/226 (20%)
Query: 459 NNFGVENKLGEGGFGPVYK-SGQGLEEF----------------------------KN-- 487
++ KLGEG FG V+ +GL EF +N
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 488 --EIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR 545
EIK+ ++L++ N++RLLG CV +I EY+ N L+ FL E I
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 546 IIE---------GIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFG 595
+ IA G+ YL + L +HRDL N L+ ++ KI+DFG++R ++
Sbjct: 125 SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181
Query: 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
GD + R V +M+ E + G F+ SDV++FGV L E +
Sbjct: 182 GDYYRIQ-GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 68/248 (27%), Positives = 116/248 (46%), Gaps = 48/248 (19%)
Query: 482 LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL-IY-EYLPNKSLDSFLFDTTK--EGL 537
++ ++EI+ L H N+V+ LG E E L I+ EY+P S+ S L + E L
Sbjct: 52 VKALRSEIETLKDLDHLNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL 109
Query: 538 LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597
+ + E + +GL YLH ++HRDLK N+L+D++ I KISDFG+++ D
Sbjct: 110 VRF-----FTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SD 159
Query: 598 ELQSN--TKRIVGTYGYMSPEYAIHGF---FSIKSDVFSFGVLLLETLSSKRSTRFFNTN 652
++ N + G+ +M+PE IH + +S K D++S G ++LE + +R
Sbjct: 160 DIYDNDQNMSMQGSVFWMAPE-VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP------- 211
Query: 653 SLTLLGHAWNLWKDDRSWELM--------DPKLQCEASYPIVKRYINVALLCVQENAADR 704
W D+ + M P + + S + ++ C N +R
Sbjct: 212 -----------WSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNR 260
Query: 705 PTMSEVIS 712
PT E++
Sbjct: 261 PTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 54/233 (23%), Positives = 85/233 (36%), Gaps = 62/233 (26%)
Query: 459 NNFGVENKLGEGGFGPVYKSGQGLEEFK-------NEIKLT---------------AKL- 495
++F +GEG F V + E K ++ +L +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVL-AKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN 59
Query: 496 QHRNLVRLLGCCVEQGENVLIYEYLPN-------KSLDSFLFDTTKEGLLGWGARIRIIE 548
H +++L ++ + EY PN + S T+
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR----------FYAA 109
Query: 549 GIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL--------- 599
I L YLH +IHRDLKP NILLD +M KI+DFG A++ +
Sbjct: 110 EILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 600 ---------QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
+ VGT Y+SPE SD+++ G ++ + L+ K
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 59/171 (34%), Positives = 88/171 (51%), Gaps = 27/171 (15%)
Query: 483 EEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEY-----LPN---KSLDSFLFDTT 533
E +E+K+ + L H N+V LLG C G ++I EY L N + +SFL T
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFL---T 139
Query: 534 KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593
E LL + ++ A+G+ +L + IHRDL N+LL I KI DFGLAR
Sbjct: 140 LEDLLSFSYQV------AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190
Query: 594 FGGDE---LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
D ++ N + V +M+PE + ++ +SDV+S+G+LL E S
Sbjct: 191 IMNDSNYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-18
Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 35/203 (17%)
Query: 467 LGEGGFGPV-----------------YKS------GQGLEEFKNEIKLTAKLQHRNLVRL 503
LGEG FG V KS G + + K EI++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 504 LGCCVEQGEN--VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL--HQ 559
G C E G N LI E+LP+ SL +L + + +++ I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT-YGYMSPEYA 618
Y +HRDL N+L++S KI DFGL + D+ K + + + +PE
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 619 IHGFFSIKSDVFSFGVLLLETLS 641
I F I SDV+SFGV L E L+
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 54/141 (38%), Positives = 68/141 (48%), Gaps = 28/141 (19%)
Query: 515 LIYEYLPNKSLDSFL-----FDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRD 569
L+ EYLP L S L D ARI I E I L YLH +IHRD
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDV-------ARIYIAE-IVLALEYLHSNG---IIHRD 118
Query: 570 LKPSNILLDSNMIPKISDFGLA------RMFGGDELQSNTKRIVGTYGYMSPEYAI---H 620
LKP NIL+DSN K++DFGL+ R ++ + KRIVGT Y++PE + H
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 621 GFFSIKSDVFSFGVLLLETLS 641
D +S G +L E L
Sbjct: 179 SK---TVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 42/115 (36%), Positives = 54/115 (46%), Gaps = 10/115 (8%)
Query: 542 ARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601
+ I E I L YLH +IHRD+KP NILLD I+DF +A D
Sbjct: 102 VKFWICE-IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--- 154
Query: 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL 656
T GT GYM+PE +S+ D +S GV E L R R + +S T+
Sbjct: 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL---RGKRPYRGHSRTI 206
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 73/285 (25%), Positives = 115/285 (40%), Gaps = 60/285 (21%)
Query: 467 LGEGGFGPVYKS-GQGLE-----------------------EFKNEIKLTAKLQHRNLVR 502
LG+G FG VY+ +G+ EF NE + + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLF----DTTKEGLLGWGARIRIIE---GIAQGLL 555
LLG +++ E + L S+L + LG + I+ IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT----YG 611
YL + +HRDL N ++ ++ KI DFG+ R D +++ R G
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 612 YMSPEYAIHGFFSIKSDVFSFGVLLLE--TLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS 669
+M+PE G F+ KSDV+SFGV+L E TL+ + N L +
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI----------D 236
Query: 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714
+D C + + + +C Q N RPT E++S L
Sbjct: 237 GGHLDLPENCP------DKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 49/281 (17%)
Query: 460 NFGVENKLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQHR 498
NF +E K+G G F VY++ + + EI L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLL-----GWGARIRIIEGIAQG 553
N+++ +E E ++ E L + K+ L W +++ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 554 LLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYM 613
H +SR RV+HRD+KP+N+ + + + K+ D GL R F +++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 614 SPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673
SPE ++ KSD++S G LL E + + + F+ G NL+ + E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFY--------GDKMNLYSLCKKIEQC 223
Query: 674 D-PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713
D P L + +++ +N +C+ + RP ++ V +
Sbjct: 224 DYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 37/202 (18%)
Query: 467 LGEGGFGPVYK-----SGQGLE------------------EFKNEIKLTAKLQHRNLVRL 503
LG G FG VYK G+ ++ EF +E + A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 504 LGCCVEQGENVLIYEYLPNKSLDSFLFD----TTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
LG C+ L+ + +P+ L ++ + + LL W +I A+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI 619
R++HRDL N+L+ S KI+DFGLAR+ GDE + N +M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 620 HGFFSIKSDVFSFGVLLLETLS 641
+ F+ +SDV+S+GV + E ++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 61/194 (31%), Positives = 94/194 (48%), Gaps = 26/194 (13%)
Query: 467 LGEGGFGPVYKSG-----------------QGLE-EFKNEIKLTAKLQHRNLVRLLGCCV 508
LG+G FG V+K Q L+ +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 509 EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHR 568
++ ++ E +P SFL E L ++ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 569 DLKPSNILLDSNMIPKISDFGLARMF-GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKS 627
DL N L+ N + KISDFG++R G S K+I + +PE +G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 628 DVFSFGVLLLETLS 641
DV+S+G+LL ET S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 44/193 (22%)
Query: 455 SAATNNFGVENKLGEGGFGPVYKSGQG------------LEEFKN--------EIKLTAK 494
+ ++ + KLGEG FG VYK+ Q + K+ EIK+ K
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKK 63
Query: 495 LQHRNLVRLLGCCVEQGENVL-----IYEYLPNKSLDSFLFDTTKEGLLGWGARIR---- 545
L+H N+V L+ VE+ + +Y P +D L GLL ++
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP--YMDHDL-----SGLLE-NPSVKLTES 115
Query: 546 ----IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601
+ + +G+ YLH+ ++HRD+K +NIL+D+ I KI+DFGLAR + G
Sbjct: 116 QIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 602 NTKRIVGTYGYMS 614
GT Y +
Sbjct: 173 KGGGGGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 35/205 (17%)
Query: 460 NFGVENKLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQHR 498
NF +E K+G G F VY++ + ++ EI L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLL-----GWGARIRIIEGIAQG 553
N+++ L +E E ++ E L + K+ L W +++ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 554 LLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYM 613
H +SR RV+HRD+KP+N+ + + + K+ D GL R F +++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 614 SPEYAIHGFFSIKSDVFSFGVLLLE 638
SPE ++ KSD++S G LL E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 9e-17
Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 487 NEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRI 546
+EI KLQH N+V+L+G C + LI+EY+ K+L L + L W R +I
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKI 785
Query: 547 IEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI 606
GIA+ L +LH V+ +L P I++D P + L + D I
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFI 840
Query: 607 VGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD 666
+ Y++PE + KSD++ FG++L+E L+ K +++ A + D
Sbjct: 841 --SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD 898
Query: 667 DRSWELMDPKLQCEASYPIVKRYI----NVALLCVQENAADRPTMSEVISML 714
+DP ++ + S + + I N+AL C + RP ++V+ L
Sbjct: 899 CHLDMWIDPSIRGDVS--VNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 9e-17
Identities = 53/159 (33%), Positives = 81/159 (50%), Gaps = 16/159 (10%)
Query: 496 QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL-----------FDTTK--EGLLGWGA 542
+H+N++ LLG C ++G +I EY +L FL FD TK E L +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602
+ +A+G+ YL SR R IHRDL N+L+ + + KI+DFGLAR +
Sbjct: 136 LVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
T +M+PE ++ +SDV+SFG+L+ E +
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 36/198 (18%)
Query: 467 LGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCV 508
LG+G FG VYK S + LE+F EI + ++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 509 EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRII-EGIAQGLLYLHQYSRLRVIH 567
+ + ++ E+ +LDS + + GL +IR + + + L +LH + +VIH
Sbjct: 73 YENKLWILIEFCDGGALDS-IMLELERGLTE--PQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 568 RDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR--IVGTYGYMSPEYAIHGFFS- 624
RDLK NILL + K++DFG++ LQ KR +GT +M+PE F
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ---KRDTFIGTPYWMAPEVVACETFKD 182
Query: 625 ----IKSDVFSFGVLLLE 638
K+D++S G+ L+E
Sbjct: 183 NPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-16
Identities = 83/313 (26%), Positives = 136/313 (43%), Gaps = 60/313 (19%)
Query: 466 KLGEGGFGPVY---------------------KSGQGLEEFKNEIKLTAKLQHRNLVRLL 504
++G G FG VY +S + ++ E+K +++H N +
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 505 GCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL--LGWGARIRIIEGIAQGLLYLHQYSR 562
GC + + L+ EY + D L + K+ L + A I G QGL YLH ++
Sbjct: 92 GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA---ITHGALQGLAYLHSHN- 145
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI--- 619
+IHRD+K NILL K++DFG A + S VGT +M+PE +
Sbjct: 146 --MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVILAMD 197
Query: 620 HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH-AWNLWKDDRSWELMDPKLQ 678
G + K DV+S G+ +E ++R FN N+++ L H A N P LQ
Sbjct: 198 EGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQN----------ESPTLQ 245
Query: 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKKSVET 738
+ +++ C+Q+ DRPT E +L + FV P+ ++++ +
Sbjct: 246 SNEWSDYFRNFVDS---CLQKIPQDRPTSEE---LLKHMFVLRERPETVLIDLIQRTKDA 299
Query: 739 VARSMNRLTLSVM 751
V R ++ L M
Sbjct: 300 V-RELDNLQYRKM 311
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 80/313 (25%), Positives = 139/313 (44%), Gaps = 58/313 (18%)
Query: 465 NKLGEGGFGPVY---------------------KSGQGLEEFKNEIKLTAKLQHRNLVRL 503
+++G G FG VY ++ + ++ E+K +L+H N +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 504 LGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL--LGWGARIRIIEGIAQGLLYLHQYS 561
GC +++ L+ EY + D L + K+ L + A I G QGL YLH ++
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA---ITHGALQGLAYLHSHN 141
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI-- 619
IHRD+K NILL K++DFG A S VGT +M+PE +
Sbjct: 142 M---IHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAM 192
Query: 620 -HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678
G + K DV+S G+ +E ++R FN N+++ L H + ++D P LQ
Sbjct: 193 DEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---IAQND------SPTLQ 241
Query: 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKKSVET 738
+ +++ C+Q+ +RP +E +L ++FV P + ++++ +
Sbjct: 242 SNEWTDSFRGFVD---YCLQKIPQERPASAE---LLRHDFVRRDRPARVLIDLIQRTKDA 295
Query: 739 VARSMNRLTLSVM 751
V R ++ L M
Sbjct: 296 V-RELDNLQYRKM 307
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQ--GLEEFKN-------------EIKLTAKLQHR 498
N + V +GEG +G V K +G+ +++FK E+K+ +L+H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH 558
N+V L +G L++EY+ L+ L + + GL A I + Q + Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGL-PPDAVRSYIWQLLQAIAYCH 117
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
+IHRD+KP NIL+ + + K+ DFG AR S V T Y +PE
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP-ASPLTDYVATRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 45/215 (20%)
Query: 464 ENKLGEGGFGPV---------------------YKSGQGLEEFKNEIKLTAKL-QHRNLV 501
E+ +GEG FG V + S +F E+++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDT---------TKE----GLLGWGARIRIIE 548
LLG C +G + EY P +L FL + KE L ++
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 549 GIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVG 608
+A G+ YL S + IHRDL N+L+ N+ KI+DFGL+R G+E+ K+ +G
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--VKKTMG 178
Query: 609 TYG--YMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+M+ E + ++ KSDV+SFGVLL E +S
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 84/313 (26%), Positives = 138/313 (44%), Gaps = 60/313 (19%)
Query: 466 KLGEGGFGPVY---------------------KSGQGLEEFKNEIKLTAKLQHRNLVRLL 504
++G G FG VY +S + ++ E++ KL+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 505 GCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL--LGWGARIRIIEGIAQGLLYLHQYSR 562
GC + + L+ EY + D L + K+ L + A + G QGL YLH ++
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA---VTHGALQGLAYLHSHN- 135
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI--- 619
+IHRD+K NILL + K+ DFG A + + VGT +M+PE +
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVILAMD 187
Query: 620 HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH-AWNLWKDDRSWELMDPKLQ 678
G + K DV+S G+ +E ++R FN N+++ L H A N P LQ
Sbjct: 188 EGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQN----------ESPALQ 235
Query: 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKKSVET 738
+ +++ C+Q+ DRPT SEV +L + FV P ++++ +
Sbjct: 236 SGHWSEYFRNFVDS---CLQKIPQDRPT-SEV--LLKHRFVLRERPPTVIMDLIQRTKDA 289
Query: 739 VARSMNRLTLSVM 751
V R ++ L M
Sbjct: 290 V-RELDNLQYRKM 301
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 24/193 (12%)
Query: 467 LGEGGFGPVY--------------KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ-G 511
+G+G FG V K+ + F E + +L+H NLV+LLG VE+ G
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73
Query: 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLK 571
++ EY+ SL +L + +LG ++ + + + YL + +HRDL
Sbjct: 74 GLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLA 129
Query: 572 PSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFS 631
N+L+ + + K+SDFGL + Q K V + +PE FS KSDV+S
Sbjct: 130 ARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWS 184
Query: 632 FGVLLLETLSSKR 644
FG+LL E S R
Sbjct: 185 FGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 36/94 (38%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I GL +LHQ R+++RDLKP N+LLD + +ISD GLA G K GT
Sbjct: 104 IICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
GYM+PE + D F+ G L E ++ +
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 33/206 (16%)
Query: 465 NKLGEGGFGPVY----KSGQGL-------------------EEFKNEIKLTAKLQHRNLV 501
LG+G +G VY GQ + E+ + E+ L L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
+ LG C++ + E++P S+ S L + G L + + I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLAR---MFGGDELQSNT-KRIVGTYGYMSPEY 617
V+HRD+K +N++L N I K+ DFG AR G SN K + GT +M+PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSK 643
+ KSD++S G + E + K
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 44/226 (19%)
Query: 460 NFGVENKLGEGGFGPVY--------------------KSGQGLEEFKNEIKLTAKLQHRN 499
+ + K+GEG FG +Y + E K E+ L AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSL-------DSFLFDTTKEGLLGWGARIRIIEGIAQ 552
+V E G ++ EY L LF +++ +L W + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ISL 112
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGLARMFGGDELQSNTKRIVGTYG 611
GL ++H +++HRD+K NI L N M+ K+ DFG+AR + T VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167
Query: 612 YMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLL 657
Y+SPE + ++ K+D++S G +L E + K F N+L L
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP---FEGNNLHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 57/226 (25%)
Query: 459 NNFGVENKLGEGGFGPV---------------------YKSGQGLEEFKNEIKLTAKL-Q 496
N+ ++ +GEG FG V Y S +F E+++ KL
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 497 HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDT-------------------TKEGL 537
H N++ LLG C +G L EY P+ +L FL + + + L
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 538 LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597
L + A +A+G+ YL Q + IHRDL NIL+ N + KI+DFGL+R G
Sbjct: 127 LHFAA------DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQ 174
Query: 598 ELQSNTKRIVGTYG--YMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
E+ K+ +G +M+ E + ++ SDV+S+GVLL E +S
Sbjct: 175 EVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 77/284 (27%), Positives = 123/284 (43%), Gaps = 68/284 (23%)
Query: 467 LGEGGFGPVYK-----SGQGLEEFKNEIKLTAKLQHR---------------NLVRLLGC 506
LG G +G V K +G + + + ++ Q R V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 507 CVEQGENVLIYEYLPNKSLDSF---LFD---TTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
+G+ V I + + SLD F ++D T E +LG +I I + L YLH
Sbjct: 69 LFREGD-VWICMEVMDTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYLH-- 120
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI-VGTYGYMSPEYAI 619
S+L VIHRD+KPSN+L++ N K+ DFG++ G + S K I G YM+PE I
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAPE-RI 175
Query: 620 HG-----FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD-----DRS 669
+ + +KSDV+S G+ ++E L ++ WK +
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIE---------------LATGRFPYDSWKTPFQQLKQV 220
Query: 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713
E P+L E P + ++N C+++N +RP E++
Sbjct: 221 VEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 34/200 (17%)
Query: 461 FGVENKLGEGGFGPVYK-----SGQ--------------GLEEFKNEIKLTAKLQHRNLV 501
F + +G+G FG VYK + Q +E+ + EI+ ++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
+ G ++ + +I EY S D K G L I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR---IVGTYGYMSPEYA 618
IHRD+K +NILL K++DFG++ +L S + VGT +M+PE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 619 IHGFFSIKSDVFSFGVLLLE 638
+ K+D++S G+ +E
Sbjct: 171 KQSGYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 35/175 (20%)
Query: 466 KLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKLQHRNLVRLLG 505
++GEG G V+K+ G + EIK QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLL----YLHQYS 561
VL+ EY+P+ L L D + ++ + LL Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERP------LPEAQVKSYMRMLLKGVAYMHA-- 117
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
++HRDLKP+N+L+ ++ + KI+DFGLAR+F +E + + + V T Y +PE
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 57/199 (28%), Positives = 83/199 (41%), Gaps = 38/199 (19%)
Query: 467 LGEGGFGPVYK--------------------SGQGLEE-FKNEIKLTAKLQHRNLVRLLG 505
LG GGFG V G +E +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLG-WGARIRIIEGIAQGLLYLHQYSRLR 564
++ ++ EY L + L D GL + AR I + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARF-YIACVVLAFEYLH---NRG 113
Query: 565 VIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI---HG 621
+I+RDLKP N+LLDSN K+ DFG A+ + T GT Y++PE + +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD 170
Query: 622 FFSIKSDVFSFGVLLLETL 640
F D +S G+LL E L
Sbjct: 171 FS---VDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 38/203 (18%)
Query: 465 NKLGEGGFGPVYKSGQGLEEFK---------------------NEIKLTAKLQ---HRNL 500
++GEG +G VYK + L + EI L +L+ H N+
Sbjct: 5 AEIGEGAYGTVYK-ARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 501 VRLLGCC-VEQGEN----VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLL 555
VRLL C + + L++E++ ++ L ++L K GL + ++ + +G+
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVD 121
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSP 615
+LH + R++HRDLKP NIL+ S+ KI+DFGLAR++ + +V T Y +P
Sbjct: 122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAP 175
Query: 616 EYAIHGFFSIKSDVFSFGVLLLE 638
E + ++ D++S G + E
Sbjct: 176 EVLLQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 37/204 (18%)
Query: 466 KLGEGGFGPVYKSGQ-------GLEEFK-------------NEIKLTAKLQHRNLVRLLG 505
K+GEG +G VYK+ L++ + EI L ++QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG----IAQGLLYLHQYS 561
+ L++EYL + L + D++ + + R+I+ I +G+ Y H +
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM-DSSPD----FAKNPRLIKTYLYQILRGIAYCHSH- 121
Query: 562 RLRVIHRDLKPSNILLD-SNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH 620
RV+HRDLKP N+L+D K++DFGLAR F G +++ T +V T Y +PE +
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEILLG 177
Query: 621 G-FFSIKSDVFSFGVLLLETLSSK 643
+S D++S G + E ++ K
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 41/210 (19%)
Query: 467 LGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNLVRL 503
LGEG FG V + + +EEF +E H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 504 LGCCVEQGEN------VLIYEYLPNKSLDSFLFDTTKEGL---LGWGARIRIIEGIAQGL 554
+G C E ++I ++ + L SFL + GL L ++ + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 555 LYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDELQSN--TKRIVGTYG 611
YL S IHRDL N +L +M ++DFGL++ ++ GD + K V
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---K 180
Query: 612 YMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+++ E ++ KSDV++FGV + E +
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 45/212 (21%)
Query: 467 LGEGGFGPV---------------------YKSGQGLEEFKNEIKLTAKL-QHRNLVRLL 504
+GEG FG V Y S +F E+++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 505 GCCVEQGENVLIYEYLPNKSLDSFLFDTT-------------KEGLLGWGARIRIIEGIA 551
G C +G L EY P+ +L FL + L + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG 611
+G+ YL S+ + IHRDL NIL+ N + KI+DFGL+R G E+ K+ +G
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGRLP 174
Query: 612 --YMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+M+ E + ++ SDV+S+GVLL E +S
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-15
Identities = 26/74 (35%), Positives = 38/74 (51%), Gaps = 8/74 (10%)
Query: 337 DCKSG---DRFIMVDDIKLPDLLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSG 393
+C D F+ + D+KLPD N S +++L+EC CL N +C AYA + G
Sbjct: 4 NCGGDGSTDGFLKLPDVKLPD--NASAITAISLEECREACLSNCSCTAYAYNNG---SGG 58
Query: 394 CLMWYGDLIDTTKA 407
CL+W G L +
Sbjct: 59 CLLWNGLLNNLRSL 72
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 495 LQHRNLVRLLGCCVEQGENVLIYEYLPNKS-LDSFLFDTTKEGLLGWGARIRIIE----- 548
L H+N++ +L C+E GE + N L FL + G + +
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQC-RLGEANNPQALSTQQLVHMA 123
Query: 549 -GIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDE--LQSNTK 604
IA G+ YLH + VIH+D+ N ++D + KI+D L+R +F D L N
Sbjct: 124 IQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 605 RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLE 638
R V +M+ E ++ +S SDV+SFGVLL E
Sbjct: 181 RPVK---WMALESLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 47/141 (33%), Positives = 76/141 (53%), Gaps = 13/141 (9%)
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK--EGLLGWGARIRIIEGIAQGLLYL 557
+V G GE + E++ SLD L + E +LG +I + +GL YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYL 115
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
+ + +++HRD+KPSNIL++S K+ DFG++ G + S VGT YMSPE
Sbjct: 116 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 169
Query: 618 AIHGFFSIKSDVFSFGVLLLE 638
++++SD++S G+ L+E
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 4e-15
Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 41/200 (20%)
Query: 466 KLGEGGFGPVYK-----SGQ------------GLEEFKN--EIKLTAKLQ-HRNLVRLLG 505
+LG+G FG VY +G+ EE N E+K KL H N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-IIEGIAQGLLYLHQ--YSR 562
E E ++EY+ +L + ++G + IR II I QGL ++H+ +
Sbjct: 66 VFRENDELYFVFEYM-EGNL--YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF-- 120
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN---TKRIVGTYGYMSPEYAI 619
HRDLKP N+L+ + KI+DFGLAR E++S T V T Y +PE +
Sbjct: 121 ---FHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTRWYRAPEILL 171
Query: 620 H-GFFSIKSDVFSFGVLLLE 638
+S D+++ G ++ E
Sbjct: 172 RSTSYSSPVDIWALGCIMAE 191
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 36/199 (18%)
Query: 466 KLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCC 507
+LG+G FG VYK S + LE++ EI++ A H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 508 VEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRII-EGIAQGLLYLHQYSRLRVI 566
G+ ++ E+ P ++D+ + + + GL +I++I + + L YLH +++I
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDR-GLTE--PQIQVICRQMLEALQYLHS---MKII 132
Query: 567 HRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR--IVGTYGYMSPEYAI----- 619
HRDLK N+LL + K++DFG++ +++ +R +GT +M+PE +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 620 HGFFSIKSDVFSFGVLLLE 638
+ K+D++S G+ L+E
Sbjct: 189 DTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 54/156 (34%), Positives = 81/156 (51%), Gaps = 17/156 (10%)
Query: 488 EIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRII 547
EI++ + H N+V+ GE ++ E++ SL+ E L AR +I+
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT--HIADEQFLADVAR-QIL 178
Query: 548 EGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIV 607
GIA YLH R ++HRD+KPSN+L++S KI+DFG++R+ N+ V
Sbjct: 179 SGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--V 229
Query: 608 GTYGYMSPEYA----IHGFFS-IKSDVFSFGVLLLE 638
GT YMSPE HG + D++S GV +LE
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 465 NKLGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLG 505
++G+G FG VYK + +E+ + EI + ++ + R G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
++ + +I EYL S D K G L I+ I +GL YLH R
Sbjct: 70 SYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSE---RK 122
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSI 625
IHRD+K +N+LL K++DFG+A +++ NT VGT +M+PE +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDF 180
Query: 626 KSDVFSFGVLLLE 638
K+D++S G+ +E
Sbjct: 181 KADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 39/203 (19%)
Query: 467 LGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNLVRL 503
LG G FG V+K Q +E + + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 504 LGCCVEQGENV-LIYEYLPNKSLDSFLF----DTTKEGLLGWGARIRIIEGIAQGLLYLH 558
LG C G ++ L+ + P SL + + LL W +I A+G+ YL
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE 126
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA 618
++ R++HR+L NILL S+ I +I+DFG+A + D+ + +M+ E
Sbjct: 127 EH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 619 IHGFFSIKSDVFSFGVLLLETLS 641
+ G ++ +SDV+S+GV + E +S
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 71/293 (24%), Positives = 121/293 (41%), Gaps = 60/293 (20%)
Query: 460 NFGVENKLGEGGFGPVYK-----SGQGLEEFK------------------------NEIK 490
+ V LG G FG VYK +GQ L K +E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 491 LTAK-LQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI----- 544
+ + L+H N+VR +E ++ + + L F++ KE R
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEK----KQRFTEERI 115
Query: 545 -RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT 603
I + L YLH+ R ++HRDL P+NI+L + I+DFGLA+ + S
Sbjct: 116 WNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE---SKL 170
Query: 604 KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL 663
+VGT Y PE + + K+DV++FG +L + F++TN L+L
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM--CTLQPPFYSTNMLSLATKIV-- 226
Query: 664 WKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
+ +E + + E ++ C+ +A RP + +V +M+++
Sbjct: 227 ---EAVYEPLPEGMYSEDVTDVITS-------CLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 42/208 (20%)
Query: 467 LGEGGFGPVY-----------------------KSGQGLEEFKNEIKLTAKLQHRNLVRL 503
LG+G FG VY ++ + + + EI+L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 504 LGCCVEQGENVL--IYEYLPNKSLDSFLFDTTKEGLLGWGARIRII-----EGIAQGLLY 556
GC ++ E L EY+P S+ K+ L +GA + I +G+ Y
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSV--------KDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR-IVGTYGYMSP 615
LH ++HRD+K +NIL DS K+ DFG ++ + R + GT +MSP
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 616 EYAIHGFFSIKSDVFSFGVLLLETLSSK 643
E + K+DV+S G ++E L+ K
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 16/159 (10%)
Query: 496 QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL-----------FDTTK--EGLLGWGA 542
+H+N++ LLG C + G +I EY +L +L +D + + + +
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602
+ +A+G+ YL + + IHRDL N+L+ N + KI+DFGLAR +
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
T +M+PE ++ +SDV+SFGVL+ E +
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 48/221 (21%)
Query: 466 KLGEGGFGPVYKSGQGLEEFKNEIKLTA----------------------------KLQH 497
++GEG +G V+K+ + KN + A +H
Sbjct: 8 EIGEGAYGKVFKA----RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 63
Query: 498 RNLVRLLGCCV-----EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQ 552
N+VRL C + + L++E++ ++ L ++L + G+ + + + + +
Sbjct: 64 PNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-LLR 121
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
GL +LH + RV+HRDLKP NIL+ S+ K++DFGLAR++ Q +V T Y
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWY 175
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS 653
+PE + ++ D++S G + E R F +S
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 16/159 (10%)
Query: 496 QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL-----------FDTTK--EGLLGWGA 542
+H+N++ LLG C + G ++ EY +L +L FDT K E L +
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602
+ +A+G+ YL + + IHRDL N+L+ + + KI+DFGLAR +
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
T +M+PE ++ +SDV+SFGVLL E +
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-14
Identities = 38/93 (40%), Positives = 54/93 (58%)
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG 611
Q LL +H +IHRD+K +NILL SN + K+ DFG ++M+ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 612 YMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKR 644
Y++PE +S K+D+FS GVLL E L+ KR
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 73/294 (24%), Positives = 126/294 (42%), Gaps = 43/294 (14%)
Query: 449 KSLASVSAATNNFGVENKLGEGGFGPVYKS-----GQGL-------------EEFKNEIK 490
+++ S+ + K+G+G G V+ + GQ + E NEI
Sbjct: 9 RTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEIL 68
Query: 491 LTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGI 550
+ +L++ N+V L + E ++ EYL SL D E + +
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCREC 124
Query: 551 AQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY 610
Q L +LH +VIHRD+K N+LL + K++DFG + QS +VGT
Sbjct: 125 LQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTP 179
Query: 611 GYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670
+M+PE + K D++S G++ +E + + + N N L A L + +
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP--YLNENPL----RALYLIATNGTP 233
Query: 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSP 724
EL +P E PI + ++N C++ + R + E +L + F+ L P
Sbjct: 234 ELQNP----EKLSPIFRDFLN---RCLEMDVEKRGSAKE---LLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-14
Identities = 42/121 (34%), Positives = 66/121 (54%), Gaps = 14/121 (11%)
Query: 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL 577
E++ SLD ++ E +LG RI + +GL YL L+++HRD+KPSN+L+
Sbjct: 79 EFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILHRDVKPSNMLV 128
Query: 578 DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLL 637
++ K+ DFG++ + S K VGT YM+PE + I SDV+S G+ +
Sbjct: 129 NTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFM 184
Query: 638 E 638
E
Sbjct: 185 E 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 11/161 (6%)
Query: 484 EFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGAR 543
+F E ++ + H N+VRL+G C ++ ++ E + +FL T+ L
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKEL 96
Query: 544 IRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT 603
I+++E A G+ YL IHRDL N L+ + KISDFG++R D + ++T
Sbjct: 97 IQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYAST 152
Query: 604 ---KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
K+I + +PE +G +S +SDV+SFG+LL E S
Sbjct: 153 GGMKQI--PVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 24/166 (14%)
Query: 485 FKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI 544
F E + H N+VRL G +++ EY+ N +LDSFL EG L G +
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLM 110
Query: 545 RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTK 604
++ G+A G+ YL S + +H+ L +L++S+++ KIS F LQ +
Sbjct: 111 GMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--------RLQED-- 157
Query: 605 RIVGTYGYMS---------PEYAIHGFFSIKSDVFSFGVLLLETLS 641
+ Y MS PE + FS SDV+SFG+++ E +S
Sbjct: 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 37/202 (18%)
Query: 467 LGEGGFGPVYK-----SGQGL------------------EEFKNEIKLTAKLQHRNLVRL 503
LG G FG VYK G+ + +E +E + A + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 504 LGCCVEQGENVLIYEYLPNKSLDSFLFDTTK----EGLLGWGARIRIIEGIAQGLLYLHQ 559
LG C+ LI + +P L ++ + + LL W +I A+G+ YL +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLEE 127
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI 619
R++HRDL N+L+ + KI+DFGLA++ G DE + + + +M+ E +
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 620 HGFFSIKSDVFSFGVLLLETLS 641
H ++ +SDV+S+GV + E ++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 39/94 (41%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I GL +LHQ R+I+RDLKP N+LLD++ +ISD GLA + QS TK GT
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGT 160
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
G+M+PE + D F+ GV L E ++++
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 60/207 (28%), Positives = 88/207 (42%), Gaps = 45/207 (21%)
Query: 467 LGEGGFGPVY-----KSGQGL------------EEFKNEIKLTAKL-QHRNLVRLLGC-- 506
+GEG +G VY K+GQ + EE K E + K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 507 ----CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR------IIEGIAQGLLY 556
+ L+ E S+ D K GL G R++ I+ +GL Y
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVT----DLVK-GLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
LH+ +VIHRD+K NILL N K+ DFG++ + NT +GT +M+PE
Sbjct: 129 LHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIGTPYWMAPE 183
Query: 617 -----YAIHGFFSIKSDVFSFGVLLLE 638
+ +SDV+S G+ +E
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 47/141 (33%), Positives = 77/141 (54%), Gaps = 13/141 (9%)
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK--EGLLGWGARIRIIEGIAQGLLYL 557
+V G GE + E++ SLD L + + E +LG ++ + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 119
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
+ + +++HRD+KPSNIL++S K+ DFG++ G + S VGT YMSPE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 618 AIHGFFSIKSDVFSFGVLLLE 638
+S++SD++S G+ L+E
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 30/206 (14%)
Query: 460 NFGVENKLGEGGFGPVYKSGQ--------GLEEFK------------NEIKLTAKLQHRN 499
NF KLGEG + VYK G+ L+E EI L +L+H N
Sbjct: 1 NFKQLEKLGEGTYATVYK-GRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHEN 59
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
+VRL + + +L++EY+ +K L ++ G L + +G+ + H+
Sbjct: 60 IVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT-KRIVGTYGYMSPEYA 618
RV+HRDLKP N+L++ K++DFGLAR FG + NT V T Y +P+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWYRAPDVL 172
Query: 619 IHG-FFSIKSDVFSFGVLLLETLSSK 643
+ +S D++S G ++ E ++ +
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 32/201 (15%)
Query: 459 NNFGVENKLGEGGFGPVYKSGQ---GLEEFKNEIKLTAKLQHRN---------------- 499
++F ++LG G G V+K GL + I L K RN
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK--EGLLGWGARIRIIEGIAQGLLYL 557
+V G GE + E++ SLD L + E +LG ++ + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 119
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
+ + +++HRD+KPSNIL++S K+ DFG++ G + S VGT YMSPE
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 618 AIHGFFSIKSDVFSFGVLLLE 638
+S++SD++S G+ L+E
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 17/170 (10%)
Query: 485 FKNEIKLTAKLQHRNLVRLL--GCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGA 542
F+ E L A+L H N+V LL G G ++EY+P ++L L +G L G
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVL---AADGALPAGE 80
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGG--- 596
R++ + L H ++HRDLKP NI++ K+ DFG+ + G
Sbjct: 81 TGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRD 137
Query: 597 -DELQ-SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKR 644
D + T ++GT Y +PE + SD++++G++ LE L+ +R
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 37/97 (38%), Positives = 57/97 (58%), Gaps = 9/97 (9%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I +GL YLH ++HRD+KP N+L++SN + KI DFGLAR+ DE + T+ +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 610 YGYMSPEY---AIHGFFSIKSDVFSFGVLLLETLSSK 643
Y Y +PE + H ++ D++S G + E L +
Sbjct: 169 Y-YRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 43/294 (14%)
Query: 449 KSLASVSAATNNFGVENKLGEGGFGPVYK-----SGQGL-------------EEFKNEIK 490
+S+ SV + K+G+G G VY +GQ + E NEI
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 491 LTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGI 550
+ + ++ N+V L + E ++ EYL SL D E + G +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCREC 125
Query: 551 AQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY 610
Q L +LH +VIHRD+K NILL + K++DFG + QS +VGT
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTP 180
Query: 611 GYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670
+M+PE + K D++S G++ +E + + + N N L A L + +
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPL----RALYLIATNGTP 234
Query: 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSP 724
EL +P E I + ++N C+ + R + E +L ++F+ + P
Sbjct: 235 ELQNP----EKLSAIFRDFLN---RCLDMDVEKRGSAKE---LLQHQFLKIAKP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 54/191 (28%)
Query: 465 NKLGEGGFGPVYKS----------------GQGLEEFK----NEIKLTAKLQHRNLVRLL 504
K+G+G FG V+K+ E F EIK+ L+H N+V L+
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 505 GCC--VEQGEN------VLIYEY--------LPNKSLDSFLFDTTKEGLLGWGARIRIIE 548
C N L++E+ L NK++ F K ++++
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-FTLSEIK----------KVMK 126
Query: 549 GIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG---GDELQSNTKR 605
+ GL Y+H R +++HRD+K +NIL+ + I K++DFGLAR F + T R
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 606 IVGTYGYMSPE 616
+V T Y PE
Sbjct: 184 VV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 496 QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLF-------------DTTKEGLLGWGA 542
+H+N++ LLG C + G +I EY +L +L E L +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602
+ +A+G+ YL + + IHRDL N+L+ + + KI+DFGLAR +
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
T +M+PE ++ +SDV+SFGVLL E +
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 36/205 (17%)
Query: 459 NNFGVENKLGEGGFG----------------------PVYKSGQGLEEFKNEIKLTAKLQ 496
++F LG G FG + K Q +E NE ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 497 HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWG-ARIRIIEGIAQGLL 555
H LV L G + L+ EY+P L S L K G AR + + L
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVARFYAAQ-VVLALE 115
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSP 615
YLH L +++RDLKP N+LLDS+ KI+DFG A+ ++ T + GT Y++P
Sbjct: 116 YLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAP 167
Query: 616 EYAIHGFFSIKSDVFSFGVLLLETL 640
E + + D ++ G+L+ E L
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 74/276 (26%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 467 LGEGGFGPVYKSGQGLEEFKNEIKLTAK-----------------------LQHRNLVRL 503
+G+G FG VY G ++ +I K H N++ L
Sbjct: 3 IGKGHFGCVY-HGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 504 LGCCVEQ-GENVLIYEYLPNKSLDSFLFDTTK----EGLLGWGARIRIIEGIAQGLLYLH 558
LG C+ G +++ Y+ + L +F+ T + L+G+G ++ A+G+ YL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLA 115
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS--NTKRIVGTYGYMSPE 616
+ +HRDL N +LD + K++DFGLAR E S N +M+ E
Sbjct: 116 SK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 617 YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676
F+ KSDV+SFGVLL E L ++ + + + +S + + L + R L+ P+
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWE-LMTRGAPPYPDVDSFDITVY---LLQGRR---LLQPE 225
Query: 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVIS 712
+ Y V L C RPT SE++S
Sbjct: 226 YCPDPLY-------EVMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 44/217 (20%)
Query: 461 FGVENKLGEGGFGPVYKSGQGL----------------EEFK----NEIKLTAKLQHRNL 500
F + ++GEG +G VYK+ E F EIK+ +L HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 501 VRLLGCCV----------EQGENVLIYEYLPNK---SLDSFLFDTTKEGLLGWGARIRII 547
V L ++G L++EY+ + L+S L +++ + +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS------FM 122
Query: 548 EGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIV 607
+ + +GL Y H+ + L HRD+K SNILL++ K++DFGLAR++ +E + T +++
Sbjct: 123 KQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 608 GTYGYMSPEYAI-HGFFSIKSDVFSFGVLLLETLSSK 643
T Y PE + + DV+S G +L E + K
Sbjct: 180 -TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 51/170 (30%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 482 LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN------VLIYEYLPNKSLDSFLF----- 530
+E+F +E + H N++RL+G C++ E+ V+I ++ + L SFL
Sbjct: 44 MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG 103
Query: 531 DTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590
D + L ++ + IA G+ YL S IHRDL N +L+ NM ++DFGL
Sbjct: 104 DCPQ--YLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGL 158
Query: 591 A-RMFGGDELQSNTKRIVGT-YGYMSPEYAIHGFFSIKSDVFSFGVLLLE 638
+ +++ GD + RI +++ E ++ KSDV+SFGV + E
Sbjct: 159 SKKIYNGDYYRQG--RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWE 206
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 43/300 (14%)
Query: 443 ETKTQGKSLASVSAATNNFGVENKLGEGGFGPVY-----KSGQGL-------------EE 484
E + +++ SV + K+G+G G VY +GQ + E
Sbjct: 3 EILEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL 62
Query: 485 FKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI 544
NEI + + +H N+V L + E ++ EYL SL D E + G
Sbjct: 63 IINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIA 118
Query: 545 RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTK 604
+ Q L +LH +VIHRD+K NILL + K++DFG + QS
Sbjct: 119 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRS 173
Query: 605 RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW 664
+VGT +M+PE + K D++S G++ +E + + + N N L A L
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP--YLNENPL----RALYLI 227
Query: 665 KDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSP 724
+ + EL +P E I + ++N C++ + R + E +L + F+ + P
Sbjct: 228 ATNGTPELQNP----EKLSAIFRDFLN---RCLEMDVEKRGSAKE---LLQHPFLKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 46/162 (28%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 483 EEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWG 541
+E E ++ +L + +VR++G C + E + L+ E L+ FL + K+ +
Sbjct: 40 DEMMREAEIMHQLDNPYIVRMIGVC--EAEALMLVMEMASGGPLNKFL--SGKKDEITVS 95
Query: 542 ARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601
+ ++ ++ G+ YL + +HRDL N+LL + KISDFGL++ G D+
Sbjct: 96 NVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SY 151
Query: 602 NTKRIVGTY--GYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
R G + + +PE FS +SDV+S+G+ + E S
Sbjct: 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 31/201 (15%)
Query: 463 VENKLGEGGFGPVYK---SGQG-----------LEEFK-NEIKLTAKLQHR----NLVRL 503
V ++LG+G +G VYK G L+E K N+I + + H+ +V
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 504 LGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRL 563
G +G + EY+ SLD + RI + +GL +L +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122
Query: 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY------ 617
+IHRD+KP+N+L++ N K+ DFG++ G+ + S K +G YM+PE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGP 178
Query: 618 AIHGFFSIKSDVFSFGVLLLE 638
+ ++++SDV+S G+ +LE
Sbjct: 179 NQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 38/207 (18%)
Query: 466 KLGEGGFGPVYK-----SGQ--GLEEFK-------------NEIKLTAKLQ---HRNLVR 502
++G G +G VYK SG L+ + E+ L +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 503 LLGCCV-----EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-IIEGIAQGLLY 556
L+ C + + L++E++ ++ L ++L GL I+ ++ +GL +
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLDF 123
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
LH ++HRDLKP NIL+ S K++DFGLAR++ Q +V T Y +PE
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPE 177
Query: 617 YAIHGFFSIKSDVFSFGVLLLETLSSK 643
+ ++ D++S G + E K
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 56/282 (19%)
Query: 466 KLGEGGFGPVYKS-GQGLE-----------------------EFKNEIKLTAKLQHRNLV 501
+LG+G FG VY+ +G+ EF NE + + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 502 RLLGCCVEQGENVL-IYEYLPNKSLDSFLF-------DTTKEGLLGWGARIRIIEGIAQG 553
RLLG V QG+ L I E + L S+L + + I++ IA G
Sbjct: 73 RLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 554 LLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDELQSNTKRIVGTYGY 612
+ YL+ + +HRDL N ++ + KI DFG+ R ++ D + K ++ +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-W 187
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLE--TLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670
MSPE G F+ SDV+SFGV+L E TL+ + N L + L K D
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCP 247
Query: 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVIS 712
+++ + +C Q N RP+ E+IS
Sbjct: 248 DML----------------FELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 65/256 (25%), Positives = 110/256 (42%), Gaps = 32/256 (12%)
Query: 484 EFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGA- 542
EF NE + ++VRLLG + +++ E + + L S+L E G
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 543 ------RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFG 595
I++ IA G+ YL+ + +HRDL N ++ + KI DFG+ R ++
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLE--TLSSKRSTRFFNTNS 653
D + K ++ M+PE G F+ SD++SFGV+L E +L+ + N
Sbjct: 172 TDYYRKGGKGLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230
Query: 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713
L + L D C +R ++ +C Q N RPT E++++
Sbjct: 231 LKFVMDGGYL----------DQPDNCP------ERVTDLMRMCWQFNPKMRPTFLEIVNL 274
Query: 714 LTNEFVNLPSPQQPGF 729
L ++ PS + F
Sbjct: 275 LKDDL--HPSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 1e-12
Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 42/186 (22%)
Query: 461 FGVENKLGEGGFGPVYK-----SGQGL------EEFKN---------EIKLTAKL-QHRN 499
+ + KLG+G +G V+K + + + + F+N EI +L H N
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPN 68
Query: 500 LVRLLGCCVEQGEN----VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLL 555
+V+LL V + EN L++EY+ ++ L + +L + I+ + + L
Sbjct: 69 IVKLLN--VIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLKALK 121
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI-----VGTY 610
Y+H S VIHRDLKPSNILL+S+ K++DFGLAR EL+ N + V T
Sbjct: 122 YIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDYVATR 176
Query: 611 GYMSPE 616
Y +PE
Sbjct: 177 WYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 42/208 (20%)
Query: 467 LGEGGFGPVY-----------------------KSGQGLEEFKNEIKLTAKLQHRNLVRL 503
LG+G FG VY ++ + + + EI+L L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 504 LGCCVEQGENVL--IYEYLPNKSLDSFLFDTTKEGLLGWGARI-----RIIEGIAQGLLY 556
GC + E L E++P S+ K+ L +GA + I +G+ Y
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSI--------KDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ-SNTKRIVGTYGYMSP 615
LH ++HRD+K +NIL DS K+ DFG ++ L + K + GT +MSP
Sbjct: 122 LHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 616 EYAIHGFFSIKSDVFSFGVLLLETLSSK 643
E + K+D++S G ++E L+ K
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 32/173 (18%)
Query: 466 KLGEGGFGPVYK-----SGQ--GLEEFKN-------------EIKLTAKLQHRNLVRLLG 505
K+GEG +G V+K +GQ +++F EI++ +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
+ + L++EY + L+ + G+ + +II Q + + H+++
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIK-KIIWQTLQAVNFCHKHN---C 121
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLARMF--GGDELQSNTKRIVGTYGYMSPE 616
IHRD+KP NIL+ K+ DFG AR+ GD+ V T Y +PE
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD----YVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 78/314 (24%), Positives = 134/314 (42%), Gaps = 46/314 (14%)
Query: 449 KSLASVSAATNNFGVENKLGEGGFGPVYK-----SGQGL-------------EEFKNEIK 490
+S+ SV + K+G+G G VY +GQ + E NEI
Sbjct: 9 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEIL 68
Query: 491 LTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGI 550
+ + ++ N+V L + E ++ EYL SL D E + G +
Sbjct: 69 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCREC 124
Query: 551 AQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY 610
Q L +LH +VIHRD+K NILL + K++DFG + QS +VGT
Sbjct: 125 LQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTP 179
Query: 611 GYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670
+M+PE + K D++S G++ +E + + + N N L A L + +
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP--YLNENPL----RALYLIATNGTP 233
Query: 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQ---P 727
EL +P E + + ++N C++ + R + E +L + F+ L P P
Sbjct: 234 ELQNP----ERLSAVFRDFLN---RCLEMDVDRRGSAKE---LLQHPFLKLAKPLSSLTP 283
Query: 728 GFSSLKKSVETVAR 741
+ K++++ +R
Sbjct: 284 LIIAAKEAIKNSSR 297
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 37/202 (18%)
Query: 467 LGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNLVRL 503
LG G FG VYK S + +E +E + A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 504 LGCCVEQGENVLIYEYLPNKSLDSFLFDTT----KEGLLGWGARIRIIEGIAQGLLYLHQ 559
LG C+ L+ + +P L ++ + + LL W +I A+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI 619
+R++HRDL N+L+ S KI+DFGLAR+ DE + + +M+ E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 620 HGFFSIKSDVFSFGVLLLETLS 641
H F+ +SDV+S+GV + E ++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 52/213 (24%)
Query: 467 LGEGGFGPVY-----------------------KSGQGLEEFKNEIKLTAKLQHRNLVRL 503
LG G FG VY ++ + + + EI+L L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 504 LGCCVEQGENVL--IYEYLPNKSLDSFLFDTTKEGLLGWGARI-----RIIEGIAQGLLY 556
GC + E L EY+P S+ K+ L +GA R I QG+ Y
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSI--------KDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR------MFGGDELQSNTKRIVGTY 610
LH ++HRD+K +NIL DS K+ DFG ++ M G + K + GT
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG-----TGIKSVTGTP 173
Query: 611 GYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
+MSPE + K+DV+S ++E L+ K
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 27/200 (13%)
Query: 459 NNFGVENKLGEGGFGPV----------------YKSGQGLEEFKN----EIKLTAKLQHR 498
N F V +GEG +G V +K + EE K E+K+ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH 558
N+V L +G+ L++EY+ L+ L + G+ R I + I +H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKA----IH 114
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA 618
+ ++HRD+KP N+L+ N + K+ DFG AR + +N V T Y SPE
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELL 173
Query: 619 IHGFFSIKSDVFSFGVLLLE 638
+ + D++S G +L E
Sbjct: 174 LGAPYGKAVDMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 38/200 (19%)
Query: 465 NKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGC 506
++G G +G VYK+ G E + EI + + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 507 CVEQGENVLIYEYLPNKSLD---SFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRL 563
+ + + ++ EY SL E + + R E + +GL YLH+
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR----ETL-KGLAYLHE---T 120
Query: 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR--IVGTYGYMSPEYA--- 618
IHRD+K +NILL + K++DFG++ + KR +GT +M+PE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLT----ATIAKRKSFIGTPYWMAPEVAAVE 176
Query: 619 IHGFFSIKSDVFSFGVLLLE 638
G + K D+++ G+ +E
Sbjct: 177 RKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 39/211 (18%)
Query: 460 NFGVENKLGEGGFGPVYK-----SGQ--GLEEFK-------------NEIKLTAKLQHRN 499
F N++GEG +G VY+ SG+ L++ + EI L L+H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 500 LVRLLGCCV-EQGENV-LIYEYLPNKSLDSFLFDTTK---EGLLGWGARIR-IIEGIAQG 553
+V L V + +++ L+ EY + L S L + E ++++ ++ + +G
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFSE------SQVKCLMLQLLRG 120
Query: 554 LLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYM 613
L YLH+ +IHRDLK SN+LL KI+DFGLAR + G + T ++V T Y
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYR 175
Query: 614 SPEYAIHGFFSIKS-DVFSFGVLLLETLSSK 643
+PE + + D+++ G +L E L+ K
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 16/164 (9%)
Query: 483 EEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN-VLIYEYLPNKSLDSFLFDTTKEGLLGWG 541
+E E + +L + +VR++G C + E+ +L+ E L+ FL K +
Sbjct: 41 DELLREANVMQQLDNPYIVRMIGIC--EAESWMLVMELAELGPLNKFL---QKNKHVTEK 95
Query: 542 ARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE--- 598
++ ++ G+ YL + + +HRDL N+LL + KISDFGL++ G DE
Sbjct: 96 NITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152
Query: 599 -LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+++ K V Y +PE + FS KSDV+SFGVL+ E S
Sbjct: 153 KAKTHGKWPVKWY---APECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 41/218 (18%)
Query: 461 FGVENKLGEGGFGPVYK-------SGQ--GLEEFK--------------NEIKLTAKLQH 497
+ +E +G G +G VYK G+ +++FK EI L +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 498 RNLVRLLGCCVEQGENV--LIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-IIEGIAQGL 554
N+V L+ +E + L+++Y + F + + + ++ ++ I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 555 LYLHQYSRLRVIHRDLKPSNILLDSNMIP----KISDFGLARMFGGDELQS--NTKRIVG 608
YLH V+HRDLKP+NIL+ KI D GLAR+F L+ + +V
Sbjct: 122 HYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADLDPVVV 177
Query: 609 TYGYMSPEY---AIHGFFSIKSDVFSFGVLLLETLSSK 643
T Y +PE A H +I D+++ G + E L+ +
Sbjct: 178 TIWYRAPELLLGARHYTKAI--DIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 68/296 (22%), Positives = 131/296 (44%), Gaps = 61/296 (20%)
Query: 466 KLGEGGFGPVYK-----SGQGL--------EEFK-------NEIKLTAKLQHRNLVRLLG 505
+GEG +G V K +GQ + E+ K EI++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
+ L++E++ + LD L + + I +G+ + H ++ +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN---I 121
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLARMF-GGDELQSNTKRIVGTYGYMSPEYAIHGF-F 623
IHRD+KP NIL+ + + K+ DFG AR E+ ++ V T Y +PE + +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPELLVGDTKY 178
Query: 624 SIKSDVFSFGVLLLETLSSK-------------RSTRFFNTNSLTLLGHAWNLWKDDRSW 670
D+++ G L+ E L+ + + L+ +++ + +
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG----NLIPRHQEIFQKNPLF 234
Query: 671 ELMD-PKLQCEASYPIVKRY-------INVALLCVQENAADRPTMSEVISMLTNEF 718
M P+++ E P+ KR+ +++A C++ + DRP+ S+ +L +EF
Sbjct: 235 AGMRLPEVK-EIE-PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ---LLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 26/150 (17%)
Query: 466 KLGEGGFGPVYKS-------------------GQGLEEFK-NEIKLTAKLQHRNLVRLLG 505
K+GEG +G V+K+ +G+ EI L +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
+ L++EY ++ L + FD+ G + + + +GL + H + V
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLARMFG 595
+HRDLKP N+L++ N K++DFGLAR FG
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 4e-12
Identities = 46/129 (35%), Positives = 59/129 (45%), Gaps = 38/129 (29%)
Query: 488 EIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSF--------LFDT------- 532
EIKL L+H N++ LL ++L S + F L +T
Sbjct: 49 EIKLLRHLRHENIIGLL--------DILRPP-----SPEDFNDVYIVTELMETDLHKVIK 95
Query: 533 TKEGLLGWGARIRIIEGIAQ---GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589
+ + L I+ + Q GL YLH VIHRDLKPSNIL++SN KI DFG
Sbjct: 96 SPQPLTD--DHIQYF--LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFG 148
Query: 590 LARMFGGDE 598
LAR DE
Sbjct: 149 LARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 32/194 (16%)
Query: 488 EIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN---KSLDS--FLFDTTKEGLLGWGA 542
E+K+ +++H N++ L+ VE L+ + + + K +D L ++ +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKC------ 123
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602
I+ I GL LH++ +HRDL P+NI ++S I KI+DFGLAR +G
Sbjct: 124 ---ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 603 TKRI------------VGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFF 649
+ V T Y +PE + + D++S G + E L+ K F
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK--PLFP 235
Query: 650 NTNSLTLLGHAWNL 663
N + LG + L
Sbjct: 236 GENEIDQLGRIFEL 249
|
Length = 335 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
IA GL +LH +I+RDLK N++LD+ KI+DFG+ + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
GT Y++PE + + D ++FGVLL E L+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 55/200 (27%), Positives = 83/200 (41%), Gaps = 33/200 (16%)
Query: 466 KLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNLVRL 503
+GEG FG VY+ S E+F E + + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 504 LGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRL 563
+G E ++ E P L S+L + L + I ++ L YL
Sbjct: 73 IGVITEN-PVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY--GYMSPEYAIHG 621
R +HRD+ N+L+ S K+ DFGL+R E +S K G +M+PE
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMAPESINFR 183
Query: 622 FFSIKSDVFSFGVLLLETLS 641
F+ SDV+ FGV + E L
Sbjct: 184 RFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 7e-12
Identities = 51/192 (26%), Positives = 89/192 (46%), Gaps = 28/192 (14%)
Query: 466 KLGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGC 506
K+G+G FG V+K + +E+ + EI + ++ + + G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVI 566
++ + +I EYL S D + G L I+ I +GL YLH + I
Sbjct: 71 YLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEKK---I 123
Query: 567 HRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIK 626
HRD+K +N+LL + K++DFG+A +++ N VGT +M+PE + K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQSAYDSK 181
Query: 627 SDVFSFGVLLLE 638
+D++S G+ +E
Sbjct: 182 ADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 9e-12
Identities = 60/183 (32%), Positives = 91/183 (49%), Gaps = 48/183 (26%)
Query: 465 NKLGEGGFGPVY-----KSGQ--GLEEFKN-------------EIKLTAKLQHRNLVRLL 504
N++ EG +G VY K+G+ L++ K EI + KLQH N+V +
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 505 GCCVEQGENV----LIYEYLPN--KSL-----DSFLFDTTKEGLLGWGARIRIIEGIAQG 553
V G N+ ++ EY+ + KSL FL K +L +++ G+A
Sbjct: 71 EVVV--GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML------QLLSGVA-- 120
Query: 554 LLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYM 613
+LH ++HRDLK SN+LL++ I KI DFGLAR + G L+ T+ +V T Y
Sbjct: 121 --HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TLWYR 173
Query: 614 SPE 616
+PE
Sbjct: 174 APE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
I GL +LH+ +I+RDLK N+LLDS KI+DFG+ + + GG T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
GT Y++PE + + D ++ GVLL E L
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 61/279 (21%), Positives = 122/279 (43%), Gaps = 64/279 (22%)
Query: 467 LGEGGFGPVYK-----SGQ--------------GLEEFKNEIKLTAKLQH---RNLVRLL 504
+G G +G VY+ +G+ + + + E+ L ++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 505 GCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRL 563
G + +G + +I EY S+ + + K G + II + L Y+H+
Sbjct: 69 GSYL-KGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG-- 121
Query: 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI--VGTYGYMSPEYAIHG 621
VIHRD+K +NIL+ + K+ DFG+A + Q+++KR VGT +M+PE G
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGTPYWMAPEVITEG 176
Query: 622 -FFSIKSDVFSFGVLLLET------LSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674
++ K+D++S G+ + E S + R ++ L+ +
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMMLIPKS------------KP 219
Query: 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713
P+L+ +++ ++ C+ E +R + E++
Sbjct: 220 PRLEDNGYSKLLREFV---AACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 21/160 (13%)
Query: 488 EIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRII 547
E L + H +++R+ V ++ LP+ S D + + T + L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 548 EGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR------MFGGDELQS 601
+ I +GL YLH R+IHRD+K NI ++ I D G A+ F G
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG----- 215
Query: 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+ GT +PE ++ K+D++S G++L E L+
Sbjct: 216 ----LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 50/141 (35%), Positives = 70/141 (49%), Gaps = 19/141 (13%)
Query: 515 LIYEYLPNKSLDSFLFDTTKEGL-LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPS 573
L+ EYL S + T GL W A+ I E + G+ LHQ +IHRD+KP
Sbjct: 74 LVMEYLNGGDCASLI--KTLGGLPEDW-AKQYIAE-VVLGVEDLHQRG---IIHRDIKPE 126
Query: 574 NILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIK-SDVFSF 632
N+L+D K++DFGL+R G E K+ VGT Y++PE I G K SD +S
Sbjct: 127 NLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPE-TILGVGDDKMSDWWSL 179
Query: 633 GVLLLETLSSKRSTRFFNTNS 653
G ++ E L F+ +
Sbjct: 180 GCVIFEFLF---GYPPFHAET 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 44/203 (21%)
Query: 466 KLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCC 507
+LG+G FG VYK S + LE++ EI + A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 508 VEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRII-EGIAQGLLYLHQYSRLRVI 566
+ ++ E+ ++D+ + + + +IR++ + + L YLH+ ++I
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 567 HRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI------VGTYGYMSPEYAI- 619
HRDLK NIL + K++DFG++ NT+ I +GT +M+PE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 620 ----HGFFSIKSDVFSFGVLLLE 638
+ K+DV+S G+ L+E
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 39/94 (41%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF--GGDELQSNTKRIV 607
+A+G+ +L SR + IHRDL NILL N + KI DFGLAR D ++ R+
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+M+PE ++ +SDV+SFGVLL E S
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 37/97 (38%), Positives = 56/97 (57%), Gaps = 17/97 (17%)
Query: 550 IAQGLLYL---HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA-RMFGGDELQSNTKR 605
I + L YL H VIHRD+KPSNILLD++ K+ DFG++ R+ + ++ T R
Sbjct: 123 IVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-R 173
Query: 606 IVGTYGYMSPEY----AIHGFFSIKSDVFSFGVLLLE 638
G YM+PE + + I++DV+S G+ L+E
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 42/208 (20%)
Query: 466 KLGEGGFGPVYK-----SGQGLEEFKN----------------EIKLTAKLQHRN-LVRL 503
K+GEG +G VYK +G+ L K EI L L +VRL
Sbjct: 8 KIGEGTYGKVYKARDKNTGK-LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 504 LGCCVEQGEN-------VLIYEYLPNKSLDSFLFDTTKEGLLGWGARI--RIIEGIAQGL 554
L VE E L++EYL + L F+ + A+ + + +G+
Sbjct: 67 L--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 555 LYLHQYSRLRVIHRDLKPSNILLD-SNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYM 613
+ H++ V+HRDLKP N+L+D + KI+D GL R F ++S T IV T Y
Sbjct: 124 AHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYR 178
Query: 614 SPEYAIHG-FFSIKSDVFSFGVLLLETL 640
+PE + +S D++S G + E
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 64/222 (28%), Positives = 91/222 (40%), Gaps = 50/222 (22%)
Query: 466 KLGEGGFGPVY--------------KSGQGLEEFK-------NEIKLTAKLQHRNLVRLL 504
+G+GG G VY K + L E E K+ A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 505 GCCVEQGENVL-IYEYLPNKSLDSFLFDT-TKEGL-------LGWGARIRIIEGIAQGLL 555
C G+ V Y+ +L S L KE L GA + I I +
Sbjct: 69 SIC-SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE-------------LQSN 602
Y+H S+ V+HRDLKP NILL I D+G A +E S+
Sbjct: 128 YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 603 -TK--RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
T +IVGT YM+PE + S +D+++ GV+L + L+
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 49/193 (25%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 465 NKLGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLG 505
++G+G FG V+K + +E+ + EI + ++ + + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
++ + +I EYL S D + G +++ I +GL YLH +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK--- 122
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSI 625
IHRD+K +N+LL K++DFG+A +++ NT VGT +M+PE +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDS 180
Query: 626 KSDVFSFGVLLLE 638
K+D++S G+ +E
Sbjct: 181 KADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 40/208 (19%)
Query: 459 NNFGVENKLGEGGFGPVY---KSGQG-----------LEEFKNEIK---------LTAKL 495
+F + ++G+GG+G V+ K G L NE++ T K
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK- 59
Query: 496 QHRNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWG-ARIRIIEGIAQG 553
LV+LL + E + L EY+P + L + G+L AR + E
Sbjct: 60 -SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFE-A 113
Query: 554 LLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYM 613
+ LH L IHRDLKP N L+D++ K++DFGL++ + + +VG+ YM
Sbjct: 114 VDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYM 165
Query: 614 SPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+PE + D +S G +L E L
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 50/156 (32%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 486 KNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR 545
K E + A++ H +V+L +G+ LI ++L L + L +KE +
Sbjct: 46 KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKF 102
Query: 546 IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR 605
+ +A L +LH L +I+RDLKP NILLD K++DFGL++ E
Sbjct: 103 YLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYS 157
Query: 606 IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
GT YM+PE + +D +SFGVL+ E L+
Sbjct: 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 466 KLGEGGFGP-------------VYK-------SGQGLEEFKNEIKLTAKLQHRNLVRLLG 505
K+GEG FG V K S + EE + E+ + + ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
E G ++ +Y L + + G+L +I++ Q L L ++
Sbjct: 67 SFEENGNLYIVMDYCEGGDL--YKKINAQRGVLF--PEDQILDWFVQICLALKHVHDRKI 122
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLARMFGGD-ELQSNTKRIVGTYGYMSPEYAIHGFFS 624
+HRD+K NI L + K+ DFG+AR+ EL + +GT Y+SPE + ++
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---ARTCIGTPYYLSPEICENRPYN 179
Query: 625 IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL 656
KSD+++ G +L E + K + N +L L
Sbjct: 180 NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 41/123 (33%), Positives = 63/123 (51%), Gaps = 10/123 (8%)
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
H ++R V++RDLKP+NILLD + +ISD GLA F + ++ VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 618 AIHGF-FSIKSDVFSFGVLLLETL---SSKRSTRFFNTNSLTLLGHAWNL-WKDDRSWEL 672
G + +D FS G +L + L S R + + + + + + D S EL
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226
Query: 673 MDP 675
Sbjct: 227 RSL 229
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 9/159 (5%)
Query: 480 QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLG 539
Q E NE+ + QH+N+V + + E ++ E+L +L D + L
Sbjct: 60 QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQTRLN 115
Query: 540 WGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599
+ E + Q L YLH VIHRD+K +ILL + K+SDFG D
Sbjct: 116 EEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-- 170
Query: 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLE 638
K +VGT +M+PE + + D++S G++++E
Sbjct: 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 35/201 (17%)
Query: 467 LGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKL-QHRNLVRLLGCCV 508
+G G +G VYK +G EE K EI + K HRN+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 509 EQG------ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
++ + L+ E+ S+ L TK L I I +GL +LHQ+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI--- 619
+VIHRD+K N+LL N K+ DFG++ + NT +GT +M+PE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDE 187
Query: 620 --HGFFSIKSDVFSFGVLLLE 638
+ KSD++S G+ +E
Sbjct: 188 NPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 40/98 (40%), Positives = 59/98 (60%), Gaps = 9/98 (9%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI--- 606
I +GL Y+H + V+HRDLKPSN+LL++N KI DFGLAR+ D +T +
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEY 169
Query: 607 VGTYGYMSPEYAIHGFFSIKS-DVFSFGVLLLETLSSK 643
V T Y +PE ++ K+ D++S G +L E LS++
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA-RMFGGDELQSNTKRIVG 608
I G+L+LH + +++RD+KP N+LLD ++SD GLA + G ++ T+R G
Sbjct: 104 ITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR-AG 156
Query: 609 TYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
T GYM+PE +S D F+ G + E ++ +
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 37/105 (35%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
IA L YLH+ ++HRDLK N+ L I K+ D G+AR+ ++T ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL 654
YMSPE + ++ KSDV++ G + E + K + + NSL
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 49/175 (28%), Positives = 77/175 (44%), Gaps = 39/175 (22%)
Query: 483 EEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL--IYEYLPNKSLDSFL-----FDTTKE 535
+ NE ++ ++ H ++RL E + L + EY+P L S+L F +
Sbjct: 46 QHVHNEKRVLKEVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNST- 102
Query: 536 GLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595
E I L YLH +++RDLKP NILLD K++DFG A+
Sbjct: 103 ------GLFYASE-IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK--- 149
Query: 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKS-------DVFSFGVLLLETLSSK 643
+L+ T + GT Y++PE I+S D ++ G+L+ E L
Sbjct: 150 --KLRDRTWTLCGTPEYLAPE-------VIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I GL LHQ R+++RDLKP NILLD + +ISD GLA + K VGT
Sbjct: 111 ICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGT 164
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
GYM+PE + ++ D ++ G LL E ++ +
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 488 EIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRII 547
E+KL L+H N++ L + E++ Y + L + L L +
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYFL 114
Query: 548 EGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIV 607
I +GL Y+H V+HRDLKPSNIL++ N KI DFGLAR+ V
Sbjct: 115 YQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYV 166
Query: 608 GTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSK 643
T Y +PE + + ++ D++S G + E L K
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 31/194 (15%)
Query: 465 NKLGEGGFGPV-----YKSG-------------QGLEEFKNEIKLTAKLQHRNLVRLLGC 506
K+GEG G V +G Q E NE+ + QH N+V +
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVI 566
+ E ++ E+L +L D + + + + L +LH VI
Sbjct: 85 YLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVI 137
Query: 567 HRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR--IVGTYGYMSPEYAIHGFFS 624
HRD+K +ILL S+ K+SDFG F + +R +VGT +M+PE +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYG 193
Query: 625 IKSDVFSFGVLLLE 638
+ D++S G++++E
Sbjct: 194 TEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 40/94 (42%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF--GGDELQSNTKRIV 607
+A+G+ +L SR + IHRDL NILL N + KI DFGLAR D ++ R+
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+M+PE ++I+SDV+SFGVLL E S
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 37/94 (39%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I GL LH R R+++RDLKP NILLD +ISD GLA E + VGT
Sbjct: 111 ITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGT 164
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
GYM+PE + ++ D + G L+ E + K
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 60/243 (24%), Positives = 107/243 (44%), Gaps = 28/243 (11%)
Query: 485 FKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI 544
F E++ +L H N+++ LG C+E +L+ E+ P L ++L + G++ A+
Sbjct: 42 FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQK 99
Query: 545 RIIE----GIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA-RMFGGDEL 599
+++ +A GLL+LHQ IH DL N L +++ KI D+GLA + D
Sbjct: 100 DVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156
Query: 600 QSNTKRIVGTYGYMSPEYAIHGFFSI-------KSDVFSFGVLLLETLSSKRSTRFFNTN 652
+ V +++PE + KS+++S GV + E L + + + +
Sbjct: 157 ITKDCHAV-PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE-LFTAADQPYPDLS 214
Query: 653 SLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVIS 712
+L ++ +L P+L R+ V C + RPT EV
Sbjct: 215 DEQVLKQVVR----EQDIKLPKPQLD----LKYSDRWYEVMQFCWLD-PETRPTAEEVHE 265
Query: 713 MLT 715
+LT
Sbjct: 266 LLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 36/81 (44%), Positives = 49/81 (60%), Gaps = 10/81 (12%)
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTK-RIVGTYGYMSPE----Y 617
L++IHRD+KPSNILLD N K+ DFG++ G + S K R G YM+PE
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPERIDPS 182
Query: 618 AIHGFFSIKSDVFSFGVLLLE 638
A G + ++SDV+S G+ L E
Sbjct: 183 ARDG-YDVRSDVWSLGITLYE 202
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE---LQSNTKRI 606
+A+G+ +L + IHRDL NILL I KI DFGLAR D ++ N +
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 607 VGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
V +M+PE + ++ +SDV+S+G+LL E S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-10
Identities = 67/245 (27%), Positives = 105/245 (42%), Gaps = 51/245 (20%)
Query: 459 NNFGVENKLGEGGFGPVYK---------------SGQGLEEFKN-----EIKLTAKLQHR 498
N + V K+G G FG V+ S +GL+E + E+ + +L+H+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 499 NLVRLLGCCVEQGENVL--IYEYLPNKSLDSFLFDTTKE-GLLGWGARIRIIEGIAQGLL 555
N+VR + + + L + E+ L + K G + A + I + L
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 556 YLHQY----SRLRVIHRDLKPSNILLDSNM-----------------IPKISDFGLARMF 594
Y H + RV+HRDLKP NI L + + I KI DFGL++
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 595 GGDELQSNTKRIVGTYGYMSPEYAIH--GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN 652
G ++S VGT Y SPE +H + KSD+++ G ++ E S K T F N
Sbjct: 193 G---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHKAN 247
Query: 653 SLTLL 657
+ + L
Sbjct: 248 NFSQL 252
|
Length = 1021 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 39/94 (41%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF--GGDELQSNTKRIV 607
+A+G+ +L SR + IHRDL NILL N + KI DFGLAR D ++ + R+
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+M+PE ++ +SDV+SFGVLL E S
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 40/173 (23%)
Query: 488 EIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSF-------------LFDTTK 534
E++L + H N++ LL + P SL+ F L + K
Sbjct: 64 ELRLLKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVK 111
Query: 535 EGLLGWGARIR-IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593
L I+ ++ I +GL Y+H +IHRDLKPSNI ++ + KI DFGLAR
Sbjct: 112 CQKLS-DDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167
Query: 594 FGGDELQSNTKRIVGTYGYMSPEYA---IHGFFSIKSDVFSFGVLLLETLSSK 643
DE+ V T Y +PE +H ++ D++S G ++ E L+ K
Sbjct: 168 -TDDEMTG----YVATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 35/84 (41%), Positives = 51/84 (60%), Gaps = 6/84 (7%)
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
H ++R V++RDLKP+NILLD + +ISD GLA F + ++ VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 618 AIHGF-FSIKSDVFSFGVLLLETL 640
G + +D FS G +L + L
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 39/102 (38%), Positives = 53/102 (51%), Gaps = 7/102 (6%)
Query: 542 ARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601
R+ I E I L +LHQ L +I+RD+K NILLDS ++DFGL++ F +E +
Sbjct: 107 VRVYIAE-IVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE- 161
Query: 602 NTKRIVGTYGYMSPEYAIHGF--FSIKSDVFSFGVLLLETLS 641
GT YM+PE G D +S GVL E L+
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 39/182 (21%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE---LQSNTKRI 606
+AQG+ +L + IHRD+ N+LL + KI DFGLAR D ++ N +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 607 VGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS--------TRFFNTNSLTLLG 658
V +M+PE ++++SDV+S+G+LL E S +S ++F+
Sbjct: 278 V---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY--------- 325
Query: 659 HAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718
+ K R +++ P Y I+K +C +RPT S+ IS L
Sbjct: 326 ---KMVK--RGYQMSRPDFAPPEIYSIMK-------MCWNLEPTERPTFSQ-ISQLIQRQ 372
Query: 719 VN 720
+
Sbjct: 373 LG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 25/147 (17%)
Query: 465 NKLGEGGFGPVYKSGQ-------GLEEFK------------NEIKLTAKLQHRNLVRLLG 505
+KLGEG + VYK L+E + E+ L L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
+ L++EYL +K L +L D + + + +GL Y H R +V
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCH---RRKV 125
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLAR 592
+HRDLKP N+L++ K++DFGLAR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 54/184 (29%), Positives = 80/184 (43%), Gaps = 59/184 (32%)
Query: 488 EIKLTAKLQHRNLVRLLGC----CVEQGENV-LIYEYL---------PNKSLDS-----F 528
EIKL L H N++ + E +V ++YE + +++L F
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYF 113
Query: 529 LFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDF 588
L+ + +GL Y+H + V+HRDLKPSN+LL++N KI DF
Sbjct: 114 LYQ------------------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDF 152
Query: 589 GLARMFGGDELQSNTKRIVGTYGYMSPE-------Y--AIHGFFSIKSDVFSFGVLLLET 639
GLAR ++ T+ +V T Y +PE Y AI DV+S G + E
Sbjct: 153 GLART-TSEKGDFMTEYVV-TRWYRAPELLLNCSEYTTAI--------DVWSVGCIFAEL 202
Query: 640 LSSK 643
L K
Sbjct: 203 LGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF--GGDELQSNTKRIV 607
I GL Y+H + V+HRDLKP N+L++++ KI DFGLAR F E V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 608 GTYGYMSPEYAIHGFFSIKS-DVFSFGVLLLETLSSK 643
T Y +PE + K+ DV+S G +L E L K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 29/200 (14%)
Query: 460 NFGVENKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKLQHRNLV 501
+F + ++G G +G VYK+ G+ + EI + +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
G + + + + E+ SL T G L + QGL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI-- 619
+ +HRD+K +NILL N K++DFG++ + K +GT +M+PE A
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVE 181
Query: 620 -HGFFSIKSDVFSFGVLLLE 638
G ++ D+++ G+ +E
Sbjct: 182 RKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 35/118 (29%), Positives = 55/118 (46%), Gaps = 27/118 (22%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA--------RMFGGDELQS 601
IA+ +L L +L IHRD+KP NIL+D++ K++DFGL R + ++ +
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 602 NTKR-------------------IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
R VGT Y++PE + ++ D +S GV+L E L
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA-RMFGGDELQSNTKRIVG 608
I GL LH+ + ++RDLKP NILLD +ISD GLA ++ G+ ++ VG
Sbjct: 111 ILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VG 163
Query: 609 TYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTR 647
T GYM+PE + +++ D + G L+ E + + R
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 477 KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDT---- 532
KS +E+ + E L AK++H N+V G ++ EY L +
Sbjct: 37 KSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKL 96
Query: 533 -TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591
++ +L W ++ + G+ ++H+ RV+HRD+K NI L N K+ DFG A
Sbjct: 97 FPEDTILQWFVQMCL------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSA 147
Query: 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNT 651
R+ + T VGT Y+ PE + ++ KSD++S G +L E + K F
Sbjct: 148 RLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP---FQA 202
Query: 652 NS 653
NS
Sbjct: 203 NS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
IA GL +LH +I+RDLK N++LDS KI+DFG+ + M+ G TK
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFC 162
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
GT Y++PE + + D ++FGVLL E L+ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 27/148 (18%)
Query: 465 NKLGEGGFGPVYKSGQ-------GLEEFK------------NEIKLTAKLQHRNLVRLLG 505
KLGEG + V+K L+E + E+ L L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRI-IEGIAQGLLYLHQYSRLR 564
L++EYL +K L ++ D G + ++I + I +GL Y H R +
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCH---RRK 124
Query: 565 VIHRDLKPSNILLDSNMIPKISDFGLAR 592
V+HRDLKP N+L++ K++DFGLAR
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 37/202 (18%)
Query: 467 LGEGGFGPVYK----SGQGLEEF---------------------KNEIKLTAKLQHRNLV 501
LG+GG+G V++ +G + K E + ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
L+ G+ LI EYL L L +EG+ + I+ L +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLHQ-- 118
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIVGTYGYMSPEYAI 619
+I+RDLKP NILLD+ K++DFGL + + G + T GT YM+PE +
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEILM 173
Query: 620 HGFFSIKSDVFSFGVLLLETLS 641
D +S G L+ + L+
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
+ +GL Y+H + VIHRDLKPSN+L++ + +I DFG+AR E + V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 608 GTYGYMSPE--YAIHGFFSIKSDVFSFGVLLLETL 640
T Y +PE ++ ++ D++S G + E L
Sbjct: 173 ATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 35/217 (16%)
Query: 451 LASVSAATNNFGVENKLGEGGFGPVYK-----SGQ------------GLEEFKNEIKLTA 493
L+++ F + +G G +G VYK +GQ EE K EI +
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 494 KL-QHRNLVRLLGCCVEQG------ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRI 546
K HRN+ G +++ + L+ E+ S+ L TK L I
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYI 126
Query: 547 IEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI 606
I +GL +LH + +VIHRD+K N+LL N K+ DFG++ + NT
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--F 181
Query: 607 VGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLE 638
+GT +M+PE + +SD++S G+ +E
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
I+ GL +LH R +I+RDLK N++LDS KI+DFG+ + M G T+
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
GT Y++PE + + D +++GVLL E L+ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 484 EFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGAR 543
+F E + LQH NL++ LG C E +L+ E+ P L +L K L+
Sbjct: 41 KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPT 100
Query: 544 I--RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601
R+ IA GLL+LH+ + IH DL N LL +++ KI D+GL+ ++
Sbjct: 101 TLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157
Query: 602 NTKRIVGTYGYMSPEYA--IHGFF-----SIKSDVFSFGVLLLE 638
++ +++PE +HG + +S+V+S GV + E
Sbjct: 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 63/215 (29%)
Query: 465 NKLGEGGFGPVYK-----SGQ------------GLEEFKN--EIKLTAKLQ-HRNLVRLL 504
K+GEG F V K +G+ LE+ N EI+ +L H N++RL+
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 505 GCCVEQGENVL----------IYE-------YLPNKSLDSFLFDTTKEGLLGWGARIRII 547
++ L +YE LP K + S+++ K
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLK------------- 111
Query: 548 EGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIV 607
L ++H R + HRD+KP NIL+ +++ K++DFG R G T+ I
Sbjct: 112 -----SLDHMH---RNGIFHRDIKPENILIKDDIL-KLADFGSCR--GIYSKPPYTEYI- 159
Query: 608 GTYGYMSPEYAI-HGFFSIKSDVFSFGVLLLETLS 641
T Y +PE + G++ K D+++ G + E LS
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 29/201 (14%)
Query: 459 NNFGVENKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKLQHRNL 500
+++ + ++G G +G VYK+ G + EI + + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
V G + + + + EY SL T G L + QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK 125
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI- 619
++ HRD+K +NILL N K++DFG+A + K +GT +M+PE A
Sbjct: 126 GKM---HRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVAAV 180
Query: 620 --HGFFSIKSDVFSFGVLLLE 638
+G ++ D+++ G+ +E
Sbjct: 181 EKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 33/86 (38%), Positives = 48/86 (55%), Gaps = 6/86 (6%)
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
G+ +LH +IHRDLKPSNI++ S+ KI DFGLAR G + T +V Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 183
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLE 638
+PE + + D++S G ++ E
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 22/150 (14%)
Query: 500 LVRLLGCCVEQGENVL--IYEYLPNKSLDSFL--FDTTKEGLLGWGARIRIIEGIAQGLL 555
+V+L Q + L + EY+P L + + +D ++ W AR E + L
Sbjct: 105 IVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----W-ARFYTAE-VVLALD 156
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA-RMFGGDELQSNTKRIVGTYGYMS 614
+H IHRD+KP N+LLD + K++DFG +M ++ +T VGT Y+S
Sbjct: 157 AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYIS 211
Query: 615 PEY----AIHGFFSIKSDVFSFGVLLLETL 640
PE G++ + D +S GV L E L
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
A+ L L + VI+RDLKP NILLD + DFGL ++ D+ ++NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 610 YGYMSPEYAI-HGFFSIKSDVFSFGVLLLETLS 641
Y++PE + HG+ D ++ GVLL E L+
Sbjct: 157 PEYLAPELLLGHGYTKA-VDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 38/125 (30%), Positives = 58/125 (46%), Gaps = 4/125 (3%)
Query: 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNIL 576
Y+ + + + L D EGL + +A+G+ +L + +HRDL N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDL-LSFTYQVARGMEFL---ASKNCVHRDLAARNVL 269
Query: 577 LDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
L I KI DFGLAR D + +M+PE ++ SDV+S+G+LL
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329
Query: 637 LETLS 641
E S
Sbjct: 330 WEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 44/222 (19%)
Query: 451 LASVSAATNNFGVENKLGEGGFGPVYKSGQGL-----------------EEFKNEIKLTA 493
L S+ T+ + + +G+G +G VYK EE + E +
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ 73
Query: 494 KL-QHRNLVRLLGCCVEQ-----GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-- 545
L H N+V+ G + G+ L+ E S+ + +GLL G R+
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDEA 128
Query: 546 ----IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601
I+ G GL +LH R+IHRD+K +NILL + K+ DFG++ L+
Sbjct: 129 MISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185
Query: 602 NTKRIVGTYGYMSPEY-----AIHGFFSIKSDVFSFGVLLLE 638
NT VGT +M+PE + + DV+S G+ +E
Sbjct: 186 NTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
L R R+++RDLKP NILLD +ISD GLA E + VGT GYM+PE
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPE 171
Query: 617 YAIHGFFSIKSDVFSFGVLLLETLSSKRSTR 647
+ ++ D + G L+ E + + R
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
I GL +LH +++RDLK NILLD++ KI+DFG+ + M G + T
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFC 157
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
GT Y++PE + ++ D +SFGVLL E L
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 35/91 (38%), Positives = 52/91 (57%), Gaps = 5/91 (5%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I GL +LH+ +I+RDLK N+LLD + KI+DFG+ + E +++T GT
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGT 159
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
Y++PE ++ D +SFGVLL E L
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 36/96 (37%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDELQSNTKRIVGTY 610
+ L Y+H + V HRDLKP NIL +++ KI DFGLAR F V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 611 GYMSPEYAIHGFFSIKS---DVFSFGVLLLETLSSK 643
Y +PE FFS + D++S G + E L+ K
Sbjct: 171 WYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 43/169 (25%), Positives = 84/169 (49%), Gaps = 17/169 (10%)
Query: 488 EIKLTAKLQHRNLVRLLGCCVEQGENV---------LIYEYLPNKSLDSFLFDTTKEGLL 538
EIK+ +L H N+V++ G ++ L Y+ + +++ L + ++G L
Sbjct: 52 EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL 111
Query: 539 GWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS-NMIPKISDFGLARMFGGD 597
+ + +GL Y+H + V+HRDLKP+N+ +++ +++ KI DFGLAR+
Sbjct: 112 SEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH 168
Query: 598 ELQSN--TKRIVGTYGYMSPEYAIHGFFSIKS-DVFSFGVLLLETLSSK 643
++ +V + Y SP + K+ D+++ G + E L+ K
Sbjct: 169 YSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG-LARMFGGDELQSNTKRIVG 608
+A+ +L + +L +HRD+KP N+LLD N +++DFG R+ +QSN VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 609 TYGYMSPEY--AIH---GFFSIKSDVFSFGVLLLETL 640
T Y+SPE A+ G + + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 21/141 (14%)
Query: 554 LLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM---------FGG----DELQ 600
L YLH Y ++HRDLKP N+L+ S K++DFGL+++ + G D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA 660
K++ GT Y++PE + + D ++ G++L E L FF L G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG--CVPFFGDTPEELFGQV 228
Query: 661 WNLWKDDRSWELMDPKLQCEA 681
+ DD W D L +A
Sbjct: 229 IS---DDIEWPEGDEALPADA 246
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
+ +L L +L +I+RD+K NILLDSN ++DFGL++ F DE++ GT
Sbjct: 111 SGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGT 169
Query: 610 YGYMSPEYAIHG--FFSIKSDVFSFGVLLLETLS 641
YM+P+ G D +S GVL+ E L+
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIVGTY 610
GL YLH+ ++++RDLK N+LLD+ KI+DFGL + M GD T GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFCGTP 165
Query: 611 GYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
+++PE ++ D + GVL+ E L
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 50/146 (34%), Positives = 72/146 (49%), Gaps = 25/146 (17%)
Query: 466 KLGEGGFGPVYK-----SGQ--GLEEFK------------NEIKLTAKLQHRNLVRLLGC 506
KLGEG + VYK +GQ L+E + E L L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVI 566
+ L++EYL + L ++ D GL R+ + + + +GL Y HQ RV+
Sbjct: 72 IHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSMHNVRLFLFQ-LLRGLAYCHQR---RVL 125
Query: 567 HRDLKPSNILLDSNMIPKISDFGLAR 592
HRDLKP N+L+ K++DFGLAR
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 58/235 (24%), Positives = 106/235 (45%), Gaps = 28/235 (11%)
Query: 480 QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDT--TKEGL 537
Q E NE+ + QH N+V + + E ++ E+L +L + T +E +
Sbjct: 59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 118
Query: 538 LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597
+ + + L LH VIHRD+K +ILL + K+SDFG
Sbjct: 119 AA------VCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-SK 168
Query: 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLL 657
E+ K +VGT +M+PE + + D++S G++++E + + +FN L
Sbjct: 169 EVPRR-KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP--YFNEPPLK-- 223
Query: 658 GHAWNLWKDDRSWELMDPKLQ-CEASYPIVKRYINVALLCVQENAADRPTMSEVI 711
A + +D+ + PKL+ P +K +++ L+ + A R T +E++
Sbjct: 224 --AMKMIRDN-----LPPKLKNLHKVSPSLKGFLDRLLV---RDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 35/144 (24%), Positives = 56/144 (38%), Gaps = 26/144 (18%)
Query: 466 KLGEGGFGPVYKSGQGLEEF--------------KNEIKLTAKLQHRNLV--RLLGCCVE 509
L G VY G E++ + E+ + L + L ++L
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES 64
Query: 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRD 569
G + L+ E++ ++LD + + I E +A+ L LHQ L + H D
Sbjct: 65 DGWSYLLMEWIEGETLDEVSEE----------EKEDIAEQLAELLAKLHQLPLLVLCHGD 114
Query: 570 LKPSNILLDSNMIPKISDFGLARM 593
L P NIL+D I I D+ A
Sbjct: 115 LHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 36/97 (37%), Positives = 55/97 (56%), Gaps = 8/97 (8%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG-LARMFGGDELQSNTKRIVG 608
IA+ +L +H +L +HRD+KP N+LLD N +++DFG +M +QS+ VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165
Query: 609 TYGYMSPEY--AIH---GFFSIKSDVFSFGVLLLETL 640
T Y+SPE A+ G + + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-08
Identities = 39/113 (34%), Positives = 61/113 (53%), Gaps = 11/113 (9%)
Query: 546 IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR 605
+I I +GL Y+H +IHRDLKPSN+ ++ + KI DFGLAR DE+
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG---- 176
Query: 606 IVGTYGYMSPEYAIHGF-FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLL 657
V T Y +PE ++ ++ D++S G ++ E L+ + T F T+ + L
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQL 227
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 35/98 (35%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 542 ARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601
A+ I E + L +LH+Y +++RDLKP NILLD+ + DFGL++ D +
Sbjct: 98 AKFYIAE-LVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153
Query: 602 NTKRIVGTYGYMSPEYAI-HGFFSIKSDVFSFGVLLLE 638
NT GT Y++PE + ++ D +S GVL+ E
Sbjct: 154 NT--FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 31/67 (46%), Positives = 38/67 (56%), Gaps = 5/67 (7%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
IA L YLH L +I+RDLKP NILLDS ++DFGL + G E T GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGT 159
Query: 610 YGYMSPE 616
Y++PE
Sbjct: 160 PEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 47/164 (28%), Positives = 65/164 (39%), Gaps = 46/164 (28%)
Query: 515 LIYEYLPNKSLDSFL--FDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKP 572
LI EYLP + + L DT E R I E I L + +L IHRD+KP
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEE----ETRFYIAETI----LAIDSIHKLGYIHRDIKP 129
Query: 573 SNILLDSNMIPKISDFGL------------ARMFGGD----------------ELQSNTK 604
N+LLD+ K+SDFGL R+ K
Sbjct: 130 DNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWK 189
Query: 605 R--------IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
R VGT Y++PE + ++ + D +S GV++ E L
Sbjct: 190 RNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 25/147 (17%)
Query: 465 NKLGEGGFGPVYKSGQ-------GLEEFK------------NEIKLTAKLQHRNLVRLLG 505
+KLGEG + V+K L+E + E+ L L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
+ L++EYL + L +L D + +I + + + +GL Y H + ++
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH---KRKI 124
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLAR 592
+HRDLKP N+L++ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 16/167 (9%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
+A G+ +L + +HRDL N+L+ + KI DFGLAR D +
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS 669
+M+PE + ++ SDV+SFG+LL E + + L + +N K R
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP----YPELPMNEQFYNAIK--RG 358
Query: 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
+ + P + Y I+++ C +E RP S+++ ++ +
Sbjct: 359 YRMAKPAHASDEIYEIMQK-------CWEEKFEIRPDFSQLVHLVGD 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 31/93 (33%), Positives = 49/93 (52%)
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG 611
Q +L L + +++HRDLK +NI L I K+ DFG ++ + GT
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 612 YMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKR 644
Y++PE +S K+D++S GV+L E L+ R
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 43/134 (32%), Positives = 66/134 (49%), Gaps = 20/134 (14%)
Query: 515 LIYEYLPNKSLDSFLF--DTTKEGLLGWGARIRIIEG-IAQGLLYLHQYSRLRVIHRDLK 571
LI +Y+ + + L+ D E +R G I L +LH +L +++RD+K
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSE------DEVRFYSGEIILALEHLH---KLGIVYRDIK 132
Query: 572 PSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY----AIHGFFSIKS 627
NILLDS ++DFGL++ F +E + T GT YM+PE HG
Sbjct: 133 LENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYMAPEIIRGKGGHG---KAV 188
Query: 628 DVFSFGVLLLETLS 641
D +S G+L+ E L+
Sbjct: 189 DWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 30/178 (16%)
Query: 482 LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN------VLIYEYLPNKSLDSFL------ 529
+EEF E + H N+++L+G + ++I ++ + L +FL
Sbjct: 45 IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG 104
Query: 530 ---FDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKIS 586
F + L +R + IA G+ YL S IHRDL N +L+ NM ++
Sbjct: 105 EEPFTLPLQTL------VRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVA 155
Query: 587 DFGLAR-MFGGDELQ--SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
DFGL++ ++ GD + +K V +++ E ++ SDV++FGV + E ++
Sbjct: 156 DFGLSKKIYSGDYYRQGCASKLPV---KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 28/90 (31%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 551 AQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY 610
AQ +L L +++RDLKP N+LLD + K++DFG A++ + + T + GT
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTP 192
Query: 611 GYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
Y++PE ++ +D ++ G+ + E L
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 51/243 (20%), Positives = 101/243 (41%), Gaps = 38/243 (15%)
Query: 482 LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN----VLIYEYLPNKSLDSFLFDTTKEGL 537
++ +NEIK ++ N++++ G ++ ++ LI EY L L KE
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL---DKEKD 118
Query: 538 LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597
L + ++ + +GL L++Y+ +++L + L+ N KI GL ++
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKI---- 172
Query: 598 ELQSNTKRIVGTYGYMSPEYAIHGF--FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLT 655
L S + V Y S + F ++IK D++S GV+L E + K T +
Sbjct: 173 -LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI- 230
Query: 656 LLGHAWNLWKDDRSWELMDPK----LQCEASYPIVKRYINVALLCVQENAADRPTMSEVI 711
++L + + + ++C IV+ C ++ RP + E++
Sbjct: 231 -----YDLIINKNNSLKLPLDCPLEIKC-----IVEA-------CTSHDSIKRPNIKEIL 273
Query: 712 SML 714
L
Sbjct: 274 YNL 276
|
Length = 283 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-07
Identities = 21/75 (28%), Positives = 37/75 (49%), Gaps = 6/75 (8%)
Query: 339 KSGDRFIMVDDIKLPDLLNVSLNKSMNLKECEAECLKNR-TCRAYANSEVTGRGSGCLMW 397
KS D F+ + + KLP + ++ +L+EC ++CL + +CR++ + T GCL+W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNNGT---KGCLLW 56
Query: 398 Y-GDLIDTTKAKFHN 411
L D
Sbjct: 57 SESSLGDARLFPSGG 71
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 36/202 (17%)
Query: 467 LGEGGFGPVYKSGQGLEEFKNEIK---------LTAKLQHRNLVRLLGCCVEQGENV--L 515
+G G +G V + K IK L AK +R L RLL + ENV L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYREL-RLLKHM--KHENVIGL 79
Query: 516 IYEYLPNKSLDSFL-------FDTTKEGLLGWGARI---RI---IEGIAQGLLYLHQYSR 562
+ + P+ SLD F F T G L ++ RI + + +GL Y+H
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG- 138
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF 622
+IHRDLKP N+ ++ + KI DFGLAR + S V T Y +PE ++
Sbjct: 139 --IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNWM 191
Query: 623 -FSIKSDVFSFGVLLLETLSSK 643
++ D++S G ++ E L+ K
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 60/247 (24%), Positives = 107/247 (43%), Gaps = 29/247 (11%)
Query: 480 QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDT--TKEGL 537
Q E NE+ + H N+V + + E ++ E+L +L + T +E +
Sbjct: 61 QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 120
Query: 538 LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597
+ + + L YLH VIHRD+K +ILL S+ K+SDFG +
Sbjct: 121 ------ATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171
Query: 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLL 657
K +VGT +M+PE + + D++S G++++E + + +FN L +
Sbjct: 172 --VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP--YFNEPPLQAM 227
Query: 658 GHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717
R + + P+++ V R + L+ V+E + R T E +L +
Sbjct: 228 ---------RRIRDNLPPRVKDSHKVSSVLRGF-LDLMLVRE-PSQRATAQE---LLQHP 273
Query: 718 FVNLPSP 724
F+ L P
Sbjct: 274 FLKLAGP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
G+ +LH +IHRDLKPSNI++ S+ KI DFGLAR G + T +V Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 184
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
+PE + + D++S G ++ E + K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 43/149 (28%), Positives = 66/149 (44%), Gaps = 15/149 (10%)
Query: 497 HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK-EGLLGWGARIRIIEGIAQGLL 555
+ N ++L +VLI +Y+ D LFD K EG L +II + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIP-KISDFGLARMFGGDELQSNTKRIVGTYGYMS 614
LH++ +IH D+K N+L D + D+GL ++ G GT Y S
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174
Query: 615 PEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
PE + + D ++ GVL E L+ K
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 34/91 (37%), Positives = 47/91 (51%), Gaps = 5/91 (5%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
+A + YLH L +I+RDLKP NILLDS ++DFGL + G E + T GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGT 159
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
Y++PE + D + G +L E L
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
I GL +LH +I+RDLK N++LD + KI+DFG+ + +FG +
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFC 157
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
GT Y++PE ++ D +SFGVLL E L
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
G+ +LH +IHRDLKPSNI++ S+ KI DFGLAR G + T +V Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
+PE + + D++S G ++ E +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 57/190 (30%), Positives = 89/190 (46%), Gaps = 27/190 (14%)
Query: 485 FKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSF--------LFDTTKEG 536
F+N+ AK +R LV LL C + L+ + P KSL+ F L D
Sbjct: 58 FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ 114
Query: 537 LLGWG---ARIR-IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592
++ R+ ++ + G+ +LH +IHRDLKPSNI++ S+ KI DFGLAR
Sbjct: 115 VIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171
Query: 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN 652
+ + T +V Y Y +PE + + D++S G ++ E + K S F T+
Sbjct: 172 TACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELV--KGSVIFQGTD 226
Query: 653 SLTLLGHAWN 662
+ WN
Sbjct: 227 HID----QWN 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 36/99 (36%), Positives = 48/99 (48%), Gaps = 6/99 (6%)
Query: 542 ARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601
AR E IA L YLH + +++RDLKP NILLDS ++DFGL + G
Sbjct: 98 ARFYAAE-IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSD 151
Query: 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
T GT Y++PE + D + G +L E L
Sbjct: 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 34/91 (37%), Positives = 45/91 (49%), Gaps = 5/91 (5%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
IA L YLH L +++RDLKP NILLDS ++DFGL + E T GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGT 159
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
Y++PE + D + G +L E L
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 30/85 (35%), Positives = 45/85 (52%), Gaps = 8/85 (9%)
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSP 615
YLH +I+RDLKP N+LLD+ K++DFG A+ ++ T + GT Y++P
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 616 EYAIHGFFSIKSDVFSFGVLLLETL 640
E D ++ GVLL E +
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 59/232 (25%), Positives = 107/232 (46%), Gaps = 27/232 (11%)
Query: 495 LQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI---RIIEGIA 551
LQH N+++ LG CVE +L++EY L S+L + ++ + R+ IA
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYL--SQEQWHRRNSQLLLLQRMACEIA 109
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA-RMFGGDELQSNTKRIVGTY 610
G+ ++H+++ L H DL N L S++ K+ D+G+ + D +++ + V
Sbjct: 110 AGVTHMHKHNFL---HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PL 165
Query: 611 GYMSPEY--AIHGFF-----SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL 663
+++PE HG + S+V++ GV L E L + + + + +L H
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE-LFENAAQPYSHLSDREVLNHVIK- 223
Query: 664 WKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715
D+ +L P+L+ P +R+ V C + R T EV +LT
Sbjct: 224 ---DQQVKLFKPQLE----LPYSERWYEVLQFC-WLSPEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 546 IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR 605
+I + +GL Y+H +IHRDLKPSN+ ++ + +I DFGLAR DE+
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG---- 174
Query: 606 IVGTYGYMSPEYAIHGF-FSIKSDVFSFGVLLLETLSSK 643
V T Y +PE ++ ++ D++S G ++ E L K
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 477 KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEG 536
+ F L ++L H++LV+L G CV EN+++ EY+ LD FL
Sbjct: 40 SDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNV 98
Query: 537 LLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL-----DSNMIP--KISDFG 589
L W ++ + + +A L YL +++H ++ NIL+ + +P K+SD G
Sbjct: 99 SLHW--KLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153
Query: 590 LARMFGG-DELQSNTKRIVGTYGYMSPEYAIHG--FFSIKSDVFSFGVLLLE-------- 638
+ +E RI +++PE +G +I +D +SFG LLE
Sbjct: 154 IPITVLSREERVE---RI----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP 206
Query: 639 --TLSSKRSTRFFNTNS 653
TLSS RF+
Sbjct: 207 LSTLSSSEKERFYQDQH 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 40/135 (29%), Positives = 67/135 (49%), Gaps = 18/135 (13%)
Query: 515 LIYEYLPNKSLDSFL---FDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLK 571
L+ EY P L S L D E + A+ + E + L +H ++ +HRD+K
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELV----LAIHSVHQMGYVHRDIK 129
Query: 572 PSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY--AIHGF----FSI 625
P N+L+D K++DFG A ++ N+K VGT Y++PE ++G + +
Sbjct: 130 PENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGV 188
Query: 626 KSDVFSFGVLLLETL 640
+ D +S GV+ E +
Sbjct: 189 ECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 554 LLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIVGTYG 611
L++LH++ VI+RDLK NILLD+ K++DFG+ + + G T GT
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTTTTFCGTPD 161
Query: 612 YMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
Y++PE + D ++ GVL+ E ++ +
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 466 KLGEGGFGPVYKSGQ---------GLEEFKN---------EIKLTAKLQHRNLVRLLGCC 507
K+G G +G VYK+ + L++ + EI L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 508 VEQGENV--LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLY-----LHQY 560
+ + L+++Y + F + +++ G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 561 SRLRVIHRDLKPSNILL----DSNMIPKISDFGLARMFGGD-ELQSNTKRIVGTYGYMSP 615
V+HRDLKP+NIL+ KI+D G AR+F + ++ +V T+ Y +P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 616 EYAIHGFFSIKS-DVFSFGVLLLETLSSK 643
E + K+ D+++ G + E L+S+
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 484 EFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE---YLPNKSLD----SFLFDTT--- 533
+ +NEI +L H N++++ E +L E Y+ + D SF++D
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260
Query: 534 KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593
K+ L R I++ + + Y+H ++IHRD+K NI L+ + + DFG A
Sbjct: 261 KDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
F E ++ VGT SPE + +D++S G++LL+ LS
Sbjct: 317 F-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 40/163 (24%), Positives = 69/163 (42%), Gaps = 16/163 (9%)
Query: 483 EEFK---NEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLG 539
E+ K EI + +LQH N++ + + E ++ + S + L EGL
Sbjct: 41 EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPE 100
Query: 540 WGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDE 598
I++ + L Y+H IHR +K S+ILL + +S + M +
Sbjct: 101 LAIAF-ILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156
Query: 599 LQ----SNTKRIVGTYGYMSPEY---AIHGFFSIKSDVFSFGV 634
Q K V ++SPE + G ++ KSD++S G+
Sbjct: 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQG-YNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 44/206 (21%)
Query: 467 LGEGGFGPVYK-----SGQG--------LEEFKNEIK-----LTAKLQHRNLVRLLGCC- 507
+G+G +G V+K +G + + EI+ L A H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 508 ---VEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARIR------IIEGIAQGLLYL 557
V+ G+ + L+ E S+ + +G L G R+ I+ GL +L
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAYILHEALMGLQHL 140
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
H + IHRD+K +NILL + K+ DFG++ L+ NT VGT +M+PE
Sbjct: 141 HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEV 195
Query: 618 -----AIHGFFSIKSDVFSFGVLLLE 638
+ + + DV+S G+ +E
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 32/94 (34%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
I L++LH +I+RDLK N+LLD K++DFG+ + +F G T
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFC 157
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
GT Y++PE + D ++ GVLL E L
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 30/158 (18%)
Query: 456 AATNNFGVENKLGEGGFGPVYK-----SGQGLEEFK---------------NEIKLTAKL 495
AAT+ +E KLGEG + VYK +GQ L K E L L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQ-LVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 496 QHRNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGL 554
+H N+V LL + E + ++EY+ + L ++ GL + R+ + + + +GL
Sbjct: 61 KHANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPG-GLHPYNVRLFMFQ-LLRGL 116
Query: 555 LYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592
Y+H ++HRDLKP N+L+ K++DFGLAR
Sbjct: 117 AYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 44/173 (25%), Positives = 69/173 (39%), Gaps = 55/173 (31%)
Query: 515 LIYEYLPNKSLDSFL--FDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKP 572
LI E+LP L + L +DT E + R + E + L + +L IHRD+KP
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECV----LAIEAVHKLGFIHRDIKP 129
Query: 573 SNILLDSNMIPKISDFGLA-------------RMFGGDELQ------------------S 601
NIL+D K+SDFGL+ ++ G + S
Sbjct: 130 DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMS 189
Query: 602 NTKRI--------------VGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
+ +I VGT Y++PE + + + D +S G ++ E L
Sbjct: 190 SKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 44/146 (30%), Positives = 69/146 (47%), Gaps = 25/146 (17%)
Query: 466 KLGEGGFGPVYKSGQG------------LEEFKN-------EIKLTAKLQHRNLVRLLGC 506
KLGEG + VYK L+E + E L L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVI 566
+ L++EY+ + L ++ D GL ++ + + + +GL Y+HQ ++
Sbjct: 72 IHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQ-LLRGLSYIHQRY---IL 125
Query: 567 HRDLKPSNILLDSNMIPKISDFGLAR 592
HRDLKP N+L+ K++DFGLAR
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I+ L YLH+ +I+RDLK N+LLDS K++D+G+ + G T GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGT 159
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
Y++PE + D ++ GVL+ E ++ +
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 466 KLGEGGFGPVYKS----GQGLEEFK--------------NEIKLTAKLQHRNLVRLLGCC 507
K+G G +G VYK+ G+ +E+ EI L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 508 VEQGENV--LIYEYLPNKSLDSFLFD-----TTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
+ + L+++Y + F K L ++ I G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 561 SRLRVIHRDLKPSNILL----DSNMIPKISDFGLARMFGGD-ELQSNTKRIVGTYGYMSP 615
V+HRDLKP+NIL+ KI+D G AR+F + ++ +V T+ Y +P
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 616 EYAIHGFFSIKS-DVFSFGVLLLETLSSK 643
E + K+ D+++ G + E L+S+
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 20/143 (13%)
Query: 507 CVEQGENVL--IYEYLPNKSLDSFL--FDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
C Q + L + EY+P L + + +D ++ W A+ +L L
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLALDAIHS 160
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLA-RMFGGDELQSNTKRIVGTYGYMSPEY---- 617
+ +IHRD+KP N+LLD + K++DFG +M ++ +T VGT Y+SPE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQ 218
Query: 618 AIHGFFSIKSDVFSFGVLLLETL 640
G++ + D +S GV L E L
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 47/174 (27%), Positives = 71/174 (40%), Gaps = 8/174 (4%)
Query: 475 VYKSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK 534
+ K+ G + EI + + HR ++ L+ V + +P D F + +
Sbjct: 123 IVKAVTGGKTPGREIDILKTISHRAIINLIHA-YRWKSTVCMV--MPKYKCDLFTY-VDR 178
Query: 535 EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594
G L I I + + L YLH +IHRD+K NI LD + DFG A
Sbjct: 179 SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRF 648
GT SPE + K+D++S G++L E +S K T F
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE-MSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 39/130 (30%), Positives = 60/130 (46%), Gaps = 12/130 (9%)
Query: 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSN 574
++ EY+P L + + + W AR A+ +L L + IHRD+KP N
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE--KW-ARFYT----AEVVLALDAIHSMGFIHRDVKPDN 172
Query: 575 ILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY----AIHGFFSIKSDVF 630
+LLD + K++DFG + + VGT Y+SPE G++ + D +
Sbjct: 173 MLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 631 SFGVLLLETL 640
S GV L E L
Sbjct: 232 SVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 9/92 (9%)
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
GL Y+H +IHRDLKP N+ ++ + KI DFGLAR + V T Y
Sbjct: 129 GLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWY 180
Query: 613 MSPEYAIHGFFSIKS-DVFSFGVLLLETLSSK 643
+PE ++ ++ D++S G ++ E L+ K
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG-LARMFGGDELQSNTKRIVG 608
+A+ ++ + +L +HRD+KP NIL+D N +++DFG ++ +QS+ VG
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VG 165
Query: 609 TYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETL 640
T Y+SPE G + + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I L YLH S V++RDLK N++LD + KI+DFGL + G + + K GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 159
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN 652
Y++PE + D + GV++ E + + F+N +
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 47/161 (29%), Positives = 67/161 (41%), Gaps = 43/161 (26%)
Query: 515 LIYEYLPNKSLDSFLF--DTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKP 572
LI E+LP + + L DT E + IA+ +L + +L IHRD+KP
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFY--------IAETVLAIDSIHQLGFIHRDIKP 129
Query: 573 SNILLDSNMIPKISDFGLARMFG-----------GDELQS-------NTKR--------- 605
N+LLDS K+SDFGL L S N+KR
Sbjct: 130 DNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNR 189
Query: 606 ------IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
VGT Y++PE + ++ D +S GV++ E L
Sbjct: 190 RQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 16/84 (19%)
Query: 515 LIYEYLPNKSLDSFL-----FDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRD 569
L+ EYL + S L FD A I E +A L YLH++ +IHRD
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEM-------AVKYISE-VALALDYLHRHG---IIHRD 129
Query: 570 LKPSNILLDSNMIPKISDFGLARM 593
LKP N+L+ + K++DFGL+++
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 5/94 (5%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I L YLH V++RD+K N++LD + KI+DFGL + D + K GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
Y++PE + D + GV++ E + +
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 42/168 (25%), Positives = 67/168 (39%), Gaps = 51/168 (30%)
Query: 516 IYEYLPNKSLDSFL--FDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPS 573
+ +Y+P + S L +E L AR I E + + +H ++ IHRD+KP
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDL----ARFYIAE-LTCAIESVH---KMGFIHRDIKPD 130
Query: 574 NILLDSNMIPKISDFGLARMF-----------GG----------DELQSNTKR------- 605
NIL+D + K++DFGL F G +E +
Sbjct: 131 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLER 190
Query: 606 -------------IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
+VGT Y++PE + ++ D +S GV+L E L
Sbjct: 191 RRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 26/67 (38%), Positives = 36/67 (53%), Gaps = 5/67 (7%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I L YLH V++RDLK N++LD + KI+DFGL + G + K GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 158
Query: 610 YGYMSPE 616
Y++PE
Sbjct: 159 PEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
I+ L +LH+ +I+RDLK N+LLD+ K++D+G+ + + GD T
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFC 157
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
GT Y++PE + D ++ GVL+ E ++ +
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 44/161 (27%), Positives = 65/161 (40%), Gaps = 43/161 (26%)
Query: 515 LIYEYLPNKSLDSFLF--DTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKP 572
LI E+LP + + L DT E + IA+ +L + +L IHRD+KP
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFY--------IAETVLAIDAIHQLGFIHRDIKP 129
Query: 573 SNILLDSNMIPKISDFGLARM--------------------FGGDELQSNTK-------- 604
N+LLD+ K+SDFGL F + S K
Sbjct: 130 DNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNR 189
Query: 605 -----RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
VGT Y++PE + ++ D +S GV++ E L
Sbjct: 190 RQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I L +LH+ +I+RDLK N+LLD++ K++D+G+ + G T GT
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGT 159
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
Y++PE + D ++ GVL+ E ++ +
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I L YLH ++++RDLK N++LD + KI+DFGL + G + K GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGT 158
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN 652
Y++PE + D + GV++ E + + F+N +
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 36/136 (26%), Positives = 56/136 (41%), Gaps = 45/136 (33%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG-------------- 595
IA+ L + ++ IHRD+KP NIL+D + K++DFGL F
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 596 -------------------GDELQSNTKR------------IVGTYGYMSPEYAIHGFFS 624
GD L++ +R +VGT Y++PE + ++
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 625 IKSDVFSFGVLLLETL 640
D +S GV+L E L
Sbjct: 227 QLCDWWSVGVILFEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 19/156 (12%)
Query: 491 LTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGI 550
L +++ H +L + G CV EN+++ E++ + LD L + W +I + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 551 AQGLLYLHQYSRLRVIHRDLKPSNIL-----LDSNMIP--KISDFGLARMFGGDELQSNT 603
A L YL + ++H ++ NIL L P K+SD G++ F +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 604 KRIVGTYGYMSPEYAIHGF-FSIKSDVFSFGVLLLE 638
+RI +++PE G S +D +SFG LLE
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 24/95 (25%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 483 EEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGA 542
E F + ++L H++LV G CV E++++ EY+ SLD++L + W
Sbjct: 44 ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW-- 101
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL 577
++ + + +A L +L + H ++ N+LL
Sbjct: 102 KLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 35/136 (25%), Positives = 54/136 (39%), Gaps = 45/136 (33%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG-------------- 595
IA+ + ++ IHRD+KP NIL+D + K++DFGL F
Sbjct: 107 IAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 596 -------------------GDELQSNTKR------------IVGTYGYMSPEYAIHGFFS 624
GD L+ +R +VGT Y++PE + ++
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226
Query: 625 IKSDVFSFGVLLLETL 640
D +S GV+L E L
Sbjct: 227 QLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 35/115 (30%), Positives = 51/115 (44%), Gaps = 23/115 (20%)
Query: 545 RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL---DSNMIP-------------KISDF 588
+II L Y H + L ++H DLKP NIL+ D+ + P +I D
Sbjct: 235 QIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
G DE S T IV T Y SPE + + +D++S G ++ E + K
Sbjct: 293 GGC----CDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 37/136 (27%), Positives = 55/136 (40%), Gaps = 45/136 (33%)
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM------------------- 593
L YLH L +++RDLKP NILL + +SDF L++
Sbjct: 115 ALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 594 --------FGGDELQSNTKRIVGTYGYMSPEY---AIHGFFSIKSDVFSFGVLLLETL-- 640
+E + VGT Y++PE HG ++ D ++ G+LL E L
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAV--DWWTLGILLYEMLYG 228
Query: 641 ------SSKRSTRFFN 650
S++ T F N
Sbjct: 229 TTPFKGSNRDET-FSN 243
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 42/171 (24%), Positives = 70/171 (40%), Gaps = 9/171 (5%)
Query: 475 VYKSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK 534
V K+GQ E + + H ++++L G LI LP D + + K
Sbjct: 121 VIKAGQ-RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAK 176
Query: 535 EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594
+ + I + + + YLH+ R+IHRD+K NI ++ + DFG A F
Sbjct: 177 RNI-AICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACF 231
Query: 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS 645
D + GT +PE + D++S G++L E + S
Sbjct: 232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282
|
Length = 391 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 64/279 (22%), Positives = 113/279 (40%), Gaps = 62/279 (22%)
Query: 482 LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWG 541
L+ +NE+ L+ +H N++ +I ++ S +S L EG+
Sbjct: 43 LKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSE-- 100
Query: 542 ARIR-IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600
A I I+ G +GL YLHQ IHR++K S+IL IS GL + G L
Sbjct: 101 ALIGNILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLY 149
Query: 601 S---NTKRIVGTYGY----------MSPEYA---IHGFFSIKSDVFSFGV---------- 634
S N ++ Y + +SPE ++G +++KSD++S G+
Sbjct: 150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGRV 208
Query: 635 ---------LLLETLS------------SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673
+LL+ L +R N+ S G ++ + +
Sbjct: 209 PFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMT 268
Query: 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVIS 712
+L+ +S + N+ LC+Q++ RP+ S ++S
Sbjct: 269 SERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 29/158 (18%)
Query: 494 KLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQG 553
++ H+++V L G CV EN+++ E++ LD LF K +L + ++ + +A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASA 117
Query: 554 LLYLHQYSRLRVIHRDLKPSNILL-----DSNMIP--KISDFG-----LARMFGGDELQS 601
L YL ++H ++ NILL D P K+SD G L+R Q
Sbjct: 118 LSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-------QE 167
Query: 602 NTKRIVGTYGYMSPE-YAIHGFFSIKSDVFSFGVLLLE 638
+RI +++PE SI +D +SFG L E
Sbjct: 168 CVERI----PWIAPECVEDSKNLSIAADKWSFGTTLWE 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 754 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.67 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.66 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.63 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.57 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.54 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.5 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.4 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.39 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.02 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.01 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.98 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.9 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.85 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 98.84 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.71 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.67 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.62 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.61 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.59 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.57 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.56 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.53 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.34 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.27 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.17 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.15 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.06 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.02 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.01 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.92 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.86 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.78 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.68 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.48 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.46 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.4 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.36 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.2 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.08 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 96.93 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.81 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.6 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.54 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.39 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.37 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.15 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.08 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.01 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.01 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.97 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.97 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.73 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.93 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 94.67 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 94.66 | |
| PLN02236 | 344 | choline kinase | 94.62 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.52 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.16 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.13 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.69 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.25 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 93.12 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 92.35 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=418.60 Aligned_cols=269 Identities=41% Similarity=0.710 Sum_probs=236.3
Q ss_pred cCCCchhhHhhhhcCccccceeccCCCcceeec----------------ccc-HHHHHHHHHHHHhhccCCeeeeeeeee
Q 036419 446 TQGKSLASVSAATNNFGVENKLGEGGFGPVYKS----------------GQG-LEEFKNEIKLTAKLQHRNLVRLLGCCV 508 (754)
Q Consensus 446 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~-~~~~~~Ev~il~~l~hpniv~l~~~~~ 508 (754)
...+++.++..+|++|...+.||+||||.||++ ... ..+|.+|+.++.+++|||+|+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 455899999999999999999999999999971 111 567999999999999999999999999
Q ss_pred ecC-eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEee
Q 036419 509 EQG-ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISD 587 (754)
Q Consensus 509 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~D 587 (754)
+.+ +.+||||||++|+|+++|+..... .++|.+|++|+.++|+||+|||+.+.++||||||||.|||||+++.+||+|
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 999 599999999999999999875544 789999999999999999999999988999999999999999999999999
Q ss_pred ccCccccCCCccccccccc-ccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCchhHhHhhhhhhc
Q 036419 588 FGLARMFGGDELQSNTKRI-VGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFN-TNSLTLLGHAWNLWK 665 (754)
Q Consensus 588 Fgla~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~ 665 (754)
||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||++|+++..... ..+..+..|++..+.
T Consensus 221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999765431 1111112 79999999999999999999999999999999999999877654 233558888888999
Q ss_pred cCccccccCcccC-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 666 DDRSWELMDPKLQ-CEASY-PIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 666 ~~~~~~l~d~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.++..+++|+.+. ..... ...+++..++.+|++.+|++||+|.+|+++|+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 9999999999987 55553 6888899999999999999999999999999665
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=363.88 Aligned_cols=237 Identities=25% Similarity=0.370 Sum_probs=195.0
Q ss_pred hhcCccccceeccCCCcceeec-------------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecC
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS-------------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG 511 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~-------------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~ 511 (754)
..+.|.+.+.||+|+||.|-++ ......+++|++||++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567889999999999999751 112344679999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC---CceEEeec
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN---MIPKISDF 588 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~---~~~kl~DF 588 (754)
..|+||||++||+|.+++- .++.+.+..-..+++|++.|+.|||+.| |+||||||+|||+..+ -.+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999994 4566888888999999999999999998 9999999999999655 78999999
Q ss_pred cCccccCCCcccccccccccccCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhc
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF---FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWK 665 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 665 (754)
|+|+..+... .+...|||+.|.|||++.... +..|+|+||+|||||-+++|.+||....... .+.++.
T Consensus 324 GlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQI----- 394 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQI----- 394 (475)
T ss_pred chhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHHHH-----
Confidence 9999887443 356789999999999998764 3458999999999999999999986543222 111111
Q ss_pred cCccccccCcc--cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 666 DDRSWELMDPK--LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 666 ~~~~~~l~d~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
...+ ........+.++.+++|.+||+.||++|||+.|+++|--
T Consensus 395 -------~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 395 -------LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred -------hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 1111 112334567899999999999999999999999998754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=357.41 Aligned_cols=238 Identities=27% Similarity=0.401 Sum_probs=195.7
Q ss_pred cCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecC-eeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG-ENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~-~~~lV~E 518 (754)
.+.+..+.||+|..|+|||..+ ..+++.+|++++++.+||+||++++.|..+. .+.++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 3455678999999999998322 3577899999999999999999999999998 5999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ-YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||++|+|++++.. .+++++...-+|+.+|++||.|||+ ++ ||||||||+||||+..|.+||||||.++.+.+.
T Consensus 159 YMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999954 3679999999999999999999996 55 999999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
....++||..|||||-+.+..|+.++||||||+.++|++.|+.|+....+......+... .+++...
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~---------~Iv~~pp 299 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC---------AIVDEPP 299 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH---------HHhcCCC
Confidence 345689999999999999999999999999999999999999998754222211111111 1122111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
........++++++++..||++||.+||++.|+++|--
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 11111135678999999999999999999999998863
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=368.27 Aligned_cols=244 Identities=30% Similarity=0.493 Sum_probs=199.2
Q ss_pred CccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecC-eeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG-ENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~-~~~lV~E~ 519 (754)
...+.+.||+|+||+||++.. ..++|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 344556799999999997211 1458999999999999999999999999988 79999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC-ceEEeeccCccccCCCc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM-IPKISDFGLARMFGGDE 598 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~-~~kl~DFgla~~~~~~~ 598 (754)
|++|+|.++++.. ....+++..+++++.|||+||.|||+.+. ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999764 45679999999999999999999999873 99999999999999997 99999999998765432
Q ss_pred ccccccccccccCcccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAI--HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~--~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
...+...||+.|||||++. ...|+.|+||||||+++|||++|+.||...... ... .......
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~~~---~~v~~~~--------- 262 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--QVA---SAVVVGG--------- 262 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--HHH---HHHHhcC---------
Confidence 2233478999999999999 569999999999999999999999998765541 111 1111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLP 722 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 722 (754)
............+..++.+||+.||++||++.+++..|+.......
T Consensus 263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 1111122255778899999999999999999999999996644444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=372.12 Aligned_cols=232 Identities=25% Similarity=0.379 Sum_probs=199.1
Q ss_pred cCccccceeccCCCcceeec---------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~---------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
.+|+..+.||+|||+.||+. ....+++.+||+|-++|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999972 334678899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
|+|++++|..++. ..+.+++.+++.+.+||+.||.|||+++ |||||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999995 4567999999999999999999999998 999999999999999999999999999988755
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhhhhhhccCccccccCcc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
.. .....+||+.|+|||++.....+..+||||+|||||-||.|++||+...-++ ...+.... .
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~----------Y---- 235 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE----------Y---- 235 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC----------c----
Confidence 33 2346899999999999999999999999999999999999999998654332 11111100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
..+...+....+||.++|+.||.+|||+++|+.|=-
T Consensus 236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 011134566789999999999999999999998753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=344.04 Aligned_cols=245 Identities=26% Similarity=0.388 Sum_probs=198.6
Q ss_pred hhcCccccceeccCCCcceeec--------------------cccHHHHHHHHHHHHhhccCCeeeeee-eeeecCe-eE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKLQHRNLVRLLG-CCVEQGE-NV 514 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~--------------------~~~~~~~~~Ev~il~~l~hpniv~l~~-~~~~~~~-~~ 514 (754)
...+|+++++||.|.||+|||. .+..+....|+.+|++|+|||||++++ .+.++.. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 3457999999999999999982 234567789999999999999999998 5666655 89
Q ss_pred EEEEecCCCChhhHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcC-CCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 515 LIYEYLPNKSLDSFLFDTTK-EGLLGWGARIRIIEGIAQGLLYLHQYS-RLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~-~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
|||||+..|+|...|....+ +..+++..+++++.|+++||..+|+.- +..|+||||||.||+|+.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999976543 457999999999999999999999832 1249999999999999999999999999999
Q ss_pred ccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
.+..+.. .....+|||.||+||.+.+.+|+.|+||||+||++|||..-+.||.+.+ +.....+.-
T Consensus 177 ~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~~~L~~KI~-------- 241 (375)
T KOG0591|consen 177 FLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----LLSLCKKIE-------- 241 (375)
T ss_pred HhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----HHHHHHHHH--------
Confidence 9876543 3456899999999999999999999999999999999999999987652 111111111
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
............+..+..||..|+..||+.||+...+++.+...
T Consensus 242 -qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 242 -QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred -cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 11111111244678899999999999999999976666666543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=347.90 Aligned_cols=234 Identities=28% Similarity=0.459 Sum_probs=186.4
Q ss_pred hcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
..+|.+.++||.|+|++|||+.+ ..+-+..|++||+.++|||||++++++..++.++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 36789999999999999998322 2345678999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC------CceEEeeccCc
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN------MIPKISDFGLA 591 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~------~~~kl~DFgla 591 (754)
|||.||+|.+||+. .+.+++..+..++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999954 457999999999999999999999998 9999999999999764 46899999999
Q ss_pred cccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
+.+.... .....+|++-|||||+++.++|+.|+|+||+|+|+|++++|+.||......+... .. -......
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~--~~---~k~~~~~- 233 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL--YI---KKGNEIV- 233 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH--HH---hcccccc-
Confidence 9987553 3456899999999999999999999999999999999999999987554443221 11 1111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..........+.+++...++.+|.+|-+..+-..+
T Consensus 234 -------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 234 -------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred -------CchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 11111222334466666667777777766655443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=345.28 Aligned_cols=234 Identities=26% Similarity=0.362 Sum_probs=195.2
Q ss_pred hhcCccccceeccCCCcceeec---------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~---------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..++|++.+.||+|+||+||+. ..+.+..++|..||.+++||+||+++..|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999961 2245678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|+||+.||.|..+| .+++.+++..+.-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+|||+++..-
T Consensus 103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999999 45678999999999999999999999998 9999999999999999999999999999654
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
... ..+..++||+.|||||++.+..|+..+|.||||+++|||++|.+||...+..... ......
T Consensus 177 ~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~-----~~I~~~--------- 240 (357)
T KOG0598|consen 177 KDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY-----DKILKG--------- 240 (357)
T ss_pred cCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH-----HHHhcC---------
Confidence 332 2345689999999999999999999999999999999999999998765433211 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRP----TMSEVISM 713 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----t~~evl~~ 713 (754)
.+ ...+.-...+.++++.++|+.||++|. .+.+|.+|
T Consensus 241 k~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 241 KL-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred cC-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 10 111222457788999999999999995 56666554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=354.35 Aligned_cols=245 Identities=33% Similarity=0.519 Sum_probs=201.0
Q ss_pred hhhhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
+.....+++.++||+|-||+||.+ ....+.|.+|+++|++|+|+|||+++++|..++.++||||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 344455677899999999999972 2345789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
||+.|+|.++|.. ...+.+...+.+.++.||++|++||++++ +|||||...||||+++..+||+|||||+....+.
T Consensus 282 ~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 282 YMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred ecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999999999976 34567999999999999999999999998 9999999999999999999999999999776665
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCC-CCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS-TRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
+..... ..=...|.|||.+..+.|+.|||||||||+|+||+|-.+. +...... ..+ +.++...
T Consensus 358 Y~~~~~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--ev~-------------~~le~Gy 421 (468)
T KOG0197|consen 358 YTASEG-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--EVL-------------ELLERGY 421 (468)
T ss_pred eeecCC-CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--HHH-------------HHHhccC
Confidence 543322 2235689999999999999999999999999999986543 2322211 111 2222333
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
+-+.+...+..+.+||..||+.+|++|||++.+...|+....
T Consensus 422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 334444567889999999999999999999999999987643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=323.53 Aligned_cols=248 Identities=21% Similarity=0.315 Sum_probs=193.0
Q ss_pred cCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
+.|+.+.++|+|+||.|||.+. -.+-..+|+++|++|+|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4678888999999999998211 12446799999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|++..-|+++-.. ..-++.+.+.++++|+++|+.|+|+++ +|||||||+||||..++.+||||||+|+.+....
T Consensus 82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 9999777665532 223788999999999999999999998 9999999999999999999999999999886321
Q ss_pred ccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhH---------hHhhhhhhccC-
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL---------LGHAWNLWKDD- 667 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~- 667 (754)
..-+..+.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+-|++...-+... ...-..++...
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 23446788999999999987 589999999999999999999999887655433211 11111122211
Q ss_pred -----ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 668 -----RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 668 -----~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
++.+.-++..-...-+....-+++++..||+.||.+|++-++++.|-
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 12122222111112233556789999999999999999999998763
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=339.62 Aligned_cols=238 Identities=25% Similarity=0.341 Sum_probs=197.8
Q ss_pred hhhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCee
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~ 513 (754)
...++|++++.||+|+|++|+++. ...+-+..|-.+|.+| .||.|++|+..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345789999999999999999732 2234456788899999 799999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
|+|+||+++|+|.++|.+ -+.+++..++.++.||+.||+|||++| ||||||||+|||||+++++||+|||-|+.
T Consensus 150 YFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999954 477999999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCccc---------ccc--cccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh
Q 036419 594 FGGDELQ---------SNT--KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 594 ~~~~~~~---------~~~--~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 662 (754)
+...... ... ..++||-.|.+||++.....+..+|+|+||||||+|+.|.+||...++.-.. .
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF--q---- 297 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF--Q---- 297 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH--H----
Confidence 8643221 112 4589999999999999999999999999999999999999999765543211 0
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
++++-.. ......++...+|+.+.|..||.+|+|.++|-+|.-
T Consensus 298 --------kI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 298 --------KIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred --------HHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 0111000 111223367889999999999999999999999873
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=339.06 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=197.6
Q ss_pred hhhcCccccceeccCCCcceeecccc-----------------HHH--HHHHHHHHHhhc-cCCeeeeeeeeeecC-eeE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQG-----------------LEE--FKNEIKLTAKLQ-HRNLVRLLGCCVEQG-ENV 514 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~~-----------------~~~--~~~Ev~il~~l~-hpniv~l~~~~~~~~-~~~ 514 (754)
..-++|.+.++||.|.||.||++... .++ -.+||+.|++|+ |||||++.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34578999999999999999984321 122 257999999999 999999999999988 999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+|||||+. +|.+++.++ +..+++..++.|++||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999977 899999764 678999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHh-h-----hhhhccC
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH-A-----WNLWKDD 667 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~-~-----~~~~~~~ 667 (754)
.... .-+..+.|.+|+|||++.. +.|+.++|+|++|||++|+.+-++.|++..+-+...... + +..|.++
T Consensus 161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 6543 3446788999999998865 579999999999999999999999988766544211100 0 0111110
Q ss_pred -ccccccCcccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 668 -RSWELMDPKLQ-------CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 668 -~~~~l~d~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.+...++-.+. ...-....+++.+++..|+++||++|||+++.++|--
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 00011111110 1111225678999999999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=334.24 Aligned_cols=240 Identities=29% Similarity=0.440 Sum_probs=190.6
Q ss_pred cCccccceeccCCCcceeeccc--------------c----HHHHHHHHHHHHhhccCCeeeeeeeeeecC--eeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ--------------G----LEEFKNEIKLTAKLQHRNLVRLLGCCVEQG--ENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~--------------~----~~~~~~Ev~il~~l~hpniv~l~~~~~~~~--~~~lV~E 518 (754)
.++...+.||+|.||.||+... . .+.+.+|+++|.+|+|||||+++|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 4577788999999999997221 1 455899999999999999999999855554 6899999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC-CCceEEeeccCccccCC-
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS-NMIPKISDFGLARMFGG- 596 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~-~~~~kl~DFgla~~~~~- 596 (754)
|+++|+|.+++.+... .+++..+..+.+||++||+|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999965332 6999999999999999999999998 999999999999999 79999999999997764
Q ss_pred CcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
...........||+.|||||++.++ ....++|||||||++.||+||.+|+... . ............... |
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~---~~~~~~~~ig~~~~~-----P 242 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F---EEAEALLLIGREDSL-----P 242 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c---chHHHHHHHhccCCC-----C
Confidence 1112223457899999999999964 3346999999999999999999998653 1 111111111111111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
..+...++...+++.+|++.||++||||+++++|.--
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 2223356788999999999999999999999999854
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=342.49 Aligned_cols=246 Identities=29% Similarity=0.427 Sum_probs=193.4
Q ss_pred hhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeec
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQ 510 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~ 510 (754)
...++|++.++||+|+||.||++. ...+.+.+|++++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 456789999999999999999742 1134578899999999 899999999988764
Q ss_pred -CeeEEEEEecCCCChhhHhhccCC-------------------------------------------------------
Q 036419 511 -GENVLIYEYLPNKSLDSFLFDTTK------------------------------------------------------- 534 (754)
Q Consensus 511 -~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------- 534 (754)
...++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 457899999999999999964321
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccccccccccc
Q 036419 535 ----EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY 610 (754)
Q Consensus 535 ----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~ 610 (754)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...............++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 134788899999999999999999988 9999999999999999999999999998654332222223345678
Q ss_pred CcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHH
Q 036419 611 GYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRY 689 (754)
Q Consensus 611 ~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l 689 (754)
.|+|||++.+..++.++|||||||++|||++ |..||........ ... ....+.. .. .....++.+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~----~~~~~~~-----~~----~~~~~~~~l 306 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQ----RLKDGTR-----MR----APENATPEI 306 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHH----HHhcCCC-----CC----CCCCCCHHH
Confidence 8999999999999999999999999999997 8888865433221 111 1111110 00 111234678
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 690 INVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 690 ~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.+++.+||+.||++|||+.+|+++|+...
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 89999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=330.34 Aligned_cols=261 Identities=26% Similarity=0.370 Sum_probs=198.9
Q ss_pred hcCccccceeccCCCcceeecccc--------------------HHHHHHHHHHHHhhccCCeeeeeeeeeec--CeeEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQG--------------------LEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GENVL 515 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~~--------------------~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~~~l 515 (754)
.+.|+.+++||+|.||.|||+.+. ..-..+||+||++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 456888899999999999994331 23357899999999999999999998876 68999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|+|||++ +|.-++.. ..-.+++.++..+++||+.||.|+|.++ |+|||||..|||||.+|.+||+|||||+.+.
T Consensus 196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999988 77777743 2346999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh--------hhcc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN--------LWKD 666 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~ 666 (754)
...... .+..+-|.+|+|||++.+. .|+.++|+||.||||.||+.|++.+++..+.+ ..+.+.+ .|..
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve--Ql~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE--QLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH--HHHHHHHHhCCCChhcccc
Confidence 654433 4456779999999999886 79999999999999999999999987665433 1112221 2331
Q ss_pred Cccc--cccCcccCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCCCCCCc
Q 036419 667 DRSW--ELMDPKLQC-----EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGF 729 (754)
Q Consensus 667 ~~~~--~l~d~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~ 729 (754)
.++. ..+.+...- +.....+...++|+..+|..||.+|.|+.++++.= .+...|.|..|..
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se--yF~t~p~~~~p~~ 414 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE--YFTTEPLPCDPSS 414 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc--ccccCCCCCCccc
Confidence 1111 111111110 00112345678999999999999999999998753 2234444444443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=307.44 Aligned_cols=260 Identities=26% Similarity=0.349 Sum_probs=201.9
Q ss_pred cCccccceeccCCCcceeecccc--------------------HHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQG--------------------LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~~--------------------~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
.+|...++||+|.||.|||+.+. .....+||+.|+.++|+||+.++++|-+.....||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888899999999999984321 2456899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
||+. +|+..|.+ +...++...+..++.++++||+|||++. |+||||||.|+||+.+|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9987 99999965 3457999999999999999999999987 9999999999999999999999999999987654
Q ss_pred ccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc---Ccc---cc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD---DRS---WE 671 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~---~~ 671 (754)
.. ....+-|.+|+|||.+.+. .|+..+|+||.|||+.||+-|.+-|++..+-+ ........+.. +.. .+
T Consensus 156 ~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 156 RI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred cc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HHHHHHHHcCCCCcccCccccc
Confidence 32 2233779999999998875 79999999999999999999988776543322 11111111110 000 01
Q ss_pred cc--------CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCCCCCCcc
Q 036419 672 LM--------DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFS 730 (754)
Q Consensus 672 l~--------d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~ 730 (754)
+. .............+...+++..|+..||.+|+|++|+++|=- +...|.|..|.-.
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y--f~~~P~pt~~~~l 296 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY--FKSLPLPTPPSKL 296 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh--hhcCCCCCChhhC
Confidence 11 111111123345667799999999999999999999999864 3456666655543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=324.79 Aligned_cols=252 Identities=23% Similarity=0.395 Sum_probs=202.7
Q ss_pred hHhhhhcCccccceeccCCCcceeec-------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKS-------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~-------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~ 513 (754)
+.....+.|++.+.||.|.-++||++ ....+.+++|++.++.++||||++++..|..+..+
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 34455689999999999999999972 23468899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||.||.+|++.++++..-..+ +++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.+..
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred EEeehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeee
Confidence 99999999999999997765554 899999999999999999999998 99999999999999999999999998775
Q ss_pred cCCCccc--ccccccccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcc
Q 036419 594 FGGDELQ--SNTKRIVGTYGYMSPEYAIHG--FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 594 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
+...... .....++||++|||||+++.. .|+.|+||||||+...||.+|..||....+-...+.. ..+. .
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-----Lqn~-p 249 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-----LQND-P 249 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hcCC-C
Confidence 5432211 111567999999999997654 7999999999999999999999999877654422211 1111 0
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
..+.-..+...........+.+++..||++||.+|||+++++++-
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 000100111122233456789999999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.94 Aligned_cols=247 Identities=27% Similarity=0.415 Sum_probs=203.3
Q ss_pred cCccccceeccCCCcceeec--------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~--------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
++|.+.+.||+|.||.|||+ +.+.+.+++|++|+++|+|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57899999999999999983 2345668999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+.| +|..+|. ..+.++++.+..|+.+++.||.|||+.. |+|||+||+|||++..+.+|++|||+|+.+....
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9988 9999994 4567999999999999999999999998 9999999999999999999999999999876432
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
...+.+.||+-|||||++.+++|+..+|.||+|||+||++.|++||-...- ..++. ....+. -
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si--~~Lv~---~I~~d~--------v-- 217 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI--TQLVK---SILKDP--------V-- 217 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH--HHHHH---HHhcCC--------C--
Confidence 345578999999999999999999999999999999999999999753211 11111 111111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH--hccccCCCCCCCCCcc
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISML--TNEFVNLPSPQQPGFS 730 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L--~~~~~~~~~p~~p~~~ 730 (754)
......+..+..++.-.|++||..|.|-.+++.|- ++.......|.+|++.
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~ 270 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFD 270 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhccccccccc
Confidence 11224567789999999999999999999999875 3333444455555553
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=334.99 Aligned_cols=236 Identities=25% Similarity=0.380 Sum_probs=197.0
Q ss_pred hhcCccccceeccCCCcceeec------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
....|...++||+|..|.||.+ +...+-+.+|+.+|+..+|+|||++++.|..++++++|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 4457888899999999999962 2344567899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
||++|+|.+.+. +..+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+....
T Consensus 351 ym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 351 YMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred ecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999984 345999999999999999999999998 9999999999999999999999999999876554
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
. .....+||+.|||||++....|++|+||||||++++||+-|.+|+-. +.... ..+.....+ ..++
T Consensus 424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln--E~Plr---AlyLIa~ng-~P~l------ 489 (550)
T KOG0578|consen 424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN--ENPLR---ALYLIATNG-TPKL------ 489 (550)
T ss_pred C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC--CChHH---HHHHHhhcC-CCCc------
Confidence 3 34468999999999999999999999999999999999999999643 22211 111111111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......+..+.+++.+||+.|+++||++.|+|+|-
T Consensus 490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 22234567899999999999999999999999875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=327.05 Aligned_cols=249 Identities=28% Similarity=0.470 Sum_probs=192.0
Q ss_pred hcCccccceeccCCCcceeecc-----------------------------------ccHHHHHHHHHHHHhhccCCeee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------------------------QGLEEFKNEIKLTAKLQHRNLVR 502 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------------------------~~~~~~~~Ev~il~~l~hpniv~ 502 (754)
.++|++.++||+|+||.||++. ....++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999642 01346889999999999999999
Q ss_pred eeeeeeecCeeEEEEEecCCCChhhHhhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcee
Q 036419 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTT----------------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVI 566 (754)
Q Consensus 503 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ii 566 (754)
+++++.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999985421 1124788899999999999999999988 99
Q ss_pred eCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 036419 567 HRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRST 646 (754)
Q Consensus 567 H~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~ 646 (754)
||||||+|||+++++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||+++..+.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999998764433323333455688999999999889999999999999999999754333
Q ss_pred CcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 647 RFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
++...................... .. .......++.+.+++.+||+.||++|||+.+|.++|+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQ-VY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhcccc-cc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 222222222222221111111000 00 0011233467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=334.39 Aligned_cols=237 Identities=25% Similarity=0.360 Sum_probs=195.1
Q ss_pred hhhcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecC
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQG 511 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~ 511 (754)
...++|++.+.||+|+||+|+++. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 455789999999999999999731 12446678999999999 999999999999999
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC-CceEEeeccC
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGL 590 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-~~~kl~DFgl 590 (754)
.+++||||+.+|+|.++|.+ .+++.+.++..+++||+.|+.|+|+++ |+||||||+|||+|.+ +.+||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999954 567999999999999999999999998 9999999999999999 9999999999
Q ss_pred ccccCCCcccccccccccccCcccccccccCC-CC-cccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF-FS-IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s-~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
+..... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||..... ..+...
T Consensus 168 s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--~~l~~k--------- 234 (370)
T KOG0583|consen 168 SAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--PNLYRK--------- 234 (370)
T ss_pred ccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--HHHHHH---------
Confidence 998741 112345689999999999999977 86 889999999999999999999876221 111111
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
+.......+.... +.++..++.+||+.||.+|+|+.+|+.+-.
T Consensus 235 ---i~~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 235 ---IRKGEFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred ---HhcCCccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 1111111111111 678899999999999999999999996543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.34 Aligned_cols=220 Identities=28% Similarity=0.394 Sum_probs=185.9
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
-++|++.+.||.|+||+|.+.+ ...+...+|..+|+.+.||+++++++.+.+...+++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3678999999999999998621 1345667899999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||.+||.|..+++ +.+++++..++-++.||+.||+|||+.+ |++|||||+|||||.+|.+||.|||+|+.+..
T Consensus 123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999994 5567999999999999999999999998 99999999999999999999999999998753
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
. +-..|||+.|+|||++....|..++|.|||||++|||+.|.+||....+ ...-+ +++...
T Consensus 197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY~------------KI~~~~ 257 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIYE------------KILEGK 257 (355)
T ss_pred c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHHH------------HHHhCc
Confidence 3 4578999999999999999999999999999999999999999865443 11111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCC
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADR 704 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~R 704 (754)
+ ..+.-....+.+|+...|+.|-.+|
T Consensus 258 v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 V--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred c--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1 1122344668899999999999999
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=316.98 Aligned_cols=234 Identities=23% Similarity=0.361 Sum_probs=200.0
Q ss_pred hhhcCccccceeccCCCcceee---------------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 456 AATNNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk---------------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
....+|++.+.||+|.||.|-+ .++++-.+++||+||..|+||||+.++++|+..+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 3457899999999999999975 3455677899999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
|||||..+|.|.+|| ...+.+++.++.++++||..|+.|+|.+. ++|||||.+|||+|.++++||+|||++.++
T Consensus 130 ivMEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 130 IVMEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999999 45667999999999999999999999998 999999999999999999999999999988
Q ss_pred CCCcccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
..+.. ...++|++-|.+||++.+.+| .+.+|.|||||+||-|+.|..||.+.+-.. ++.+. -
T Consensus 204 ~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--lvrQI------------s 266 (668)
T KOG0611|consen 204 ADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--LVRQI------------S 266 (668)
T ss_pred ccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH--HHHHh------------h
Confidence 66543 456899999999999999988 589999999999999999999987664332 11111 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.... ..++.+....-||+|||..||++|-|+.+|..|.-
T Consensus 267 ~GaY---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 267 RGAY---REPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred cccc---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1111 11223455778999999999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.03 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=203.0
Q ss_pred CchhhHhhhhcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC
Q 036419 449 KSLASVSAATNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG 511 (754)
Q Consensus 449 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~ 511 (754)
.+..++++..+...+.++||+|.||+||++. ...+.|++||..+++-+|-||+-+.|+|....
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 4456777777888999999999999999832 25689999999999999999999999999887
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
. .||..+|+|.+|..+|+... ..+...+.+.|++||++|+.|||.++ |||||||..|||+.+++.|||+|||++
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 7 99999999999999997543 45889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHG---FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
..-..-.-........|...|||||+++.+ +|++.+||||||+|+|||++|..|+.....+.. +|..++
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--------ifmVGr 607 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--------IFMVGR 607 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--------EEEecc
Confidence 754322111222334577899999999754 799999999999999999999999873322221 122222
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
..-..|... ......+++.+|+..||.+++++||.+.+|+.+|+..
T Consensus 608 G~l~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 608 GYLMPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred cccCccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 211111111 1223456889999999999999999999999988776
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.86 Aligned_cols=232 Identities=26% Similarity=0.346 Sum_probs=196.3
Q ss_pred cCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
.-|++++.||+|+-|.|-.+.+ ....+.+|+-||+-|.|||++++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4688999999999999976322 2467899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|.|.+++ ..++.+++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|.+...+
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999999 45678999999999999999999999998 999999999999999999999999999976554
Q ss_pred cccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
. .....||+++|.|||++++.+| +.++||||.|||||.||+|+.||...+ -..+...+. .+ .
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--ir~LLlKV~----~G-~------- 228 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--IRVLLLKVQ----RG-V------- 228 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--HHHHHHHHH----cC-c-------
Confidence 3 3456799999999999999998 489999999999999999999987322 112211111 11 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
-..+..++.++.+|+.+||..||++|.|++||++|.-
T Consensus 229 --f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 229 --FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred --ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 0112345678899999999999999999999999874
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=335.09 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=206.3
Q ss_pred hhhcCccccceeccCCCcceee---------------------ccccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCee
Q 036419 456 AATNNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk---------------------~~~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~ 513 (754)
..-++|.+++.||+|.||+|++ ..++.+..+.|.+|+.... ||.|++++.+|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 4457899999999999999986 3456788899999988876 99999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+.||++..++ ..+.+++..+.-++..|+.||.|||+++ |||||||.+|||||.+|++||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999955444 4467999999999999999999999998 99999999999999999999999999996
Q ss_pred cCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.-.. ...+..++||+.|||||++.+..|+.++|.|||||+|||||.|..||++.++++. +
T Consensus 518 ~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------------------F 577 (694)
T KOG0694|consen 518 GMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------------------F 577 (694)
T ss_pred cCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------------------H
Confidence 4321 2346689999999999999999999999999999999999999999987655442 1
Q ss_pred CcccCC--CCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHHh--------ccccCCCCCCCCCccccccc
Q 036419 674 DPKLQC--EASYPIVKRYINVALLCVQENAADRPTM-----SEVISMLT--------NEFVNLPSPQQPGFSSLKKS 735 (754)
Q Consensus 674 d~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~L~--------~~~~~~~~p~~p~~~~~~~~ 735 (754)
|..+.. .++.-.+.+...|+.++|.++|++|.-+ ++|.+|-- -+...+.+|-.|....++-.
T Consensus 578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~ 654 (694)
T KOG0694|consen 578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDV 654 (694)
T ss_pred HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhh
Confidence 111111 2233456788999999999999999855 55655421 12236778777777555433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=325.14 Aligned_cols=238 Identities=21% Similarity=0.307 Sum_probs=193.8
Q ss_pred hhhcCccccceeccCCCcceeec---------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~---------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
...++|++++.||+|+||.||++ ....+.++.|-.||...++|.||+|+..|++.+++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35579999999999999999962 234567888999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
|||||++||++..+| ...+.|++..+..++.+++.|+.-||+.| +|||||||+|+|||..|++||+||||+.-+
T Consensus 218 LiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999999 45678999999999999999999999998 999999999999999999999999998533
Q ss_pred CC----------------------Ccccc-----c------------------ccccccccCcccccccccCCCCcccch
Q 036419 595 GG----------------------DELQS-----N------------------TKRIVGTYGYMSPEYAIHGFFSIKSDV 629 (754)
Q Consensus 595 ~~----------------------~~~~~-----~------------------~~~~~gt~~y~APE~~~~~~~s~ksDV 629 (754)
.. ..... . ....+|||.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 00000 0 012589999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCcccCCc--hhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCC--
Q 036419 630 FSFGVLLLETLSSKRSTRFFNTNS--LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRP-- 705 (754)
Q Consensus 630 wSlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-- 705 (754)
||||||+||||.|.+||....+.+ ..+..|... +..+.......+..++|.+|+. ||++|.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------LKFPEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 999999999999999998766544 222222110 1111122334678899999998 999997
Q ss_pred -CHHHHHHHH
Q 036419 706 -TMSEVISML 714 (754)
Q Consensus 706 -t~~evl~~L 714 (754)
.++||-+|-
T Consensus 437 ~G~~EIK~HP 446 (550)
T KOG0605|consen 437 KGAEEIKKHP 446 (550)
T ss_pred ccHHHHhcCC
Confidence 477777765
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.34 Aligned_cols=244 Identities=27% Similarity=0.437 Sum_probs=192.2
Q ss_pred hhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecC
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQG 511 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~ 511 (754)
..++|++.++||+|+||.||++. ...+.+.+|++++..+ +||||+++++++.++.
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 45679999999999999998631 1234678999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhhHhhccCC---------------------------------------------------------
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTK--------------------------------------------------------- 534 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 534 (754)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999864321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 535 ---------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 535 ---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 124788999999999999999999987 99999999999999999999999999987654332
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
........++..|+|||++.+..++.++|||||||++|||++ |..|+....... ... .....+.. ..
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~----~~~~~~~~--~~----- 337 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFY----KMIKEGYR--ML----- 337 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHH----HHHHhCcc--CC-----
Confidence 222223445678999999999999999999999999999998 777765432221 111 11111100 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.....+.++.+++.+||+.||++||++.+|+++|+..
T Consensus 338 --~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 --SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0111245788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.24 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=192.8
Q ss_pred hcCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
.++|++.++||+|+||.||++.. ..+++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 47899999999999999997221 23568899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999954 345889999999999999999999853 4999999999999999999999999999865432
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh-hhcc-Ccc-------
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN-LWKD-DRS------- 669 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~~~-~~~------- 669 (754)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... .... ...
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE--AIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHhcccccccccCCccccCcc
Confidence 123457899999999999999999999999999999999999998644322210 00000 0000 000
Q ss_pred ---------------------ccccC----cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 670 ---------------------WELMD----PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 670 ---------------------~~l~d----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.++.+ ..............+.+++.+||+.||++|||+++|++|.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 00000 00000011124567899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=334.64 Aligned_cols=245 Identities=28% Similarity=0.438 Sum_probs=192.9
Q ss_pred hhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeec
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQ 510 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~ 510 (754)
...++|++.+.||+|+||.||++. ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 445689999999999999999621 0134578999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChhhHhhccCC--------------------------------------------------------
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTK-------------------------------------------------------- 534 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 534 (754)
...++||||+++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999999864211
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccc
Q 036419 535 -----------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT 603 (754)
Q Consensus 535 -----------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~ 603 (754)
...+++.++.+++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++...........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 124788899999999999999999988 999999999999999999999999999865433221222
Q ss_pred cccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 604 KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 604 ~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
....++..|||||++.+..++.++|||||||++|||++ |+.||........ .. ...... ... ...
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~----~~~~~~-----~~~----~~~ 337 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FY----KMVKRG-----YQM----SRP 337 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HH----HHHHcc-----cCc----cCC
Confidence 23345678999999998999999999999999999997 9998765432221 11 111110 000 001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
...+..+.+++.+||+.||++|||+.+|+++|+..
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11246788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=324.63 Aligned_cols=239 Identities=26% Similarity=0.409 Sum_probs=195.9
Q ss_pred ccccceeccCCCcceeeccc--------cHHH-HHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhc
Q 036419 461 FGVENKLGEGGFGPVYKSGQ--------GLEE-FKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFD 531 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~~--------~~~~-~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 531 (754)
...++-||.|+.|.||.++- ..++ -+.+|+-|++|+||||+.+.|+|...--+|||||||+.|-|...|.
T Consensus 126 IsELeWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk- 204 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK- 204 (904)
T ss_pred hhhhhhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh-
Confidence 34467899999999998432 2222 2468999999999999999999999999999999999999999994
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccC
Q 036419 532 TTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG 611 (754)
Q Consensus 532 ~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 611 (754)
....+.......+..+||.|+.|||.+. |||||||.-||||..+..|||+|||-++.+... ...-.++||..
T Consensus 205 --a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVa 276 (904)
T KOG4721|consen 205 --AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVA 276 (904)
T ss_pred --ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHh
Confidence 4556888999999999999999999998 999999999999999999999999999977543 23446899999
Q ss_pred cccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHH
Q 036419 612 YMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYIN 691 (754)
Q Consensus 612 y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~ 691 (754)
|||||++.+.+.++|+|||||||||||||||..|+...+...+ .|.-+. ..+..+.+...++-+.-
T Consensus 277 WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI--------IwGVGs------NsL~LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 277 WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI--------IWGVGS------NSLHLPVPSTCPDGFKL 342 (904)
T ss_pred hhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee--------EEeccC------CcccccCcccCchHHHH
Confidence 9999999999999999999999999999999999654332211 122221 12222334456677889
Q ss_pred HHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 036419 692 VALLCVQENAADRPTMSEVISMLTNEFVNLP 722 (754)
Q Consensus 692 li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 722 (754)
|+++||+..|..||++++++.||+-...++-
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 9999999999999999999999975444433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=345.32 Aligned_cols=246 Identities=30% Similarity=0.485 Sum_probs=201.4
Q ss_pred HhhhhcCccccceeccCCCcceeec------------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeee
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKS------------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~------------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~ 509 (754)
.+....+.+..++||+|.||+||++ .+..++|++|++++..|+|||||+|+|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3445566777889999999999972 2256789999999999999999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTK-----------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD 578 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld 578 (754)
++..++|+|||..|+|.+||..... ...++..+.+.|+.|||.|+.||-++. ++||||-.+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceec
Confidence 9999999999999999999975321 223889999999999999999999987 99999999999999
Q ss_pred CCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHh
Q 036419 579 SNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLL 657 (754)
Q Consensus 579 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~ 657 (754)
++..|||+||||++.+...++......-.-...|||||.++.++|+++||||||||+|||+++ |+.|+.....++ .+
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--VI 715 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--VI 715 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--HH
Confidence 999999999999998876665544434444679999999999999999999999999999987 445544333222 11
Q ss_pred HhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 658 GHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 658 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+ ....+++ -+.+...+.++.+||+.||+.+|++||+++||-..|...
T Consensus 716 e----~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 716 E----CIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred H----HHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 1 1111211 233345678899999999999999999999999999875
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.34 Aligned_cols=240 Identities=30% Similarity=0.496 Sum_probs=194.7
Q ss_pred cCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
++|++.+.||+|+||.||++. ...+++.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 578899999999999999621 11356889999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC
Q 036419 515 LIYEYLPNKSLDSFLFDTTK-------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM 581 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~ 581 (754)
++|||+++++|.+++..... ...+++.++..++.||+.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999965322 145889999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhh
Q 036419 582 IPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHA 660 (754)
Q Consensus 582 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 660 (754)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ ...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~-- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIE-- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH--
Confidence 999999999987644332223334567889999999998899999999999999999998 988876443222 111
Q ss_pred hhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 661 WNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 661 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
....... .......+.++.+++.+||+.||++||++.+|+++|++
T Consensus 238 --~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 --MIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111 11122345779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=326.89 Aligned_cols=235 Identities=26% Similarity=0.377 Sum_probs=200.4
Q ss_pred cCccccceeccCCCcceee--------------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe-eEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE-NVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk--------------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~-~~lV~ 517 (754)
++|..++.+|+|+||.++. .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788999999999999874 12234567899999999999999999999999988 99999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
+|++||+|.+.|.+.+ ...++++.+..++.||+.|+.|||++. |+|||||+.|||+..+..|||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997654 567999999999999999999999877 999999999999999999999999999998765
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
. ......+||+.||.||++.+.+|..|+|||||||++|||++-+++|...+...... +.. +..
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~-----ki~----------~~~ 222 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL-----KIN----------RGL 222 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH-----HHh----------hcc
Confidence 4 23456899999999999999999999999999999999999999987665443211 111 011
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
..+.+...+.++..++..||+.+|..||++.+++.+.
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 2233445678899999999999999999999998763
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.88 Aligned_cols=239 Identities=25% Similarity=0.347 Sum_probs=192.2
Q ss_pred hhcCccccceeccCCCcceeec--------------------------------cccHHHHHHHHHHHHhhccCCeeeee
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS--------------------------------GQGLEEFKNEIKLTAKLQHRNLVRLL 504 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~--------------------------------~~~~~~~~~Ev~il~~l~hpniv~l~ 504 (754)
.-+.|++.+.||+|.||.|.++ ....+++++||.||++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3478999999999999999751 11346899999999999999999999
Q ss_pred eeeee--cCeeEEEEEecCCCChhhHhhccCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC
Q 036419 505 GCCVE--QGENVLIYEYLPNKSLDSFLFDTTKEGL-LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM 581 (754)
Q Consensus 505 ~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~ 581 (754)
++..+ .+.+|||+|||..|.+... ...++ +++.++++++++++.||+|||.++ ||||||||+|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 99875 4679999999999887532 23334 999999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCccccCCC---cccccccccccccCcccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCcccCCch
Q 036419 582 IPKISDFGLARMFGGD---ELQSNTKRIVGTYGYMSPEYAIHGF----FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL 654 (754)
Q Consensus 582 ~~kl~DFgla~~~~~~---~~~~~~~~~~gt~~y~APE~~~~~~----~s~ksDVwSlGvil~elltg~~p~~~~~~~~~ 654 (754)
++||+|||.+...... .........+||+.|||||...++. .+.+.||||+||.||.|+.|+.||-... ..
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--~~ 325 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--EL 325 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--HH
Confidence 9999999999876322 1112234578999999999988742 3688999999999999999999974321 11
Q ss_pred hHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 655 TLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 655 ~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
.+ ..++++..+..+...++.+.+.+||++||++||+.|.+..+|..|.--
T Consensus 326 ~l------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 326 EL------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HH------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 11 012333333344444677899999999999999999999999999853
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.77 Aligned_cols=234 Identities=24% Similarity=0.352 Sum_probs=197.8
Q ss_pred hcCccccceeccCCCcceeec-------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKS-------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~-------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
...|...+.||+|.||.|||+ ....+.+++|+.++.+++++||.++++.+..+..+.++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 356777789999999999983 3456788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+.||++.+++. ....+.+..+.-|+++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+-.+....
T Consensus 92 y~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999993 3444588888899999999999999998 9999999999999999999999999999876655
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
... ..++||+.|||||++....|+.|+||||||+.++||++|.+|+....+-. ...++.....
T Consensus 166 ~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------------vlflIpk~~P 228 (467)
T KOG0201|consen 166 KRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------------VLFLIPKSAP 228 (467)
T ss_pred hcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------------EEEeccCCCC
Confidence 433 57899999999999998899999999999999999999999976554321 1122222222
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...+...+..+.+++..||.+||+.||++.++++|=
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~ 264 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHK 264 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence 222334556789999999999999999999999873
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=293.25 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=200.7
Q ss_pred hhhcCccccceeccCCCcceeec------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecC-----e
Q 036419 456 AATNNFGVENKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG-----E 512 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~-----~ 512 (754)
...++|++.+.||+|||+-||.. .++.+..++|+..-++++|||+++++++...+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 45679999999999999999973 356788899999999999999999999986544 3
Q ss_pred eEEEEEecCCCChhhHhhccCCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEG-LLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
.||+++|...|+|.+.|.....++ .+++.++++|+.+|.+||++||+.. .+++||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999998765555 7999999999999999999999986 57999999999999999999999999998
Q ss_pred cccCC-----Cccc--ccccccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhh
Q 036419 592 RMFGG-----DELQ--SNTKRIVGTYGYMSPEYAI---HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW 661 (754)
Q Consensus 592 ~~~~~-----~~~~--~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 661 (754)
....- .+.. ........|..|+|||.+. +...++++|||||||+||.|+.|..||+..-...
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-------- 248 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-------- 248 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC--------
Confidence 75421 1100 0112346789999999885 4468999999999999999999999986332211
Q ss_pred hhhccCcc-ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 662 NLWKDDRS-WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 662 ~~~~~~~~-~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+.+ .....+...-+.....++.+.+++.+||+.||.+||++.+++.++...
T Consensus 249 -----gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 -----GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111 122233333344445789999999999999999999999999998764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.43 Aligned_cols=236 Identities=25% Similarity=0.301 Sum_probs=189.0
Q ss_pred CccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
.|++.+.||+|+||.||++.. ....+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999997211 12346789999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998886432 335899999999999999999999988 9999999999999999999999999998754322
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||......... .......... .
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~~~~~~----------~ 221 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDRRVKED----------Q 221 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHHHhhcc----------c
Confidence 1 23457899999999999999999999999999999999999998754432210 0010000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPT-----MSEVISML 714 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 714 (754)
.......++.+.+++.+||+.||++||+ ++++++|-
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 1112234567889999999999999997 89998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=325.23 Aligned_cols=237 Identities=22% Similarity=0.359 Sum_probs=192.0
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.++||+|+||.||++. ...+.+.+|++++.+++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 478999999999999999732 12346788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999943 346899999999999999999999988 99999999999999999999999999986543
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
......||+.|+|||++.+..++.++|||||||++|||++|..||......+. ..... .+... +..+..
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i~-~~~~~----~~~~~~ 222 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WENLK-YWKET----LQRPVY 222 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHHHH-hcccc----ccCCCC
Confidence 23346799999999999999999999999999999999999999865433221 11110 01000 001111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.......+..+.+++.+||+.+|.+||++.++++|.
T Consensus 223 -~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 223 -DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred -CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 111123456788999999999999999999999884
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.05 Aligned_cols=248 Identities=22% Similarity=0.292 Sum_probs=189.4
Q ss_pred cCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 479999999999999999721 124567899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999988776552 2345899999999999999999999988 9999999999999999999999999998764322
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhH-hHhh--------hhhhccCc-
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL-LGHA--------WNLWKDDR- 668 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~-~~~~--------~~~~~~~~- 668 (754)
. .......|+..|+|||++.+..++.++|||||||++|||++|+.||......+... .... ...+....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 12234578999999999998899999999999999999999999987543222100 0000 00000000
Q ss_pred cccccCcccCCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 669 SWELMDPKLQCE------ASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 669 ~~~l~d~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
......+..... .....+..+.+++.+||+.||++|||++++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000100000 011235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=314.94 Aligned_cols=242 Identities=26% Similarity=0.414 Sum_probs=191.8
Q ss_pred hhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG 511 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~ 511 (754)
..+++|++.++||+|+||.||++. ....++.+|+.++++++||||+++++++.++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 356789999999999999999521 12345789999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceE
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTK-------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPK 584 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~k 584 (754)
..++||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999999965322 234678899999999999999999987 99999999999999999999
Q ss_pred EeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhh
Q 036419 585 ISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNL 663 (754)
Q Consensus 585 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 663 (754)
|+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..|+....... .....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~~~--- 234 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLRFV--- 234 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH---
Confidence 999999986654333222223455788999999998899999999999999999999 677765432211 11111
Q ss_pred hccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 664 WKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 664 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
....... .....+..+.+++.+||+.||++|||+.|++++|+
T Consensus 235 -~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 -MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -HcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0111100 01123457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.52 Aligned_cols=229 Identities=23% Similarity=0.288 Sum_probs=188.5
Q ss_pred cCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4789999999999999997221 2345788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999953 346899999999999999999999988 999999999999999999999999999876432
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..... . ....
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~~~i---~-~~~~-------- 215 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IYEKI---L-AGKL-------- 215 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH---H-hCCc--------
Confidence 224578999999999999899999999999999999999999986433211 11110 0 0000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPT-----MSEVISML 714 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 714 (754)
.........+.+++.+||+.||.+||+ ++++++|-
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 011122456889999999999999995 99999885
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=292.76 Aligned_cols=237 Identities=24% Similarity=0.352 Sum_probs=194.9
Q ss_pred hhcCccccceeccCCCcceee--------------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk--------------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
.++.|++.+.||+|.|+.|++ ...+.+++++|+.|-+.|+||||+++.+.+.+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 457899999999999999986 344678899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc---CCCceEEeeccCccc
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD---SNMIPKISDFGLARM 593 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld---~~~~~kl~DFgla~~ 593 (754)
+|+|.|++|..-|-. +-.+++..+-+.++||+++|.|+|.++ |||||+||+|+|+- ..--+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999766633 245888899999999999999999998 99999999999994 334689999999998
Q ss_pred cCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
++.. ......+||++|||||++...+|+..+|||+-|||||-|+.|..||....... +-+... .+
T Consensus 163 l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--lye~I~----~g------ 227 (355)
T KOG0033|consen 163 VNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYEQIK----AG------ 227 (355)
T ss_pred eCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--HHHHHh----cc------
Confidence 8733 23456889999999999999999999999999999999999999986432221 111110 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+-......-..+.++..+++++||..||.+|.|+.|.+.|-
T Consensus 228 ~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 228 AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 11122223344667889999999999999999999987653
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.58 Aligned_cols=243 Identities=27% Similarity=0.476 Sum_probs=195.9
Q ss_pred cCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.+|.+.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 468888999999999999632 113568899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc
Q 036419 516 IYEYLPNKSLDSFLFDTT-------------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI 582 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~ 582 (754)
||||+++++|.+++.... ..+.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996532 1245899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhh
Q 036419 583 PKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAW 661 (754)
Q Consensus 583 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 661 (754)
+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~--- 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIE--- 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH---
Confidence 99999999986654332222334557789999999999999999999999999999998 888865433211 111
Q ss_pred hhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 662 NLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 662 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
......... .....+..+.+++.+||+.+|++||++.+|+++|+....
T Consensus 237 -~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 -CITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -HHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111111 111234678899999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=327.29 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=194.7
Q ss_pred hhhhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhc-cCCeeeeeeeeee
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQ-HRNLVRLLGCCVE 509 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~-hpniv~l~~~~~~ 509 (754)
....++|.+.++||+|+||.||++.. ..+.+.+|+++++++. ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 34467899999999999999996321 1356889999999996 9999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCC-------------------------------------------------------
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTK------------------------------------------------------- 534 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------- 534 (754)
....++||||+++|+|.++|.....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999999864311
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceE
Q 036419 535 --------------------------------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNIL 576 (754)
Q Consensus 535 --------------------------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIl 576 (754)
...+++..+..++.||++||.|||+.+ |+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence 124788889999999999999999987 999999999999
Q ss_pred EcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchh
Q 036419 577 LDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLT 655 (754)
Q Consensus 577 ld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~ 655 (754)
+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 99999999999999987643322222233456788999999998899999999999999999997 88887543221111
Q ss_pred HhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 656 LLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 656 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.. ...... ........+..+.+++.+||+.||++||++.+|+++|+..
T Consensus 350 -~~----~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 -YN----KIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred -HH----HHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 00 000110 0011123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=325.76 Aligned_cols=251 Identities=17% Similarity=0.194 Sum_probs=189.0
Q ss_pred hhcCccccceeccCCCcceeeccc------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCC
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKS 524 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gs 524 (754)
...+|++.++||+|+||.||++.+ ..+.+.+|++++++|+||||+++++++..+...++|+|++. ++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~ 168 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TD 168 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CC
Confidence 346899999999999999998322 23567899999999999999999999999999999999996 57
Q ss_pred hhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccccc
Q 036419 525 LDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTK 604 (754)
Q Consensus 525 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~ 604 (754)
|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 169 L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~ 241 (391)
T PHA03212 169 LYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYY 241 (391)
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccc
Confidence 8887743 345889999999999999999999988 9999999999999999999999999997543211 11223
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-----hhHhHhhhhhhccC----------cc
Q 036419 605 RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-----LTLLGHAWNLWKDD----------RS 669 (754)
Q Consensus 605 ~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~----------~~ 669 (754)
...||+.|+|||++.+..++.++|||||||++|||++|+.|+....... .............. ..
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 4679999999999999999999999999999999999998764321100 00000000000000 00
Q ss_pred ccc---------cCcccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 670 WEL---------MDPKLQ--CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 670 ~~l---------~d~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.+. ..+... .......+..+.+++.+||+.||++|||++|++++--
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 000 000000 0001134567899999999999999999999998764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.07 Aligned_cols=239 Identities=26% Similarity=0.419 Sum_probs=190.1
Q ss_pred hcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.++|++.+.||+|+||.||++. .....+.+|++++.+++||||+++++++..+...++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 4678999999999999998631 123468899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999642 346899999999999999999999988 9999999999999999999999999877543
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.... .......++..|+|||.+.+..++.++|||||||++||+++ |..||....... ..... ....
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~----~~~~------ 225 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAV----EDGF------ 225 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHH----HCCC------
Confidence 2211 11112345678999999999999999999999999999775 998875432221 11111 1110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
..+.....+..+.+++..||+.+|.+||++++|++.|+..
T Consensus 226 ---~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ---RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0011122456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.01 Aligned_cols=248 Identities=20% Similarity=0.277 Sum_probs=198.0
Q ss_pred hhcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
..++|++.+.||+|+||.||++. ...+.+.+|+++++.++||||+++++++.++...+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34679999999999999999732 12345678999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999954 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||....... .... ... ..
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~~---i~~-~~------ 244 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--IYQK---ILE-GI------ 244 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--HHHH---Hhc-CC------
Confidence 432 234679999999999999899999999999999999999999986433211 1111 110 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHh--c------cccCCCCCCCCCccc
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISMLT--N------EFVNLPSPQQPGFSS 731 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~--~------~~~~~~~p~~p~~~~ 731 (754)
. ..+......+.+++.+||+.||++|+ +++++++|-- + ....++.|..|.+..
T Consensus 245 --~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 245 --I--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred --C--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 0 01112345678999999999999995 8999998742 1 123456667776633
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=337.19 Aligned_cols=237 Identities=20% Similarity=0.258 Sum_probs=191.7
Q ss_pred cCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
..|.+.+.||+|+||.||++.. ....+++|++++++++|||||++++++..++..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3488999999999999997311 134578899999999999999999999999999999999
Q ss_pred cCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 520 LPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 520 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
+++|+|.++|... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988653 23456899999999999999999999987 9999999999999999999999999999765433
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ..... . +
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~--~~~~---~~~~~-~----~---- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--IMQQ---VLYGK-Y----D---- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH---HHhCC-C----C----
Confidence 2223445679999999999999999999999999999999999999985432211 1111 10000 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
......+..+.+++.+||+.||++||++.+++++
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1111234678999999999999999999998754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=323.48 Aligned_cols=229 Identities=21% Similarity=0.278 Sum_probs=188.4
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 579999999999999999721 12346789999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999954 356889999999999999999999988 999999999999999999999999999876432
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
. ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...... .....
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i----~~~~~-------- 232 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RIYEKI----LAGRL-------- 232 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HHHHHH----hcCCc--------
Confidence 2 2357999999999999999999999999999999999999998543221 111110 01110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPT-----MSEVISML 714 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 714 (754)
. .+.....++.+++.+||+.||.+||+ +.+++.|-
T Consensus 233 ~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 233 K--FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred C--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 0 01113456889999999999999997 78888774
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.52 Aligned_cols=240 Identities=30% Similarity=0.462 Sum_probs=191.0
Q ss_pred cCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
++|++.++||+|+||.||++. ...+++.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 568889999999999999732 112568899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC
Q 036419 516 IYEYLPNKSLDSFLFDTTK--------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM 581 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~ 581 (754)
||||+++++|.+++..... ...+++.++..++.||+.||.|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853221 235788999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhh
Q 036419 582 IPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHA 660 (754)
Q Consensus 582 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 660 (754)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...... ......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 999999999987644332222334456778999999988889999999999999999998 88786543221 111111
Q ss_pred hhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 661 WNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 661 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
..... ........+.+.+++.+||+.||++||++.+|+++|..
T Consensus 240 ----~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 ----RKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11100 01111234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.95 Aligned_cols=228 Identities=20% Similarity=0.301 Sum_probs=183.7
Q ss_pred ceeccCCCcceeecc---------------c-c---HHHHHHHHHHHHhhccCCeeeeeeeeee----cCeeEEEEEecC
Q 036419 465 NKLGEGGFGPVYKSG---------------Q-G---LEEFKNEIKLTAKLQHRNLVRLLGCCVE----QGENVLIYEYLP 521 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------~-~---~~~~~~Ev~il~~l~hpniv~l~~~~~~----~~~~~lV~E~~~ 521 (754)
..||+|++|.||++. . . .+.+.+|++++.+++||||+++++++.+ ....++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 579999999999721 1 1 3667899999999999999999999877 346789999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY-SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
+|+|.+++.. ...+++..+..++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 106 ~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 106 RGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999954 34688999999999999999999985 5 8899999999999999999999999998654321
Q ss_pred ccccccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 601 SNTKRIVGTYGYMSPEYAIH--GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ +.... ..... .
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~~i---~~~~~---------~ 240 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYDLI---INKNN---------S 240 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHHHH---HhcCC---------C
Confidence 23468899999999976 689999999999999999999999987543221 11111 00100 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
...+...++.+.+++.+||+.||++|||+.+|++.|+..
T Consensus 241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 011123456789999999999999999999999999764
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=321.22 Aligned_cols=245 Identities=29% Similarity=0.429 Sum_probs=192.1
Q ss_pred hhhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhh-ccCCeeeeeeeeee-
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKL-QHRNLVRLLGCCVE- 509 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l-~hpniv~l~~~~~~- 509 (754)
...++|++.+.||+|+||.||++.. ..+.+.+|++++.++ +||||++++++|..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3456899999999999999996420 124567899999999 89999999998864
Q ss_pred cCeeEEEEEecCCCChhhHhhccCC-------------------------------------------------------
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTK------------------------------------------------------- 534 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------- 534 (754)
+...+++|||+++++|.++|.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4568899999999999999854221
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccC
Q 036419 535 ---EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG 611 (754)
Q Consensus 535 ---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 611 (754)
...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 125889999999999999999999987 99999999999999999999999999987643332222334456778
Q ss_pred cccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHH
Q 036419 612 YMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYI 690 (754)
Q Consensus 612 y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~ 690 (754)
|+|||++.+..++.++|||||||++|||++ |..|+......+. +.. ....... ........+++.
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~----~~~~~~~---------~~~~~~~~~~~~ 306 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCR----RLKEGTR---------MRAPEYATPEIY 306 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHH----HHhccCC---------CCCCccCCHHHH
Confidence 999999999999999999999999999998 9888764332221 110 0111100 001112346789
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 691 NVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 691 ~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+++.+||+.+|++||++.+|+++|+..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.78 Aligned_cols=225 Identities=21% Similarity=0.257 Sum_probs=182.7
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNK 523 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 523 (754)
+.||+|+||.||++. .....+.+|++++++++||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999621 12345678999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccc
Q 036419 524 SLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT 603 (754)
Q Consensus 524 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~ 603 (754)
+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 99999853 456899999999999999999999998 9999999999999999999999999997532211 123
Q ss_pred cccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCH
Q 036419 604 KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASY 683 (754)
Q Consensus 604 ~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~ 683 (754)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... .... . . ....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~---~~~~-~------~----~~p~ 216 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFEL---ILME-E------I----RFPR 216 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHHH---HHcC-C------C----CCCC
Confidence 34679999999999999999999999999999999999999985432211 1110 0000 0 0 1112
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036419 684 PIVKRYINVALLCVQENAADRP-----TMSEVISM 713 (754)
Q Consensus 684 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 713 (754)
.....+.+++.+||+.||++|| ++.++++|
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2456788999999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.85 Aligned_cols=241 Identities=29% Similarity=0.467 Sum_probs=191.8
Q ss_pred CccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
+|++.+.||+|+||.||++.. ..+++.+|++++++++||||+++++.+.+++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 478889999999999997321 13468899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 036419 516 IYEYLPNKSLDSFLFDTT---------------------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSN 574 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~N 574 (754)
|+||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 1235889999999999999999999987 9999999999
Q ss_pred eEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCc
Q 036419 575 ILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNS 653 (754)
Q Consensus 575 Illd~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~ 653 (754)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986543322222233456778999999988899999999999999999998 888875433221
Q ss_pred hhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
+.. ..... ..........+.+.+++.+||+.+|++||++.++++.|+...
T Consensus 238 --~~~----~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 --LFN----LLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred --HHH----HHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111 11110 000111223467889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=318.43 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=190.6
Q ss_pred hhcCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
..++|++.++||+|+||.||++.. ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 357899999999999999997211 2356889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ +|+|+||||+|||++.++.+||+|||++..+...
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999953 345889999999999999999999752 3999999999999999999999999999765322
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc---------
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR--------- 668 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 668 (754)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||........... .........
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM--FGCPVEGDPAESETSPRP 231 (333)
T ss_pred ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHH--hcCcccCCccccccCccc
Confidence 12345789999999999988999999999999999999999999864432211100 000000000
Q ss_pred -------------------cccccCcccC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 669 -------------------SWELMDPKLQ----CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 669 -------------------~~~l~d~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
...+.+.... .........++.+++.+||+.||++|||+.|+++|--
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 0000000000 0000113456889999999999999999999988753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.25 Aligned_cols=247 Identities=22% Similarity=0.299 Sum_probs=186.8
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|++.++||+|+||.||++. .....+.+|++++++++||||+++++++..+...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 579999999999999999731 1234678999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++ +|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 986 888888542 335789999999999999999999988 9999999999999999999999999998653322
Q ss_pred cccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCch-hHhHhh-----hhhhccCc----
Q 036419 600 QSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-TLLGHA-----WNLWKDDR---- 668 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~-----~~~~~~~~---- 668 (754)
.......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||......+. ...... ...|....
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 11234568999999998875 5689999999999999999999999865433221 000000 00111100
Q ss_pred cccccCcccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 669 SWELMDPKLQC----EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 669 ~~~l~d~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
......+.... ........++.+++.+||+.||.+|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00111111000 0011234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=312.84 Aligned_cols=243 Identities=28% Similarity=0.472 Sum_probs=194.7
Q ss_pred hcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
.++|.+.+.||+|+||.||+.. ...+.+.+|++++++++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 4678999999999999999732 12346889999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceE
Q 036419 515 LIYEYLPNKSLDSFLFDTT----------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPK 584 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~k 584 (754)
+||||+++++|.+++.... ....+++.++..++.||+.||+|||+++ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999996432 2235899999999999999999999988 99999999999999999999
Q ss_pred EeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhh
Q 036419 585 ISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNL 663 (754)
Q Consensus 585 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 663 (754)
|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..|+....... ....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~---- 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIEC---- 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----
Confidence 999999986644332222334456788999999998899999999999999999998 888865332211 1111
Q ss_pred hccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 664 WKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 664 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
...+.... . ....+..+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 235 i~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGRVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCCcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11111100 0 1123356899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=297.14 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=199.9
Q ss_pred cCccccceeccCCCcceeeccccH--------------------HHHHHHHHHHHhhccCCeeeeeeeeee--cCeeEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQGL--------------------EEFKNEIKLTAKLQHRNLVRLLGCCVE--QGENVLI 516 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~~~--------------------~~~~~Ev~il~~l~hpniv~l~~~~~~--~~~~~lV 516 (754)
+.|+.+++|++|.||.||++.+.. ---.+||.+|.+.+|||||.+.++... -+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 468889999999999999843321 123689999999999999999998753 4579999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++ +|..++.... .++...++..+..|+++|++|||.+. |+|||||++|+|+...|.+||+|||+|+.++.
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999988 8888886533 56899999999999999999999987 99999999999999999999999999998865
Q ss_pred CcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh--------hhccC
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN--------LWKDD 667 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~ 667 (754)
. ....+..+-|.+|+|||++.+. .|++++|+||+|||+.||+.+++.|.+..+-+ ....+.. .|..-
T Consensus 230 p--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 230 P--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred C--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhCCCccccCCCc
Confidence 4 2345567889999999999876 79999999999999999999999887654322 1111111 12111
Q ss_pred ccccccC-c--------ccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCCCCCCccc
Q 036419 668 RSWELMD-P--------KLQCEASYP-IVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSS 731 (754)
Q Consensus 668 ~~~~l~d-~--------~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~ 731 (754)
....... - .+...+... ..+.-.+++..+|..||++|.|+++.|+| +-+.+.|.|..|..+.
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~P 377 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFP 377 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhcC
Confidence 1111110 0 001111111 44677899999999999999999999998 4556777777766643
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=310.25 Aligned_cols=252 Identities=30% Similarity=0.397 Sum_probs=190.2
Q ss_pred cCc-cccceeccCCCcceeec-----------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeec--Ce
Q 036419 459 NNF-GVENKLGEGGFGPVYKS-----------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GE 512 (754)
Q Consensus 459 ~~y-~~~~~lG~G~fg~Vyk~-----------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~ 512 (754)
++| ++.+.||+|+||+||+. ....+.+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 88899999999999641 01245678999999999999999999988654 45
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+++++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 7899999999999999953 34899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccc-ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 593 MFGGDELQSN-TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 593 ~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
.......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+........................+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 7654322111 122345667999999988899999999999999999999999875433221111111100011111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+++...........+..+.+++.+||+.+|++|||+++|+++|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 2222111122223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=310.03 Aligned_cols=239 Identities=26% Similarity=0.359 Sum_probs=189.0
Q ss_pred cCccccceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
++|++.+.||+|+||.||++.. ...++..|+.++++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 5788899999999999997321 2346677888999999999999999875 456789
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
++||+++|+|.+++... .+.+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999642 346899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
............++..|+|||++.+..++.++||||||+++|||++ |..|+....... .. .....+.. ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~----~~~~~~~~--~~~ 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VP----DLLEKGER--LAQ 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH----HHHHCCCc--CCC
Confidence 4332222334557789999999998899999999999999999998 888875433221 11 11111111 011
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
+. .....+.+++.+||..||++|||+.|+++.|....
T Consensus 233 ~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 233 PQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11 12345788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.12 Aligned_cols=245 Identities=27% Similarity=0.450 Sum_probs=194.9
Q ss_pred hhhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeee
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVE 509 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~ 509 (754)
....++|++.+.||+|+||.||++. ....++.+|++++.++ +||||+++++++.+
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3455689999999999999999732 1124578899999999 79999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceE
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDT-------------TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNIL 576 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIl 576 (754)
+...++||||+++++|..++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 99999999999999999999643 22356899999999999999999999987 999999999999
Q ss_pred EcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchh
Q 036419 577 LDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLT 655 (754)
Q Consensus 577 ld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~ 655 (754)
+++++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 242 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--
Confidence 99999999999999987654332222223345678999999988999999999999999999997 888875432211
Q ss_pred HhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 656 LLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 656 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.. ....... ...........+.+++.+||+.||++|||+.++++.|+..
T Consensus 243 ~~----~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 LF----KLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HH----HHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11 1111110 0011223356788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.80 Aligned_cols=240 Identities=30% Similarity=0.484 Sum_probs=192.0
Q ss_pred hcCccccceeccCCCcceeeccc----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.++|++.+.||+|+||.||++.. ...++.+|++++++++||||+++++++.+....++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 35789999999999999997311 23567889999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++... .+.+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999999643 246899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
............++..|+|||.+.+..++.++||||||+++|+|++ |..|+...... ....... ... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~----~~~----~- 226 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVE----DGY----R- 226 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHH----cCC----C-
Confidence 2222112222345678999999998899999999999999999998 88886432211 1111110 000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.+.....++.+.+++.+||+.+|++||++++|+++|+..
T Consensus 227 ----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 ----LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011122356789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=306.10 Aligned_cols=240 Identities=29% Similarity=0.453 Sum_probs=193.9
Q ss_pred hhcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
..++|++.++||+|+||.||++. ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 34689999999999999999722 13467889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++++|.+++... ....+++.++..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999999653 2346889999999999999999999987 999999999999999999999999999876543221
Q ss_pred ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
. .....++..|+|||++....++.++|||||||++|+|++ |..|+....... ...... ... . .
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~----~~~-----~----~ 223 (261)
T cd05072 160 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQ----RGY-----R----M 223 (261)
T ss_pred c-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHH----cCC-----C----C
Confidence 1 223346678999999988899999999999999999998 888875432221 111111 000 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
+.....++.+.+++.+||+.+|++||++++++++|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.94 Aligned_cols=240 Identities=25% Similarity=0.455 Sum_probs=193.5
Q ss_pred hcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~ 513 (754)
.++|.+.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 45788999999999999997321 246788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc
Q 036419 514 VLIYEYLPNKSLDSFLFDTT-----------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI 582 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~ 582 (754)
++||||+++++|.++|.... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999996532 2345889999999999999999999988 999999999999999999
Q ss_pred eEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhh
Q 036419 583 PKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAW 661 (754)
Q Consensus 583 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 661 (754)
+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..|+....... ......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~ 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECIT 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH
Confidence 99999999986543332222334456788999999999999999999999999999998 998875433221 111111
Q ss_pred hhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 662 NLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 662 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.+.. .......+..+.+++.+||+.||++||++.||++.|+
T Consensus 239 ----~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ----QGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111 0111124467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=315.48 Aligned_cols=223 Identities=23% Similarity=0.302 Sum_probs=180.1
Q ss_pred eccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCCh
Q 036419 467 LGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 467 lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
||+|+||.||++. .....+.+|++++++++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999721 1234567899999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccc
Q 036419 526 DSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR 605 (754)
Q Consensus 526 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~ 605 (754)
.+++.. .+.+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 999954 356899999999999999999999988 9999999999999999999999999998643222 12334
Q ss_pred cccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHH
Q 036419 606 IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPI 685 (754)
Q Consensus 606 ~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~ 685 (754)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ....... .. ......
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~--~---~~~~~~~---------~~--~~~~~~ 216 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE--M---YRKILQE---------PL--RFPDGF 216 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH--H---HHHHHcC---------CC--CCCCcC
Confidence 679999999999999999999999999999999999999986432211 1 1111110 00 111224
Q ss_pred HHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 036419 686 VKRYINVALLCVQENAADRPT---MSEVISM 713 (754)
Q Consensus 686 ~~~l~~li~~cl~~dP~~RPt---~~evl~~ 713 (754)
.+.+.+++.+||+.||++||+ +.+++.|
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 467889999999999999985 6677665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=304.62 Aligned_cols=240 Identities=28% Similarity=0.432 Sum_probs=192.9
Q ss_pred hhcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
..++|++.+.||+|++|.||++. ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45679999999999999999721 23467899999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999996533 346899999999999999999999988 999999999999999999999999999877532211
Q ss_pred ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
.......+..|+|||++.+..++.++||||||+++|||++ |+.|+...... ...... ... ...
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~----~~~---------~~~ 223 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQV----DQG---------YRM 223 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH----HcC---------CCC
Confidence 1112223457999999998899999999999999999999 88887533211 111111 010 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
......++.+.+++.+|++.+|++||++.+|++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1112345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=323.96 Aligned_cols=237 Identities=22% Similarity=0.312 Sum_probs=184.5
Q ss_pred CccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
.|++.++||+|+||+||++. ...+.+++|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58889999999999999731 123457889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999954 345889999999999999999999988 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------cccccccccccCcccccccccCCCCcccchhhHH
Q 036419 599 L---------------------------------------------QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFG 633 (754)
Q Consensus 599 ~---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlG 633 (754)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHH
Q 036419 634 VLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALL--CVQENAADRPTMSEVI 711 (754)
Q Consensus 634 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~evl 711 (754)
|++|||++|+.||........... ..... .....+........+.+++.+ |+..+|.+||++.+|+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~-----i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLK-----VINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHH-----HHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999999865433221110 00000 000111111234567778877 5566677799999999
Q ss_pred HHH
Q 036419 712 SML 714 (754)
Q Consensus 712 ~~L 714 (754)
+|-
T Consensus 304 ~hp 306 (381)
T cd05626 304 AHP 306 (381)
T ss_pred cCc
Confidence 985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=309.28 Aligned_cols=247 Identities=26% Similarity=0.440 Sum_probs=190.5
Q ss_pred hcCccccceeccCCCcceeecc---------------------------------ccHHHHHHHHHHHHhhccCCeeeee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------------------QGLEEFKNEIKLTAKLQHRNLVRLL 504 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------------------~~~~~~~~Ev~il~~l~hpniv~l~ 504 (754)
.++|++.++||+|+||.||+.. ...+.+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999998521 1134688899999999999999999
Q ss_pred eeeeecCeeEEEEEecCCCChhhHhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCce
Q 036419 505 GCCVEQGENVLIYEYLPNKSLDSFLFDTTK---------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNI 575 (754)
Q Consensus 505 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 575 (754)
+++......++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999854321 124788999999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCC--CCCCcccCCc
Q 036419 576 LLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK--RSTRFFNTNS 653 (754)
Q Consensus 576 lld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~--~p~~~~~~~~ 653 (754)
++++++.+||+|||++..+.............++..|+|||++.+..++.++|||||||++|+|+++. .|+.... .
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~--~ 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS--D 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC--h
Confidence 99999999999999998664333222233345577899999999889999999999999999999854 4443322 1
Q ss_pred hhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
..........+...... .. .......++.+.+++.+||+.||++||++.+|++.|.
T Consensus 239 ~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGRQ-IY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhcccc-cc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111111111000 00 0111123467999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=305.03 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=192.0
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee-----cC
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE-----QG 511 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~-----~~ 511 (754)
....|...+.||+|+||.|.++. -..++..+|+++|++++|+||+.+.+++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34566667899999999998722 124567899999999999999999999865 45
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..|+|+|+| +-+|...|. .+..++.+.+..+++||++||.|+|+.+ |+||||||.|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 689999999 458999884 3445999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhh--------h
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHA--------W 661 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~--------~ 661 (754)
+...........+..+.|.+|+|||++.. ..|+.+.||||.|||+.||++|++-|.+.+.-. ..+.-.. .
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 98865433344567889999999998865 489999999999999999999999988765432 1111000 0
Q ss_pred hhhccCccccccC------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 662 NLWKDDRSWELMD------PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 662 ~~~~~~~~~~l~d------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
...........+. +.......+......++++.+||..||.+|+|++|.++|--
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence 0001000111110 00000111123466889999999999999999999999864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=308.67 Aligned_cols=241 Identities=27% Similarity=0.413 Sum_probs=190.6
Q ss_pred hhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
.+++|++.+.||+|+||.||++.. ....+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 457899999999999999996211 13468889999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC---ceEE
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTK----EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM---IPKI 585 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~---~~kl 585 (754)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999965432 135899999999999999999999988 99999999999998754 5899
Q ss_pred eeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhh
Q 036419 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLW 664 (754)
Q Consensus 586 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 664 (754)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..||....... ..... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~---~ 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFV---T 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH---H
Confidence 99999987644332222223334568999999999999999999999999999997 888876433221 11111 0
Q ss_pred ccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 665 KDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 665 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
...+ .......+..+.+++.+||+.+|++||++.+|+++|+
T Consensus 236 ~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0000 0111223467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=312.32 Aligned_cols=250 Identities=23% Similarity=0.291 Sum_probs=186.4
Q ss_pred hcCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
.++|++.++||+|+||.||++.. ....+.+|++++++++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46899999999999999997221 12457889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|++ ++|.+++.. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 577777743 2345889999999999999999999998 9999999999999999999999999997543221
Q ss_pred ccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh-------hhccCccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN-------LWKDDRSW 670 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~ 670 (754)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........+...... .|......
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 11234568999999998865 468999999999999999999999987543321111111000 00000000
Q ss_pred cccCcc-cC--CCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 671 ELMDPK-LQ--CEAS-------YPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 671 ~l~d~~-~~--~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
...++. .. .... ......+.+++.+||+.||++|||+.++++|--
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 000000 00 0000 012346789999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.24 Aligned_cols=247 Identities=29% Similarity=0.471 Sum_probs=193.5
Q ss_pred hcCccccceeccCCCcceeecc-----------------------------------ccHHHHHHHHHHHHhhccCCeee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------------------------QGLEEFKNEIKLTAKLQHRNLVR 502 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------------------------~~~~~~~~Ev~il~~l~hpniv~ 502 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999511 12457888999999999999999
Q ss_pred eeeeeeecCeeEEEEEecCCCChhhHhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 036419 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK--------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSN 574 (754)
Q Consensus 503 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~N 574 (754)
+++++..+...++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999965431 125899999999999999999999988 9999999999
Q ss_pred eEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCcccCC
Q 036419 575 ILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS--SKRSTRFFNTN 652 (754)
Q Consensus 575 Illd~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt--g~~p~~~~~~~ 652 (754)
|+++.++.+||+|||+++...............++..|+|||.+....++.++|||||||++|||++ +..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999987654433333344556789999999988899999999999999999998 455553222
Q ss_pred chhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 653 SLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
...........+......... ......++++.+++.+||+.||.+|||+.+|+++|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 122222222111111111111 111223467999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=303.53 Aligned_cols=236 Identities=30% Similarity=0.450 Sum_probs=189.2
Q ss_pred cCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 459 NNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
++|++.+.||+|+||.||++ ....+.+.+|++++++++||||+++++++.++...++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 46888999999999999962 12346789999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|.+++... .+.+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~- 157 (256)
T cd05114 84 GCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS- 157 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec-
Confidence 9999998643 245899999999999999999999988 9999999999999999999999999998654332211
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+...... ....... .... ...+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~---~~~~---~~~~------ 223 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMIS---RGFR---LYRP------ 223 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH---CCCC---CCCC------
Confidence 122345668999999988899999999999999999999 88887543221 1111111 1110 0111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 682 SYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
......+.+++.+||+.+|++||++.++++.|.
T Consensus 224 -~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 -KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112356899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=332.38 Aligned_cols=243 Identities=24% Similarity=0.312 Sum_probs=197.9
Q ss_pred hhhhcCccccceeccCCCcceee------------------ccccHHHHHHHHHHHHhhc-cCCeeeeeee-eee-----
Q 036419 455 SAATNNFGVENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQ-HRNLVRLLGC-CVE----- 509 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk------------------~~~~~~~~~~Ev~il~~l~-hpniv~l~~~-~~~----- 509 (754)
.....++++.+.|.+|||+.||. .++..+.+++||++|++|+ |||||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34456788899999999999997 2345678899999999998 9999999993 321
Q ss_pred -cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeec
Q 036419 510 -QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDF 588 (754)
Q Consensus 510 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DF 588 (754)
..+++|.||||++|.|-+++......+ |++.++++|+.|+++|+++||... .+|||||||-+||||..+++.|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 246789999999999999997654444 999999999999999999999875 78999999999999999999999999
Q ss_pred cCccccCCCccccc-------ccccccccCccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhH
Q 036419 589 GLARMFGGDELQSN-------TKRIVGTYGYMSPEYA---IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLG 658 (754)
Q Consensus 589 gla~~~~~~~~~~~-------~~~~~gt~~y~APE~~---~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~ 658 (754)
|.|...-....... .-...-|+.|+|||.+ .+..+++|+|||+|||+||.|+....||+....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------- 263 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------- 263 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence 99874322110000 0012358899999976 577899999999999999999999999874422
Q ss_pred hhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 659 HAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 659 ~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
..+++....-+....+..++.+||+.||+.||.+||++-+|+..+-.+
T Consensus 264 -----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 264 -----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred -----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 234555555555567899999999999999999999999999988654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=315.36 Aligned_cols=240 Identities=25% Similarity=0.403 Sum_probs=189.8
Q ss_pred hcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
..+|++.+.||+|+||.||++. ...+++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3579999999999999999732 1235688899999999999999999998765 578
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999999643 345889999999999999999999988 999999999999999999999999999977
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.............++..|+|||++.+..++.++|||||||++|||++ |+.|+....... +.. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~----- 228 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS----ILEKGE----- 228 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----HHhCCC-----
Confidence 54332222222334678999999999999999999999999999997 888875432211 111 011110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
...........+.+++.+||+.+|.+||++.+|+.+|....
T Consensus 229 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 229 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00111123356889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=304.93 Aligned_cols=239 Identities=28% Similarity=0.448 Sum_probs=191.7
Q ss_pred cCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecC
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 521 (754)
.+|.+.++||+|+||.||++. ...+++.+|++++++++||||+++++++.++...++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 468888999999999999721 134678999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~ 601 (754)
+++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 86 YGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 999999995432 345899999999999999999999987 999999999999999999999999999876543221
Q ss_pred cccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
......++..|+|||.+.+..++.++|||||||++|||++ |..|+....... . ....... ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~----~~~~~~~---------~~~~ 225 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V----YELLEKG---------YRME 225 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHHCC---------CCCC
Confidence 1112334668999999998999999999999999999998 888875432211 1 1111100 0001
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.....+..+.+++.+||+.+|++||++.+++++|+..
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1122346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=308.53 Aligned_cols=241 Identities=27% Similarity=0.421 Sum_probs=193.4
Q ss_pred hhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
..++|++.+.||+|+||.||++. .....+.+|++++++++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45689999999999999999621 113467899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEE
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTK-------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKI 585 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl 585 (754)
.++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 9999999999999999965322 234789999999999999999999987 999999999999999999999
Q ss_pred eeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhh
Q 036419 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLW 664 (754)
Q Consensus 586 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 664 (754)
+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+....... .... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~----~ 234 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKF----V 234 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHH----H
Confidence 99999987654433223334557789999999988899999999999999999998 888875433221 1111 1
Q ss_pred ccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 665 KDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 665 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
...... ......+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111110 011123567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.47 Aligned_cols=237 Identities=23% Similarity=0.342 Sum_probs=191.5
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.++||+|+||.||++. .....+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 478999999999999999721 23456788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999543 56899999999999999999999987 999999999999999999999999999876433
Q ss_pred c---------------------------ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 036419 598 E---------------------------LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFN 650 (754)
Q Consensus 598 ~---------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~ 650 (754)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012234579999999999999999999999999999999999999986544
Q ss_pred CCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHH
Q 036419 651 TNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPT-MSEVISML 714 (754)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L 714 (754)
.... . ....... .....+.....++.+.+++..||+ ||.+||+ ++++++|.
T Consensus 235 ~~~~--~---~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 235 LQET--Y---NKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHH--H---HHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 2211 0 0111000 001111111245778899999997 9999999 99999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=306.82 Aligned_cols=246 Identities=22% Similarity=0.292 Sum_probs=186.5
Q ss_pred CccccceeccCCCcceeeccc--------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecC-----eeEEEEEec
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ--------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG-----ENVLIYEYL 520 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~--------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~-----~~~lV~E~~ 520 (754)
.|...+++|.|+||.||++.. +.+.--+|+++|++++|||||+++-+|.... ...+|||||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 566788999999999998321 2223347999999999999999999986432 345899999
Q ss_pred CCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC-CceEEeeccCccccCCCc
Q 036419 521 PNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGLARMFGGDE 598 (754)
Q Consensus 521 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-~~~kl~DFgla~~~~~~~ 598 (754)
|. +|.+.+... ..+..++...+.-+..||.+||.|||+.+ |+||||||+|+|+|.+ |.+||||||.|+.+..+.
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 88 888888642 22445778888889999999999999987 9999999999999976 899999999999886654
Q ss_pred ccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccc-------
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW------- 670 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 670 (754)
.. .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+....+ ++.. ..+.+......
T Consensus 181 pn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d-QL~e-Iik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 181 PN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD-QLVE-IIKVLGTPTREDIKSMNP 255 (364)
T ss_pred Cc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH-HHHH-HHHHhCCCCHHHHhhcCc
Confidence 32 345678999999999876 79999999999999999999999987744332 2221 11111110000
Q ss_pred ---cccCcccC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 671 ---ELMDPKLQ-----CEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 671 ---~l~d~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+...+.+. .........+..+++.++|+.+|.+|.++.|++.|-
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~ 307 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP 307 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence 11111111 112334567889999999999999999999999875
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=306.05 Aligned_cols=247 Identities=28% Similarity=0.462 Sum_probs=190.9
Q ss_pred hcCccccceeccCCCcceeecc-----------------------------------ccHHHHHHHHHHHHhhccCCeee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------------------------QGLEEFKNEIKLTAKLQHRNLVR 502 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------------------------~~~~~~~~Ev~il~~l~hpniv~ 502 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4679999999999999999631 12356889999999999999999
Q ss_pred eeeeeeecCeeEEEEEecCCCChhhHhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 036419 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK--------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSN 574 (754)
Q Consensus 503 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~N 574 (754)
+++++.+++..++||||+++++|.+++..... ...+++.++..++.||+.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999965321 134778899999999999999999998 9999999999
Q ss_pred eEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCcccCC
Q 036419 575 ILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS--SKRSTRFFNTN 652 (754)
Q Consensus 575 Illd~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt--g~~p~~~~~~~ 652 (754)
||++.++.+||+|||+++.+.............++..|+|||....+.++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999987644332222233345678999999888899999999999999999998 55665432221
Q ss_pred chhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 653 SLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.........+..... .... +.....+..+.+++.+||+.||++||++.+|++.|+
T Consensus 241 --~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 --QVIENTGEFFRDQGR-QVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred --HHHHHHHHHHhhccc-cccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111111111111100 0000 111123467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=302.70 Aligned_cols=240 Identities=22% Similarity=0.277 Sum_probs=198.6
Q ss_pred hhcCccccceeccCCCcceee---------------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk---------------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.-+.|+++++||.|.-|+||+ .++...+.+.|-+||+.++||.++.|+..++.+...|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 346788899999999999997 23345677889999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|||||+||+|..+.++ +..+.++++.++-++.+|+-||+|||..| ||+|||||+||||.++|++-|+||.|+....
T Consensus 155 ~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999998866 45678999999999999999999999998 9999999999999999999999999975431
Q ss_pred C---------------------------------Ccc---------------------cccccccccccCcccccccccC
Q 036419 596 G---------------------------------DEL---------------------QSNTKRIVGTYGYMSPEYAIHG 621 (754)
Q Consensus 596 ~---------------------------------~~~---------------------~~~~~~~~gt~~y~APE~~~~~ 621 (754)
. ... ......++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 000 0112347899999999999999
Q ss_pred CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCC
Q 036419 622 FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENA 701 (754)
Q Consensus 622 ~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP 701 (754)
..+.++|.|+||+++||||.|..||.+.+..+-. ..++-..+.-+.....+..+.+||++.|.+||
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl--------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL--------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH--------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 9999999999999999999999999876654411 11122222222223566789999999999999
Q ss_pred CCCCC----HHHHHHHH
Q 036419 702 ADRPT----MSEVISML 714 (754)
Q Consensus 702 ~~RPt----~~evl~~L 714 (754)
.+|.. +.||-+|-
T Consensus 377 ~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRHP 393 (459)
T ss_pred hhhhccccchHHhhcCc
Confidence 99998 89988875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=317.50 Aligned_cols=225 Identities=21% Similarity=0.255 Sum_probs=182.8
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNK 523 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 523 (754)
+.||+|+||.||++. .....+.+|++++++++||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999621 12356788999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccc
Q 036419 524 SLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT 603 (754)
Q Consensus 524 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~ 603 (754)
+|..++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 99988843 346899999999999999999999988 9999999999999999999999999987542221 122
Q ss_pred cccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCH
Q 036419 604 KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASY 683 (754)
Q Consensus 604 ~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~ 683 (754)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .... .... +. ....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--~~~~---~~~~-------~~----~~p~ 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFEL---ILME-------DI----KFPR 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--HHHH---hccC-------Cc----cCCC
Confidence 34679999999999999999999999999999999999999986433211 1100 0000 00 1112
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036419 684 PIVKRYINVALLCVQENAADRP-----TMSEVISM 713 (754)
Q Consensus 684 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 713 (754)
.....+.+++.+||+.||++|| ++.++++|
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2456788999999999999997 89999887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=324.03 Aligned_cols=245 Identities=30% Similarity=0.428 Sum_probs=194.8
Q ss_pred hhhhcCccccceeccCCCcceeec-------------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeee
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKS-------------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~-------------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~ 509 (754)
+...++-.+.++||+|+||.||++ .....++.+|.++|++++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 344456666799999999999971 1235788999999999999999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
+..+++|||+|+||+|+++|.+... .++..++..++.+.|.||+|||+++ +|||||-.+|+|+..++.+||+|||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999999999999965332 5999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCc
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
+++.-. .+........-...|+|||.+....|++++|||||||++||+++ |..|+....... ....+. .
T Consensus 308 Ls~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--v~~kI~---~--- 377 (474)
T KOG0194|consen 308 LSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--VKAKIV---K--- 377 (474)
T ss_pred cccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--HHHHHH---h---
Confidence 988643 11111111234568999999999999999999999999999999 677765443322 111110 0
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVN 720 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 720 (754)
.......+...++.+..++.+|+..+|++||+|.++.+.|+.....
T Consensus 378 ------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 378 ------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred ------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 0111111224456788888999999999999999999999876444
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=322.85 Aligned_cols=237 Identities=23% Similarity=0.300 Sum_probs=187.1
Q ss_pred cCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||.||++.. ....+++|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999997221 2245678999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999954 346899999999999999999999998 999999999999999999999999999765321
Q ss_pred cccc------------------------------------cccccccccCcccccccccCCCCcccchhhHHHHHHHHHh
Q 036419 598 ELQS------------------------------------NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641 (754)
Q Consensus 598 ~~~~------------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt 641 (754)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHH
Q 036419 642 SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPT---MSEVISML 714 (754)
Q Consensus 642 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~L 714 (754)
|..||........ .. ...... ..+..+......+.+.+++.+|+. +|.+|++ +.++++|-
T Consensus 235 G~~Pf~~~~~~~~--~~---~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 235 GYPPFCSDNPQET--YR---KIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCCCHHHH--HH---HHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 9999864432211 11 111000 000111111234667889999996 9999998 99998864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=333.31 Aligned_cols=244 Identities=22% Similarity=0.299 Sum_probs=194.2
Q ss_pred hhHhhhhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC
Q 036419 452 ASVSAATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG 511 (754)
Q Consensus 452 ~~~~~~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~ 511 (754)
.+.....++|++.+.||+|+||+||++. .....+.+|++++..++|+|++++++.+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 3445566899999999999999999721 22456788999999999999999988775432
Q ss_pred --------eeEEEEEecCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc
Q 036419 512 --------ENVLIYEYLPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI 582 (754)
Q Consensus 512 --------~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~ 582 (754)
.+++||||+++|+|.++|.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 3679999999999999996532 2356899999999999999999999988 999999999999999999
Q ss_pred eEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh
Q 036419 583 PKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 583 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 662 (754)
+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--~~---~~ 256 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--VM---HK 256 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HH---HH
Confidence 99999999987654332233345679999999999999999999999999999999999999986432211 11 11
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
... .. .+ ......++.+.+++.+||+.||++||++.+++++
T Consensus 257 ~~~-~~----~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLA-GR----YD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred Hhc-CC----CC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 100 00 00 1122345678999999999999999999999876
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=316.52 Aligned_cols=226 Identities=21% Similarity=0.256 Sum_probs=182.1
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNK 523 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 523 (754)
+.||+|+||.||++. .....+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999721 12345678999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccc
Q 036419 524 SLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT 603 (754)
Q Consensus 524 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~ 603 (754)
+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99988843 346899999999999999999999988 9999999999999999999999999987542221 112
Q ss_pred cccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCH
Q 036419 604 KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASY 683 (754)
Q Consensus 604 ~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~ 683 (754)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... ..... .. ...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~~---~~~~~-------~~----~p~ 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FEL---ILMEE-------IR----FPR 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH--HHH---HhcCC-------CC----CCC
Confidence 345799999999999999999999999999999999999999864332211 110 00000 00 111
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036419 684 PIVKRYINVALLCVQENAADRP-----TMSEVISML 714 (754)
Q Consensus 684 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 714 (754)
...+.+.+++.+||+.||++|| ++.++++|-
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 2346788999999999999998 899988763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=319.85 Aligned_cols=237 Identities=23% Similarity=0.314 Sum_probs=182.8
Q ss_pred cCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||+||++.. ....+++|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999997211 2245778999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999953 456899999999999999999999988 999999999999999999999999999865321
Q ss_pred ccc---------------------------------ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 036419 598 ELQ---------------------------------SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKR 644 (754)
Q Consensus 598 ~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~ 644 (754)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 036419 645 STRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQ--ENAADRPTMSEVISM 713 (754)
Q Consensus 645 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~evl~~ 713 (754)
||....... ..... ..... .+..+ ......+.+.+++.+++. .++..||+++||++|
T Consensus 235 Pf~~~~~~~--~~~~i---~~~~~--~~~~p-----~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQE--TYKKV---MNWKE--TLIFP-----PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHH--HHHHH---HcCcC--cccCC-----CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 986443221 11111 10000 00000 011233456666666443 344567999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=304.83 Aligned_cols=240 Identities=30% Similarity=0.481 Sum_probs=195.1
Q ss_pred hhhcCccccceeccCCCcceeeccc-----------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ-----------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~-----------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
....+|++.++||+|+||.||++.. ..+++.+|++++++++||||+++++++.+....++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 3456799999999999999997321 35678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999996532 346899999999999999999999988 9999999999999999999999999998765432
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
... ....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+......+ ...... .. .
T Consensus 159 ~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~~~---~~----------~ 221 (261)
T cd05148 159 YLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQIT---AG----------Y 221 (261)
T ss_pred ccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHH---hC----------C
Confidence 211 13345678999999988899999999999999999998 788875433211 111110 00 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
........++.+.+++.+||+.||.+|||+.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 011122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=308.79 Aligned_cols=245 Identities=25% Similarity=0.378 Sum_probs=183.4
Q ss_pred cCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhh---ccCCeeeeeeeee-----e
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKL---QHRNLVRLLGCCV-----E 509 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l---~hpniv~l~~~~~-----~ 509 (754)
++|++.+.||+|+||.||++.. ....+.+|+.+++++ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4789999999999999997321 123566788887776 6999999999985 3
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999997 58988885432 345899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh---cc
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW---KD 666 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~ 666 (754)
+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+. ........ ..
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~--~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCCh
Confidence 99876433 223345789999999999888999999999999999999999999875433221 11110000 00
Q ss_pred Ccc-------ccccCcccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 667 DRS-------WELMDPKLQC---EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 667 ~~~-------~~l~d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
... ...+.+.... .......+.+.+++.+||+.||++|||+.++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 0000000000 0011234667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=323.06 Aligned_cols=235 Identities=23% Similarity=0.322 Sum_probs=182.8
Q ss_pred CccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
+|++.++||+|+||.||++.. ..+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999997321 23467889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999854 346889999999999999999999988 9999999999999999999999999975331100
Q ss_pred ---------------------------------------------ccccccccccccCcccccccccCCCCcccchhhHH
Q 036419 599 ---------------------------------------------LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFG 633 (754)
Q Consensus 599 ---------------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlG 633 (754)
........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHH
Q 036419 634 VLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPT---MSEV 710 (754)
Q Consensus 634 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ev 710 (754)
|++|||++|+.||.......... ...... .....+........+.+++.+|+ .+|.+|++ +.++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~-----~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQM-----KVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHH-----HHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999986543322110 000000 00111111223455677777765 49999997 8888
Q ss_pred HHH
Q 036419 711 ISM 713 (754)
Q Consensus 711 l~~ 713 (754)
++|
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=323.38 Aligned_cols=237 Identities=23% Similarity=0.281 Sum_probs=184.5
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.++||+|+||.||++. ...+.+++|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 478999999999999999721 12356788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999953 356889999999999999999999998 999999999999999999999999999643210
Q ss_pred cc-------------c--------------------------------ccccccccccCcccccccccCCCCcccchhhH
Q 036419 598 EL-------------Q--------------------------------SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSF 632 (754)
Q Consensus 598 ~~-------------~--------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSl 632 (754)
.. . ......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 00012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHH
Q 036419 633 GVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADR---PTMSE 709 (754)
Q Consensus 633 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~e 709 (754)
||++|||++|..||........ .. ........ +..+........+.+++.+||+ +|.+| +++.+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~--~~---~i~~~~~~-------~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET--YR---KIINWRET-------LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH--HH---HHHccCCc-------cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 9999999999999864432211 10 00000000 0001111234567889999997 66664 69999
Q ss_pred HHHHH
Q 036419 710 VISML 714 (754)
Q Consensus 710 vl~~L 714 (754)
+++|.
T Consensus 302 ~l~hp 306 (377)
T cd05629 302 IKSHP 306 (377)
T ss_pred HhcCC
Confidence 99885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.10 Aligned_cols=236 Identities=23% Similarity=0.292 Sum_probs=186.2
Q ss_pred CccccceeccCCCcceeeccc-------------------------cHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCee
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ-------------------------GLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~-------------------------~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~ 513 (754)
+|++.++||+|+||.||+... ..+.+.+|++++.+++ ||||+++++++.++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999996211 1245678999999994 89999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999854 345899999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
+..... .......||..|+|||++.+. .++.++|||||||++|||++|..||......... .........
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~------- 225 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRILK------- 225 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHhc-------
Confidence 543221 122346799999999998865 4789999999999999999999998644322211 000000000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 714 (754)
.++. ........+.+++.+||+.||++|| +++++++|-
T Consensus 226 ~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 226 CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 0111 1122346688999999999999999 788888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.74 Aligned_cols=239 Identities=27% Similarity=0.476 Sum_probs=190.0
Q ss_pred cCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.+|...++||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 567888999999999999732 124578999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCce
Q 036419 516 IYEYLPNKSLDSFLFDTTK------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIP 583 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~ 583 (754)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999965321 135889999999999999999999988 9999999999999999999
Q ss_pred EEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhh
Q 036419 584 KISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 584 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 662 (754)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~--- 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIEC--- 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHH---
Confidence 9999999986543322222233445778999999999999999999999999999998 888864322211 1100
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
...... . ......+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 237 ~~~~~~---~-------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ITQGRE---L-------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCcc---C-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000000 0 111123456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=308.67 Aligned_cols=240 Identities=28% Similarity=0.421 Sum_probs=190.3
Q ss_pred cCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
.+|++.++||+|+||.||++.. ..+.+.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4578889999999999997321 1356889999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC
Q 036419 515 LIYEYLPNKSLDSFLFDTT-------------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM 581 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~ 581 (754)
+++||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 1235888999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhh
Q 036419 582 IPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHA 660 (754)
Q Consensus 582 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 660 (754)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+...... ......
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~i 239 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEMI 239 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 999999999987654333222334456789999999988899999999999999999998 77776543221 111111
Q ss_pred hhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 661 WNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 661 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
..... .......+..+.+++..||+.+|++||++.+|++.|+.
T Consensus 240 ----~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 ----RNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----HcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11110 01112344668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=317.64 Aligned_cols=248 Identities=22% Similarity=0.290 Sum_probs=183.2
Q ss_pred CccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec-----CeeE
Q 036419 460 NFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ-----GENV 514 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~-----~~~~ 514 (754)
+|++.++||+|+||.||++. ....++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 58889999999999999721 1234578999999999999999999988543 3579
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||++ ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 588888843 345899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcc-cccccccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCch-hHhHh--------hhh
Q 036419 595 GGDEL-QSNTKRIVGTYGYMSPEYAIH--GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-TLLGH--------AWN 662 (754)
Q Consensus 595 ~~~~~-~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~--------~~~ 662 (754)
..... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..... ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 33221 112234579999999999876 6789999999999999999999999865432110 00000 000
Q ss_pred hhccCcccccc---CcccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 663 LWKDDRSWELM---DPKLQC---EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 663 ~~~~~~~~~l~---d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.+......+.+ ...... .........+.+++.+||+.||++|||+++++++-
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 00000000000 000000 00011345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.85 Aligned_cols=239 Identities=23% Similarity=0.415 Sum_probs=187.8
Q ss_pred ccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe-----
Q 036419 461 FGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE----- 512 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~----- 512 (754)
|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999621 123568899999999999999999998876554
Q ss_pred -eEEEEEecCCCChhhHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeec
Q 036419 513 -NVLIYEYLPNKSLDSFLFDTT---KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDF 588 (754)
Q Consensus 513 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DF 588 (754)
.++||||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999986532 2246899999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccC
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDD 667 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 667 (754)
|+++...............++..|+|||.+....++.++|||||||++|||++ |..|+...... ...... ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~---~~~~ 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYL---RHGN 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH---HcCC
Confidence 99987654332222222345678999999988899999999999999999999 77777543221 111111 1111
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 668 RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 668 ~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.. .........+.+++.+||+.||++||++.+|+++|+..
T Consensus 233 -~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 -RL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -CC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 11122346789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.21 Aligned_cols=230 Identities=24% Similarity=0.308 Sum_probs=183.5
Q ss_pred eccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCCh
Q 036419 467 LGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 467 lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
||+|+||+||+... ..+.+..|++++++++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999996211 224567899999999999999999999999999999999999999
Q ss_pred hhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccccc
Q 036419 526 DSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTK 604 (754)
Q Consensus 526 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~ 604 (754)
..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 98885432 3456899999999999999999999988 99999999999999999999999999986644322 223
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHH
Q 036419 605 RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYP 684 (754)
Q Consensus 605 ~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~ 684 (754)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... ...... .....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~---------~~~~~~--~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQR---------ILNDSV--TYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHh---------hcccCC--CCccc
Confidence 457899999999999999999999999999999999999998654322110 000000 001100 11123
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036419 685 IVKRYINVALLCVQENAADRP-----TMSEVISM 713 (754)
Q Consensus 685 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 713 (754)
.+..+.+++.+||+.||++|| +++++++|
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 456788999999999999999 88899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=323.82 Aligned_cols=237 Identities=23% Similarity=0.328 Sum_probs=185.0
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
.+|++.++||+|+||.||++. ...+.+++|++++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368999999999999999722 12345788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999954 356889999999999999999999988 999999999999999999999999998533100
Q ss_pred c-----------------------------------------ccccccccccccCcccccccccCCCCcccchhhHHHHH
Q 036419 598 E-----------------------------------------LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLL 636 (754)
Q Consensus 598 ~-----------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil 636 (754)
. ........+||+.|||||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 036419 637 LETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRP---TMSEVISM 713 (754)
Q Consensus 637 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~~ 713 (754)
|||++|+.||......+.... . ..+.. .............+.+++.+|+ .+|.+|+ ++.++++|
T Consensus 235 yell~G~~Pf~~~~~~~~~~~--i-~~~~~---------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLK--V-INWET---------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHH--H-hccCc---------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999865443221110 0 00100 0001111123455677777765 5999999 89999988
Q ss_pred H
Q 036419 714 L 714 (754)
Q Consensus 714 L 714 (754)
-
T Consensus 302 ~ 302 (376)
T cd05598 302 P 302 (376)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.66 Aligned_cols=239 Identities=24% Similarity=0.412 Sum_probs=185.2
Q ss_pred ccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec------Ce
Q 036419 461 FGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ------GE 512 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~------~~ 512 (754)
|.+.++||+|+||.||++. ...+.+.+|++++++++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467899999999999721 1245678899999999999999999987532 24
Q ss_pred eEEEEEecCCCChhhHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTT---KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
.++||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874322 2345899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCc
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~----~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYD----YLRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH----HHHcCC
Confidence 9987654332222223345678999999999999999999999999999999 77777543221 1111 111111
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.. .........+.+++.+||+.||++|||+.+|+++|+..
T Consensus 232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10 01112345688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.98 Aligned_cols=248 Identities=25% Similarity=0.343 Sum_probs=189.3
Q ss_pred cCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCC-eeeeeeeeeecC------
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRN-LVRLLGCCVEQG------ 511 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpn-iv~l~~~~~~~~------ 511 (754)
..|...++||+|.||+||++.. ......+|+.++++|+|+| ||++.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4577788999999999998321 2234589999999999999 999999998877
Q ss_pred eeEEEEEecCCCChhhHhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKE-GLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
..++|+||++. +|..++...... ..++...+..+..||++||+|||+++ |+||||||+||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78899999966 899998665432 34667889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh------
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL------ 663 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~------ 663 (754)
|+...-.. ......++|.+|+|||++.+. .|+..+||||+|||+.||++++.-|++..+.+ ........
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHHHHHHcCCCCc
Confidence 99664221 224467899999999999887 79999999999999999999988877654422 12122211
Q ss_pred --hccCccccccCcccCC---CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 664 --WKDDRSWELMDPKLQC---EAS-----YPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 664 --~~~~~~~~l~d~~~~~---~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
|.......-.+..... ... ........+++.+||+.+|++|.|+...++|-
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~ 303 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP 303 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence 2111111111110000 000 11124688999999999999999999999983
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.44 Aligned_cols=236 Identities=30% Similarity=0.441 Sum_probs=189.3
Q ss_pred cCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 459 NNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
++|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++.+....++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 468889999999999999631 1246789999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~- 157 (256)
T cd05113 84 GCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS- 157 (256)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee-
Confidence 99999996432 36899999999999999999999988 9999999999999999999999999998664432211
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..|+....... ..... ....+. ..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~---~~~~~~----------~~ 222 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKV---SQGLRL----------YR 222 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHH---hcCCCC----------CC
Confidence 112345678999999988889999999999999999998 888875433211 11111 011000 00
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 682 SYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.....+.+.+++.+||+.+|.+||++.+|++.|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1113467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=317.79 Aligned_cols=233 Identities=25% Similarity=0.368 Sum_probs=182.6
Q ss_pred cCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|+..++||+|+||.||++.. ..+.+.+|++++++++|+||+++++++.++...++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 5677789999999999997321 235688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.... ...+..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986532 3567788899999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIH-----GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
......||..|+|||++.. ...+.++|||||||++|||++|+.||........... ........
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--~~~~~~~~------- 292 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL--MCAICMSQ------- 292 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH--HHHHhccC-------
Confidence 1234579999999998743 2345799999999999999999999873322221110 00000000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
...........+.+++.+||+.||++||++.||++|--
T Consensus 293 ---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 293 ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred ---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00111234567899999999999999999999999853
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.31 Aligned_cols=231 Identities=26% Similarity=0.384 Sum_probs=181.8
Q ss_pred ceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCCh
Q 036419 465 NKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
++||+|+||.||++. .....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 469999999999721 1235689999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccc
Q 036419 526 DSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR 605 (754)
Q Consensus 526 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~ 605 (754)
.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998532 345889999999999999999999988 99999999999999999999999999986543221111112
Q ss_pred cccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHH
Q 036419 606 IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYP 684 (754)
Q Consensus 606 ~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~ 684 (754)
...+..|+|||.+.+..++.++||||||+++|||++ |..|+....... ..... ... ........
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~----~~~---------~~~~~~~~ 220 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAI----EQG---------VRLPCPEL 220 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHH----HcC---------CCCCCccc
Confidence 233457999999998899999999999999999998 777764332211 11111 000 00011122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 685 IVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 685 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.+..+.+++.+||+.+|++|||+.+|+++|.
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.77 Aligned_cols=251 Identities=20% Similarity=0.234 Sum_probs=191.7
Q ss_pred hcCccccceeccCCCcceeeccc---------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ---------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~---------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
..+|++.++||+|+||.||++.. ..+...+|++++++++||||+++++++......++|||++.
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 45799999999999999997321 12345789999999999999999999999999999999986
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+........
T Consensus 170 ~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 170 CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 57888883 3456999999999999999999999988 99999999999999999999999999987654433333
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhhhhhhccCccc-------c---
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHAWNLWKDDRSW-------E--- 671 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~-------~--- 671 (754)
.....||+.|+|||++....++.++|||||||++|||++|+.||....... ................. .
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 345679999999999999999999999999999999999999986544322 11111111100000000 0
Q ss_pred ---ccCcccCCCC-------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 672 ---LMDPKLQCEA-------SYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 672 ---l~d~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.......... .......+.+++.+||+.||++|||+.+++.|--
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 0000000000 0112356788999999999999999999999853
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.89 Aligned_cols=239 Identities=27% Similarity=0.419 Sum_probs=188.1
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV 516 (754)
++|++.+.||+|+||.||++. ...+.+.+|++++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999721 1124678899999999 799999999999999999999
Q ss_pred EEecCCCChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCce
Q 036419 517 YEYLPNKSLDSFLFDTT-------------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIP 583 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~ 583 (754)
|||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996432 1235889999999999999999999987 9999999999999999999
Q ss_pred EEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhh
Q 036419 584 KISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 584 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 662 (754)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |..||....... ....
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~~~--- 230 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LYEK--- 230 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH---
Confidence 99999998743211 11111223557999999988899999999999999999997 888875433211 1110
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
...+ .........+..+.+++.+||+.+|.+||++.+++++|+...
T Consensus 231 -~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 231 -LPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred -HhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0000 000111123467889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.10 Aligned_cols=244 Identities=25% Similarity=0.415 Sum_probs=194.1
Q ss_pred hhhcCccccceeccCCCcceeecc--------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeee
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG--------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCV 508 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~--------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~ 508 (754)
...++|.+.+.||+|+||.||++. ...+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 446788999999999999999531 1234678899999999 8999999999999
Q ss_pred ecCeeEEEEEecCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCce
Q 036419 509 EQGENVLIYEYLPNKSLDSFLFDTTK-------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNI 575 (754)
Q Consensus 509 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 575 (754)
.....++||||+++++|.+++..... ...+++.++..++.||++||.|||+++ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999975321 235788999999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCch
Q 036419 576 LLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSL 654 (754)
Q Consensus 576 lld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~ 654 (754)
++++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|+|++ |..|+.......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 999999999999999987754332222333456678999999998899999999999999999998 667664332111
Q ss_pred hHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 655 TLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 655 ~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+ ........+. ......++.+.+++.+||+.+|++||++.+|++.|+..
T Consensus 248 -~---~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 248 -L---FKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred -H---HHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 1 1111111100 11123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=284.81 Aligned_cols=233 Identities=29% Similarity=0.386 Sum_probs=196.1
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
-++|++++.||+|-||.||.+. +-..++++|++|-..|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3689999999999999999732 2356788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
+||.+.|.|...|... ..+.+++.....++.|+|.||.|+|..+ +|||||||+|+|++..+.+||+|||-+..-.
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999653 3456899999999999999999999988 9999999999999999999999999987543
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
.......+||..|.|||.+.+..++.++|+|++|++.||++.|.+||......+ .+. .. +-.++..
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-tYk-rI-------~k~~~~~-- 241 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-TYK-RI-------RKVDLKF-- 241 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-HHH-HH-------HHccccC--
Confidence 223446899999999999999999999999999999999999999987544211 110 00 0111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+..++....++|..|+..+|.+|.+..|+++|-
T Consensus 242 -----p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 242 -----PSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred -----CcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 134567788999999999999999999999875
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=320.43 Aligned_cols=240 Identities=22% Similarity=0.276 Sum_probs=190.5
Q ss_pred hhhhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~ 513 (754)
....++|++.++||+|+||.||++. ...+.+.+|+.+++.++||||+++++++.++...
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3456789999999999999999621 1223467899999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999999843 34788899999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHG----FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... . .........
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~---~~~i~~~~~- 264 (370)
T cd05596 192 MDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--T---YSKIMDHKN- 264 (370)
T ss_pred ccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH--H---HHHHHcCCC-
Confidence 643321 122345799999999998653 48899999999999999999999986433211 1 111111110
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAAD--RPTMSEVISML 714 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 714 (754)
.+..+.....+..+.+++.+||+.+|++ ||++.++++|.
T Consensus 265 ------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 265 ------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred ------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0111112234577889999999999998 99999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=306.62 Aligned_cols=233 Identities=35% Similarity=0.558 Sum_probs=180.5
Q ss_pred ccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 463 VENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 463 ~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+.+.||.|.||.||++. ...+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 46789999999999721 1257899999999999999999999999988889999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++|+|.++|... ....+++..+..|+.||++||.|||+.+ ++|+||+++|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999764 2356899999999999999999999987 99999999999999999999999999998743322
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
............|+|||.+....++.++||||||+++|||++ |+.|+..... ..+.... .....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~----~~~~~--------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKL----KQGQR--------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHH----HTTEE---------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc----ccccc---------
Confidence 223334457789999999999999999999999999999999 6677644322 1111111 11111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.......+..+.+++.+||+.||++||++.+|++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 011112356688999999999999999999999976
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.29 Aligned_cols=226 Identities=28% Similarity=0.356 Sum_probs=182.5
Q ss_pred ceeccCCCcceeeccc-------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 465 NKLGEGGFGPVYKSGQ-------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~-------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++||+|+||.||+... ....+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999996211 123467899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++.. .+.+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999999843 456889999999999999999999988 9999999999999999999999999987543221
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ...... ..
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~--~~---~~~~~~---------~~-- 217 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK--TI---DKILKG---------KL-- 217 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH--HH---HHHHcC---------CC--
Confidence 12234579999999999998899999999999999999999999986433211 11 111110 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRP-----TMSEVISML 714 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 714 (754)
.........+.+++.+||+.||++|| ++.+++++-
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 11122346788999999999999999 899988864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.67 Aligned_cols=246 Identities=25% Similarity=0.434 Sum_probs=193.4
Q ss_pred hhhcCccccceeccCCCcceeecc--------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeee
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG--------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCV 508 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~--------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~ 508 (754)
...++|.+.++||+|+||.||++. ...+++.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 345688999999999999999732 1134678899999999 5999999999999
Q ss_pred ecCeeEEEEEecCCCChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCce
Q 036419 509 EQGENVLIYEYLPNKSLDSFLFDTT-------------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNI 575 (754)
Q Consensus 509 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 575 (754)
++...++||||+++++|.+++.... ....+++.++..++.||+.||.|||+++ |+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 9999999999999999999996532 1245899999999999999999999987 99999999999
Q ss_pred EEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCch
Q 036419 576 LLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSL 654 (754)
Q Consensus 576 lld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~ 654 (754)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..|+......+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~- 244 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE- 244 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999987643222121222234567999999998899999999999999999999 777775432211
Q ss_pred hHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 655 TLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 655 ~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
.... ...... .......+..+.+++.+||+.+|++|||+.++++.|.....
T Consensus 245 -~~~~----~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 -LFKL----LREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -HHHH----HHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111 011100 01112234578899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.52 Aligned_cols=243 Identities=26% Similarity=0.434 Sum_probs=191.7
Q ss_pred hhcCccccceeccCCCcceeecc--------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeee
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVE 509 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~ 509 (754)
..++|.+.++||+|+||.||++. ...+++.+|+++++++ +||||+++++++.+
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34689999999999999999632 1234677899999999 79999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceE
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTK-------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNIL 576 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIl 576 (754)
+...++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+.+ ++||||||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 9999999999999999999975422 235889999999999999999999987 999999999999
Q ss_pred EcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchh
Q 036419 577 LDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLT 655 (754)
Q Consensus 577 ld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~ 655 (754)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+.......
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~-- 250 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 250 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--
Confidence 99999999999999986643222122222234568999999998899999999999999999998 777765332211
Q ss_pred HhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 656 LLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 656 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+.. ....... ..........+.+++.+||+.+|++||++.+|+++|+..
T Consensus 251 ~~~----~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 251 LFK----LLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHH----HHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111 0111100 011112346788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.93 Aligned_cols=235 Identities=26% Similarity=0.301 Sum_probs=188.8
Q ss_pred CccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
+|++.++||+|+||.||++.. ....+.+|++++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999997221 12346789999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++... ....+++..+..++.||++||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999988643 2345899999999999999999999988 9999999999999999999999999998754322
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
. .....|+..|+|||++.+..++.++||||+||++|||++|+.||........ ........... .
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~~~~~~~~----------~ 221 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEVERRVKED----------Q 221 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHHHHHhhhc----------c
Confidence 1 2235789999999999988999999999999999999999999875433211 00110000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRP-----TMSEVISM 713 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 713 (754)
.......+..+.+++.+||+.||++|| +++++++|
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111223456788999999999999999 89999776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=318.27 Aligned_cols=242 Identities=21% Similarity=0.279 Sum_probs=189.8
Q ss_pred hHhhhhcCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecC
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG 511 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~ 511 (754)
.+....++|++.++||+|+||.||++.. ..+.+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3445568899999999999999996221 2344778999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 99999999999999999943 34789999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHG----FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD 667 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 667 (754)
+....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .........
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-----~~~~i~~~~ 263 (370)
T cd05621 190 MKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-----TYSKIMDHK 263 (370)
T ss_pred eecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCC
Confidence 87643221 122356799999999998754 37899999999999999999999986433211 111111111
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 036419 668 RSWELMDPKLQCEASYPIVKRYINVALLCVQENAAD--RPTMSEVISML 714 (754)
Q Consensus 668 ~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 714 (754)
.. +..+.....+..+.+++..||+.++.+ ||++.++++|-
T Consensus 264 ~~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 264 NS-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred cc-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 00 111112234566788899999866654 89999999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.93 Aligned_cols=236 Identities=30% Similarity=0.447 Sum_probs=188.5
Q ss_pred cCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 459 NNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
.+|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++.+....++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 468889999999999999621 1245788999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 99999996432 36899999999999999999999988 9999999999999999999999999998664332211
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..|+......+ ...... .. ... ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~----~~-----~~~----~~ 222 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVS----AG-----YRL----YR 222 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHH----cC-----CcC----CC
Confidence 111223457999999998999999999999999999999 788775433221 111110 00 000 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 682 SYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
....+..+.+++.+||+.+|++|||+.+|+++|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1124567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=312.19 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=204.2
Q ss_pred hhhhcCccccceeccCCCcceee------------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 455 SAATNNFGVENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk------------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
+.+.....+.++||+|-||+|.. ..+...+|.+|+++|.+|+|||||+++++|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34556778899999999999975 223468899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
+|||++|+|.+|+..+... .+..+...+|+.||+.|++||.+.. ++||||.+.|+|+|.++++||+|||+++.+..
T Consensus 614 ~EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999999765332 2455666789999999999999987 99999999999999999999999999998877
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS--SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
..+.....+.+-...|||||.+..++++.++|||+||+.+||+++ ..+|+.. ....+..+..-.++........+
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~--lt~e~vven~~~~~~~~~~~~~l- 766 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ--LTDEQVVENAGEFFRDQGRQVVL- 766 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh--hhHHHHHHhhhhhcCCCCcceec-
Confidence 766666667777889999999999999999999999999999865 4555442 33334444444444333322211
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
..+...+..+.++++.||..|-++||++++|..+|...
T Consensus 767 -----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 -----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 22233566788999999999999999999999999764
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=318.17 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=193.5
Q ss_pred HhhhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhc-cCCeeeeeeeee
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQ-HRNLVRLLGCCV 508 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~-hpniv~l~~~~~ 508 (754)
.....++|.+.++||+|+||.||++. ...+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 44555678899999999999999742 11246889999999998 999999999999
Q ss_pred ecCeeEEEEEecCCCChhhHhhccCC------------------------------------------------------
Q 036419 509 EQGENVLIYEYLPNKSLDSFLFDTTK------------------------------------------------------ 534 (754)
Q Consensus 509 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------ 534 (754)
.....++||||+++|+|.++|.....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999965321
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCC
Q 036419 535 -----------------------------------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPS 573 (754)
Q Consensus 535 -----------------------------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~ 573 (754)
...+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 124677888999999999999999987 999999999
Q ss_pred ceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCC
Q 036419 574 NILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTN 652 (754)
Q Consensus 574 NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~ 652 (754)
|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986543222112223456788999999998889999999999999999998 78887543322
Q ss_pred chhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 653 SLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+. .. .....+. ...........+.+++.+||+.+|.+||++++|++.|+..
T Consensus 349 ~~-~~----~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 EQ-FY----NAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HH-HH----HHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 11 0001110 0001112346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=316.64 Aligned_cols=237 Identities=22% Similarity=0.312 Sum_probs=188.8
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.++||+|+||.||++. ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 478999999999999999721 12356788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999653 246899999999999999999999988 999999999999999999999999999876543
Q ss_pred cccccccccccccCcccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAI------HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~------~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ..........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~~i~~~~~~-- 227 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-----YNNIMNFQRF-- 227 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-----HHHHHcCCCc--
Confidence 221 222357899999999986 45688999999999999999999999864332111 1111111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...+.....+..+.+++.+||+ +|.+||++.++++|-
T Consensus 228 -----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 228 -----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred -----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 0111112345678899999998 999999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.79 Aligned_cols=239 Identities=28% Similarity=0.433 Sum_probs=188.9
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~l 515 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++.++ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 3578899999999999999832 1234678899999999 89999999999999999999
Q ss_pred EEEecCCCChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc
Q 036419 516 IYEYLPNKSLDSFLFDTT-------------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI 582 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~ 582 (754)
||||+++++|.+++.... ....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999996532 1235889999999999999999999987 999999999999999999
Q ss_pred eEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhh
Q 036419 583 PKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAW 661 (754)
Q Consensus 583 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 661 (754)
+||+|||+++..... .......++..|+|||++....++.++|||||||++|||++ |..||......+ .....
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~- 236 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKL- 236 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHHH-
Confidence 999999998743211 11112234667999999988889999999999999999998 888875433221 11110
Q ss_pred hhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 662 NLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 662 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
... ............+.+++.+||+.+|++||++.+++++|+..
T Consensus 237 ---~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 237 ---PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred ---hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000 00001112345688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=288.38 Aligned_cols=235 Identities=25% Similarity=0.350 Sum_probs=189.2
Q ss_pred cCccccceeccCCCcceee--------------------------ccccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecC
Q 036419 459 NNFGVENKLGEGGFGPVYK--------------------------SGQGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQG 511 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk--------------------------~~~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~ 511 (754)
+.|...+.||.|..++|.+ ...-.++..+|+.||+++. ||+|+++.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4556666777777776653 1122456678999999995 999999999999999
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
-.++|+|.|+.|.|.++|. ..-.++++...+|.+|+.+|++|||... |+||||||+|||+|++.++||+|||+|
T Consensus 97 F~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 9999999999999999994 4456999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhc
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIH------GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWK 665 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 665 (754)
..+..+.. ....+||++|+|||.+.. ..|+..+|+|+.|||+|-|+.|.+||.... ...+.....
T Consensus 171 ~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--QmlMLR~Im---- 241 (411)
T KOG0599|consen 171 CQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QMLMLRMIM---- 241 (411)
T ss_pred eccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHHHHHHHH----
Confidence 98876643 456899999999999864 368899999999999999999999974221 111111111
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 666 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+++ -.+..+.-...+....++|.+||+.||.+|.|++|+++|-
T Consensus 242 eGk------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 242 EGK------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred hcc------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 110 1122233345677789999999999999999999998875
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=305.97 Aligned_cols=244 Identities=25% Similarity=0.417 Sum_probs=192.1
Q ss_pred hhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG 511 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~ 511 (754)
...++|++.++||+|+||.||++. ....++.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 456789999999999999999621 01235778999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceE
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTK-------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPK 584 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~k 584 (754)
..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999965321 234677888999999999999999988 99999999999999999999
Q ss_pred EeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhh
Q 036419 585 ISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNL 663 (754)
Q Consensus 585 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 663 (754)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......+ ... ..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~---~~ 234 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLK---FV 234 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH---HH
Confidence 999999986644332222233345678999999999999999999999999999998 677764322111 111 01
Q ss_pred hccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 664 WKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 664 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.... .. ......++.+.+++.+||+.||++|||+.++++.|.+.
T Consensus 235 ~~~~-~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 MDGG-YL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HcCC-CC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111 00 00112246799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=298.80 Aligned_cols=242 Identities=24% Similarity=0.389 Sum_probs=194.1
Q ss_pred cCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.++||+|+||.||++.. ....+.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999997321 1245788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 518 EYLPNKSLDSFLFDTTK-EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
||+++++|.+++..... ...+++..+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998864332 345889999999999999999999987 99999999999999999999999999987653
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.|+.............. ... .
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~----~~~-----~--- 224 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI----EQC-----D--- 224 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH----hcC-----C---
Confidence 321 12235688899999999888899999999999999999999999753322211111111 000 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
............+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00111123456789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.14 Aligned_cols=245 Identities=23% Similarity=0.337 Sum_probs=194.5
Q ss_pred hhhcCccccceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeee-cC
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE-QG 511 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~-~~ 511 (754)
...++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++.+ +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3457899999999999999997321 13557889999999999999999998766 57
Q ss_pred eeEEEEEecCCCChhhHhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEe
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKE-----GLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKIS 586 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~ 586 (754)
..++++||+++++|.+++...... ..+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999999654332 46899999999999999999999987 9999999999999999999999
Q ss_pred eccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhc
Q 036419 587 DFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWK 665 (754)
Q Consensus 587 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 665 (754)
|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+..... ..+..... .
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~---~ 234 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLK---D 234 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHH---c
Confidence 9999987644332222223456778999999988899999999999999999998 8888754322 11111111 0
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 666 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.... ......++.+.+++.+||+.+|++|||+.+|++.|+...
T Consensus 235 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 GYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1000 011123467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=336.08 Aligned_cols=242 Identities=30% Similarity=0.477 Sum_probs=196.7
Q ss_pred hcCccccceeccCCCcceee------------------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee
Q 036419 458 TNNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk------------------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~ 513 (754)
..+-++.+.||+|.||.||+ ..+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 34566788999999999997 234568899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTK----EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
++++|||++|+|..||++.+. ...++....+.++.|||+|+.|||+++ .|||||..+|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987532 345889999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCC-CCCcccCCchhHhHhhhhhhccCc
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKR-STRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
+|+.+...++........-...|||||.+..+.|+.|+|||||||++||+++... |+...... +....+ ...++
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--~v~~~~---~~ggR 922 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--EVLLDV---LEGGR 922 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--HHHHHH---HhCCc
Confidence 9996655544433333223458999999999999999999999999999998664 44322221 111111 11221
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+ ..+...++.+.++|.+||+.+|++||++..|++.+..+
T Consensus 923 L----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 923 L----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred c----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 1 22334567889999999999999999999999988764
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=311.97 Aligned_cols=245 Identities=26% Similarity=0.430 Sum_probs=193.3
Q ss_pred hhhcCccccceeccCCCcceeecc--------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeee
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG--------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCV 508 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~--------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~ 508 (754)
....+|++.++||+|+||.||++. ...+++.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 344679999999999999999632 1135688999999999 7999999999999
Q ss_pred ecCeeEEEEEecCCCChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCce
Q 036419 509 EQGENVLIYEYLPNKSLDSFLFDTT-------------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNI 575 (754)
Q Consensus 509 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 575 (754)
++...++||||+++++|.+++.... ....+++.++..++.||++||.|||+.+ |+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence 9999999999999999999996532 2235888999999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCch
Q 036419 576 LLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSL 654 (754)
Q Consensus 576 lld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~ 654 (754)
|+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 244 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 244 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence 999999999999999987644322222222334567999999999999999999999999999998 777765432211
Q ss_pred hHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 655 TLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 655 ~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.. ... ..... ..........+.+++.+||+.+|++||++.++++.|+...
T Consensus 245 -~~---~~~-~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 245 -LF---KLL-KEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -HH---HHH-HcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 11 101 11100 0111123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=315.06 Aligned_cols=226 Identities=21% Similarity=0.250 Sum_probs=181.6
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNK 523 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 523 (754)
+.||+|+||.||++. ....++.+|++++.+++||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999621 12345678999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 524 SLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ-YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 524 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99988843 3468999999999999999999997 56 9999999999999999999999999987543221 11
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..... .. .. ..+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~~i---~~-~~------~~~----p 216 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELI---LM-EE------IRF----P 216 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHHHH---hc-CC------CCC----C
Confidence 234579999999999999999999999999999999999999986433221 11100 00 00 001 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036419 683 YPIVKRYINVALLCVQENAADRP-----TMSEVISML 714 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 714 (754)
......+.+++.+||+.||++|+ ++.++++|.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 12345688999999999999996 899998773
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=299.34 Aligned_cols=237 Identities=27% Similarity=0.417 Sum_probs=181.5
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNK 523 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 523 (754)
+.||+|+||.||++. .....+.+|++++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999731 12246888999999999999999999999999999999999999
Q ss_pred ChhhHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc
Q 036419 524 SLDSFLFDTTK--EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601 (754)
Q Consensus 524 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~ 601 (754)
+|.+++..... ....++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965332 234677888899999999999999988 9999999999999999999999999998654433322
Q ss_pred cccccccccCcccccccccC-------CCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 602 NTKRIVGTYGYMSPEYAIHG-------FFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~-------~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||........ .... .. .....+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~---~~-~~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT---VR-EQQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH---hh-cccCCCC
Confidence 23345678889999988642 35889999999999999996 9988864432221 1000 00 1111112
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
++... ....+.+.+++..|+ .+|++|||+++|++.|+
T Consensus 232 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22211 123456788999998 58999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.50 Aligned_cols=243 Identities=28% Similarity=0.439 Sum_probs=192.8
Q ss_pred hhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeec
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQ 510 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~ 510 (754)
...++|.+.+.||+|+||.||++. ...+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 345689999999999999998631 1124688999999999 799999999999999
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
+..++||||+++++|.+++.... ...+++.++..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999996432 234899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcc
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+........ ... ......
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~----~~~~~~- 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYK----LIKEGY- 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHH----HHHcCC-
Confidence 986643322112223456778999999999999999999999999999998 8888754332211 111 111110
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
........++.+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 262 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 --------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred --------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 000111234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=310.42 Aligned_cols=236 Identities=26% Similarity=0.336 Sum_probs=199.7
Q ss_pred hhcCccccceeccCCCcceeec---------------------cccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~---------------------~~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~ 514 (754)
....|++.+.||+|.||.||+. ....+.+.+|++||++++ |||||.+.+.++.....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4567899999999999999971 123468999999999999 999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC----CceEEeeccC
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN----MIPKISDFGL 590 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~----~~~kl~DFgl 590 (754)
+|||++.||.|.+.|... . +++..+..++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999665 2 999999999999999999999988 9999999999999533 5799999999
Q ss_pred ccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccc
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (754)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||........... ...
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-----i~~----- 252 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-----ILR----- 252 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-----HHc-----
Confidence 998865 2345678999999999999999999999999999999999999999876554332210 000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 671 ~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.+.....+......+.+.+++..|+..||.+|+|+.++++|.
T Consensus 253 --~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 253 --GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred --CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 011233344455678899999999999999999999999984
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=319.88 Aligned_cols=251 Identities=21% Similarity=0.252 Sum_probs=187.4
Q ss_pred hhcCccccceeccCCCcceeeccc------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCC
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKS 524 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gs 524 (754)
....|.+.++||+|+||.||++.+ ....+.+|++++++|+|||||++++++..+...++|||++. ++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~ 245 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SD 245 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CC
Confidence 355899999999999999998432 12356789999999999999999999999999999999995 68
Q ss_pred hhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccccc
Q 036419 525 LDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTK 604 (754)
Q Consensus 525 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~ 604 (754)
|..++... ...+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..........
T Consensus 246 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 246 LYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 88877432 346999999999999999999999988 9999999999999999999999999998764332222223
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCC------chhHhHhhhhhh-ccCccccc-----
Q 036419 605 RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN------SLTLLGHAWNLW-KDDRSWEL----- 672 (754)
Q Consensus 605 ~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~------~~~~~~~~~~~~-~~~~~~~l----- 672 (754)
...||..|+|||++.+..++.++|||||||++|||++|..++-..... ...+.......- ........
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 467999999999999999999999999999999999988654222111 011111111000 00000000
Q ss_pred -----------cCcccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 673 -----------MDPKLQCEA---SYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 673 -----------~d~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..+...... .......+.+|+.+||+.||.+|||+.|+++|
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 01123468899999999999999999999987
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.57 Aligned_cols=229 Identities=23% Similarity=0.339 Sum_probs=181.9
Q ss_pred ccccceeccCCCcceeecc---------------------ccHHHHHHHHHHH---HhhccCCeeeeeeeeeecCeeEEE
Q 036419 461 FGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLT---AKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il---~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
|++.+.||+|+||.||++. ...+.+.+|++++ .+++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 6788999999999999732 1234566666655 456799999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++++|..++.. +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988843 46899999999999999999999988 99999999999999999999999999875432
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||....... .... ... .. ..
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--~~~~---i~~-~~------~~ 219 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--VFDS---IVN-DE------VR 219 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--HHHH---HHh-CC------CC
Confidence 21 12334679999999999999999999999999999999999999986443221 1110 000 00 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 714 (754)
.....+..+.+++.+||+.||.+|| ++.+++++.
T Consensus 220 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 220 ----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 1112346688999999999999999 688887764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=310.60 Aligned_cols=231 Identities=19% Similarity=0.285 Sum_probs=180.6
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||.||++. ...+.+..|+.++.++ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999721 1234567888888877 799999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|..++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999988843 356899999999999999999999988 9999999999999999999999999997542211 12
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc---hhHhHhhhhhhccCccccccCcccCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS---LTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....... .....+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 234679999999999999999999999999999999999999986432211 1111111111111100
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPT------MSEVISM 713 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 713 (754)
..+......+.+++.+||+.||++||+ +.++++|
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 111223466889999999999999998 5677766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=297.59 Aligned_cols=239 Identities=29% Similarity=0.473 Sum_probs=189.5
Q ss_pred hhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
..++|++.++||+|+||.||++ ....+.+.+|+.++++++|||++++++++. ....++||||+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 3467999999999999999962 223567899999999999999999999875 45689999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999999653 2345899999999999999999999988 999999999999999999999999999876433211
Q ss_pred ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
. .....++..|+|||.+....++.++||||||+++|+|++ |..||...... ...... .... ..
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~---~~~~----------~~ 222 (260)
T cd05070 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQV---ERGY----------RM 222 (260)
T ss_pred c-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH---HcCC----------CC
Confidence 1 112235668999999988889999999999999999999 78887543211 111111 0000 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
......+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112334678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.34 Aligned_cols=240 Identities=26% Similarity=0.351 Sum_probs=191.8
Q ss_pred hhhcCccccceeccCCCcceeec-------------------cccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKS-------------------GQGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~-------------------~~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~l 515 (754)
.....|++.++||.||.++|||. .+..+.|++|+.+|.+|+ |.+||+|++|-..++.+|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34567999999999999999982 234677899999999997 8999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||= .-+|..+|..... .++.-.++.+..||+.++.++|+++ |||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99975 4499999965322 2332377889999999999999998 999999999999964 689999999999998
Q ss_pred CCcccccccccccccCcccccccccC-----------CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHG-----------FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW 664 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 664 (754)
.+.........+||+.||+||.+... +.+.++||||+|||||+|+.|+.||...... +
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~----- 579 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------I----- 579 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------H-----
Confidence 87766666778999999999998532 3678999999999999999999998633210 1
Q ss_pred ccCccccccCcccCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 665 KDDRSWELMDPKLQCEASY-PIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 665 ~~~~~~~l~d~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.++..+.+|...-+++. ....+++++++.||+.||++|||..+||+|--
T Consensus 580 --aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF 629 (677)
T KOG0596|consen 580 --AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF 629 (677)
T ss_pred --HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence 11233455533222221 12233999999999999999999999998753
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.83 Aligned_cols=244 Identities=27% Similarity=0.384 Sum_probs=188.3
Q ss_pred cCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec--Cee
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GEN 513 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~~ 513 (754)
+.|++.++||+|+||.||++. ...+.+.+|++++++++|||++++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 457889999999999998521 1235788999999999999999999998775 568
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999998542 235899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCC----------chhHhHhhhh
Q 036419 594 FGGDELQ-SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN----------SLTLLGHAWN 662 (754)
Q Consensus 594 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~----------~~~~~~~~~~ 662 (754)
+...... .......++..|+|||.+.+..++.++||||||+++|||++++.|....... ........ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 237 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-R 237 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-H
Confidence 6533211 1122355677899999998889999999999999999999987653211100 00000000 0
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
..... ...+.....+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 238 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 00111122456799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.91 Aligned_cols=242 Identities=26% Similarity=0.456 Sum_probs=191.0
Q ss_pred hhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
..++|++.++||+|+||.||++.. ..+++.+|++++++++||||+++++++.++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 457899999999999999997321 13568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCC
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTK-------------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPS 573 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~ 573 (754)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 9999999999999999964221 124788899999999999999999987 999999999
Q ss_pred ceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCC
Q 036419 574 NILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTN 652 (754)
Q Consensus 574 NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~ 652 (754)
||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986543322222223345678999999988899999999999999999997 77776432221
Q ss_pred chhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 653 SLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
+ ... ........ ......+.++.+++.+||+.+|.+|||+.||++.|+.
T Consensus 240 ~--~~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 E--VIY----YVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H--HHH----HHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 111 11111110 0111234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=297.70 Aligned_cols=240 Identities=28% Similarity=0.447 Sum_probs=190.6
Q ss_pred hhcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
..++|++.++||+|+||.||++. ...+++++|++++++++||||+++++++. ....++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 34679999999999999999732 22467899999999999999999999875 45679999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||+++.+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999643 2345789999999999999999999988 999999999999999999999999999876543221
Q ss_pred ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
......++..|+|||+..+..++.++||||||+++|+|++ |..|+....... ..... .... ..
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~~~~---~~~~----------~~ 222 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQV---ERGY----------RM 222 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HHHHH---hcCC----------CC
Confidence 1123346678999999988899999999999999999999 777765332211 11110 0000 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
......++.+.+++.+|++.+|++||++.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=298.10 Aligned_cols=236 Identities=28% Similarity=0.396 Sum_probs=188.7
Q ss_pred cCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
++|++.+.||+|++|.||++. ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 578999999999999999621 123467889999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|+||+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999854 345889999999999999999999988 9999999999999999999999999998654
Q ss_pred CCccccc-ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 596 GDELQSN-TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 596 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
....... .....|+..|+|||++.+..++.++||||||+++|||++|+.||........ . .......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~---~~~~~~~------- 223 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--I---FKIATQP------- 223 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--H---HHHhccC-------
Confidence 3221111 1235678899999999998999999999999999999999999753321111 0 0000000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
............+.+++.+||+.+|++|||+.+++++.
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 224 --TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred --CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 00111223446788999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=297.29 Aligned_cols=230 Identities=27% Similarity=0.398 Sum_probs=182.1
Q ss_pred eeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCC
Q 036419 466 KLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNK 523 (754)
Q Consensus 466 ~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 523 (754)
+||+|+||.||++. ...+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 68999999999631 12357889999999999999999999875 45778999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc-cc
Q 036419 524 SLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ-SN 602 (754)
Q Consensus 524 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~-~~ 602 (754)
+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999953 345899999999999999999999988 999999999999999999999999999876543221 11
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
.....++..|+|||.+....++.++|||||||++|||++ |..||......+ ..... ..... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~i----~~~~~---------~~~ 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VTQMI----ESGER---------MEC 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----HCCCC---------CCC
Confidence 122334678999999988889999999999999999998 888876433221 11111 11100 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 682 SYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
....++.+.+++.+||+.||++||++.+|.++|++-
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 122456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=309.62 Aligned_cols=231 Identities=18% Similarity=0.277 Sum_probs=181.5
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||.||++. ...+.+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999621 1234577899999998 699999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 999988843 356999999999999999999999988 9999999999999999999999999987532111 12
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc---hhHhHhhhhhhccCccccccCcccCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS---LTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .............. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~- 223 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------QIR- 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------CCC-
Confidence 234679999999999999999999999999999999999999986432211 01111111111111 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPT------MSEVISM 713 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 713 (754)
.+......+.+++.+||+.||.+||+ +.++++|
T Consensus 224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11123456889999999999999997 6788776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=309.60 Aligned_cols=230 Identities=23% Similarity=0.306 Sum_probs=183.7
Q ss_pred CccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccC-CeeeeeeeeeecCeeEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHR-NLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hp-niv~l~~~~~~~~~~~lV~ 517 (754)
+|++.+.||+|+||.||++. ...+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58889999999999999721 1234577899999999765 6888999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999999853 345889999999999999999999988 999999999999999999999999998753221
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .. .. .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i---~~-~~------~-- 218 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQSI---ME-HN------V-- 218 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHH---Hc-CC------C--
Confidence 1 12234679999999999999999999999999999999999999986443221 11111 00 00 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTM-----SEVISM 713 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 713 (754)
.......+.+.+++.+||+.||.+||+. .++++|
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 219 --SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111234678899999999999999976 677765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=322.86 Aligned_cols=250 Identities=18% Similarity=0.239 Sum_probs=183.1
Q ss_pred hhcCccccceeccCCCcceeeccc--------------cHHHHHHHHHHHHhhccCCeeeeeeeeeec--------CeeE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ--------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--------GENV 514 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~--------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--------~~~~ 514 (754)
..++|++.++||+|+||.||++.. ......+|+.++++++||||+++++++... ...+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 456899999999999999997322 123456799999999999999999886432 2467
Q ss_pred EEEEecCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC-ceEEeeccCcc
Q 036419 515 LIYEYLPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM-IPKISDFGLAR 592 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~-~~kl~DFgla~ 592 (754)
+||||+++ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccch
Confidence 89999986 666665432 33456899999999999999999999988 99999999999999665 79999999998
Q ss_pred ccCCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC----
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD---- 667 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 667 (754)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|..||......+. +.. ........
T Consensus 220 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~-i~~~~~~p~~~~ 294 (440)
T PTZ00036 220 NLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVR-IIQVLGTPTEDQ 294 (440)
T ss_pred hccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHH-HHHHhCCCCHHH
Confidence 7643321 2235789999999988764 699999999999999999999999865432221 110 00000000
Q ss_pred -----------ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 668 -----------RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 668 -----------~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.........+........++++.+++.+||+.||.+|||+.++++|--
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 000000000000111123467899999999999999999999998754
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=308.93 Aligned_cols=230 Identities=24% Similarity=0.318 Sum_probs=183.2
Q ss_pred CccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~ 517 (754)
+|++.+.||+|+||.||++. ...+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58889999999999999721 1223456777888777 5799999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999998843 345899999999999999999999988 999999999999999999999999999854322
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.... . ... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~~~~i---~-~~~--------~ 218 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSI---M-EHN--------V 218 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--HHHHH---H-hCC--------C
Confidence 1 12334679999999999999999999999999999999999999986543221 11111 0 000 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTM-----SEVISM 713 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 713 (754)
..+....+.+.+++.+||+.||.+|++. .++++|
T Consensus 219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1112245678899999999999999984 677654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=307.15 Aligned_cols=225 Identities=24% Similarity=0.311 Sum_probs=180.9
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||.||++. ...+.+.+|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999721 1234567888888888 699999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|..++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999998853 346899999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
....+|++.|+|||++.+..++.++|||||||++|+|++|+.||....... .... ... .. . ...
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~~~~---i~~-~~--------~--~~~ 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--LFQS---ILE-DE--------V--RYP 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--HHHH---HHc-CC--------C--CCC
Confidence 234578999999999999999999999999999999999999986433211 1111 000 00 0 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 036419 683 YPIVKRYINVALLCVQENAADRPTM-----SEVISM 713 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 713 (754)
...++.+.+++.+||+.||++||++ .+++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1234678899999999999999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=296.78 Aligned_cols=242 Identities=25% Similarity=0.400 Sum_probs=194.2
Q ss_pred cCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||.||++.. ..+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999997321 2356788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 518 EYLPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
||+++++|.+++.... ....+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999986422 3456899999999999999999999988 99999999999999999999999999887643
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
... ......|+..|+|||.+.+..++.++||||||+++|+|++|..|+.............. .....+.
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~ 227 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI---------EQCDYPP 227 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh---------hcCCCCC
Confidence 321 12235688999999999888999999999999999999999999754322211111110 0000111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
. ......+.+.+++.+||+.||.+|||+.+|+++++..
T Consensus 228 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 1123456789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=295.68 Aligned_cols=233 Identities=27% Similarity=0.400 Sum_probs=190.4
Q ss_pred CccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|.+.+.||+|++|.||++. ...+++.+|++++++++|||++++++++.++...++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 47788999999999999721 2356788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999653 2356899999999999999999999987 99999999999999999999999999987654322
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
......|+..|+|||++.+..++.++||||||+++++|++|+.|+....... ..... . ... . .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~---~-~~~----~-----~ 219 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LILKI---I-RGV----F-----P 219 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH---H-cCC----C-----C
Confidence 1223568889999999999999999999999999999999999986443211 11110 0 000 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.........+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=297.71 Aligned_cols=237 Identities=26% Similarity=0.395 Sum_probs=178.2
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNK 523 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 523 (754)
++||+|+||.||++. .....+.+|+++++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999621 11346788999999999999999999999999999999999999
Q ss_pred ChhhHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc
Q 036419 524 SLDSFLFDTTK--EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601 (754)
Q Consensus 524 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~ 601 (754)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999966432 234568888999999999999999988 9999999999999999999999999987643332222
Q ss_pred cccccccccCccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 602 NTKRIVGTYGYMSPEYAIH-------GFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~-------~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
......++..|+|||++.. ..++.++|||||||++|||++ |..|+....... .+. ...... ...+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~----~~~~~~-~~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLK----QVVREQ-DIKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHH----HHhhcc-CccCC
Confidence 2233456778999998743 357889999999999999999 667765332211 111 111111 11111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.+.. .......+.+++..|+ .||++|||+++|+++|.
T Consensus 232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2211 1233456677888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=314.93 Aligned_cols=244 Identities=22% Similarity=0.280 Sum_probs=190.5
Q ss_pred hhhHhhhhcCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeee
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~ 509 (754)
+..+....++|++.+.||+|+||.||++.. ..+.+.+|+++++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 344555678999999999999999997221 12346789999999999999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
+...++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999999843 34788899999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhc
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHG----FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWK 665 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 665 (754)
+++....... .......||+.|+|||++... .++.++|||||||++|||++|+.||....... .......
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----TYSKIMN 261 (371)
T ss_pred ceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-----HHHHHHc
Confidence 9987643321 122346799999999998754 38899999999999999999999986433211 1111111
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 036419 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAAD--RPTMSEVISML 714 (754)
Q Consensus 666 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 714 (754)
.... ...+........+.+++.+||+.++.+ ||+++++++|.
T Consensus 262 ~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1110 111112234567889999999854443 78999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=299.91 Aligned_cols=239 Identities=24% Similarity=0.361 Sum_probs=188.6
Q ss_pred hcCccccceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
.++|++.++||+|+||.||++.. ..+++.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 46788999999999999997321 13467889999999999999999999875 4578
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+++||+++|+|.+++... .+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999999642 346899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.............++..|+|||.+.+..++.++|||||||++|||++ |..|+....... +... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~---- 229 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDL----LEKGER---- 229 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH----HHCCCc----
Confidence 53322111222345678999999998899999999999999999998 888875332211 1111 111100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.......+..+.+++.+||+.||++||++.++++.|+..
T Consensus 230 -----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 230 -----LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 011112345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=307.87 Aligned_cols=225 Identities=25% Similarity=0.322 Sum_probs=177.3
Q ss_pred ceeccCCCcceeeccc---------------------cHHHHHHHHHHHHh-hccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAK-LQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~-l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||.||++.. ..+.+..|..++.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999997321 12344556666665 4799999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|..++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999999853 346899999999999999999999988 9999999999999999999999999998643222 22
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... .... .+ ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--~~~~---i~~~-------~~----~~~ 216 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--LFDS---ILND-------RP----HFP 216 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--HHHH---HHcC-------CC----CCC
Confidence 335679999999999999899999999999999999999999986543221 1111 1000 00 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMS-EVISM 713 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~ 713 (754)
......+.+++.+||+.||.+||++. +++++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 12345678999999999999999875 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=305.22 Aligned_cols=225 Identities=24% Similarity=0.319 Sum_probs=178.5
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHh-hccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAK-LQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~-l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||+||++. ...+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999732 122345667778776 4899999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999999953 346889999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....... ..... ... .+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i----~~~------~~~~----~ 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSI----RMD------NPCY----P 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHH----HhC------CCCC----C
Confidence 234578999999999999999999999999999999999999986543221 11111 000 0111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMS-EVISM 713 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~ 713 (754)
......+.+++.+||+.||++||++. ++++|
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 12345688999999999999999997 67654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=295.79 Aligned_cols=240 Identities=30% Similarity=0.451 Sum_probs=191.4
Q ss_pred hhhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 456 AATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
...++|++.++||+|+||.||++ ....+++.+|+.++++++|||++++++++ ..+..++||||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 34578999999999999999972 22356889999999999999999999986 45678999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999986532 346899999999999999999999987 99999999999999999999999999987653322
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
.. .....++..|+|||++....++.++||||||+++|||++ |+.|+....... ..... .... .
T Consensus 158 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~----~~~~---------~ 221 (260)
T cd05067 158 TA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNL----ERGY---------R 221 (260)
T ss_pred cc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH----HcCC---------C
Confidence 11 122345678999999988899999999999999999998 898876433211 11111 1110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
.+.....++.+.+++.+||+.+|++||++++++..|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01111234679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.32 Aligned_cols=242 Identities=25% Similarity=0.413 Sum_probs=194.8
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.++||+|+||.||++. ...+.+.+|++++++++|+|++++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 579999999999999999721 12457889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 518 EYLPNKSLDSFLFDTTK-EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
||+++++|..++..... ...+++.++..++.||++||.|||+.+ |+|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999865332 345899999999999999999999988 99999999999999999999999999986543
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
... ......++..|+|||.+.+..++.++|||||||++|+|++|+.|+.............. .... ..+
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~----~~~- 227 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----EKCD----YPP- 227 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhh----hcCC----CCC-
Confidence 221 12235688899999999988999999999999999999999999753322111111110 0000 000
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.........+.+++.+||+.+|.+||++.+|+++|+..
T Consensus 228 ---~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 ---LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11113456788999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=297.56 Aligned_cols=238 Identities=25% Similarity=0.394 Sum_probs=188.3
Q ss_pred hcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
.++|++.++||+|+||.||++. ...+.+++|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 4679999999999999999732 1234678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999999853 346899999999999999999999987 99999999999999999999999999987643221
Q ss_pred cccccccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 600 QSNTKRIVGTYGYMSPEYAI---HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
......|+..|+|||.+. ...++.++|||||||++|||++|+.|+.......... ..... .+..+.
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~~---~~~~~~ 230 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSKS---NFQPPK 230 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeecC---CCCCCC
Confidence 122356889999999874 3457889999999999999999999875332211100 00000 001111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. .....+..+.+++.+||+.+|++||++++|+++|
T Consensus 231 ~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11 1122456788999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=307.99 Aligned_cols=232 Identities=20% Similarity=0.289 Sum_probs=181.6
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||.||++. ...+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999621 1234577899999888 599999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|..++.. .+.+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 999988843 346999999999999999999999988 9999999999999999999999999997532211 12
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhhhhhhccCccccccCcccCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............... . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~--~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------I--RI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------C--CC
Confidence 234679999999999999999999999999999999999999986433221 111111111111110 0 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHH
Q 036419 682 SYPIVKRYINVALLCVQENAADRPT------MSEVISML 714 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~L 714 (754)
+...+..+.+++.+||+.||++||+ ++++++|-
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 1123466789999999999999998 46777663
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=297.64 Aligned_cols=240 Identities=28% Similarity=0.483 Sum_probs=190.4
Q ss_pred hcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.++|+..+.||+|+||.||++. ...+++.+|++++++++|||++++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578888999999999999621 113568889999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++... .+.+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999999542 356899999999999999999999988 9999999999999999999999999998664
Q ss_pred CCccccc-ccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 596 GDELQSN-TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 596 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
....... ......+..|+|||++....++.++|||||||++|||++ |..|+....... ..... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~~~i----~~~------ 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKAI----NDG------ 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHH----hcC------
Confidence 3221111 111223457999999988899999999999999999997 999975433211 11111 110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
...+.....+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 227 ---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ---FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011112346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=301.64 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=187.1
Q ss_pred hcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee--cCee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE--QGEN 513 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~--~~~~ 513 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 3578999999999999999732 123578899999999999999999998753 3468
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 8999999999999999542 245899999999999999999999988 99999999999999999999999999997
Q ss_pred cCCCcccc-cccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh-hhccCcccc
Q 036419 594 FGGDELQS-NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN-LWKDDRSWE 671 (754)
Q Consensus 594 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 671 (754)
........ ......++..|+|||++.+..++.++|||||||+++||+++..+................. ........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 64332111 1112223456999999988899999999999999999999876643221110000000000 000000000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.+............+..+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111111111122346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=308.65 Aligned_cols=226 Identities=23% Similarity=0.297 Sum_probs=181.3
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
++||+|+||.||++. ...+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999721 1224466788888866 799999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999998853 346899999999999999999999998 9999999999999999999999999998543222 12
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ..... .. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~~~---i~~~~----~~-------~p 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LFES---ILHDD----VL-------YP 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HHHH---HHcCC----CC-------CC
Confidence 234579999999999999999999999999999999999999986543221 1111 11110 00 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-------CHHHHHHHH
Q 036419 683 YPIVKRYINVALLCVQENAADRP-------TMSEVISML 714 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~L 714 (754)
......+.+++.+||+.||++|| ++.++++|-
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 12346788999999999999999 889998774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.43 Aligned_cols=230 Identities=25% Similarity=0.387 Sum_probs=184.4
Q ss_pred cccceeccCCCcceeec----------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe--eEEEE
Q 036419 462 GVENKLGEGGFGPVYKS----------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE--NVLIY 517 (754)
Q Consensus 462 ~~~~~lG~G~fg~Vyk~----------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~--~~lV~ 517 (754)
+....||+|+|-+|||+ ....++|..|+.+|+.|+|||||++++++.+... +.+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34568999999999993 2245789999999999999999999999987665 77899
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC-CceEEeeccCccccCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGLARMFGG 596 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-~~~kl~DFgla~~~~~ 596 (754)
|.|..|+|..|+.+ .+.++.+.+..|++||++||.|||++. ++|||||||.+||||+.+ |.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999954 456889999999999999999999985 899999999999999865 8999999999998765
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
.. ...+.|||.|||||... ..|++.+|||||||.++||+|+..|+..-.. ...+++..-.+. .|.
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYKKV~SGi-----KP~ 263 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYKKVTSGI-----KPA 263 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHHHHHcCC-----CHH
Confidence 43 33478999999999665 8899999999999999999999999642111 112222211111 111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
-... ....++.++|.+||.. ..+|||+.|+|++-
T Consensus 264 sl~k---V~dPevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 264 ALSK---VKDPEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred Hhhc---cCCHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 1001 1124578999999999 99999999999864
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=294.76 Aligned_cols=233 Identities=33% Similarity=0.492 Sum_probs=189.3
Q ss_pred ceeccCCCcceeeccc----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSGQ----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
++||+|+||.||++.. ..+.+.+|++++.+++|+|++++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4799999999997322 146788999999999999999999999999999999999999
Q ss_pred CChhhHhhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 523 KSLDSFLFDTTK------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 523 gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
++|.+++..... ...+++..+..++.||++||.|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999966422 367999999999999999999999988 99999999999999999999999999998765
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
...........++..|+|||.+....++.++||||||+++|+|++ |..|+....... +..... ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~----~~~------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYLR----KGY------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH----cCC-------
Confidence 432222344567889999999988899999999999999999999 588876542211 111110 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
........+..+.+++.+||+.+|.+||++.+++++|+
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00111223567899999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=304.00 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=189.0
Q ss_pred cCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|++.++||+|+||.||++.. ..+++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4689999999999999997211 134578999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++.. .+.+++..+..++.||++||.|||+.. +++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 999999999954 356899999999999999999999842 3999999999999999999999999998765322
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcc----------
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS---------- 669 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 669 (754)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+......... ............
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE--AMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH--HhhcCccccccccCCcccccCC
Confidence 123457899999999998888999999999999999999999997543321110 000000000000
Q ss_pred ----------ccccC----cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 670 ----------WELMD----PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 670 ----------~~l~d----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.++.+ ..............+.+++.+||+.+|++|||+.+|+++.-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000 00000000113456899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=310.30 Aligned_cols=245 Identities=28% Similarity=0.419 Sum_probs=188.7
Q ss_pred hhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeec-
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQ- 510 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~- 510 (754)
..++|++.+.||+|+||.||++. ...+.+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 34689999999999999999742 1134577899999999 689999999988654
Q ss_pred CeeEEEEEecCCCChhhHhhccCC--------------------------------------------------------
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTK-------------------------------------------------------- 534 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 534 (754)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 567899999999999999864211
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccccccc
Q 036419 535 --------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI 606 (754)
Q Consensus 535 --------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~ 606 (754)
...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 124688889999999999999999988 999999999999999999999999999875433222222234
Q ss_pred ccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHH
Q 036419 607 VGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPI 685 (754)
Q Consensus 607 ~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~ 685 (754)
.++..|+|||++.+..++.++||||||+++|+|++ |..|+........ .... ...... ... ....
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~----~~~~~~-----~~~----~~~~ 307 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRR----LKEGTR-----MRA----PDYT 307 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHH----HhccCC-----CCC----CCCC
Confidence 45678999999998899999999999999999997 8888754322211 1110 111100 000 0112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 686 VKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 686 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.+.+.+++..||+.||++|||+.+|+++|+...
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 356889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=308.47 Aligned_cols=225 Identities=22% Similarity=0.296 Sum_probs=180.0
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||.||++. ...+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999721 1234566788888876 699999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999998854 346899999999999999999999988 9999999999999999999999999987542221 12
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..... . .... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~~i---~-~~~~----------~~~ 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEAI---L-NDEV----------VYP 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHHH---h-cCCC----------CCC
Confidence 334679999999999999999999999999999999999999986543221 11111 0 1100 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 036419 683 YPIVKRYINVALLCVQENAADRPTM------SEVISM 713 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 713 (754)
......+.+++.+||+.||++||++ +++++|
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1234678899999999999999998 777765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=314.60 Aligned_cols=236 Identities=23% Similarity=0.322 Sum_probs=184.3
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||.||++. ...+.+++|++++.+++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468899999999999999721 12356788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999953 356899999999999999999999988 999999999999999999999999998755321
Q ss_pred cc---------------------------------cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 036419 598 EL---------------------------------QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKR 644 (754)
Q Consensus 598 ~~---------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~ 644 (754)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 000123579999999999999999999999999999999999999
Q ss_pred CCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 036419 645 STRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPT---MSEVISM 713 (754)
Q Consensus 645 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 713 (754)
||........ ... ..... ..+..+......+.+.+++.+|+. ||.+|++ +.++++|
T Consensus 235 Pf~~~~~~~~--~~~---i~~~~-------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQET--YRK---VMNWK-------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHH--HHH---HHcCC-------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 9865433221 111 11000 000001111234567788888764 9999985 6777776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=304.41 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=187.0
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|.+.++||+|+||.||++. .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 579999999999999999721 1224577899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++ +|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 986 787777542 345889999999999999999999988 99999999999999999999999999986533221
Q ss_pred cccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCch-hHhHhhh-----hhhccCcc-cc
Q 036419 600 QSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-TLLGHAW-----NLWKDDRS-WE 671 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~-----~~~~~~~~-~~ 671 (754)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+. ....... ..|..... .+
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223467899999998865 4689999999999999999999999865443221 1000000 00100000 00
Q ss_pred ccC---cccC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 672 LMD---PKLQ----CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 672 l~d---~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
..+ +... ..........+.+++.+||+.||.+|||+.|+++|--
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 000 0000 0011124566889999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=297.13 Aligned_cols=240 Identities=27% Similarity=0.464 Sum_probs=191.1
Q ss_pred hcCccccceeccCCCcceeeccc----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..+|++.+.||+|+||.||++.. ..+.+.+|+.++++++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 35788999999999999996211 13568899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++... .+.+++.++..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999999543 346899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcccc-cccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 596 GDELQS-NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 596 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
...... ......++..|+|||.+.+..++.++||||||+++||+++ |..|+......+ ...... ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~---~~~~----- 227 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIE---EGYR----- 227 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHh---CCCc-----
Confidence 332111 1112233568999999998899999999999999999886 998875443221 111110 0000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.+.....++.+.+++.+|++.+|.+||++.++++.|+..
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011122356788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.43 Aligned_cols=234 Identities=23% Similarity=0.386 Sum_probs=186.1
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|++.++||+|+||.||++. ...+++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 468889999999999999732 1235688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999997553 3678889999999999999999988 999999999999999999999999999865432
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchh-HhHhhhhhhccCccccccCcccC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLT-LLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......... ............. .+..
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~- 220 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL- 220 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC-
Confidence 123457899999999999889999999999999999999999998643322111 0000011100000 0011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......+.+.+++.+||+.+|++||++++++++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 1112345688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.80 Aligned_cols=234 Identities=26% Similarity=0.409 Sum_probs=186.9
Q ss_pred cCccccceeccCCCcceeec--------------cccHHHHHHHHHHHHhhccCCeeeeeeeee-ecCeeEEEEEecCCC
Q 036419 459 NNFGVENKLGEGGFGPVYKS--------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCV-EQGENVLIYEYLPNK 523 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~--------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~-~~~~~~lV~E~~~~g 523 (754)
++|++.+.||+|+||.||++ ....+.+.+|++++++++|+|++++++++. ++...++||||++++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 57889999999999999973 123457889999999999999999999764 556789999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccc
Q 036419 524 SLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT 603 (754)
Q Consensus 524 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~ 603 (754)
+|.+++... ....+++..+..++.||+.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 86 ~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----- 156 (256)
T cd05082 86 SLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 156 (256)
T ss_pred cHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence 999998653 2335889999999999999999999988 9999999999999999999999999998653221
Q ss_pred cccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 604 KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 604 ~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
....++..|+|||++.+..++.++|||||||++|+|++ |+.|+....... ...... ... .+ ...
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~~----~~~-----~~----~~~ 221 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVE----KGY-----KM----DAP 221 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHh----cCC-----CC----CCC
Confidence 22344568999999988899999999999999999997 888865332211 111110 000 00 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
...+..+.+++.+||+.+|++|||+.+++++|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.67 Aligned_cols=232 Identities=28% Similarity=0.440 Sum_probs=181.4
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||.||++. ...+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999721 1234677899999999 799999999999999999999999999
Q ss_pred CChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 523 KSLDSFLFDTT-------------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 523 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
++|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999996532 1235789999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCc
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||......+ ..... ...
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~----~~~- 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKL----PQG- 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HHHHH----hCC-
Confidence 98643211 11111233567999999988899999999999999999997 888875432211 11110 000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
............+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00011112345688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.71 Aligned_cols=221 Identities=27% Similarity=0.322 Sum_probs=178.1
Q ss_pred ceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecC
Q 036419 465 NKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 521 (754)
+.||+|+||.||+... ....+.+|++++++++||||+++++++.++...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999996211 22346789999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~ 601 (754)
+++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999999843 346899999999999999999999988 9999999999999999999999999998654321 1
Q ss_pred cccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCC
Q 036419 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ... .. ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~i---~~~---------~~--~~ 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--TMTMI---LKA---------KL--GM 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--HHHHH---HcC---------CC--CC
Confidence 2234679999999999998899999999999999999999999986433211 11111 000 00 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHH
Q 036419 682 SYPIVKRYINVALLCVQENAADRPTMSE 709 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt~~e 709 (754)
.......+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1123467889999999999999999444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=297.89 Aligned_cols=235 Identities=31% Similarity=0.484 Sum_probs=185.5
Q ss_pred ccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 461 FGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
|++.+.||+|+||+||+... ......+|++++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 67889999999999998211 1123345999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++++|.+++. ....+++..+..++.||++||.+||+.+ |+|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999996 3456899999999999999999999998 99999999999999999999999999986421 11
Q ss_pred ccccccccccCcccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhhhhhhccCccccccCcccC
Q 036419 601 SNTKRIVGTYGYMSPEYAI-HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
.......++..|+|||++. +..++.++||||+|+++++|++|..|+....... ......... . ......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~----~~~~~~-- 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---R----PLPSSS-- 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---T----HHHHHT--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---c----cccccc--
Confidence 2344567899999999998 7889999999999999999999999987541111 111100000 0 000000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.......+.+.+++.+||+.||++||++.+++++
T Consensus 224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112789999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=322.43 Aligned_cols=240 Identities=28% Similarity=0.485 Sum_probs=200.3
Q ss_pred cCccccceeccCCCcceee----------------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 459 NNFGVENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk----------------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
...+|.+.||.|.||+|++ .+....+|..|..||.+.+||||++|.|+.......+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 3456889999999999996 234567899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
.|||++|+|+.||+.+ .+.+++.+..-++++|+.|+.||-+.+ ++||||...|||++.+..+|++|||+++.+..
T Consensus 709 TEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999754 356999999999999999999999998 99999999999999999999999999998765
Q ss_pred Cccccccccccc--ccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 597 DELQSNTKRIVG--TYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 597 ~~~~~~~~~~~g--t~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
+.. ...+...| ...|.|||.+...+++.++||||||+||||.++ |.+|+.....++ +.+.+
T Consensus 784 d~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd---------------VIkaI 847 (996)
T KOG0196|consen 784 DPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---------------VIKAI 847 (996)
T ss_pred CCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---------------HHHHH
Confidence 542 11222222 458999999999999999999999999999764 777754332222 11223
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
+....-+.++..+..|.+|++.|||+|..+||.+.+|+.+|.+...
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 3334445566788899999999999999999999999999987644
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=297.79 Aligned_cols=238 Identities=26% Similarity=0.411 Sum_probs=188.0
Q ss_pred hhhcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeec------C
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQ------G 511 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~------~ 511 (754)
.+++.|++.++||+|+||.||++. .....+.+|+.++.++ +||||+++++++... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 467789999999999999999732 2356789999999999 699999999998753 4
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 688999999999999998652 2346899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD 666 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 666 (754)
....... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+......... .....
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~~~~~- 230 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FLIPR- 230 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----HHHhc-
Confidence 8654322 1233467899999999986 346889999999999999999999998533221111 00010
Q ss_pred CccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 667 DRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 667 ~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.. .+. ......+..+.+++.+||+.+|.+|||+.+++++
T Consensus 231 ~~-----~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 NP-----APR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CC-----CCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 000 1111234568899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.42 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=177.0
Q ss_pred cceeccCCCcceeeccc------------------cHHHHHHHHHHHHhhccCCeeeeeeeeee--cCeeEEEEEecCCC
Q 036419 464 ENKLGEGGFGPVYKSGQ------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE--QGENVLIYEYLPNK 523 (754)
Q Consensus 464 ~~~lG~G~fg~Vyk~~~------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~--~~~~~lV~E~~~~g 523 (754)
.++||+|+||.||++.. ....+.+|++++++++||||+++++++.. +...++||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 46899999999998431 13467899999999999999999998854 4568899999865
Q ss_pred ChhhHhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE----cCCCceEEeeccCccc
Q 036419 524 SLDSFLFDTT------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL----DSNMIPKISDFGLARM 593 (754)
Q Consensus 524 sL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll----d~~~~~kl~DFgla~~ 593 (754)
+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 7777764321 1235889999999999999999999988 9999999999999 4567899999999987
Q ss_pred cCCCcc-cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCch-------hHhHhhhhh-
Q 036419 594 FGGDEL-QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-------TLLGHAWNL- 663 (754)
Q Consensus 594 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~- 663 (754)
...... ........||+.|+|||++.+. .++.++||||+||++|+|++|+.||........ .........
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 653321 1223356789999999998774 689999999999999999999999864432110 000000000
Q ss_pred -------hccC-------ccccccCcccCC---------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 664 -------WKDD-------RSWELMDPKLQC---------EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 664 -------~~~~-------~~~~l~d~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
|... ...+........ .........+.+++.+||+.||++|||++|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 000000000000 0000112457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.19 Aligned_cols=228 Identities=22% Similarity=0.306 Sum_probs=178.5
Q ss_pred eccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCCh
Q 036419 467 LGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 467 lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
||+|+||.||+... ..+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999997221 123446699999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccc
Q 036419 526 DSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR 605 (754)
Q Consensus 526 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~ 605 (754)
.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 98885432 234889999999999999999999988 99999999999999999999999999987643321 223
Q ss_pred cccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHH
Q 036419 606 IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPI 685 (754)
Q Consensus 606 ~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~ 685 (754)
..|+..|+|||++.+..++.++|||||||++|||++|+.|+......... ......... ..... .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~---------~~~~~-~~~~~ 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EELKRRTLE---------DEVKF-EHQNF 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHHHhhc---------ccccc-ccccC
Confidence 56899999999999889999999999999999999999998644322110 000011010 00000 00123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 036419 686 VKRYINVALLCVQENAADRPTMSEVIS 712 (754)
Q Consensus 686 ~~~l~~li~~cl~~dP~~RPt~~evl~ 712 (754)
...+.+++.+||+.||++||++.|+++
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchh
Confidence 566889999999999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=299.96 Aligned_cols=254 Identities=28% Similarity=0.400 Sum_probs=191.2
Q ss_pred cCccccceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeee--cCee
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE--QGEN 513 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~--~~~~ 513 (754)
+.|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 4678889999999999997321 24678999999999999999999999877 5678
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999996432 35899999999999999999999987 99999999999999999999999999997
Q ss_pred cCCCccc-ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 594 FGGDELQ-SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 594 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
....... .......++..|+|||.+.+..++.++||||||++++||++|..|+........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 7532211 111123445679999999888999999999999999999999988653322111100000000000000001
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+............+..+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111122346789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.94 Aligned_cols=238 Identities=29% Similarity=0.465 Sum_probs=188.7
Q ss_pred hcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecC
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 521 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++|||++++++++. ....++||||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3578899999999999999721 12357889999999999999999999875 456889999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~ 601 (754)
+++|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999999653 2345889999999999999999999988 999999999999999999999999999876433221
Q ss_pred cccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
......++..|+|||.+.+..++.++||||||+++|+|++ |..|+...... ....+.. .... ..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~---~~~~----------~~ 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVE---RGYR----------MP 223 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH---cCCC----------CC
Confidence 1122345678999999988899999999999999999999 88887543221 1111111 0000 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
.....+..+.+++.+||+.||++||++++|++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.50 Aligned_cols=239 Identities=27% Similarity=0.472 Sum_probs=188.4
Q ss_pred cCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
.+|++.+.||+|+||.||++. ...+++..|++++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 458889999999999999621 1235788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++++|.+++... .+.+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998543 346899999999999999999999987 99999999999999999999999999986643
Q ss_pred Cccccccc-ccc--cccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 597 DELQSNTK-RIV--GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 597 ~~~~~~~~-~~~--gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
........ ... .+..|+|||.+....++.++|||||||++|||++ |..|+....... ....... ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i~~---~~~---- 229 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAIEQ---DYR---- 229 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHHHc---CCc----
Confidence 22111111 111 2457999999998999999999999999999886 888875432211 1111110 000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.+.....+..+.+++.+||+.+|.+||++.+|+++|+..
T Consensus 230 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011112345688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=294.42 Aligned_cols=233 Identities=31% Similarity=0.497 Sum_probs=184.7
Q ss_pred ceeccCCCcceeecc-------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 465 NKLGEGGFGPVYKSG-------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~-------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+.||+|+||.||++. ....++.+|++++++++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999622 1234678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC-----ceEEeeccC
Q 036419 520 LPNKSLDSFLFDTT----KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM-----IPKISDFGL 590 (754)
Q Consensus 520 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~-----~~kl~DFgl 590 (754)
+++++|.+++.... ....+++.++..++.||+.||.|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 2235789999999999999999999987 99999999999999877 899999999
Q ss_pred ccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcc
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
++...............++..|+|||++.+..++.++|||||||++|||++ |..|+..... ....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~----~~~~- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHV----TAGG- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHH----hcCC-
Confidence 986644332222233455778999999999999999999999999999998 8888753321 1111111 0000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
........++.+.+++.+||+.+|.+||++.+|+++|+
T Consensus 231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00111234567889999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=296.17 Aligned_cols=248 Identities=26% Similarity=0.286 Sum_probs=204.4
Q ss_pred cCCCchhhHhhhhcCccccceeccCCCcceee---------------------ccccHHHHHHHHHHHHhhccCCeeeee
Q 036419 446 TQGKSLASVSAATNNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQHRNLVRLL 504 (754)
Q Consensus 446 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vyk---------------------~~~~~~~~~~Ev~il~~l~hpniv~l~ 504 (754)
-|.+.++......+.|+..+.||+||||.||- .+++.....+|-+||++++.|.||.+-
T Consensus 172 lQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsla 251 (591)
T KOG0986|consen 172 LQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLA 251 (591)
T ss_pred HHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEe
Confidence 35667777777778999999999999999983 234555677899999999999999999
Q ss_pred eeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceE
Q 036419 505 GCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPK 584 (754)
Q Consensus 505 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~k 584 (754)
..|+..+.++||+..|.||+|..+|.+... ..+++..++-++.+|+-||++||... |++|||||+|||+|+.|+++
T Consensus 252 YAfeTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 252 YAFETKDALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred eeecCCCceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeE
Confidence 999999999999999999999999987554 46999999999999999999999987 99999999999999999999
Q ss_pred EeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch--hHhHhhhh
Q 036419 585 ISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL--TLLGHAWN 662 (754)
Q Consensus 585 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~ 662 (754)
|+|+|+|..+..... ....+||.+|||||++.++.|+...|.|||||+||||+.|+.||........ .+....
T Consensus 328 ISDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~-- 402 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT-- 402 (591)
T ss_pred eeccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH--
Confidence 999999998865542 2334899999999999999999999999999999999999999976554331 111100
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISML 714 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 714 (754)
+ .....++...+++..++....|++||++|. .+.+|-+|-
T Consensus 403 ---------~---~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 403 ---------L---EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred ---------h---cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence 0 001223344567788888899999999997 455776653
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=305.42 Aligned_cols=225 Identities=24% Similarity=0.302 Sum_probs=177.9
Q ss_pred ceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||.||++. ...+....|..++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999621 1234466777787754 899999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|..++.. .+.+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999999853 356899999999999999999999988 9999999999999999999999999987432111 12
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+..... .. .+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~----~~------~~~~----~ 216 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIR----VD------TPHY----P 216 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHH----hC------CCCC----C
Confidence 33467999999999999999999999999999999999999998643321 1111110 00 0111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH-HHHHHH
Q 036419 683 YPIVKRYINVALLCVQENAADRPTM-SEVISM 713 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~-~evl~~ 713 (754)
......+.+++.+||+.||++||++ +++++|
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 1234568899999999999999998 467644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.41 Aligned_cols=248 Identities=21% Similarity=0.261 Sum_probs=183.5
Q ss_pred hhcCccccceeccCCCcceeeccc------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCC
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKS 524 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gs 524 (754)
...+|++.+.||+|+||.||++.. .......|+.++++++||||+++++++.++...++||||+. ++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 142 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SD 142 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-Cc
Confidence 346799999999999999998432 12345679999999999999999999999999999999996 57
Q ss_pred hhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccccc
Q 036419 525 LDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTK 604 (754)
Q Consensus 525 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~ 604 (754)
|.+++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 143 l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~ 214 (357)
T PHA03209 143 LYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFL 214 (357)
T ss_pred HHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc---ccc
Confidence 7777743 3346899999999999999999999988 9999999999999999999999999997543221 123
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hh----HhHhhhhhhcc-----Cccc----
Q 036419 605 RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LT----LLGHAWNLWKD-----DRSW---- 670 (754)
Q Consensus 605 ~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~----~~~~~~~~~~~-----~~~~---- 670 (754)
...||..|+|||++.+..++.++|||||||++|||+++..++....... .. ...+....... ....
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 4568999999999999999999999999999999998766542221111 00 00000000000 0000
Q ss_pred -----cccC-------c--ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 671 -----ELMD-------P--KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 671 -----~l~d-------~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.+++ + .............+.+++.+||+.||++|||+.||++|
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000 0 00000011223456679999999999999999999987
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.86 Aligned_cols=241 Identities=31% Similarity=0.484 Sum_probs=193.2
Q ss_pred hhhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 456 AATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
...++|++.++||+|+||.||++ ....+++.+|++++++++||||+++++++......++||||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 34678999999999999999972 22356899999999999999999999999998999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.....
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999653 2346899999999999999999999988 99999999999999999999999999987653221
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
.. .....++..|+|||.+.+..++.++||||||+++++|++ |+.|+....... ...... ... .
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~---~~~----------~ 222 (261)
T cd05034 159 TA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VLEQVE---RGY----------R 222 (261)
T ss_pred hh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---cCC----------C
Confidence 11 112234568999999998899999999999999999998 888875432211 111110 000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
.......++.+.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01111224678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=296.53 Aligned_cols=240 Identities=26% Similarity=0.395 Sum_probs=190.4
Q ss_pred hcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
..+|++.+.||+|+||.||++. ....++.+|++++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3678899999999999999732 123567899999999999999999999887 7889
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999999643 335899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.............++..|+|||.+....++.++||||||+++||+++ |+.|+......+ +.... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~----~~~~~---- 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLL----EKGER---- 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHH----hCCCC----
Confidence 54322111222234568999999988899999999999999999998 999876543222 11111 00000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
..........+.+++.+||..+|++||++.++++.|+...
T Consensus 230 -----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 230 -----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0111112346789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.71 Aligned_cols=231 Identities=24% Similarity=0.397 Sum_probs=181.0
Q ss_pred eeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCC
Q 036419 466 KLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKS 524 (754)
Q Consensus 466 ~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gs 524 (754)
.||+|+||.||++. ...+++.+|++++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 48999999999621 11356889999999999999999999875 457899999999999
Q ss_pred hhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc-cc
Q 036419 525 LDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS-NT 603 (754)
Q Consensus 525 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~-~~ 603 (754)
|.+++.. ....+++..+..++.||++||.|||+++ ++||||||+|||++.++.+||+|||+++......... ..
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999854 2346899999999999999999999988 9999999999999999999999999998654332111 11
Q ss_pred cccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 604 KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 604 ~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
....++..|+|||++....++.++|||||||++||+++ |..|+......+ .... ...... ...+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~----~~~~~~---------~~~~ 220 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSF----IEQGKR---------LDCP 220 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHH----HHCCCC---------CCCC
Confidence 12233578999999988889999999999999999996 888875433221 1111 111100 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
....+.+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22356788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.10 Aligned_cols=235 Identities=26% Similarity=0.408 Sum_probs=190.9
Q ss_pred hcCccccceeccCCCcceeecc---------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
.++|++.+.||+|+||.||++. ...+++.+|+.++++++|+||+++++++......++||||+++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4678999999999999999621 1356889999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 85 GSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 99999996532 236899999999999999999999988 99999999999999999999999999987632211
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
....+..|+|||++....++.++||||||+++++|++ |..|+....... +..... .+. ....
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~----~~~---------~~~~ 220 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVE----KGY---------RMEA 220 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHh----cCC---------CCCC
Confidence 2334568999999988899999999999999999997 888875432211 111111 000 0011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 682 SYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
....++.+.+++.+||+.+|.+||++++|+++|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11235678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.12 Aligned_cols=233 Identities=24% Similarity=0.322 Sum_probs=188.2
Q ss_pred CccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 460 NFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
+|++.++||+|+||.||+.. ...+.+.+|++++++++||||+++++.+.++...++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 57889999999999998621 13467888999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999988542 3345889999999999999999999988 99999999999999999999999999986643221
Q ss_pred ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||........ . ..... .... .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~---~~~~~-~~~~---------~ 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--I---LKVCQ-GSYK---------P 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--H---HHHhc-CCCC---------C
Confidence 12235688999999999888999999999999999999999999864322111 1 11111 1000 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
........+.+++.+||+.||++||++.+|+..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=298.93 Aligned_cols=236 Identities=23% Similarity=0.356 Sum_probs=190.4
Q ss_pred hhcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
...+|++.+.||+|+||.||++. ...+.+.+|+.++++++|||++++++.+..+...++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 44689999999999999999732 124578899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999999843 34789999999999999999999988 9999999999999999999999999988654322
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
. ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......... ...... . +..
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~-----~~~~~~-~-----~~~- 236 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----LIATNG-T-----PEL- 236 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH-----HHhcCC-C-----CCC-
Confidence 1 1223468899999999998889999999999999999999999986433211110 000000 0 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.........+.+++.+||+.+|++||++.+|+++-
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 11123446688999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=307.02 Aligned_cols=225 Identities=24% Similarity=0.264 Sum_probs=176.4
Q ss_pred ceeccCCCcceeeccc---------------------cHHHHHHHHH-HHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSGQ---------------------GLEEFKNEIK-LTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~-il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||+||++.. ...++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999997321 1223444544 56789999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|..++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999998853 456899999999999999999999988 9999999999999999999999999987542211 12
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +... ... . .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~---i~~-~--------~~--~~~ 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--MYDN---ILN-K--------PL--RLK 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH--HHHH---HHc-C--------CC--CCC
Confidence 334679999999999999999999999999999999999999986433211 1110 000 0 00 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 036419 683 YPIVKRYINVALLCVQENAADRPTM----SEVISM 713 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~----~evl~~ 713 (754)
...+..+.+++.+||+.||.+||++ .+++++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 1235678899999999999999988 466544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.20 Aligned_cols=244 Identities=25% Similarity=0.371 Sum_probs=181.8
Q ss_pred CccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhh---ccCCeeeeeeeeee-----cC
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKL---QHRNLVRLLGCCVE-----QG 511 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l---~hpniv~l~~~~~~-----~~ 511 (754)
+|++.+.||+|+||.||++.. ....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588899999999999997321 123466788877766 69999999998864 34
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..++||||+++ +|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999985 8888885432 245899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh--------
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL-------- 663 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------- 663 (754)
+...... ......||..|+|||++.+..++.++|||||||++|+|++|++||........ +. .....
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~-~~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LG-KIFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HH-HHHHHhCCCChhh
Confidence 8764322 12345689999999999988999999999999999999999998864432211 10 00000
Q ss_pred hccCc-c-ccccCccc---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 664 WKDDR-S-WELMDPKL---QCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 664 ~~~~~-~-~~l~d~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
|.... . .....+.. .........+.+.+++.+||+.||++|||+.++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0 00000000 001112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=291.94 Aligned_cols=231 Identities=30% Similarity=0.430 Sum_probs=182.5
Q ss_pred ceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
++||+|+||.||++. ...+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999998621 12456889999999999999999999875 5568999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc-
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS- 601 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~- 601 (754)
++|.+++... +.+++..+..++.|++.+|.|||+.+ ++|+||||+|||++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999543 36899999999999999999999987 9999999999999999999999999998764332111
Q ss_pred cccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
......++..|+|||.+....++.++||||||+++|+|++ |..|+..... ........ ... .. .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~----~~~--~~-------~ 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLE----SGE--RL-------P 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHH----cCC--cC-------C
Confidence 1112234567999999988899999999999999999998 8888754332 11111111 110 00 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.....+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1112346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=292.48 Aligned_cols=240 Identities=28% Similarity=0.451 Sum_probs=191.2
Q ss_pred hhhcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
...++|++.++||+|+||.||++. ...+.+.+|++++++++|+||+++.+++.+ ...++||||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 345789999999999999999621 124578899999999999999999999887 778999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999999653 2345889999999999999999999987 99999999999999999999999999987643322
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
. ......++..|+|||++....++.++|+|||||++|+|++ |..|+...... ...... ..+..
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~----~~~~~--------- 221 (260)
T cd05073 158 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRAL----ERGYR--------- 221 (260)
T ss_pred c-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH----hCCCC---------
Confidence 1 1122345678999999988889999999999999999998 88887543221 111111 11100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
.......+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.76 Aligned_cols=233 Identities=23% Similarity=0.338 Sum_probs=196.8
Q ss_pred hcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
..-|.+.+.||+|.|..|-+++ .....+.+||+.|+-+||||||+||++...+..+|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3558888999999999886522 12356789999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc-CCCceEEeeccCccccCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD-SNMIPKISDFGLARMFGG 596 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld-~~~~~kl~DFgla~~~~~ 596 (754)
|.=++|+|.+||.++.. -+.++.+.+++.||+.|+.|+|+.. ++||||||+||.+- .-|.+||.|||++..+..
T Consensus 97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999976543 4899999999999999999999987 99999999999875 568999999999998866
Q ss_pred CcccccccccccccCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFS-IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
+. .....+|+..|-|||++.+..|+ +++||||||||||.|++|+.||+..+..+- +..++|-
T Consensus 172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------------LTmImDC 234 (864)
T KOG4717|consen 172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------------LTMIMDC 234 (864)
T ss_pred cc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------------hhhhhcc
Confidence 54 34568999999999999999886 889999999999999999999976554331 1223333
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. ..+...+.+|.+||..||+.||++|.+.+||+..-
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 32 23345788999999999999999999999998754
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=311.77 Aligned_cols=245 Identities=22% Similarity=0.328 Sum_probs=184.7
Q ss_pred CccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecC-----eeE
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG-----ENV 514 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~-----~~~ 514 (754)
+|++.++||+|+||.||++.. ..+++.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999997321 2356789999999999999999999998776 789
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 47777773 3356899999999999999999999988 999999999999999999999999999865
Q ss_pred CCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcc----
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS---- 669 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 669 (754)
..... .......++..|+|||++.+. .++.++|||||||++|||++|+.||........ .............
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHH
Confidence 43321 122335678999999998774 589999999999999999999999865432211 0000000000000
Q ss_pred ------cc-cc----Cc-ccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 670 ------WE-LM----DP-KLQ--CEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 670 ------~~-l~----d~-~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. +. .+ ... ........+.+.+++.+||+.||++|||+.++++|-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 00 00 00 000 001112356788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=291.02 Aligned_cols=234 Identities=24% Similarity=0.367 Sum_probs=190.3
Q ss_pred CccccceeccCCCcceeec--------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~--------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|++.+.||+|+||.||.. ....+++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999988751 22345688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++.... ...+++.++..++.|++++|.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999996532 356899999999999999999999987 99999999999999999999999999987644331
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
......|++.|+|||.+.+..++.++||||||+++++|++|..|+......+ .. .... .... .
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~--~~---~~~~-~~~~--------~- 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN--LV---VKIV-QGNY--------T- 219 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH--HH---HHHH-cCCC--------C-
Confidence 2234568999999999988889999999999999999999999975432211 11 1111 1100 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.........+.+++.+||+.+|++||++.++++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123456788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=290.88 Aligned_cols=236 Identities=26% Similarity=0.387 Sum_probs=178.9
Q ss_pred eeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCC
Q 036419 466 KLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKS 524 (754)
Q Consensus 466 ~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gs 524 (754)
.||+|+||.||++. ...+.+.+|+.+++.++||||+++++.+.+....++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 69999999999721 124578899999999999999999999999999999999999999
Q ss_pred hhhHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccc
Q 036419 525 LDSFLFDTTK-EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT 603 (754)
Q Consensus 525 L~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~ 603 (754)
|.+++..... ....++..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999965322 234677788899999999999999987 999999999999999999999999998653322222222
Q ss_pred cccccccCccccccccc-------CCCCcccchhhHHHHHHHHHhC-CCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 604 KRIVGTYGYMSPEYAIH-------GFFSIKSDVFSFGVLLLETLSS-KRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 604 ~~~~gt~~y~APE~~~~-------~~~s~ksDVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
....++..|+|||++.. ..++.++||||||+++|||+++ ..|+..... ....... ... ....+.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~---~~~-~~~~~~~~ 232 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNHV---IKD-QQVKLFKP 232 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---Hhh-cccccCCC
Confidence 34567889999998753 2457899999999999999975 455532221 1111111 111 11223333
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.... ...+.+.+++..|| .+|++||++++|++.|.
T Consensus 233 ~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3322 23466788999999 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=328.41 Aligned_cols=243 Identities=26% Similarity=0.351 Sum_probs=189.9
Q ss_pred cCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.++||+|+||.||++.. ..+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999997311 1356889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 518 EYLPNKSLDSFLFDTTK--------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 224567788999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcc----------------cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc
Q 036419 590 LARMFGGDEL----------------QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS 653 (754)
Q Consensus 590 la~~~~~~~~----------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~ 653 (754)
+++....... .......+||+.|||||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621100 011123579999999999999999999999999999999999999986532221
Q ss_pred hhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcc
Q 036419 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRP-TMSEVISMLTNE 717 (754)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 717 (754)
.... . .+.++... ......+..+.+++.+||+.||++|| +++++++.|+..
T Consensus 239 i~~~---------~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ISYR---------D---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhh---------h---hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1100 0 00011000 00113446688999999999999996 677788877654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.95 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=186.3
Q ss_pred CccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|++.++||+|++|.||++.. ..+.+.+|++++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 578899999999999997321 235688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
++ ++|.+++........+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 98 588888865444567899999999999999999999987 9999999999999999999999999998654321
Q ss_pred cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHh--Hhh----hhhhccCccc--
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLL--GHA----WNLWKDDRSW-- 670 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~--~~~----~~~~~~~~~~-- 670 (754)
.......++..|+|||++.+. .++.++||||||+++++|++|+.|+........... ... ...|......
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 112234578899999988654 578999999999999999999999864332111000 000 0000000000
Q ss_pred ------cccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 671 ------ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 671 ------~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
....... .......+.++.+++.+||+.||++|||+.+|+++
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 00011245677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=292.07 Aligned_cols=223 Identities=22% Similarity=0.347 Sum_probs=175.5
Q ss_pred ceeccCCCcceeeccc------------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 465 NKLGEGGFGPVYKSGQ------------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~------------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
+.||+|+||.||++.. ....+..|+.++.+++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999997420 1235678899999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc-------eEEee
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI-------PKISD 587 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~-------~kl~D 587 (754)
+||||+++++|..++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999998853 2345899999999999999999999987 999999999999987664 89999
Q ss_pred ccCccccCCCcccccccccccccCcccccccc-cCCCCcccchhhHHHHHHHHH-hCCCCCCcccCCchhHhHhhhhhhc
Q 036419 588 FGLARMFGGDELQSNTKRIVGTYGYMSPEYAI-HGFFSIKSDVFSFGVLLLETL-SSKRSTRFFNTNSLTLLGHAWNLWK 665 (754)
Q Consensus 588 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~ 665 (754)
||++...... ....++..|+|||.+. ...++.++|||||||++|||+ .|..|+......+. .....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~ 223 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------ERFYE 223 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH------HHHHh
Confidence 9998765322 2345788999999887 467899999999999999998 46666543221111 00111
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 666 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.. .. ...+..+.+.+++.+||+.||.+||++.+|+++|+
T Consensus 224 ~~--~~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQ--CM---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cC--cc---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 00 01122456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=296.56 Aligned_cols=236 Identities=25% Similarity=0.402 Sum_probs=187.2
Q ss_pred CccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecC
Q 036419 460 NFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 521 (754)
-|++.++||+|+||.||++. ...+.+.+|++++++++|||++++++++..+...++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 46888999999999999721 134568899999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~ 601 (754)
+++|..++.. ....+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 9999988754 2346899999999999999999999988 9999999999999999999999999997653321 1
Q ss_pred cccccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 602 NTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
......++..|+|||++. +..++.++|||||||++|+|++|+.|+........ .... .... . +.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~---~~~~-~-----~~ 227 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKI---AKSE-P-----PT 227 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHH---hhcC-C-----CC
Confidence 223456899999999884 34578899999999999999999999764332111 1000 0000 0 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
. ......+..+.+++.+||+.||.+||++.+++++--
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 228 L--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 0 011123467889999999999999999999988764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=296.65 Aligned_cols=236 Identities=26% Similarity=0.318 Sum_probs=186.8
Q ss_pred CccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
.|++.+.||+|+||.||++.. ..+.+.+|+.++++++|+|++++++.+.+++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377788999999999996211 12456789999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999885432 235889999999999999999999987 9999999999999999999999999997654322
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||......... ...........
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~~~~~~~~~---------- 221 (285)
T cd05630 157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKEVQ---------- 221 (285)
T ss_pred ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHHHhhhhhhh----------
Confidence 112346899999999999999999999999999999999999998653321100 00111110000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPT-----MSEVISML 714 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 714 (754)
..........+.+++.+||+.||++||| ++++++|-
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 0011123456889999999999999999 88998854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=306.69 Aligned_cols=246 Identities=21% Similarity=0.213 Sum_probs=183.8
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC-----
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG----- 511 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~----- 511 (754)
..++|++.+.||+|+||.||++. ...+++.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 35789999999999999999721 12456788999999999999999999986443
Q ss_pred -eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 512 -ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 512 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 57999999976 4555552 23788899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchh-------------H-
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLT-------------L- 656 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~-------------~- 656 (754)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..... .
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 98653321 223457899999999999999999999999999999999999998754321100 0
Q ss_pred ---hHhhhhhhccCc------cccccCcccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 657 ---LGHAWNLWKDDR------SWELMDPKLQ---CEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 657 ---~~~~~~~~~~~~------~~~l~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
............ ..++...... ........+.+.+++.+||+.||++|||+.|+++|-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000000000000 0000000000 001112346688999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=294.81 Aligned_cols=239 Identities=29% Similarity=0.407 Sum_probs=190.2
Q ss_pred cCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
++|++.+.||+|+||.||++.. ..+++.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 6788999999999999997321 2357899999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeec
Q 036419 515 LIYEYLPNKSLDSFLFDTTKE------GLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDF 588 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DF 588 (754)
+||||+++++|.+++...... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999654422 15899999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccC
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDD 667 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 667 (754)
|+++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... ....
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~----~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNR----LQAG 234 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHH----HHcC
Confidence 99875533221 12223456778999999988889999999999999999998 66776432211 11111 1111
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 668 RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 668 ~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
... .......+..+.+++.+||+.+|.+||++.+++++|.
T Consensus 235 ~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 110 0111234467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=295.72 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=190.3
Q ss_pred hhHhhhhcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeee-----
Q 036419 452 ASVSAATNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCV----- 508 (754)
Q Consensus 452 ~~~~~~~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~----- 508 (754)
..+..+.++|++.+.||+|+||.||++. ...+++.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 4456678899999999999999999721 1235678899999999 6999999999884
Q ss_pred ecCeeEEEEEecCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEee
Q 036419 509 EQGENVLIYEYLPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISD 587 (754)
Q Consensus 509 ~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~D 587 (754)
.+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEcc
Confidence 345689999999999999988643 23356889999999999999999999987 99999999999999999999999
Q ss_pred ccCccccCCCcccccccccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh
Q 036419 588 FGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH-----GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 588 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 662 (754)
||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+........ + ..
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~----~~ 240 (286)
T cd06638 168 FGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-L----FK 240 (286)
T ss_pred CCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-H----hh
Confidence 999987643221 1233568999999998753 4578999999999999999999999764332111 0 00
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
........+.++ ....+.+.+++.+||+.||++|||+.+|++++
T Consensus 241 -~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 -IPRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -ccccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000000011111 11245688999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=319.43 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=183.0
Q ss_pred hhcCccccceeccCCCcceeecc------------------------------------ccHHHHHHHHHHHHhhccCCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------------------------QGLEEFKNEIKLTAKLQHRNL 500 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------------------------~~~~~~~~Ev~il~~l~hpni 500 (754)
..++|++.++||+|+||+||+.. .....+++|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999621 012356789999999999999
Q ss_pred eeeeeeeeecCeeEEEEEecCCCChhhHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc
Q 036419 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK--EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD 578 (754)
Q Consensus 501 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld 578 (754)
+++++++.+.+..++|+|++.+ +|..++..... ........+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 9999999999999999999865 66666643221 223446677889999999999999988 99999999999999
Q ss_pred CCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCc-ccCCc-hhH
Q 036419 579 SNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRF-FNTNS-LTL 656 (754)
Q Consensus 579 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~-~~~~~-~~~ 656 (754)
.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..++.. ..... ..+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999987654322 112246799999999999999999999999999999999998754322 22111 111
Q ss_pred hHhhhhhh-ccC-------ccccccCcccC----CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 657 LGHAWNLW-KDD-------RSWELMDPKLQ----CE-----ASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 657 ~~~~~~~~-~~~-------~~~~l~d~~~~----~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.......- ... ...+.++.... .. ........+.+++.+||+.||++|||+.|+++|-
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 11110000 000 00000000000 00 0011234567889999999999999999999874
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=290.70 Aligned_cols=236 Identities=28% Similarity=0.486 Sum_probs=188.6
Q ss_pred cCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 459 NNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
.+|++.+.||+|+||.||++. ...+++.+|++++++++|||++++++++......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 468889999999999999732 1246789999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|.+++... .+.++++.+..++.|++.+|+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~- 157 (256)
T cd05112 84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS- 157 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc-
Confidence 9999998542 345889999999999999999999988 9999999999999999999999999998664332211
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
.....++..|+|||.+.+..++.++||||||+++|||++ |..|+....... .... .... .....+.
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~---~~~~---~~~~~~~----- 224 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVET---INAG---FRLYKPR----- 224 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHH---HhCC---CCCCCCC-----
Confidence 112335678999999998899999999999999999998 888875332211 1111 1000 0111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 682 SYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
..++.+.+++.+||+.+|++||++.+|+++|.
T Consensus 225 --~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 --LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=288.90 Aligned_cols=230 Identities=27% Similarity=0.385 Sum_probs=182.7
Q ss_pred ceeccCCCcceeeccc------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChh
Q 036419 465 NKLGEGGFGPVYKSGQ------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLD 526 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~ 526 (754)
++||+|+||.||++.. ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999997311 1346789999999999999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccccccc
Q 036419 527 SFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI 606 (754)
Q Consensus 527 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~ 606 (754)
+++... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 998542 345889999999999999999999988 999999999999999999999999999765432221 11122
Q ss_pred ccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHH
Q 036419 607 VGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPI 685 (754)
Q Consensus 607 ~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~ 685 (754)
.++..|+|||++....++.++||||||+++|+|++ |..||....... ...... ... ........
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~---~~~----------~~~~~~~~ 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVE---KGY----------RMSCPQKC 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHH---cCC----------CCCCCCCC
Confidence 34568999999988899999999999999999998 888875432211 111110 000 00111224
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 686 VKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 686 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
+..+.+++.+|++.+|++||++.++++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.74 Aligned_cols=237 Identities=24% Similarity=0.395 Sum_probs=187.4
Q ss_pred hcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
.++|++.++||+|+||.||++. .....+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 4588999999999999999732 1234578899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++.. .+.+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 999999999843 346899999999999999999999988 9999999999999999999999999997654321
Q ss_pred cccccccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 600 QSNTKRIVGTYGYMSPEYAI---HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
.......|+..|+|||++. ...++.++|||||||++|+|++|..|+....+.... .. ..... ...+.
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~----~~~~~----~~~~~ 230 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FL----MTKSN----FQPPK 230 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-Hh----hhccC----CCCCc
Confidence 1223457899999999874 456889999999999999999999987543321110 00 00000 00011
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
... ....++.+.+++.+||+.+|++||++++|++|
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 110 11234568899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.14 Aligned_cols=246 Identities=22% Similarity=0.245 Sum_probs=183.9
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec------
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ------ 510 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~------ 510 (754)
..++|++.+.||+|+||.||++. ...+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999721 1235677899999999999999999988643
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
...++||||+++ +|.+.+. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999976 5655553 23788999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchh--HhH----------
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLT--LLG---------- 658 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~--~~~---------- 658 (754)
++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||......... ...
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98654322 123457899999999999999999999999999999999999998654321100 000
Q ss_pred -----hhhhhhccC-ccc-----ccc-CcccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 659 -----HAWNLWKDD-RSW-----ELM-DPKLQ--CEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 659 -----~~~~~~~~~-~~~-----~l~-d~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......... ... ... +.... ..........+.+++.+||+.||++|||+.|+++|-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 000000000 000 000 00000 001112346788999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.25 Aligned_cols=220 Identities=23% Similarity=0.259 Sum_probs=173.0
Q ss_pred ceeccCCCcceeeccc---------------------cHHHHHHHH-HHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSGQ---------------------GLEEFKNEI-KLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev-~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||.||++.. ...++.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999997321 122344454 367889999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999988843 356889999999999999999999987 9999999999999999999999999987532221 12
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+... +... ... .. . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~---i~~-~~--------~--~~~ 216 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ--MYDN---ILH-KP--------L--QLP 216 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH--HHHH---Hhc-CC--------C--CCC
Confidence 334679999999999999899999999999999999999999986443211 1111 110 00 0 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMS 708 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~ 708 (754)
......+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 22345688999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=329.66 Aligned_cols=243 Identities=27% Similarity=0.403 Sum_probs=188.0
Q ss_pred hHhhhhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee--c
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE--Q 510 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~--~ 510 (754)
......++|++.++||+|+||.||++. .....+..|+.++++|+|||||++++++.+ .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 344556799999999999999999721 124568899999999999999999998854 4
Q ss_pred CeeEEEEEecCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CceeeCCCCCCceEEcC------
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYSR----LRVIHRDLKPSNILLDS------ 579 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~----~~iiH~Dlkp~NIlld~------ 579 (754)
..++|||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 56899999999999999996532 23569999999999999999999998542 34999999999999964
Q ss_pred -----------CCceEEeeccCccccCCCcccccccccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 036419 580 -----------NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH--GFFSIKSDVFSFGVLLLETLSSKRST 646 (754)
Q Consensus 580 -----------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSlGvil~elltg~~p~ 646 (754)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|..||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 3358999999998764332 1234579999999999864 45899999999999999999999998
Q ss_pred CcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 647 RFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
....... .+... .... +.+. ....+..+.+||..||+.+|.+||++.+++++
T Consensus 244 ~~~~~~~-qli~~----lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 244 HKANNFS-QLISE----LKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcCCcHH-HHHHH----HhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 6432211 11111 1110 0000 01124668899999999999999999999954
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.08 Aligned_cols=241 Identities=26% Similarity=0.408 Sum_probs=191.6
Q ss_pred hcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
.++|++.++||+|+||+||++. ...+.+.+|++++++++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 4678999999999999999721 124678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++.. .+.+++..+..++.|++.+|.|||+.. +++|+||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 9999999998843 346899999999999999999999742 3999999999999999999999999998754322
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc------hhHhHhhhhhhccCccccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS------LTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~l 672 (754)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ..............
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 1234578999999999988899999999999999999999999987543321 01111111111100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
.+.+ .....+..+.+++.+||+.||++|||+.||++++..
T Consensus 230 -~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 230 -PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred -CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 0111 111244678899999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=290.33 Aligned_cols=232 Identities=31% Similarity=0.431 Sum_probs=185.1
Q ss_pred ceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
++||+|++|.||++. ...+.+.+|++++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999732 224578899999999999999999999988 889999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc-c
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ-S 601 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~-~ 601 (754)
++|.+++.+... ..+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999966432 56899999999999999999999988 999999999999999999999999999877542211 1
Q ss_pred cccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
......++..|+|||.+....++.++|||||||++|||++ |..|+....... ...... .... .. .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~---~~~~--~~-------~ 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKID---KEGE--RL-------E 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---hcCC--cC-------C
Confidence 1223457789999999998899999999999999999998 999875332211 111111 0000 00 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.....+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=299.58 Aligned_cols=239 Identities=28% Similarity=0.425 Sum_probs=187.9
Q ss_pred hcCccccceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
.++|+..+.||+|+||.||++.. ...++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 46788899999999999997321 123678899999999999999999998654 567
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+|+||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998542 335889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ... ....+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~--~- 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPD----LLEKGER--L- 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHCCCC--C-
Confidence 54332222223445778999999998899999999999999999997 888875432111 111 1111100 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.........+.+++..||..+|++||++.+|+++|...
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 231 ------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00111235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=289.65 Aligned_cols=238 Identities=24% Similarity=0.400 Sum_probs=191.3
Q ss_pred hcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++..+...+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 4689999999999999999732 1356789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++... ...+++.++..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++..+.....
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999998543 246899999999999999999999987 99999999999999999999999999986643211
Q ss_pred cccccccccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHG---FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+........... .... .+..+.
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-----~~~~----~~~~~~ 225 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-----ISKS----NFPPPK 225 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhc----cCCCcc
Confidence 12235688899999998776 889999999999999999999999764332211110 0000 000011
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
. ......+..+.+++.+||+.+|.+|||+++|+.+
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1 1123456779999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=317.45 Aligned_cols=267 Identities=21% Similarity=0.270 Sum_probs=189.8
Q ss_pred hhhhcCccccceeccCCCcceeeccc-----------------cHHHHHHHHHHHHhhccC------Ceeeeeeeeeec-
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSGQ-----------------GLEEFKNEIKLTAKLQHR------NLVRLLGCCVEQ- 510 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~~-----------------~~~~~~~Ev~il~~l~hp------niv~l~~~~~~~- 510 (754)
...+++|++.++||+|+||+||++.. ...+++.|++++++++|. +++++++++..+
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 34568999999999999999998321 123567788888888654 488899888754
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCceEEcCCC--------
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY-SRLRVIHRDLKPSNILLDSNM-------- 581 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NIlld~~~-------- 581 (754)
.+.++|||++ +++|.+++.+ .+.+++..+..|+.||+.||.|||++ + ||||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccc
Confidence 5788999987 6788888853 35689999999999999999999984 6 99999999999998765
Q ss_pred --------ceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc
Q 036419 582 --------IPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS 653 (754)
Q Consensus 582 --------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~ 653 (754)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998864321 1235689999999999999999999999999999999999999986544322
Q ss_pred -hhHhHhh-----------------hhhhccC-ccccccCccc-----C--CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 036419 654 -LTLLGHA-----------------WNLWKDD-RSWELMDPKL-----Q--CEASYPIVKRYINVALLCVQENAADRPTM 707 (754)
Q Consensus 654 -~~~~~~~-----------------~~~~~~~-~~~~l~d~~~-----~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 707 (754)
....... ..++... ......++.. . ..........+++|+.+||+.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 1111000 0000000 0000000000 0 00001123567899999999999999999
Q ss_pred HHHHHHHhccccCCCCC-CCCCcccccc
Q 036419 708 SEVISMLTNEFVNLPSP-QQPGFSSLKK 734 (754)
Q Consensus 708 ~evl~~L~~~~~~~~~p-~~p~~~~~~~ 734 (754)
+|+++|---. ...+.. ..|.|+..+.
T Consensus 433 ~e~L~Hp~~~-~~~~~~~~~~~~~~~~~ 459 (467)
T PTZ00284 433 RQMTTHPYVL-KYYPECRQHPNYPDNRS 459 (467)
T ss_pred HHHhcCcccc-ccCCccccCCCCCCccc
Confidence 9999975432 222322 4466665443
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.69 Aligned_cols=221 Identities=24% Similarity=0.274 Sum_probs=173.5
Q ss_pred ceeccCCCcceeeccc---------------------cHHHHHHHHH-HHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSGQ---------------------GLEEFKNEIK-LTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~-il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||.||++.. ...++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999997321 1123334443 46778999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|.+++.. .+.+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999999953 345788899999999999999999988 9999999999999999999999999997543211 12
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... .. .. . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i---~~-~~--------~--~~~ 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYDNI---LN-KP--------L--QLK 216 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HHHHH---Hh-CC--------c--CCC
Confidence 334679999999999999999999999999999999999999986433211 11111 00 00 0 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHH
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMSE 709 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~e 709 (754)
......+.+++.+||+.||.+||++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 234567889999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=287.79 Aligned_cols=231 Identities=28% Similarity=0.420 Sum_probs=183.5
Q ss_pred ceeccCCCcceeeccc------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChh
Q 036419 465 NKLGEGGFGPVYKSGQ------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLD 526 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~ 526 (754)
++||+|+||.||++.. ..+++.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4799999999996221 2457889999999999999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccccccc
Q 036419 527 SFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI 606 (754)
Q Consensus 527 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~ 606 (754)
+++... ...+++..+..++.|++.+|.|||+++ ++||||||+|||++.++.+||+|||+++..............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 999543 235789999999999999999999988 999999999999999999999999999866432222222223
Q ss_pred ccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHH
Q 036419 607 VGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPI 685 (754)
Q Consensus 607 ~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~ 685 (754)
.++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ...... .. .........
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~~----~~---------~~~~~~~~~ 220 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERIE----SG---------YRMPAPQLC 220 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHHh----cC---------CCCCCCccC
Confidence 34667999999988899999999999999999998 777765433211 111110 00 000111123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 686 VKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 686 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
+..+.+++.+||+.+|++|||+.||++.|.
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=299.22 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=176.5
Q ss_pred cceeccCCCcceeeccc------------------cHHHHHHHHHHHHhhccCCeeeeeeeeee--cCeeEEEEEecCCC
Q 036419 464 ENKLGEGGFGPVYKSGQ------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE--QGENVLIYEYLPNK 523 (754)
Q Consensus 464 ~~~lG~G~fg~Vyk~~~------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~--~~~~~lV~E~~~~g 523 (754)
.++||+|+||.||++.. ....+.+|++++++++||||+++++++.. +...++||||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 46899999999998431 12467899999999999999999999853 5678899999876
Q ss_pred ChhhHhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE----cCCCceEEeeccCccc
Q 036419 524 SLDSFLFDT------TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL----DSNMIPKISDFGLARM 593 (754)
Q Consensus 524 sL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll----d~~~~~kl~DFgla~~ 593 (754)
+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 666666421 12235889999999999999999999988 9999999999999 5667999999999987
Q ss_pred cCCCccc-ccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCch-------hHhHhhhhh-
Q 036419 594 FGGDELQ-SNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-------TLLGHAWNL- 663 (754)
Q Consensus 594 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~- 663 (754)
....... .......||..|+|||++.+. .++.++|||||||++|||++|+.||........ .........
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 6543211 123345789999999998764 589999999999999999999999864432210 000000000
Q ss_pred -------hccCc----cccccC----cccC--------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 664 -------WKDDR----SWELMD----PKLQ--------CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 664 -------~~~~~----~~~l~d----~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
|.... ...+.. .... ..........+.+++.+||+.||.+|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 000000 0000 00011123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=290.94 Aligned_cols=223 Identities=24% Similarity=0.395 Sum_probs=176.1
Q ss_pred ceeccCCCcceeeccc-------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 465 NKLGEGGFGPVYKSGQ-------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~-------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+.||+|+||.||++.. ..+++..|+.++++++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 4699999999998421 124577899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc--------eEEeeccCc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI--------PKISDFGLA 591 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~--------~kl~DFgla 591 (754)
+++++|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999996432 35889999999999999999999988 999999999999987765 699999998
Q ss_pred cccCCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCC-CCCCcccCCchhHhHhhhhhhccCcc
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSK-RSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+........ .. .... +
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~~----~~~~-~- 221 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--LQ----FYED-R- 221 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--HH----HHHc-c-
Confidence 755322 234678899999998864 5899999999999999999995 44332221110 00 0000 0
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
. .........+.+++.+||+.||++|||++++++.|+
T Consensus 222 -----~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -----H----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----c----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 111123356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=288.73 Aligned_cols=236 Identities=23% Similarity=0.383 Sum_probs=191.7
Q ss_pred hcCccccceeccCCCcceeeccc----------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecC
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ----------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~----------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 521 (754)
.++|++.++||+|+||.||++.. ..+++.+|++++++++||||+++++++.++...++++||++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 46899999999999999997321 25679999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~ 601 (754)
+++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 82 AGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 9999999854 2356899999999999999999999988 99999999999999999999999999987654321
Q ss_pred cccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCC
Q 036419 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
......++..|+|||++.+..++.++||||||+++++|++|+.|+........... .... ..+.. ..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~~~~-----~~~~~--~~ 221 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------IPNK-----PPPTL--SD 221 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------hccC-----CCCCC--Cc
Confidence 12234578899999999888999999999999999999999999864332211100 0000 00000 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 682 SYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.......+.+++.+||+.||++|||+++|+++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 12244678999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=289.15 Aligned_cols=233 Identities=27% Similarity=0.410 Sum_probs=186.2
Q ss_pred cCccccceeccCCCcceeecc--------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCC
Q 036419 459 NNFGVENKLGEGGFGPVYKSG--------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKS 524 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~--------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gs 524 (754)
++|++.+.||+|+||.||++. ...+.+.+|+.++++++|||++++++++.++ ..++||||+++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 568899999999999999722 2345788999999999999999999998654 5799999999999
Q ss_pred hhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccccc
Q 036419 525 LDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTK 604 (754)
Q Consensus 525 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~ 604 (754)
|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..... ..
T Consensus 85 L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~ 155 (254)
T cd05083 85 LVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VD 155 (254)
T ss_pred HHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----CC
Confidence 999996532 345889999999999999999999987 999999999999999999999999999864322 11
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCH
Q 036419 605 RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASY 683 (754)
Q Consensus 605 ~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~ 683 (754)
....+..|+|||.+.+..++.++|+||||+++|+|++ |+.|+....... ..... .... ......
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~----~~~~---------~~~~~~ 220 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECV----EKGY---------RMEPPE 220 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHH----hCCC---------CCCCCC
Confidence 2234567999999988899999999999999999997 888875433221 11111 0110 001112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 684 PIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 684 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
..++.+.+++.+||+.+|++||++.+|++.|+.
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 235678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=302.18 Aligned_cols=230 Identities=23% Similarity=0.329 Sum_probs=182.1
Q ss_pred CccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~lV~ 517 (754)
+|++.+.||+|+||.||++. ...+.+..|+.++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47788999999999999721 12345677888888886 477888999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. .+.+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999999843 356899999999999999999999988 999999999999999999999999999854322
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .. . ..
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i---~~-~--------~~ 218 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQSI---ME-H--------NV 218 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHH---Hh-C--------CC
Confidence 11 1234569999999999999999999999999999999999999986543221 11111 10 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTM-----SEVISM 713 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 713 (754)
......+..+.+++.+||+.+|.+|++. .++.+|
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 0111234568899999999999999974 566665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=302.42 Aligned_cols=239 Identities=20% Similarity=0.254 Sum_probs=183.6
Q ss_pred cCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||.||++.. ..+.+++|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999997221 2345788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999999542 345899999999999999999999998 999999999999999999999999999765432
Q ss_pred cccccccccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIH-----GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
.. .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+ .............+
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-----~~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHKEHFQF 229 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-----HHHHHHcCCCcccC
Confidence 21 11223468999999999863 457899999999999999999999986432211 11111111111111
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCC--CCCCCHHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENA--ADRPTMSEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP--~~RPt~~evl~~L 714 (754)
. ......++.+.+++.+||..++ ..||++.++++|-
T Consensus 230 ~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 230 P------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred C------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 0 0111245567788888775543 4488999999984
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=302.79 Aligned_cols=238 Identities=19% Similarity=0.259 Sum_probs=183.6
Q ss_pred cCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.++||+|+||.||+... ..+.+..|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4789999999999999997221 1234778999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999642 346899999999999999999999988 999999999999999999999999999765332
Q ss_pred cccccccccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .............+
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-----~~~~i~~~~~~~~~ 229 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHKERFQF 229 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-----HHHHHhCCCccccC
Confidence 21 1123457999999999986 3468999999999999999999999986432211 11111111100000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAAD--RPTMSEVISM 713 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 713 (754)
+ ......++.+.+++.+|+..++++ |+++.++++|
T Consensus 230 --p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 --P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 001123566788888888655444 7899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=292.37 Aligned_cols=205 Identities=23% Similarity=0.352 Sum_probs=162.3
Q ss_pred HHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 036419 483 EEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562 (754)
Q Consensus 483 ~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~ 562 (754)
.++.+|++++++++||||+++++++.++...++||||+++++|..++.. ..+.+++..+..++.||++||.|||+.+
T Consensus 61 ~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~- 137 (274)
T cd05076 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN- 137 (274)
T ss_pred HHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC-
Confidence 4577889999999999999999999999999999999999999999854 2346889999999999999999999987
Q ss_pred CceeeCCCCCCceEEcCCC-------ceEEeeccCccccCCCcccccccccccccCccccccccc-CCCCcccchhhHHH
Q 036419 563 LRVIHRDLKPSNILLDSNM-------IPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGV 634 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~-------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGv 634 (754)
|+||||||+|||++..+ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+
T Consensus 138 --iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~ 209 (274)
T cd05076 138 --LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGT 209 (274)
T ss_pred --ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHH
Confidence 99999999999997643 3799999998654221 12356788999998876 56899999999999
Q ss_pred HHHHHH-hCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 635 LLLETL-SSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 635 il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
++|||+ +|..|+........ ... .... .... ......+.+++.+||+.+|++||++.+|++.
T Consensus 210 ~l~el~~~g~~p~~~~~~~~~--~~~----~~~~-------~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 210 TLLEICFDGEVPLKERTPSEK--ERF----YEKK-------HRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHhCCCCCccccChHHH--HHH----HHhc-------cCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 999995 68887754332211 100 0000 0000 1122468899999999999999999999998
Q ss_pred Hh
Q 036419 714 LT 715 (754)
Q Consensus 714 L~ 715 (754)
|+
T Consensus 273 L~ 274 (274)
T cd05076 273 LT 274 (274)
T ss_pred hC
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=288.57 Aligned_cols=241 Identities=26% Similarity=0.425 Sum_probs=193.2
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|++.+.||.|+||.||++. ...+.+.+|+++++.++|+|++++++.+..++..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 478999999999999999721 1356789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++........+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999966444456899999999999999999999988 99999999999999999999999999987654322
Q ss_pred c--ccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 600 Q--SNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 600 ~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
. .......|+..|+|||++... .++.++|+||||+++++|++|+.|+........ ... ..... .+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~----~~~~~------~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LML----TLQND------PPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHH----HhcCC------CCC
Confidence 1 122345688999999998877 789999999999999999999999864432211 110 00000 011
Q ss_pred cCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 677 LQCEA-SYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 677 ~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..... .....+.+.+++.+||+.||++||++.+|++|
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111 12345778899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=293.76 Aligned_cols=235 Identities=23% Similarity=0.287 Sum_probs=186.1
Q ss_pred CccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
.|+..+.||+|+||+||++.. ..+.+.+|++++++++|+|++++.+.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367788999999999997211 12346789999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999999886532 345899999999999999999999988 9999999999999999999999999997654321
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||........ ........ .... .
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~-~~~~------~--- 222 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRV-LETE------E--- 222 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhh-hccc------c---
Confidence 12235789999999999988999999999999999999999999864432211 01111000 0000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPT-----MSEVISM 713 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 713 (754)
.........+.+++..||+.||++||+ +.+++++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111123456789999999999999999 7788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=291.05 Aligned_cols=233 Identities=28% Similarity=0.453 Sum_probs=187.3
Q ss_pred CccccceeccCCCcceeeccc---------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ---------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~---------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
+|.+.+.||+|+||.||++.. ..+.+++|++++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999997311 12457889999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999953 345889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccc----ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc
Q 036419 593 MFGGDELQ----SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 593 ~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
........ .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ . ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~---~~~~---- 225 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--I---FKIG---- 225 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--H---HHHh----
Confidence 77532111 111234588899999999988899999999999999999999999864322111 0 0000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
....+ .......+.+.+++.+||+.||.+||++.+|+++
T Consensus 226 --~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 226 --ENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred --ccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00111 1112345678899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=290.42 Aligned_cols=241 Identities=27% Similarity=0.405 Sum_probs=186.5
Q ss_pred hhhhcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
+.+++++.....||+|+||.||++. ...+.+.+|++++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 4455666666799999999999732 1345788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC-CCceEEeeccCccccC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS-NMIPKISDFGLARMFG 595 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~-~~~~kl~DFgla~~~~ 595 (754)
+||+++++|.+++.........++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999965322212278888999999999999999987 999999999999986 6799999999998654
Q ss_pred CCcccccccccccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHG--FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.... ......|+..|+|||++.+. .++.++||||||+++|+|++|+.|+........... ... . .
T Consensus 161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-------~~~-~---~ 227 (268)
T cd06624 161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-------KVG-M---F 227 (268)
T ss_pred cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-------hhh-h---h
Confidence 3221 12234578999999998664 378999999999999999999999754322111100 000 0 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
...........+.+.+++.+||+.+|++|||+.+|+++
T Consensus 228 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 --KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00011122344678899999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=290.89 Aligned_cols=235 Identities=26% Similarity=0.415 Sum_probs=187.0
Q ss_pred CccccceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
+|++.+.||+|+||.||++.. ..+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999997211 124578899999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999954 245789999999999999999999988 99999999999999999999999999986532
Q ss_pred Cc----ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 597 DE----LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 597 ~~----~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
.. .........|+..|+|||++.+..++.++|||||||++|+|++|..||........... . ... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~--~---~~~----~~ 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY--I---GAH----RG 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH--h---hhc----cC
Confidence 11 11112335688999999999988999999999999999999999999864322111100 0 000 00
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..+. ......+.+.+++.+||+.+|++||++.+++++
T Consensus 226 ~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 226 LMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0011 112345678999999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=292.34 Aligned_cols=233 Identities=25% Similarity=0.394 Sum_probs=190.0
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|++.+.||.|+||.||++. .....+.+|++++++++|||++++.+++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 468889999999999999721 1245688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999999953 26899999999999999999999988 9999999999999999999999999998775432
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
.......++..|+|||++.+..++.++||||||+++|+|++|+.|+........ .... . .. ..+.+..
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~~~~---~-~~-----~~~~~~~ 220 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--LFLI---P-KN-----NPPSLEG 220 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--HHHh---h-hc-----CCCCCcc
Confidence 122345688899999999988899999999999999999999999864332111 0000 0 00 0111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...++.+.+++.+||+.+|++|||+++++++-
T Consensus 221 ---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 221 ---NKFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred ---cccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 11456788999999999999999999998864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=297.33 Aligned_cols=246 Identities=24% Similarity=0.306 Sum_probs=186.0
Q ss_pred cCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|++.++||+|+||.||++.. ....+.+|++++++++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5789999999999999997311 234677899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
++ ++|.+++... ...+++..+..++.||++||.|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 98 4888888543 345889999999999999999999988 99999999999999999999999999986532221
Q ss_pred cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh--------hhccC---
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN--------LWKDD--- 667 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~--- 667 (754)
......++..|+|||.+.+. .++.++|||||||++|+|++|+.||......+. ...... .|...
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ--LHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCChhhchhhhcc
Confidence 12234578899999988654 588999999999999999999999865433211 000000 01000
Q ss_pred -ccccccCcccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 668 -RSWELMDPKLQC----EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 668 -~~~~l~d~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.....-.+.... .........+.+++.+||+.||.+|||+.++++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000000000000 01112345688999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=301.84 Aligned_cols=239 Identities=19% Similarity=0.250 Sum_probs=184.9
Q ss_pred cCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.++||+|+||.||+... ..+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999997211 1234678899999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999642 346889999999999999999999988 999999999999999999999999999876443
Q ss_pred cccccccccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIH-----GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ . ............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~---~~~i~~~~~~~~- 228 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--T---YGKIMNHEERFQ- 228 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH--H---HHHHHcCCCccc-
Confidence 22 11223579999999998875 468899999999999999999999986432211 1 111111110000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAAD--RPTMSEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 714 (754)
+. ......++.+.+++.+|+..++++ |++++++++|.
T Consensus 229 ~p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 229 FP-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred CC-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 00 011123567888999998866544 56899998873
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=293.16 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=188.0
Q ss_pred cCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
++|++.+.||+|+||.||++.. ..+.+.+|++++++++|||++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4788999999999999997211 22457899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|..++.. ...+++..+..++.||+.+|.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999999887743 345899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhH--hHhh-------hhhhccCc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL--LGHA-------WNLWKDDR 668 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~--~~~~-------~~~~~~~~ 668 (754)
. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+... .... ...+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999999876 468999999999999999999999986544322110 0000 00010000
Q ss_pred c-ccccCcccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 669 S-WELMDPKLQCEA-----SYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 669 ~-~~l~d~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
. ..+..+...... .......+.+++.+||+.+|++||++.++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 000011111000 01235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=296.24 Aligned_cols=237 Identities=23% Similarity=0.336 Sum_probs=191.0
Q ss_pred hhhcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
...++|.+.++||+|+||.||++. ...+.+.+|+.++++++|||++++++++..+...++||
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 345789999999999999999732 23466789999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.+ ..+++.++..++.|++.+|.|||+.+ ++|+||||+|||++.++.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999999843 35789999999999999999999987 999999999999999999999999999865433
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.. ......+++.|+|||.+.+..++.++|||||||++|+|++|..||........... ..... ..
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~--------~~ 233 (297)
T cd06656 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG--------TP 233 (297)
T ss_pred cc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC--------CC
Confidence 21 12235688899999999998999999999999999999999999854332111000 00000 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...........+.+++.+||+.+|++||++.+|+++=
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (297)
T cd06656 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270 (297)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0011122446678999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=293.62 Aligned_cols=239 Identities=25% Similarity=0.419 Sum_probs=188.3
Q ss_pred hhcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
..+.|++.++||+|+||.||++. ...+.+.+|++++++++|||++++++++..+...++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 34679999999999999999721 134568889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|..++... ...+++..+..++.||+.+|.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 90 FCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred cCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 99999999887542 345899999999999999999999987 9999999999999999999999999987643221
Q ss_pred ccccccccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.......++..|+|||++. ...++.++|||||||++|+|++|..|+........ . ...... .
T Consensus 165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~----~~~~~~------~ 231 (292)
T cd06644 165 --QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-L----LKIAKS------E 231 (292)
T ss_pred --cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-H----HHHhcC------C
Confidence 1123456888999999885 34578899999999999999999999764332111 0 000000 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.+.. .........+.+++.+||+.+|++||++++++++--
T Consensus 232 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 232 PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000 111233456889999999999999999999988643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=296.29 Aligned_cols=237 Identities=22% Similarity=0.343 Sum_probs=191.3
Q ss_pred hhcCccccceeccCCCcceeec------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
..++|++.++||.|+||.||++ ....+.+.+|++++++++|||++++++++......++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 4467999999999999999962 1234678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|..++.. ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 97 YLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred ecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999998843 35899999999999999999999998 9999999999999999999999999988654332
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......... . ... ..... +
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~--~---~~~-~~~~~-----~- 235 (296)
T cd06655 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L---IAT-NGTPE-----L- 235 (296)
T ss_pred c--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H---HHh-cCCcc-----c-
Confidence 1 1223568899999999998889999999999999999999999986543221110 0 000 00000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.........+.+++.+||+.||.+||++.+|+++=-
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~ 271 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 011123456889999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=307.50 Aligned_cols=246 Identities=21% Similarity=0.236 Sum_probs=183.7
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec------
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ------ 510 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~------ 510 (754)
..++|++.+.||+|+||.||++. ...+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 35789999999999999998621 1235678899999999999999999987543
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
...++||||+++ +|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 66666632 3788899999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch--hHhH-------hh-
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL--TLLG-------HA- 660 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~--~~~~-------~~- 660 (754)
++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+.... .... ..
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98654322 12345789999999999999999999999999999999999999865432110 0000 00
Q ss_pred -------hhhhccCcc------ccccCccc---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 661 -------WNLWKDDRS------WELMDPKL---QCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 661 -------~~~~~~~~~------~~l~d~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......... .++..... ...........+.+++.+||+.||++|||+.++++|-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000000000 00000000 0001111345688999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=299.81 Aligned_cols=248 Identities=17% Similarity=0.226 Sum_probs=180.6
Q ss_pred ccceeccC--CCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 463 VENKLGEG--GFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 463 ~~~~lG~G--~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
+.++||+| +|++||+.. ...+.+++|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 678898721 12245778999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc-
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL- 599 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~- 599 (754)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999996432 234899999999999999999999988 99999999999999999999999987654321110
Q ss_pred ----cccccccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhh---hhhhcc----
Q 036419 600 ----QSNTKRIVGTYGYMSPEYAIH--GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA---WNLWKD---- 666 (754)
Q Consensus 600 ----~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~---- 666 (754)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||.............. ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 001122356778999999876 4689999999999999999999999864332211100000 000000
Q ss_pred -----------CccccccC--------c----ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 667 -----------DRSWELMD--------P----KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 667 -----------~~~~~l~d--------~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.......+ + .............+.+++.+||+.||++|||+++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 00000000 0 000011122456789999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=288.37 Aligned_cols=233 Identities=23% Similarity=0.347 Sum_probs=187.1
Q ss_pred CccccceeccCCCcceeec--------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeee-cCeeEEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVE-QGENVLIYE 518 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~--------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~-~~~~~lV~E 518 (754)
+|++.+.||+|++|.||++ ....+.+.+|++++++++|||++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999962 1223567889999999999999999998764 446789999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++... ....+++.++..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999653 2345899999999999999999999988 9999999999999999999999999998764322
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
.......+++.|+|||++.+..++.++||||||+++++|++|+.|+...+.... ..... .+..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-----~~~~~-~~~~--------- 219 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-----VYRII-EGKL--------- 219 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-----HHHHH-hcCC---------
Confidence 122345688999999999999999999999999999999999998764322111 11111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..........+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01122345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=340.79 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=198.7
Q ss_pred hcCccccceeccCCCcceeecccc--------------HHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCC
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQG--------------LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNK 523 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~~--------------~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 523 (754)
...|...+.||+|+||.||++... ......|++++++++|||||+++++|.++...++||||+++|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g 768 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence 456778889999999999984321 122356799999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccc
Q 036419 524 SLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT 603 (754)
Q Consensus 524 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~ 603 (754)
+|.+++. .++|..+.+|+.||++||+|||..+..+|+||||||+||+++.++.+++. |+.+......
T Consensus 769 ~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------ 835 (968)
T PLN00113 769 NLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------ 835 (968)
T ss_pred cHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------
Confidence 9999994 28899999999999999999997655679999999999999999888875 6665433211
Q ss_pred cccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC--CC
Q 036419 604 KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC--EA 681 (754)
Q Consensus 604 ~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~--~~ 681 (754)
....||..|||||++.+..++.|+|||||||++|||++|+.|+............+.............+|+.+.. ..
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 1236789999999999999999999999999999999999998543333334445554444444444555655533 23
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 682 SYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
...+..++.+++.+||+.||++||||+||+++|+...
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 3456678899999999999999999999999998763
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=289.42 Aligned_cols=234 Identities=28% Similarity=0.408 Sum_probs=179.2
Q ss_pred ceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeee-ecCeeEEEEEecC
Q 036419 465 NKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCV-EQGENVLIYEYLP 521 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~-~~~~~~lV~E~~~ 521 (754)
+.||+|+||.||++. ...+.+.+|+.+++.++||||+++++++. .+...++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999621 12356788999999999999999999875 4556889999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc-
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ- 600 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~- 600 (754)
+++|.+++... ...+++..+..++.||++||.|||+.+ ++||||||+|||+++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999999643 234678888999999999999999987 999999999999999999999999999865432211
Q ss_pred -ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCC-CCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 601 -SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKR-STRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 601 -~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
.......++..|+|||.+.+..++.++||||||+++|||++|.. |+.... ........ ......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~---~~~~~~--------- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYL---LQGRRL--------- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH---hcCCCC---------
Confidence 11123456778999999988899999999999999999999654 443221 11111111 111100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
......++.+.+++.+||+.+|++||++.+|++.|+...
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001112456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.45 Aligned_cols=220 Identities=22% Similarity=0.250 Sum_probs=173.6
Q ss_pred ceeccCCCcceeeccc---------------------cHHHHHHHHH-HHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSGQ---------------------GLEEFKNEIK-LTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~-il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||.||++.. ...++..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999997211 1234455554 46778999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|..++. ....+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 99998884 3456899999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..... .. . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~---~~~~~-~~--------~--~~~ 216 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--MY---DNILH-KP--------L--VLR 216 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--HH---HHHHc-CC--------c--cCC
Confidence 334679999999999999999999999999999999999999986433221 11 11110 00 0 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMS 708 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~ 708 (754)
......+.+++.+||+.+|.+||++.
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 12345678999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=290.52 Aligned_cols=238 Identities=24% Similarity=0.367 Sum_probs=188.6
Q ss_pred hcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.++|.+.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568889999999999999721 123568899999999999999999998865 55789
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999999543 235899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
...... .....++..|+|||.+....++.++||||||+++|||++ |..||......+ ..... ......
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~---~~~~~~----- 227 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRI---ENGERL----- 227 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHH---HcCCcC-----
Confidence 432211 112334568999999988889999999999999999986 998875443221 11111 011100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
......+..+.+++.+|+..+|.+|||+.++++.|+..
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01122346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=293.21 Aligned_cols=232 Identities=26% Similarity=0.400 Sum_probs=188.0
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+.|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 457778899999999999731 1234688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++.. +.+++..+..++.||++|+.|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999998842 45889999999999999999999987 99999999999999999999999999987643321
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
......|+..|+|||++.+..++.++||||||++++||++|+.|+......... . ..... ..+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~----~~~~~-----~~~---- 219 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL--F----LIPKN-----SPP---- 219 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH--h----hhhcC-----CCC----
Confidence 122346788999999999889999999999999999999999987533221110 0 00000 011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......+..+.+++.+||+.+|++||++.+|+++-
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 11123456788999999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=292.52 Aligned_cols=238 Identities=23% Similarity=0.379 Sum_probs=188.2
Q ss_pred cCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++.+..+...++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 3688999999999999997221 135688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|..++........+++..+..++.||+.||.|||+.. +|+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999999865433457899999999999999999999742 39999999999999999999999999998653321
Q ss_pred cccccccccccCcccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHG------FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~------~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||........ ...... +.
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~---------~~ 223 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--FAQLSA---------IV 223 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--HHHHHH---------Hh
Confidence 2234688899999988544 358899999999999999999999854322111 101000 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+.. .........+.+.+++.+||+.+|++||++.+++.+-
T Consensus 224 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 224 DGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred hcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 100 0111223567788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=292.60 Aligned_cols=244 Identities=25% Similarity=0.371 Sum_probs=189.8
Q ss_pred chhhHhhhhcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeee--
Q 036419 450 SLASVSAATNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVE-- 509 (754)
Q Consensus 450 ~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~-- 509 (754)
++.++..+.+.|++.++||+|+||.||++. ....++..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 344555677899999999999999999722 2345788899999999 69999999999853
Q ss_pred ----cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEE
Q 036419 510 ----QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKI 585 (754)
Q Consensus 510 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl 585 (754)
....++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 467899999999999999986532 345888899999999999999999988 999999999999999999999
Q ss_pred eeccCccccCCCcccccccccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhh
Q 036419 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA 660 (754)
Q Consensus 586 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 660 (754)
+|||++....... .......|+..|+|||++. ...++.++|||||||++|||++|..||..........
T Consensus 163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---- 236 (282)
T cd06636 163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---- 236 (282)
T ss_pred eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----
Confidence 9999988653221 1223456899999999876 3468889999999999999999999975432211100
Q ss_pred hhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 661 WNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 661 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
. ..............+..+.+++.+||+.||.+||++.+|+++
T Consensus 237 -~---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 -L---------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -h---------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 000000001111244678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=304.32 Aligned_cols=244 Identities=21% Similarity=0.293 Sum_probs=182.9
Q ss_pred hhhcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeec-----
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ----- 510 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~----- 510 (754)
...++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999997311 234577899999999999999999987543
Q ss_pred -CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 511 -GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 511 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
...++++|++ +++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 4568999987 778988773 345899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc--
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD-- 666 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 666 (754)
+++..... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..........
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 236 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTPS 236 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence 99865432 234578999999999877 5789999999999999999999999864332110 0000000000
Q ss_pred ---------CccccccCc--ccCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 667 ---------DRSWELMDP--KLQCE----ASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 667 ---------~~~~~l~d~--~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......+.. ..... ......+.+.+++.+||+.||++|||+.++++|-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 000000000 00000 0001224578999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.91 Aligned_cols=239 Identities=22% Similarity=0.375 Sum_probs=185.2
Q ss_pred ccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC------
Q 036419 461 FGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG------ 511 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~------ 511 (754)
|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5678899999999999632 12346789999999999999999999886542
Q ss_pred eeEEEEEecCCCChhhHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeec
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTT---KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDF 588 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DF 588 (754)
..++++||+++++|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875432 1235789999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccC
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDD 667 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 667 (754)
|+++...............++..|++||.+....++.++||||||+++|+|++ |+.|+...... ....... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~---~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLI---KGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHH---cCC
Confidence 99987644332222223445678999999988889999999999999999999 77776533221 1111110 110
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 668 RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 668 ~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.. .......+.+.+++.+||+.+|++||++.+|++.|++.
T Consensus 233 ~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 01112346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=288.88 Aligned_cols=234 Identities=27% Similarity=0.426 Sum_probs=181.7
Q ss_pred cCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee--cCee
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE--QGEN 513 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~--~~~~ 513 (754)
.+|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478899999999999999721 113457889999999999999999998875 3567
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++++||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999953 345889999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCcc-cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 594 FGGDEL-QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 594 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
+..... ........++..|+|||++.+..++.++|||||||++|||++|+.||......... ..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~-----~~~~~-----~~ 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI-----FKIAT-----QP 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH-----HHHhc-----CC
Confidence 543211 11122356888999999999888999999999999999999999998643221110 00000 00
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..+. ......+.+.+++ .||..+|++||++++|++|
T Consensus 226 ~~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 TNPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0111 1122345566666 6888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=289.45 Aligned_cols=233 Identities=24% Similarity=0.378 Sum_probs=190.3
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
..|+..++||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 467788999999999999732 1245688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++.. +.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999999843 45889999999999999999999987 99999999999999999999999999987644321
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
......++..|+|||++.+..++.++|||||||++|||++|..|+.......... ........
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---------------~~~~~~~~ 219 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF---------------LIPKNNPP 219 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh---------------hhhcCCCC
Confidence 1223467889999999988889999999999999999999999975433221100 00001111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
......+..+.+++.+||+.+|++||++.+++++--
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 222345677899999999999999999999988753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=283.65 Aligned_cols=236 Identities=22% Similarity=0.373 Sum_probs=198.1
Q ss_pred hhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
..+-|.++++||+|+||.|||+ ..+++++.+|+.|+++.+.|++|++++.+-....+++|||||
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3456889999999999999982 346789999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
..|++.++++- .++++++.++..+++..++||+|||... -||||||..|||++-+|++||+|||.|-.+....
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-- 183 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-- 183 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence 99999999964 4567999999999999999999999976 8999999999999999999999999998775443
Q ss_pred ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
.....+.||+.|||||++..-.|..++||||||+...||..|++|+..-.+-. ...++.......
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------------AIFMIPT~PPPT 248 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------------AIFMIPTKPPPT 248 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------------eeEeccCCCCCC
Confidence 23346789999999999999999999999999999999999999975332211 111111111111
Q ss_pred C--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 681 A--SYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 681 ~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+ +..-+.++.+++++||.++|++|-|+.++++|-
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 1 223457789999999999999999999998875
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=285.54 Aligned_cols=222 Identities=26% Similarity=0.442 Sum_probs=175.8
Q ss_pred ceeccCCCcceeeccc---------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 465 NKLGEGGFGPVYKSGQ---------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~---------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
+.||+|+||.||++.. ....+.+|++++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 4689999999986111 14567889999999999999999999988 7789999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC-------ceEEeeccC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM-------IPKISDFGL 590 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~-------~~kl~DFgl 590 (754)
||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 9999999999996532 26899999999999999999999987 99999999999999887 799999999
Q ss_pred ccccCCCcccccccccccccCcccccccccC--CCCcccchhhHHHHHHHHHhC-CCCCCcccCCchhHhHhhhhhhccC
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHG--FFSIKSDVFSFGVLLLETLSS-KRSTRFFNTNSLTLLGHAWNLWKDD 667 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 667 (754)
+..... .....++..|+|||++... .++.++||||||+++|+|++| ..|+........ .. .+...
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--~~----~~~~~ 222 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--ER----FYQDQ 222 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH--HH----HHhcC
Confidence 986543 1234567789999998876 789999999999999999995 555543321110 00 01000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 668 RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 668 ~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
. .. ..+....+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 223 ~-------~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H-------RL----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C-------CC----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 0011167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=291.23 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=190.4
Q ss_pred hhhHhhhhcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeec--
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQ-- 510 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~-- 510 (754)
+.++..+.++|++.+.||+|+||.||++. ...+.+.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 34555678899999999999999999721 1235678899999999 799999999998754
Q ss_pred ---CeeEEEEEecCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEe
Q 036419 511 ---GENVLIYEYLPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKIS 586 (754)
Q Consensus 511 ---~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~ 586 (754)
...++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 35899999999999999886432 3356899999999999999999999987 9999999999999999999999
Q ss_pred eccCccccCCCcccccccccccccCcccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhh
Q 036419 587 DFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG-----FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW 661 (754)
Q Consensus 587 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 661 (754)
|||++......... .....|+..|+|||.+... .++.++|||||||++|||++|+.|+........ +.
T Consensus 171 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~---- 243 (291)
T cd06639 171 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LF---- 243 (291)
T ss_pred ecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HH----
Confidence 99999876433221 2235688999999987643 368999999999999999999999764322111 11
Q ss_pred hhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 662 NLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 662 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.. .......+.+ .......+.+++.+||+.+|++||++.++++|
T Consensus 244 ~~-~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KI-PRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HH-hcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 0111111111 11233568999999999999999999999886
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=288.38 Aligned_cols=238 Identities=26% Similarity=0.401 Sum_probs=187.2
Q ss_pred CccccceeccCCCcceeeccc----------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecC
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ----------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG 511 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~----------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~ 511 (754)
+|.+.+.||+|+||.||++.. ..+.+.+|++++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999997311 0235778999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..++||||+++++|.+++... +.+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999543 56899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcc
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHGF--FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
+...............|+..|+|||.+.... ++.++||||||++++++++|..|+....... ......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~-~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AMFKLGNKR-S 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HHHHhhccc-c
Confidence 8654322222233456889999999987654 8999999999999999999999974322111 011111110 0
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.+..........+..+.+++.+||+.+|++||++.+|++|
T Consensus 230 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 ----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0111111122345778999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=291.73 Aligned_cols=238 Identities=26% Similarity=0.413 Sum_probs=189.1
Q ss_pred hhcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
..++|++.++||+|+||.||++. ...+.+.+|++++++++|||++++++.+..+...++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 35679999999999999999732 134568899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++... ...+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 83 FCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred ccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999998542 345899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccccccccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
. ......++..|+|||++. ...++.++||||||+++|+|++|+.|+........ .... ....
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~~~~----- 224 (280)
T cd06611 158 Q--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKI----LKSE----- 224 (280)
T ss_pred c--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHH----hcCC-----
Confidence 1 122456889999999875 34578899999999999999999999864432111 1000 0000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.+.+. ........+.+++..||+.+|.+||++.+|+++-
T Consensus 225 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 225 PPTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred CCCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 01110 1112345688999999999999999999998873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.74 Aligned_cols=240 Identities=27% Similarity=0.412 Sum_probs=189.0
Q ss_pred hhhcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecC------
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQG------ 511 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~------ 511 (754)
.++++|++.+.||+|+||.||++. ...+.+.+|+.+++++ +||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 467899999999999999999732 1346789999999999 6999999999997644
Q ss_pred eeEEEEEecCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999986532 2457899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhc
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIH-----GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWK 665 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 665 (754)
+....... .......|+..|+|||++.. ..++.++|||||||++|+|++|..||........ .. ...
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~- 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LF----KIP- 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HH----Hhh-
Confidence 98654322 12234568899999998753 3578899999999999999999999853322111 00 000
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 666 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
... .+.. .......+.+.+++.+||..||++|||+.+|+++
T Consensus 232 ~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000 0111 1112245678999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.33 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=189.0
Q ss_pred cCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
++|++.++||+|+||.||++. ...+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 468999999999999999721 123568899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|++++.+..++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9999888776632 345899999999999999999999988 9999999999999999999999999998765443
Q ss_pred ccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHh-Hhh--------hhhhccCc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLL-GHA--------WNLWKDDR 668 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~-~~~--------~~~~~~~~ 668 (754)
. .......++..|+|||++... .++.++||||||+++|+|++|+.|+......+.... ... ...+....
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 122345678899999999888 889999999999999999999998864432211000 000 00000000
Q ss_pred cc---cccCccc----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 669 SW---ELMDPKL----QCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 669 ~~---~l~d~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.. ++.+... ........+..+.+++.+||+.+|++||++++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 0000000 000111236779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=302.66 Aligned_cols=246 Identities=23% Similarity=0.299 Sum_probs=188.9
Q ss_pred CccccceeccCCCcceeeccc-----------------cHHHHHHHHHHHHhhc-c-----CCeeeeeeeeeecCeeEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ-----------------GLEEFKNEIKLTAKLQ-H-----RNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~-----------------~~~~~~~Ev~il~~l~-h-----pniv~l~~~~~~~~~~~lV 516 (754)
+|.+.+.||+|.||.|.|+.+ -..+...|++||..|+ | -|+|+++++|...++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 789999999999999987321 2345677999999997 4 3899999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC--ceEEeeccCcccc
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM--IPKISDFGLARMF 594 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~--~~kl~DFgla~~~ 594 (754)
+|.+.. +|.++|...... .++...++.|+.||+.||..||+.+ |||+||||+||||.+.. .+||+|||.|...
T Consensus 267 fELL~~-NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ehhhhh-hHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 998855 999999775544 4999999999999999999999988 99999999999997543 7999999999976
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch-hHh------------Hhh-
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-TLL------------GHA- 660 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~------------~~~- 660 (754)
..... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.+..+.+. ..+ ..+
T Consensus 342 ~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 54322 45678899999999999999999999999999999999888776554331 111 000
Q ss_pred --hhhhcc-Cccc------c-----------------ccCcccC-C------CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 036419 661 --WNLWKD-DRSW------E-----------------LMDPKLQ-C------EASYPIVKRYINVALLCVQENAADRPTM 707 (754)
Q Consensus 661 --~~~~~~-~~~~------~-----------------l~d~~~~-~------~~~~~~~~~l~~li~~cl~~dP~~RPt~ 707 (754)
.+++.. .... + ..+.... . .......+.+++++++||+.||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 011111 0000 0 0000000 0 0011234668999999999999999999
Q ss_pred HHHHHHHh
Q 036419 708 SEVISMLT 715 (754)
Q Consensus 708 ~evl~~L~ 715 (754)
.+.++|--
T Consensus 497 ~qal~Hpf 504 (586)
T KOG0667|consen 497 AQALNHPF 504 (586)
T ss_pred HHHhcCcc
Confidence 99999864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.79 Aligned_cols=246 Identities=27% Similarity=0.452 Sum_probs=200.5
Q ss_pred hHhhhhcCccccceeccCCCcceee-----------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk-----------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.++....+..+.++||-|.||.||. .....++|.+|..+|+.++|||+|+|+++|..+-..||
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 3444455666778999999999995 23357899999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|.|||..|+|.+||.+..+ ..++....+.++.||..|+.||..+. +|||||...|+|+.++..+||+||||++++.
T Consensus 341 iTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 9999999999999977544 35777788899999999999999988 9999999999999999999999999999998
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.+.+..... ..=.+.|.|||-+.-..++.|+|||+|||+||||.| |..|+.+-+ ...++. ++.
T Consensus 417 gDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY~---------LLE 480 (1157)
T KOG4278|consen 417 GDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYG---------LLE 480 (1157)
T ss_pred CCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHH---------HHh
Confidence 776544332 223568999999999999999999999999999987 444543322 122222 233
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
..........+++.+.+||+.||+++|.+||++.|+-+.+|..+
T Consensus 481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 33333333446678999999999999999999999999988644
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.44 Aligned_cols=237 Identities=26% Similarity=0.415 Sum_probs=186.9
Q ss_pred CccccceeccCCCcceeeccc-----------------------------cHHHHHHHHHHHHh-hccCCeeeeeeeeee
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ-----------------------------GLEEFKNEIKLTAK-LQHRNLVRLLGCCVE 509 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~-----------------------------~~~~~~~Ev~il~~-l~hpniv~l~~~~~~ 509 (754)
+|++.+.||+|+||.||++.. ...++.+|++++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 478889999999999997221 12346678888865 799999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeec
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDF 588 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DF 588 (754)
++..++||||+++++|.+++... .....+++..++.++.|++.+|.|||+.. +++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988542 23356899999999999999999999632 3999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
|++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ..... ....
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--~~~~~----~~~~ 229 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--LATKI----VEAV 229 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--HHHHH----hhcc
Confidence 9998764432 2334568899999999998889999999999999999999999875332111 11100 0010
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
. .+ .........+.+++.+||+.||++||++.||..+|+
T Consensus 230 ~----~~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 Y----EP----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred C----Cc----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 00 001123467889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=293.09 Aligned_cols=247 Identities=22% Similarity=0.343 Sum_probs=186.9
Q ss_pred cCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
++|++.++||+|+||.||++.. ..+.+.+|++++++++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688999999999999997221 23467899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|..++.. ...+++.++..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887743 234899999999999999999999987 9999999999999999999999999998764432
Q ss_pred ccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCch--hHhHhhh-------hhhccCc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL--TLLGHAW-------NLWKDDR 668 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~-------~~~~~~~ 668 (754)
. ......++..|+|||++.+ ..++.++||||||++++||++|++|+......+. ....... ..+....
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 1 1233567899999998875 4578999999999999999999988754322110 0000000 0000000
Q ss_pred cc-cccCcccCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 669 SW-ELMDPKLQC-----EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 669 ~~-~l~d~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.. ....+.... ......+..+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 000000000 0011345679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=292.64 Aligned_cols=245 Identities=25% Similarity=0.324 Sum_probs=183.2
Q ss_pred CccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|++.++||+|+||.||++.. ....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588899999999999997321 124577899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++ +|.+++... .+.+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 975 777776432 346899999999999999999999988 9999999999999999999999999998654322
Q ss_pred cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc------cccc
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR------SWEL 672 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~l 672 (754)
.......++..|+|||++.+. .++.++|||||||++|+|++|+.|+.........+. .......... ..+.
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHH-HHHHHhCCCChHHhHHhhhc
Confidence 112234678899999988765 479999999999999999999988532222111111 0000000000 0000
Q ss_pred cCc----ccC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 673 MDP----KLQ-----CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 673 ~d~----~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.+. ... ........+.+.+++.+||+.||.+|||++++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 000 01112245678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=301.14 Aligned_cols=228 Identities=29% Similarity=0.487 Sum_probs=187.9
Q ss_pred eeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChhh
Q 036419 466 KLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDS 527 (754)
Q Consensus 466 ~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~ 527 (754)
.||+|.||+||-++ ...+-+..||.+-++|+|.|||+++|.+.+++..-+.||-+|||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999632 234557889999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc-CCCceEEeeccCccccCCCccccccc
Q 036419 528 FLFDTTKEGLL--GWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD-SNMIPKISDFGLARMFGGDELQSNTK 604 (754)
Q Consensus 528 ~l~~~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld-~~~~~kl~DFgla~~~~~~~~~~~~~ 604 (754)
++.. +=+++ ++.++--+.+||++||.|||+.. |+|||||-+||||+ -.|.+||+|||-++.+..- ...+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 9953 33455 78888889999999999999998 99999999999996 5689999999999987543 34456
Q ss_pred ccccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 605 RIVGTYGYMSPEYAIHG--FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 605 ~~~gt~~y~APE~~~~~--~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.+.||..|||||++-.+ .|+.++|||||||.+.||.||++||.........+ ++-+. -....+.+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-------FkVGm------yKvHP~iP 801 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-------FKVGM------YKVHPPIP 801 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-------hhhcc------eecCCCCc
Confidence 78999999999999766 69999999999999999999999986544322111 11110 01123345
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.+.+.+...+|++|+..||.+||+++++++-
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 5678899999999999999999999999863
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=303.34 Aligned_cols=224 Identities=23% Similarity=0.301 Sum_probs=173.8
Q ss_pred eccCCCcceeeccc---------------------cHHHHHHHHHHHHhh---ccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 467 LGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKL---QHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 467 lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l---~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
||+|+||.||++.. ....+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999997321 112334566666655 699999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|..++.. .+.+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999998843 456899999999999999999999998 9999999999999999999999999997543222 12
Q ss_pred ccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
.....||..|+|||++.+. .++.++|||||||++|+|++|+.||....... ..... . .... .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--~~~~i---~-~~~~------~~~--- 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--MYRNI---A-FGKV------RFP--- 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--HHHHH---H-cCCC------CCC---
Confidence 3346799999999998765 58999999999999999999999986432211 11110 0 0000 000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 036419 682 SYPIVKRYINVALLCVQENAADRP----TMSEVISM 713 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RP----t~~evl~~ 713 (754)
.....+.+.+++.+||+.||++|| ++.++++|
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 112346778999999999999998 67777775
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=285.01 Aligned_cols=233 Identities=23% Similarity=0.351 Sum_probs=188.2
Q ss_pred CccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|++.++||+|+||.||+.. ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 58889999999999999621 1235788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++... ....+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988542 2235789999999999999999999987 99999999999999999999999999987644321
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
......|+..|+|||++.+..++.++|||||||++++|++|+.|+......+ . ........ . .
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~--~---~~~~~~~~-~---------~ 219 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN--L---VLKIIRGS-Y---------P 219 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH--H---HHHHhcCC-C---------C
Confidence 1223468889999999998899999999999999999999999875332111 1 11111000 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.........+.+++.+||+.+|++||++.+|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1112335678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=294.07 Aligned_cols=240 Identities=20% Similarity=0.293 Sum_probs=186.6
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||.||++. ...+.+.+|+++++.++||||+++++.+.++...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 478899999999999999621 12346778999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. .+.+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999944 346899999999999999999999987 999999999999999999999999998742111
Q ss_pred cc-------------cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh
Q 036419 598 EL-------------QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW 664 (754)
Q Consensus 598 ~~-------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 664 (754)
.. ........++..|+|||.+.+..++.++||||||+++|||++|..||....... +.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--~~~~~---~ 229 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFGQV---I 229 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH---H
Confidence 00 001112467889999999988899999999999999999999999985432211 11110 0
Q ss_pred ccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 665 KDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 665 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
. . ....+.. ....+..+.+++.+||+.+|++||++.++.+.|+..
T Consensus 230 ~-~---~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 230 S-D---DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred h-c---ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 0 0 0001111 112345688999999999999999976666666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=295.50 Aligned_cols=237 Identities=22% Similarity=0.280 Sum_probs=190.0
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++.+.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 478899999999999999721 13356888999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++... ....+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998643 3356899999999999999999999988 999999999999999999999999998755321
Q ss_pred cc---------------------------cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 036419 598 EL---------------------------QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFN 650 (754)
Q Consensus 598 ~~---------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~ 650 (754)
.. ........|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 10 011123468899999999998889999999999999999999999986443
Q ss_pred CCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 036419 651 TNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPT----MSEVISM 713 (754)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~~ 713 (754)
.... + .... +...........++.+.+++.+||+.||++||+ +.+++.+
T Consensus 237 ~~~~-~----~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDET-F----SNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHH-H----HHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 2211 1 0011 111111111225678999999999999999999 8888876
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=286.24 Aligned_cols=234 Identities=26% Similarity=0.366 Sum_probs=184.0
Q ss_pred cCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec--Cee
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GEN 513 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~~ 513 (754)
++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 578999999999999999621 1234678899999999999999999998764 467
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++++|.+++.. ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999999853 245788999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCcc-cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 594 FGGDEL-QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 594 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
...... ........|+..|+|||.+.+..++.++|||||||++|+|++|+.|+........ ... ... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~----~~~-----~~ 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-IFK----IAT-----QP 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-HHH----Hhc-----CC
Confidence 543211 1122335688999999999888899999999999999999999999764321111 100 000 00
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
. ...........+.+++.+|+. +|++||++++|+++
T Consensus 226 ~----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 T----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred C----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0 111223455678889999985 99999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.44 Aligned_cols=231 Identities=27% Similarity=0.423 Sum_probs=186.9
Q ss_pred CccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
+|+..+.||+|+||.||++. ...+.+.+|++++++++||||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999721 1335688999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
+||+++++|.+++.. .+.+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999954 345889999999999999999999988 99999999999999999999999999987643
Q ss_pred CcccccccccccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGF-FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.. ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||........ . .........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~---~~~~~~~~~------ 220 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--V---FKIGRSKEL------ 220 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--H---HHHHhcccC------
Confidence 32 123456889999999987776 89999999999999999999999764331111 0 000000000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
........+.+.+++.+||+.+|++||++.+++++
T Consensus 221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 01112235678899999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=285.86 Aligned_cols=237 Identities=28% Similarity=0.426 Sum_probs=188.2
Q ss_pred CccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee--cCeeEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE--QGENVLIY 517 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~--~~~~~lV~ 517 (754)
+|++.+.||.|+||.||++. ...+++.+|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 57889999999999999721 124567889999999999999999998753 45678999
Q ss_pred EecCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 518 EYLPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYS--RLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
||+++++|.+++.... ....+++..+..++.||++||.|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999996532 2457899999999999999999999332 234999999999999999999999999999977
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
...... .....++..|+|||.+....++.++||||||+++++|++|+.|+..... ..+.... .....
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~----~~~~~----- 227 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKI----KEGKF----- 227 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHH----hcCCC-----
Confidence 543321 2235689999999999988899999999999999999999999865431 1111111 11100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..........+.+++.+||+.+|++||++.+|++|
T Consensus 228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11122345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=287.47 Aligned_cols=237 Identities=27% Similarity=0.408 Sum_probs=189.2
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 467888999999999999721 2235688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ-YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
+++++|.+++.... ..+++..+..++.|++++|.|||+ .+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999996532 568899999999999999999999 76 9999999999999999999999999987653221
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
. ....++..|+|||.+.+..++.++||||||+++++|++|+.|+..................... .+.+.
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 225 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------PPRLP 225 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC------CCCCC
Confidence 1 1266888999999999889999999999999999999999998644321111111111111100 01110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.......+.+++.+||..||++|||+.+++.+
T Consensus 226 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 ---SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11145678899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=293.40 Aligned_cols=236 Identities=22% Similarity=0.307 Sum_probs=187.2
Q ss_pred cCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 459 NNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
+.|....+||+|+||.||++. ...+.+.+|+.++++++||||+++++.+..++..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 344445689999999999721 12456889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++++|.+++.. +.+++.++..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 102 ~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-- 172 (292)
T cd06658 102 EGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-- 172 (292)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence 99999998843 35889999999999999999999988 9999999999999999999999999997654322
Q ss_pred ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... ...... ..+.+.+..
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~---------~~~~~~~~~- 240 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMRRIR---------DNLPPRVKD- 240 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH---------hcCCCcccc-
Confidence 12234568899999999988899999999999999999999999976432211 110000 001111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
.......+.+++.+||+.||.+|||+++++++---
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 275 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL 275 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 11244568899999999999999999999987433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=286.38 Aligned_cols=242 Identities=27% Similarity=0.374 Sum_probs=189.0
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec--CeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~~~lV~ 517 (754)
++|++.++||.|++|.||+.. ....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 468889999999999999721 1346789999999999999999999998653 4689999
Q ss_pred EecCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 518 EYLPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999875422 3456889999999999999999999988 99999999999999999999999999876533
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCC---chhHhHhhhhhhccCcccccc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN---SLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..|+...... ......+.. ......+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 229 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPNPELK 229 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCCchhhc
Confidence 21 12345788999999999899999999999999999999999998755321 111111111 10111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+ .. .......+.+.+++.+||+.+|.+|||+.||+++-
T Consensus 230 ~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 230 D-EP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred c-CC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 0 00 11122457789999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=286.31 Aligned_cols=237 Identities=25% Similarity=0.433 Sum_probs=188.4
Q ss_pred CccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 460 NFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
+|+..+.||+|+||.||++. ...+.+++|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999621 124678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC-ceEEeeccCcccc
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM-IPKISDFGLARMF 594 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~-~~kl~DFgla~~~ 594 (754)
||||+++++|.+++.+ .+.+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999954 346889999999999999999999998 99999999999998776 5999999999876
Q ss_pred CCCccc--ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 595 GGDELQ--SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 595 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
...... .......|+..|+|||.+.+..++.++||||+|+++++|++|..|+......... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~--------- 223 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--ALIFKI--------- 223 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH--HHHHHH---------
Confidence 543111 1122356889999999998888999999999999999999999998643322111 000000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
................+.+++.+||+.+|.+||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00011112223455778899999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=283.24 Aligned_cols=232 Identities=25% Similarity=0.387 Sum_probs=187.2
Q ss_pred CccccceeccCCCcceeec--------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~--------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|++.+.||+|+||.||++ ....+.+.+|++++++++|||++++++.+..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999961 12345788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC-CceEEeeccCccccCCCc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGLARMFGGDE 598 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-~~~kl~DFgla~~~~~~~ 598 (754)
+++++|.+++.... ...+++..+..++.|++++|.|||+.+ ++|+||||+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999996532 345899999999999999999999987 9999999999999865 467999999998765432
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
......|+..|+|||.+.+..++.++||||||+++++|++|+.|+....... ..... .. ....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~---~~-~~~~-------- 219 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLKI---MS-GTFA-------- 219 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHHH---Hh-cCCC--------
Confidence 1223568889999999998889999999999999999999999975433221 11111 00 0000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.........+.+++.+||+.+|++|||+.+++++
T Consensus 220 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 -PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0111235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=288.45 Aligned_cols=229 Identities=26% Similarity=0.369 Sum_probs=187.8
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 478899999999999999621 12356788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. .+.+++..+..++.||++||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999954 356899999999999999999999987 999999999999999999999999999876443
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.|+...... ..... .. .. ..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~---~~-~~--------~~ 215 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--QIYEK---IL-EG--------KV 215 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH---Hh-cC--------Cc
Confidence 23456889999999998888999999999999999999999997543311 11100 00 00 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISML 714 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 714 (754)
.........+.+++.+||+.||.+|| +++++++|-
T Consensus 216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence 01112356788999999999999999 888888664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=288.97 Aligned_cols=246 Identities=24% Similarity=0.320 Sum_probs=183.3
Q ss_pred cCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|++.++||+|++|.||++.. ....+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 6789999999999999997321 124567899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++ +|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 8988885432 36889999999999999999999988 99999999999999999999999999875432111
Q ss_pred cccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc---Ccc------
Q 036419 600 QSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD---DRS------ 669 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~------ 669 (754)
......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.........+ ...+..... ...
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL-HKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH-HHHHHhcCCCChhhhhhhhhc
Confidence 1122346889999998875 468999999999999999999999986443211111 111110000 000
Q ss_pred -------ccccCcccCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 670 -------WELMDPKLQCEA--SYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 670 -------~~l~d~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.....+...... .......+.+++.+||+.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000000000 01112667899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=288.39 Aligned_cols=248 Identities=23% Similarity=0.256 Sum_probs=183.8
Q ss_pred hhcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++++|++.+.||+|+||.||++. .....+.+|++++++++|+||+++.+++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 45789999999999999999731 11236788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 5676666432 245788889999999999999999987 999999999999999999999999999864322
Q ss_pred cccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc----------
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD---------- 666 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 666 (754)
.. ......++..|+|||++.+. .++.++|||||||++|+|++|..||.........+.. .+..+..
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK-IWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH-HHHHcCCCChhhhhhhh
Confidence 11 12234578899999998764 5889999999999999999999998654332111111 1110000
Q ss_pred ---CccccccCcccCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 667 ---DRSWELMDPKLQC-----EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 667 ---~~~~~l~d~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
............. .........+.+++.+|++.||.+|||+.+++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000 0001124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-33 Score=297.70 Aligned_cols=238 Identities=24% Similarity=0.422 Sum_probs=193.1
Q ss_pred hhcCccccceeccCCCcceee------------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk------------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
..+.|.|+..||.|+||.||| .+..++.+..||.||+..+||+||+|++.|..++.+.++.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 446788899999999999998 33456788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
||.||-++.++.. -...+.+.++.-+++|++.||.|||+.. |||||||..|||+.-+|.++|+|||.+......
T Consensus 110 FC~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t- 183 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST- 183 (1187)
T ss_pred ecCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-
Confidence 9999999998854 3456999999999999999999999998 999999999999999999999999998754322
Q ss_pred ccccccccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
......+.||+.|||||+++ ..+|+.++||||||+.|.||..+.+|.+...+-. . ..+.-+..
T Consensus 184 -~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--V---llKiaKSe------ 251 (1187)
T KOG0579|consen 184 -RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--V---LLKIAKSE------ 251 (1187)
T ss_pred -HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--H---HHHHhhcC------
Confidence 12234688999999999886 4589999999999999999999999865433211 1 11111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.|.+ ..+..-...+.+++..||.+||..||++.++++|-
T Consensus 252 PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 252 PPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred CCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 0111 11122345688999999999999999999999875
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-33 Score=325.32 Aligned_cols=243 Identities=26% Similarity=0.361 Sum_probs=193.6
Q ss_pred hHhhhhcCccccceeccCCCcceeec--------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~--------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
.+...+-+++-..+||.|.||.||-+ ....+...+|++++..|+|||+|+++++=.+.+.
T Consensus 1229 ~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred HhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 34455667888899999999999961 2234567899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.+|.||||++|+|.+++.. .+-.++-....+..|++.|+.|||+++ ||||||||.||+++.+|.+|++|||.|.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence 9999999999999999943 233556666778899999999999999 9999999999999999999999999999
Q ss_pred ccCCCc--ccccccccccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC
Q 036419 593 MFGGDE--LQSNTKRIVGTYGYMSPEYAIHG---FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD 667 (754)
Q Consensus 593 ~~~~~~--~~~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 667 (754)
.+.... .........||+.|||||++.+. .-.-+.||||+|||++||+||++|+...+.+=..+- ....+
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy-----~V~~g 1457 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY-----HVAAG 1457 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh-----HHhcc
Confidence 886542 22233467899999999999764 356789999999999999999999875543321111 11111
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 668 RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 668 ~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.. ...+...+.+-.+++..||+.||++|.++.|++++=-
T Consensus 1458 h~---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1458 HK---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred CC---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 11 1122235677789999999999999999998888753
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=288.26 Aligned_cols=245 Identities=19% Similarity=0.242 Sum_probs=175.6
Q ss_pred hhhcCccccceeccCCCcceeeccccH-----------------H---------------HHHHHHHHHHhhccCCeeee
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQGL-----------------E---------------EFKNEIKLTAKLQHRNLVRL 503 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~~~-----------------~---------------~~~~Ev~il~~l~hpniv~l 503 (754)
...++|++.++||+|+||.||++.... + ....+...+..++|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 344789999999999999999842110 0 01122234455689999999
Q ss_pred eeeeeecC----eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC
Q 036419 504 LGCCVEQG----ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS 579 (754)
Q Consensus 504 ~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~ 579 (754)
++++.... ..++++|++.. ++.+++.. ....++..+..++.||++||.|||+.+ |+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 99876543 34677887644 55555532 223578888999999999999999987 999999999999999
Q ss_pred CCceEEeeccCccccCCCcc-----cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch
Q 036419 580 NMIPKISDFGLARMFGGDEL-----QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL 654 (754)
Q Consensus 580 ~~~~kl~DFgla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~ 654 (754)
++.+||+|||+|+.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 99999999999987642211 1112235799999999999999999999999999999999999999876533221
Q ss_pred hHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 655 TLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 655 ~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.......... ..+....... ...++.+.+++..|++.+|++||++.++++.|+
T Consensus 242 ~~~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFI-----KRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHH-----HHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1110000010 0111111110 112466889999999999999999999998764
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=285.35 Aligned_cols=232 Identities=25% Similarity=0.392 Sum_probs=187.5
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+-|++.++||+|+||.||++. ...+.+.+|++++.+++||||+++++++.++...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 347788999999999999721 1235688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++.. ..+++..+..++.|++.++.|||+.+ ++|+||||+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999999843 45899999999999999999999987 99999999999999999999999999987643221
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
......++..|+|||.+.+..++.++|||||||++++|++|..|+....... .... ..... .+
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~----~~~~~-----~~---- 219 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFL----IPKNN-----PP---- 219 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHH----HhcCC-----CC----
Confidence 1223467889999999988889999999999999999999999975432211 1100 00000 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......+..+.+++.+||+.+|.+||++.+++++-
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 11122346688999999999999999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=280.75 Aligned_cols=234 Identities=33% Similarity=0.509 Sum_probs=185.6
Q ss_pred ccccceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 461 FGVENKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
+.+.+.||.|+||.||++.. ..+.+..|++++.+++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 35678999999999996211 3567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++..... ..+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999965322 12899999999999999999999998 999999999999999999999999999876544
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
...... ...++..|+|||.+....++.++||||||+++++|++ |..|+..... ........ ....
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~----~~~~------- 222 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLK----KGYR------- 222 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHh----cCCC-------
Confidence 222211 2336789999999988889999999999999999998 6776643221 11111110 0100
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.......+..+.+++.+||..+|++|||+.++++.|
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011112456788999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=290.38 Aligned_cols=236 Identities=25% Similarity=0.334 Sum_probs=187.5
Q ss_pred cCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 459 NNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
..|....+||+|+||.||++. ...+.+.+|+.++.+++||||+++++++..++..++||||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 345556689999999999721 23457889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++++|..++.. ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 101 ~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~- 172 (297)
T cd06659 101 QGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP- 172 (297)
T ss_pred CCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-
Confidence 99999998733 45889999999999999999999988 99999999999999999999999999976543321
Q ss_pred ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
......|+..|+|||++.+..++.++|||||||++|||++|+.|+....... ..... ..... +.. .
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~----~~~~~-----~~~--~ 238 (297)
T cd06659 173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRL----RDSPP-----PKL--K 238 (297)
T ss_pred -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH----hccCC-----CCc--c
Confidence 1234568999999999998899999999999999999999999986432211 11110 00000 000 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
........+.+++.+||+.+|++||++++|+++---
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~ 274 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhh
Confidence 011234568899999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=287.15 Aligned_cols=245 Identities=25% Similarity=0.322 Sum_probs=185.1
Q ss_pred CccccceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
+|++.+.||+|+||.||++.. ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999997221 123467899999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999995432 36899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh-------hcc-C
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL-------WKD-D 667 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~-~ 667 (754)
... ......++..|+|||.+.+ ..++.++|||||||+++||++|..++....... .+....... +.. .
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhcc
Confidence 321 1223356788999998865 467899999999999999999977765433211 111000000 000 0
Q ss_pred ccccccCcccC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 668 RSWELMDPKLQ-----CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 668 ~~~~l~d~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
........... ..........+.+++.+||+.||++|||+.+|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 00112345778999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=285.59 Aligned_cols=245 Identities=24% Similarity=0.334 Sum_probs=187.3
Q ss_pred CccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58889999999999999732 1245788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+ +++|.+++.... ..+++.++..++.||+++|.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999986433 56899999999999999999999988 99999999999999999999999999987654321
Q ss_pred cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh--------hccCc--
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL--------WKDDR-- 668 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~-- 668 (754)
.......|+..|+|||.+.+. .++.++||||+|++++||++|.+++....... .+ ...... |....
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QL-AIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HH-HHHHHHcCCCChHHHhhccCc
Confidence 112345688999999988654 56899999999999999999977765332211 11 011000 00000
Q ss_pred --cccccCcccC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 669 --SWELMDPKLQ----CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 669 --~~~l~d~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
...+..+... ........+.+.+++.+||+.+|++||+++++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 00111234788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=283.94 Aligned_cols=231 Identities=26% Similarity=0.295 Sum_probs=188.2
Q ss_pred CccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
+|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58889999999999999721 235678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++... ..+++..+..++.||++||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999542 56899999999999999999999988 9999999999999999999999999998765432
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+........... ...... ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~----------~~ 218 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI---RAKQET----------AD 218 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH---HHHhcc----------cc
Confidence 12345688899999999888899999999999999999999999865443211110 000000 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTM--SEVIS 712 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl~ 712 (754)
.......+..+.+++.+||+.||.+||++ +++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 11112234778899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=287.29 Aligned_cols=235 Identities=23% Similarity=0.336 Sum_probs=189.9
Q ss_pred hcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
.++|++.+.||+|+||.||++. ...+.+.+|+.++++++|||++++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 4689999999999999999731 1235678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999843 34789999999999999999999998 99999999999999999999999999876543322
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
......|++.|+|||.+.+..++.++||||||+++|++++|+.||.......... ..... +....
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----~~~~~--------~~~~~ 235 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATN--------GTPEL 235 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----ehhcC--------CCCCC
Confidence 1223468889999999988889999999999999999999999986433211100 00000 00001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.........+.+++.+||+.+|.+||++.+++.|-
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 11122456788999999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=280.38 Aligned_cols=236 Identities=28% Similarity=0.459 Sum_probs=187.8
Q ss_pred CccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|++.++||+|+||.||++. ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 58889999999999999731 1456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999954 345889999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccc--ccccccccCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 600 QSN--TKRIVGTYGYMSPEYAIHGF---FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 600 ~~~--~~~~~gt~~y~APE~~~~~~---~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
... .....++..|+|||++.... ++.++||||||+++++|++|+.||........ ..... . .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~~---~-~~-----~~ 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFHV---G-AG-----HK 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHHH---h-cC-----CC
Confidence 111 12356788999999998766 89999999999999999999999864332111 11000 0 00 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
+.+ +........+.+++.+||+.+|++||++.+++.+
T Consensus 225 ~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 225 PPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 011 1111235667899999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=285.33 Aligned_cols=236 Identities=25% Similarity=0.389 Sum_probs=180.7
Q ss_pred cCccccceeccCCCcceeeccc-------------------cHHHHHHHHHH-HHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKL-TAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~i-l~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
++|++.+.||+|+||.||++.. ...++..|+.+ ++.++||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4788999999999999998321 22345556665 566789999999999999999999999
Q ss_pred ecCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 519 YLPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQGLLYLHQY-SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 519 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|++ ++|.+++... .....+++..+..++.||+.||.|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 5888877543 2335689999999999999999999986 5 99999999999999999999999999986543
Q ss_pred CcccccccccccccCccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIH----GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~----~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
.. ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.|+.........+. .... .
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~-~----- 223 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK----QVVE-E----- 223 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH----HHHh-c-----
Confidence 21 1123468889999998864 4578999999999999999999999753222111111 0000 0
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
..+... ....++.+.+++.+||+.+|++||++.+|+++-
T Consensus 224 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 224 PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 001110 112356789999999999999999999998853
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=283.47 Aligned_cols=232 Identities=24% Similarity=0.424 Sum_probs=186.2
Q ss_pred CccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhc---cCCeeeeeeeeeecCeeEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQ---HRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~---hpniv~l~~~~~~~~~~~lV~ 517 (754)
.|++.++||+|+||.||++. ...+++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 57888999999999999722 23457889999999997 999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. +.+++..+..++.||+++|.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999843 36899999999999999999999988 999999999999999999999999999876543
Q ss_pred cccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
. .......|+..|+|||.+.++ .++.++||||||+++|+|++|..|+......... . ..... ..+.
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-----~-~~~~~-----~~~~ 221 (277)
T cd06917 155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-----M-LIPKS-----KPPR 221 (277)
T ss_pred c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-----h-ccccC-----CCCC
Confidence 3 122345688999999988754 5789999999999999999999998643221110 0 00000 0111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+... .....+.+++.+||+.||++||++.+++++-
T Consensus 222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 1110 1346788999999999999999999998864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=287.19 Aligned_cols=245 Identities=25% Similarity=0.363 Sum_probs=183.8
Q ss_pred CccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|++.+.||+|++|.||++.. ..+.+.+|++++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488899999999999997311 124688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+. ++|..++... ....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 96 5888888543 2356899999999999999999999987 9999999999999999999999999998654321
Q ss_pred cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh-------hccC----
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL-------WKDD---- 667 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~---- 667 (754)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.||........ ........ |...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhhhhHHH
Confidence 112234568899999988764 468999999999999999999999864332111 10000000 0000
Q ss_pred ----ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 668 ----RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 668 ----~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
........... .........+.+++.+||+.||.+|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 0011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=291.66 Aligned_cols=250 Identities=23% Similarity=0.283 Sum_probs=183.9
Q ss_pred CccccceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeec--CeeE
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GENV 514 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~~~ 514 (754)
+|++.++||+|+||.||++.. ..+.+.+|++++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 478889999999999997321 124567899999999999999999999988 8899
Q ss_pred EEEEecCCCChhhHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC----CCceEEeec
Q 036419 515 LIYEYLPNKSLDSFLFDTTK--EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS----NMIPKISDF 588 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~----~~~~kl~DF 588 (754)
+||||+++ +|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 56666643222 236899999999999999999999988 999999999999999 999999999
Q ss_pred cCccccCCCcc-cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCc--------hhHhH
Q 036419 589 GLARMFGGDEL-QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS--------LTLLG 658 (754)
Q Consensus 589 gla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~--------~~~~~ 658 (754)
|++..+..... ........++..|+|||.+.+. .++.++||||||+++++|++|+.|+....... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1223345788999999988764 68999999999999999999999987554322 00000
Q ss_pred hhhhhhcc-----------CccccccCcccCCCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 659 HAWNLWKD-----------DRSWELMDPKLQCEAS---------Y--PIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 659 ~~~~~~~~-----------~~~~~l~d~~~~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
....+... .......+........ . ....++.+++.+||+.||++|||+.++++|
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000 0000000000000000 0 234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=281.40 Aligned_cols=233 Identities=26% Similarity=0.400 Sum_probs=187.5
Q ss_pred CccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|++.+.||+|+||.||++. ...+.+.+|++++++++|||++++++.+.++...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 57889999999999999721 2345788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC-ceEEeeccCccccCCCc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM-IPKISDFGLARMFGGDE 598 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~-~~kl~DFgla~~~~~~~ 598 (754)
+++++|.+++.... ...+++..+..++.||++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999986532 235799999999999999999999987 99999999999999885 46999999998765332
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
. ......|++.|+|||++.+..++.++||||||+++++|++|..|+........ ....... . ..
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~-~----~~---- 220 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL-----VLKICQG-Y----FA---- 220 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHhcc-c----CC----
Confidence 1 12234688999999999888899999999999999999999999754322111 1111110 0 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.........+.+++.+|++.+|++|||+.+|+++
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-33 Score=297.10 Aligned_cols=231 Identities=30% Similarity=0.460 Sum_probs=187.7
Q ss_pred hcCccccceeccCCCcceee---------------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk---------------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
.+.|..++.||.|+||.||- +....+.+.+||+.|.+++|||+|.+.+||..+...+||
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 34577788999999999995 122356789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
||||-| +-.+++.- ..+++.+.++..|..+.+.||+|||+++ .||||||..|||+.+.|.|||+|||.|.+...
T Consensus 105 MEYClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 999965 77777743 3456899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAI---HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
...++|||.|||||++. .+.|+-|+||||||+...||...++|.-..+ .....-++ ..++
T Consensus 179 ------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--AMSALYHI---AQNe------ 241 (948)
T KOG0577|consen 179 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHI---AQNE------ 241 (948)
T ss_pred ------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--HHHHHHHH---HhcC------
Confidence 44689999999999985 4689999999999999999999998853221 11111111 0010
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.|.+ ....-++.+++++..||++-|.+|||.+++++|-
T Consensus 242 sPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 242 SPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred CCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 1112 1345577899999999999999999999988764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=277.70 Aligned_cols=235 Identities=28% Similarity=0.424 Sum_probs=191.4
Q ss_pred CccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec--CeeEEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GENVLIY 517 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~~~lV~ 517 (754)
+|++.+.||+|++|.||++. ...+.+.+|++++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47788999999999999721 2356789999999999999999999999988 8899999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++... ..+++..+..++.|++++|.|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999999643 27899999999999999999999987 999999999999999999999999999977654
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
..........++..|+|||.+....++.++||||||+++++|++|..|+........ ..+.... ...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~---------~~~ 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA----ALYKIGS---------SGE 221 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----HHHhccc---------cCC
Confidence 321123345688899999999888899999999999999999999999865541111 1111110 001
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
...........+.+++.+|++.+|++||++.+++++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111112235779999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=283.44 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=186.9
Q ss_pred CccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
+|++.++||+|++|.||++.. ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588899999999999997321 2456778999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++ +|.+++........+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 86 88888865554557899999999999999999999987 99999999999999999999999999986543211
Q ss_pred ccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh--------hccCcccc
Q 036419 601 SNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL--------WKDDRSWE 671 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 671 (754)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+......+. .. ..... |.......
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LL-KIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HH-HHHHHhCCCChhhHHHHhcCc
Confidence 12234578899999988664 578999999999999999999999865433221 00 00000 00000000
Q ss_pred ccCcccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 672 LMDPKLQ-------CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 672 l~d~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
....... ..........+.+++.+|++.||.+||++.+|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 00111235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=279.85 Aligned_cols=234 Identities=28% Similarity=0.424 Sum_probs=192.1
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|++.+.||+|++|.||++. ...+.+.+|++++.+++|||++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468889999999999999721 2356789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ-YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
+++++|.+++... ..+++..+..++.||+++|.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999543 568999999999999999999999 87 9999999999999999999999999998765433
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhhhhhhccCccccccCccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ....... .... . +
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~~~-~-----~-- 221 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDGP-P-----P-- 221 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH---hcCC-C-----C--
Confidence 21 124567889999999998899999999999999999999999986554211 1111111 1000 0 0
Q ss_pred CCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 678 QCEASYP-IVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 678 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..... .++.+.+++.+||+.+|++||++.+++++
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 --SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11112 45789999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=268.36 Aligned_cols=266 Identities=23% Similarity=0.341 Sum_probs=194.2
Q ss_pred hhcCccccceeccCCCcceeeccc-----------cHH-------------HHHHHHHHHHhhccCCeeeeeeeeee-cC
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ-----------GLE-------------EFKNEIKLTAKLQHRNLVRLLGCCVE-QG 511 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~-----------~~~-------------~~~~Ev~il~~l~hpniv~l~~~~~~-~~ 511 (754)
-...|+..++||+|.||.|||+.. ..+ ...+|+.+++.|+|||++.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 345799999999999999998411 112 34589999999999999999999977 77
Q ss_pred eeEEEEEecCCCChhhHhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC----CceEE
Q 036419 512 ENVLIYEYLPNKSLDSFLFDT--TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN----MIPKI 585 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~----~~~kl 585 (754)
..++++||.+. +|..+|+-+ ...+.++...+..|+.||+.|+.|||++= |+||||||.|||+..+ |.+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 88999999987 777777543 23457999999999999999999999975 9999999999999877 89999
Q ss_pred eeccCccccCCCc-ccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCC-----ch--hH
Q 036419 586 SDFGLARMFGGDE-LQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTN-----SL--TL 656 (754)
Q Consensus 586 ~DFgla~~~~~~~-~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~-----~~--~~ 656 (754)
+|||+++++...- .......++-|.+|+|||.+.+. .|+++.|||+.|||+.||++-.+.|...... +. ..
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999999886532 22234567889999999999876 7999999999999999999999887654321 11 11
Q ss_pred hHhhhhhhcc--CccccccCc-----------c--cCCCCCH-H-------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 657 LGHAWNLWKD--DRSWELMDP-----------K--LQCEASY-P-------IVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 657 ~~~~~~~~~~--~~~~~l~d~-----------~--~~~~~~~-~-------~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
......+... +..+.-+.. . ....... . ......+|+.++|+.||.+|.|+++.+++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 1111111110 001100000 0 0000000 0 11226788999999999999999999998
Q ss_pred HhccccCCCCCCCCC
Q 036419 714 LTNEFVNLPSPQQPG 728 (754)
Q Consensus 714 L~~~~~~~~~p~~p~ 728 (754)
.-.. +.+-|++|.
T Consensus 338 ~yF~--~d~lpp~pt 350 (438)
T KOG0666|consen 338 PYFT--EDPLPPLPT 350 (438)
T ss_pred cccc--cCCCCCCcc
Confidence 7544 344444443
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=295.44 Aligned_cols=232 Identities=22% Similarity=0.328 Sum_probs=196.2
Q ss_pred hhhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.....|.+.++||+|.|++|..+. ...+.+.+|+++|+.|+|||||+++.+.+.+..+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 345689999999999999998622 134568899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||..+|.+.++|. +.++..+..+..++.|+.+|++|||+++ |+|||||++||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 999999999999994 4566777999999999999999999998 9999999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.. ......+|++.|.|||++.+..| ++.+|+||+|+++|-|++|..||.+..-.+ +-+
T Consensus 207 ~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~------------------Lr~ 265 (596)
T KOG0586|consen 207 YG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE------------------LRP 265 (596)
T ss_pred cc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc------------------ccc
Confidence 43 33556899999999999998877 589999999999999999999987543322 222
Q ss_pred cccCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 675 PKLQCEA--SYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 675 ~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+.+...+ +.....++.++++++|..+|.+|++++++.++-
T Consensus 266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 2222221 223456788999999999999999999998864
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=285.00 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=185.0
Q ss_pred cCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeec--CeeEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GENVLI 516 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~~~lV 516 (754)
++|++.+.||+|+||.||++.. ....+.+|++++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4788999999999999997321 123467899999999999999999999877 889999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 8988885432 35899999999999999999999988 99999999999999999999999999987654
Q ss_pred CcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchh--HhHh-------hhhhhcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLT--LLGH-------AWNLWKD 666 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~--~~~~-------~~~~~~~ 666 (754)
.. .......++..|+|||.+.+. .++.++|+||||+++++|++|..||......... .... .+..+..
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 32 112234578899999988764 4689999999999999999999998654322100 0000 0000000
Q ss_pred ------CccccccCcccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 667 ------DRSWELMDPKLQCEASYP-IVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 667 ------~~~~~l~d~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..........+....... ..+.+.+++.+||+.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000001111111111 35678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=287.50 Aligned_cols=234 Identities=29% Similarity=0.432 Sum_probs=184.9
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..+.|++.++||+|+||.||++. ...+++.+|++++++++|||++++.+++.+++..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 44679999999999999999721 112468899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++ ++.+++... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||++++++.+||+|||++....
T Consensus 93 v~e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9999974 666666432 345899999999999999999999988 9999999999999999999999999997653
Q ss_pred CCcccccccccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAI---HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
.. ....++..|+|||++. ...++.++||||||+++|||++|..|+........ . ....... .
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~---~~~~~~~-~--- 231 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L---YHIAQND-S--- 231 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--H---HHHhcCC-C---
Confidence 22 2346788999999874 45689999999999999999999998753322111 0 0000000 0
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
+. .......+.+.+++.+||+.+|++||++.+|+++.--
T Consensus 232 --~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 232 --PT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred --CC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 00 1112245678999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=285.25 Aligned_cols=247 Identities=25% Similarity=0.344 Sum_probs=182.7
Q ss_pred cCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCe-----
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGE----- 512 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~----- 512 (754)
++|++.+.||+|+||.||++.. ..+.+.+|++++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999998321 2256788999999995 6999999999987666
Q ss_pred eEEEEEecCCCChhhHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC-CCceEEeecc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTK--EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS-NMIPKISDFG 589 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~-~~~~kl~DFg 589 (754)
.++||||+++ +|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78888754332 346899999999999999999999988 999999999999998 8899999999
Q ss_pred CccccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC-
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD- 667 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 667 (754)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........ +. .........
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~-~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LL-HIFKLLGTPT 232 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HH-HHHHHhCCCC
Confidence 9986533211 1122356888999998865 4679999999999999999999998864322111 10 000000000
Q ss_pred -ccc----ccc--------CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 668 -RSW----ELM--------DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 668 -~~~----~l~--------d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
... ... .+...........+.+.+++.+||+.||.+||++.+++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 000 0000000111245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.37 Aligned_cols=241 Identities=24% Similarity=0.330 Sum_probs=193.1
Q ss_pred hhhhcCccccceeccCCCcceeeccc-----------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSGQ-----------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~~-----------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
...++.|++.+.||+|++|.||++.. ..+.+.+|++++++++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34667899999999999999997322 2567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999996533 36999999999999999999999987 999999999999999999999999998765432
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.. ......++..|+|||++.+..++.++||||||+++|+|++|..|+......... . .. ....... .
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~-~-~~----~~~~~~~-----~ 236 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL-F-LI----TTKGIPP-----L 236 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH-H-HH----HhcCCCC-----C
Confidence 21 122345788999999998888999999999999999999999997543221110 0 00 0000000 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.........+.+++.+||+.+|.+||++.+|+++.-
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 237 --KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred --cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 011113467889999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=279.04 Aligned_cols=226 Identities=26% Similarity=0.352 Sum_probs=182.0
Q ss_pred eccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCCh
Q 036419 467 LGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 467 lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
||.|+||.||++. ...+.+.+|++++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6889999998621 2345788999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccc
Q 036419 526 DSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR 605 (754)
Q Consensus 526 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~ 605 (754)
.+++.+ ...+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999954 345899999999999999999999987 9999999999999999999999999998765432 1223
Q ss_pred cccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHH
Q 036419 606 IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPI 685 (754)
Q Consensus 606 ~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~ 685 (754)
..|+..|+|||.+....++.++|+||||+++|+|++|..|+.............. .+...........
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~ 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI------------LKGNGKLEFPNYI 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH------------hccCCCCCCCccc
Confidence 5688899999999888899999999999999999999999865543221111110 0000011111222
Q ss_pred HHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036419 686 VKRYINVALLCVQENAADRPT-----MSEVISM 713 (754)
Q Consensus 686 ~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 713 (754)
...+.+++.+||+.+|++||+ +.|+++|
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 567999999999999999999 7888774
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=279.53 Aligned_cols=238 Identities=25% Similarity=0.310 Sum_probs=182.2
Q ss_pred hhHhhhhcCcccccee--ccCCCcceeeccc------------cHHHH-HHHHHHHHhh-ccCCeeeeeeeeeecCeeEE
Q 036419 452 ASVSAATNNFGVENKL--GEGGFGPVYKSGQ------------GLEEF-KNEIKLTAKL-QHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 452 ~~~~~~~~~y~~~~~l--G~G~fg~Vyk~~~------------~~~~~-~~Ev~il~~l-~hpniv~l~~~~~~~~~~~l 515 (754)
.+.....++|.+.+++ |+|+||.||+... ....+ ..|+.+...+ +|||++++++.+..++..++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 3444455778887777 9999999997321 01111 1233333323 69999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC-ceEEeeccCcccc
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM-IPKISDFGLARMF 594 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~-~~kl~DFgla~~~ 594 (754)
||||+++++|.+++.. ...+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999954 237899999999999999999999988 99999999999999998 9999999999865
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
... ....++..|+|||++.+..++.++||||||+++|+|++|+.|+................. .
T Consensus 161 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~------- 224 (267)
T PHA03390 161 GTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---Q------- 224 (267)
T ss_pred CCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---c-------
Confidence 432 134688999999999988999999999999999999999999874433322211111110 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPT-MSEVISM 713 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 713 (754)
... .........+.+++.+||+.+|.+||+ ++++++|
T Consensus 225 ~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 225 KKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 000 111135567899999999999999996 6998865
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=293.07 Aligned_cols=251 Identities=23% Similarity=0.285 Sum_probs=185.1
Q ss_pred hhcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec-----Ce
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ-----GE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~-----~~ 512 (754)
.+++|++.++||+|+||.||++. .....+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 35789999999999999999731 1234577899999999999999999987644 35
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++|+||+++ +|..++. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 7999999975 7777773 245899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-ccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC---
Q 036419 593 MFGGDELQ-SNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD--- 667 (754)
Q Consensus 593 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 667 (754)
........ .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~--~~~~~~~~~~~~~~ 232 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ--LNLILGVLGTPSQE 232 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCCHH
Confidence 76432211 11233568999999998765 4689999999999999999999999864332110 00000000000
Q ss_pred ccccccCcc---------cCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 036419 668 RSWELMDPK---------LQCE-----ASYPIVKRYINVALLCVQENAADRPTMSEVISM--LTNE 717 (754)
Q Consensus 668 ~~~~l~d~~---------~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 717 (754)
....+.+.. .... ........+.+++.+||+.+|++|||+.+++++ ++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000000000 0000 011235678899999999999999999999998 5444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=285.17 Aligned_cols=250 Identities=26% Similarity=0.324 Sum_probs=185.3
Q ss_pred hcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeec--CeeEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GENVL 515 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~~~l 515 (754)
.++|++.+.||+|+||.||++.. ....+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999997211 123456899999999999999999998755 56899
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++ +|.+++... ...+++.++..++.||++||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 788887542 256899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc--Cccc--
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD--DRSW-- 670 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~-- 670 (754)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........... ...+
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE--QLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCChhhchh
Confidence 332 11222345788999998865 468999999999999999999999986443221 11111100000 0000
Q ss_pred ----------cccCcccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 671 ----------ELMDPKLQC--EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 671 ----------~l~d~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.+....... .......+.+.+++.+||+.||++|||++++++|---.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 000000000 00011356678999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=278.32 Aligned_cols=232 Identities=28% Similarity=0.391 Sum_probs=189.9
Q ss_pred CccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|++.++||+|+||.||++. ....++.+|++++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 57889999999999999721 1234677899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 520 LPNKSLDSFLFDTTK-EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
+++++|.+++.+... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999865322 356899999999999999999999988 9999999999999999999999999998775441
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
.....++..|+|||.+.+..++.++|+||||+++++|++|+.|+....... +... ......
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~----~~~~~~--------- 218 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRYK----VQRGKY--------- 218 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----HhcCCC---------
Confidence 223457889999999999899999999999999999999999986443221 1110 011111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..........+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11122455779999999999999999999999886
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=273.31 Aligned_cols=233 Identities=28% Similarity=0.435 Sum_probs=189.1
Q ss_pred CccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecC
Q 036419 460 NFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 521 (754)
+|.+.+.||+|++|.||++. ...+.+.+|++++++++|||++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47788999999999999721 134678999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~ 601 (754)
+++|.+++.... ..+++..+..++.|++++|.|||+.+ ++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999985532 46899999999999999999999987 99999999999999999999999999987654322
Q ss_pred cccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCC
Q 036419 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
.....++..|+|||.+....++.++||||||+++++|++|+.|+.......... .. . ......+. .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~---~-~~~~~~~~-------~ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF--KI---A-TNGPPGLR-------N 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH--HH---H-hcCCCCcC-------c
Confidence 234568889999999988889999999999999999999999976433221110 00 0 00000000 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 682 SYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.......+.+++.+||+.||++|||+.+++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124678999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=281.76 Aligned_cols=233 Identities=24% Similarity=0.319 Sum_probs=186.4
Q ss_pred CccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecC
Q 036419 460 NFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 521 (754)
.|...++||+|++|.||++. ...+.+.+|+.++++++|||++++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 45556799999999999732 123567899999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~ 601 (754)
+++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999999854 45889999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCC
Q 036419 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
......|+..|+|||.+.+..++.++||||||+++++|++|+.|+...... .... ..... . .+... .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~---~~~~~-~-----~~~~~--~ 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMK---RIRDN-L-----PPKLK--N 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHH---HHHhc-C-----CCCCc--c
Confidence 122356889999999998888999999999999999999999997543221 1111 11101 0 01111 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 682 SYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
....+..+.+++.+||+.+|++||++.+++++-
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 270 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP 270 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence 112446789999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=283.92 Aligned_cols=239 Identities=25% Similarity=0.380 Sum_probs=182.3
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~lV~E 518 (754)
++|...++||+|+||.||+.. .....+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 356677899999999999621 12456788999999996 9999999999999999999999
Q ss_pred ecCCCChhhHhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 519 YLPNKSLDSFLFD--TTKEGLLGWGARIRIIEGIAQGLLYLHQY-SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 519 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|++. ++.++... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9865 55443321 12235689999999999999999999975 5 9999999999999999999999999998654
Q ss_pred CCcccccccccccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHG---FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
.... .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||..... ...........
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~------ 226 (288)
T cd06616 160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKG------ 226 (288)
T ss_pred cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCC------
Confidence 3321 1234688899999998766 689999999999999999999999864431 11111110000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
..+.+........+..+.+++.+||+.+|++|||+.+|+++-
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 011111122223566789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=279.93 Aligned_cols=226 Identities=26% Similarity=0.307 Sum_probs=174.3
Q ss_pred eeccCCCcceeeccc---------------------cHHHHHHHHHHHH---hhccCCeeeeeeeeeecCeeEEEEEecC
Q 036419 466 KLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTA---KLQHRNLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 466 ~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~---~l~hpniv~l~~~~~~~~~~~lV~E~~~ 521 (754)
.||+|+||.||++.. ....+.+|..++. ..+|||++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999996211 1122344443333 3479999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~ 601 (754)
+++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999998853 346999999999999999999999988 9999999999999999999999999997653321
Q ss_pred cccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 602 NTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||............... ..... .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---------~~~~~----~ 217 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------LTVNV----E 217 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---------hcCCc----C
Confidence 223468999999998864 56899999999999999999999998654332211111000 00011 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036419 681 ASYPIVKRYINVALLCVQENAADRP-----TMSEVISML 714 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 714 (754)
.....+..+.+++.+||+.||.+|| +++++++|.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 1223456788999999999999999 699999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=271.83 Aligned_cols=247 Identities=22% Similarity=0.256 Sum_probs=194.8
Q ss_pred hcCccccceeccCCCcceee---------------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk---------------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
-++|..++.||+|.||+|-+ +..+...-..|-++|+..+||.+..+...|+..+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 36889999999999999975 222334456678889999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||..||.|.-+| +....+++...+-+-..|+.||.|||+++ ||+||||.+|+|+|.+|++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999888 44567889888889999999999999988 99999999999999999999999999985322
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch-hHhHhhhhhhccCccccccCc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-TLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.-..+..++||+.|+|||++....|..++|.|.+|||+|||++|+.||...+.+.. .++- . .++
T Consensus 321 --~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-~---------ed~--- 385 (516)
T KOG0690|consen 321 --YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-M---------EDL--- 385 (516)
T ss_pred --ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-h---------hhc---
Confidence 12345679999999999999999999999999999999999999999865443331 1110 0 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhc--------cccCCCCCCCCCc
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISMLTN--------EFVNLPSPQQPGF 729 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~--------~~~~~~~p~~p~~ 729 (754)
.++..+..+...|+.-.|.+||++|. .+.||.+|--- ....+++|-.|..
T Consensus 386 ----kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqV 448 (516)
T KOG0690|consen 386 ----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQV 448 (516)
T ss_pred ----cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence 11223445667888889999999996 46666655321 1235666666655
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=290.04 Aligned_cols=246 Identities=21% Similarity=0.228 Sum_probs=184.8
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec------
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ------ 510 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~------ 510 (754)
..++|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 45789999999999999999721 1234677899999999999999999988643
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
...++||||+.+ +|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 357999999975 77777732 2888999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch-------------hHh
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-------------TLL 657 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-------------~~~ 657 (754)
++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... .+.
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 987643321 2334678899999999999999999999999999999999999864432110 000
Q ss_pred Hh----hhhhhccC------ccccccCcc----cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 658 GH----AWNLWKDD------RSWELMDPK----LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 658 ~~----~~~~~~~~------~~~~l~d~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. ........ ...++.... ..........+.+.+++.+||+.||++|||+.+++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 00 00000000 000111100 00011123456788999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=280.01 Aligned_cols=241 Identities=21% Similarity=0.308 Sum_probs=180.1
Q ss_pred ccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhc-cCCeeeeeeeeeec--CeeEEEEE
Q 036419 461 FGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQ--GENVLIYE 518 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~--~~~~lV~E 518 (754)
|++.++||+|+||.||++.. ......+|+.++.++. |||++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67789999999999998321 1123457889999986 99999999999987 88999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++ +|.+++... ...+++.++..++.||+.||.|||+.+ ++||||||+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 777777432 246899999999999999999999988 999999999999999 999999999998764332
Q ss_pred ccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh-----------hhcc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN-----------LWKD 666 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~~ 666 (754)
. .....++..|+|||++.. ..++.++|||||||++|||++|..||...+..+ ....... ....
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhcc
Confidence 1 123467889999997654 567899999999999999999999986543321 1111100 0000
Q ss_pred CccccccCcccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 667 DRSWELMDPKLQC----EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 667 ~~~~~l~d~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
........+.... ......+..+.+++.+||+.+|++||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000000 0011346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=284.61 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=181.0
Q ss_pred hcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecC------
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG------ 511 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~------ 511 (754)
-++|++.++||+|+||.||++.. ....+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35799999999999999997321 1234578999999999999999999987654
Q ss_pred --eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 512 --ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 512 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
..++||||+.+ +|.+++.. ....+++.++..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 45999999975 77777743 2235899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCccc--ccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhc-
Q 036419 590 LARMFGGDELQ--SNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWK- 665 (754)
Q Consensus 590 la~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~- 665 (754)
++......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~~~~~ 242 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQLCGS 242 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCC
Confidence 99866432211 112234578899999988664 47899999999999999999999876443221 1111111100
Q ss_pred -------cCccccccCc-ccCCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 666 -------DDRSWELMDP-KLQCEA---------SYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 666 -------~~~~~~l~d~-~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
........+. ...... .......+.+++.+||+.||.+|||++++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000000 000000 00123457799999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=289.81 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=184.7
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec-----C
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ-----G 511 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~-----~ 511 (754)
..++|++.+.||+|+||.||++. ....++.+|+.++++++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 34689999999999999999722 1234677899999999999999999988654 3
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..++||||+. ++|.+++.. .+.+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 5799999996 588888843 356999999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhh--------h
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHA--------W 661 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~--------~ 661 (754)
+...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+... ....... +
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 8764332 11233567889999998865 468999999999999999999999986543211 0000000 0
Q ss_pred hhhccCcccccc-------CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 662 NLWKDDRSWELM-------DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 662 ~~~~~~~~~~l~-------d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.........+.+ ++... .........+.+++.+||+.+|++|||++++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000000 00000 0011245678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=284.22 Aligned_cols=233 Identities=29% Similarity=0.411 Sum_probs=184.3
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
+.|...+.||+|+||.||++. ...+.+.+|++++++++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 457888999999999999721 12246888999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++ +|.+++.. ....+++.++..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 99975 77776643 2345899999999999999999999988 99999999999999999999999999875432
Q ss_pred cccccccccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAI---HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.|+........ .... ....
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~---~~~~------- 240 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHI---AQNE------- 240 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHH---Hhcc-------
Confidence 22346888999999874 45789999999999999999999998754321111 1000 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
............+.+++.+||+.+|.+||++.+|++++...
T Consensus 241 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 241 --SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred --CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 00011122445688999999999999999999999988654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=277.70 Aligned_cols=228 Identities=26% Similarity=0.343 Sum_probs=180.2
Q ss_pred eccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCCh
Q 036419 467 LGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 467 lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
||+|+||+||++. ...+.+.+|++++++++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999721 1233467899999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccc
Q 036419 526 DSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR 605 (754)
Q Consensus 526 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~ 605 (754)
.+++..... ..+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 999965332 36899999999999999999999988 9999999999999999999999999998654321 1223
Q ss_pred cccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHH
Q 036419 606 IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPI 685 (754)
Q Consensus 606 ~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~ 685 (754)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... ..... . .. .........
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~-----~---~~--~~~~~~~~~ 221 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--ELKRR-----T---LE--MAVEYPDKF 221 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--HHHhc-----c---cc--ccccCCccC
Confidence 467889999999988889999999999999999999999986543311100 00000 0 00 000111223
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036419 686 VKRYINVALLCVQENAADRP-----TMSEVISM 713 (754)
Q Consensus 686 ~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 713 (754)
...+.+++.+||+.||.+|| ++.++++|
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 56788999999999999999 78888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=277.79 Aligned_cols=233 Identities=26% Similarity=0.397 Sum_probs=185.4
Q ss_pred CccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 460 NFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
+|.+.++||+|+||.||++. ....++..|++++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58889999999999999621 1223466789999999999999999999999999999
Q ss_pred EEecCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 517 YEYLPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988653 23456899999999999999999999987 999999999999975 569999999998764
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.... ......|+..|+|||.+.+..++.++|+||||+++++|++|..|+...... ... .... ... .+
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~---~~~~-~~~-----~~ 223 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--SVV---LRIV-EGP-----TP 223 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHH---HHHH-cCC-----CC
Confidence 3321 122356788999999998888999999999999999999999997532211 111 1110 010 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.........+.+++.+||+.+|++||++.+++++
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1122445678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=280.36 Aligned_cols=245 Identities=25% Similarity=0.331 Sum_probs=183.2
Q ss_pred ccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 461 FGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
|++.++||+|++|.||++. ...+.+.+|++++++++|||++++++++.++...++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 6778899999999999732 12356889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
+ ++|.+++.... ...+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 58998885432 235899999999999999999999987 99999999999999999999999999986543211
Q ss_pred ccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh-------hcc-Ccccc
Q 036419 601 SNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL-------WKD-DRSWE 671 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~-~~~~~ 671 (754)
......++..|+|||++.+. .++.++||||||+++|+|++|..||........ +....... |.. ....+
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhhhhhchh
Confidence 11233568899999988664 578999999999999999999999864432111 00000000 000 00000
Q ss_pred ccC------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 672 LMD------PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 672 l~d------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
... ..............+.+++.+||+.+|++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000001112234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=276.29 Aligned_cols=235 Identities=26% Similarity=0.359 Sum_probs=184.6
Q ss_pred cCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec--Cee
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GEN 513 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~~ 513 (754)
.+|++.+.||+|+||.||++. .....+++|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 478999999999999999721 1234678899999999999999999998664 457
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++|+||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999853 345889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCcc-cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 594 FGGDEL-QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 594 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
...... ........|+..|+|||++.+..++.++|||||||++++|++|+.||........ .. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~~------- 223 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-IF----KIAT------- 223 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-HH----HHHc-------
Confidence 532111 1112235688999999999988899999999999999999999999754321111 10 0000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.......+....+.+.+++.+|++ +|.+||++.+++.|.
T Consensus 224 --~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 224 --QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred --CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 000111223345778999999999 579999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=287.87 Aligned_cols=248 Identities=27% Similarity=0.313 Sum_probs=184.7
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeec--Cee
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQ--GEN 513 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~--~~~ 513 (754)
..++|++.+.||+|+||.||++. .....+.+|+++++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 45789999999999999999731 1234567899999999 999999999998653 468
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++ +|..++.. ..+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||++..
T Consensus 85 ~lv~e~~~~-~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYMET-DLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEeccccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 999999985 89888843 26889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc---ccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh-------
Q 036419 594 FGGDELQ---SNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN------- 662 (754)
Q Consensus 594 ~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~------- 662 (754)
....... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||........ .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHH
Confidence 6443221 22334578999999998765 4678999999999999999999999864332211 0000000
Q ss_pred ---hhccCccccccCccc------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 663 ---LWKDDRSWELMDPKL------QCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 663 ---~~~~~~~~~l~d~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.+.......+++... ...........+.+++.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000111000 000011135678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=280.28 Aligned_cols=247 Identities=25% Similarity=0.322 Sum_probs=182.4
Q ss_pred cCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
++|++.++||+|++|.||++. ...+.+.+|++++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 478999999999999999832 123567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC-CCceEEeeccCccccCCC
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS-NMIPKISDFGLARMFGGD 597 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~-~~~~kl~DFgla~~~~~~ 597 (754)
|+++ +|.+++... ....+++..+..++.||+.||.|||+++ ++|+||||+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9965 777777432 2234678888999999999999999987 999999999999985 567999999999865432
Q ss_pred cccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhh-------hhhccCc-
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW-------NLWKDDR- 668 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~- 668 (754)
. .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+. ...... ..|....
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhcccccc
Confidence 1 112234678899999988664 678999999999999999999999865332211 100000 0000000
Q ss_pred ccccc--CcccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 669 SWELM--DPKLQC----EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 669 ~~~l~--d~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..... .+.... .......+.+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 000000 0112235668899999999999999999999986
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=294.53 Aligned_cols=236 Identities=28% Similarity=0.368 Sum_probs=192.5
Q ss_pred cCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
+..++.++||+|.||.|+++. ...+.|.+|+.+|.+|+|||++||+|+..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 455677899999999999732 256899999999999999999999999887 788999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
||.++.|+|.+.|.+ .....+-......++.|||+|+.||.++. +|||||-..|+|+-....+||+||||.+.++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999987 55667888899999999999999999988 99999999999999999999999999998865
Q ss_pred Ccc-cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 597 DEL-QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK-RSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 597 ~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.+. ........-...|+|||.+...+|+.++|||+|||.+|||+++. .|+.+... ..+.+.+|
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---------------~qIL~~iD 329 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---------------IQILKNID 329 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---------------HHHHHhcc
Confidence 432 22223334456899999999999999999999999999999865 34322211 11222333
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
..-.-......++++.++++.||..+|.+|||+..|.+.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 3323334445789999999999999999999999998544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=286.20 Aligned_cols=236 Identities=25% Similarity=0.408 Sum_probs=193.9
Q ss_pred cCccccceeccCCCcceeec-----------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 459 NNFGVENKLGEGGFGPVYKS-----------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~-----------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
+...+.+.||+|-||.||++ .+..+.|..|..+|++++|||||+++|+|.+. ...+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 34455689999999999971 23467899999999999999999999998765 6899
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|||.++-|.|..||... ...++......+++||..||+|||+.. .+||||...|||+.....+||+|||+++.+.
T Consensus 468 vmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 99999999999999653 345888888999999999999999987 9999999999999999999999999999987
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.+.+.... +..-...|||||-+.-..++.++|||.|||.+|||+. |.+||.+....+.. --+.
T Consensus 543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI---------------~~iE 606 (974)
T KOG4257|consen 543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI---------------GHIE 606 (974)
T ss_pred ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE---------------EEec
Confidence 76554333 3344668999999999999999999999999999865 77888765443311 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
..-+.+.+..++..+..|+.+||..+|.+||++.++...|..
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 112224445567889999999999999999999998887764
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=285.31 Aligned_cols=246 Identities=21% Similarity=0.287 Sum_probs=179.8
Q ss_pred ceeccC--CCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEG--GFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G--~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
..||+| +||+||++.+ ..+.+++|+.+++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 8889997211 236788999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc-
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS- 601 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~- 601 (754)
++|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999865432 34889999999999999999999987 9999999999999999999999998654332211000
Q ss_pred ----cccccccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh-------------
Q 036419 602 ----NTKRIVGTYGYMSPEYAIHG--FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN------------- 662 (754)
Q Consensus 602 ----~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~------------- 662 (754)
......++..|+|||++.+. .++.++|||||||++|+|++|+.|+................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 01112345679999998764 57899999999999999999999986443211100000000
Q ss_pred --hhc----------------cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 663 --LWK----------------DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 663 --~~~----------------~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.+. .......................+.+++.+||+.||++|||+++++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 000 0000011111111222234567899999999999999999999998775
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=272.51 Aligned_cols=234 Identities=25% Similarity=0.419 Sum_probs=190.8
Q ss_pred CccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|++.+.||.|+||.||++. ...+++.+|++++++++|||++++.+.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 57888999999999999621 2346688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 520 LPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 520 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
+++++|.+++.... ....+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999996532 2367999999999999999999999987 9999999999999999999999999998765443
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
.......|++.|+|||.+.+..++.++||||+|+++++|++|..|+....... ... ... .... .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~---~~~-~~~~----~---- 221 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--LAL---KIL-KGQY----P---- 221 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--HHH---HHh-cCCC----C----
Confidence 12233568889999999988899999999999999999999999975443211 111 111 1101 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.........+.+++.+||..+|.+||++.+++++
T Consensus 222 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 -PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111344678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=271.82 Aligned_cols=231 Identities=28% Similarity=0.428 Sum_probs=188.4
Q ss_pred CccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|++.++||+|++|.||++. ...+.+.+|++++.+++|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 57889999999999999721 2346789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++... ..+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998543 56899999999999999999999987 99999999999999999999999999987754332
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
. .....++..|+|||.+.+..++.++||||+|+++++|++|+.|+......... +.... .. ..
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~-~~---------~~ 217 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL-----FRIVQ-DD---------HP 217 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH-----HHHhc-cC---------CC
Confidence 1 23356888999999988888899999999999999999999997643311110 00000 00 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.......+.+.+++.+||+.+|++||++.+++.+
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 1112235678899999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=277.52 Aligned_cols=243 Identities=24% Similarity=0.328 Sum_probs=185.4
Q ss_pred ccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 461 FGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
|++.+.||+|++|.||++. .....+.+|++++++++||||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 5677899999999999721 12356788999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++ +|.+++... ...+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 86 888777542 246899999999999999999999988 9999999999999999999999999998775443
Q ss_pred ccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc---Ccccc-----
Q 036419 601 SNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD---DRSWE----- 671 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~----- 671 (754)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+. + ......... .....
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-L-FKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHHcCCCchHhcccchhhh
Confidence 112234578899999998876 789999999999999999999988864432211 0 000000000 00000
Q ss_pred ------ccCcccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 672 ------LMDPKLQ--CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 672 ------l~d~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..+.... ..........+.+++.+||+.||.+||++++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000 01112346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=278.47 Aligned_cols=244 Identities=26% Similarity=0.377 Sum_probs=191.3
Q ss_pred hhhcCccccceeccCCCcceeec-------------------------cccHHHHHHHHHHHHhhccCCeeeeeeeee-e
Q 036419 456 AATNNFGVENKLGEGGFGPVYKS-------------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCV-E 509 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~-------------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~-~ 509 (754)
...++|-++..||+|||++|||+ ....+...+|..|-+.|+||.||++++++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 34468999999999999999982 112355678999999999999999999996 5
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc---CCCceEEe
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD---SNMIPKIS 586 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld---~~~~~kl~ 586 (754)
.+..|-|.||++|.+|+.||. .+..++++++..|+.||+.||.||.+.. .+|||-||||.|||+. .-|.+||.
T Consensus 540 tdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 667899999999999999994 4567999999999999999999999875 7899999999999995 35789999
Q ss_pred eccCccccCCCcccc-----cccccccccCccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHh
Q 036419 587 DFGLARMFGGDELQS-----NTKRIVGTYGYMSPEYAIH----GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLL 657 (754)
Q Consensus 587 DFgla~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~----~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~ 657 (754)
|||+++++..+.+.. .+....||.+|++||.+.- .+++.|+||||.|||+|+.+.|++||.........+.
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 999999997655432 2345689999999997743 3688999999999999999999999865433322111
Q ss_pred HhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 658 GHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 658 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.. ...+.. .+.-+..+.+..+...+|+.||+.-.++|....++..+
T Consensus 696 eN--TIlkAt--------EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 696 EN--TILKAT--------EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hh--chhcce--------eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 10 111111 11122233455678899999999999999988776543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=287.49 Aligned_cols=252 Identities=19% Similarity=0.262 Sum_probs=186.9
Q ss_pred hcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee----cCee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE----QGEN 513 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~----~~~~ 513 (754)
..+|++.+.||+|+||.||++. ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 4789999999999999999621 234567889999999999999999998753 3568
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+. ++|.+++.. .+.+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 588888843 345899999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccc--ccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCch-hHhHh--------hh
Q 036419 594 FGGDELQ--SNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-TLLGH--------AW 661 (754)
Q Consensus 594 ~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~--------~~ 661 (754)
....... .......|+..|+|||.+.. ..++.++|||||||++|||++|+.||........ ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 6433211 11224578999999998866 4689999999999999999999999864432210 00000 00
Q ss_pred hhhccCccccccCcc-cCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 662 NLWKDDRSWELMDPK-LQCEA-----SYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 662 ~~~~~~~~~~l~d~~-~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
.........+..+.. ..... ....++.+.+++.+||+.+|.+||++++++++.--
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 000000000000000 00000 11235779999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=280.53 Aligned_cols=230 Identities=20% Similarity=0.251 Sum_probs=173.7
Q ss_pred cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 036419 481 GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560 (754)
Q Consensus 481 ~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 560 (754)
..+.+.+|++++++++||||+++++++.+++..+++|||+++++|.+++.... ...+++..+..++.||++||.|||++
T Consensus 42 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~ 120 (314)
T cd08216 42 DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK 120 (314)
T ss_pred HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34678999999999999999999999999999999999999999999996532 23588999999999999999999998
Q ss_pred CCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc-----cccccccccccCccccccccc--CCCCcccchhhHH
Q 036419 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL-----QSNTKRIVGTYGYMSPEYAIH--GFFSIKSDVFSFG 633 (754)
Q Consensus 561 ~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSlG 633 (754)
+ |+||||||+||+++.++.+||+|||.+........ ........++..|+|||++.. ..++.++||||||
T Consensus 121 ~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G 197 (314)
T cd08216 121 G---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVG 197 (314)
T ss_pred C---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHH
Confidence 8 99999999999999999999999999875532211 111223457788999999876 3588999999999
Q ss_pred HHHHHHHhCCCCCCcccCCchhHhHhhhh----hhccC-------cccc----ccCcc----cCCCCCHHHHHHHHHHHH
Q 036419 634 VLLLETLSSKRSTRFFNTNSLTLLGHAWN----LWKDD-------RSWE----LMDPK----LQCEASYPIVKRYINVAL 694 (754)
Q Consensus 634 vil~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~-------~~~~----l~d~~----~~~~~~~~~~~~l~~li~ 694 (754)
|+++||++|..||......... ...... .+... .... ..++. ............+.+++.
T Consensus 198 ~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 276 (314)
T cd08216 198 ITACELANGHVPFKDMPATQML-LEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVE 276 (314)
T ss_pred HHHHHHHhCCCCCCCCCHHHHH-HHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHH
Confidence 9999999999998654322211 111000 00000 0000 00110 111122334567899999
Q ss_pred HccccCCCCCCCHHHHHHHHh
Q 036419 695 LCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 695 ~cl~~dP~~RPt~~evl~~L~ 715 (754)
+||+.||++|||++++++|--
T Consensus 277 ~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 277 LCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred HHhhcCCCcCcCHHHHhcCch
Confidence 999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=277.52 Aligned_cols=244 Identities=25% Similarity=0.361 Sum_probs=183.7
Q ss_pred ccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeec--CeeEEEEE
Q 036419 461 FGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GENVLIYE 518 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~~~lV~E 518 (754)
|++.++||+|+||.||++.. ..+.+.+|++++++++|||++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67789999999999998321 234678899999999999999999999888 89999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++ +|.+++... ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 888888543 246899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc---Ccc-----
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD---DRS----- 669 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~----- 669 (754)
. .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+....... ........... ...
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchhhcccccc
Confidence 1 11223456788999998765 468999999999999999999999986443221 11111110000 000
Q ss_pred ---ccccCc------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 670 ---WELMDP------KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 670 ---~~l~d~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.....+ .+.......++..+.+++.+||+.+|.+||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000 00000011125678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=275.97 Aligned_cols=239 Identities=23% Similarity=0.285 Sum_probs=186.3
Q ss_pred CccccceeccCCCcceeeccc-------------------------cHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCee
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ-------------------------GLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~-------------------------~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~ 513 (754)
+|++.+.||+|+||.||++.. ..+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999996210 124567899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++++|.+++.. ...+++..+..++.|++++|.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999999853 345889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGF--FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
+...... ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..|+........ ...........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~----- 227 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRRILKS----- 227 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHHHHHcc-----
Confidence 5433211 122356889999999987664 78999999999999999999999854322111 11111111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.+ .........+.+++.+||+.||++|||+.++.+.|+..
T Consensus 228 --~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 --KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00 11112345678999999999999999998888877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=278.11 Aligned_cols=233 Identities=26% Similarity=0.364 Sum_probs=189.3
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~lV 516 (754)
++|++.+.||+|+||.||++. ...+.+.+|++++.+++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 478999999999999999721 12356788999999999 99999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999954 346999999999999999999999988 99999999999999999999999999987654
Q ss_pred Cccc------------------ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhH
Q 036419 597 DELQ------------------SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLG 658 (754)
Q Consensus 597 ~~~~------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~ 658 (754)
.... .......++..|+|||++....++.++||||||++++++++|+.|+....... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~ 232 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--TFQ 232 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--HHH
Confidence 3211 22234567889999999988889999999999999999999999986443211 000
Q ss_pred hhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 036419 659 HAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTM----SEVISM 713 (754)
Q Consensus 659 ~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~~ 713 (754)
.... ..........+.+.+++.+||+.+|.+||++ +++++|
T Consensus 233 ---~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 233 ---KILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ---HHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 0000 0001112235678999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=278.72 Aligned_cols=249 Identities=27% Similarity=0.342 Sum_probs=183.7
Q ss_pred hhhcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecC----
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG---- 511 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~---- 511 (754)
...++|++.++||+|+||.||++.. ....+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567899999999999999997221 2245678999999999999999999987654
Q ss_pred ------eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEE
Q 036419 512 ------ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKI 585 (754)
Q Consensus 512 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl 585 (754)
..++|+||+++ ++..++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999987 666666432 346899999999999999999999988 999999999999999999999
Q ss_pred eeccCccccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh
Q 036419 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW 664 (754)
Q Consensus 586 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 664 (754)
+|||++......... ......++..|+|||.+.+ ..++.++|||||||++++|++|+.|+....... .........
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLELISRLC 234 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHh
Confidence 999999876543221 1122346778999998765 457899999999999999999999886432211 111111110
Q ss_pred ccCc-----------cccccCcccC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 665 KDDR-----------SWELMDPKLQ-----CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 665 ~~~~-----------~~~l~d~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.... .....++... .......+..+.+++..||+.+|.+||++.+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0000000000 00001135678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=280.17 Aligned_cols=248 Identities=25% Similarity=0.326 Sum_probs=181.2
Q ss_pred hcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecC------
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG------ 511 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~------ 511 (754)
.++|++.++||+|+||.||++.. ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999997321 1235788999999999999999999875443
Q ss_pred --eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 512 --ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 512 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
..++||||+.+ +|...+.. ....+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999976 56666643 2346999999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCccc---------ccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHh
Q 036419 590 LARMFGGDELQ---------SNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH 659 (754)
Q Consensus 590 la~~~~~~~~~---------~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~ 659 (754)
+++........ .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||....... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~--~~~~ 238 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID--QLHL 238 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence 99865432211 111234678889999987654 58999999999999999999999976433221 1111
Q ss_pred hhhhhccC---------cccccc----CcccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 660 AWNLWKDD---------RSWELM----DPKLQC---EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 660 ~~~~~~~~---------~~~~l~----d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
....+... ...... ...... .......+.+.+++.+||+.||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11110000 000000 000000 0001123568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=302.91 Aligned_cols=181 Identities=26% Similarity=0.347 Sum_probs=130.5
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
+||=||||+.-++.++|.+..... .....++++++|++||+|+|+.+ ||||||||.|||+|++..|||+|||+|.
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLAT 745 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccch
Confidence 356699999988888885432211 46778899999999999999998 9999999999999999999999999998
Q ss_pred ccC----------------CCcccccccccccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCcccCCc
Q 036419 593 MFG----------------GDELQSNTKRIVGTYGYMSPEYAIHG---FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS 653 (754)
Q Consensus 593 ~~~----------------~~~~~~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwSlGvil~elltg~~p~~~~~~~~ 653 (754)
... ........+..+||.-|+|||++.+. +|+.|+|+||||+|++||+.- |...
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~Ts---- 818 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTS---- 818 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCch----
Confidence 721 01111234567899999999998765 599999999999999999853 3211
Q ss_pred hhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036419 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVIS 712 (754)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 712 (754)
+....-.. ..+.+.+... .....+....=.++|.+|++.||.+|||+.|+|.
T Consensus 819 MERa~iL~-~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 819 MERASILT-NLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHH-hcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 11111111 1111111111 1112223334468899999999999999999876
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=278.25 Aligned_cols=228 Identities=23% Similarity=0.300 Sum_probs=182.2
Q ss_pred cceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCCh
Q 036419 464 ENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 464 ~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
..+||+|+||.||++. ...+.+.+|+.++++++|||++++++.+..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 4689999999999721 2345688899999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccc
Q 036419 526 DSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR 605 (754)
Q Consensus 526 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~ 605 (754)
.+++.. ..+++..+..++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 998743 35789999999999999999999987 99999999999999999999999999876543221 1233
Q ss_pred cccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHH
Q 036419 606 IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPI 685 (754)
Q Consensus 606 ~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~ 685 (754)
..|+..|+|||.+.+..++.++||||||+++|+|++|..|+....... ....... .+.+.... ....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--~~~~~~~---------~~~~~~~~--~~~~ 242 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRD---------NLPPKLKN--LHKV 242 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh---------hCCcccCC--cccC
Confidence 568899999999988889999999999999999999999975432211 1111100 00011100 1123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 686 VKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 686 ~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
...+.+++.+||+.+|.+||++.+++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 4567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=260.85 Aligned_cols=245 Identities=19% Similarity=0.253 Sum_probs=187.6
Q ss_pred hhhcCcccc-ceeccCCCcceeeccc-------------cHHHHHHHHHHHHhh-ccCCeeeeeeeeee----cCeeEEE
Q 036419 456 AATNNFGVE-NKLGEGGFGPVYKSGQ-------------GLEEFKNEIKLTAKL-QHRNLVRLLGCCVE----QGENVLI 516 (754)
Q Consensus 456 ~~~~~y~~~-~~lG~G~fg~Vyk~~~-------------~~~~~~~Ev~il~~l-~hpniv~l~~~~~~----~~~~~lV 516 (754)
..+++|.+. ++||-|-.|.|....+ +..+.++||++-... .|||||.++++++. ...+++|
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 356777765 4899999999975211 234567888776655 49999999999863 3456799
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC---CCceEEeeccCccc
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARM 593 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~---~~~~kl~DFgla~~ 593 (754)
||+|+||.|...|.+. ....+++.++..|.+||..|+.|||+.+ |.||||||+|+|... +-.+||+|||+|+.
T Consensus 138 mE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccc
Confidence 9999999999999663 3456999999999999999999999998 999999999999964 45789999999997
Q ss_pred cCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
-... ......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||-........ ...-.+ ...+ ..
T Consensus 214 t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-pgMk~r-I~~g-qy--- 284 (400)
T KOG0604|consen 214 TQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKRR-IRTG-QY--- 284 (400)
T ss_pred cCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-hhHHhH-hhcc-Cc---
Confidence 5432 2344578899999999999999999999999999999999999998533321110 000000 0000 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.+..+.-...++...++|+.+|..+|.+|.|+++++.|--
T Consensus 285 --~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 285 --EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred --cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 1122223457788999999999999999999999998763
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=277.30 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=194.5
Q ss_pred hcCccccceeccCCCcceeec-------------cccHHHHHHHHHHHHh--hccCCeeeeeeeeeecC----eeEEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKS-------------GQGLEEFKNEIKLTAK--LQHRNLVRLLGCCVEQG----ENVLIYE 518 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~-------------~~~~~~~~~Ev~il~~--l~hpniv~l~~~~~~~~----~~~lV~E 518 (754)
....++.+.||+|.||.|||+ .+..+.|++|-.|.+- ++|+||+++++.-.... ++.||+|
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 345667789999999999983 3456778888887764 58999999999876555 7899999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY------SRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~------~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
|.+.|+|.+||. ...++|....+|+.-|++||+|||+. .+++|+|||||.+||||.+++++.|+|||+|.
T Consensus 289 fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999994 45699999999999999999999974 34679999999999999999999999999999
Q ss_pred ccCCCcccccccccccccCcccccccccC-CCC-----cccchhhHHHHHHHHHhCCCCCCcc--cCCchhHhH------
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHG-FFS-----IKSDVFSFGVLLLETLSSKRSTRFF--NTNSLTLLG------ 658 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s-----~ksDVwSlGvil~elltg~~p~~~~--~~~~~~~~~------ 658 (754)
.+..+.........+||..|||||++.+. .+. .+.||||+|.|||||++....+... ++-...+..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 99877666666678999999999998764 233 4589999999999999987655321 111111111
Q ss_pred ---hhhh-hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 036419 659 ---HAWN-LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVN 720 (754)
Q Consensus 659 ---~~~~-~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 720 (754)
..+. .........+.+.-.. ..-...+++.+..||..||+.|.|+.=|-+++......
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 1111 1111111111111111 13456688999999999999999999999999876443
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=271.94 Aligned_cols=228 Identities=23% Similarity=0.269 Sum_probs=175.1
Q ss_pred ceeccCCCcceeeccc---------------------cHHHHHHHHHHH-HhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLT-AKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il-~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
+.||+|+||.||++.. ....+..|..++ ...+|||++++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999997321 012234444443 445899999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|.+++.. .+.+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999953 346899999999999999999999987 99999999999999999999999999886432
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..|+....... .... ...... .......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~----~~~~~~------~~~~~~~ 217 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--VFDN----ILSRRI------NWPEEVK 217 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--HHHH----HHhccc------CCCCccc
Confidence 223568889999999988889999999999999999999999986433221 1100 000000 0011111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
...+..+.+++.+||+.+|++||++.++.+.|..
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 1345678999999999999999987666555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=287.17 Aligned_cols=246 Identities=21% Similarity=0.303 Sum_probs=183.5
Q ss_pred hhhhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC---
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG--- 511 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~--- 511 (754)
....++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 3456789999999999999999721 11245788999999999999999999987553
Q ss_pred ---eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeec
Q 036419 512 ---ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDF 588 (754)
Q Consensus 512 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DF 588 (754)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 458999998 6799888842 45899999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhh-------
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA------- 660 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~------- 660 (754)
|++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........ .....
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 236 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPS 236 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCC
Confidence 999865432 223467889999998876 4688999999999999999999999864432111 00000
Q ss_pred ---hhhhccCccccccC--cccC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 661 ---WNLWKDDRSWELMD--PKLQ----CEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 661 ---~~~~~~~~~~~l~d--~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...+.......... +... ..........+.+++.+|++.||++|||+.+++.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00000000000000 0000 000112345688999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=273.30 Aligned_cols=226 Identities=27% Similarity=0.310 Sum_probs=174.4
Q ss_pred eeccCCCcceeeccc---------------------cHHHHHHHHH---HHHhhccCCeeeeeeeeeecCeeEEEEEecC
Q 036419 466 KLGEGGFGPVYKSGQ---------------------GLEEFKNEIK---LTAKLQHRNLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 466 ~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~---il~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 521 (754)
.||+|+||.||++.. ....+..|.. +++..+||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999996211 1112334433 4444579999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~ 601 (754)
+++|.+++.. .+.+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999998843 356999999999999999999999988 9999999999999999999999999998654321
Q ss_pred cccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 602 NTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
.....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||.............. .. .....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~------~~~~~---- 217 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL------TMAVE---- 217 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH---hh------ccCCC----
Confidence 2235789999999998754 689999999999999999999999865432221110000 00 00111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036419 681 ASYPIVKRYINVALLCVQENAADRP-----TMSEVISML 714 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 714 (754)
.....+..+.+++.+||+.+|.+|| ++.+++++-
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 1112356788999999999999999 999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=273.53 Aligned_cols=235 Identities=24% Similarity=0.306 Sum_probs=183.7
Q ss_pred CccccceeccCCCcceeeccc-------------------------cHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCee
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ-------------------------GLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~-------------------------~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~ 513 (754)
+|++.+.||+|+||.||++.. ..+++.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999996221 125577899999999 589999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||||+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999954 345889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHG--FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
....... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..|+....... .............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~---- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSE---- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHhhccC----
Confidence 6433221 12245688999999998753 57889999999999999999999986432221 1111111111100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISM 713 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 713 (754)
+ .........+.+++.+||+.||++|| ++++++.+
T Consensus 229 ---~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ---P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 11112345678999999999999997 77888776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=274.36 Aligned_cols=230 Identities=26% Similarity=0.367 Sum_probs=181.6
Q ss_pred eccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCCh
Q 036419 467 LGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 467 lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
||+|+||.||++. ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6889999998722 2345688899999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc------
Q 036419 526 DSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL------ 599 (754)
Q Consensus 526 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~------ 599 (754)
.+++.+. +.+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9999543 36899999999999999999999988 99999999999999999999999999886543211
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
........++..|+|||.+....++.++||||||+++++|++|..|+........ ... .. .... ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~---~~-~~~~--------~~ 220 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI--FQN---IL-NGKI--------EW 220 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH---Hh-cCCc--------CC
Confidence 1122345678899999999888899999999999999999999999764432211 100 00 0000 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
.........+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0111135678899999999999999999666666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=277.50 Aligned_cols=228 Identities=30% Similarity=0.435 Sum_probs=179.3
Q ss_pred ccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 461 FGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
|...++||+|+||+||++. ...+.+.+|++++++++|||++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 6667889999999999731 1124678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+.+ ++.+++.. ....+++..+..++.||+.+|.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 965 67666643 2345899999999999999999999988 99999999999999999999999999864321
Q ss_pred cccccccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 600 QSNTKRIVGTYGYMSPEYAI---HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
.....|+..|+|||++. ...++.++|||||||++|+|++|..|+........ .... .... . +.
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~--~~~~---~~~~-~-----~~ 239 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHI---AQND-S-----PT 239 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH---HhcC-C-----CC
Confidence 22456888999999884 45688999999999999999999998754322111 1000 0000 0 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.........+.+++.+||+.+|.+||++.+++++-
T Consensus 240 ---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 240 ---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHD 274 (313)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 11112335688999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=283.42 Aligned_cols=246 Identities=26% Similarity=0.306 Sum_probs=187.5
Q ss_pred CccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC-----eeE
Q 036419 460 NFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG-----ENV 514 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~-----~~~ 514 (754)
+|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58889999999999999721 12457889999999999999999999998775 789
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++ +|.+++.. ...+++..+..++.||++||.|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999985 78888843 337999999999999999999999998 999999999999999999999999999976
Q ss_pred CCCcc-cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh--------
Q 036419 595 GGDEL-QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW-------- 664 (754)
Q Consensus 595 ~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 664 (754)
..... ........++..|+|||++.+. .++.++||||||+++++|++|+.||......+. ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ--LNLIVEVLGTPSEEDL 231 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHhcCCCChhHh
Confidence 54321 0112345678899999999887 899999999999999999999999865443211 00000000
Q ss_pred ---ccCccccccC---ccc---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 665 ---KDDRSWELMD---PKL---QCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 665 ---~~~~~~~l~d---~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
........+. ... ........+..+.+++.+||+.+|.+||++++++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 0000000000 000 0001112456789999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=273.17 Aligned_cols=245 Identities=24% Similarity=0.286 Sum_probs=182.3
Q ss_pred ccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEEEEEec
Q 036419 461 FGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
|++.+.||+|+||+||++.. ......+|+..+++++ |||++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 67789999999999997321 1223457899999999 999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 778988885432 246899999999999999999999987 99999999999999999999999999986643221
Q ss_pred ccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhH--hH---------hhhhhhccCc
Q 036419 601 SNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL--LG---------HAWNLWKDDR 668 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~--~~---------~~~~~~~~~~ 668 (754)
.....++..|+|||++.. ..++.++|+||||++++||++|+.|+.......... .. +.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 223567889999998754 468999999999999999999998876543221100 00 0000000000
Q ss_pred cccccCcccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 669 SWELMDPKLQ---CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 669 ~~~l~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
....+..... ..........+.+++.+||+.+|++|||++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 00001124678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=278.36 Aligned_cols=235 Identities=29% Similarity=0.418 Sum_probs=184.2
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..+.|...+.||+|+||.||++. ...+++.+|++++++++|||++++++++..+...++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 34558888999999999999621 113457789999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+. +++.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 93 VMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 999997 5777766432 345889999999999999999999987 9999999999999999999999999988653
Q ss_pred CCcccccccccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAI---HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
.. ....++..|+|||++. ...++.++|||||||++|+|++|..|+........ .... .....
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~----~~~~~--- 231 (308)
T cd06634 167 PA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHI----AQNES--- 231 (308)
T ss_pred Cc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HHHH----hhcCC---
Confidence 22 2346788999999875 35688999999999999999999998754322111 0000 00000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+. .........+.+++.+||+.+|++||++.+|+++....
T Consensus 232 --~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 232 --PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred --CC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 11 11123456688999999999999999999999986544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=270.61 Aligned_cols=243 Identities=25% Similarity=0.378 Sum_probs=181.8
Q ss_pred ccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhh---ccCCeeeeeeeeeecCe-----
Q 036419 461 FGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKL---QHRNLVRLLGCCVEQGE----- 512 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l---~hpniv~l~~~~~~~~~----- 512 (754)
|++.+.||+|+||.||++.. ....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67789999999999997221 123466788877766 59999999999988776
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.+++|||+++ +|.+++.... ...+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 9999999985 7888885432 235899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh--------h
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL--------W 664 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~ 664 (754)
....... .....++..|+|||++.+..++.++|||||||++|+|++|..|+......+ ........ +
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhc
Confidence 7643321 223457889999999999999999999999999999999988876433221 11111000 0
Q ss_pred ccCcc--ccccCcccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 665 KDDRS--WELMDPKLQ---CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 665 ~~~~~--~~l~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..... ......... ..........+.+++.+||+.||.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000 000000000 11112345778899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=275.36 Aligned_cols=237 Identities=24% Similarity=0.396 Sum_probs=181.1
Q ss_pred hcCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~lV~ 517 (754)
-++|++.++||+|+||.||++.. ...++..|+.++.++. ||||+++++++.++...++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 46789999999999999997221 2244566777777775 999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY-SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
||+++ ++.+++... ...+++..+..++.||++||.|||+. + |+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99864 777766442 24689999999999999999999974 5 99999999999999999999999999986643
Q ss_pred CcccccccccccccCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHG----FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
... .....++..|+|||.+... .++.++||||||+++|+|++|+.|+.........+. ...... .
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~-~--- 236 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT----KILQEE-P--- 236 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH----HHhcCC-C---
Confidence 321 1233578899999998755 388999999999999999999999854322111111 111111 0
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
+.. .......+++.+++.+||+.||++||++.+++++.-
T Consensus 237 --~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 237 --PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred --CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 000 001123467899999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=282.06 Aligned_cols=250 Identities=20% Similarity=0.264 Sum_probs=185.4
Q ss_pred hhHhhhhcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeec-
Q 036419 452 ASVSAATNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ- 510 (754)
Q Consensus 452 ~~~~~~~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~- 510 (754)
.++...+++|.+.+.||+|+||.||++.. ..+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45666789999999999999999997211 134577899999999999999999988643
Q ss_pred -----CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEE
Q 036419 511 -----GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKI 585 (754)
Q Consensus 511 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl 585 (754)
...+++++++ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3467788876 7799888742 35899999999999999999999988 999999999999999999999
Q ss_pred eeccCccccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh-
Q 036419 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL- 663 (754)
Q Consensus 586 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~- 663 (754)
+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.......
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~ 235 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVG 235 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 999999865322 233567889999998876 578899999999999999999999986433211 000000000
Q ss_pred ---------hccCcccc---ccCcccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 664 ---------WKDDRSWE---LMDPKLQC---EASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 664 ---------~~~~~~~~---l~d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
........ .+...... .........+.+++..||+.||.+||++.+++.+--
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 00000000 00000000 000012456889999999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=283.52 Aligned_cols=248 Identities=21% Similarity=0.258 Sum_probs=180.4
Q ss_pred hcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec---------
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--------- 510 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--------- 510 (754)
..+|.+.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 4689999999999999999731 2346688999999999999999999876543
Q ss_pred -----CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc-CCCceE
Q 036419 511 -----GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD-SNMIPK 584 (754)
Q Consensus 511 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld-~~~~~k 584 (754)
...++||||+++ +|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 357899999974 8888773 245889999999999999999999988 99999999999997 456789
Q ss_pred EeeccCccccCCCccc-ccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh
Q 036419 585 ISDFGLARMFGGDELQ-SNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 585 l~DFgla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 662 (754)
|+|||+++.+...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||......... ......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-QLILES 234 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHh
Confidence 9999999865432111 11123467889999998755 46889999999999999999999998644321110 000000
Q ss_pred hhc--c---C----cccc-ccCcccCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 663 LWK--D---D----RSWE-LMDPKLQC-----EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 663 ~~~--~---~----~~~~-l~d~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
... . . .... ........ ........++.+++.+||+.||++|||+++++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~ 301 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP 301 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCC
Confidence 000 0 0 0000 00000000 00112346788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=284.24 Aligned_cols=238 Identities=26% Similarity=0.343 Sum_probs=182.7
Q ss_pred ccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC------eeEE
Q 036419 461 FGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG------ENVL 515 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~------~~~l 515 (754)
+...+.||+||||.||+.+ ...+...+|+++|++|+|||||++.++=++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4456789999999999843 23467789999999999999999999865443 5689
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc--CCC--ceEEeeccCc
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD--SNM--IPKISDFGLA 591 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld--~~~--~~kl~DFgla 591 (754)
|||||.+|+|...+.+..+..-+++.+.+.++.++..||.|||+++ |+||||||.||++- ++| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998888788999999999999999999999988 99999999999993 333 4699999999
Q ss_pred cccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCch--hHhHhhhhhhcc--
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL--TLLGHAWNLWKD-- 666 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~-- 666 (754)
+.+..+. ....++||..|++||.+.. +.|+..+|.|||||++|+.+||..||.-...... ....+.. .-+.
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~-tkkp~~ 247 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHII-TKKPSG 247 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhh-ccCCCc
Confidence 9886654 4567899999999999985 7899999999999999999999999854332211 0100000 0000
Q ss_pred ----------CccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 036419 667 ----------DRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRP 705 (754)
Q Consensus 667 ----------~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 705 (754)
+++..-..-............++-..+..+|..+|++|-
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 011000000112333445667777888888899999998
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=277.86 Aligned_cols=247 Identities=24% Similarity=0.286 Sum_probs=185.1
Q ss_pred hhhhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee-cCee
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE-QGEN 513 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~-~~~~ 513 (754)
...+++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 3467899999999999999999731 123567899999999999999999999865 5678
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++|+||+ +++|..++. ...+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 458888874 235788889999999999999999988 99999999999999999999999999985
Q ss_pred cCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchh--HhHh-------hhhh
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLT--LLGH-------AWNL 663 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~--~~~~-------~~~~ 663 (754)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... +... ....
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4321 223467889999998766 57899999999999999999999998654321100 0000 0000
Q ss_pred hccCccccccCc-ccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 664 WKDDRSWELMDP-KLQCEAS-----YPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 664 ~~~~~~~~l~d~-~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.......+++.. ....... ......+.+++.+||+.+|++||++.+++.+-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 000000000000 0000001 12346789999999999999999999998874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=281.71 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=181.4
Q ss_pred hcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeec------C
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ------G 511 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~------~ 511 (754)
.++|.+.+.||+|+||.||++.. ....+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999997321 124578899999999999999999998754 3
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..++|+||+.. +|..++ ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999975 676655 135889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhh---------
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW--------- 661 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------- 661 (754)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+.....
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEF 238 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHH
Confidence 865322 223567889999999876 468999999999999999999999986543211 0100000
Q ss_pred -hhhccCccccccC--cccC-C---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 036419 662 -NLWKDDRSWELMD--PKLQ-C---EASYPIVKRYINVALLCVQENAADRPTMSEVISM--LTNE 717 (754)
Q Consensus 662 -~~~~~~~~~~l~d--~~~~-~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 717 (754)
..+.......... +... . .........+.+++.+||+.||++||++.++++| ++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000000000000 0000 0 0001234568899999999999999999999977 5544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=261.68 Aligned_cols=237 Identities=23% Similarity=0.321 Sum_probs=185.2
Q ss_pred cceeccCCCcceee------------------ccccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEEEEEecCCCC
Q 036419 464 ENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVLIYEYLPNKS 524 (754)
Q Consensus 464 ~~~lG~G~fg~Vyk------------------~~~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~lV~E~~~~gs 524 (754)
.+.||+|+|+.|-- ..+...++.+||+++.+.+ |+||++|+++|+++...|||||.|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 35799999999853 3456788999999999997 9999999999999999999999999999
Q ss_pred hhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc---eEEeeccCccccCCCc---
Q 036419 525 LDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI---PKISDFGLARMFGGDE--- 598 (754)
Q Consensus 525 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~---~kl~DFgla~~~~~~~--- 598 (754)
|..+|.+ +..+++.++.++.++|+.||.+||.++ |.||||||+|||-..... +||+||.+..-+....
T Consensus 163 lLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9999954 456999999999999999999999998 999999999999976654 6999999986443211
Q ss_pred --ccccccccccccCcccccccc---c--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccc-
Q 036419 599 --LQSNTKRIVGTYGYMSPEYAI---H--GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW- 670 (754)
Q Consensus 599 --~~~~~~~~~gt~~y~APE~~~---~--~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 670 (754)
........+|+..|||||++. + ..|+.++|.||||||||-||+|..||.+....+. .|+.+..-
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdrGe~Cr 308 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDRGEVCR 308 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccCCCccH
Confidence 112233568999999999763 2 3689999999999999999999999976543321 11111110
Q ss_pred --------cccCcc--cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 671 --------ELMDPK--LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 671 --------~l~d~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.+.+.. +....-..++.+..+++...|..|+.+|.++.+++.|-
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 011111 11112234667788999999999999999999998843
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=269.46 Aligned_cols=245 Identities=27% Similarity=0.352 Sum_probs=183.8
Q ss_pred ccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 461 FGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
|++.+.||+|++|.||++. ...+.+.+|++++++++|||++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5667899999999999721 12356788999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++ +|.+++.... ..+++..+..++.|+++||.|||+.+ |+|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 DM-DLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred Cc-CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 84 8999996532 45899999999999999999999988 99999999999999999999999999987643321
Q ss_pred ccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCch--hHh-------HhhhhhhccCc-c
Q 036419 601 SNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL--TLL-------GHAWNLWKDDR-S 669 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~--~~~-------~~~~~~~~~~~-~ 669 (754)
......++..|+|||.+.+. .++.++||||||++++||++|+.|+........ ... ...+..+.... .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12234457789999998776 889999999999999999999988754332110 000 00000000000 0
Q ss_pred ccccCc---ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 670 WELMDP---KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 670 ~~l~d~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
...... .............+.+++..||+.+|++||++++|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000 00000111235679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=277.76 Aligned_cols=249 Identities=24% Similarity=0.305 Sum_probs=184.5
Q ss_pred hcCcc-ccceeccCCCcceeecccc--------------------------------HHHHHHHHHHHHhhccCCeeeee
Q 036419 458 TNNFG-VENKLGEGGFGPVYKSGQG--------------------------------LEEFKNEIKLTAKLQHRNLVRLL 504 (754)
Q Consensus 458 ~~~y~-~~~~lG~G~fg~Vyk~~~~--------------------------------~~~~~~Ev~il~~l~hpniv~l~ 504 (754)
.++|. +.+.||+|+||.||++... ...+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35665 4577999999999983210 11467899999999999999999
Q ss_pred eeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceE
Q 036419 505 GCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPK 584 (754)
Q Consensus 505 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~k 584 (754)
+++..++..++||||++ ++|.+++.. ...+++.....++.||+.||.|||+.+ |+|+||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 588888843 346899999999999999999999988 99999999999999999999
Q ss_pred EeeccCccccCCCcc------------cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccC
Q 036419 585 ISDFGLARMFGGDEL------------QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNT 651 (754)
Q Consensus 585 l~DFgla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~ 651 (754)
|+|||+++....... ........++..|+|||.+.+. .++.++|||||||++|+|++|..|+...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999987652111 1111233568899999998764 478999999999999999999999865443
Q ss_pred CchhHhHhhhhhhccCccc---c--------ccCcccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 652 NSLTLLGHAWNLWKDDRSW---E--------LMDPKLQ---CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~---~--------l~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.. ............... + ....... ..........+.+++.+||+.+|++||++++++.+.-
T Consensus 240 ~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 240 ID--QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HH--HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 22 111111111000000 0 0000000 0001123467889999999999999999999998764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=278.71 Aligned_cols=248 Identities=23% Similarity=0.271 Sum_probs=179.4
Q ss_pred CccccceeccCCCcceeeccc----------------------cHHHHHHHHHHHHhh-ccCCeeeeeeeeeec----Ce
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ----------------------GLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQ----GE 512 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~----------------------~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~----~~ 512 (754)
+|++.+.||+|+||.||++.. ..+.+.+|+++++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478889999999999997221 134577899999999 599999999976433 45
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++++||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788889886 58888884 3456899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccc--ccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCch-hHhHhh--------
Q 036419 593 MFGGDELQ--SNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-TLLGHA-------- 660 (754)
Q Consensus 593 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~-------- 660 (754)
.+...... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||........ ......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 66432211 11234578999999998765 4689999999999999999999998865432110 000000
Q ss_pred hhhhccCccccc---cC--c-ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 661 WNLWKDDRSWEL---MD--P-KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 661 ~~~~~~~~~~~l---~d--~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...+........ .. + .............+.+++.+||+.||.+|||+.+++++=
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000000000 00 0 000000111245788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=268.22 Aligned_cols=251 Identities=24% Similarity=0.299 Sum_probs=192.4
Q ss_pred hcCccccceeccCCCcceeecccc-HH--------------------HHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQG-LE--------------------EFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~~-~~--------------------~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~l 515 (754)
..+|.++..||+|+||.|.+++.. .+ --+.|-++|+-.. -|.++++..+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357888999999999999974432 11 1234555555443 5789999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+.||+|..+|+ +-+.+.+..+.-++.+|+-||-+||+++ ||+||||.+|||+|.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999994 4466888889999999999999999998 9999999999999999999999999998432
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
-+ ...+..++||+.|+|||++.-++|+.++|.|||||+||||+.|++||.+.++.+.... +.+.
T Consensus 502 ~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a--------------I~eh 565 (683)
T KOG0696|consen 502 FD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA--------------IMEH 565 (683)
T ss_pred cC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------------HHHc
Confidence 11 2345678999999999999999999999999999999999999999987665542211 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHH--------hccccCCCCCCCCCcccc
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTM-----SEVISML--------TNEFVNLPSPQQPGFSSL 732 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~L--------~~~~~~~~~p~~p~~~~~ 732 (754)
. ..++...+.+...+....|.++|.+|.-. .+|..|- .-+..++++|-.|.....
T Consensus 566 n--vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~ 633 (683)
T KOG0696|consen 566 N--VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCG 633 (683)
T ss_pred c--CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccC
Confidence 1 13334456777888888899999999632 2333221 112246677777766433
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=294.93 Aligned_cols=262 Identities=21% Similarity=0.253 Sum_probs=203.2
Q ss_pred hhhHhhhhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~ 509 (754)
+.++....++|.+.+.||+|+||.|.... ....-|..|-.||..-+.+=|+.++..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 44556667899999999999999997521 223456778888888888899999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
..++|+|||||+||+|-.++. +..+++++.++-++..|+.||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999994 3347999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIH-----GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW 664 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 664 (754)
.+-.+..+.. ......+|||.|++||++.. +.|++.+|.||+||++|||+.|..||... .+++...+..
T Consensus 221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIM 294 (1317)
T ss_pred hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHh
Confidence 9988875433 33446789999999999852 46899999999999999999999998532 2222222233
Q ss_pred ccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHHhc------cccCCCCCCCCCcccc
Q 036419 665 KDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPT---MSEVISMLTN------EFVNLPSPQQPGFSSL 732 (754)
Q Consensus 665 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~L~~------~~~~~~~p~~p~~~~~ 732 (754)
+......+ +....+++...+||...+. +|+.|.. ++++-.|.-. ...+..+|-.|..++.
T Consensus 295 ~hk~~l~F-------P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd 363 (1317)
T KOG0612|consen 295 NHKESLSF-------PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSD 363 (1317)
T ss_pred chhhhcCC-------CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCC
Confidence 33222211 1223366777888886654 8888887 9999988742 1234556666665443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=282.18 Aligned_cols=231 Identities=22% Similarity=0.250 Sum_probs=184.6
Q ss_pred hhcCccccceeccCCCcceeeccc--------------cHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEecC
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ--------------GLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~--------------~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~~~ 521 (754)
.+..|.+...+|.|+|+.|-.... ...+..+|+.++... +||||+++.+.+.++.+.++|||.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 467888888999999999875211 122345677565555 69999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE-cCCCceEEeeccCccccCCCccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL-DSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll-d~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++-+.+-|... .... .++..|+.+|+.|+.|||+++ ++||||||+|||+ ++.++++|+|||.++...+.
T Consensus 400 g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 400 GGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred ccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 99888877432 2233 777889999999999999988 9999999999999 58899999999999987654
Q ss_pred ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
....+-|..|.|||++....|++++|+||||++||+||+|+.|+...... .++. .......
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~----------------~~i~~~~ 530 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIH----------------TRIQMPK 530 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHH----------------HhhcCCc
Confidence 22346688999999999999999999999999999999999998754433 1111 1111122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
....+++...+|+.+||+.||.+||+|.++..|--.
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 224466778999999999999999999999887544
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=281.75 Aligned_cols=244 Identities=23% Similarity=0.297 Sum_probs=184.5
Q ss_pred hhhcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCe---
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE--- 512 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~--- 512 (754)
...++|++.+.||+|++|.||++.. ..+.+.+|++++++++|||++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4567899999999999999997211 22456789999999999999999998876654
Q ss_pred ---eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 513 ---NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 513 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
.++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5699988843 45899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh----
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW---- 664 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---- 664 (754)
++...... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||........ ........
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~~~i~~~~~~~~ 236 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--LKRIMNLVGTPD 236 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCC
Confidence 99865432 2334678899999988653 688999999999999999999999864432110 00000000
Q ss_pred -------ccCccccccCc---ccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 665 -------KDDRSWELMDP---KLQC---EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 665 -------~~~~~~~l~d~---~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.......++.. .... .........+.+++.+||+.+|++|||+.+|+++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 00000000000 0000 00011356789999999999999999999998864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=255.35 Aligned_cols=236 Identities=23% Similarity=0.366 Sum_probs=182.1
Q ss_pred cCccccceeccCCCcceeec-------------------cccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKS-------------------GQGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~-------------------~~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~lV~E 518 (754)
++.+++..||.|..|.|+|. ..+.+++...+.++.+-+ .|.||+.+|+|..+....+.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 44556778999999999971 223456667777776665 7999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
.|.. -++.++.. -.+++++..+-++...+++||.||.++. +|||||+||+|||+|+.|++||||||++-.+-...
T Consensus 172 lMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 8844 45555543 3356888888899999999999998865 69999999999999999999999999998765432
Q ss_pred ccccccccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIH---GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
..++..|-+.|||||-+.- ..|+.++||||||+.++||.||+.|+..-+.+-..+.. ..++. .|
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk----vln~e------PP 313 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK----VLNEE------PP 313 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH----HHhcC------CC
Confidence 2345679999999998853 47999999999999999999999998754433222111 11111 12
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.+.... ..+..+++++..||++|+.+||...++++|-
T Consensus 314 ~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 314 LLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred CCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 222111 1456789999999999999999999999875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=286.74 Aligned_cols=237 Identities=27% Similarity=0.385 Sum_probs=195.5
Q ss_pred ccccceeccCCCcceee-----------------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 461 FGVENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk-----------------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
.+..++||+|+||+||| +....+++..|+-+|.+|+|||++||+++|.... ..||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34467999999999998 2334678999999999999999999999998776 88999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
+||+.|.|.+|++. .+..+..+..+.|..||++||.|||++. ++||||-.+|||+....++||.|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999976 3456889999999999999999999987 999999999999999999999999999999876
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
..+-......-.+.|||-|.+....|+.++|||||||.+||++| |.+|+......+. .+++...
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI---------------~dlle~g 916 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI---------------PDLLEKG 916 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh---------------hHHHhcc
Confidence 65555544555678999999999999999999999999999987 5566543332221 1112211
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.+-+.++....++..++.+||..|++.||+++++...+....
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 222334456677899999999999999999999999887653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=264.77 Aligned_cols=250 Identities=24% Similarity=0.269 Sum_probs=189.9
Q ss_pred hhhhcCccccceeccCCCcceeec-----------------cccHHHHHHHHHHHHhhcc--CC----eeeeeeeeeecC
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKS-----------------GQGLEEFKNEIKLTAKLQH--RN----LVRLLGCCVEQG 511 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~-----------------~~~~~~~~~Ev~il~~l~h--pn----iv~l~~~~~~~~ 511 (754)
...+++|.+.+++|+|.||.|.+. ....+..+-|+++++++.+ |+ +|.+.++|...+
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 345789999999999999999861 1223455679999999953 33 788899999999
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC------------
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS------------ 579 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~------------ 579 (754)
+.|+|+|.+ |.|+.+++... ...+++...+..|+.|+++++++||+.+ ++|-||||+|||+..
T Consensus 165 hiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred ceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 999999987 56899999553 3356899999999999999999999988 999999999999932
Q ss_pred --------CCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccC
Q 036419 580 --------NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNT 651 (754)
Q Consensus 580 --------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~ 651 (754)
+..+||+|||.|...... ...++.|..|+|||++.+-.++.++||||+||||+|+.+|..-|+..+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 335899999999875433 2457889999999999999999999999999999999999988876553
Q ss_pred Cc-hhHhHh--------------hhhhhccCccc--------------cccCcc-cCCCCCHHHHHHHHHHHHHccccCC
Q 036419 652 NS-LTLLGH--------------AWNLWKDDRSW--------------ELMDPK-LQCEASYPIVKRYINVALLCVQENA 701 (754)
Q Consensus 652 ~~-~~~~~~--------------~~~~~~~~~~~--------------~l~d~~-~~~~~~~~~~~~l~~li~~cl~~dP 701 (754)
.+ ..+.+. ..+.+..+++. +...+. ........+...+.+|+..||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 32 111111 11111111111 000000 0011123456779999999999999
Q ss_pred CCCCCHHHHHHHH
Q 036419 702 ADRPTMSEVISML 714 (754)
Q Consensus 702 ~~RPt~~evl~~L 714 (754)
.+|+|+.|+++|-
T Consensus 395 ~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 395 ARRITLREALSHP 407 (415)
T ss_pred cccccHHHHhcCH
Confidence 9999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=297.26 Aligned_cols=128 Identities=29% Similarity=0.453 Sum_probs=116.2
Q ss_pred cCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.++||+|+||.||++.. ....+..|+.+++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 6799999999999999997321 1367889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
||+++++|.+++.. .+.+++..++.|+.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999953 345889999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=260.12 Aligned_cols=223 Identities=27% Similarity=0.354 Sum_probs=178.9
Q ss_pred eccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCCh
Q 036419 467 LGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 467 lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
||+|+||.||+.. ...+.+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6889999888621 1345788999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccc
Q 036419 526 DSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR 605 (754)
Q Consensus 526 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~ 605 (754)
.+++... ..+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9999543 35899999999999999999999987 9999999999999999999999999998764432 12334
Q ss_pred cccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHH
Q 036419 606 IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPI 685 (754)
Q Consensus 606 ~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~ 685 (754)
..++..|+|||.+.+...+.++|+||||+++|+|++|..|+...... ...... .. .. .......
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~---~~---------~~--~~~~~~~ 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--EIYEKI---LK---------DP--LRFPEFL 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH---hc---------CC--CCCCCCC
Confidence 56888999999998888999999999999999999999998543321 111110 00 00 0111122
Q ss_pred HHHHHHHHHHccccCCCCCCCH---HHHHHH
Q 036419 686 VKRYINVALLCVQENAADRPTM---SEVISM 713 (754)
Q Consensus 686 ~~~l~~li~~cl~~dP~~RPt~---~evl~~ 713 (754)
+..+.+++.+||..||++||++ ++++++
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 5678899999999999999999 555543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=273.54 Aligned_cols=234 Identities=25% Similarity=0.358 Sum_probs=187.4
Q ss_pred cCccc--cceeccCCCcceee--------------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 459 NNFGV--ENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 459 ~~y~~--~~~lG~G~fg~Vyk--------------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
.-|++ .+.||.|-||+||- .......+++|++||++++||.||.+...|+..+..++|
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVV 641 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVV 641 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEE
Confidence 34554 47999999999994 223457899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC---CCceEEeeccCccc
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARM 593 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~---~~~~kl~DFgla~~ 593 (754)
||.+.|.-|+-+| . .+.+++++....-++.||+.||.|||.++ |+|+||||+|||+.. --++||||||+|++
T Consensus 642 MEKl~GDMLEMIL-S-sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 642 MEKLHGDMLEMIL-S-SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred ehhhcchHHHHHH-H-hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceee
Confidence 9999664444444 3 45678999999999999999999999998 999999999999954 34799999999999
Q ss_pred cCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
++..... ..++||+.|+|||++.++.|...-|+||.|||+|--++|..||....+-. ..+..+.. +.
T Consensus 717 IgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-dQIQNAaF---------My 783 (888)
T KOG4236|consen 717 IGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-DQIQNAAF---------MY 783 (888)
T ss_pred cchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-HHhhcccc---------cc
Confidence 9876543 35799999999999999999999999999999999999999975322111 11111110 11
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
....-.++.+..+++|...||..-.+|.+..+-+.|.
T Consensus 784 ----Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 784 ----PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred ----CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 1112234567789999999999999999998876653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=249.38 Aligned_cols=252 Identities=21% Similarity=0.390 Sum_probs=184.6
Q ss_pred cCccccceeccCCCcceeecccc--------------------HHHHHHHHHHHHhhccCCeeeeeeeeee--------c
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQG--------------------LEEFKNEIKLTAKLQHRNLVRLLGCCVE--------Q 510 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~~--------------------~~~~~~Ev~il~~l~hpniv~l~~~~~~--------~ 510 (754)
..|+-..+||+|.||+|||++.. .....+|+++|..|+|+|++.++++|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666779999999999984332 1223579999999999999999999853 3
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
...++||+++++ +|.-++.+ ...+++..++.++..+++.||.|+|... |+|||+|+.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 357999999987 77777743 2346899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcc--cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhh-----h
Q 036419 591 ARMFGGDEL--QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHA-----W 661 (754)
Q Consensus 591 a~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~-----~ 661 (754)
++.+..... ...-+..+-|.+|++||.+.+. .|+++.|||..|||+.||.++.+.++...+.. ..++... .
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987643221 1222345569999999988875 79999999999999999999998876544332 2211111 1
Q ss_pred hhhccC---cccccc--CcccCCCC--------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 662 NLWKDD---RSWELM--DPKLQCEA--------SYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 662 ~~~~~~---~~~~l~--d~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
..|.+- .+++-+ .|...... .........+++.+++..||.+|+++++++.|--.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 122221 111111 11110000 01112356789999999999999999999988644
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=278.63 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=200.8
Q ss_pred hhhHhhhhcCccccceeccCCCcceee-----------------ccccHHHHHHHHHHHHhh-ccCCeeeeeeeeee---
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKL-QHRNLVRLLGCCVE--- 509 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk-----------------~~~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~--- 509 (754)
+..+...++.|++.+.||+|.+|.||| .....++++.|..|++.+ +|||++.+++++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 445566778899999999999999998 234567888999999988 58999999999863
Q ss_pred --cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEee
Q 036419 510 --QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISD 587 (754)
Q Consensus 510 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~D 587 (754)
++.+.||||||.+|+..+++.+.. ...+.|..+..|++.+++|+.+||.+. ++|||||-.|||++.++.+||.|
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence 578999999999999999998765 678999999999999999999999987 99999999999999999999999
Q ss_pred ccCccccCCCcccccccccccccCcccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh
Q 036419 588 FGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG-----FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 588 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 662 (754)
||.+..+.... .......||+.|||||++... .|+..+|+||||++..||.-|.+|+....+...
T Consensus 167 FGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-------- 236 (953)
T KOG0587|consen 167 FGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-------- 236 (953)
T ss_pred eeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--------
Confidence 99998776543 334457899999999999643 578899999999999999999999754433210
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
++. -..+|......+..-.+++.++|..||.+|-++||++.++++|-
T Consensus 237 LF~-----IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 237 LFL-----IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred hcc-----CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 000 01122222223344578899999999999999999999988764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=257.56 Aligned_cols=193 Identities=19% Similarity=0.123 Sum_probs=156.0
Q ss_pred HHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 036419 484 EFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRL 563 (754)
Q Consensus 484 ~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~ 563 (754)
.+.+|...+....||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+
T Consensus 31 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~-- 105 (237)
T cd05576 31 EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF---LNIPEECVKRWAAEMVVALDALHREG-- 105 (237)
T ss_pred hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 4566777777778999999999999999999999999999999998543 35899999999999999999999987
Q ss_pred ceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCC
Q 036419 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643 (754)
Q Consensus 564 ~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~ 643 (754)
|+||||||+||+++.++.++++|||.+...... .....++..|+|||.+....++.++||||+|+++|||++|+
T Consensus 106 -i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~ 179 (237)
T cd05576 106 -IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179 (237)
T ss_pred -eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCc
Confidence 999999999999999999999999988765432 12234567899999998888999999999999999999999
Q ss_pred CCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 036419 644 RSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTM 707 (754)
Q Consensus 644 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 707 (754)
.++....... ... ... ..+....+.+.+++.+||+.||++||++
T Consensus 180 ~~~~~~~~~~-----------~~~-----~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 180 TLVECHPSGI-----------NTH-----TTL----NIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred chhhcCchhc-----------ccc-----ccc----CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 7754221100 000 000 0111234678899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=232.35 Aligned_cols=110 Identities=52% Similarity=0.840 Sum_probs=82.5
Q ss_pred CCeEEEeecCCCCCCCC--CceEEEecCccEEEEcCCCCeEEee-cCCCCC-CCceEEEccCCCEEEEecCCCCCCcCce
Q 036419 71 PDTVVWVANRNSPIIEP--NAALTISNNGNLVILNLTNGAIWSS-NTSRKA-ENPVAQLLDTGNLIVRDNFSRSASEGSC 146 (754)
Q Consensus 71 ~~tvVW~ANr~~p~~~~--~~~l~~~~~g~l~l~~~~~~~~ws~-~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~ 146 (754)
++||||+|||++|+..+ .++|.|+.||+|+|++..++++|++ ++.+.+ ....|+|+|+|||||++.. +.+
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~------~~~ 74 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS------GNV 74 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT------SEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec------ceE
Confidence 46999999999999543 4899999999999999999999999 666555 5778999999999999854 899
Q ss_pred eccccCCCcccccccCcccceecCCCeeeEEecCCCCCCC
Q 036419 147 LWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPS 186 (754)
Q Consensus 147 lWQSFd~PtDTlLpg~~l~~~~~~g~~~~l~Sw~s~~dps 186 (754)
|||||||||||+||||+|+.+..+|....++||++.+|||
T Consensus 75 lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 75 LWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999999999988887777899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=228.59 Aligned_cols=246 Identities=25% Similarity=0.298 Sum_probs=183.6
Q ss_pred CccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+|.-.++||+|.||+|||++. -.....+|+-+++.|+|+|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999998322 235678999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
|.. +|..+.. .-++.++.+.+..++.|+++||.++|++. +.|||+||+|+||+.+|.+||+|||+++.++-...
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 955 7777664 34567999999999999999999999998 99999999999999999999999999998754321
Q ss_pred cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCC-CcccCCchhHhHhhhhh--hccCc---cccc
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRST-RFFNTNSLTLLGHAWNL--WKDDR---SWEL 672 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~-~~~~~~~~~~~~~~~~~--~~~~~---~~~l 672 (754)
. ..-.+-|.+|++|.++.+. -|+...|+||.|||+.|+....+|. ++.+. ..++..-.+.+ ..++. +.++
T Consensus 157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCCCccccCCccccC
Confidence 1 1224568999999999876 5899999999999999999877664 33222 22222211111 11111 1122
Q ss_pred cCcccCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 673 MDPKLQCEAS---------YPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.|-.....+. +.....=.+++.+.|.-+|..|.++++.+++-
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 2222111111 11223346777788888999999999998875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=287.23 Aligned_cols=247 Identities=29% Similarity=0.442 Sum_probs=192.6
Q ss_pred HhhhhcCccccceeccCCCcceeec--------------------------cccHHHHHHHHHHHHhh-ccCCeeeeeee
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKS--------------------------GQGLEEFKNEIKLTAKL-QHRNLVRLLGC 506 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~--------------------------~~~~~~~~~Ev~il~~l-~hpniv~l~~~ 506 (754)
++...++..+.+.||+|.||.|+++ ..+.+.+..|+++|+.+ +||||+.++++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4445566677789999999999872 12357889999999999 59999999999
Q ss_pred eeecCeeEEEEEecCCCChhhHhhccC-----------CC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCC
Q 036419 507 CVEQGENVLIYEYLPNKSLDSFLFDTT-----------KE--GLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPS 573 (754)
Q Consensus 507 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~ 573 (754)
|.++...++|+||++.|+|.++++..+ .. ..++....+.++.||+.|++||++.. ++||||-.+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999997655 01 13889999999999999999999987 999999999
Q ss_pred ceEEcCCCceEEeeccCccccCCCcccccc-cccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCC-CCCcccC
Q 036419 574 NILLDSNMIPKISDFGLARMFGGDELQSNT-KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKR-STRFFNT 651 (754)
Q Consensus 574 NIlld~~~~~kl~DFgla~~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~-p~~~~~~ 651 (754)
|||+.++..+||+|||+|+........... ....=...|||||.+....|+.|+||||||++||||++... |+.....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999976554432211 11112345999999999999999999999999999998664 3332110
Q ss_pred CchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 652 NSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
. ..+. ...+.+ .+...+....+++.++++.||+.+|++||++.++++.|+..
T Consensus 528 ~-~~l~----~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 T-EELL----EFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred H-HHHH----HHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1 1111 111111 11122223457788999999999999999999999999873
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=253.69 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=191.1
Q ss_pred hhhhcCccccceeccCCCcceeec-------------cccHHHHHHHHHHHHh--hccCCeeeeeeeeeecC----eeEE
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKS-------------GQGLEEFKNEIKLTAK--LQHRNLVRLLGCCVEQG----ENVL 515 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~-------------~~~~~~~~~Ev~il~~--l~hpniv~l~~~~~~~~----~~~l 515 (754)
....+...+.+.||+|.||+||++ ..+++.+.+|.+|.+. |+|+||+.+++.-..+. .++|
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 445567888999999999999983 2356778888888775 69999999999866543 5789
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ-----YSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-----~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
|.+|.++|||.|||.. ..++.+..++++..+|.||++||. ++++.|.|||||..|||+..++.+.|+|+||
T Consensus 287 vTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 9999999999999943 568999999999999999999994 5678899999999999999999999999999
Q ss_pred ccccCCC--cccccccccccccCcccccccccC----CC-C-cccchhhHHHHHHHHHhCCC----------CCCcccCC
Q 036419 591 ARMFGGD--ELQSNTKRIVGTYGYMSPEYAIHG----FF-S-IKSDVFSFGVLLLETLSSKR----------STRFFNTN 652 (754)
Q Consensus 591 a~~~~~~--~~~~~~~~~~gt~~y~APE~~~~~----~~-s-~ksDVwSlGvil~elltg~~----------p~~~~~~~ 652 (754)
|...... ......+..+||..|||||++... .+ + ..+||||||.|+||+..... ||...-+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9876543 333445667999999999988653 12 2 35899999999999976532 22111111
Q ss_pred chhHhHhhhhhhccCccccccCcccC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 653 SLTLLGHAWNLWKDDRSWELMDPKLQ-CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~l~d~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
+....+ ..+..-. +-+.|.+. .-...+....+.++|+.||..||.-|.|+-.+-+.|.++.
T Consensus 443 DPs~ee-MrkVVCv----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 443 DPSFEE-MRKVVCV----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCHHH-Hhcceee----cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 111111 0011111 11112211 2233467788999999999999999999999999887763
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=261.93 Aligned_cols=189 Identities=25% Similarity=0.385 Sum_probs=161.5
Q ss_pred cCccccceeccCCCcceeec---------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~---------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
.-|..++.||-|+||+|.+. +.....++.|-.||+.-+++=||+|+..|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 45777899999999999862 223345678999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc---
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF--- 594 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~--- 594 (754)
||++||++..+|. +.+.+.+..++-++.++..|+++.|..| +|||||||+|||||.+|++||.||||+.=+
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999984 4567899999999999999999999998 999999999999999999999999997532
Q ss_pred ------CCCcc-------------------------------cccccccccccCcccccccccCCCCcccchhhHHHHHH
Q 036419 595 ------GGDEL-------------------------------QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLL 637 (754)
Q Consensus 595 ------~~~~~-------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ 637 (754)
..... .......+||+.|+|||++....|+..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 11000 01112368999999999999999999999999999999
Q ss_pred HHHhCCCCCCcccCCc
Q 036419 638 ETLSSKRSTRFFNTNS 653 (754)
Q Consensus 638 elltg~~p~~~~~~~~ 653 (754)
||+.|+.||....+.+
T Consensus 863 em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHhhCCCCccCCCCCc
Confidence 9999999997766554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-29 Score=264.38 Aligned_cols=249 Identities=23% Similarity=0.310 Sum_probs=201.6
Q ss_pred cCccccceeccCCCcceee---------------------ccccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk---------------------~~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
.+++.+..||-||||.|=+ .....+.+..|-.||.+.+.|.||+++-.|.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 5667778999999999854 1223456778999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
|-|-||.|...+ +.++.++..++.-++..+++|+.|||.++ ||+|||||+|+++|.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999 45567999999999999999999999998 999999999999999999999999999998765
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhhhhhhccCccccccCcc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
. .+..++||+.|.|||++.+...+.++|.||||+++|||++|.+||...++-. .++. ++....
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------LkGid~------- 637 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LKGIDK------- 637 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hhhhhh-------
Confidence 3 3557899999999999999999999999999999999999999998766433 1111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHh--c------cccCCCCCCCCCccc
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPT-----MSEVISMLT--N------EFVNLPSPQQPGFSS 731 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~--~------~~~~~~~p~~p~~~~ 731 (754)
-..+..+.+...+++++....+|.+|.- +.+|-+|-- + ....+|+|-.|....
T Consensus 638 --i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ 703 (732)
T KOG0614|consen 638 --IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVAN 703 (732)
T ss_pred --hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCC
Confidence 1112334566778888888999999986 677777642 1 223567776665533
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=245.69 Aligned_cols=260 Identities=19% Similarity=0.306 Sum_probs=195.0
Q ss_pred hhhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCee
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~ 513 (754)
...++|.+++.||+|+|.+|...+ .+.+=++.|..+..+- +||.+|.+..+|+.+..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 345789999999999999987521 1222344555566554 699999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++|.||++||+|.-+++ ....++++.+.-+...|..||.|||+.+ ||+||||.+|||+|.+|++||.|+|+.+.
T Consensus 327 ffvieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999988774 3455899999999999999999999998 99999999999999999999999999985
Q ss_pred cCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc--hhHhHhhhhhhccCcccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS--LTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 671 (754)
--... ..+..++||+.|+|||++.+..|...+|.|+|||+++||+.|+.||....... .+-.......
T Consensus 401 ~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-------- 470 (593)
T KOG0695|consen 401 GLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-------- 470 (593)
T ss_pred CCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------
Confidence 43221 23557899999999999999999999999999999999999999997654332 1111111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH----------HHhccccCCCCCCCCCccccccc
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPT------MSEVIS----------MLTNEFVNLPSPQQPGFSSLKKS 735 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~----------~L~~~~~~~~~p~~p~~~~~~~~ 735 (754)
++...+..+ ...+-+...+++.-|.+||.+|.. ++++.. +||. .++.+|-+|+....+..
T Consensus 471 ilekqirip--rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq--k~v~ppf~p~i~~d~~l 546 (593)
T KOG0695|consen 471 ILEKQIRIP--RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ--KQVLPPFQPQITDDYGL 546 (593)
T ss_pred Hhhhccccc--ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh--cccCCCCCCccccccCc
Confidence 111111111 122334567778888999999853 333332 3433 36778888887655544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-30 Score=250.59 Aligned_cols=240 Identities=24% Similarity=0.321 Sum_probs=181.5
Q ss_pred CccccceeccCCCcceee-------------------ccccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk-------------------~~~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
+.+.+..||.|.||+|+| .+.+.+++..|+....+- +.||||+++|.+-.+...++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 334467899999999997 123456778888765554 579999999999999999999999
Q ss_pred cCCCChhhHhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 520 LPNKSLDSFLFD--TTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 520 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
|.- +|+.+... ..+...+++...-+|....+.||.||.+.- .|||||+||+|||+|..|.+||||||++-.+..+
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 965 66655432 123456888888889999999999998754 6999999999999999999999999999876543
Q ss_pred cccccccccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIH--GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
. ..+...|-..|||||-+.. ..|+.++||||||+.|||+.+|..|+...+..-.++. .....+ ...++
T Consensus 222 i---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~----~Vv~gd-pp~l~-- 291 (361)
T KOG1006|consen 222 I---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC----QVVIGD-PPILL-- 291 (361)
T ss_pred H---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH----HHHcCC-CCeec--
Confidence 2 2345678899999998854 3599999999999999999999999765543211111 111111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...........+..++..||.+|..+||...++.++-
T Consensus 292 --~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 292 --FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred --CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 1122234567799999999999999999999988764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=279.73 Aligned_cols=251 Identities=19% Similarity=0.172 Sum_probs=159.8
Q ss_pred hhcCccccceeccCCCcceeeccccH---------------HHHHHHHHHHHhhc---cCCeeeeeee------eeecCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQGL---------------EEFKNEIKLTAKLQ---HRNLVRLLGC------CVEQGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~~~---------------~~~~~Ev~il~~l~---hpniv~l~~~------~~~~~~ 512 (754)
..++|++.++||+|+||.||++.... +.-..|+.+..+++ +.++..++.. ..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 56789999999999999999843211 11123333333333 2233322222 245678
Q ss_pred eEEEEEecCCCChhhHhhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCce
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKE-----------------GLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNI 575 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 575 (754)
.++||||+++++|.+++...... .......+..++.||+.||.|||+.+ |+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHE
Confidence 99999999999999988643210 01123446689999999999999987 99999999999
Q ss_pred EEcC-CCceEEeeccCccccCCCcccccccccccccCcccccccccC----------------------CCCcccchhhH
Q 036419 576 LLDS-NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG----------------------FFSIKSDVFSF 632 (754)
Q Consensus 576 lld~-~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~s~ksDVwSl 632 (754)
|+++ ++.+||+|||+|+.+..... .......+++.|||||.+... .++.++|||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9986 57999999999986543221 123346789999999965322 24456799999
Q ss_pred HHHHHHHHhCCCCCCcccCCchhHhHhhhhh-hccCccccccCcccCCC------CCHHHHHHHHHHHHHccccCCCCCC
Q 036419 633 GVLLLETLSSKRSTRFFNTNSLTLLGHAWNL-WKDDRSWELMDPKLQCE------ASYPIVKRYINVALLCVQENAADRP 705 (754)
Q Consensus 633 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~d~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RP 705 (754)
||+||||+++..+.... ...+....... .........+.+..... ..........+|+.+||+.||++||
T Consensus 366 GviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 99999999876543211 01110000000 00000000011110000 0000122456899999999999999
Q ss_pred CHHHHHHHH
Q 036419 706 TMSEVISML 714 (754)
Q Consensus 706 t~~evl~~L 714 (754)
|+.++++|-
T Consensus 443 ta~e~L~Hp 451 (566)
T PLN03225 443 SAKAALAHP 451 (566)
T ss_pred CHHHHhCCc
Confidence 999999984
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=242.49 Aligned_cols=210 Identities=30% Similarity=0.341 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 036419 482 LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561 (754)
Q Consensus 482 ~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 561 (754)
.+.+.+|++++++++|+|++++++++......++++||+++++|.+++.... .+++..+..++.++++++.|||+.+
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~ 107 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG---RLSEDEARFYARQILSALEYLHSNG 107 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 6889999999999999999999999999999999999999999999985432 2889999999999999999999987
Q ss_pred CCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh
Q 036419 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641 (754)
Q Consensus 562 ~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt 641 (754)
++|+||+|+||++++++.++|+|||.+....... ......++..|+|||.+....++.++||||||+++++|++
T Consensus 108 ---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~ 181 (244)
T smart00220 108 ---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLT 181 (244)
T ss_pred ---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999999775432 2334568889999999998889999999999999999999
Q ss_pred CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 642 SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYP-IVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 642 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
|..|+........ ..... ... ......... ....+.+++.+|+..+|++||++.+++++
T Consensus 182 ~~~p~~~~~~~~~-~~~~~----~~~--------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 182 GKPPFPGDDQLLE-LFKKI----GKP--------KPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred CCCCCCCCCcHHH-HHHHH----hcc--------CCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 9998764321111 11110 000 000000000 44678999999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=266.04 Aligned_cols=249 Identities=20% Similarity=0.279 Sum_probs=170.0
Q ss_pred hhcCccccceeccCCCcceeeccc----------------------------------cHHHH--------------HHH
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ----------------------------------GLEEF--------------KNE 488 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~----------------------------------~~~~~--------------~~E 488 (754)
..++|++.++||+|+||.||++.. ..++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467999999999999999997421 01122 236
Q ss_pred HHHHHhhccCCe-----eeeeeeeee--------cCeeEEEEEecCCCChhhHhhccCC---------------------
Q 036419 489 IKLTAKLQHRNL-----VRLLGCCVE--------QGENVLIYEYLPNKSLDSFLFDTTK--------------------- 534 (754)
Q Consensus 489 v~il~~l~hpni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 534 (754)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777776654 677777753 3568999999999999999864211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCccc
Q 036419 535 EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMS 614 (754)
Q Consensus 535 ~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~A 614 (754)
...+++..+..++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123567888999999999999999987 99999999999999999999999999976543221 11112234789999
Q ss_pred ccccccCC--------------------C--CcccchhhHHHHHHHHHhCCC-CCCcccCCchhHh--HhhhhhhccCcc
Q 036419 615 PEYAIHGF--------------------F--SIKSDVFSFGVLLLETLSSKR-STRFFNTNSLTLL--GHAWNLWKDDRS 669 (754)
Q Consensus 615 PE~~~~~~--------------------~--s~ksDVwSlGvil~elltg~~-p~~~~~~~~~~~~--~~~~~~~~~~~~ 669 (754)
||.+.... + ..+.||||+|||+|+|+++.. |+.....-...+. ......|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875432 1 235799999999999999875 5432111110000 001111111100
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHHH
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENA---ADRPTMSEVISML 714 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~L 714 (754)
....-.......+...+++.+||..+| .+|+|++|+++|-
T Consensus 459 -----~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 459 -----QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred -----cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 000111112245678899999999765 7899999999874
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=213.83 Aligned_cols=108 Identities=39% Similarity=0.916 Sum_probs=101.7
Q ss_pred EecCCCCcccccccCcccc--ccccceEeeCCCceEEEEeecCCCeEEEEEEccCCcEEEEEEeecCCceEEEEeccccc
Q 036419 212 SRSGPWNGIFFGAAPSYAS--ILSEPILVDNEDEIYYSYESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPTLF 289 (754)
Q Consensus 212 ~~~g~w~~~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~Ld~~G~l~~~~w~~~~~~W~~~~~~p~~~ 289 (754)
||+|||||..|+|+|++.. .+.+.| +.+.+|++++|...+.+.++|++||.+|+++++.|++++++|...|.+|.++
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~f-v~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~ 79 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSF-VSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQ 79 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEE-EECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccC
Confidence 8999999999999999974 366666 7999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCcCCcCCCCCCCC
Q 036419 290 CQFYGHCGGNRVCSYEKTPNCECLKGFKPKS 320 (754)
Q Consensus 290 C~~~g~CG~~g~C~~~~~~~C~C~~Gf~~~~ 320 (754)
||+|+.||+||+|+.+..+.|+|++||+|++
T Consensus 80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999988889999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=235.99 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=200.6
Q ss_pred CchhhHhhhhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeeeee
Q 036419 449 KSLASVSAATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVRLL 504 (754)
Q Consensus 449 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~l~ 504 (754)
...+++.....+++....+-+|.||+||.+.+ ....+..|-.++..+.|||+..+.
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 45667777788899999999999999997411 223456677777888899999999
Q ss_pred eeeeec-CeeEEEEEecCCCChhhHhh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc
Q 036419 505 GCCVEQ-GENVLIYEYLPNKSLDSFLF-----DTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD 578 (754)
Q Consensus 505 ~~~~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld 578 (754)
++++++ ...+.++.++.-|+|..|+. +......++..+...++.|++.|+.|||.++ +||.||...|++||
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceeh
Confidence 998765 45678899999999999998 4444556888889999999999999999998 99999999999999
Q ss_pred CCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCcccCCchhHh
Q 036419 579 SNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK-RSTRFFNTNSLTLL 657 (754)
Q Consensus 579 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~-~p~~~~~~~~~~~~ 657 (754)
+..++||+|=.+++.+-..++.......-....||+||.+.+..|+.++|||||||+||||++-. .|+..-++.+
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE---- 506 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE---- 506 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH----
Confidence 99999999999999876666655554455567899999999999999999999999999999854 4433222211
Q ss_pred HhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 658 GHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 658 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
....+-++.++ ..+...+.++..++.-||...|++||++++++.-|...
T Consensus 507 -m~~ylkdGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 507 -MEHYLKDGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -HHHHHhcccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 11222223322 22345678899999999999999999999999988653
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=227.20 Aligned_cols=244 Identities=21% Similarity=0.334 Sum_probs=186.2
Q ss_pred hcCccccceeccCCCcceeecc---------------ccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCe--eEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------QGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGE--NVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~--~~lV~E~ 519 (754)
.++|++.+++|+|-+++||.+. -..+.+++|++||..|. ||||++++++..+... .-||+||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 4689999999999999999632 24578999999999998 9999999999876654 5699999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC-CceEEeeccCccccCCCc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGLARMFGGDE 598 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-~~~kl~DFgla~~~~~~~ 598 (754)
+.+.+...+. ..++...+..++.++++||.|+|+.| |+|||+||.|++||.. -.++|+|+|+|.......
T Consensus 117 v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 117 VNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9998887766 34778889999999999999999998 9999999999999954 579999999999876543
Q ss_pred ccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccc-------
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW------- 670 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 670 (754)
. -...+.+..|--||.+..- .|+.+-|+|||||++..|+..+.||-.......+++.-+. ....+.+.
T Consensus 188 e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak-VLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 188 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK-VLGTDELYAYLNKYQ 263 (338)
T ss_pred e---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH-HhChHHHHHHHHHHc
Confidence 2 2234567788999988765 6899999999999999999999998655444444332221 11100000
Q ss_pred cccCccc----------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 671 ELMDPKL----------------QCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 671 ~l~d~~~----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
--+|+.. ......-...+.++++.+.|..|..+|||+.|.+.|-
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 0011111 1111111346788999999999999999999998764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=240.73 Aligned_cols=116 Identities=29% Similarity=0.425 Sum_probs=98.8
Q ss_pred hcCccccceeccCCCcceee-----------------ccccHHHHHHHHHHHHhhc-----c---CCeeeeeeeeee---
Q 036419 458 TNNFGVENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQ-----H---RNLVRLLGCCVE--- 509 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk-----------------~~~~~~~~~~Ev~il~~l~-----h---pniv~l~~~~~~--- 509 (754)
..+|.+.++||.|-|++||+ +++..+....||++|++++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 36899999999999999997 3445677789999999984 3 369999999974
Q ss_pred -cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE
Q 036419 510 -QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL 577 (754)
Q Consensus 510 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll 577 (754)
+.++|+|+|++ |-+|..+|.....+ -++...+.+|++||+.||.|||.++ +|||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 57899999998 55777777654443 4889999999999999999999987 79999999999999
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-28 Score=235.96 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=181.3
Q ss_pred CccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec-----CeeE
Q 036419 460 NFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ-----GENV 514 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~-----~~~~ 514 (754)
+.+-.+.||.|+||.||... ..-+++.+|+++|.-.+|.|++..+++..-. +++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34456799999999999511 1235678899999999999999999886543 3567
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+|.|.|.. +|..+|- ....++.+.+.-+++||++||+|||+.+ |.||||||.|+|++.+-.+||||||+|+..
T Consensus 134 V~TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 88888854 7888774 3345888888889999999999999998 999999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHh--------hhhhh
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGH--------AWNLW 664 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~--------~~~~~ 664 (754)
..++. ..++..+-|..|+|||++++. .|+.++||||.|||+.|++..+..|....+-+ .+++.. +.+..
T Consensus 207 e~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 65543 334556779999999999986 79999999999999999998888776555432 111100 00000
Q ss_pred ccCccccccC-----cccC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 665 KDDRSWELMD-----PKLQ----CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 665 ~~~~~~~l~d-----~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
-++--..++. |... -........+...+..+++..||++|.+..+.+.++..
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 0010001111 1110 00111123445677788999999999999999988753
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=205.97 Aligned_cols=114 Identities=47% Similarity=0.762 Sum_probs=100.5
Q ss_pred ccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEcCCCCeEEee
Q 036419 33 SFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSS 112 (754)
Q Consensus 33 ~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~ 112 (754)
+| .++++|+|+++.|++|||.+..+...+.+|||++++.++||.||++.| ....++|.|+.||+|+|+|.+|.++|++
T Consensus 3 ~l-~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 3 PL-SSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred Cc-CCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 45 889999999999999999987654488999999877899999999998 4457899999999999999999999999
Q ss_pred cCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCC
Q 036419 113 NTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYP 154 (754)
Q Consensus 113 ~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~P 154 (754)
++.+.....+|+|+|+|||||++.. +.+||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~~------~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDSD------GNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC------CCEEEcCCCCC
Confidence 9876334567899999999999854 88999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-27 Score=259.40 Aligned_cols=235 Identities=24% Similarity=0.317 Sum_probs=174.5
Q ss_pred ccccceeccCCCcce-eeccc-------------cHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEecCCCCh
Q 036419 461 FGVENKLGEGGFGPV-YKSGQ-------------GLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 461 y~~~~~lG~G~fg~V-yk~~~-------------~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
|.-.+.+|.|.-|+| |++.- -.+...+||+.|..- +||||||+++.-.++...||..|.|.. +|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL 589 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL 589 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence 444567899999974 55211 123457899988877 599999999998889999999999866 99
Q ss_pred hhHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC---C--CceEEeeccCccccCCCcc
Q 036419 526 DSFLFDTTK-EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---N--MIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 526 ~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~---~--~~~kl~DFgla~~~~~~~~ 599 (754)
++++..... .........+....|+++||++||+.+ ||||||||+||||+. + ..++|+|||+++.+..+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 999966311 111121345778899999999999977 999999999999975 2 4789999999999876432
Q ss_pred -cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 600 -QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSS-KRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 600 -~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
........||-+|+|||++....-+.++||||+|||+|+.++| .+||...-..+.++.... ..+. .+.+.
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~------~~L~-~L~~~- 738 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN------YTLV-HLEPL- 738 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc------ccee-eeccC-
Confidence 2334567899999999999998888899999999999999998 788764433222211111 1110 01110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. .+..+||.+|+..+|..||++.+|+.|-
T Consensus 739 ------~d-~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 739 ------PD-CEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred ------ch-HHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 10 1678999999999999999999998764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-27 Score=248.60 Aligned_cols=178 Identities=26% Similarity=0.381 Sum_probs=155.1
Q ss_pred cCccccceeccCCCcceeecccc--------------------------HHHHHHHHHHHHhhc---cCCeeeeeeeeee
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQG--------------------------LEEFKNEIKLTAKLQ---HRNLVRLLGCCVE 509 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~~--------------------------~~~~~~Ev~il~~l~---hpniv~l~~~~~~ 509 (754)
.+|..++++|+|+||.|+.+.+. +-.+-.||+||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 36889999999999999863221 112346999999998 9999999999999
Q ss_pred cCeeEEEEEec-CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeec
Q 036419 510 QGENVLIYEYL-PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDF 588 (754)
Q Consensus 510 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DF 588 (754)
++.+||+||-- ++-+|.++|. .+..+++.++..|++||+.|+++||+.+ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999975 6678999993 4456999999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCC
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRST 646 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~ 646 (754)
|.|.+...+. ...++||..|.|||++.+.+| +..-|||++|++||-++....|+
T Consensus 715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9998876543 346899999999999999887 56789999999999999888775
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=217.27 Aligned_cols=188 Identities=27% Similarity=0.391 Sum_probs=152.9
Q ss_pred hhhcCccccceeccCCCcceee-------------------ccccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk-------------------~~~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~l 515 (754)
...+...-...||+|++|.|=| ..+..++..+|+.+..+- ..|.+|+++|...+.....+
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 3445555677899999998754 223456677788776655 58999999999999999999
Q ss_pred EEEecCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 516 IYEYLPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
.||.|.. ||+.+-.+. ...+.+++...-+|+..|++||.|||++- .+||||+||+||||+.+|++|+||||.+-.+
T Consensus 123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999966 777766443 34567899999999999999999999964 6999999999999999999999999999887
Q ss_pred CCCcccccccccccccCccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIH----GFFSIKSDVFSFGVLLLETLSSKRSTRFF 649 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~----~~~s~ksDVwSlGvil~elltg~~p~~~~ 649 (754)
..+-. .+...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++..
T Consensus 200 ~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 200 VDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 54422 223568889999998753 37999999999999999999999997643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=229.53 Aligned_cols=224 Identities=23% Similarity=0.224 Sum_probs=169.6
Q ss_pred ccHHHHHHHHHHHHhhccCCeeeeeeeeee------cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 036419 480 QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE------QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQG 553 (754)
Q Consensus 480 ~~~~~~~~Ev~il~~l~hpniv~l~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~ 553 (754)
...++..+|..++..++|+|+++++.++.- -...|+|||+|.. +|...+. -.++-+++..|+.|++.|
T Consensus 57 ~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ 130 (369)
T KOG0665|consen 57 THAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCG 130 (369)
T ss_pred ccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHH
Confidence 345677899999999999999999999853 3467999999965 7777774 236777889999999999
Q ss_pred HHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHH
Q 036419 554 LLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFG 633 (754)
Q Consensus 554 L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlG 633 (754)
++|||+.+ |+||||||+||++..+..+||.|||+|+.-..+ ...+..+.|..|.|||++.+..|.+++||||+|
T Consensus 131 ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvG 204 (369)
T KOG0665|consen 131 IKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204 (369)
T ss_pred HHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhh
Confidence 99999998 999999999999999999999999999975433 345668899999999999998899999999999
Q ss_pred HHHHHHHhCCCCCCcccCCc-----------------hhHhHhhhhhhccCc------ccc-ccCcccCC--CCCHHHHH
Q 036419 634 VLLLETLSSKRSTRFFNTNS-----------------LTLLGHAWNLWKDDR------SWE-LMDPKLQC--EASYPIVK 687 (754)
Q Consensus 634 vil~elltg~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~------~~~-l~d~~~~~--~~~~~~~~ 687 (754)
|++.||+.|..-|.+.+--+ .++...+..+..... ..+ +-|..... ........
T Consensus 205 ci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~ 284 (369)
T KOG0665|consen 205 CIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCS 284 (369)
T ss_pred hHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchH
Confidence 99999999998876433111 011111111111000 000 11111111 11122345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 688 RYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 688 ~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
...+++.+||-.||++|.+++++|+|--
T Consensus 285 ~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 285 LARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred HHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 6789999999999999999999999975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-25 Score=218.61 Aligned_cols=194 Identities=41% Similarity=0.663 Sum_probs=168.2
Q ss_pred eccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChhh
Q 036419 467 LGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDS 527 (754)
Q Consensus 467 lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~ 527 (754)
||+|++|.||+... ..+.+.+|+++++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 57888888887221 13679999999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC-CCceEEeeccCccccCCCccccccccc
Q 036419 528 FLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS-NMIPKISDFGLARMFGGDELQSNTKRI 606 (754)
Q Consensus 528 ~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~-~~~~kl~DFgla~~~~~~~~~~~~~~~ 606 (754)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 995432 35889999999999999999999997 999999999999999 89999999999987654321 12235
Q ss_pred ccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHH
Q 036419 607 VGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPI 685 (754)
Q Consensus 607 ~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~ 685 (754)
.+...|++||.+... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999998877 889999999999999998
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 686 VKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 686 ~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+.+.+++.+|++.+|++||++.+++++|
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4578999999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-26 Score=241.30 Aligned_cols=253 Identities=21% Similarity=0.238 Sum_probs=195.1
Q ss_pred HhhhhcCccccceeccCCCcceeeccc-----------------cHHHHHHHHHHHHhhc------cCCeeeeeeeeeec
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSGQ-----------------GLEEFKNEIKLTAKLQ------HRNLVRLLGCCVEQ 510 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~~-----------------~~~~~~~Ev~il~~l~------hpniv~l~~~~~~~ 510 (754)
.+....+|.+....|+|-|++|..+.+ ..+.=++|++||++|+ .-++++|+-.|.+.
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 345668999999999999999987322 2344578999999996 34799999999999
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC-CceEEeecc
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFG 589 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-~~~kl~DFg 589 (754)
+++|||+|-+ ..+|.+.|.....+--|....+..++.|+..||..|...+ |+|.||||+|||+++. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999977 4589999988777777899999999999999999999887 9999999999999876 567999999
Q ss_pred CccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchh-HhHhhhhh-----
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLT-LLGHAWNL----- 663 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~----- 663 (754)
.|........ +...-+..|.|||++.+.+|+...|+||.||.||||.||+..|++.....+. +.-.....
T Consensus 583 SA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 583 SASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 9987655432 3345567899999999999999999999999999999999998776544321 10000000
Q ss_pred ----------hcc---------Cc--------cccccCc------cc-----CCCCCHHHHHHHHHHHHHccccCCCCCC
Q 036419 664 ----------WKD---------DR--------SWELMDP------KL-----QCEASYPIVKRYINVALLCVQENAADRP 705 (754)
Q Consensus 664 ----------~~~---------~~--------~~~l~d~------~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RP 705 (754)
++. +. +...+.| .+ .....+.....+.+|+.+||..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 000 00 0001111 00 1122345677889999999999999999
Q ss_pred CHHHHHHHH
Q 036419 706 TMSEVISML 714 (754)
Q Consensus 706 t~~evl~~L 714 (754)
|..+.|+|-
T Consensus 739 t~nqAL~Hp 747 (752)
T KOG0670|consen 739 TVNQALKHP 747 (752)
T ss_pred CHHHHhcCC
Confidence 999998874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=270.57 Aligned_cols=200 Identities=20% Similarity=0.220 Sum_probs=142.3
Q ss_pred HHhhcc-CCeeeeeeee-------eecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 036419 492 TAKLQH-RNLVRLLGCC-------VEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRL 563 (754)
Q Consensus 492 l~~l~h-pniv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~ 563 (754)
.+.++| +||++++++| .+....++++||+ +++|.++|... ...+++.+++.++.||++||.|||+++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g-- 100 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG-- 100 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 345667 6888888887 3344677888987 55999999542 345999999999999999999999988
Q ss_pred ceeeCCCCCCceEEcC-------------------CCceEEeeccCccccCCCcc--------------ccccccccccc
Q 036419 564 RVIHRDLKPSNILLDS-------------------NMIPKISDFGLARMFGGDEL--------------QSNTKRIVGTY 610 (754)
Q Consensus 564 ~iiH~Dlkp~NIlld~-------------------~~~~kl~DFgla~~~~~~~~--------------~~~~~~~~gt~ 610 (754)
|+||||||+||||+. ++.+||+|||+++....... ........||+
T Consensus 101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 999999999999954 44566666776654211000 00011246889
Q ss_pred CcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHH
Q 036419 611 GYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYI 690 (754)
Q Consensus 611 ~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~ 690 (754)
.|||||++.+..++.++|||||||+||||+++..|+..... ....... ..+.+.. ........
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~---------~~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRH---------RVLPPQI-----LLNWPKEA 242 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHH---------hhcChhh-----hhcCHHHH
Confidence 99999999999999999999999999999998877432110 0000000 0011110 11223456
Q ss_pred HHHHHccccCCCCCCCHHHHHHHH
Q 036419 691 NVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 691 ~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.++.+||+.+|.+||++.||++|-
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhch
Confidence 788899999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=228.34 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=188.4
Q ss_pred hHhhhhcCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCe
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGE 512 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~ 512 (754)
.+....+.|.++++||+|.|++||++.. ...++.+|+++|..+. +.||+++.+++..++.
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3455667899999999999999998322 3467889999999996 7999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC-CceEEeeccCc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGLA 591 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-~~~kl~DFgla 591 (754)
..+|+||+++-...+++.. ++..++..+++.+++||.++|..| ||||||||.|+|.+.. +.-.|.|||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 9999999999999998843 778899999999999999999998 9999999999999854 66789999999
Q ss_pred cccCCC-------c---------------------------c--------cccccccccccCcccccccccC-CCCcccc
Q 036419 592 RMFGGD-------E---------------------------L--------QSNTKRIVGTYGYMSPEYAIHG-FFSIKSD 628 (754)
Q Consensus 592 ~~~~~~-------~---------------------------~--------~~~~~~~~gt~~y~APE~~~~~-~~s~ksD 628 (754)
...... . + ........||+||+|||++... ..++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 821100 0 0 0001124799999999998764 6799999
Q ss_pred hhhHHHHHHHHHhCCCCCCcccCCchhHhHhhh---------------h--hhccCcccc---------ccC-ccc----
Q 036419 629 VFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW---------------N--LWKDDRSWE---------LMD-PKL---- 677 (754)
Q Consensus 629 VwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---------------~--~~~~~~~~~---------l~d-~~~---- 677 (754)
|||.|||++.+++++.||-.....-..+.+.+- . +|...+... -++ ...
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999998544332221111110 0 111111000 000 000
Q ss_pred ----CCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 678 ----QCEASY-PIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 678 ----~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
...... ..+..+.+++.+|++.||.+|.|+++.|+|--
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 000001 12346889999999999999999999998864
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=194.60 Aligned_cols=110 Identities=45% Similarity=0.767 Sum_probs=97.1
Q ss_pred cCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEcCCCCeEEeecCC
Q 036419 36 RDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTS 115 (754)
Q Consensus 36 ~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~ 115 (754)
.++++|+|+++.|++|||.+..+ ..+.+|||+..+.++||+|||+.|+.+ ++.|.|+.||+|+|+|.+|.++|++++.
T Consensus 5 ~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S~t~ 82 (114)
T smart00108 5 SSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSSNTT 82 (114)
T ss_pred CCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEeccc
Confidence 78999999999999999998654 578999999877889999999999866 4899999999999999999999999987
Q ss_pred CCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCC
Q 036419 116 RKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDY 153 (754)
Q Consensus 116 ~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~ 153 (754)
......+|+|+|+|||||++.. +.+|||||||
T Consensus 83 ~~~~~~~~~L~ddGnlvl~~~~------~~~~W~Sf~~ 114 (114)
T smart00108 83 GANGNYVLVLLDDGNLVIYDSD------GNFLWQSFDY 114 (114)
T ss_pred CCCCceEEEEeCCCCEEEECCC------CCEEeCCCCC
Confidence 3334567899999999999854 7899999997
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=208.36 Aligned_cols=167 Identities=18% Similarity=0.138 Sum_probs=126.3
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
|+|.+++... ...+++.++..++.||++||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888988542 346999999999999999999999875 999999999999999 99998754321
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
..||+.|||||++.+..++.++|||||||++|||++|+.|+.........+....... .. .++... ...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~------~~~~~~-~~~ 132 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM-PA------DDPRDR-SNL 132 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh-cc------CCcccc-ccH
Confidence 2688999999999999999999999999999999999999854332222111111100 00 000000 011
Q ss_pred HHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 683 YPIVK--RYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 683 ~~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
....+ .+.+++.+||+.+|++||++.++++++...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 12222 689999999999999999999999999754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-25 Score=238.59 Aligned_cols=238 Identities=24% Similarity=0.365 Sum_probs=188.2
Q ss_pred hhhcCccccceeccCCCcceeeccc------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
...++|....++|.|.||.|||+++ ...-.++|+-+++..+|||||-+++.+...+...++|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 4567899999999999999999543 2344567888888999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+.+|+|++.-+ -.+.+++.++....+..+++|+|||+.+ -+|||||-.|||+.+.|.+|++|||.+-.+...
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999999874 3467999999999999999999999998 799999999999999999999999998876543
Q ss_pred cccccccccccccCccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 598 ELQSNTKRIVGTYGYMSPEYA---IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~---~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
- .....+.||+.|||||+. ..+.|..++|||++|+...|+-.-++|... ....... . +... ...+
T Consensus 166 i--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd--lhpmr~l----~-LmTk---S~~q 233 (829)
T KOG0576|consen 166 I--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD--LHPMRAL----F-LMTK---SGFQ 233 (829)
T ss_pred h--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc--cchHHHH----H-Hhhc---cCCC
Confidence 2 223457899999999976 456899999999999999999877776322 1111110 0 0011 1111
Q ss_pred c-ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 675 P-KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 675 ~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
+ .+. ....-.+.+.++++.||-++|++|||++.+++|
T Consensus 234 pp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 234 PPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCccc--CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 1 111 112235668899999999999999999987664
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=209.27 Aligned_cols=182 Identities=35% Similarity=0.498 Sum_probs=156.6
Q ss_pred ccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecC
Q 036419 461 FGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 521 (754)
|.+.+.||+|++|.||+... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56778999999999997211 46688899999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~ 601 (754)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999999954322 1789999999999999999999987 99999999999999999999999999987754321 1
Q ss_pred cccccccccCccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 036419 602 NTKRIVGTYGYMSPEYA-IHGFFSIKSDVFSFGVLLLETLSSKRSTRF 648 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~-~~~~~s~ksDVwSlGvil~elltg~~p~~~ 648 (754)
......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345678899999998 666788899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=206.78 Aligned_cols=238 Identities=21% Similarity=0.353 Sum_probs=174.9
Q ss_pred hhcCccccceeccCCCcceeeccc-----------------cHHHHHHHHHHHHhhc-cCCeeeeeee-eeecCeeEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ-----------------GLEEFKNEIKLTAKLQ-HRNLVRLLGC-CVEQGENVLIY 517 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~-----------------~~~~~~~Ev~il~~l~-hpniv~l~~~-~~~~~~~~lV~ 517 (754)
..+.|.|.+.||+|.||.+-+.++ ...+|.+|...--.|. |.||+.-++. |+..+.+++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 446899999999999999876332 3567777776655564 8899987765 66777889999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc--CCCceEEeeccCccccC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD--SNMIPKISDFGLARMFG 595 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld--~~~~~kl~DFgla~~~~ 595 (754)
||+|.|+|..-+.. .-+.+....+++.|++.||.|+|+++ ++|||||.+||||- +..++||||||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999887732 33778888999999999999999998 99999999999993 34589999999998754
Q ss_pred CCcccccccccccccCccccccccc---C--CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIH---G--FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~---~--~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (754)
.. ......+..|.|||.... + ...+.+|||.||+|+|.+++|..|++.....+..+.. |..|......
T Consensus 175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~--~~~w~~rk~~ 247 (378)
T KOG1345|consen 175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWE--WEQWLKRKNP 247 (378)
T ss_pred ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHH--HHHHhcccCc
Confidence 32 223345668999997643 2 3468899999999999999999998844333333322 2334333332
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHH
Q 036419 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADR---PTMSEVISML 714 (754)
Q Consensus 671 ~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~L 714 (754)
.+... ....++++.++.++-|..++++| -++.....-+
T Consensus 248 -----~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 248 -----ALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred -----cCchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 11111 12355778889999999999999 4444444333
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-19 Score=191.69 Aligned_cols=245 Identities=31% Similarity=0.449 Sum_probs=186.6
Q ss_pred ccccceeccCCCcceeeccc------------------cHHHHHHHHHHHHhhccC-CeeeeeeeeeecCeeEEEEEecC
Q 036419 461 FGVENKLGEGGFGPVYKSGQ------------------GLEEFKNEIKLTAKLQHR-NLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~~------------------~~~~~~~Ev~il~~l~hp-niv~l~~~~~~~~~~~lV~E~~~ 521 (754)
|.+.+.||.|+||.||++.. ....+.+|+++++.+.|+ +++++.+.+......++++|++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 67788999999999997221 366789999999999988 79999999977777899999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC-ceEEeeccCccccCCCccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM-IPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~-~~kl~DFgla~~~~~~~~~ 600 (754)
++++.+++........+.......++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||.++.+......
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999977743221136889999999999999999999998 99999999999999988 7999999999866544322
Q ss_pred c----cccccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcccCC--chhHhHhhhhhhccCcccc
Q 036419 601 S----NTKRIVGTYGYMSPEYAIH---GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN--SLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 601 ~----~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 671 (754)
. ......|+..|+|||.+.. ..+....|+||+|+++++++.+..|+...... .............. ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 237 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLAS 237 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cccc
Confidence 1 2456789999999999987 57899999999999999999999996544431 11111111111100 0000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
...... .......+.+++..++..+|..|.++.+....
T Consensus 238 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSN----PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccc----cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000 02234567889999999999999999887765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-21 Score=222.67 Aligned_cols=237 Identities=22% Similarity=0.275 Sum_probs=179.0
Q ss_pred ccceeccCCCcceeecc-------ccHHH-----------------HHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 463 VENKLGEGGFGPVYKSG-------QGLEE-----------------FKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 463 ~~~~lG~G~fg~Vyk~~-------~~~~~-----------------~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
..+.+|.|.+|.|+... ...++ +..|+.+-..|.|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45688999999665310 01111 3334455566799999988888877777777799
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|++. +|..++.. .+.+...++..+++|++.|+.|+|+.+ |.|||||++|+++..++.+||+|||.+..+.-..
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99998843 356888999999999999999999998 9999999999999999999999999999876544
Q ss_pred cc--ccccccccccCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 599 LQ--SNTKRIVGTYGYMSPEYAIHGFFS-IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 599 ~~--~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.. .....++|+..|+|||.+.+..|. ..+||||.|+++..|++|+.|+......+........ ..+.-..
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~-------~~~~~~~ 547 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY-------SDQRNIF 547 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-------ccccccc
Confidence 33 445678999999999999999887 4689999999999999999998665544322100000 0000000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.-.......++.+.+.++..||+.||.+|.|+++|++.
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 01111223466788999999999999999999999873
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-19 Score=195.59 Aligned_cols=244 Identities=24% Similarity=0.291 Sum_probs=180.8
Q ss_pred CccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhcc----CCeeeeeeee-eecCeeEE
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQH----RNLVRLLGCC-VEQGENVL 515 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~h----pniv~l~~~~-~~~~~~~l 515 (754)
+|++.++||+|+||.||+... ....++.|++++..+++ +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999997321 11268889999999983 6899999988 47778899
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC-----CceEEeeccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-----MIPKISDFGL 590 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-----~~~kl~DFgl 590 (754)
||+.+ |.+|.++..... .+.++..++..|+.|++.+|.+||+.| ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99966 789999875544 577999999999999999999999998 9999999999999765 4689999999
Q ss_pred cc--ccCCCcc---c-c-c-ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh
Q 036419 591 AR--MFGGDEL---Q-S-N-TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 591 a~--~~~~~~~---~-~-~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 662 (754)
++ ....... . . . ....+||..|+++....+...+.+.|+||++.++.|++.|..|+......... .....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~--~~~~~ 251 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK--SKFEK 251 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH--HHHHH
Confidence 99 3322211 1 1 1 23466999999999999999999999999999999999999887554432210 00000
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
.. ....... .....++.+.++...+-..+..++|....+...|.....
T Consensus 252 ~~----~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 252 DP----RKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred Hh----hhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 00 0001110 111122344455554555899999999999998875433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-20 Score=199.83 Aligned_cols=159 Identities=20% Similarity=0.227 Sum_probs=122.1
Q ss_pred hhhhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeee-eeeeeee
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVR-LLGCCVE 509 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~-l~~~~~~ 509 (754)
....++|.+.+.||+|+||+||++.. ..+.+++|++++++++|+|++. +++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 44567899999999999999997311 1235889999999999999985 5432
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCC-CCCceEEcCCCceEEeec
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDL-KPSNILLDSNMIPKISDF 588 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dl-kp~NIlld~~~~~kl~DF 588 (754)
...++||||+++++|.... ..+ ...++.|++++|.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 91 -~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 4679999999999996321 111 1467899999999999988 999999 999999999999999999
Q ss_pred cCccccCCCccccc------ccccccccCcccccccccCC------CCcccchh
Q 036419 589 GLARMFGGDELQSN------TKRIVGTYGYMSPEYAIHGF------FSIKSDVF 630 (754)
Q Consensus 589 gla~~~~~~~~~~~------~~~~~gt~~y~APE~~~~~~------~s~ksDVw 630 (754)
|+|+.+........ .....+++.|+|||.+.... .+...|-|
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99997754331111 13567888999999886432 23446666
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.3e-18 Score=172.93 Aligned_cols=189 Identities=21% Similarity=0.320 Sum_probs=159.8
Q ss_pred hhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhcc-CCeeeeeeeeeecCeeEEEEEe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQH-RNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~h-pniv~l~~~~~~~~~~~lV~E~ 519 (754)
..-.|+++++||+|.||..+.+ ..+..+++.|.+..+.|.+ +.|...+.+-.++.+..||+|.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3458999999999999999862 2245678889999998874 9999999999999999999998
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC-----CceEEeeccCcccc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-----MIPKISDFGLARMF 594 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-----~~~kl~DFgla~~~ 594 (754)
+ |.+|+++..-. ...++.+++..++.|++.-++|+|++. +|+|||||+|+||... ..+.|+|||+|+..
T Consensus 106 L-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 7 77999887432 346999999999999999999999998 9999999999999643 35899999999977
Q ss_pred CCCccc-----ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccC
Q 036419 595 GGDELQ-----SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNT 651 (754)
Q Consensus 595 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~ 651 (754)
...... .......||-.||+-.-..+...+..-|+-|||-|++++|.|..|+.+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 543322 123356799999999999999999999999999999999999999986643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-19 Score=173.97 Aligned_cols=228 Identities=21% Similarity=0.351 Sum_probs=172.4
Q ss_pred cceeccCCCcceeecccc------------------HHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCCh
Q 036419 464 ENKLGEGGFGPVYKSGQG------------------LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 464 ~~~lG~G~fg~Vyk~~~~------------------~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
.-+|.+...|+.|++++. ...|..|.-.|+-..||||..+++.|....+..++..||+.|+|
T Consensus 195 ~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 457778888888874432 23456666677777899999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeC-CCCCCceEEcCCCceEEe--eccCccccCCCccccc
Q 036419 526 DSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHR-DLKPSNILLDSNMIPKIS--DFGLARMFGGDELQSN 602 (754)
Q Consensus 526 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~-Dlkp~NIlld~~~~~kl~--DFgla~~~~~~~~~~~ 602 (754)
...+++.. .-..+..++.+++.+|++|++|||+.. +++-| -|....++||++.+++|+ |--++- .
T Consensus 275 ynvlhe~t-~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsf---------q 342 (448)
T KOG0195|consen 275 YNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSF---------Q 342 (448)
T ss_pred HHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeee---------e
Confidence 99997643 345788899999999999999999976 44444 689999999999988774 321111 1
Q ss_pred ccccccccCcccccccccCCCC---cccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFS---IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s---~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
.....-.+.||+||.+...+-+ .++|+|||++++||+.|...||....+-+.-+. +--..+..
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk--------------ialeglrv 408 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK--------------IALEGLRV 408 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh--------------hhhccccc
Confidence 1122346789999999876543 579999999999999999999875544332111 00111222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
..++..+..+.+++.-|+..||.+||.+..|+-.||..
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 33445667788999999999999999999999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-18 Score=187.89 Aligned_cols=217 Identities=24% Similarity=0.350 Sum_probs=164.2
Q ss_pred HHhhccCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 036419 492 TAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLK 571 (754)
Q Consensus 492 l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlk 571 (754)
|+.+.|.|+.++++.+.++...+.|.+|+..|+|.+.+.. ....+++.-...++++|++||.|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4578999999999999999999999999999999999976 3345888899999999999999999976 12999999
Q ss_pred CCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccC-------CCCcccchhhHHHHHHHHHhCCC
Q 036419 572 PSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG-------FFSIKSDVFSFGVLLLETLSSKR 644 (754)
Q Consensus 572 p~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-------~~s~ksDVwSlGvil~elltg~~ 644 (754)
+.|+++|....+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999999876431111111122334579999998764 14677999999999999999999
Q ss_pred CCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 645 STRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 645 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
||......... .+.+....+ .....+.|.+.... +..+.+..++..||..+|.+||++++|-..++..
T Consensus 157 ~~~~~~~~~~~-~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 157 PFDLRNLVEDP-DEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccccCCh-HHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 98765444322 111111111 11122223222111 3344789999999999999999999999988765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.7e-18 Score=164.79 Aligned_cols=191 Identities=21% Similarity=0.292 Sum_probs=159.8
Q ss_pred hhhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhcc-CCeeeeeeeeeecCeeEEEEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQH-RNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~h-pniv~l~~~~~~~~~~~lV~E 518 (754)
.....|+++++||.|+||.+|.+ .....++..|.++...|+| ..|..+..+..+.....+|||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 34578999999999999999972 2345678889999999997 789999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC---CceEEeeccCccccC
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN---MIPKISDFGLARMFG 595 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~---~~~kl~DFgla~~~~ 595 (754)
.+ |.+|+++..-.. ..++.++++-++-|++.-++|+|.++ .|||||||+|+|..-+ ..+.|+|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 889999885433 45899999999999999999999998 9999999999999644 357899999999775
Q ss_pred CCccc-----ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCC
Q 036419 596 GDELQ-----SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN 652 (754)
Q Consensus 596 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~ 652 (754)
.-... .......||..|.+--...+...+..-|+-|+|.+|.++..|..|++.....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 32221 2233567999999988888888899999999999999999999999876543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-18 Score=190.16 Aligned_cols=198 Identities=24% Similarity=0.233 Sum_probs=158.6
Q ss_pred HHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 036419 484 EFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562 (754)
Q Consensus 484 ~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~ 562 (754)
..+.|-+++...+ ||.+|++...++.+...+++.+|..+|.|...+ .....+.+.....+...++-++.++|+.+
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~- 117 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG- 117 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH-
Confidence 4567888899888 999999999999999999999999999998877 34455677777778888999999999998
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhC
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSS 642 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg 642 (754)
|+|||+|++||+++.+|++|+.|||+++..-... ..+||..|||||++. ....++|.||||++++||++|
T Consensus 118 --iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg 187 (612)
T KOG0603|consen 118 --IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTG 187 (612)
T ss_pred --HHHhcccccceeecccCccccCCchhhhHhHhhh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhC
Confidence 9999999999999999999999999999754322 128999999999988 678899999999999999999
Q ss_pred CCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHHHHHh
Q 036419 643 KRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTM--SEVISMLT 715 (754)
Q Consensus 643 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl~~L~ 715 (754)
..||.. ..... ++. .....+........+++..++..+|..|.-. ..+.++++
T Consensus 188 ~~pf~~------~~~~~------------Il~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 188 TLPFGG------DTMKR------------ILK--AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred CCCCch------HHHHH------------Hhh--hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 999865 11000 011 1112334556677888889999999999855 45555554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=163.02 Aligned_cols=169 Identities=19% Similarity=0.135 Sum_probs=127.8
Q ss_pred cccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhcc-CCeeeeeeeeeecCeeEEEEEec
Q 036419 462 GVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQH-RNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 462 ~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~h-pniv~l~~~~~~~~~~~lV~E~~ 520 (754)
.+...|++|+||+||.... ....+++|+++|++|+| +++++++++ +..+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 3467899999999996221 01257899999999964 889999886 4569999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCC-CCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDL-KPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dl-kp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+|.+|...+.. ....++.|++++|.++|+.+ |+|||| ||+|||++.++.++|+|||+|........
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99998654311 11357889999999999998 999999 79999999999999999999996543321
Q ss_pred c----cc-------ccccccccCcccccccccC-CCC-cccchhhHHHHHHHHHhCCCCCC
Q 036419 600 Q----SN-------TKRIVGTYGYMSPEYAIHG-FFS-IKSDVFSFGVLLLETLSSKRSTR 647 (754)
Q Consensus 600 ~----~~-------~~~~~gt~~y~APE~~~~~-~~s-~ksDVwSlGvil~elltg~~p~~ 647 (754)
. .. ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 00 1122367788888754322 233 56788999999999999998753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.1e-18 Score=170.57 Aligned_cols=156 Identities=16% Similarity=0.178 Sum_probs=122.5
Q ss_pred hhhcCccccceeccCCCcceeeccc----------------cH---------HHHHHHHHHHHhhccCCeeeeeeeeeec
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ----------------GL---------EEFKNEIKLTAKLQHRNLVRLLGCCVEQ 510 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~----------------~~---------~~~~~Ev~il~~l~hpniv~l~~~~~~~ 510 (754)
...++|++.+.||.|+||.||.... .. +.+++|++.+.+++||+|..+.+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 3568999999999999999997221 11 1268999999999999999999886643
Q ss_pred --------CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc
Q 036419 511 --------GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI 582 (754)
Q Consensus 511 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~ 582 (754)
...+|||||++|.+|.++.. ++. ....+|+.+|..+|+.+ ++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999987741 222 34569999999999998 99999999999999988
Q ss_pred eEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHH
Q 036419 583 PKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640 (754)
Q Consensus 583 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ell 640 (754)
++|+|||........... ..++....|..++|+|+||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988755322110 11455566778999999999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.7e-17 Score=171.14 Aligned_cols=197 Identities=20% Similarity=0.274 Sum_probs=136.5
Q ss_pred ccCCeeeeeeeeee---------------------------cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHH
Q 036419 496 QHRNLVRLLGCCVE---------------------------QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIE 548 (754)
Q Consensus 496 ~hpniv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 548 (754)
+|||||++..+|.+ +..+|+||.-++. +|..++.. ...+...+.-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence 49999999988753 2356899988766 78888843 2356667778999
Q ss_pred HHHHHHHHHHhcCCCceeeCCCCCCceEE--cCCC--ceEEeeccCccccCCC----cccccccccccccCccccccccc
Q 036419 549 GIAQGLLYLHQYSRLRVIHRDLKPSNILL--DSNM--IPKISDFGLARMFGGD----ELQSNTKRIVGTYGYMSPEYAIH 620 (754)
Q Consensus 549 qi~~~L~yLH~~~~~~iiH~Dlkp~NIll--d~~~--~~kl~DFgla~~~~~~----~~~~~~~~~~gt~~y~APE~~~~ 620 (754)
|+++|+.|||.++ |.|||+|.+|||| |+++ .+.|+|||.+-....- .+.+..-...|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 9999999999999 4444 4689999987543221 11111112457778999998754
Q ss_pred CC-----C-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHH
Q 036419 621 GF-----F-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVAL 694 (754)
Q Consensus 621 ~~-----~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~ 694 (754)
.+ . -.|+|.|+.|.+.||++....||-...+-...... ..+..+ |.+ +...+..+.+++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~qL-----Pal----p~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQL-----PAL----PSRVPPVARQLVF 491 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhhC-----CCC----cccCChHHHHHHH
Confidence 32 1 26899999999999999999997643222111110 111111 111 1223456788999
Q ss_pred HccccCCCCCCCHHHHHHHH
Q 036419 695 LCVQENAADRPTMSEVISML 714 (754)
Q Consensus 695 ~cl~~dP~~RPt~~evl~~L 714 (754)
..|+.||.+||+..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999876544444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.4e-17 Score=167.96 Aligned_cols=216 Identities=18% Similarity=0.250 Sum_probs=135.9
Q ss_pred CccccceeccCCCcceee---------------------ccccHHHHHHHHHHHHhhc----------cCCeeeeeeeee
Q 036419 460 NFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQ----------HRNLVRLLGCCV 508 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk---------------------~~~~~~~~~~Ev~il~~l~----------hpniv~l~~~~~ 508 (754)
.....+.||.|+++.||. +....+++++|...+..+. |-.++--++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 345577999999999996 2234677777776655532 212222222211
Q ss_pred ---------ecC--------eeEEEEEecCCCChhhHhh---ccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceee
Q 036419 509 ---------EQG--------ENVLIYEYLPNKSLDSFLF---DTTKE-GLLGWGARIRIIEGIAQGLLYLHQYSRLRVIH 567 (754)
Q Consensus 509 ---------~~~--------~~~lV~E~~~~gsL~~~l~---~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH 567 (754)
... +.+++|+-+ .++|.+++. ..... ..+....++.+..|+++.+++||..+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 336777776 457877753 22221 23445556777799999999999998 999
Q ss_pred CCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCccccccccc--------CCCCcccchhhHHHHHHHH
Q 036419 568 RDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH--------GFFSIKSDVFSFGVLLLET 639 (754)
Q Consensus 568 ~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~ksDVwSlGvil~el 639 (754)
+||||+|+|++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999988765432211 233478999997644 2578999999999999999
Q ss_pred HhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCC
Q 036419 640 LSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADR 704 (754)
Q Consensus 640 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 704 (754)
.+++.|+........... .+ .... ..++.+..||..+|+.||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999875433221100 11 1223 677889999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-16 Score=156.58 Aligned_cols=120 Identities=23% Similarity=0.342 Sum_probs=95.9
Q ss_pred cceeccCCCcceeec---------------cccHHHHHHHHHHHHhh-----ccCCeeeeeeeeeecC---e-eEEEEEe
Q 036419 464 ENKLGEGGFGPVYKS---------------GQGLEEFKNEIKLTAKL-----QHRNLVRLLGCCVEQG---E-NVLIYEY 519 (754)
Q Consensus 464 ~~~lG~G~fg~Vyk~---------------~~~~~~~~~Ev~il~~l-----~hpniv~l~~~~~~~~---~-~~lV~E~ 519 (754)
.+.||+|+||.||+. ....+.+.+|+++++++ +||||++++++++++. . ..+|+||
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~ 86 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADF 86 (210)
T ss_pred cceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecC
Confidence 468999999999962 11356799999999999 5799999999998874 3 3378999
Q ss_pred --cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCceeeCCCCCCceEEcC----CCceEEeeccCcc
Q 036419 520 --LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGL-LYLHQYSRLRVIHRDLKPSNILLDS----NMIPKISDFGLAR 592 (754)
Q Consensus 520 --~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L-~yLH~~~~~~iiH~Dlkp~NIlld~----~~~~kl~DFgla~ 592 (754)
+++++|.+++.+ +.+++. ..++.|++.++ +|||+++ |+||||||+|||++. +..++|+||+.+.
T Consensus 87 ~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 87 DGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred CCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 668999999954 235554 35678888887 9999998 999999999999974 3479999955444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.3e-16 Score=156.38 Aligned_cols=100 Identities=16% Similarity=0.165 Sum_probs=79.7
Q ss_pred HHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCce
Q 036419 487 NEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL-HQYSRLRV 565 (754)
Q Consensus 487 ~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~i 565 (754)
+|++++.++.|+++.....+ . ....++||||++++++...+. ....+++..+..++.|++.+|.|| |+.+ |
T Consensus 68 ~E~~~l~~l~~~~v~~p~~~-~-~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---i 139 (190)
T cd05147 68 KEMRNLKRLVTAGIPCPEPI-L-LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---L 139 (190)
T ss_pred HHHHHHHHHHHCCCCCCcEE-E-ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 49999999988776433322 1 223489999999987765532 234688999999999999999999 6777 9
Q ss_pred eeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 566 IHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 566 iH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
+||||||+|||++ ++.++|+|||+|....
T Consensus 140 iHrDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 140 VHADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred ccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 9999999999998 4789999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.5e-17 Score=177.24 Aligned_cols=124 Identities=31% Similarity=0.435 Sum_probs=109.9
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..++.|+++...+|.++|.+.......++.....++.|++.++.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999876666678899999999999999999 55 999999999999999999999999999
Q ss_pred cccCCCc----ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh
Q 036419 592 RMFGGDE----LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641 (754)
Q Consensus 592 ~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt 641 (754)
....... .....+..+||..||+||++.+..|+.|+||||||+||+|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8765443 1223456789999999999999999999999999999999997
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.2e-16 Score=153.70 Aligned_cols=103 Identities=20% Similarity=0.205 Sum_probs=82.3
Q ss_pred HHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCC
Q 036419 485 FKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ-YSRL 563 (754)
Q Consensus 485 ~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~ 563 (754)
++.|.+.+.++.|+++.....+... ..++||||++++++...+. ....++...+..++.|++.++.+||+ .+
T Consensus 66 ~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g-- 138 (190)
T cd05145 66 AEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG-- 138 (190)
T ss_pred HHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 3578999999999987444333222 3489999999986544321 22457788999999999999999999 77
Q ss_pred ceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 564 ~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|+||||||+|||++ ++.++|+|||++.....
T Consensus 139 -ivHrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 139 -LVHGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -EecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 99999999999999 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-16 Score=182.47 Aligned_cols=234 Identities=18% Similarity=0.168 Sum_probs=160.9
Q ss_pred CccccceeccCCCcceeecc-----------------ccHHHHHHHHHH--HHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 460 NFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKL--TAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~i--l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
+|...+.||.+.|=+|.++. -.+..++++++- ...++|||.+.+.-....+..-|||-+|.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 45556777877776655421 123444444333 45568999999988877778888998888
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc--CCCc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF--GGDE 598 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~--~~~~ 598 (754)
.+ +|.|.| ..+..+..-+...|+.|++.||..+|..+ |+|+|||.+||||..=.=+.|+||..-+.. ..+.
T Consensus 104 kh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 KH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred hh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 66 777777 55667888889999999999999999998 999999999999998777899999877643 2211
Q ss_pred c---cccccccccccCcccccccccC----------C-CCcccchhhHHHHHHHHHhCC-CCCCcccCCchhHhHhhhhh
Q 036419 599 L---QSNTKRIVGTYGYMSPEYAIHG----------F-FSIKSDVFSFGVLLLETLSSK-RSTRFFNTNSLTLLGHAWNL 663 (754)
Q Consensus 599 ~---~~~~~~~~gt~~y~APE~~~~~----------~-~s~ksDVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~ 663 (754)
. .........-.+|+|||-+... . .+++-||||+||+++||++-. ++|... ....+.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--------QL~aYr 248 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--------QLLAYR 248 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--------HHHhHh
Confidence 1 1111112233479999977431 2 678899999999999998874 444321 111110
Q ss_pred hc-cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 664 WK-DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 664 ~~-~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
.. .....+++.. .+...++++++.|++.||.+|.++++.|+.-.+
T Consensus 249 ~~~~~~~e~~Le~--------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 249 SGNADDPEQLLEK--------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred ccCccCHHHHHHh--------CcCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 00 0111111110 112357899999999999999999999997443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.6e-16 Score=180.25 Aligned_cols=240 Identities=19% Similarity=0.236 Sum_probs=173.8
Q ss_pred hhHhhhhcCccccceeccCCCcceeeccccHH--------------HHHHHHHHHHhhc---cCCeeeeeeeeeecCeeE
Q 036419 452 ASVSAATNNFGVENKLGEGGFGPVYKSGQGLE--------------EFKNEIKLTAKLQ---HRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 452 ~~~~~~~~~y~~~~~lG~G~fg~Vyk~~~~~~--------------~~~~Ev~il~~l~---hpniv~l~~~~~~~~~~~ 514 (754)
.+.+.....|.|.+.||+|+||.||++.+... +|.-=.+++.+|+ -+-|..+...+.-.+.-+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 34555668899999999999999998544321 2222344555555 244566666667788889
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc-------CCCceEEee
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD-------SNMIPKISD 587 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld-------~~~~~kl~D 587 (754)
||+||.+.|+|.+++. ..+.++|...+.++.|+++.+..||..+ |||+||||+|+||. +.-.++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999994 5667999999999999999999999998 99999999999993 234689999
Q ss_pred ccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC
Q 036419 588 FGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD 667 (754)
Q Consensus 588 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 667 (754)
||.+..+.--.........++|-.+-.+|...+.+++..+|.|.|+.+++-||.|+..- .++ +
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----------------~~~-g 907 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----------------VKN-G 907 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----------------hcC-C
Confidence 99997553222123344577899999999999999999999999999999999998531 111 1
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 668 RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 668 ~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
..+. ++..+. .....+-+.+++..+|..|-..=|...++...|+..+
T Consensus 908 ~~~~-~~~~~~---Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 908 SSWM-VKTNFP---RYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred ccee-ccccch---hhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 1111 111111 1122233455555666666666777777777776543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.1e-16 Score=177.94 Aligned_cols=208 Identities=22% Similarity=0.327 Sum_probs=139.8
Q ss_pred hhcCccccceeccCCCcceeecccc--HHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCC
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQG--LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK 534 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~~--~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~ 534 (754)
...+|..+|.|..|+||.||...+. .+.|-. +++..|+|-= ++...-++.+.| |+-...+. .
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~------kiNkq~lilR-nilt~a~npfvv------gDc~tllk---~ 144 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM------KINKQNLILR-NILTFAGNPFVV------GDCATLLK---N 144 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh------cccccchhhh-ccccccCCccee------chhhhhcc---c
Confidence 4568899999999999999986554 444432 2222222210 011111223333 34444442 2
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC--------Cc-----ccc
Q 036419 535 EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG--------DE-----LQS 601 (754)
Q Consensus 535 ~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~--------~~-----~~~ 601 (754)
-+.++.. ++.+++|||+.+ |+|||+||+|++|..=|++|+.|||+.+.... .. .+.
T Consensus 145 ~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef 213 (1205)
T KOG0606|consen 145 IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEF 213 (1205)
T ss_pred CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHh
Confidence 2333332 378999999998 99999999999999999999999999885421 11 111
Q ss_pred cccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch-hHhHhhhhhhccCccccccCcccCCC
Q 036419 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-TLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
....++||+.|+|||++..+.|...+|.|++|+|+||.+-|..||....+++. .........|.+.
T Consensus 214 ~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~------------- 280 (1205)
T KOG0606|consen 214 QDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE------------- 280 (1205)
T ss_pred hhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc-------------
Confidence 22356999999999999999999999999999999999999999865544431 1111111112111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC
Q 036419 681 ASYPIVKRYINVALLCVQENAADRP 705 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RP 705 (754)
+.....+..+++.+.|+.+|..|-
T Consensus 281 -dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 281 -DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -CcCCCHHHHHHHHHHHHhChHhhc
Confidence 223445678888999999999997
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.1e-15 Score=121.70 Aligned_cols=66 Identities=50% Similarity=1.066 Sum_probs=58.0
Q ss_pred cCCCCceEEEcccCCCCcccccccccCChhHHHHHhhccceeeeeeecccCCCCcceeccccCcccc
Q 036419 338 CKSGDRFIMVDDIKLPDLLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDT 404 (754)
Q Consensus 338 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~g~L~d~ 404 (754)
|+.+|+|+++++|++|++.....+.+.++++|+++||+||+|+||+|.+.. ++++|++|+|+|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 556789999999999999777766779999999999999999999997654 567999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.7e-15 Score=169.57 Aligned_cols=123 Identities=20% Similarity=0.300 Sum_probs=105.0
Q ss_pred hhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
....|...++||+|+||.||++.. ..+++.+|++++++++|++++....++.....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345567789999999999998110 12457899999999999999988877777778
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+++++|.+++. ....++.|++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999999883 34679999999999999988 9999999999999 67799999999998
Q ss_pred cc
Q 036419 593 MF 594 (754)
Q Consensus 593 ~~ 594 (754)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.4e-14 Score=144.72 Aligned_cols=118 Identities=20% Similarity=0.337 Sum_probs=100.8
Q ss_pred ceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 465 NKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
+.||+|++|.||++.. ....+.+|++++.+++|++++....++......++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999997310 1135778999999999999887777777778889999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
+|++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998432 12 77899999999999999998 99999999999999 78899999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.6e-14 Score=141.22 Aligned_cols=114 Identities=21% Similarity=0.349 Sum_probs=93.9
Q ss_pred eeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecC
Q 036419 466 KLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 466 ~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 521 (754)
.||+|+||.||++.. ..+++.+|++++..++|+++....-++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 379999999997320 12456789999999999876555555566777899999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
|++|.+++.... ..++.+++++|.+||+.+ ++|+|+||+||+++ ++.++++|||+++.
T Consensus 81 g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998874311 178999999999999988 99999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.2e-15 Score=173.23 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=182.8
Q ss_pred hcCccccceeccCCCcceee---------------------ccccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEE
Q 036419 458 TNNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk---------------------~~~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~l 515 (754)
...|++.+.||+|.|+.|-. .....+....|..+-+.+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 45677788899999998764 1222344455777777787 9999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceeeCCCCCCceEEcCCC-ceEEeeccCccc
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH-QYSRLRVIHRDLKPSNILLDSNM-IPKISDFGLARM 593 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~iiH~Dlkp~NIlld~~~-~~kl~DFgla~~ 593 (754)
+.||..++++.+.+... .....+...+-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+|++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999998888421 1113556667789999999999999 777 99999999999999999 999999999998
Q ss_pred cCC-Cccccccccccc-ccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccc
Q 036419 594 FGG-DELQSNTKRIVG-TYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670 (754)
Q Consensus 594 ~~~-~~~~~~~~~~~g-t~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (754)
+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|............ .|.....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-----~~~~~~~- 248 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-----SWKSNKG- 248 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-----eeccccc-
Confidence 876 454555566788 9999999998885 557889999999999999999999765544432211 1111110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 671 ~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
...............+++.+++..+|..|.+.+++...
T Consensus 249 -----~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 249 -----RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred -----ccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 00111122334556788888999999999999887654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.6e-14 Score=142.49 Aligned_cols=131 Identities=16% Similarity=0.137 Sum_probs=100.3
Q ss_pred hhhhcCccccceeccCCCcceeecc-cc------------------------------------------HHHHHHHHHH
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSG-QG------------------------------------------LEEFKNEIKL 491 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~-~~------------------------------------------~~~~~~Ev~i 491 (754)
......|++.+.||+|+||.||++. .. ...++.|+++
T Consensus 24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 3344468899999999999999853 10 0124689999
Q ss_pred HHhhccC--CeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCC
Q 036419 492 TAKLQHR--NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRD 569 (754)
Q Consensus 492 l~~l~hp--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~D 569 (754)
+.++++. .+.++++. ...++||||+++.+|..... ....+...+...++.||+.++.+||+.+ .|+|||
T Consensus 104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~D 174 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGD 174 (237)
T ss_pred HHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCC
Confidence 9999863 34444442 23589999999988876542 2234566677899999999999999876 499999
Q ss_pred CCCCceEEcCCCceEEeeccCccccC
Q 036419 570 LKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 570 lkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|||+||+++ ++.++|+|||.+....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999 8899999999988643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=9.8e-14 Score=138.89 Aligned_cols=127 Identities=17% Similarity=0.161 Sum_probs=99.0
Q ss_pred HhhhhcCccccceeccCCCcceeecccc---------------------------------------HHHHHHHHHHHHh
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSGQG---------------------------------------LEEFKNEIKLTAK 494 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~~~---------------------------------------~~~~~~Ev~il~~ 494 (754)
+......|.+.+.||+|+||.||++... ...+..|..++.+
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3344445888899999999999973220 1125678999999
Q ss_pred hccCC--eeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCC
Q 036419 495 LQHRN--LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKP 572 (754)
Q Consensus 495 l~hpn--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp 572 (754)
+.|++ +++.++ ....++||||+++++|..+... .....++.+++.++.++|+.+ |+|+||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 98874 444443 2455899999999999775421 234678899999999999987 99999999
Q ss_pred CceEEcCCCceEEeeccCccccCC
Q 036419 573 SNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 573 ~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
+||++++++.++|+|||++..+..
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.2e-13 Score=138.16 Aligned_cols=207 Identities=20% Similarity=0.198 Sum_probs=145.1
Q ss_pred HHHHhhccCCeeeeeeeeeec-----CeeEEEEEecCCCChhhHhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 036419 490 KLTAKLQHRNLVRLLGCCVEQ-----GENVLIYEYLPNKSLDSFLFDTTKE-GLLGWGARIRIIEGIAQGLLYLHQYSRL 563 (754)
Q Consensus 490 ~il~~l~hpniv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~ 563 (754)
.-|-++.|.|||+++.|+.+. ....++.|||+.|++..+|++..+. ..+..+...+++-||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 345667899999999987543 4578999999999999999876543 45778888899999999999999964 8
Q ss_pred ceeeCCCCCCceEEcCCCceEEee--ccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh
Q 036419 564 RVIHRDLKPSNILLDSNMIPKISD--FGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641 (754)
Q Consensus 564 ~iiH~Dlkp~NIlld~~~~~kl~D--Fgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt 641 (754)
+|+|+++..+.|++..++.+|+.- +......-............+-++|.|||.=...+.+.++|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 899999999999999999888853 111111111111222334567889999997776778889999999999999987
Q ss_pred CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 642 SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 642 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
+..-......... ...... ..+..+-++ .=..++.+|++-.|..||+|.+++.|.-
T Consensus 278 lEiq~tnseS~~~-~ee~ia-----~~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 278 LEIQSTNSESKVE-VEENIA-----NVIIGLENG------------LQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred heeccCCCcceee-hhhhhh-----hheeeccCc------------cccCcCcccccCCCCCCcchhhhhcCce
Confidence 7643221111100 000000 000011111 1135667899999999999999987753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=2e-12 Score=132.98 Aligned_cols=100 Identities=25% Similarity=0.280 Sum_probs=81.2
Q ss_pred HHHHHHHHHHHhhccCCe--eeeeeeeeecCe----eEEEEEecCC-CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 036419 483 EEFKNEIKLTAKLQHRNL--VRLLGCCVEQGE----NVLIYEYLPN-KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLL 555 (754)
Q Consensus 483 ~~~~~Ev~il~~l~hpni--v~l~~~~~~~~~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~ 555 (754)
..+.+|++++.+|+|+++ ++.+++...+.. .++|||++++ .+|.+++.. ..++.. .+.+|+++|.
T Consensus 85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~ 156 (239)
T PRK01723 85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIA 156 (239)
T ss_pred hHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHH
Confidence 457889999999998875 777776544322 2599999997 699988843 234443 3678999999
Q ss_pred HHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 556 yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
+||+.+ |+||||||+|||++.++.++|+|||.+..
T Consensus 157 ~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 157 RFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 999998 99999999999999989999999999875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.39 E-value=2e-12 Score=122.20 Aligned_cols=121 Identities=27% Similarity=0.329 Sum_probs=102.3
Q ss_pred ccceeccCCCcceeeccc------------c--HHHHHHHHHHHHhhcc--CCeeeeeeeeeecCeeEEEEEecCCCChh
Q 036419 463 VENKLGEGGFGPVYKSGQ------------G--LEEFKNEIKLTAKLQH--RNLVRLLGCCVEQGENVLIYEYLPNKSLD 526 (754)
Q Consensus 463 ~~~~lG~G~fg~Vyk~~~------------~--~~~~~~Ev~il~~l~h--pniv~l~~~~~~~~~~~lV~E~~~~gsL~ 526 (754)
+.+.||+|.++.||+... . ...+.+|+.+++.++| .++++++.+...++..+++|||+++..+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 457899999999996211 1 3579999999999987 58999999888888899999999998775
Q ss_pred hHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 527 SFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 527 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
.+ +......++.++++++++||.....+++|+|+||+||++++.+.+++.|||.+..
T Consensus 82 ~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 43 4566778899999999999986555699999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.6e-11 Score=121.45 Aligned_cols=97 Identities=19% Similarity=0.242 Sum_probs=69.2
Q ss_pred HHHHHHHhhccCC--eeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCC
Q 036419 487 NEIKLTAKLQHRN--LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ-YSRL 563 (754)
Q Consensus 487 ~Ev~il~~l~hpn--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~ 563 (754)
.|.+.+.++.+.. +.+.+++ ...++||||++++.+......... . ...+..++.+++.++.++|. .+
T Consensus 66 ~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~-- 135 (187)
T cd05119 66 KEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG-- 135 (187)
T ss_pred HHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC--
Confidence 4555666665432 3444433 246899999999544321111000 1 15678899999999999999 76
Q ss_pred ceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 564 ~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|+|+||||+||+++ ++.++|+|||.+....
T Consensus 136 -ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 136 -LVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred -cCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 99999999999999 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4e-11 Score=132.24 Aligned_cols=233 Identities=24% Similarity=0.299 Sum_probs=168.7
Q ss_pred cCccccceecc--CCCcceeeccc----------------------cHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCee
Q 036419 459 NNFGVENKLGE--GGFGPVYKSGQ----------------------GLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 459 ~~y~~~~~lG~--G~fg~Vyk~~~----------------------~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~ 513 (754)
..|.+.+.+|. |.+|.||++.. ....-.+|+..-++++ |+|.++....++.++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999998433 1122345555555554 89999988889999999
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCceeeCCCCCCceEEcCC-CceEEeec
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQ----GLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDF 588 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----~L~yLH~~~~~~iiH~Dlkp~NIlld~~-~~~kl~DF 588 (754)
++-.|++. .+|..+.... ...++......++.+..+ ||.++|... |+|-|+||.||++..+ ...++.||
T Consensus 194 fiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999875 6887777432 334777888888888888 999999988 9999999999999999 88999999
Q ss_pred cCccccCCCcccccc---cccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhc
Q 036419 589 GLARMFGGDELQSNT---KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWK 665 (754)
Q Consensus 589 gla~~~~~~~~~~~~---~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 665 (754)
|+...+......... .+..|...|++|| +.++-++.+.|+|++|.++.+...+........... |.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke-~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----------W~ 336 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKE-LLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS----------WS 336 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChh-hhccccchHhhhcchhhhhHhhHhhcccccCCCCCC----------cc
Confidence 999988765432221 2335777899999 456678999999999999999999887654321111 11
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 666 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..+-.. +..++......++...+.+|++.+|..|++.+.++.+
T Consensus 337 ~~r~~~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 337 QLRQGY-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cccccc-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 111111 1111111223345558889999999999999877654
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.1e-10 Score=94.61 Aligned_cols=62 Identities=21% Similarity=0.368 Sum_probs=51.8
Q ss_pred cCCCCceEEEcccCCCCcccccccccCChhHHHHHhhc---cceeeeeeecccCCCCcceeccccCc-ccccccc
Q 036419 338 CKSGDRFIMVDDIKLPDLLNVSLNKSMNLKECEAECLK---NRTCRAYANSEVTGRGSGCLMWYGDL-IDTTKAK 408 (754)
Q Consensus 338 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---~CsC~a~~~~~~~~~~~~C~~w~g~L-~d~~~~~ 408 (754)
|.....|+++.++++|++.. ++++||++.|++ ||+|+||+|.+. +.+|++|++++ +|++...
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~ 70 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEF 70 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhcc
Confidence 44556799999999998753 689999999999 999999999643 35899999999 8886553
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.5e-09 Score=120.89 Aligned_cols=162 Identities=20% Similarity=0.263 Sum_probs=121.8
Q ss_pred eccCCCcceee--cccc--HHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHH
Q 036419 467 LGEGGFGPVYK--SGQG--LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGA 542 (754)
Q Consensus 467 lG~G~fg~Vyk--~~~~--~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 542 (754)
...|++-.||. ...+ .+..++.++-|+.|+||||+++++.++++...|||+|-+ ..|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence 34466666654 2333 455788899999999999999999999999999999976 456666633 33666
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCC
Q 036419 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF 622 (754)
Q Consensus 543 ~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 622 (754)
....+.||+.||.+||+.+ .++|++|..+.|++++.|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 7788899999999999876 599999999999999999999999999875432211 111122223566676443222
Q ss_pred CCcccchhhHHHHHHHHHhC
Q 036419 623 FSIKSDVFSFGVLLLETLSS 642 (754)
Q Consensus 623 ~s~ksDVwSlGvil~elltg 642 (754)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 457999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.6e-09 Score=105.15 Aligned_cols=115 Identities=27% Similarity=0.233 Sum_probs=83.0
Q ss_pred ceeccCCCcceeec------------cc---cHHHHHHHHHHHHhhccCCe-eeeeeeeeecCeeEEEEEecCCCChhhH
Q 036419 465 NKLGEGGFGPVYKS------------GQ---GLEEFKNEIKLTAKLQHRNL-VRLLGCCVEQGENVLIYEYLPNKSLDSF 528 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~------------~~---~~~~~~~Ev~il~~l~hpni-v~l~~~~~~~~~~~lV~E~~~~gsL~~~ 528 (754)
+.|+.|.++.||+. .. ....+.+|+++++.+.+.++ .+++.+. ....++||||+++.++...
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE 81 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc
Confidence 46677777777751 11 12346899999999976554 4555443 3345899999999887542
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 529 LFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS--RLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 529 l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
- .....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 82 ~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 D-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 0 011346789999999999976 23469999999999999 66899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-09 Score=121.14 Aligned_cols=231 Identities=19% Similarity=0.207 Sum_probs=163.3
Q ss_pred hhcCccccceeccCCCcceeecc---------------ccH------HHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------QGL------EEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------~~~------~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~ 514 (754)
...+|.++..||.|.|+.|++.. +.. ..-..|+.+...+. |.+++++...+.+..+.+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 34578889999999999988611 011 11234666666664 899999998888888888
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC-CceEEeeccCccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGLARM 593 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-~~~kl~DFgla~~ 593 (754)
+=-||++++++...+ .....+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||....
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999988776 33345788888999999999999999987 9999999999999876 7789999999875
Q ss_pred cCCCcccccccccccccCcc--cccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 594 FGGDELQSNTKRIVGTYGYM--SPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
+.-.. ....+.-++. +|+......+..+.|++|||.-+.+.+++..-.+-.. ....
T Consensus 417 ~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----------------~~~~ 474 (524)
T KOG0601|consen 417 LAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----------------QSLT 474 (524)
T ss_pred cceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-----------------ccee
Confidence 32111 1122233444 4555556688999999999999999998875422110 0001
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+...... ........+..+...++..++..||.+.++..+.+..
T Consensus 475 i~~~~~p--~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 475 IRSGDTP--NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred eeccccc--CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111111 0111225566777778899999999999988876543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.88 E-value=7.9e-09 Score=115.64 Aligned_cols=103 Identities=22% Similarity=0.262 Sum_probs=70.9
Q ss_pred HHHHHHHHHhhc----cCCeeeeeeeee-ecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 036419 485 FKNEIKLTAKLQ----HRNLVRLLGCCV-EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQ-GLLYLH 558 (754)
Q Consensus 485 ~~~Ev~il~~l~----hpniv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-~L~yLH 558 (754)
+.+|.+.+.++. |.+-+.+-.++. .....+|||||++|++|.++...... + . .+..++.+++. .+..+|
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~-~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-G-L---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-C-C---CHHHHHHHHHHHHHHHHH
Confidence 344555555542 333333333332 23457999999999999887643211 1 1 23456666666 467889
Q ss_pred hcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 559 ~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
..+ ++|+|+||.||++++++.++++|||++..+.
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 887 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=8.2e-10 Score=127.83 Aligned_cols=232 Identities=20% Similarity=0.244 Sum_probs=158.7
Q ss_pred hhcCccccceeccCCCcceeeccc---c------------------HHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ---G------------------LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~---~------------------~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.-+.+.+.+.+-.|.++.++.... + .+....+-.++-...||-+++....+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 346677888888999998885211 0 1111111112222234666655555556778899
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|++|+.+++|...++. .+..+.+.....+..+.+++.|||... +.|+|++|.|+|+..+++.++.||+.....+
T Consensus 882 ~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999988854 334666666777888999999999976 8999999999999999999999998543321
Q ss_pred C-------------------------Cccc----ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 036419 596 G-------------------------DELQ----SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRST 646 (754)
Q Consensus 596 ~-------------------------~~~~----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~ 646 (754)
. .... .......||+.|.|||.+.+......+|.|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0000 1123467999999999999999999999999999999999999998
Q ss_pred CcccCCchhHhHhhhhhhccCccccccCcccCC-CCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 036419 647 RFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMS 708 (754)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 708 (754)
....++... ..++...... ........+..+++...+..+|.+|-.|.
T Consensus 1036 na~tpq~~f--------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIF--------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhh--------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 654433211 0111111110 11122345566777778888999998776
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.2e-09 Score=90.38 Aligned_cols=65 Identities=37% Similarity=0.809 Sum_probs=52.1
Q ss_pred CccCCC---CceEEEcccCCCCcccccccccCChhHHHHHhhccceeeeeeecccCCCCcceeccccCccccc
Q 036419 336 ADCKSG---DRFIMVDDIKLPDLLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYGDLIDTT 405 (754)
Q Consensus 336 ~~C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~g~L~d~~ 405 (754)
+.|..+ +.|+.+.++++|+..... .+.++++|++.|++||+|+||++.+ ++++|.+|.+.+.+..
T Consensus 3 ~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~ 70 (84)
T cd01098 3 LNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLR 70 (84)
T ss_pred cccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceE
Confidence 456543 589999999999875433 6789999999999999999999964 2568999988776654
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.71 E-value=7e-08 Score=95.30 Aligned_cols=99 Identities=13% Similarity=0.104 Sum_probs=75.4
Q ss_pred HHHHHHHHHhhcc--CCeeeeeeeeeecCeeEEEEEecCCCChhh-HhhccCCCCCCCHHHHHHHHHHHHHHHHHH-Hhc
Q 036419 485 FKNEIKLTAKLQH--RNLVRLLGCCVEQGENVLIYEYLPNKSLDS-FLFDTTKEGLLGWGARIRIIEGIAQGLLYL-HQY 560 (754)
Q Consensus 485 ~~~Ev~il~~l~h--pniv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~ 560 (754)
.++|.+.|+++.. -++.+.+++ ..-+|||||+.+..+.. .+. ...++.++...+..+++.+|..| |..
T Consensus 73 a~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~ 144 (197)
T cd05146 73 AEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKEC 144 (197)
T ss_pred HHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3489999999964 466667654 56789999998754321 221 12345566778889999999999 777
Q ss_pred CCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 561 ~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
+ |+|+||++.|||+++ +.+.|+|||.+....
T Consensus 145 g---lVHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 145 N---LVHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred C---eecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 7 999999999999974 679999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.1e-07 Score=90.76 Aligned_cols=98 Identities=23% Similarity=0.375 Sum_probs=79.3
Q ss_pred HHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 036419 482 LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561 (754)
Q Consensus 482 ~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 561 (754)
..+..+|.++|.++.--.|.--+=+..+.....|+|||++|..|.+.|... ...++..|-+-+.-||..+
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g 112 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG 112 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC
Confidence 355678999999987544433333445777889999999999999888442 2567888888999999998
Q ss_pred CCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 562 ~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
|+|+||.++||++..+. +.++||||+..
T Consensus 113 ---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 113 ---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999998775 89999999984
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.62 E-value=2e-07 Score=94.52 Aligned_cols=108 Identities=19% Similarity=0.312 Sum_probs=85.1
Q ss_pred HHHHHHHHHHHHhhcc--CCeeeeeeeeeecC---eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 036419 482 LEEFKNEIKLTAKLQH--RNLVRLLGCCVEQG---ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLY 556 (754)
Q Consensus 482 ~~~~~~Ev~il~~l~h--pniv~l~~~~~~~~---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~y 556 (754)
...+.+|+++++.+++ .++.+++.+..+.. ..++||||++|.++.+.+.. ..++......++.+++++|.+
T Consensus 39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~ 114 (223)
T cd05154 39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAA 114 (223)
T ss_pred cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999976 44677777766543 56899999999988776521 346777888888999999999
Q ss_pred HHhcC-----------------------------------------------------CCceeeCCCCCCceEEcC--CC
Q 036419 557 LHQYS-----------------------------------------------------RLRVIHRDLKPSNILLDS--NM 581 (754)
Q Consensus 557 LH~~~-----------------------------------------------------~~~iiH~Dlkp~NIlld~--~~ 581 (754)
||+.. ...++|+|++|.||++++ ++
T Consensus 115 lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~ 194 (223)
T cd05154 115 LHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPR 194 (223)
T ss_pred HhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCc
Confidence 98521 245899999999999998 66
Q ss_pred ceEEeeccCccc
Q 036419 582 IPKISDFGLARM 593 (754)
Q Consensus 582 ~~kl~DFgla~~ 593 (754)
.+.|+||+.+..
T Consensus 195 ~~~iID~e~~~~ 206 (223)
T cd05154 195 VVAVLDWELATL 206 (223)
T ss_pred EEEEEecccccc
Confidence 789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.2e-06 Score=92.77 Aligned_cols=249 Identities=14% Similarity=0.111 Sum_probs=149.3
Q ss_pred ccceeccCCCcceeeccccHH------------HHHHHHHHHHhh-ccCCeeeeeeee-------eecCeeEEEEEecCC
Q 036419 463 VENKLGEGGFGPVYKSGQGLE------------EFKNEIKLTAKL-QHRNLVRLLGCC-------VEQGENVLIYEYLPN 522 (754)
Q Consensus 463 ~~~~lG~G~fg~Vyk~~~~~~------------~~~~Ev~il~~l-~hpniv~l~~~~-------~~~~~~~lV~E~~~~ 522 (754)
..+.||+||-+.+|--..-.+ .-.+.+..|.+. .||-+-.-+.+= .++...-++|..+++
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v~g 94 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKVSG 94 (637)
T ss_pred CCccccCCccceeeecchhhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccCCC
Confidence 456899999999885221111 111122222222 455443311110 123336678888777
Q ss_pred CChhhHhhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 523 KSLDSFLFD----TTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 523 gsL~~~l~~----~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
.---.-|.. .+......|.-.++.++.++.+.+.||++| .+-+|++++|+|+.+++.+.|.|=..-....++.
T Consensus 95 ~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~ 171 (637)
T COG4248 95 KEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGT 171 (637)
T ss_pred ccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccCCc
Confidence 522222222 122345889999999999999999999998 8899999999999999999998854433322221
Q ss_pred ccccccccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCcccCC---chhHhHhhhh--hhccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSS-KRSTRFFNTN---SLTLLGHAWN--LWKDD 667 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltg-~~p~~~~~~~---~~~~~~~~~~--~~~~~ 667 (754)
...-.+|...|.+||... +-.-+...|-|.||+++++++.| ++|+.+-... ...+...+.. +....
T Consensus 172 ---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~ 248 (637)
T COG4248 172 ---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYAS 248 (637)
T ss_pred ---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeech
Confidence 112357888999999654 22446789999999999999988 8888654321 1111100000 00000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHhcc
Q 036419 668 RSWELMDPKLQCEASYPIVKRYINVALLCVQEN--AADRPTMSEVISMLTNE 717 (754)
Q Consensus 668 ~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPt~~evl~~L~~~ 717 (754)
....-..+.............+..+..+|+..- +.-|||++..+..|...
T Consensus 249 ~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 249 DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 000111111111222234566778888888753 56899999988888654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.5e-07 Score=87.03 Aligned_cols=108 Identities=24% Similarity=0.321 Sum_probs=82.1
Q ss_pred HHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC-CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 036419 482 LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN-KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560 (754)
Q Consensus 482 ~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 560 (754)
..+.++|.+++.++.--.|.--.=++.+.+.-.|+|||+++ .++.+++......... .......+..|-+.+.-||..
T Consensus 54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~n 132 (229)
T KOG3087|consen 54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHDN 132 (229)
T ss_pred HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhhC
Confidence 46778999999998744443333345677778899999988 5788888664443322 233367889999999999999
Q ss_pred CCCceeeCCCCCCceEEcCCC---ceEEeeccCccc
Q 036419 561 SRLRVIHRDLKPSNILLDSNM---IPKISDFGLARM 593 (754)
Q Consensus 561 ~~~~iiH~Dlkp~NIlld~~~---~~kl~DFgla~~ 593 (754)
+ |||+||..+||++..++ .+.++|||++..
T Consensus 133 d---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 133 D---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred C---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 8 99999999999997554 358999999874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.2e-08 Score=112.18 Aligned_cols=157 Identities=22% Similarity=0.292 Sum_probs=107.3
Q ss_pred HHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC------ccccccc-ccccccCcccccc
Q 036419 545 RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD------ELQSNTK-RIVGTYGYMSPEY 617 (754)
Q Consensus 545 ~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~------~~~~~~~-~~~gt~~y~APE~ 617 (754)
.-+.+++.|+.|+|.+. .+||++|-|++|.++..+..||+.|+.+...... .+..... -..-...|.|||+
T Consensus 103 ~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~ 180 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY 180 (700)
T ss_pred hhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence 33455668999999865 6999999999999999999999999998765431 1111111 1223458999999
Q ss_pred cccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHcc
Q 036419 618 AIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCV 697 (754)
Q Consensus 618 ~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl 697 (754)
+.+...+.++|+||+|+++|-+..++++.-.......... .....+......+...++.++.+-+.+++
T Consensus 181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-----------~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 181 LLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-----------FSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred hccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-----------hhhcccccccccccccCcHHHHHHHHHHh
Confidence 9998899999999999999999966655322221111000 00001111111222456678888888999
Q ss_pred ccCCCCCCCHHHHHHHH
Q 036419 698 QENAADRPTMSEVISML 714 (754)
Q Consensus 698 ~~dP~~RPt~~evl~~L 714 (754)
..++.-||++.++....
T Consensus 250 ~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSIP 266 (700)
T ss_pred cCCcccCcchhhhhccc
Confidence 99999999887776543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.2e-08 Score=111.23 Aligned_cols=77 Identities=17% Similarity=0.196 Sum_probs=53.1
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC----c
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKE---GLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM----I 582 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~----~ 582 (754)
....+|||||++|+.+.++..-.... ..+....+..++.||. ..+ ++|+|+||.||+++.++ .
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~G---ffHaDpHPGNIlv~~~g~~~~~ 302 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDG---FFHADMHPGNIFVSYDPPENPR 302 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCC---eeeCCCChHHeEEecCCCCCCe
Confidence 34568999999999998753211111 1132333333344433 345 99999999999999888 9
Q ss_pred eEEeeccCccccCC
Q 036419 583 PKISDFGLARMFGG 596 (754)
Q Consensus 583 ~kl~DFgla~~~~~ 596 (754)
+++.|||++..+..
T Consensus 303 i~llDFGivg~l~~ 316 (537)
T PRK04750 303 YIALDFGIVGSLNK 316 (537)
T ss_pred EEEEecceEEECCH
Confidence 99999999987753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.4e-06 Score=94.74 Aligned_cols=139 Identities=21% Similarity=0.289 Sum_probs=109.3
Q ss_pred HHHHHHHHHhhccCCeeeeeeeee----ecCeeEEEEEecCC-CChhhHhhccCC------------CCCCCHHHHHHHH
Q 036419 485 FKNEIKLTAKLQHRNLVRLLGCCV----EQGENVLIYEYLPN-KSLDSFLFDTTK------------EGLLGWGARIRII 547 (754)
Q Consensus 485 ~~~Ev~il~~l~hpniv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~l~~~~~------------~~~l~~~~~~~i~ 547 (754)
...-+++.+++.|+|+|++.+++. .+..+++||+|.|+ ++|.++-+.... ....++...+.++
T Consensus 320 ~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~ 399 (655)
T KOG3741|consen 320 DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYI 399 (655)
T ss_pred chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHH
Confidence 345678899999999999999987 45678999999976 577776654322 2347788999999
Q ss_pred HHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCccc
Q 036419 548 EGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKS 627 (754)
Q Consensus 548 ~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ks 627 (754)
.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+-.|....+..+.. +| +.. -.+-
T Consensus 400 ~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~--------------~~--le~---~Qq~ 457 (655)
T KOG3741|consen 400 SQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT--------------EP--LES---QQQN 457 (655)
T ss_pred HHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCC--------------cc--hhH---Hhhh
Confidence 99999999999998 77799999999999999999988888776654331 01 111 1356
Q ss_pred chhhHHHHHHHHHhCCCC
Q 036419 628 DVFSFGVLLLETLSSKRS 645 (754)
Q Consensus 628 DVwSlGvil~elltg~~p 645 (754)
|.=.||.+++.|.+|...
T Consensus 458 D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 458 DLRDLGLLLLALATGTEN 475 (655)
T ss_pred hHHHHHHHHHHHhhcccc
Confidence 888999999999999754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=7.6e-07 Score=92.85 Aligned_cols=106 Identities=17% Similarity=0.162 Sum_probs=82.6
Q ss_pred HHHHHHHHHHhhccCC--eeeeeeeeee-----cCeeEEEEEecCCC-ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 036419 484 EFKNEIKLTAKLQHRN--LVRLLGCCVE-----QGENVLIYEYLPNK-SLDSFLFDTTKEGLLGWGARIRIIEGIAQGLL 555 (754)
Q Consensus 484 ~~~~Ev~il~~l~hpn--iv~l~~~~~~-----~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~ 555 (754)
.+.+|...+.+|...+ .++.+.+.+. ...-+||+|++++. +|.+++.... ....+...+..++.++++.+.
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~ 152 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVR 152 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHH
Confidence 5788999998886433 3444555543 23568999999986 8999885332 234566778899999999999
Q ss_pred HHHhcCCCceeeCCCCCCceEEcC-------CCceEEeeccCccc
Q 036419 556 YLHQYSRLRVIHRDLKPSNILLDS-------NMIPKISDFGLARM 593 (754)
Q Consensus 556 yLH~~~~~~iiH~Dlkp~NIlld~-------~~~~kl~DFgla~~ 593 (754)
-||..+ |+|+|+++.|||++. +..+.|+||+.++.
T Consensus 153 ~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 153 DMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999998 999999999999975 46889999998863
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.4e-06 Score=87.67 Aligned_cols=109 Identities=24% Similarity=0.270 Sum_probs=86.7
Q ss_pred ccHHHHHHHHHHHHhhccC--CeeeeeeeeeecC----eeEEEEEecCCC-ChhhHhhccCCCCCCCHHHHHHHHHHHHH
Q 036419 480 QGLEEFKNEIKLTAKLQHR--NLVRLLGCCVEQG----ENVLIYEYLPNK-SLDSFLFDTTKEGLLGWGARIRIIEGIAQ 552 (754)
Q Consensus 480 ~~~~~~~~Ev~il~~l~hp--niv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~ 552 (754)
.......+|...+..|... ..++.+++.+... .-+||+|++++. +|.+++..... ++......++.++++
T Consensus 53 ~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 53 LRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALAR 129 (206)
T ss_pred ccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHH
Confidence 4556788899988888643 3456666655432 458999999984 89999854222 566778899999999
Q ss_pred HHHHHHhcCCCceeeCCCCCCceEEcCCC---ceEEeeccCcccc
Q 036419 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNM---IPKISDFGLARMF 594 (754)
Q Consensus 553 ~L~yLH~~~~~~iiH~Dlkp~NIlld~~~---~~kl~DFgla~~~ 594 (754)
.++-||+.+ |+|+|+++.|||++.+. .+.++||+.++..
T Consensus 130 ~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999998 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.8e-06 Score=78.12 Aligned_cols=87 Identities=23% Similarity=0.275 Sum_probs=61.0
Q ss_pred EEEecCccEEEEcCC-CCeEEeecCCCCCC-CceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccccCccccee
Q 036419 91 LTISNNGNLVILNLT-NGAIWSSNTSRKAE-NPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDL 168 (754)
Q Consensus 91 l~~~~~g~l~l~~~~-~~~~ws~~~~~~~~-~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~ 168 (754)
+.+..||+||+++.. +.++|++++..... ...+.|.++|||||++.+ +.++|+| +|
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~------g~~vW~S-----~t----------- 81 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD------GRVVWSS-----NT----------- 81 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC------CCEEEEe-----cc-----------
Confidence 345578999999765 58999999865432 356789999999999854 6789986 11
Q ss_pred cCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecC
Q 036419 169 KNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSG 215 (754)
Q Consensus 169 ~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g 215 (754)
....|.+.+.++.+|...++-.. ..+.|.+.
T Consensus 82 ---------------~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 112 (114)
T smart00108 82 ---------------TGANGNYVLVLLDDGNLVIYDSD-GNFLWQSF 112 (114)
T ss_pred ---------------cCCCCceEEEEeCCCCEEEECCC-CCEEeCCC
Confidence 11346678899999877653222 34677653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.7e-06 Score=83.78 Aligned_cols=101 Identities=25% Similarity=0.302 Sum_probs=68.7
Q ss_pred HHHHHHHHHHHHhhccC--CeeeeeeeeeecCeeEEEEEecC--CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 036419 482 LEEFKNEIKLTAKLQHR--NLVRLLGCCVEQGENVLIYEYLP--NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557 (754)
Q Consensus 482 ~~~~~~Ev~il~~l~hp--niv~l~~~~~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yL 557 (754)
....++|.+.|.++..- ++.+.+++ ....|||||++ |..+..+.... ++.+....++.+++..+..+
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~----~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDY----NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEE----ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEE----eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHH
Confidence 45678999999999865 56777654 24579999998 66665544221 11334567788888866664
Q ss_pred -HhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 558 -HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 558 -H~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|..+ |+|+||.+.|||++++ .+.|+|||.+....
T Consensus 123 ~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 123 LHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp HHCTT---EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred HHhcC---ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 6776 9999999999999988 99999999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.17 E-value=6.3e-06 Score=74.75 Aligned_cols=85 Identities=21% Similarity=0.237 Sum_probs=60.0
Q ss_pred Eec-CccEEEEcCC-CCeEEeecCCCC-CCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccccCcccceec
Q 036419 93 ISN-NGNLVILNLT-NGAIWSSNTSRK-AENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLK 169 (754)
Q Consensus 93 ~~~-~g~l~l~~~~-~~~~ws~~~~~~-~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~ 169 (754)
... ||+||+++.. +.++|++++... ...+.+.|.++|||||++.+ +.++|||=-
T Consensus 26 ~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~------g~~vW~S~~----------------- 82 (116)
T cd00028 26 MQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS------GTVVWSSNT----------------- 82 (116)
T ss_pred CCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC------CcEEEEecc-----------------
Confidence 444 8999999765 589999998653 33456789999999999754 778998511
Q ss_pred CCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecC
Q 036419 170 NGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSG 215 (754)
Q Consensus 170 ~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g 215 (754)
..+.+.+.+.++.+|...++-.+ ..+.|.+.
T Consensus 83 --------------~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 113 (116)
T cd00028 83 --------------TRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSF 113 (116)
T ss_pred --------------cCCCCceEEEEeCCCCEEEECCC-CCEEEcCC
Confidence 01246788889998876653222 35678764
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.15 E-value=2e-05 Score=78.22 Aligned_cols=109 Identities=12% Similarity=0.127 Sum_probs=84.4
Q ss_pred ccHHHHHHHHHHHHhhccC--Ceeeeeeeee-e----cCeeEEEEEecCC-CChhhHhhccCCCCCCCHHHHHHHHHHHH
Q 036419 480 QGLEEFKNEIKLTAKLQHR--NLVRLLGCCV-E----QGENVLIYEYLPN-KSLDSFLFDTTKEGLLGWGARIRIIEGIA 551 (754)
Q Consensus 480 ~~~~~~~~Ev~il~~l~hp--niv~l~~~~~-~----~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~ 551 (754)
.+...|.+|...|.+|+.- .+.+.+ ++. . ...-+||+|-+++ .+|.+++.+.. ....+...+..++.+++
T Consensus 61 ~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va 138 (216)
T PRK09902 61 FGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVA 138 (216)
T ss_pred CCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHH
Confidence 3567899999999999743 345555 332 2 2235799997764 58888885432 23567888889999999
Q ss_pred HHHHHHHhcCCCceeeCCCCCCceEEcCCCc--eEEeeccCccc
Q 036419 552 QGLLYLHQYSRLRVIHRDLKPSNILLDSNMI--PKISDFGLARM 593 (754)
Q Consensus 552 ~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~--~kl~DFgla~~ 593 (754)
+.+.-||+.+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 139 ~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 139 LAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9999999998 999999999999986667 89999987764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1e-06 Score=97.91 Aligned_cols=181 Identities=18% Similarity=0.087 Sum_probs=135.5
Q ss_pred HhhhhcCccccceeccCCCcceeeccccH------------HHHHHHHHHHHhhccCC-eeeeeeeeeecCeeEEEEEec
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSGQGL------------EEFKNEIKLTAKLQHRN-LVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~~~~------------~~~~~Ev~il~~l~hpn-iv~l~~~~~~~~~~~lV~E~~ 520 (754)
+...++.+...+.+++|++++++|.+... ....-++++|.+.+||| .++.++-+..+....++++++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 44455666677788999999999844322 34456889999999999 888888888888999999999
Q ss_pred CCC-ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 521 PNK-SLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 521 ~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
.++ +-.... ....-.+...+...+.+.-+++++|||+.. =+|+| ||+..+ +..|..||+....+.+..
T Consensus 317 s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 317 STGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred cCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-
Confidence 887 221111 011112334444566677788999999864 48888 777765 578999999998776554
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTR 647 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~ 647 (754)
......+++.++|||+.....+..+.|+|++|+-..++.-|-+|..
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2345679999999999999999999999999998888887777643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.02 E-value=6.6e-05 Score=76.58 Aligned_cols=121 Identities=20% Similarity=0.229 Sum_probs=76.3
Q ss_pred ceeccCCCcceeec------------cccHHHHHHHHHHHHhhccCC--eeeeeeeeeecCeeEEEEEecCCCC-hhhHh
Q 036419 465 NKLGEGGFGPVYKS------------GQGLEEFKNEIKLTAKLQHRN--LVRLLGCCVEQGENVLIYEYLPNKS-LDSFL 529 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~------------~~~~~~~~~Ev~il~~l~hpn--iv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l 529 (754)
..||+|..+.||+. ........+|.++++.+..-. +.+.+.+....+...+|||+++|.. +...+
T Consensus 7 ~~i~~G~t~~~y~~~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~ 86 (226)
T TIGR02172 7 TQTGEGGNGESYTHKTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRII 86 (226)
T ss_pred eeecCCCCcceeEecCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhh
Confidence 46777877777762 123456899999999997543 4777888777778889999999963 21111
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHh-cCCCceeeCC
Q 036419 530 FDTTKEGLLGWGARIRIIEGIAQG---------------------------------------LLYLHQ-YSRLRVIHRD 569 (754)
Q Consensus 530 ~~~~~~~~l~~~~~~~i~~qi~~~---------------------------------------L~yLH~-~~~~~iiH~D 569 (754)
. .+......++.++++. ..+|.. .....++|+|
T Consensus 87 ~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 87 S-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred c-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 0 0000111111111111 112211 1224578999
Q ss_pred CCCCceEEcCCCceEEeeccCccc
Q 036419 570 LKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 570 lkp~NIlld~~~~~kl~DFgla~~ 593 (754)
+.|.||++++++ +.|+||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.3e-05 Score=77.35 Aligned_cols=105 Identities=22% Similarity=0.186 Sum_probs=83.9
Q ss_pred HHHHHHHHhhcc-CCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 036419 486 KNEIKLTAKLQH-RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLR 564 (754)
Q Consensus 486 ~~Ev~il~~l~h-pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ 564 (754)
..|.-+++.+++ +++++++|+| ..++|.||.+.+++...-..-..--..+|..|.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999987 6999999999 45789999987755321000011123689999999999999999999866666
Q ss_pred eeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 565 VIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 565 iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+..+|++++|+-+++++.+|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999887654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=4.3e-05 Score=77.67 Aligned_cols=97 Identities=16% Similarity=0.196 Sum_probs=70.0
Q ss_pred HHHHHHHHHHHhhccC--CeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 036419 483 EEFKNEIKLTAKLQHR--NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560 (754)
Q Consensus 483 ~~~~~Ev~il~~l~hp--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 560 (754)
...++|.++|.+|.-. .+.+-+++ +.-.+||||++|..|...- ++.+..-.++..|++-+.-+-..
T Consensus 154 l~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~ 221 (304)
T COG0478 154 LAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR 221 (304)
T ss_pred HHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc
Confidence 3457899999999755 66666653 5567999999997764322 12333344555555555555455
Q ss_pred CCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 561 ~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
| |||+|+.+-||+++++|.+.++||-.+...
T Consensus 222 G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 222 G---IVHGDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred C---ccccCCchheEEEecCCCEEEEeCcccccC
Confidence 5 999999999999999999999999877654
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00016 Score=65.24 Aligned_cols=100 Identities=23% Similarity=0.366 Sum_probs=65.0
Q ss_pred CeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEee-cCCCCCCCCCceEEEecCccEEEEcCCCCeEEeecCCCC
Q 036419 39 EKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVA-NRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRK 117 (754)
Q Consensus 39 ~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~A-Nr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~ 117 (754)
+.+.+.+|.+.|-|-..++ |.|. + ...++||.. +...... ..+.+.|..||||||+|..+.++|++...
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~-~-~~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~-- 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLY-D-SNGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY-- 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEE-E-TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS--
T ss_pred cccccccccccceECCCCe-----EEEE-c-CCCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC--
Confidence 4565655888888876553 4443 2 235779999 4343332 46899999999999999999999999432
Q ss_pred CCCceEEEcc--CCCEEEEecCCCCCCcCceeccccCCCc
Q 036419 118 AENPVAQLLD--TGNLIVRDNFSRSASEGSCLWQSFDYPS 155 (754)
Q Consensus 118 ~~~~~a~l~d--~GNlvl~~~~~~~~~~~~~lWQSFd~Pt 155 (754)
...++...++ .||++ +... ..+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~~------~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKND------SLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EEST------SSEEEESS----
T ss_pred CccEEEeccCcccCCCc-cccc------eEEeECCCCCCC
Confidence 2345566777 88988 6422 467898876664
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.78 E-value=3.9e-05 Score=63.77 Aligned_cols=59 Identities=32% Similarity=0.755 Sum_probs=45.7
Q ss_pred CceEEEcccCCCCcccccccccCChhHHHHHhhc-cceeeeeeecccCCCCcceeccc-cCcccc
Q 036419 342 DRFIMVDDIKLPDLLNVSLNKSMNLKECEAECLK-NRTCRAYANSEVTGRGSGCLMWY-GDLIDT 404 (754)
Q Consensus 342 ~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-~CsC~a~~~~~~~~~~~~C~~w~-g~L~d~ 404 (754)
..|+.++++.+++..... ....++++|++.|++ +|+|.||.|.. ....|.+|. +.+.+.
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~ 64 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDA 64 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccc
Confidence 359999999998654322 456799999999999 99999999964 456899998 544433
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00037 Score=69.53 Aligned_cols=68 Identities=28% Similarity=0.372 Sum_probs=53.7
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
...++||||++|..|.++.. +++ .+...|++++.-||..| ++|+|.+|.|+++.+++ ++++||+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~ 180 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQG 180 (229)
T ss_pred eEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECcc
Confidence 44578999999988866541 222 34566788899999998 99999999999998655 89999987
Q ss_pred ccc
Q 036419 591 ARM 593 (754)
Q Consensus 591 a~~ 593 (754)
.+.
T Consensus 181 k~~ 183 (229)
T PF06176_consen 181 KRM 183 (229)
T ss_pred ccc
Confidence 764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00027 Score=84.26 Aligned_cols=203 Identities=19% Similarity=0.199 Sum_probs=139.7
Q ss_pred cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE----EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 036419 479 GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV----LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGL 554 (754)
Q Consensus 479 ~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L 554 (754)
.........|+..+.++.|+|+++++.+-.+....- +..|++...++...+ ...+.++..+.+.+..++.+||
T Consensus 223 k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL 299 (1351)
T KOG1035|consen 223 KKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGL 299 (1351)
T ss_pred HHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhH
Confidence 344555677888899999999999999876654333 445788888888877 3445688889999999999999
Q ss_pred HHHHhcCCCceeeCCCCCC---ceEEcCCCceEEe--eccCccccCCCcccccccccccccCcccccccccCCCC--ccc
Q 036419 555 LYLHQYSRLRVIHRDLKPS---NILLDSNMIPKIS--DFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFS--IKS 627 (754)
Q Consensus 555 ~yLH~~~~~~iiH~Dlkp~---NIlld~~~~~kl~--DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s--~ks 627 (754)
.|+|+.. ..|.-+... +--.+.++...++ ||+..+.+..... .....-+..+.|||......+. .+.
T Consensus 300 ~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~ 373 (1351)
T KOG1035|consen 300 AYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLT 373 (1351)
T ss_pred HHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhh
Confidence 9999975 444444443 4445666677777 8888886643322 1122334567788877666554 447
Q ss_pred chhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 036419 628 DVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTM 707 (754)
Q Consensus 628 DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 707 (754)
|+|.+|..+..+..+..+...... ...+++.... ..+.+...+|+..++++|+++
T Consensus 374 dL~~lgll~~~~~~~~~i~~~~~~-----------------~~~~l~~~~~--------~~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 374 DLWCLGLLLLQLSQGEDISEKSAV-----------------PVSLLDVLST--------SELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred HHHHHHHHHhhhhhcCcccccccc-----------------hhhhhccccc--------hhhhhhhhhhcchhhhhccch
Confidence 999999999999988765321110 0011111110 145677778999999999999
Q ss_pred HHHHHHHh
Q 036419 708 SEVISMLT 715 (754)
Q Consensus 708 ~evl~~L~ 715 (754)
.+++.+.-
T Consensus 429 ~~ll~~~f 436 (1351)
T KOG1035|consen 429 LELLTHPF 436 (1351)
T ss_pred hhhhhchh
Confidence 99999874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00066 Score=69.74 Aligned_cols=31 Identities=29% Similarity=0.519 Sum_probs=26.6
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
..++|+|+.+.||+++++...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4489999999999999776667999998864
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0013 Score=67.97 Aligned_cols=111 Identities=15% Similarity=0.147 Sum_probs=67.1
Q ss_pred HHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEEEEEecCCCChhhHhh-------------------ccCC-CCCCCH-
Q 036419 483 EEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLF-------------------DTTK-EGLLGW- 540 (754)
Q Consensus 483 ~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~-------------------~~~~-~~~l~~- 540 (754)
..+.+|+++++.+. +--+.+++++....+..++|||+++|.++..... .... ...+..
T Consensus 36 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~ 115 (244)
T cd05150 36 YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRR 115 (244)
T ss_pred cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchh
Confidence 46788999999885 3446677887776667899999999988764421 0000 001100
Q ss_pred -HHHHHHHH--------------------HHHHHHHHHHh----cCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 541 -GARIRIIE--------------------GIAQGLLYLHQ----YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 541 -~~~~~i~~--------------------qi~~~L~yLH~----~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
........ .+...+..|-. .....++|+|+.|.|||++++..+.|+||+.+..
T Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 116 LDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 00000000 01111122211 1124599999999999999987788999998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00099 Score=67.68 Aligned_cols=129 Identities=26% Similarity=0.285 Sum_probs=70.4
Q ss_pred ceeccCCCcceeec--------------cccHHHHHHHHHHHHhhccCC--eeeeeeeee---ecCeeEEEEEecCCCCh
Q 036419 465 NKLGEGGFGPVYKS--------------GQGLEEFKNEIKLTAKLQHRN--LVRLLGCCV---EQGENVLIYEYLPNKSL 525 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~--------------~~~~~~~~~Ev~il~~l~hpn--iv~l~~~~~---~~~~~~lV~E~~~~gsL 525 (754)
+.|+.|..+.||+. ......+.+|+.+++.+.... +.+++.... .....+++|+++++..+
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~ 82 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPL 82 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEH
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccc
Confidence 46677777777751 123477889999999986443 566666442 23346899999999988
Q ss_pred hh----------------Hhh---cc-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh----
Q 036419 526 DS----------------FLF---DT-TKEGLLGWGAR---------IRI------------IEGIAQ-GLLYLHQ---- 559 (754)
Q Consensus 526 ~~----------------~l~---~~-~~~~~l~~~~~---------~~i------------~~qi~~-~L~yLH~---- 559 (754)
.. .+. .. .....+..... ... ...+.+ .+..++.
T Consensus 83 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (239)
T PF01636_consen 83 DDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPK 162 (239)
T ss_dssp HHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHC
T ss_pred cccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhcc
Confidence 77 111 01 01111111110 000 111222 2333332
Q ss_pred cCCCceeeCCCCCCceEEc-CCCceEEeeccCccc
Q 036419 560 YSRLRVIHRDLKPSNILLD-SNMIPKISDFGLARM 593 (754)
Q Consensus 560 ~~~~~iiH~Dlkp~NIlld-~~~~~kl~DFgla~~ 593 (754)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 163 ~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 163 PLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp CSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred CCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1345699999999999999 566668999988763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0029 Score=77.03 Aligned_cols=44 Identities=20% Similarity=0.448 Sum_probs=34.6
Q ss_pred HHHHHHHHHHHHhhc-cCCe--eeeeeeeeec---CeeEEEEEecCCCCh
Q 036419 482 LEEFKNEIKLTAKLQ-HRNL--VRLLGCCVEQ---GENVLIYEYLPNKSL 525 (754)
Q Consensus 482 ~~~~~~Ev~il~~l~-hpni--v~l~~~~~~~---~~~~lV~E~~~~gsL 525 (754)
...+.+|+++++.+. |+++ .+++.+|.+. ...++||||++|..+
T Consensus 82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 357889999999996 6654 8888887664 457899999998653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0042 Score=61.76 Aligned_cols=95 Identities=20% Similarity=0.282 Sum_probs=69.1
Q ss_pred HHHHHHHHHHHHhhc------cCCeeeeeeeeeecCeeEEEEEecCC------CChhhHhhccCCCCCCCHHHHHHHHHH
Q 036419 482 LEEFKNEIKLTAKLQ------HRNLVRLLGCCVEQGENVLIYEYLPN------KSLDSFLFDTTKEGLLGWGARIRIIEG 549 (754)
Q Consensus 482 ~~~~~~Ev~il~~l~------hpniv~l~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~q 549 (754)
.++..+|+.....+. +.+|.+++|+.+.+...-+|+|.+.+ .+|.+++.+ +.++. ...+.+
T Consensus 55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L-- 127 (199)
T PF10707_consen 55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQAL-- 127 (199)
T ss_pred hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHH--
Confidence 577788888777776 78899999999999999999998733 367777732 33554 333333
Q ss_pred HHHHHHHHHhcCCCceeeCCCCCCceEEcCCC----ceEEee
Q 036419 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM----IPKISD 587 (754)
Q Consensus 550 i~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~----~~kl~D 587 (754)
-+-..||-++. |+.+|++|.||++.... .+.|+|
T Consensus 128 -~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 128 -DEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred -HHHHHHHHHcC---CeecCCCcccEEEEecCCCceEEEEEe
Confidence 34445666665 99999999999995322 567777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.00044 Score=51.30 Aligned_cols=37 Identities=38% Similarity=0.663 Sum_probs=30.7
Q ss_pred ccCCCCCCCCCccccccccch---------hccccCceecccccCC
Q 036419 718 FVNLPSPQQPGFSSLKKSVET---------VARSMNRLTLSVMDAR 754 (754)
Q Consensus 718 ~~~~~~p~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~~~ 754 (754)
...+|.|+||+|+..+...+. ...++|++|+|+|+||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 468999999999998877221 4578999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.01 Score=63.28 Aligned_cols=61 Identities=16% Similarity=0.214 Sum_probs=44.4
Q ss_pred ceeccCCCcceeec-------------c-ccHHHHHHHHHHHHhhcc---CCeeeeeeeeee---cCeeEEEEEecCCCC
Q 036419 465 NKLGEGGFGPVYKS-------------G-QGLEEFKNEIKLTAKLQH---RNLVRLLGCCVE---QGENVLIYEYLPNKS 524 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~-------------~-~~~~~~~~Ev~il~~l~h---pniv~l~~~~~~---~~~~~lV~E~~~~gs 524 (754)
+.||.|..+.||+- . .....+.+|.+.|+.|.. -.+.++++++.. .+..+||||++++.+
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~ 99 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVS 99 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEe
Confidence 46777777777651 1 123588999999999963 368888887754 356899999999876
Q ss_pred h
Q 036419 525 L 525 (754)
Q Consensus 525 L 525 (754)
+
T Consensus 100 ~ 100 (297)
T PRK10593 100 V 100 (297)
T ss_pred c
Confidence 5
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0089 Score=57.35 Aligned_cols=115 Identities=19% Similarity=0.248 Sum_probs=79.2
Q ss_pred cccceeccCCCcceeecc--------------ccHHHHHHHHHHHHhhccCCe-eeeeeeeeecCeeEEEEEecCCCChh
Q 036419 462 GVENKLGEGGFGPVYKSG--------------QGLEEFKNEIKLTAKLQHRNL-VRLLGCCVEQGENVLIYEYLPNKSLD 526 (754)
Q Consensus 462 ~~~~~lG~G~fg~Vyk~~--------------~~~~~~~~Ev~il~~l~hpni-v~l~~~~~~~~~~~lV~E~~~~gsL~ 526 (754)
+..+.|++|.+|.||+.. .-...++.|+++|..++--++ .+++.+- ..++.|||+.|..|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~ 100 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence 456789999999999832 235778999999999987655 3444432 234559999998887
Q ss_pred hHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCC-CCceEEcCCCceEEeeccCccc
Q 036419 527 SFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLK-PSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 527 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlk-p~NIlld~~~~~kl~DFgla~~ 593 (754)
+.-... + .+-+..+++...-|...+ |-|..|. |...+|..+..+.|+||.-|..
T Consensus 101 ~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 655221 1 233445666655555555 9999886 4555555555999999999884
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.0073 Score=68.63 Aligned_cols=104 Identities=16% Similarity=0.207 Sum_probs=65.6
Q ss_pred HHHHHHHHHhhc----cCCeeeeeeee-eecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHH-HHHH
Q 036419 485 FKNEIKLTAKLQ----HRNLVRLLGCC-VEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGL-LYLH 558 (754)
Q Consensus 485 ~~~Ev~il~~l~----hpniv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L-~yLH 558 (754)
+.+|..-+.++. +..-+++=.++ +-.....|+|||++|-.+.++..-.. ...+.+. ++..++++. ..+=
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~ 282 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHH
Confidence 445666565553 22233333333 33567799999999999988853322 2233322 222222221 1111
Q ss_pred hcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 559 ~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
..+ ++|.|.+|.||+++.++.+.+.|||+...+..
T Consensus 283 ~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 233 99999999999999999999999999987653
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.013 Score=62.39 Aligned_cols=114 Identities=22% Similarity=0.228 Sum_probs=67.3
Q ss_pred ccHHHHHHHHHHHHhhccCC--eeeeeee------eeecCeeEEEEEecCCCChhh----Hh----------hccCC---
Q 036419 480 QGLEEFKNEIKLTAKLQHRN--LVRLLGC------CVEQGENVLIYEYLPNKSLDS----FL----------FDTTK--- 534 (754)
Q Consensus 480 ~~~~~~~~Ev~il~~l~hpn--iv~l~~~------~~~~~~~~lV~E~~~~gsL~~----~l----------~~~~~--- 534 (754)
...++...|++++..|.+.. +.+++.. ....+..++|+++++|..+.. .. +....
T Consensus 48 ~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~ 127 (296)
T cd05153 48 VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFP 127 (296)
T ss_pred CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCC
Confidence 34567888999999986433 4454432 123445689999999977532 11 00000
Q ss_pred -----CCCCCHHHHH----------HHHHHHHHHHHHHHh----cCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 535 -----EGLLGWGARI----------RIIEGIAQGLLYLHQ----YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 535 -----~~~l~~~~~~----------~i~~qi~~~L~yLH~----~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
.....|.... .....+..++.++.. .....++|+|+.|.||+++++..+.|+||+.+..
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 128 GERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred ccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 0111121111 011123344555543 1224599999999999999987788999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.0034 Score=51.62 Aligned_cols=49 Identities=12% Similarity=0.341 Sum_probs=34.7
Q ss_pred EcccCCCCcccccccccCChhHHHHHhhccceeeeeeecccCCCCcceecccc
Q 036419 347 VDDIKLPDLLNVSLNKSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYG 399 (754)
Q Consensus 347 ~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~g 399 (754)
+.++.++....... ...+.++|++.|+.+|+|.||.|.. ....|+++.+
T Consensus 9 ~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~ 57 (73)
T cd01100 9 GSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS 57 (73)
T ss_pred cCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence 34556655432222 3568999999999999999999963 3458998754
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.0006 Score=82.99 Aligned_cols=159 Identities=13% Similarity=-0.038 Sum_probs=114.2
Q ss_pred HHHHHHHHhhccCCeeeeeeeee--ecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHH-HHHHHHHHhcC-
Q 036419 486 KNEIKLTAKLQHRNLVRLLGCCV--EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGI-AQGLLYLHQYS- 561 (754)
Q Consensus 486 ~~Ev~il~~l~hpniv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi-~~~L~yLH~~~- 561 (754)
..|..-++..+|+++.+...-.. +....+.+++|+.+|.+.+.|-+..++...-.........++ +....-+|...
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34444556678999887765543 344568899999999999988765544332223333333333 55555555432
Q ss_pred -CCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHH
Q 036419 562 -RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640 (754)
Q Consensus 562 -~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ell 640 (754)
....+|+++|+-|.+|+.+..+|++++|+.++.... ....+...+++.|++|++...-.++.++|+|..|+.+|+.-
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 245789999999999999999999999999943322 22334567888999999888889999999999999999988
Q ss_pred hCCCCC
Q 036419 641 SSKRST 646 (754)
Q Consensus 641 tg~~p~ 646 (754)
.|..++
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 777664
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.027 Score=57.12 Aligned_cols=99 Identities=19% Similarity=0.220 Sum_probs=67.2
Q ss_pred HHHHHHHHhhc--cCCeeeeeeeeeecCeeEEEEEecCCCC-hhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 036419 486 KNEIKLTAKLQ--HRNLVRLLGCCVEQGENVLIYEYLPNKS-LDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562 (754)
Q Consensus 486 ~~Ev~il~~l~--hpniv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~ 562 (754)
.+|..-|.++. +-.+.+-+.+ .+..|||||+.... -.-.|. .-.+..++...+..++++.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 46777777764 3333444433 24579999986541 111121 112333367778888888888887633
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
+++|+||..-|||+. ++.+.|+||+.|....
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 399999999999999 8899999999988654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.022 Score=59.19 Aligned_cols=30 Identities=23% Similarity=0.341 Sum_probs=26.5
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
..++|+|+.|.||++++++ ++|+||..+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 3589999999999999877 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.045 Score=58.59 Aligned_cols=112 Identities=24% Similarity=0.307 Sum_probs=64.1
Q ss_pred HHHHHHHHHHHHhhccCC--eeeeeeee------eecCeeEEEEEecCCCChhh----Hh----------hccCCC----
Q 036419 482 LEEFKNEIKLTAKLQHRN--LVRLLGCC------VEQGENVLIYEYLPNKSLDS----FL----------FDTTKE---- 535 (754)
Q Consensus 482 ~~~~~~Ev~il~~l~hpn--iv~l~~~~------~~~~~~~lV~E~~~~gsL~~----~l----------~~~~~~---- 535 (754)
.++...|++++..|.... +.+++... ...+..++|+||++|..+.. .+ +.....
T Consensus 59 ~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~ 138 (307)
T TIGR00938 59 AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPEN 138 (307)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCC
Confidence 567778888888885322 44444321 22355789999999865421 11 110000
Q ss_pred -----CCCCHHHHH------------HHHHHHHHHHHHHHh----cCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 536 -----GLLGWGARI------------RIIEGIAQGLLYLHQ----YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 536 -----~~l~~~~~~------------~i~~qi~~~L~yLH~----~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
....|.... .....+.+.+.++.. .-...++|+|+++.||++++++.+.|+||+.+..
T Consensus 139 ~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 139 RKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 001111110 011123344555542 1235699999999999999988778999998863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.026 Score=64.09 Aligned_cols=79 Identities=20% Similarity=0.273 Sum_probs=52.5
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC----CCceEE
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS----NMIPKI 585 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~----~~~~kl 585 (754)
...+.|+||||+|..+.+.-.-.. ..++...+. ..+.++ |++..-..+.+|+|=+|.||++.. ++.+.+
T Consensus 274 st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~---~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivl 346 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDAIDK--RGISPHDIL---NKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVL 346 (538)
T ss_pred CcceEEEEEecCCccCCCHHHHHH--cCCCHHHHH---HHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEE
Confidence 346899999999998877643222 224444333 333332 222211123999999999999983 678999
Q ss_pred eeccCccccC
Q 036419 586 SDFGLARMFG 595 (754)
Q Consensus 586 ~DFgla~~~~ 595 (754)
.|||+...+.
T Consensus 347 lDhGl~~~is 356 (538)
T KOG1235|consen 347 LDHGLYAVIS 356 (538)
T ss_pred Eccccccccc
Confidence 9999988664
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.035 Score=56.78 Aligned_cols=31 Identities=26% Similarity=0.368 Sum_probs=27.4
Q ss_pred CceeeCCCCCCceEEcC-CCceEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILLDS-NMIPKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~-~~~~kl~DFgla~~ 593 (754)
..++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 46999999999999998 57899999998864
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.052 Score=58.39 Aligned_cols=31 Identities=32% Similarity=0.432 Sum_probs=26.7
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
.++||+|++|.||+++++...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4699999999999999776668999998864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.038 Score=58.87 Aligned_cols=32 Identities=25% Similarity=0.477 Sum_probs=29.2
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
..++|+|+++.||+|+++..+-|.||+++..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 56999999999999999988999999999864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.062 Score=56.44 Aligned_cols=94 Identities=13% Similarity=0.137 Sum_probs=65.9
Q ss_pred HHHHHHHHHhhcc--CCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 036419 485 FKNEIKLTAKLQH--RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562 (754)
Q Consensus 485 ~~~Ev~il~~l~h--pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~ 562 (754)
..+|.+.|+.|.. --+.+.+++ +.-++|||++.+..|...- ...+.. .+...+..-+.-|-.+|
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~---~ly~~lm~~Iv~la~~G- 222 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPP---TLYDDLMGLIVRLANHG- 222 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChH---HHHHHHHHHHHHHHHcC-
Confidence 4578888888863 234444443 4567899999998875432 122333 34444555556676777
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||+|.+-=||++++++.++++||-.....
T Consensus 223 --lIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 223 --LIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred --ceecccchheeEEecCCCEEEeechHhhcc
Confidence 999999999999999999999999876543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.22 Score=55.09 Aligned_cols=30 Identities=23% Similarity=0.321 Sum_probs=25.9
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
..++|+|+.+.|||+.++ .++|+||.++..
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 469999999999999876 589999987764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.18 Score=50.05 Aligned_cols=109 Identities=27% Similarity=0.457 Sum_probs=78.0
Q ss_pred cCccccceeccCCC-cceeec----------------------------c---------ccHHHHHHHHHHHHhhcc---
Q 036419 459 NNFGVENKLGEGGF-GPVYKS----------------------------G---------QGLEEFKNEIKLTAKLQH--- 497 (754)
Q Consensus 459 ~~y~~~~~lG~G~f-g~Vyk~----------------------------~---------~~~~~~~~Ev~il~~l~h--- 497 (754)
.+++.++.||.|.- |.|||. + ...+-|..|.+...+|++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78888999999999 999871 0 112357789998888863
Q ss_pred CCe--eeeeeeeeec------------------CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 036419 498 RNL--VRLLGCCVEQ------------------GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557 (754)
Q Consensus 498 pni--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yL 557 (754)
..+ |+.+|+..-. -..-||.||.+... .+ ...-+.+|.+-+.-+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHHH
Confidence 455 8999887311 12357888775533 11 133456788888889
Q ss_pred HhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 558 H~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
|..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9988 999999999986 2389999864
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.12 Score=56.21 Aligned_cols=31 Identities=29% Similarity=0.448 Sum_probs=27.1
Q ss_pred CceeeCCCCCCceEEcC-CCceEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILLDS-NMIPKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~-~~~~kl~DFgla~~ 593 (754)
..++|+|+++.|||+++ ++.++++||..+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 46999999999999986 46899999998874
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.061 Score=54.14 Aligned_cols=31 Identities=39% Similarity=0.562 Sum_probs=22.2
Q ss_pred CceeeCCCCCCceEE-cCCCceEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILL-DSNMIPKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIll-d~~~~~kl~DFgla~~ 593 (754)
..++|+|+.|.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8889999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.16 E-value=0.25 Score=52.06 Aligned_cols=31 Identities=29% Similarity=0.549 Sum_probs=26.1
Q ss_pred CceeeCCCCCCceEEcCCCc-eEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILLDSNMI-PKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~-~kl~DFgla~~ 593 (754)
..++|+|++|.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.19 Score=53.07 Aligned_cols=43 Identities=16% Similarity=0.244 Sum_probs=28.0
Q ss_pred cHHHHHHHHHHHHhhc---cCCeeeeeeeeeecCeeEEEEEecCCC
Q 036419 481 GLEEFKNEIKLTAKLQ---HRNLVRLLGCCVEQGENVLIYEYLPNK 523 (754)
Q Consensus 481 ~~~~~~~Ev~il~~l~---hpniv~l~~~~~~~~~~~lV~E~~~~g 523 (754)
....|..|.+-|+.|. --.+++.+.+...++.-+|||||++.+
T Consensus 52 ~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 52 GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4567899999998884 345778888887777789999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.69 E-value=0.048 Score=60.47 Aligned_cols=47 Identities=21% Similarity=0.301 Sum_probs=35.4
Q ss_pred HHHHHHHHHHhhccCCeeeeeeeeeecC-eeEEEEEecCCCChhhHhhc
Q 036419 484 EFKNEIKLTAKLQHRNLVRLLGCCVEQG-ENVLIYEYLPNKSLDSFLFD 531 (754)
Q Consensus 484 ~~~~Ev~il~~l~hpniv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~ 531 (754)
++.-..++++.++|+|+..++++..... ...+|||++ +.+|++++..
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 3445677899999999999999876443 366789987 5588888743
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.25 E-value=0.22 Score=53.23 Aligned_cols=75 Identities=20% Similarity=0.148 Sum_probs=56.8
Q ss_pred ecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeec
Q 036419 509 EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDF 588 (754)
Q Consensus 509 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DF 588 (754)
+....|++|++- |+++. .+ ....++++..++.+-+..+.-+...- +.-|||+..+||||+ +|++.|+||
T Consensus 297 e~~y~yl~~kdh-gt~is-~i------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 297 ETLYLYLHFKDH-GTPIS-II------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred CceEEEEEEecC-Cceee-ee------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEe
Confidence 344556777753 33332 11 23568888999998888888887654 689999999999999 999999999
Q ss_pred cCcccc
Q 036419 589 GLARMF 594 (754)
Q Consensus 589 gla~~~ 594 (754)
-+++.-
T Consensus 366 klsRl~ 371 (488)
T COG5072 366 KLSRLS 371 (488)
T ss_pred eeeecc
Confidence 999953
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=93.12 E-value=0.25 Score=53.53 Aligned_cols=31 Identities=23% Similarity=0.321 Sum_probs=26.8
Q ss_pred CceeeCCCCCCceEEcC-CCceEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILLDS-NMIPKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~-~~~~kl~DFgla~~ 593 (754)
..++|.|+.+.|||+++ ++.++++||..|..
T Consensus 182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred eEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 35899999999999975 57899999999864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=92.35 E-value=0.94 Score=50.04 Aligned_cols=29 Identities=17% Similarity=0.363 Sum_probs=24.3
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
..++|+|+.+.|||+.+++ .+++|...+.
T Consensus 230 ~~L~HGDl~~g~i~~~~~~-~~~id~ef~~ 258 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPDS-TQVIDPEFAF 258 (418)
T ss_pred cceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence 5699999999999999875 7888866554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 754 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-43 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-42 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-35 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-32 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 366 bits (942), Expect = e-122
Identities = 101/294 (34%), Positives = 142/294 (48%), Gaps = 37/294 (12%)
Query: 450 SLASVSAATNNF------GVENKLGEGGFGPVYK--------------------SGQGLE 483
S + TNNF NK+GEGGFG VYK + + +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ 75
Query: 484 EFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGAR 543
+F EIK+ AK QH NLV LLG + + L+Y Y+PN SL L L W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 544 IRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT 603
+I +G A G+ +LH+ IHRD+K +NILLD KISDFGLAR T
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 604 KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL 663
RIVGT YM+PE + G + KSD++SFGV+LLE ++ + + LL +
Sbjct: 193 SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD-EHREPQLLLDIKEEI 250
Query: 664 WKDDRSWE-LMDPKLQCEASYPI--VKRYINVALLCVQENAADRPTMSEVISML 714
++++ E +D K+ V+ +VA C+ E RP + +V +L
Sbjct: 251 EDEEKTIEDYIDKKMN---DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-117
Identities = 108/290 (37%), Positives = 159/290 (54%), Gaps = 23/290 (7%)
Query: 450 SLASVSAATNNFGVENKLGEGGFGPVYK-----------------SGQGLE-EFKNEIKL 491
SL + A++NF +N LG GGFG VYK QG E +F+ E+++
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 492 TAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK-EGLLGWGARIRIIEGI 550
+ HRNL+RL G C+ E +L+Y Y+ N S+ S L + + + L W R RI G
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 551 AQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY 610
A+GL YLH + ++IHRD+K +NILLD + DFGLA++ + T + GT
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTI 199
Query: 611 GYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRST---RFFNTNSLTLLGHAWNLWKDD 667
G+++PEY G S K+DVF +GV+LLE ++ +R+ R N + + LL L K+
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 668 RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717
+ L+D LQ V++ I VALLC Q + +RP MSEV+ ML +
Sbjct: 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-102
Identities = 99/310 (31%), Positives = 160/310 (51%), Gaps = 24/310 (7%)
Query: 426 SFSSGGASYYFMHILSMETKTQGK--SLASVSAATNNFGVENKLGEGGFGPVYK------ 477
+S S S + L + ATNNF + +G G FG VYK
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 478 -----------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLD 526
S QG+EEF+ EI+ + +H +LV L+G C E+ E +LIY+Y+ N +L
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 527 SFLFDTTKEGL-LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKI 585
L+ + + + W R+ I G A+GL YLH + +IHRD+K NILLD N +PKI
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS 645
+DFG+++ + + + GT GY+ PEY I G + KSDV+SFGV+L E L ++ +
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 646 T-RFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADR 704
+ + L A + + +++DP L + ++++ + A+ C+ ++ DR
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300
Query: 705 PTMSEVISML 714
P+M +V+ L
Sbjct: 301 PSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 250 bits (639), Expect = 6e-77
Identities = 62/300 (20%), Positives = 108/300 (36%), Gaps = 46/300 (15%)
Query: 457 ATNNFGVENKLGEGGFGPVYK---------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+ + G FG V+K + + + E+ ++H N++
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 502 RLLGCCVE----QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557
+ +G + LI + SL FL + W I E +A+GL YL
Sbjct: 82 QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYL 137
Query: 558 HQ-------YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY 610
H+ + + HRD+K N+LL +N+ I+DFGLA F + +T VGT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 611 GYMSPEYAIHGF-----FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWK 665
YM+PE ++ D+++ G++L E S R T +L + +
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS--RCTAADGPVDEYMLPFEEEIGQ 255
Query: 666 DDRSWEL--------MDPKL-QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
++ P L + + C +A R + V +T
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 3e-65
Identities = 63/327 (19%), Positives = 110/327 (33%), Gaps = 53/327 (16%)
Query: 450 SLASVSAATNNFGVENKLGEGGFGPVYK-------------SGQGLEEFKNE--IKLTAK 494
+ + S +N + +G G +G VYK S + F NE I
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPL 63
Query: 495 LQHRNLVRLLGCCVEQGENV-----LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG 549
++H N+ R + + L+ EY PN SL +L T W + R+
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHS 119
Query: 550 IAQGLLYLHQ------YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG------D 597
+ +GL YLH + + + HRDL N+L+ ++ ISDFGL+ G
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 598 ELQSNTKRIVGTYGYMSPEYA-------IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFN 650
E + VGT YM+PE + D+++ G++ E
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 651 TNSLTLLGHAWNLWKDDRSWELMD--------PKL--QCEASYPIVKRYINVALLCVQEN 700
+ + + ++ PK + + V+ C ++
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 701 AADRPTMSEVISMLTNEFVNLPSPQQP 727
A R T + + +
Sbjct: 300 AEARLTAQXAEERMAELMMIWERNKSV 326
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 9e-57
Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 35/288 (12%)
Query: 463 VENKLGEGGFGPVYK--------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCCV 508
VE +G G FG V K S + F E++ +++ H N+V+L G C+
Sbjct: 12 VEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 509 EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHR 568
L+ EY SL + L + +QG+ YLH +IHR
Sbjct: 72 N--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 569 DLKPSNILLDSNM-IPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKS 627
DLKP N+LL + + KI DFG A ++Q++ G+ +M+PE +S K
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 628 DVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVK 687
DVFS+G++L E ++ + + F+ W + R P L + P K
Sbjct: 185 DVFSWGIILWEVITRR---KPFDEIGGPAFRIMWAVHNGTR------PPLI--KNLP--K 231
Query: 688 RYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKKS 735
++ C ++ + RP+M E++ ++T+ P +P + S
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS 279
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-54
Identities = 66/302 (21%), Positives = 107/302 (35%), Gaps = 60/302 (19%)
Query: 463 VENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNLVRLL 504
LG+G FG K + F E+K+ L+H N+++ +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 505 GCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLR 564
G + I EY+ +L + + W R+ + IA G+ YLH +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 565 VIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR------------IVGTYGY 612
+IHRDL N L+ N ++DFGLAR+ ++ Q R +VG +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672
M+PE + K DVFSFG++L E + A D
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN---------------AD----PDYLPRT 229
Query: 673 MDPKLQCEASY--PIVK----RYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQ 726
MD L + + + C + RP+ ++ L ++L
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289
Query: 727 PG 728
G
Sbjct: 290 LG 291
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 7e-54
Identities = 66/275 (24%), Positives = 116/275 (42%), Gaps = 41/275 (14%)
Query: 463 VENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNLVRLL 504
++ K+G G FG V++ + + EF E+ + +L+H N+V +
Sbjct: 41 IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 505 GCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLR 564
G + ++ EYL SL L + L R+ + +A+G+ YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 565 VIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFS 624
++HR+LK N+L+D K+ DFGL+R+ L S + GT +M+PE +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSN 217
Query: 625 IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL--QCEAS 682
KSDV+SFGV+L E + + N N ++ +K R ++
Sbjct: 218 EKSDVYSFGVILWELAT--LQQPWGNLNPAQVVAAV--GFKCKR------LEIPRNLNPQ 267
Query: 683 Y-PIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
I++ C RP+ + ++ +L
Sbjct: 268 VAAIIEG-------CWTNEPWKRPSFATIMDLLRP 295
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 8e-53
Identities = 65/273 (23%), Positives = 118/273 (43%), Gaps = 38/273 (13%)
Query: 463 VENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLG 505
V ++G G FG VYK + Q L+ FKNE+ + K +H N++ +G
Sbjct: 28 VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 506 CCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLR 564
+ ++ ++ SL L E I I A+G+ YLH
Sbjct: 88 YSTA--PQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA---KS 140
Query: 565 VIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE---YAIHG 621
+IHRDLK +NI L + KI DFGLA +++ G+ +M+PE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 622 FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681
+S +SDV++FG++L E ++ + + N N+ + + + + +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQI--IEMVGRGSL----SPDLSKVRS 252
Query: 682 SYPIVKRYINVALLCVQENAADRPTMSEVISML 714
+ P KR + C+++ +RP+ +++ +
Sbjct: 253 NCP--KRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 78/282 (27%), Positives = 119/282 (42%), Gaps = 50/282 (17%)
Query: 463 VENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
+E +G GGFG VY+ Q +E + E KL A L+H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
L G C+++ L+ E+ L+ L + + IA+G+ YLH +
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 563 LRVIHRDLKPSNILLD--------SNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMS 614
+ +IHRDLK SNIL+ SN I KI+DFGLAR + S G Y +M+
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMA 182
Query: 615 PEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674
PE FS SDV+S+GVLL E L+ F + L +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLT--GEVPFRGIDGLAVAYGV--AMNKLA------ 232
Query: 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
L ++ P + + + C + RP+ + ++ LT
Sbjct: 233 --LPIPSTCP--EPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-50
Identities = 65/286 (22%), Positives = 117/286 (40%), Gaps = 54/286 (18%)
Query: 463 VENKLGEGGFGPVYK-------------------------SGQGLEEFKNEIKLTAKLQH 497
E ++G+GGFG V+K + +EF+ E+ + + L H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 498 RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557
N+V+L G ++ E++P L L D K + W ++R++ IA G+ Y+
Sbjct: 83 PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYM 138
Query: 558 HQYSRLRVIHRDLKPSNILLDS-----NMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
++HRDL+ NI L S + K++DFGL++ + + ++G + +
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQW 192
Query: 613 MSPE--YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670
M+PE A ++ K+D +SF ++L L+ F + + + R
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILT--GEGPFDEYSYGKIKFINMIREEGLR-- 248
Query: 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
P R NV LC + RP S ++ L+
Sbjct: 249 ------PTIPEDCP--PRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-50
Identities = 65/304 (21%), Positives = 116/304 (38%), Gaps = 51/304 (16%)
Query: 463 VENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLG 505
+ +G+G FG VY + L+ FK E+ + +H N+V +G
Sbjct: 37 IGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
C+ +I ++L S + D + +L +I + I +G+ YLH +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI---VGTYGYMSPE------ 616
+H+DLK N+ D+ + I+DFGL + G + ++ G +++PE
Sbjct: 152 LHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 617 ---YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673
FS SDVF+ G + E + R F + + W + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHA--REWPFKTQPAEAI---IWQMGTGMK---PN 262
Query: 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLK 733
++ K ++ L C +RPT ++++ ML PG
Sbjct: 263 LSQIGMG------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW-- 314
Query: 734 KSVE 737
KS E
Sbjct: 315 KSAE 318
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-48
Identities = 50/289 (17%), Positives = 98/289 (33%), Gaps = 74/289 (25%)
Query: 463 VENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNLVRLL 504
KL E G ++K S + +F E H N++ +L
Sbjct: 14 FLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 505 GCCVEQGEN--VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
G C LI ++P SL + L + T ++ ++ +A+G+ +LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG- 621
L + L ++++D +M +IS + F + + +++PE A+
Sbjct: 133 L-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE-ALQKK 183
Query: 622 ---FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678
+D++SF VLL E + TR + + +
Sbjct: 184 PEDTNRRSADMWSFAVLLWELV-----TR-------------------EVPFADLSNM-- 217
Query: 679 CEASYPIV-------------KRYINVALLCVQENAADRPTMSEVISML 714
E + + +C+ E+ A RP ++ +L
Sbjct: 218 -EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-45
Identities = 67/296 (22%), Positives = 114/296 (38%), Gaps = 52/296 (17%)
Query: 464 ENKLGEGGFGPVYK-------------SGQGLEEFKNE--IKLTAKLQHRNLVRLLGCCV 508
+G+G +G V++ S + + + E + T L+H N++ + +
Sbjct: 13 LECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 509 EQGENV----LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH-----Q 559
+ LI Y SL +L + L + +RI+ IA GL +LH
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF--GGDELQSNTKRIVGTYGYMSPE- 616
+ + HRDLK NIL+ N I+D GLA M ++L VGT YM+PE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 617 -----YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW-NLWKDDRSW 670
+ D+++FG++L E R + + + ++ +D S+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVA-----RRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 671 ELMD---------PKL-QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
E M P + S P + + C +N + R T + LT
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 7e-45
Identities = 69/296 (23%), Positives = 111/296 (37%), Gaps = 52/296 (17%)
Query: 464 ENKLGEGGFGPVYK-------------SGQGLEEFKNE--IKLTAKLQHRNLVRLLGCCV 508
++G+G +G V+ + E I T ++H N++ + +
Sbjct: 42 VKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 509 EQGENV----LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH-----Q 559
+ + LI +Y N SL +L TT L + +++ GL +LH
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF--GGDELQSNTKRIVGTYGYMSPE- 616
+ + HRDLK NIL+ N I+D GLA F +E+ VGT YM PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 617 -----YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW-NLWKDDRSW 670
H I +D++SFG++L E R + + + +L D S+
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVA-----RRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 671 ELMD---------PKL-QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
E M P +S +++ + C N A R T V L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 63/296 (21%), Positives = 104/296 (35%), Gaps = 50/296 (16%)
Query: 463 VENKLGEGGFGPVYK-------------SGQGLEEFKNE--IKLTAKLQHRNLVRLLGCC 507
++ +G+G FG V++ S + + E I T L+H N++ +
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 508 VEQGENV----LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ---- 559
+ L+ +Y + SL +L T + I++ A GL +LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 560 -YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF--GGDELQSNTKRIVGTYGYMSPE 616
+ + HRDLK NIL+ N I+D GLA D + VGT YM+PE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 617 ------YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670
H ++D+++ G++ E L + D S
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS----DPSV 277
Query: 671 ELMD---------PKL-QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
E M P + S ++ + C N A R T + L+
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-40
Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 40/278 (14%)
Query: 459 NNFGVENKLGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKLQHRN 499
+ + ++G G FG V+ +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
+VRL+G C ++ ++ E + +FL T+ L ++++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI 619
IHRDL N L+ + KISDFG++R ++ + +PE
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 620 HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679
+G +S +SDV+SFG+LL ET S S +N T + K R + C
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE----FVEKGGR----LPCPELC 340
Query: 680 -EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
+A + ++++ C RP+ S + L +
Sbjct: 341 PDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQS 371
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 70/292 (23%), Positives = 115/292 (39%), Gaps = 57/292 (19%)
Query: 464 ENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+LG+G FG V + + L +F+ EI++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 502 RLLGCCVEQGENV--LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
+ G C G LI EYLP SL +L + + ++ I +G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE----LQSNTK---RIVGTYGY 612
R IHRDL NIL+++ KI DFGL ++ D+ ++ + +
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF------W 183
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA-WNLWKDDRSWE 671
+PE FS+ SDV+SFGV+L E + ++ + ++G+ E
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243
Query: 672 L------MDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
L + C + Y I+ C N RP+ ++ +
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMIMTE-------CWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 57/292 (19%)
Query: 464 ENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+LG+G FG V + + L +F+ EI++ LQH N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 502 RLLGCCVEQGENV--LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
+ G C G LI EYLP SL +L + + ++ I +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE----LQSNTK---RIVGTYGY 612
R IHRDL NIL+++ KI DFGL ++ D+ ++ + +
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF------W 214
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA--WNLWKDD--- 667
+PE FS+ SDV+SFGV+L E + ++ + ++G+ +
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 668 --RSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
++ + C + Y I+ C N RP+ ++ +
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIMTE-------CWNNNVNQRPSFRDLALRVDQ 319
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-40
Identities = 80/303 (26%), Positives = 118/303 (38%), Gaps = 60/303 (19%)
Query: 464 ENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNL 500
LGEG FG V Q +K EI + L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 501 VRLLGCCVEQGENV--LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH 558
++ GCC + G L+ EY+P SL +L +G + + I +G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE----LQSNTK---RIVGTYG 611
IHRDL N+LLD++ + KI DFGLA+ ++ +
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF------ 202
Query: 612 YMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671
+ +PE F SDV+SFGV L E L+ S++ T L L+G A R E
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 672 L------MDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSP 724
L + +C Y ++K C + A+ RPT +I +L
Sbjct: 263 LLERGERLPRPDKCPAEVYHLMKN-------CWETEASFRPTFENLIPILKTVHEKY-QG 314
Query: 725 QQP 727
Q P
Sbjct: 315 QAP 317
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-40
Identities = 69/290 (23%), Positives = 113/290 (38%), Gaps = 57/290 (19%)
Query: 464 ENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNL 500
LGEG FG V G + + K EI++ L H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 501 VRLLGCCVEQGENV--LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH 558
V+ G C E G N LI E+LP+ SL +L + + +++ I +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL- 142
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE----LQSNTK---RIVGTYG 611
+ +HRDL N+L++S KI DFGL + D+ ++ +
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF------ 194
Query: 612 YMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671
+ +PE + F I SDV+SFGV L E L+ S L ++G R
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254
Query: 672 L------MDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714
+ C + Y ++++ C + ++R + +I
Sbjct: 255 TLKEGKRLPCPPNCPDEVYQLMRK-------CWEFQPSNRTSFQNLIEGF 297
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 70/306 (22%), Positives = 117/306 (38%), Gaps = 56/306 (18%)
Query: 464 ENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
++LG+G FG V +F+ EI++ L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 502 RLLGCCVEQGENV--LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
+ G G L+ EYLP+ L FL L + I +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE----LQSNTK---RIVGTYGY 612
R +HRDL NIL++S KI+DFGLA++ D+ ++ + +
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF------W 196
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672
+PE FS +SDV+SFGV+L E + + + L ++G ++ R EL
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256
Query: 673 ------MDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQ 725
+ C + ++K C + DRP+ S + L + +
Sbjct: 257 LEEGQRLPAPPACPAEVHELMKL-------CWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309
Query: 726 QPGFSS 731
F++
Sbjct: 310 THAFTA 315
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-38
Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 38/276 (13%)
Query: 463 VENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLG 505
+++KLG G +G VY+ +EEF E + +++H NLV+LLG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
C + +I E++ +L +L + ++ + + + I+ + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 339
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSI 625
IHR+L N L+ N + K++DFGL+R+ GD ++ + +PE + FSI
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSI 398
Query: 626 KSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC-EASYP 684
KSDV++FGVLL E + S S L KD R M+ C E Y
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----LLEKDYR----MERPEGCPEKVYE 450
Query: 685 IVKRYINVALLCVQENAADRPTMSEVISMLTNEFVN 720
+++ C Q N +DRP+ +E+ F
Sbjct: 451 LMRA-------CWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 76/280 (27%), Positives = 123/280 (43%), Gaps = 48/280 (17%)
Query: 464 ENKLGEGGFGPVYK---SGQGL--------------EEFKNEIKLTAKLQHRNLVRLLGC 506
++KLG G +G VY+ L EEF E + +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVI 566
C + +I E++ +L +L + ++ + + + I+ + YL + I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 567 HRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTK-----RIVGTYGYMSPEYAIHG 621
HRDL N L+ N + K++DFGL+R+ GD ++ + + +PE +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYN 187
Query: 622 FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC-E 680
FSIKSDV++FGVLL E + S S L KD R M+ C E
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----LLEKDYR----MERPEGCPE 239
Query: 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVN 720
Y +++ C Q N +DRP+ +E+ F
Sbjct: 240 KVYELMRA-------CWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-38
Identities = 72/277 (25%), Positives = 115/277 (41%), Gaps = 40/277 (14%)
Query: 463 VENKLGEGGFGPVY--------------KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCV 508
+ +G+G FG V K+ + F E + +L+H NLV+LLG V
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 509 EQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIH 567
E+ + ++ EY+ SL +L + +LG ++ + + + YL +H
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNFVH 312
Query: 568 RDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKS 627
RDL N+L+ + + K+SDFGL + Q K V + +PE FS KS
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALREKKFSTKS 367
Query: 628 DVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC-EASYPIV 686
DV+SFG+LL E S R + + K + MD C A Y ++
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVVP----RVEKGYK----MDAPDGCPPAVYDVM 419
Query: 687 KRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPS 723
K C +AA RPT ++ L + +
Sbjct: 420 KN-------CWHLDAATRPTFLQLREQLEHIRTHELH 449
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 42/276 (15%)
Query: 464 ENKLGEGGFGPVY---------------KSG-QGLEEFKNEIKLTAKLQHRNLVRLLGCC 507
++G G FG V+ + G E+F E ++ KL H LV+L G C
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 508 VEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIH 567
+EQ L+ E++ + L +L T+ GL + + + +G+ YL VIH
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127
Query: 568 RDLKPSNILLDSNMIPKISDFGLARMFGGDE--LQSNTKRIVGTYGYMSPEYAIHGFFSI 625
RDL N L+ N + K+SDFG+ R D+ + TK V + SPE +S
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFSFSRYSS 184
Query: 626 KSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC-EASYP 684
KSDV+SFGVL+ E S + +NS + ++ R + Y
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFR----LYKPRLASTHVYQ 236
Query: 685 IVKRYINVALLCVQENAADRPTMSEVISMLTNEFVN 720
I+ C +E DRP S ++ L +
Sbjct: 237 IMNH-------CWRERPEDRPAFSRLLRQLAEIAES 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 71/318 (22%), Positives = 113/318 (35%), Gaps = 65/318 (20%)
Query: 459 NNFGVENKLGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKLQHRN 499
+F LG GGFG V++ E+ E+K AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 500 LVRLLGCCVE---------QGENVLIY---EYLPNKSLDSFLFDTTKEGLLGWGARIRII 547
+VR +E V +Y + ++L ++ + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 548 EGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR-- 605
IA+ + +LH ++HRDLKPSNI + + K+ DFGL DE +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 606 --------IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLL 657
VGT YMSPE +S K D+FS G++L E L F+T +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP------FSTQMERVR 235
Query: 658 GHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717
D R+ + P L + P + + + +RP + + N
Sbjct: 236 -----TLTDVRNLKF--PPLFTQKY-PCEYVMVQ---DMLSPSPMERPEAINI---IENA 281
Query: 718 FV-NLPSPQQPGFSSLKK 734
+L P + +
Sbjct: 282 VFEDLDFPGKTVLRQRSR 299
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 6e-38
Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 36/200 (18%)
Query: 463 VENKLGEGGFGPVY--------------KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCV 508
+ +G+G FG V K+ + F E + +L+H NLV+LLG V
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 509 EQGENVLI-YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIH 567
E+ + I EY+ SL +L + +LG ++ + + + YL +H
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNFVH 140
Query: 568 RDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG------YMSPEYAIHG 621
RDL N+L+ + + K+SDFGL + + + + +PE
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTAPEALREK 189
Query: 622 FFSIKSDVFSFGVLLLETLS 641
FS KSDV+SFG+LL E S
Sbjct: 190 KFSTKSDVWSFGILLWEIYS 209
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 50/213 (23%)
Query: 463 VENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNL 500
+E +G G G V + + +F +E + + H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
+RL G +++ EY+ N SLD+FL T +G + ++ G+ G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL--- 167
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY-------- 612
S L +HRDL N+L+DSN++ K+SDFGL+R+ D
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTTGGKI 216
Query: 613 ----MSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+PE FS SDV+SFGV++ E L+
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 73/274 (26%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 464 ENKLGEGGFGPVY---------------KSG-QGLEEFKNEIKLTAKLQHRNLVRLLGCC 507
+LG G FG V K G +EF E K+ L H LV+L G C
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 508 VEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIH 567
+Q +I EY+ N L ++L + + + + + + YL + +H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143
Query: 568 RDLKPSNILLDSNMIPKISDFGLARMFGGDE--LQSNTKRIVGTYGYMSPEYAIHGFFSI 625
RDL N L++ + K+SDFGL+R DE +K V + PE ++ FS
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLMYSKFSS 200
Query: 626 KSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC-EASYP 684
KSD+++FGVL+ E S + TNS T ++ + R + E Y
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQGLR----LYRPHLASEKVYT 252
Query: 685 IVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718
I+ C E A +RPT ++S + +
Sbjct: 253 IMYS-------CWHEKADERPTFKILLSNILDVM 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 75/301 (24%), Positives = 120/301 (39%), Gaps = 66/301 (21%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQ---------GLEEFKNEIKLTAKLQHRNLVRLL 504
+F +G GGFG V+K G+ E+ + E+K AKL H N+V
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYN 70
Query: 505 GCCVE---------------QGENVLIY-EYLPNKSLDSFLFDTTKEGL---LGWGARIR 545
GC + + + I E+ +L+ ++ E L L
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL----E 126
Query: 546 IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR 605
+ E I +G+ Y+H ++I+RDLKPSNI L KI DFGL D R
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRTR 180
Query: 606 IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWK 665
GT YMSPE + + D+++ G++L E L F T+ + +
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--TAFETSKF------FTDLR 232
Query: 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQ 725
D ++ D K + ++++ + + DRP SE+ L V SP+
Sbjct: 233 DGIISDIFDKKEKT-----LLQK-------LLSKKPEDRPNTSEI---LRTLTVWKKSPE 277
Query: 726 Q 726
+
Sbjct: 278 K 278
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 87/286 (30%), Positives = 126/286 (44%), Gaps = 46/286 (16%)
Query: 464 ENKLGEGGFGPVY---------------KSGQ-GLEEFKNEIKLTAKLQHRNLVRLLGCC 507
+LG G FG V+ K G + F E L +LQH+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 508 VEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIH 567
++ +I EY+ N SL FL T L + + IA+G+ ++ IH
Sbjct: 78 TQEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132
Query: 568 RDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY--MSPEYAIHGFFSI 625
RDL+ +NIL+ + KI+DFGLAR+ +E T R + +PE +G F+I
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 626 KSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC-EASYP 684
KSDV+SFG+LL E ++ R TN + NL + R M C E Y
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ----NLERGYR----MVRPDNCPEELYQ 241
Query: 685 IVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQ---QP 727
+++ C +E DRPT + S+L +F Q QP
Sbjct: 242 LMRL-------CWKERPEDRPTFDYLRSVL-EDFFTATEGQYQPQP 279
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 39/208 (18%)
Query: 463 VENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRN 499
+ +G G FG VYK + + +F E + + H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
++RL G + ++I EY+ N +LD FL K+G + ++ GIA G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL-- 163
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG------YM 613
+ + +HRDL NIL++SN++ K+SDFGL+R+ D + T G +
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWT 217
Query: 614 SPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+PE + F+ SDV+SFG+++ E ++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-37
Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 42/271 (15%)
Query: 463 VENKLGEGGFGPVYK----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGC 506
+ +LG G FG V +EF E + KL H LV+ G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVI 566
C ++ ++ EY+ N L ++L + L + + + +G+ +L + I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 567 HRDLKPSNILLDSNMIPKISDFGLARMFGGDE--LQSNTKRIVGTYGYMSPEYAIHGFFS 624
HRDL N L+D ++ K+SDFG+ R D+ TK V + +PE + +S
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV---KWSAPEVFHYFKYS 183
Query: 625 IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC-EASY 683
KSDV++FG+L+ E S + TNS +L + + R + + Y
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL----KVSQGHR----LYRPHLASDTIY 235
Query: 684 PIVKRYINVALLCVQENAADRPTMSEVISML 714
I+ C E RPT +++S +
Sbjct: 236 QIMYS-------CWHELPEKRPTFQQLLSSI 259
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-37
Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 463 VENKLGEGGFGPVYK----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGC 506
+E KLG+G FG V+ E F E ++ KL+H LV+L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEG-LLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
E+ ++ EY+ SL FL + G L + + IA G+ Y+ R+
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYV---ERMNY 301
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSI 625
+HRDL+ +NIL+ N++ K++DFGLAR+ +E + + +PE A++G F+I
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 360
Query: 626 KSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC-EASYP 684
KSDV+SFG+LL E + R N L + + R M +C E+ +
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVERGYR----MPCPPECPESLHD 412
Query: 685 IVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPG 728
++ + C ++ +RPT + + L + F + QPG
Sbjct: 413 LMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-37
Identities = 67/298 (22%), Positives = 110/298 (36%), Gaps = 66/298 (22%)
Query: 463 VENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+ +LG G FG V + EE E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 502 RLLGCCVEQGENVLI-YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
RL+G C Q E +++ E L FL K + ++ ++ G+ YL
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL--- 126
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL----QSNTKRIVGTYGYMSPE 616
+HRDL N+LL + KISDFGL++ G D+ +S K + + +PE
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPE 183
Query: 617 YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA--WNLWKDD-----RS 669
FS +SDV+S+GV + E LS G + +
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS---------------YGQKPYKKMKGPEVMAFIEQ 228
Query: 670 WELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQ 726
+ M+ +C Y ++ C DRP V + + +L S +
Sbjct: 229 GKRMECPPECPPELYALMSD-------CWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-37
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 34/205 (16%)
Query: 463 VENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNL 500
++ +G G FG V + + +F E + + H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
+RL G + +++ EY+ N SLDSFL + + ++ GIA G+ YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE----LQSNTKRIVGTYGYMSPE 616
S + +HRDL NIL++SN++ K+SDFGL R+ D K + + SPE
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI---RWTSPE 220
Query: 617 YAIHGFFSIKSDVFSFGVLLLETLS 641
+ F+ SDV+S+G++L E +S
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 9e-37
Identities = 69/221 (31%), Positives = 100/221 (45%), Gaps = 52/221 (23%)
Query: 464 ENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKLQHRN 499
+LGE FG VYK G EEF++E L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFL-------------FDTTKEGLLGWGARIRI 546
+V LLG + +I+ Y + L FL D T + L + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 547 IEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGD--ELQSNT 603
+ IA G+ YL S V+H+DL N+L+ + KISD GL R ++ D +L N+
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 604 K---RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
R +M+PE ++G FSI SD++S+GV+L E S
Sbjct: 191 LLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-36
Identities = 79/282 (28%), Positives = 122/282 (43%), Gaps = 43/282 (15%)
Query: 463 VENKLGEGGFGPVYK----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGC 506
+E KLG G FG V+ +E F E + LQH LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVI 566
++ +I E++ SL FL I IA+G+ ++ + I
Sbjct: 252 VTKEP-IYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 567 HRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY--MSPEYAIHGFFS 624
HRDL+ +NIL+ ++++ KI+DFGLAR+ +E T R + +PE G F+
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFT 363
Query: 625 IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC-EASY 683
IKSDV+SFG+LL+E ++ R +N + L + R M C E Y
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR----ALERGYR----MPRPENCPEELY 415
Query: 684 PIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQ 725
I+ R C + +RPT + S+L ++F Q
Sbjct: 416 NIMMR-------CWKNRPEERPTFEYIQSVL-DDFYTATESQ 449
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 70/306 (22%), Positives = 126/306 (41%), Gaps = 75/306 (24%)
Query: 464 ENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNL 500
+ +LGEG FG V+ + ++F+ E +L LQH ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFL-------------FDTTKEGLLGWGARIRII 547
V+ G C + ++++EY+ + L+ FL +G LG + I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 548 EGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGD--ELQSNTK 604
IA G++YL + +HRDL N L+ +N++ KI DFG++R ++ D + +T
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 605 ---RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS--TRFFNTNSLTLL-- 657
R +M PE ++ F+ +SDV+SFGV+L E + + + NT + +
Sbjct: 197 LPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250
Query: 658 GHAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
G +++ C + Y ++ C Q R + E+ +L
Sbjct: 251 GR------------VLERPRVCPKEVYDVMLG-------CWQREPQQRLNIKEIYKILHA 291
Query: 717 EFVNLP 722
P
Sbjct: 292 LGKATP 297
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-36
Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 463 VENKLGEGGFGPVYK----------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGC 506
+E KLG+G FG V+ E F E ++ KL+H LV+L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEG-LLGWGARIRIIEGIAQGLLYLHQYSRLRV 565
E+ ++ EY+ SL FL + G L + + IA G+ Y+ R+
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYV---ERMNY 384
Query: 566 IHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSI 625
+HRDL+ +NIL+ N++ K++DFGLAR+ +E + + +PE A++G F+I
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 443
Query: 626 KSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC-EASYP 684
KSDV+SFG+LL E + R N L + + R M +C E+ +
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVERGYR----MPCPPECPESLHD 495
Query: 685 IVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPG 728
++ + C ++ +RPT + + L + F + QPG
Sbjct: 496 LMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 71/310 (22%), Positives = 121/310 (39%), Gaps = 80/310 (25%)
Query: 463 VENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRN 499
++ +LGEG FG V+ S ++F+ E +L LQH++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFL------------FDTTKEGLLGWGARIRII 547
+VR G C E ++++EY+ + L+ FL + G LG G + +
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 548 EGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGD--ELQSNTK 604
+A G++YL + L +HRDL N L+ ++ KI DFG++R ++ D + T
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 605 ---RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLG--- 658
R +M PE ++ F+ +SDV+SFGV+L E + G
Sbjct: 222 LPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFT---------------YGKQP 260
Query: 659 ----HAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713
++ C Y I++ C Q R ++ +V +
Sbjct: 261 WYQLSNTEAIDCITQGRELERPRACPPEVYAIMRG-------CWQREPQQRHSIKDVHAR 313
Query: 714 LTNEFVNLPS 723
L P
Sbjct: 314 LQALAQAPPV 323
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 41/207 (19%)
Query: 464 ENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNL 500
LG G FG VYK S + +E +E + A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
RLLG C+ LI + +P L ++ + + +G + IA+G+ YL
Sbjct: 80 CRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL---QSNTK---RIVGTYGYMS 614
R++HRDL N+L+ + KI+DFGLA++ G +E K + +M+
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK------WMA 187
Query: 615 PEYAIHGFFSIKSDVFSFGVLLLETLS 641
E +H ++ +SDV+S+GV + E ++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 65/305 (21%), Positives = 112/305 (36%), Gaps = 76/305 (24%)
Query: 463 VENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRN 499
+ LGEG FG V + S + +EEF +E H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 500 LVRLLGCCVEQGENV-----LIYEYLPNKSLDSFL---FDTTKEGLLGWGARIRIIEGIA 551
++RLLG C+E +I ++ L ++L T + ++ + IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDELQSNTK-----R 605
G+ YL S +HRDL N +L +M ++DFGL++ ++ GD + +
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 606 IVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLG------- 658
+++ E ++ KSDV++FGV + E + G
Sbjct: 215 ------WIAIESLADRVYTSKSDVWAFGVTMWEIAT---------------RGMTPYPGV 253
Query: 659 HAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717
++ + C + Y I+ C + + DRPT S + L
Sbjct: 254 QNHEMYDYLLHGHRLKQPEDCLDELYEIMYS-------CWRTDPLDRPTFSVLRLQLEKL 306
Query: 718 FVNLP 722
+LP
Sbjct: 307 LESLP 311
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 39/206 (18%)
Query: 464 ENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNL 500
LG G FG V+K Q + + + L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
VRLLG C L+ +YLP SL + G LG + IA+G+ YL
Sbjct: 78 VRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL--- 131
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG-----YMSP 615
++HR+L N+LL S +++DFG+A + D+ Q +M+
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMAL 186
Query: 616 EYAIHGFFSIKSDVFSFGVLLLETLS 641
E G ++ +SDV+S+GV + E ++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 56/205 (27%), Positives = 82/205 (40%), Gaps = 35/205 (17%)
Query: 464 ENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKLQHRN 499
KLG+G FG V + + +++F E+ L HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
L+RL G + ++ E P SL L +G G R +A+G+ YL
Sbjct: 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYL-- 137
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT---YGYMSPE 616
R IHRDL N+LL + + KI DFGL R ++ + + + +PE
Sbjct: 138 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPE 194
Query: 617 YAIHGFFSIKSDVFSFGVLLLETLS 641
FS SD + FGV L E +
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 65/294 (22%), Positives = 106/294 (36%), Gaps = 64/294 (21%)
Query: 464 ENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+GEG FG V++ S E+F E + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
+L+G E +I E L SFL ++ L + I ++ L YL
Sbjct: 80 KLIGVITEN-PVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---E 133
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE--LQSNTKRIVGTYGYMSPEYAI 619
R +HRD+ N+L+ SN K+ DFGL+R S K + +M+PE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMAPESIN 190
Query: 620 HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA--WNLWKDD-----RSWEL 672
F+ SDV+ FGV + E L G + +D + E
Sbjct: 191 FRRFTSASDVWMFGVCMWEILM---------------HGVKPFQGVKNNDVIGRIENGER 235
Query: 673 MDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQ 725
+ C Y ++ + C + + RP +E+ + L + + Q
Sbjct: 236 LPMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQL-STILEEEKAQ 281
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 67/293 (22%), Positives = 112/293 (38%), Gaps = 56/293 (19%)
Query: 463 VENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNL 500
+ +LG G FG V K +E E + +L + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
VR++G C + +L+ E L+ +L + + I ++ ++ G+ YL
Sbjct: 81 VRMIGICEAES-WMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL--- 133
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE----LQSNTKRIVGTYGYMSPE 616
+HRDL N+LL + KISDFGL++ DE Q++ K V + +PE
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---KWYAPE 190
Query: 617 YAIHGFFSIKSDVFSFGVLLLETLSSKRS--TRFFNTNSLTLLGHAWNLWKDDRSWELMD 674
+ FS KSDV+SFGVL+ E S + + +L E M
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG----------ERMG 240
Query: 675 PKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQ 726
C Y ++ C + +RP + V L N + ++ +
Sbjct: 241 CPAGCPREMYDLMNL-------CWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 64/295 (21%), Positives = 107/295 (36%), Gaps = 68/295 (23%)
Query: 464 ENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+G G FG VY + +F E + H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 502 RLLGCCVEQGENVL-IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
LLG C+ + L + Y+ + L +F+ + I +A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG------YMS 614
+ + +HRDL N +LD K++DFGLAR D + G +M+
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 615 PEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH-------AWNLWKDD 667
E F+ KSDV+SFGVLL E ++ G +++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT---------------RGAPPYPDVNTFDITVYL 245
Query: 668 RSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNL 721
+ C + Y ++ + C A RP+ SE++S ++ F
Sbjct: 246 LQGRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 78/328 (23%), Positives = 132/328 (40%), Gaps = 87/328 (26%)
Query: 464 ENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKL-QHRNLV 501
++ +GEG FG V K S +F E+++ KL H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFL-------------FDTTKEGLLGWGARIRIIE 548
LLG C +G L EY P+ +L FL + L +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 549 GIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTK---- 604
+A+G+ YL S+ + IHRDL NIL+ N + KI+DFGL+R G + T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 204
Query: 605 -RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH---- 659
R +M+ E + ++ SDV+S+GVLL E +S LG
Sbjct: 205 VR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------------LGGTPYC 243
Query: 660 ---AWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISML- 714
L++ ++ L C + Y ++++ C +E +RP+ ++++ L
Sbjct: 244 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQ-------CWREKPYERPSFAQILVSLN 296
Query: 715 -----TNEFVNLPSPQQPGFSSLKKSVE 737
+VN ++ ++ + S E
Sbjct: 297 RMLEERKTYVNTTLYEKFTYAGIDCSAE 324
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 71/313 (22%), Positives = 119/313 (38%), Gaps = 79/313 (25%)
Query: 459 NNFGVENKLGEGGFGPVYK--------------------------SGQGLEEFKNEIKLT 492
+ + LGEG FG V + + L + +E+++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 493 AKL-QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL-------------FDTTKEGLL 538
+ +H+N++ LLG C + G +I EY +L +L + E +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 539 GWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGD 597
+ + +A+G+ YL + + IHRDL N+L+ N + KI+DFGLAR + D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 598 ELQSNTK-----RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLE--TLSSKRSTRFFN 650
+ T + +M+PE ++ +SDV+SFGVL+ E TL
Sbjct: 258 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311
Query: 651 TNSLTLL--GHAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTM 707
LL GH MD C Y +++ C + RPT
Sbjct: 312 EELFKLLKEGH------------RMDKPANCTNELYMMMRD-------CWHAVPSQRPTF 352
Query: 708 SEVISMLTNEFVN 720
+++ L
Sbjct: 353 KQLVEDLDRILTL 365
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 70/299 (23%), Positives = 113/299 (37%), Gaps = 76/299 (25%)
Query: 465 NKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKLQHRNL 500
+LG+G FG VY+ S + EF NE + + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFL-------FDTTKEGLLGWGARIRIIEGIAQG 553
VRLLG + ++I E + L S+L + I++ IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 554 LLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDELQSNTK-----RIV 607
+ YL + + +HRDL N ++ + KI DFG+ R ++ D + K R
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 205
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH-------A 660
+MSPE G F+ SDV+SFGV+L E + L
Sbjct: 206 ----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSN 246
Query: 661 WNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718
+ + L+D C + + +++ C Q N RP+ E+IS + E
Sbjct: 247 EQVLRFVMEGGLLDKPDNCPDMLFELMRM-------CWQYNPKMRPSFLEIISSIKEEM 298
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 76/327 (23%), Positives = 126/327 (38%), Gaps = 87/327 (26%)
Query: 459 NNFGVENKLGEGGFGPVYK--------------------------SGQGLEEFKNEIKLT 492
+ + LGEG FG V + + L + +E+++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 493 AKL-QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG-- 549
+ +H+N++ LLG C + G +I EY +L +L G+ R+ E
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 550 -----------IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGD 597
+A+G+ YL + + IHRDL N+L+ N + KI+DFGLAR + D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 598 ELQSNTK-----RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLE--TLSSKRSTRFFN 650
+ T + +M+PE ++ +SDV+SFGVL+ E TL
Sbjct: 212 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265
Query: 651 TNSLTLL--GHAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTM 707
LL GH MD C Y +++ C + RPT
Sbjct: 266 EELFKLLKEGH------------RMDKPANCTNELYMMMRD-------CWHAVPSQRPTF 306
Query: 708 SEVISMLTN--------EFVNLPSPQQ 726
+++ L E+++L P +
Sbjct: 307 KQLVEDLDRILTLTTNEEYLDLSQPLE 333
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 64/293 (21%), Positives = 107/293 (36%), Gaps = 60/293 (20%)
Query: 464 ENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+ +G+G FG VY Q +E F E L L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 502 RLLGCCVEQGENVLI-YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
L+G + + Y+ + L F+ + I +A+G+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY--GYMSPEYA 618
+ + +HRDL N +LD + K++DFGLAR E S + + + E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 619 IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLG-------HAWNLWKDDRSWE 671
F+ KSDV+SFGVLL E L+ G ++L
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT---------------RGAPPYRHIDPFDLTHFLAQGR 245
Query: 672 LMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPS 723
+ C ++ Y ++++ C + + A RPT ++ + L
Sbjct: 246 RLPQPEYCPDSLYQVMQQ-------CWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 67/307 (21%), Positives = 108/307 (35%), Gaps = 70/307 (22%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAK 494
N LG G FG V + E +E+K+ +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 495 L-QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG---- 549
L H N+V LLG C G ++I EY L +FL + + + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 550 -----------IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGD 597
+A+G+ +L + IHRDL NILL I KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS---TRFFNTNSL 654
+ +M+PE + ++ +SDV+S+G+ L E S S ++
Sbjct: 200 NYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 655 TLL--GHAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVI 711
++ G M Y I+K C + RPT +++
Sbjct: 259 KMIKEGF------------RMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIV 299
Query: 712 SMLTNEF 718
++ +
Sbjct: 300 QLIEKQI 306
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-35
Identities = 66/292 (22%), Positives = 110/292 (37%), Gaps = 50/292 (17%)
Query: 463 VENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+ +LG G FG V + EE E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
RL+G C + +L+ E L FL K + ++ ++ G+ YL
Sbjct: 400 RLIGVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE----LQSNTKRIVGTYGYMSPEY 617
+HR+L N+LL + KISDFGL++ G D+ +S K + + +PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677
FS +SDV+S+GV + E LS + + + + R M+
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM----AFIEQGKR----MECPP 562
Query: 678 QC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPG 728
+C Y + C DRP V + + +L S + G
Sbjct: 563 ECPPELY-------ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 58/311 (18%), Positives = 109/311 (35%), Gaps = 77/311 (24%)
Query: 463 VENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRN 499
+ LG+G FG V + + +EEF E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 500 LVRLLGCCVEQGENV------LIYEYLPNKSLDSFLFD---TTKEGLLGWGARIRIIEGI 550
+ +L+G + +I ++ + L +FL L +R + I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 551 AQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDELQSNTK----- 604
A G+ YL S IHRDL N +L +M ++DFGL+R ++ GD +
Sbjct: 147 ACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 605 RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLG------ 658
+ +++ E +++ SDV++FGV + E ++ G
Sbjct: 204 K------WLALESLADNLYTVHSDVWAFGVTMWEIMT---------------RGQTPYAG 242
Query: 659 -HAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
++ + +C E Y ++ + C + RP+ + + L N
Sbjct: 243 IENAEIYNYLIGGNRLKQPPECMEEVYDLMYQ-------CWSADPKQRPSFTCLRMELEN 295
Query: 717 EFVNLPSPQQP 727
+L
Sbjct: 296 ILGHLSVLSTS 306
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 39/206 (18%)
Query: 463 VENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNL 500
+ LGEG FG VY+ + E+F +E + L H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
V+L+G E+ +I E P L +L + L + I + + YL
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYL--- 129
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE--LQSNTK---RIVGTYGYMSP 615
+ +HRD+ NIL+ S K+ DFGL+R ++ S T+ + +MSP
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------WMSP 183
Query: 616 EYAIHGFFSIKSDVFSFGVLLLETLS 641
E F+ SDV+ F V + E LS
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 39/206 (18%)
Query: 464 ENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNL 500
LG G FG VYK S + +E +E + A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
RLLG C+ LI + +P L ++ + + +G + IA+G+ YL
Sbjct: 80 CRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG-----YMSP 615
R++HRDL N+L+ + KI+DFGLA++ G +E + + + G +M+
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMAL 188
Query: 616 EYAIHGFFSIKSDVFSFGVLLLETLS 641
E +H ++ +SDV+S+GV + E ++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 68/298 (22%), Positives = 107/298 (35%), Gaps = 66/298 (22%)
Query: 464 ENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKL-QHR 498
LG G FG V + E +E+K+ + L QH
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFL-----------FDTTKEGLLGWGARIRII 547
N+V LLG C G ++I EY L +FL +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 548 EGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDELQSNTKRI 606
+AQG+ +L + IHRD+ N+LL + + KI DFGLAR +
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 607 VGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS---TRFFNTNSLTLL--GHAW 661
+ +M+PE ++++SDV+S+G+LL E S + N+ L+ G+
Sbjct: 228 L-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY-- 284
Query: 662 NLWKDDRSWELMDPKLQCEAS-YPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718
M + Y I++ C RPT ++ S L +
Sbjct: 285 ----------QMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQICSFLQEQA 325
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 75/311 (24%), Positives = 111/311 (35%), Gaps = 73/311 (23%)
Query: 464 ENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKLQHRN 499
LG G FG VY+ S Q +F E + +K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFL----FDTTKEGLLGWGARIRIIEGIAQGLL 555
+VR +G ++ ++ E + L SFL ++ L + + IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 556 YLHQYSRLRVIHRDLKPSNILLD---SNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
YL IHRD+ N LL + KI DFG+AR ++ + G
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAM 206
Query: 613 -----MSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS--TRFFNTNSLTLL--GHAWNL 663
M PE + G F+ K+D +SFGVLL E S N L + G
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---- 262
Query: 664 WKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN-----E 717
MDP C Y I+ + C Q DRP + ++ + +
Sbjct: 263 --------RMDPPKNCPGPVYRIMTQ-------CWQHQPEDRPNFAIILERIEYCTQDPD 307
Query: 718 FVNLPSPQQPG 728
+N P + G
Sbjct: 308 VINTALPIEYG 318
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 72/336 (21%), Positives = 125/336 (37%), Gaps = 72/336 (21%)
Query: 441 SMETKTQGKSLASVSAATNNFGVENKLGEGGFGPVYK-------------------SGQG 481
++ T+ S+S + + ++G GG V++ Q
Sbjct: 10 GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 69
Query: 482 LEEFKNEIKLTAKLQHRNL--VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLG 539
L+ ++NEI KLQ + +RL + ++ E N L+S+L K+ +
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSID 125
Query: 540 WGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599
R + + + + +HQ+ ++H DLKP+N L+ M+ K+ DFG+A D
Sbjct: 126 PWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTT 181
Query: 600 QSNTKRIVGTYGYMSPE-----------YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRF 648
VGT YM PE S KSDV+S G +L K T F
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPF 239
Query: 649 FN-TNSLTLL------GHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENA 701
N ++ L H D +L D ++K C++ +
Sbjct: 240 QQIINQISKLHAIIDPNHEIEFP-DIPEKDLQD----------VLKC-------CLKRDP 281
Query: 702 ADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKKSVE 737
R ++ E+ L + +V + + K + E
Sbjct: 282 KQRISIPEL---LAHPYVQIQTHPVN--QMAKGTTE 312
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 69/285 (24%), Positives = 108/285 (37%), Gaps = 52/285 (18%)
Query: 459 NNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHR 498
++ V +G G +G K + + +E+ L +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 499 NLVRLLGCCVEQGENVL--IYEYLPNKSLDSFLFDTTKEGLLGWGARI-RIIEGIAQGLL 555
N+VR +++ L + EY L S + TKE + R++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 556 YLHQ--YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYM 613
H+ V+HRDLKP+N+ LD K+ DFGLAR+ D + T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 614 SPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673
SPE ++ KSD++S G LL E + F S EL
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP---FTAFSQK---------------ELA 225
Query: 674 DPKLQCEASY-PIVKRY----INVALLCVQENAADRPTMSEVISM 713
E + I RY + + RP++ E++
Sbjct: 226 --GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-34
Identities = 75/311 (24%), Positives = 110/311 (35%), Gaps = 73/311 (23%)
Query: 464 ENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKLQHRN 499
LG G FG VY+ S Q +F E + +K H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFL----FDTTKEGLLGWGARIRIIEGIAQGLL 555
+VR +G ++ ++ E + L SFL ++ L + + IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 556 YLHQYSRLRVIHRDLKPSNILLD---SNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
YL IHRD+ N LL + KI DFG+AR ++ G
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAM 247
Query: 613 -----MSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS--TRFFNTNSLTLL--GHAWNL 663
M PE + G F+ K+D +SFGVLL E S N L + G
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---- 303
Query: 664 WKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN-----E 717
MDP C Y I+ + C Q DRP + ++ + +
Sbjct: 304 --------RMDPPKNCPGPVYRIMTQ-------CWQHQPEDRPNFAIILERIEYCTQDPD 348
Query: 718 FVNLPSPQQPG 728
+N P + G
Sbjct: 349 VINTALPIEYG 359
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-34
Identities = 76/317 (23%), Positives = 120/317 (37%), Gaps = 80/317 (25%)
Query: 464 ENKLGEGGFGPVYK--------------------------SGQGLEEFKNEIKLTAKL-Q 496
LGEG FG V + + L + +E+++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 497 HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG------- 549
H+N++ LLG C + G +I EY +L +L GL E
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 550 ------IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDELQSN 602
+A+G+ YL + + IHRDL N+L+ + + KI+DFGLAR + D +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 603 TK-----RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLE--TLSSKRSTRFFNTNSLT 655
T + +M+PE ++ +SDV+SFGVLL E TL
Sbjct: 251 TNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304
Query: 656 LL--GHAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVIS 712
LL GH MD C Y +++ C + RPT +++
Sbjct: 305 LLKEGH------------RMDKPSNCTNELYMMMRD-------CWHAVPSQRPTFKQLVE 345
Query: 713 MLTNEFVNLPSPQQPGF 729
L S Q+ G+
Sbjct: 346 DLDRIVAL-TSNQEMGY 361
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 68/319 (21%), Positives = 114/319 (35%), Gaps = 90/319 (28%)
Query: 464 ENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKLQHRN 499
+GEG FG V++ S +F+ E L A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGAR---------------- 543
+V+LLG C L++EY+ L+ FL + +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 544 -----IRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGD 597
+ I +A G+ YL S + +HRDL N L+ NM+ KI+DFGL+R ++ D
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 598 --ELQSNTK---RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN 652
+ N R +M PE + ++ +SDV+++GV+L E S
Sbjct: 229 YYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS----------- 271
Query: 653 SLTLLGH-------AWNLWKDDRSWELMDPKLQCEAS-YPIVKRYINVALLCVQENAADR 704
G + R ++ C Y +++ C + ADR
Sbjct: 272 ----YGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRL-------CWSKLPADR 320
Query: 705 PTMSEVISMLTNEFVNLPS 723
P+ + +L
Sbjct: 321 PSFCSIHRILQRMCERAEG 339
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-34
Identities = 65/294 (22%), Positives = 109/294 (37%), Gaps = 66/294 (22%)
Query: 464 ENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+G G FG VY + +F E + H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 502 RLLGCCVEQGENVL-IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
LLG C+ + L + Y+ + L +F+ + T I +A+G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL--- 208
Query: 561 SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG-----YMSP 615
+ + +HRDL N +LD K++DFGLAR E S + T +M+
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 265
Query: 616 EYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH-------AWNLWKDDR 668
E F+ KSDV+SFGVLL E ++ G +++
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMT---------------RGAPPYPDVNTFDITVYLL 310
Query: 669 SWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNL 721
+ C + Y ++ + C A RP+ SE++S ++ F
Sbjct: 311 QGRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 68/322 (21%), Positives = 123/322 (38%), Gaps = 60/322 (18%)
Query: 459 NNFGVENKLGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKLQHRN 499
+ + ++G GG V++ Q L+ ++NEI KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 500 L--VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557
+RL + ++ E N L+S+L K+ + R + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE- 616
HQ+ ++H DLKP+N L+ M+ K+ DFG+A D VGT YM PE
Sbjct: 125 HQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 617 ----------YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFN-TNSLTLLGHAWNLWK 665
S KSDV+S G +L K T F N ++ L +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHAIIDPNH 238
Query: 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQ 725
+ ++ + L +V C++ + R ++ E+ L + +V + +
Sbjct: 239 EIEFPDIPEKDL------------QDVLKCCLKRDPKQRISIPEL---LAHPYVQIQTH- 282
Query: 726 QPGFSSLKKSVETVARSMNRLT 747
P K + E + + +L
Sbjct: 283 -PVNQMAKGTTEEMKYVLGQLV 303
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 60/234 (25%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAK 494
N + LGEG FG V K S L + +E + +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 495 LQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL-------FDTTKEGLLGWGARIRII 547
+ H ++++L G C + G +LI EY SL FL G + +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 548 EG--------------IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR- 592
+ I+QG+ YL + ++++HRDL NIL+ KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 593 MFGGDELQSNTK-----RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
++ D ++ + +M+ E ++ +SDV+SFGVLL E ++
Sbjct: 200 VYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 70/339 (20%), Positives = 128/339 (37%), Gaps = 60/339 (17%)
Query: 441 SMETKTQGKSLASVSAATNNFGVENKLGEGGFGPVYK-------------------SGQG 481
+ K + +S + + ++G GG V++ Q
Sbjct: 38 DDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 97
Query: 482 LEEFKNEIKLTAKLQHRNL--VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLG 539
L+ ++NEI KLQ + +RL + ++ E N L+S+L K+ +
Sbjct: 98 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSID 153
Query: 540 WGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599
R + + + + +HQ+ ++H DLKP+N L+ M+ K+ DFG+A D
Sbjct: 154 PWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTT 209
Query: 600 QSNTKRIVGTYGYMSPE-----------YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRF 648
VG YM PE S KSDV+S G +L K T F
Sbjct: 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPF 267
Query: 649 FN-TNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTM 707
N ++ L + + ++ + LQ +V C++ + R ++
Sbjct: 268 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQ------------DVLKCCLKRDPKQRISI 315
Query: 708 SEVISMLTNEFVNLPSPQQPGFSSLKKSVETVARSMNRL 746
E+ L + +V + + P K + E + + +L
Sbjct: 316 PEL---LAHPYVQIQTH--PVNQMAKGTTEEMKYVLGQL 349
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 44/217 (20%), Positives = 79/217 (36%), Gaps = 55/217 (25%)
Query: 464 ENKLGEGGFGPVYK-------------------------SGQGLEEFKNEIKLTAKLQHR 498
LG+G F ++K E F + +KL H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH 558
+LV G CV EN+L+ E++ SLD++L + + ++ + + +A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFL- 129
Query: 559 QYSRLRVIHRDLKPSNILLDS--------NMIPKISDFGLARMFGGDELQSNTKRIVGTY 610
+IH ++ NILL K+SD G++ +
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------I 176
Query: 611 GY-----MSPEYAIHG-FFSIKSDVFSFGVLLLETLS 641
+ PE + ++ +D +SFG L E S
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 70/305 (22%), Positives = 109/305 (35%), Gaps = 79/305 (25%)
Query: 465 NKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKL-QHRN 499
LG G FG V + + +E+K+ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 500 LVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG--------- 549
+V LLG C + G + +I E+ +L ++L E + A + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 550 ----IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGDELQSNTK 604
+A+G+ +L + + IHRDL NILL + KI DFGLAR ++ +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 605 -----RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS---TRFFNTNSLTL 656
+ +M+PE ++I+SDV+SFGVLL E S S +
Sbjct: 210 ARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 657 L--GHAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713
L G M Y + C + RPT SE++
Sbjct: 264 LKEGT------------RMRAPDYTTPEMYQTMLD-------CWHGEPSQRPTFSELVEH 304
Query: 714 LTNEF 718
L N
Sbjct: 305 LGNLL 309
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-33
Identities = 64/291 (21%), Positives = 105/291 (36%), Gaps = 58/291 (19%)
Query: 464 ENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+GEG FG V++ S E+F E + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
+L+G E +I E L SFL ++ L + I ++ L YL
Sbjct: 455 KLIGVITEN-PVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---E 508
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG 621
R +HRD+ N+L+ SN K+ DFGL+R +K + +M+PE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFR 567
Query: 622 FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA--WNLWKDD-----RSWELMD 674
F+ SDV+ FGV + E L G + +D + E +
Sbjct: 568 RFTSASDVWMFGVCMWEILM---------------HGVKPFQGVKNNDVIGRIENGERLP 612
Query: 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQ 725
C + Y ++ C + + RP +E+ + L+ Q
Sbjct: 613 MPPNCPPTL-----Y-SLMTKCWAYDPSRRPRFTELKAQLSTILEE-EKLQ 656
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 62/277 (22%), Positives = 111/277 (40%), Gaps = 39/277 (14%)
Query: 459 NNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQH 497
NF +E K+G G F VY+ + + EI L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 498 RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI-RIIEGIAQGLLY 556
N+++ +E E ++ E L + K+ L + + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
+H RV+HRD+KP+N+ + + + K+ D GL R F +++ +VGT YMSPE
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 617 YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676
++ KSD++S G LL E + + F + + L + + D P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQCD-----YPPL 258
Query: 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713
S + + +C+ + RP ++ V +
Sbjct: 259 PSDHYSEEL----RQLVNMCINPDPEKRPDVTYVYDV 291
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 65/315 (20%), Positives = 111/315 (35%), Gaps = 79/315 (25%)
Query: 460 NFGVENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
++ KLGEGGF V Q EE + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 502 RLLGCCVEQGENV----LIYEYLPNKSLDSFLFDTTKEGLLGWGARI------RIIEGIA 551
RL+ C+ + L+ + +L + + E L G + ++ GI
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGIC 144
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-----MFGGDELQSNTKRI 606
+GL +H HRDLKP+NILL P + D G + G + +
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 607 --VGTYGYMSPE------YAIHGFFSIKSDVFSFGVLLLETLSSKR--STRFFNTNSLTL 656
T Y +PE + + ++DV+S G +L + + F +S+ L
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258
Query: 657 LGHAWNLWKDDRSWELMDPKLQCEASYPIVKRY----INVALLCVQENAADRPTMSEVIS 712
+Q + S P R+ + + + RP + ++S
Sbjct: 259 -------------------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299
Query: 713 MLTNEFVNLPSPQQP 727
L E + P+P Q
Sbjct: 300 QL--EALQPPAPGQH 312
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 61/311 (19%), Positives = 114/311 (36%), Gaps = 53/311 (17%)
Query: 459 NNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHR 498
+ K+GEG FG S + EE + E+ + A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH 558
N+V+ E G ++ +Y L + + K L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA 618
+++HRD+K NI L + ++ DFG+AR+ + +GT Y+SPE
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 619 IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678
+ ++ KSD+++ G +L E + K + F + L+
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA--FEAGSMKNLV------------------LKI 237
Query: 679 CEASY-PIVKRY----INVALLCVQENAADRPTMSEVISM--LTNEFVNLPSPQQPGFSS 731
S+ P+ Y ++ + N DRP+++ ++ + SPQ
Sbjct: 238 ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEF 297
Query: 732 LKKSVETVARS 742
K+
Sbjct: 298 CLKTFSKFGSQ 308
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 68/300 (22%), Positives = 110/300 (36%), Gaps = 66/300 (22%)
Query: 458 TNNFGVENKLGEGGFGPVY-----------------KSGQGLEEFKNEIKLTAKLQHRNL 500
++F LG+G FG V + + L +E+ L A L H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 501 VRLLGCCVEQGENVL----------IY---EYLPNKSLDSFLFDT-TKEGLLGWGARI-R 545
VR +E+ V ++ EY N +L +D E L R
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYWR 120
Query: 546 IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF----------- 594
+ I + L Y+H +IHRDLKP NI +D + KI DFGLA+
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 595 -GGDELQSNTKRIVGTYGYMSPE-YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN 652
N +GT Y++ E G ++ K D++S G++ E + F
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-----YPFSTGM 232
Query: 653 SLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVIS 712
N+ K RS + P + + K+ I L + + RP +++
Sbjct: 233 ERV------NILKKLRSVSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPGARTLLN 283
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 69/314 (21%), Positives = 107/314 (34%), Gaps = 85/314 (27%)
Query: 464 ENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAKL-QHR 498
LG G FG V E +E+K+ +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG--------- 549
N+V LLG C G LI+EY L ++L ++
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 550 -----------IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR-MFGGD 597
+A+G+ +L +HRDL N+L+ + KI DFGLAR +
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 598 ELQSNTK-----RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRS---TRFF 649
+ +M+PE G ++IKSDV+S+G+LL E S +
Sbjct: 227 NYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280
Query: 650 NTNSLTLL--GHAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPT 706
+ N L+ G MD E Y I++ C ++ RP+
Sbjct: 281 DANFYKLIQNGF------------KMDQPFYATEEIYIIMQS-------CWAFDSRKRPS 321
Query: 707 MSEVISMLTNEFVN 720
+ S L + +
Sbjct: 322 FPNLTSFLGCQLAD 335
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 28/199 (14%)
Query: 463 VENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+ +KLG GG VY + L+ F+ E+ +++L H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
++ E L+ EY+ +L ++ G L I I G+ + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH--- 128
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG 621
+R++HRD+KP NIL+DSN KI DFG+A+ L + T ++GT Y SPE A
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGE 187
Query: 622 FFSIKSDVFSFGVLLLETL 640
+D++S G++L E L
Sbjct: 188 ATDECTDIYSIGIVLYEML 206
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 63/279 (22%), Positives = 109/279 (39%), Gaps = 50/279 (17%)
Query: 466 KLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRNLVRLLG 505
++G G F VYK + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 506 CCVEQGEN----VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
+ VL+ E + + +L ++L + ++ I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 562 RLRVIHRDLKPSNILLDSNM-IPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH 620
+IHRDLK NI + KI D GLA + S K ++GT +M+PE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEM-YE 203
Query: 621 GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680
+ DV++FG+ +LE +S+ + + + +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTS-------GVKPASFDKV 254
Query: 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719
A P VK I C+++N +R ++ + +L + F
Sbjct: 255 AI-PEVKEIIE---GCIRQNKDERYSIKD---LLNHAFF 286
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 72/313 (23%), Positives = 126/313 (40%), Gaps = 69/313 (22%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQ-----------GLEEFK---NEIKLTAKLQHRN 499
++F ++LG G G V+K SG E+++ +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFL--FDTTKEGLLGWGARIRIIEGIAQGLLYL 557
+V G GE + E++ SLD L E +LG ++ + +GL YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 147
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
+ +++HRD+KPSNIL++S K+ DFG++ G + S VGT YMSPE
Sbjct: 148 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 201
Query: 618 AIHGFFSIKSDVFSFGVLLLET------LSSKRSTRFFNTNSLTLLGHAWNLWKDDRS-- 669
+S++SD++S G+ L+E + + + G A R+
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 670 ----------------WELMD-------PKLQCEASYPIVKRYINVALLCVQENAADRPT 706
+EL+D PKL + ++N C+ +N A+R
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNPAERAD 318
Query: 707 MSEVISMLTNEFV 719
+ + ++ + F+
Sbjct: 319 LKQ---LMVHAFI 328
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 51/227 (22%), Positives = 88/227 (38%), Gaps = 34/227 (14%)
Query: 441 SMETKTQGKSLASVSAATNNFGVENKLGEGGFGPVYKSG--------------QGLEEFK 486
S+E + + V +F ++ LG G G + G +
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD 65
Query: 487 NEIKLTAKL-QHRNLVRLLGCCVEQGENV--LIYEYLPNKSLDSFLFDTTKEGLLGWGAR 543
E++L + +H N++R C E+ + E +L ++ K+
Sbjct: 66 REVQLLRESDEHPNVIRYF--CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEP 120
Query: 544 IRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL-----DSNMIPKISDFGLARMFGGDE 598
I +++ GL +LH L ++HRDLKP NIL+ + ISDFGL +
Sbjct: 121 ITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 599 L-QSNTKRIVGTYGYMSPEY---AIHGFFSIKSDVFSFGVLLLETLS 641
S + GT G+++PE + D+FS G + +S
Sbjct: 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 32/208 (15%)
Query: 463 VENKLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQHRNLV 501
+ LG GG V+ + F+ E + A L H +V
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 502 RLLGCCVEQGENVLIY----EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557
+ + + EY+ +L + EG + I +I Q L +
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFS 132
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ-SNTKRIVGTYGYMSPE 616
H + +IHRD+KP+NI++ + K+ DFG+AR + T ++GT Y+SPE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 617 YAIHGFFSIKSDVFSFGVLLLETLSSKR 644
A +SDV+S G +L E L+ +
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 57/247 (23%), Positives = 95/247 (38%), Gaps = 30/247 (12%)
Query: 477 KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEG 536
S ++ +I+ +N V L + + + ++L ++
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159
Query: 537 LLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596
G + I IA+ + +LH ++HRDLKPSNI + + K+ DFGL
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 597 DELQSNTK----------RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRST 646
DE + VGT YMSPE +S K D+FS G++L E L S
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS---- 272
Query: 647 RFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPT 706
F+T + + D R+ + P L YP + + + +RP
Sbjct: 273 --FSTQMERV-----RIITDVRNLKF--PLL-FTQKYPQEHMMVQ---DMLSPSPTERPE 319
Query: 707 MSEVISM 713
+++I
Sbjct: 320 ATDIIEN 326
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 72/313 (23%), Positives = 129/313 (41%), Gaps = 51/313 (16%)
Query: 441 SMETKTQGKSLASVSAATNNFGVENK---LGEGGFGPVYK------------------SG 479
SM + +G + + + LG+G +G VY
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 480 QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY-EYLPNKSLDSFLFDTTKEGLL 538
+ + EI L L+H+N+V+ LG E + I+ E +P SL + L
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSE-NGFIKIFMEQVPGGSLSALLRSKWGPLKD 119
Query: 539 GWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS-NMIPKISDFGLARMFGGD 597
+ I +GL YLH +++HRD+K N+L+++ + + KISDFG ++ G
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG- 175
Query: 598 ELQSNTKRIVGTYGYMSPEYAIHGF---FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL 654
+ T+ GT YM+PE I + +D++S G ++E + K F+
Sbjct: 176 -INPCTETFTGTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGKPP--FYE---- 227
Query: 655 TLLGHAWN-LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713
LG ++K P++ S K +I L C + + R ++ +
Sbjct: 228 --LGEPQAAMFKVGMFKVH--PEIPESMS-AEAKAFI---LKCFEPDPDKRACAND---L 276
Query: 714 LTNEFVNLPSPQQ 726
L +EF+ + S ++
Sbjct: 277 LVDEFLKVSSKKK 289
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 44/200 (22%), Positives = 78/200 (39%), Gaps = 30/200 (15%)
Query: 463 VENKLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQHRNLV 501
+ +G GG G VY++ + E + +LQ ++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
+ G+ + + L + L ++G L + I+ I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH--- 151
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL-QSNTKRIVGTYGYMSPEYAIH 620
HRD+KP NIL+ ++ + DFG+A ++L Q VGT YM+PE
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGTLYYMAPERFSE 209
Query: 621 GFFSIKSDVFSFGVLLLETL 640
+ ++D+++ +L E L
Sbjct: 210 SHATYRADIYALTCVLYECL 229
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 32/205 (15%)
Query: 459 NNFGVENKLGEGGFGPVY-----KSGQ---------------GLEE-FKNEIKLTAKLQH 497
+F V N LG+G F VY +G G+ + +NE+K+ +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 498 RNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLG-WGARIRIIEGIAQGLL 555
+++ L E V L+ E N ++ +L + AR + I G+L
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEAR-HFMHQIITGML 126
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSP 615
YLH + ++HRDL SN+LL NM KI+DFGLA + T + GT Y+SP
Sbjct: 127 YLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISP 181
Query: 616 EYAIHGFFSIKSDVFSFGVLLLETL 640
E A ++SDV+S G + L
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLL 206
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 55/201 (27%), Positives = 82/201 (40%), Gaps = 35/201 (17%)
Query: 460 NFGVENKLGEGGFGPVY-----KSGQ---------------GLEE-FKNEIKLTAKLQHR 498
+ LG+GGF + + + E EI + L H+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 499 NLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKE--GLLGWGARIRIIEGIAQGLL 555
++V G E + V ++ E +SL + K L AR + I G
Sbjct: 76 HVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQ 129
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSP 615
YLH R RVIHRDLK N+ L+ ++ KI DFGLA D + + GT Y++P
Sbjct: 130 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAP 184
Query: 616 EYAIHGFFSIKSDVFSFGVLL 636
E S + DV+S G ++
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIM 205
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 54/194 (27%), Positives = 81/194 (41%), Gaps = 35/194 (18%)
Query: 467 LGEGGFGPVY-----KSGQ---------------GLEE-FKNEIKLTAKLQHRNLVRLLG 505
LG+GGF + + + E EI + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 506 CCVEQGENV-LIYEYLPNKSLDSFLFDTTKE--GLLGWGARIRIIEGIAQGLLYLHQYSR 562
E + V ++ E +SL + K L AR + I G YLH+
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHR--- 159
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF 622
RVIHRDLK N+ L+ ++ KI DFGLA D + + GT Y++PE
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 217
Query: 623 FSIKSDVFSFGVLL 636
S + DV+S G ++
Sbjct: 218 HSFEVDVWSIGCIM 231
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 59/286 (20%), Positives = 98/286 (34%), Gaps = 60/286 (20%)
Query: 455 SAATNNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAK 494
S +F ++LG G +G V+K + E+ K
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 495 L-QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-IIEGIAQ 552
+ QH VRL E G L E SL G A++ +
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLL 168
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
L +LH ++H D+KP+NI L K+ DFGL G + G Y
Sbjct: 169 ALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRY 222
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672
M+PE + G + +DVFS G+ +LE + L W+
Sbjct: 223 MAPE-LLQGSYGTAADVFSLGLTILE------------------VACNMELPHGGEGWQQ 263
Query: 673 M-----DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713
+ P+ S + +V ++ ++ + R T ++++
Sbjct: 264 LRQGYLPPEFTAGLSSEL----RSVLVMMLEPDPKLRATAEALLAL 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 56/215 (26%), Positives = 84/215 (39%), Gaps = 33/215 (15%)
Query: 452 ASVSAATNNFGVENKLGEGGFGPVYK-----SGQ-------GLEEFK-NEIKLTAKLQHR 498
+ + ++G G FG V++ +G LE F+ E+ A L
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSP 110
Query: 499 NLVRLLGCCVEQGENVLIY-EYLPNKSLDSFL--FDTTKEGLLGWGARIRIIEG-IAQGL 554
+V L G E G V I+ E L SL + E G +GL
Sbjct: 111 RIVPLYGAVRE-GPWVNIFMELLEGGSLGQLIKQMGCLPEDR------ALYYLGQALEGL 163
Query: 555 LYLHQYSRLRVIHRDLKPSNILLDSNMIP-KISDFGLARMFGGDELQSNTKR---IVGTY 610
YLH R++H D+K N+LL S+ + DFG A D L + I GT
Sbjct: 164 EYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 611 GYMSPEYAIHGF-FSIKSDVFSFGVLLLETLSSKR 644
+M+PE + G K D++S ++L L+
Sbjct: 221 THMAPE-VVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 45/221 (20%), Positives = 88/221 (39%), Gaps = 41/221 (18%)
Query: 455 SAATNNFGVENKLGEGGFGPVYK-----SGQ--------------GLEEFKNEIKLTAKL 495
S + + + + + LG+G V++ +G ++ E ++ KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 496 QHRNLVRLLGCCVEQGENVLIY---EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQ 552
H+N+V+L E+ E+ P SL + L + + L + ++ +
Sbjct: 65 NHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILL----DSNMIPKISDFGLARMFGGDELQSNTKRIVG 608
G+ +L + ++HR++KP NI+ D + K++DFG AR DE + G
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYG 177
Query: 609 TYGYMSPE--------YAIHGFFSIKSDVFSFGVLLLETLS 641
T Y+ P+ + D++S GV +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 41/216 (18%)
Query: 453 SVSAATNNFGVENKLGEGGFGPVYK-----SGQ-----------GLEEFK---NEIKLTA 493
S+ ++ +LG G +G V K SGQ +E K ++ ++
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 494 KL-QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK------EGLLGWGARIRI 546
+ V G +G+ + E + + SLD F E +LG +I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KI 114
Query: 547 IEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI 606
I + L +LH S+L VIHRD+KPSN+L+++ K+ DFG++ D++ +
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID-- 169
Query: 607 VGTYGYMSPE----YAIHGFFSIKSDVFSFGVLLLE 638
G YM+PE +S+KSD++S G+ ++E
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 60/204 (29%), Positives = 85/204 (41%), Gaps = 33/204 (16%)
Query: 459 NNFGVENKLGEGGFGPVY-----KSGQ---------------GLEE-FKNEIKLTAKLQH 497
+F + LG+G FG VY +S G+E + E+++ + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 498 RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLG-WGARIRIIEGIAQGLLY 556
N++RL G + LI EY P ++ L K I +A L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTA-TYITELANALSY 124
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
H RVIHRD+KP N+LL S KI+DFG + + GT Y+ PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPPE 177
Query: 617 YAIHGFFSIKSDVFSFGVLLLETL 640
K D++S GVL E L
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 45/216 (20%), Positives = 87/216 (40%), Gaps = 41/216 (18%)
Query: 455 SAATNNFGVENKLGEGGFGPVYK-----SGQ--------------GLEEFKNEIKLTAKL 495
S + + + + + LG+G V++ +G ++ E ++ KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 496 QHRNLVRLLGCCVEQGENVLIY---EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQ 552
H+N+V+L E+ E+ P SL + L + + L + ++ +
Sbjct: 65 NHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILL----DSNMIPKISDFGLARMFGGDELQSNTKRIVG 608
G+ +L + ++HR++KP NI+ D + K++DFG AR DE + G
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYG 177
Query: 609 TYGYMSPE--------YAIHGFFSIKSDVFSFGVLL 636
T Y+ P+ + D++S GV
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 34/200 (17%)
Query: 460 NFGVENKLGEGGFGPVYK-----SGQ-------------GLEEFKNEIKLTAKLQHRNLV 501
LG G FG V+K +G EE KNEI + +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFD--TTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
+L + + VL+ EY+ LFD + L I ++ I +G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 560 YSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
+ ++H DLKP NIL D+ I KI DFGLAR + E K GT +++PE
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPRE---KLKVNFGTPEFLAPE 258
Query: 617 YAIHGFFSIKSDVFSFGVLL 636
+ F S +D++S GV+
Sbjct: 259 VVNYDFVSFPTDMWSVGVIA 278
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 51/225 (22%), Positives = 88/225 (39%), Gaps = 52/225 (23%)
Query: 459 NNFGVENKLGEGGFGPVY---KSGQG------------------------------LEEF 485
N++ + L +G F + K + ++F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 486 KNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL-----FDTTKEGLLGW 540
KNE+++ +++ + G E +IYEY+ N S+ F D +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 541 GARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600
II+ + Y+H + + HRD+KPSNIL+D N K+SDFG + +++
Sbjct: 151 QVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 601 SNTKRIVGTYGYMSPE-----YAIHGFFSIKSDVFSFGVLLLETL 640
GTY +M PE + +G K D++S G+ L
Sbjct: 209 G----SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMF 246
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 46/201 (22%), Positives = 78/201 (38%), Gaps = 33/201 (16%)
Query: 458 TNNFGVENKLGEGGFGPVY-----------------KSGQGLEEFKNEIKLTAKLQHRNL 500
+ + LG G FG V+ G K EI + +HRN+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFD--TTKEGLLGWGARIRIIEGIAQGLLYLH 558
+ L E V+I+E++ +F+ T L + + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 559 QYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSP 615
+ H D++P NI+ S+ I KI +FG AR + + + Y +P
Sbjct: 120 S---HNIGHFDIRPENIIYQTRRSSTI-KIIEFGQARQLKPGDNF---RLLFTAPEYYAP 172
Query: 616 EYAIHGFFSIKSDVFSFGVLL 636
E H S +D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-27
Identities = 40/207 (19%), Positives = 75/207 (36%), Gaps = 41/207 (19%)
Query: 463 VENKLGEGGFGPVYK------SG--------------QGLEEFKNEIKLTAKLQHRNLVR 502
V+ + GG G +Y +G + E + A++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 503 LL--GCCVEQGENVLIY---EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557
+ ++ + + Y EY+ +SL L I + I L YL
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYL 198
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
H + +++ DLKP NI+L + K+ D G + GT G+ +PE
Sbjct: 199 H---SIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINS------FGYLYGTPGFQAPEI 248
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSKR 644
++ +D+++ G L
Sbjct: 249 V-RTGPTVATDIYTVGRTLAALTLDLP 274
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 42/211 (19%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQ-----------GLEEFK---NEIKLTAKL-QHR 498
+ ++G G +G V K SGQ +E K ++ + +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI------RIIEGIAQ 552
+V+ G +G+ + E + + S D F K I +I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI-VGTYG 611
L +L L++IHRD+KPSNILLD + K+ DFG++ G + S K G
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGCRP 190
Query: 612 YMSPE----YAIHGFFSIKSDVFSFGVLLLE 638
YM+PE A + ++SDV+S G+ L E
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 56/178 (31%), Positives = 89/178 (50%), Gaps = 27/178 (15%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQG-------LEEFKN--------EIKLTAKLQHR 498
NF K+GEG +G VYK +G+ L+ EI L +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH 558
N+V+LL + + L++E+L + L F+ D + + + + QGL + H
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
+ RV+HRDLKP N+L+++ K++DFGLAR F G +++ T +V T Y +PE
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPE 173
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 53/208 (25%), Positives = 85/208 (40%), Gaps = 39/208 (18%)
Query: 458 TNNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTA 493
+ + + +LG G F V K G EE + E+ +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 494 KLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQ 552
++ H N++ L + + VLI E + L FD ++ L I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILD 126
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIP----KISDFGLARMFGGDELQSNTKRIVG 608
G+ YLH ++ H DLKP NI+L IP K+ DFGLA K I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 609 TYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
T +++PE + +++D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 49/215 (22%), Positives = 74/215 (34%), Gaps = 40/215 (18%)
Query: 463 VENKLGEGGFGPVY------------------KSGQGLEEFKNEIKLTAKLQ-HRNLVRL 503
V L EGGF VY + E+ KL H N+V+
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 504 LGCCVEQGEN-------VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLY 556
E L+ L L FL G L ++I + + +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI---------- 606
+H + +IHRDLK N+LL + K+ DFG A S + +
Sbjct: 152 MH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 607 VGTYGYMSPE-YAIHGFFSI--KSDVFSFGVLLLE 638
T Y +PE ++ F I K D+++ G +L
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 52/208 (25%), Positives = 83/208 (39%), Gaps = 42/208 (20%)
Query: 458 TNNFGVENKLGEGGFGPVY-------------------KSGQGLEEFKNEIKLTAKLQHR 498
+ F + KLG G FG V+ +S +E+ + EI++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 499 NLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWG------ARIRIIEGIA 551
N++++ E N+ ++ E L + +++ +
Sbjct: 81 NIIKIFEVF-EDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVA-ELMKQMM 134
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFGGDELQSNTKRIVG 608
L Y H V+H+DLKP NIL + KI DFGLA +F DE G
Sbjct: 135 NALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAG 188
Query: 609 TYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
T YM+PE + K D++S GV++
Sbjct: 189 TALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 30/179 (16%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQG-------LEEFKN--------EIKLTAKLQHR 498
+ K+GEG +G V+K + + L++ EI L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-IIEGIAQGLLYL 557
N+VRL + L++E+ + L + D+ L ++ + + +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF-DSCNGDLDP--EIVKSFLFQLLKGLGFC 117
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
H V+HRDLKP N+L++ N K+++FGLAR F G ++ + +V T Y P+
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPD 171
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 53/208 (25%), Positives = 85/208 (40%), Gaps = 39/208 (18%)
Query: 458 TNNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTA 493
+ + + +LG G F V K G EE + E+ +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 494 KLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQ 552
++ H N++ L + + VLI E + L FD ++ L I+ I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILD 126
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIP----KISDFGLARMFGGDELQSNTKRIVG 608
G+ YLH ++ H DLKP NI+L IP K+ DFGLA K I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 609 TYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
T +++PE + +++D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-26
Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 34/202 (16%)
Query: 458 TNNFGVENKLGEGGFGPVY------------------KSGQGLEEFKNEIKLTAKLQHRN 499
+ + + +LG G FG V+ KNEI + +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFD--TTKEGLLGWGARIRIIEGIAQGLLYL 557
L+ L ++ E VLI E+L LFD ++ + I + +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 558 HQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMS 614
H+ ++H D+KP NI+ ++ + KI DFGLA DE K T + +
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSV-KIIDFGLATKLNPDE---IVKVTTATAEFAA 218
Query: 615 PEYAIHGFFSIKSDVFSFGVLL 636
PE +D+++ GVL
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLG 240
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 57/191 (29%), Positives = 94/191 (49%), Gaps = 29/191 (15%)
Query: 446 TQGKSLASVSAATNNFGVENKLGEGGFGPVYK----SGQ-------GLEEFKN------- 487
+ G+ + K+GEG +G VYK G+ L+
Sbjct: 8 SSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI 67
Query: 488 -EIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR- 545
EI L +L H N+V L+ + L++E++ K L L D K GL ++I+
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQD--SQIKI 123
Query: 546 IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR 605
+ + +G+ + HQ+ R++HRDLKP N+L++S+ K++DFGLAR F G ++S T
Sbjct: 124 YLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHE 179
Query: 606 IVGTYGYMSPE 616
+V T Y +P+
Sbjct: 180 VV-TLWYRAPD 189
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-26
Identities = 62/219 (28%), Positives = 92/219 (42%), Gaps = 38/219 (17%)
Query: 448 GKSLASVSAATNNFGVENKLGEGGFGPVYK-----SGQ--------------GLEEFKNE 488
G+S + + + ++ +LG GGFG V + +G+ E + E
Sbjct: 3 GRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLE 62
Query: 489 IKLTAKLQHRNLVRLLGCCVEQGEN--------VLIYEYLPNKSLDSFLFDTTKEGLLGW 540
I++ KL H N+V V G +L EY L +L L
Sbjct: 63 IQIMKKLNHPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 541 GARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN---MIPKISDFGLARMFGGD 597
G ++ I+ L YLH+ R+IHRDLKP NI+L +I KI D G A+
Sbjct: 121 GPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177
Query: 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
EL VGT Y++PE +++ D +SFG L
Sbjct: 178 EL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-26
Identities = 49/202 (24%), Positives = 85/202 (42%), Gaps = 34/202 (16%)
Query: 458 TNNFGVENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRN 499
+++ + +LG G FG V++ E + EI+ + L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFD--TTKEGLLGWGARIRIIEGIAQGLLYL 557
LV L + E V+IYE++ LF+ + + + + + +GL ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 558 HQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMS 614
H+ +H DLKP NI+ SN + K+ DFGL + + K GT + +
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQ---SVKVTTGTAEFAA 324
Query: 615 PEYAIHGFFSIKSDVFSFGVLL 636
PE A +D++S GVL
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLS 346
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 39/208 (18%)
Query: 458 TNNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTA 493
+++ + +LG G F V K G EE + E+ +
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 494 KLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQ 552
+++H N++ L + + VLI E + L FD ++ L + ++ I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILD 119
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIP----KISDFGLARMFGGDELQSNTKRIVG 608
G+ YLH R+ H DLKP NI+L +P K+ DFG+A K I G
Sbjct: 120 GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFG 173
Query: 609 TYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
T +++PE + +++D++S GV+
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 33/204 (16%)
Query: 459 NNFGVENKLGEGGFGPVY-----KSGQ---------------GLEE-FKNEIKLTAKLQH 497
++F + LG+G FG VY ++ G+E + EI++ + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 498 RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLG-WGARIRIIEGIAQGLLY 556
N++R+ ++ L+ E+ P L L K G + +E +A L Y
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSA-TFMEELADALHY 129
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
H +VIHRD+KP N+L+ KI+DFG + ++ + GT Y+ PE
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----MCGTLDYLPPE 182
Query: 617 YAIHGFFSIKSDVFSFGVLLLETL 640
K D++ GVL E L
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 59/215 (27%)
Query: 458 TNNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQH 497
+ + LG+G FG V K + E++L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 498 RNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARI------------ 544
N+++L E + ++ E L FD I
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGEL----FD-----------EIIKRKRFSEHDAA 124
Query: 545 RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFGGDELQS 601
RII+ + G+ Y+H+ ++HRDLKP NILL+S + KI DFGL+ F +
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM- 180
Query: 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
K +GT Y++PE + G + K DV+S GV+L
Sbjct: 181 --KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 52/215 (24%), Positives = 83/215 (38%), Gaps = 41/215 (19%)
Query: 453 SVSAATNNFGVENKLGEGGFGPVYK-----SGQ-------GLEEFKNEIK--------LT 492
A N+ ++G G G V+K +G K E K +
Sbjct: 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL 78
Query: 493 AKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSF---LFDTTKEGLLGWGARIRIIEG 549
+V+ G + + + E + + + E +LG ++
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILG-----KMTVA 132
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI-VG 608
I + L YL + VIHRD+KPSNILLD K+ DFG++ G + K G
Sbjct: 133 IVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS----GRLVDDKAKDRSAG 186
Query: 609 TYGYMSPE-----YAIHGFFSIKSDVFSFGVLLLE 638
YM+PE + I++DV+S G+ L+E
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 59/215 (27%)
Query: 458 TNNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQH 497
+ + KLG G +G V S + E+ + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 498 RNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARI------------ 544
N+++L E N L+ E L FD I
Sbjct: 96 PNIMKLYDFF-EDKRNYYLVMECYKGGEL----FD-----------EIIHRMKFNEVDAA 139
Query: 545 RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFGGDELQS 601
II+ + G+ YLH+ ++HRDLKP N+LL+S + + KI DFGL+ +F +
Sbjct: 140 VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--- 193
Query: 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
K +GT Y++PE + + K DV+S GV+L
Sbjct: 194 KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 58/231 (25%), Positives = 86/231 (37%), Gaps = 57/231 (24%)
Query: 459 NNFGVENKLGEGGFGPVYKSG--------------QGLEEFKNEIK-LTAKLQHRNLVRL 503
N E LG G G V G + EIK LT H N++R
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 504 LGCCVEQGENVL----------IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQG 553
C E + L + + + +K++ KE I ++ IA G
Sbjct: 75 Y--CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP-----ISLLRQIASG 127
Query: 554 LLYLHQYSRLRVIHRDLKPSNILLDS-------------NMIPKISDFGLARMFGGDE-- 598
+ +LH L++IHRDLKP NIL+ + N+ ISDFGL + +
Sbjct: 128 VAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 599 LQSNTKRIVGTYGYMSPE-------YAIHGFFSIKSDVFSFGVLLLETLSS 642
++N GT G+ +PE + D+FS G + LS
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 55/317 (17%), Positives = 107/317 (33%), Gaps = 82/317 (25%)
Query: 450 SLASVSAATNNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEI 489
++ S T F K+G G FG V+K + E+
Sbjct: 2 AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV 61
Query: 490 KLTAKL-QHRNLVRLLGCCVEQGENVLIY-EYLPNKSLDSFLFDTTKEGLLGWGARIRII 547
A L QH ++VR E +++LI EY SL + + + A ++ +
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 548 EG-IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIP-------------------KISD 587
+ +GL Y+H + ++H D+KPSNI + IP KI D
Sbjct: 121 LLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 588 FGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFS--IKSDVFSFGVLLLETLSSKRS 645
G S+ + G +++ E + ++ K+D+F+ + ++
Sbjct: 178 LGHVTRI------SSPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVC------- 223
Query: 646 TRFFNTNSLTLLGHAW---NLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAA 702
+ W + R L P++ S + + + +
Sbjct: 224 --------AAGAEPLPRNGDQWHEIRQGRL--PRIPQVLSQEF----TELLKVMIHPDPE 269
Query: 703 DRPTMSEVISMLTNEFV 719
RP+ + + + +
Sbjct: 270 RRPSAMAL---VKHSVL 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 60/216 (27%)
Query: 458 TNNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQ 496
++ + + LG+G FG V E E++L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 497 HRNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARI----------- 544
H N+++L E L+ E L FD I
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGEL----FD-----------EIISRKRFSEVDA 128
Query: 545 -RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFGGDELQ 600
RII + G+ Y+H+ +++HRDLKP N+LL+S + +I DFGL+ F +
Sbjct: 129 ARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
K +GT Y++PE +HG + K DV+S GV+L
Sbjct: 186 ---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 29/178 (16%)
Query: 459 NNFGVENKLGEGGFGPVYK----SGQ-------GLEEFKN--------EIKLTAKLQHRN 499
+ K+GEG +G VYK G+ LE+ EI + +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-IIEGIAQGLLYLH 558
+V+L + VL++E+L + L L D + GL + + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-QDLKKLL-DVCEGGLES--VTAKSFLLQLLNGIAYCH 117
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
RV+HRDLKP N+L++ KI+DFGLAR F G ++ T IV T Y +P+
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPD 170
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 26/239 (10%), Positives = 50/239 (20%), Gaps = 60/239 (25%)
Query: 454 VSAATNNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLT 492
+S + L G V+ S LE
Sbjct: 57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116
Query: 493 AKLQHRNLVRLLGCC-------------------------VEQGENVLIYEYLPNKSLDS 527
A+L + N L+ + L+
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176
Query: 528 FL----FDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIP 583
F G G A + + + L ++H P N+ + +
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRL 233
Query: 584 KISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG--FFSIKSDVFSFGVLLLETL 640
+ D G + Y E+ F+ + + G+ +
Sbjct: 234 MLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 39/208 (18%)
Query: 458 TNNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTA 493
+ + +LG G F V K G E+ + E+ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 494 KLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQ 552
++QH N++ L + + +LI E + L FD ++ L ++ I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILN 125
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIP----KISDFGLARMFGGDELQSNTKRIVG 608
G+ YLH L++ H DLKP NI+L +P KI DFGLA K I G
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179
Query: 609 TYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
T +++PE + +++D++S GV+
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 30/179 (16%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQ-------GLEEFKN--------EIKLTAKLQHR 498
+ K+GEG +G V+K +GQ E EI++ +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-IIEGIAQGLLYL 557
NLV LL + L++EY + ++ L D + G+ ++ I Q + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVPE--HLVKSITWQTLQAVNFC 118
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
H++ IHRD+KP NIL+ + + K+ DFG AR+ + T Y SPE
Sbjct: 119 HKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRWYRSPE 172
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 59/215 (27%)
Query: 458 TNNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQH 497
+ + LG+G FG V K + E++L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 498 RNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARI------------ 544
N+++L E + ++ E L FD I
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGEL----FD-----------EIIKRKRFSEHDAA 124
Query: 545 RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFGGDELQS 601
RII+ + G+ Y+H+ ++HRDLKP NILL+S + KI DFGL+ F +
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179
Query: 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
K +GT Y++PE + G + K DV+S GV+L
Sbjct: 180 -MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 33/187 (17%)
Query: 454 VSAATNNFGVENKLGEGGFGPVYK-----SGQ----------GLEEFKN--------EIK 490
V + + + LGEG F VYK + Q E K+ EIK
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 491 LTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-IIEG 549
L +L H N++ LL + L+++++ L+ + L + I+ +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVII-KDNSLVLTP--SHIKAYMLM 120
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
QGL YLHQ+ ++HRDLKP+N+LLD N + K++DFGLA+ F G ++ T ++V T
Sbjct: 121 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-T 175
Query: 610 YGYMSPE 616
Y +PE
Sbjct: 176 RWYRAPE 182
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 51/196 (26%), Positives = 82/196 (41%), Gaps = 27/196 (13%)
Query: 461 FGVENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
K+GEG G V Q E NE+ + QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
+ + E ++ E+L +L D + L + E + Q L YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA--- 159
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF 622
VIHRD+K +ILL + K+SDFG D + + +VGT +M+PE
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSL 217
Query: 623 FSIKSDVFSFGVLLLE 638
++ + D++S G++++E
Sbjct: 218 YATEVDIWSLGIMVIE 233
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 27/196 (13%)
Query: 461 FGVENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
+ K+G+G G VY E NEI + + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
L + E ++ EYL SL D E + G + Q L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS--- 134
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF 622
+VIHRD+K NILL + K++DFG ++ + +T +VGT +M+PE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192
Query: 623 FSIKSDVFSFGVLLLE 638
+ K D++S G++ +E
Sbjct: 193 YGPKVDIWSLGIMAIE 208
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 440 LSMETKTQGKSLASVSAATN---NFGVENKLGEGGFGPVYK-----SGQ----------- 480
L + Q K L S F V KLGEG +G VYK +GQ
Sbjct: 7 LRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES 66
Query: 481 GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGW 540
L+E EI + + ++V+ G + + ++ EY S+ + + L
Sbjct: 67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTE 124
Query: 541 GARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600
I++ +GL YLH +R IHRD+K NILL++ K++DFG+A +
Sbjct: 125 DEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181
Query: 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLE 638
NT ++GT +M+PE ++ +D++S G+ +E
Sbjct: 182 RNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 8e-25
Identities = 55/184 (29%), Positives = 90/184 (48%), Gaps = 30/184 (16%)
Query: 456 AATNNFGVENKLGEGGFGPVYK-----SGQ--GLEEFKN------------EIKLTAKLQ 496
++++ F KLG G + VYK +G L+E K EI L +L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 497 HRNLVRLLGCCVEQGENVLIYEYLPN---KSLDSFLFDTTKEGLLGWGARIR-IIEGIAQ 552
H N+VRL + + L++E++ N K +DS T GL ++ + Q
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLE--LNLVKYFQWQLLQ 119
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
GL + H+ +++HRDLKP N+L++ K+ DFGLAR F G + + + +V T Y
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLWY 174
Query: 613 MSPE 616
+P+
Sbjct: 175 RAPD 178
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 60/223 (26%)
Query: 448 GKSLASVSAATNNFGVENKLGEGGFGPVYK-----SGQ-------------GLEEFKNEI 489
G + + + +EN +G G +G V + ++ FK EI
Sbjct: 1 GSTKGDI---NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI 57
Query: 490 KLTAKLQHRNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARI---- 544
++ L H N++RL E ++ L+ E L F+ R+
Sbjct: 58 EIMKSLDHPNIIRLYETF-EDNTDIYLVMELCTGGEL----FE-----------RVVHKR 101
Query: 545 --------RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARM 593
RI++ + + Y H+ L V HRDLKP N L + + K+ DFGLA
Sbjct: 102 VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158
Query: 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
F ++ + VGT Y+SP+ + G + + D +S GV++
Sbjct: 159 FKPGKMM---RTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-24
Identities = 47/179 (26%), Positives = 82/179 (45%), Gaps = 30/179 (16%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQ--GLEEFKN-------------EIKLTAKLQHR 498
+ +GEG +G V K +G+ +++F EIKL +L+H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-IIEGIAQGLLYL 557
NLV LL C ++ L++E++ + ++ L + GL ++ + I G+ +
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDY--QVVQKYLFQIINGIGFC 140
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
H + +IHRD+KP NIL+ + + K+ DFG AR + + T Y +PE
Sbjct: 141 HSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TRWYRAPE 194
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 442 METKTQGKSLASVSAATNN----FGVENKLGEGGFGPVYK-----SGQ------------ 480
M L + + F K+G+G FG V+K + +
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA 60
Query: 481 --GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLL 538
+E+ + EI + ++ + + G ++ + +I EYL S D + G L
Sbjct: 61 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPL 116
Query: 539 GWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598
I+ I +GL YLH + IHRD+K +N+LL + K++DFG+A +
Sbjct: 117 DETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173
Query: 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLE 638
++ NT VGT +M+PE + K+D++S G+ +E
Sbjct: 174 IKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 70/226 (30%)
Query: 458 TNNFGVENKLGEGGFGPVYK-----SGQ--------------------------GLEEFK 486
++ KLG G +G V EE
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 487 NEIKLTAKLQHRNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARI- 544
NEI L L H N+++L E + L+ E+ L F+ +I
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGEL----FE-----------QII 138
Query: 545 -----------RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGL 590
I++ I G+ YLH+ ++HRD+KP NILL++ + KI DFGL
Sbjct: 139 NRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGL 195
Query: 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
+ F D + +GT Y++PE + ++ K DV+S GV++
Sbjct: 196 SSFFSKDYKL---RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 38/222 (17%), Positives = 73/222 (32%), Gaps = 39/222 (17%)
Query: 458 TNNFGVENKLGEGGFGPVYK----------SGQG----------LEEFKNEIKLTAKLQ- 496
+ V + LGEG F VY+ + Q EF +L +L+
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 497 --HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL--FDTTKEGLLGWGARIRIIEGIAQ 552
++ + Q +VL+ E +L + + + T E ++ G I +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIP-----------KISDFGLARMFGGDELQS 601
+ +H +IH D+KP N +L + + + D G + +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
T G+ E + ++ + D F + L
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 29/178 (16%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQ--GLEEFKN------------EIKLTAKLQHRN 499
+ +KLGEG + VYK + L+E + E+ L L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-IIEGIAQGLLYLH 558
+V L + L++EYL +K L +L D + ++ + + +GL Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNIIN--MHNVKLFLFQLLRGLAYCH 117
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
+ +V+HRDLKP N+L++ K++DFGLAR ++ +V T Y P+
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPPD 170
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 50/204 (24%), Positives = 96/204 (47%), Gaps = 36/204 (17%)
Query: 461 FGVENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
+ + +LG+G FG VYK S + LE++ EI++ A H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK---EGLLGWGARIRIIEGIAQGLLYLHQ 559
LLG G+ ++ E+ P ++D+ + + + E + + + + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-----VCRQMLEALNFLHS 135
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI 619
R+IHRDLK N+L+ +++DFG++ + ++ +GT +M+PE +
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 620 HGFFS-----IKSDVFSFGVLLLE 638
K+D++S G+ L+E
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIE 214
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 36/204 (17%)
Query: 458 TNNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQH 497
++N+ V+ +LG+G F V + S + ++ + E ++ KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 498 RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFD--TTKEGLLGWGARIRIIEGIAQGLL 555
N+VRL E+ + L+++ + L F+ +E A I+ I + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 556 YLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
Y H ++HR+LKP N+LL S K++DFGLA E GT GY
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 173
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLL 636
+SPE +S D+++ GV+L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 48/203 (23%), Positives = 74/203 (36%), Gaps = 42/203 (20%)
Query: 466 KLGEGGFGPVY-----------------------KSGQGLEEFKNEIKLTAKLQHRNLVR 502
+G+G F V G E+ K E + L+H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDT-TKEGLLGWG-----ARIRIIEGIAQGLLY 556
LL G +++E++ L K G+ A + I + L Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVAS-HYMRQILEALRY 145
Query: 557 LHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYM 613
H +IHRD+KP +LL S + K+ FG+A G VGT +M
Sbjct: 146 CHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGTPHFM 200
Query: 614 SPEYAIHGFFSIKSDVFSFGVLL 636
+PE + DV+ GV+L
Sbjct: 201 APEVVKREPYGKPVDVWGCGVIL 223
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 56/189 (29%), Positives = 77/189 (40%), Gaps = 46/189 (24%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQG-------LEEFKN--------EIKLTAKLQHR 498
+ + KLGEG +G VYK + + LE + E+ L +LQHR
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 499 NLVRLLGCCVEQGENVLIYEYLPN---KSLDS---FLFDTTKEGLLGWGARIRIIEGIAQ 552
N++ L LI+EY N K +D K L +
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLY----------QLIN 143
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIP-----KISDFGLARMFGGDELQSNTKRIV 607
G+ + H R +HRDLKP N+LL + KI DFGLAR F G ++ T I+
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII 199
Query: 608 GTYGYMSPE 616
T Y PE
Sbjct: 200 -TLWYRPPE 207
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 38/318 (11%), Positives = 81/318 (25%), Gaps = 84/318 (26%)
Query: 467 LGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQH-------- 497
LG+ + +++ K E+ L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 498 --------RNLVRLLGCC-----VEQGENVLIYEYL--------PNKSLDSFLFDTTKE- 535
+LV+ ++ + ++ L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 536 GLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595
L AR+++ + + L LH ++H L+P +I+LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 596 GDELQSNTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFN 650
G S R + + D ++ G+ +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW---------- 311
Query: 651 TNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYP-IVKRYINVALLCVQENAADRPTMSE 709
L DD + + + + P V+ + L + DR +
Sbjct: 312 CADLP--------NTDDAALGGSEWIFRSCKNIPQPVRALLEGFL---RYPKEDRLLPLQ 360
Query: 710 VISMLTNEFVNLPSPQQP 727
M T E+ L +
Sbjct: 361 A--METPEYEQLRTELSA 376
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 33/209 (15%)
Query: 459 NNFGVENKLGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKLQHRN 499
+++ ++ +G G V ++E EI+ ++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWG----ARIRII-EGIAQGL 554
+V V + E L+ + L S+ + +G G + I I + +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 555 LYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL-ARMFGGDELQSNTKR--IVGTYG 611
YLH + IHRD+K NILL + +I+DFG+ A + G ++ N R VGT
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 612 YMSPE--YAIHGFFSIKSDVFSFGVLLLE 638
+M+PE + G + K+D++SFG+ +E
Sbjct: 192 WMAPEVMEQVRG-YDFKADIWSFGITAIE 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 39/199 (19%)
Query: 466 KLGEGGFGPVYK-----SGQGL---------------EEFKNEIKLTAKLQHR-NLVRLL 504
+LG G F V + +GQ E +EI + + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 505 GCCVEQGENVLIYEYLPNKSLDSFLFD---TTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
E +LI EY + F ++ IR+I+ I +G+ YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-- 149
Query: 562 RLRVIHRDLKPSNILLDSN----MIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
++H DLKP NILL S I KI DFG++R G + I+GT Y++PE
Sbjct: 150 -NNIVHLDLKPQNILLSSIYPLGDI-KIVDFGMSRKIGHAC---ELREIMGTPEYLAPEI 204
Query: 618 AIHGFFSIKSDVFSFGVLL 636
+ + +D+++ G++
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 56/209 (26%)
Query: 463 VENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
V+ +LG+G F V + S + ++ + E ++ KLQH N+VR
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI------------RIIEGI 550
L E+ + L+++ + LF+ I I+ I
Sbjct: 93 LHDSIQEESFHYLVFDLVTG----GELFE-----------DIVAREFYSEADASHCIQQI 137
Query: 551 AQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFGGDELQSNTKRIV 607
+ + Y H ++HR+LKP N+LL S K++DFGLA E
Sbjct: 138 LESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFA 191
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
GT GY+SPE +S D+++ GV+L
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 51/238 (21%), Positives = 94/238 (39%), Gaps = 60/238 (25%)
Query: 441 SMETKTQGKSLASVSAATNNFGVENKLGEGGFGPVYK-----SGQ--------------- 480
SM + + A+ + ++ +G G V + +G
Sbjct: 76 SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 481 ------GLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFD- 531
E + E + ++ H +++ L+ E + L+++ + L FD
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGEL----FDY 190
Query: 532 -------TTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPK 584
+ KE R I+ + + + +LH ++HRDLKP NILLD NM +
Sbjct: 191 LTEKVALSEKE------TR-SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIR 240
Query: 585 ISDFGLARMFGGDELQSNTKRIVGTYGYMSPE------YAIHGFFSIKSDVFSFGVLL 636
+SDFG + E + + GT GY++PE H + + D+++ GV+L
Sbjct: 241 LSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 48/216 (22%), Positives = 85/216 (39%), Gaps = 59/216 (27%)
Query: 463 VENKLGEGGFGPVYK-----SGQ----------------------GLEEFKNEIKLTAKL 495
+ LG G V + + + E E+ + K+
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 496 -QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFD--------TTKEGLLGWGARIRI 546
H N+++L L+++ + L FD + KE R +I
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKE------TR-KI 129
Query: 547 IEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRI 606
+ + + + LH+ L ++HRDLKP NILLD +M K++DFG + E + +
Sbjct: 130 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREV 183
Query: 607 VGTYGYMSPE------YAIHGFFSIKSDVFSFGVLL 636
GT Y++PE H + + D++S GV++
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-22
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 57/223 (25%)
Query: 451 LASVSAA--TNNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNE 488
+A+++ T + + +LG+G F V + S + ++ + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 489 IKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI---- 544
++ L+H N+VRL E+G + LI++ + LF+ I
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTG----GELFE-----------DIVARE 105
Query: 545 --------RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARM 593
I+ I + +L+ HQ + V+HR+LKP N+LL S K++DFGLA
Sbjct: 106 YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162
Query: 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
G+ Q GT GY+SPE + D+++ GV+L
Sbjct: 163 VEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 50/207 (24%), Positives = 80/207 (38%), Gaps = 55/207 (26%)
Query: 463 VENKLGEGGFGPVYK-----SGQ-------------GLEEFKNEIKLTAKLQHRNLVRLL 504
LG G F V+ +G+ +NEI + K++H N+V L
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 505 GCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI------------RIIEGIAQ 552
L+ + + L FD RI +I+ +
Sbjct: 73 DIYESTTHYYLVMQLVSGGEL----FD-----------RILERGVYTEKDASLVIQQVLS 117
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFGGDELQSNTKRIVGT 609
+ YLH+ ++HRDLKP N+L + N I+DFGL++M + + GT
Sbjct: 118 AVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGT 170
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLL 636
GY++PE +S D +S GV+
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 7e-22
Identities = 51/335 (15%), Positives = 106/335 (31%), Gaps = 76/335 (22%)
Query: 449 KSLASVSAATNNFGVENKLGEG--GFGPVYK-----SGQ---------------GLEEFK 486
+ ++S + + +G+G V +G+ + +
Sbjct: 15 QGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQ 74
Query: 487 NEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKS----LDSFLFDTTKEGLLGWGA 542
E+ ++ H N+V + E ++ ++ S + + D E + +
Sbjct: 75 GELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-- 132
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602
I++G+ + L Y+H + +HR +K S+IL+ + +S +
Sbjct: 133 ---ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186
Query: 603 T-----KRIVGTYGYMSPE---YAIHGFFSIKSDVFSFGVLLLE---------------- 638
K V ++SPE + G + KSD++S G+ E
Sbjct: 187 VVHDFPKYSVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANGHVPFKDMPATQM 245
Query: 639 ----------TLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKR 688
L + A + D + P S+P +
Sbjct: 246 LLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRT 305
Query: 689 Y----INVALLCVQENAADRPTMSEVISMLTNEFV 719
+ + C+Q N RP+ S +L + F
Sbjct: 306 FSPHFHHFVEQCLQRNPDARPSAST---LLNHSFF 337
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 482 LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY---EYLPNKSLDSFLFDTTKEGLL 538
+E+ EI + KL H N+V+L+ ++ +Y E + + + L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPL 134
Query: 539 GWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF-GGD 597
+ + +G+ YLH ++IHRD+KPSN+L+ + KI+DFG++ F G D
Sbjct: 135 SEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 598 ELQSNTKRIVGTYGYMSPE---YAIHGFFSIKSDVFSFGVLL 636
L SNT VGT +M+PE F DV++ GV L
Sbjct: 192 ALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 1e-21
Identities = 32/269 (11%), Positives = 70/269 (26%), Gaps = 74/269 (27%)
Query: 438 HILSMETKTQGKSLASVSAATN---NFGVENKLGEGGFGPVY------------------ 476
++S G+ S LG+
Sbjct: 49 SLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYF 108
Query: 477 ---KSGQGLEEFKNEIKLTAKLQ-------------------------HRNLVRLLGCC- 507
+++ K E+ L+ + ++R+
Sbjct: 109 TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 168
Query: 508 VEQGENVLIYEYLPNKSLDSF---LFD-TTKEGLLGWGARIRIIEGIAQGLLYLHQYSRL 563
+ +L +F L ++ L AR+++ + + L LH Y
Sbjct: 169 DMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--- 225
Query: 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH--- 620
++H L+P +I+LD ++ F G + G+ PE
Sbjct: 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVSRGFEPPELEARRAT 279
Query: 621 --------GFFSIKSDVFSFGVLLLETLS 641
+ D ++ G+++
Sbjct: 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 3e-21
Identities = 46/245 (18%), Positives = 77/245 (31%), Gaps = 69/245 (28%)
Query: 458 TNNFGVENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAK 494
+ ++ +G+G +G V + + +E K E++L K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 495 LQHRNLVRLLGC------------CVEQGE---------------NVLIYEYLPNKSLDS 527
L H N+ RL G +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 528 FLFDTTKEGLLGWGARI----------RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL 577
+ + G+ + I+ I L YLH + HRD+KP N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201
Query: 578 DS--NMIPKISDFGLARMFGGDELQSNT--KRIVGTYGYMSPE--YAIHGFFSIKSDVFS 631
+ + K+ DFGL++ F GT +++PE + + K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 632 FGVLL 636
GVLL
Sbjct: 262 AGVLL 266
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 42/191 (21%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQG-------LEEFKN--------EIKLTAKLQHR 498
+ + K+G+G FG V+K +GQ +E K EIK+ L+H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 499 NLVRLLGCCVEQGENV--------LIYEYLPNKSLD-SFLFDTTKEGLLGWGARIR-IIE 548
N+V L+ C + L++++ D + L + I+ +++
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTL--SEIKRVMQ 131
Query: 549 GIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG---GDELQSNTKR 605
+ GL Y+H+ +++HRD+K +N+L+ + + K++DFGLAR F + T R
Sbjct: 132 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 606 IVGTYGYMSPE 616
+V T Y PE
Sbjct: 189 VV-TLWYRPPE 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 34/166 (20%)
Query: 459 NNFGVENKLGEGGFGPVYK------SGQG-------LEEFKN--------EIKLTAKLQ- 496
+ ++GEG +G V+K G+ ++ + E+ + L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 497 --HRNLVRLLGCCVEQGEN-----VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEG 549
H N+VRL C + L++E++ ++ L ++L D E + ++
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQ 128
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595
+ +GL +LH + RV+HRDLKP NIL+ S+ K++DFGLAR++
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 44/234 (18%)
Query: 441 SMETKTQGKSLASVSAA-----TNNFGVENKLGEGGFGPVYK-----------------S 478
SM + + +SL + + F + +G G +G VYK +
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 479 GQGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENV------LIYEYLPNKSLDSFLFD 531
G EE K EI + K HRN+ G +++ L+ E+ S+ L
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIK 119
Query: 532 TTKEGLL--GWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589
TK L W A I I +GL +LHQ +VIHRD+K N+LL N K+ DFG
Sbjct: 120 NTKGNTLKEEWIAYI--CREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 590 LARMFGGDELQSNTKRIVGTYGYMSPE-----YAIHGFFSIKSDVFSFGVLLLE 638
++ + NT +GT +M+PE + KSD++S G+ +E
Sbjct: 175 VSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 46/220 (20%), Positives = 81/220 (36%), Gaps = 60/220 (27%)
Query: 458 TNNFGVENKLGEGGFGPVYK-----SGQ---------------------GLEEFKNEIKL 491
+ + + LG G G V + + + EI++
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 492 TAKLQHRNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFD--------TTKEGLLGWGA 542
KL H ++++ E+ ++ E + L FD
Sbjct: 69 LKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGEL----FDKVVGNKRLKEAT------C 116
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFGGDEL 599
+ + + YLH +IHRDLKP N+LL S + + KI+DFG +++ G L
Sbjct: 117 K-LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 600 QSNTKRIVGTYGYMSPE---YAIHGFFSIKSDVFSFGVLL 636
+ + GT Y++PE ++ D +S GV+L
Sbjct: 173 ---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-21
Identities = 56/290 (19%), Positives = 103/290 (35%), Gaps = 76/290 (26%)
Query: 382 YANSEVTGRGSGCLMWYGDLIDTTKAKFHNGQPMAREAILVICPSFSSGGASYYFMHILS 441
+ N+E+ G+G + I + S + F +
Sbjct: 86 FVNTELVGKGKRRPLNNNSEIALSL----------------------SRNKVFVFFDLTV 123
Query: 442 METKTQGKSLASVSAATNNFGVENKLGEGGFGPVYK-----SGQ---------------- 480
+ K+L + + + LG G G V + +
Sbjct: 124 DDQSVYPKAL------RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS 177
Query: 481 -----GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFD--T 532
+ EI++ KL H ++++ E+ ++ E + L FD
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGEL----FDKVV 231
Query: 533 TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFG 589
+ L + + + YLH+ +IHRDLKP N+LL S + + KI+DFG
Sbjct: 232 GNKRLKEATCK-LYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 590 LARMFGGDELQSNTKRIVGTYGYMSPE---YAIHGFFSIKSDVFSFGVLL 636
+++ G L + + GT Y++PE ++ D +S GV+L
Sbjct: 288 HSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 48/197 (24%), Positives = 79/197 (40%), Gaps = 33/197 (16%)
Query: 467 LGEGGFGPVY----------------------KSGQGLEEFKNEIKLTAKLQHRNLVRLL 504
LGEG +G V + G K EI+L +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 505 GCCVEQGEN--VLIYEYLPNKSLDSFLFDTTKEGLLG-WGARIRIIEGIAQGLLYLHQYS 561
+ + ++ EY + + D+ E A + GL YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAH-GYFCQLIDGLEYLH--- 126
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA--I 619
++H+D+KP N+LL + KIS G+A + G+ + PE A +
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186
Query: 620 HGFFSIKSDVFSFGVLL 636
F K D++S GV L
Sbjct: 187 DTFSGFKVDIWSAGVTL 203
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 52/205 (25%)
Query: 463 VENKLGEGGFGPVYK-----SGQGL-----------EEFKNEIKLTAKLQHRNLVRLLGC 506
VE++LG G VY+ + + + + EI + +L H N+++L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI------------RIIEGIAQGL 554
E L+ E + L FD RI ++ I + +
Sbjct: 117 FETPTEISLVLELVTGGEL----FD-----------RIVEKGYYSERDAADAVKQILEAV 161
Query: 555 LYLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG 611
YLH+ ++HRDLKP N+L + KI+DFGL+++ L K + GT G
Sbjct: 162 AYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPG 215
Query: 612 YMSPEYAIHGFFSIKSDVFSFGVLL 636
Y +PE + + D++S G++
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 9e-21
Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 36/172 (20%)
Query: 455 SAATNNFGVENKLGEGGFGPVYK-----SGQ-------GLEEFKN-----------EIKL 491
S AT+ + ++G G +G VYK SG + E+ L
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 492 TAKLQ---HRNLVRLLGCCVEQGENV-----LIYEYLPNKSLDSFLFDTTKEGLLGWGAR 543
+L+ H N+VRL+ C + L++E++ ++ L ++L D L
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETI 122
Query: 544 IRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595
++ +GL +LH ++HRDLKP NIL+ S K++DFGLAR++
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 45/182 (24%), Positives = 77/182 (42%), Gaps = 35/182 (19%)
Query: 466 KLGEGGFGPVYKSGQ---------GLEEFKN---------EIKLTAKLQHRNLVRLLGCC 507
K+G G +G VYK+ + L++ + EI L +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 508 VEQGEN--VLIYEYLPN---KSLDSFLFDTTKEGLLGWGARIR--IIEGIAQGLLYLHQY 560
+ + L+++Y + + + + + ++ I G+ YLH
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 561 SRLRVIHRDLKPSNILLDS----NMIPKISDFGLARMFG--GDELQSNTKRIVGTYGYMS 614
V+HRDLKP+NIL+ KI+D G AR+F L +V T+ Y +
Sbjct: 148 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRA 203
Query: 615 PE 616
PE
Sbjct: 204 PE 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 44/206 (21%)
Query: 461 FGVENKLGEGGFGPVYK-----SGQ----------------GLEEFKNEIKLTAKLQHRN 499
F ++G G FG VY + + ++ E++ KL+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRII-EGIAQGLLYLH 558
++ GC + + L+ EY + D L + K+ L I + G QGL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE--VEIAAVTHGALQGLAYLH 171
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGL-ARMFGGDELQSNTKR--IVGTYGYMSP 615
+IHRD+K NILL + K+ DFG + M VGT +M+P
Sbjct: 172 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------APANSFVGTPYWMAP 219
Query: 616 EYAIH---GFFSIKSDVFSFGVLLLE 638
E + G + K DV+S G+ +E
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 37/215 (17%)
Query: 448 GKSLASVSAATNNFG---VENKLGEGGFGPVY-----KSGQ---------------GLEE 484
G S+AS + + G + +G+G F V +G+ L++
Sbjct: 1 GNSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK 60
Query: 485 FKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFD--TTKEGLLGWGA 542
E+++ L H N+V+L + LI EY + FD + A
Sbjct: 61 LFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEA 116
Query: 543 RIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602
R I + Y H + R++HRDLK N+LLD++M KI+DFG + F
Sbjct: 117 R-SKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--- 169
Query: 603 TKRIVGTYGYMSPE-YAIHGFFSIKSDVFSFGVLL 636
G Y +PE + + + DV+S GV+L
Sbjct: 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 458 TNNFGVENKLGEGGFGPVYK-----SGQ------GLE-EFKN-EIKLTAKLQHRNLVRLL 504
+ +G G FG V++ S + + FKN E+++ ++H N+V L
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLK 98
Query: 505 GCCVEQGENV------LIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-IIEGIAQGLLYL 557
G+ L+ EY+P +++ K I+ + + + L Y+
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 558 HQYSRLRVIHRDLKPSNILLDSNM-IPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
H + + HRD+KP N+LLD + K+ DFG A++ + N I Y Y +PE
Sbjct: 158 HS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-YRAPE 211
Query: 617 YAIHGF--FSIKSDVFSFGVLLLETLSSK 643
I G ++ D++S G ++ E + +
Sbjct: 212 -LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 51/205 (24%), Positives = 75/205 (36%), Gaps = 53/205 (25%)
Query: 464 ENKLGEGGFGPVYK-----SGQ----------GLEEFKNEIKLTAKLQ-HRNLVRLLGCC 507
+ LGEG F K S Q + EI + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 508 VEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARI------------RIIEGIAQGL 554
+ L+ E L L F+ RI I+ + +
Sbjct: 76 -HDQLHTFLVMELLNGGEL----FE-----------RIKKKKHFSETEASYIMRKLVSAV 119
Query: 555 LYLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG 611
++H + V+HRDLKP N+L + N+ KI DFG AR+ D T T
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLH 174
Query: 612 YMSPEYAIHGFFSIKSDVFSFGVLL 636
Y +PE + D++S GV+L
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVIL 199
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 4e-20
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 32/210 (15%)
Query: 458 TNNFGVENKLGEGGFGPVYK-----SGQGL--------EEFKN-EIKLTAKLQHRNLVRL 503
++ +G G FG VY+ SG+ + + FKN E+++ KL H N+VRL
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 504 LGCCVEQGENV------LIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-IIEGIAQGLLY 556
GE L+ +Y+P +++ ++ ++ + + + L Y
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNM-IPKISDFGLARMFGGDELQSNTKRIVGTYGYMSP 615
+H + HRD+KP N+LLD + + K+ DFG A+ E N I Y Y +P
Sbjct: 172 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 225
Query: 616 EYAIHGF--FSIKSDVFSFGVLLLETLSSK 643
E I G ++ DV+S G +L E L +
Sbjct: 226 E-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 50/228 (21%), Positives = 89/228 (39%), Gaps = 39/228 (17%)
Query: 440 LSMETKTQGKSLASVSAATN----NFGVENKLGEGGFGPVY-----KSGQ---------- 480
+++E + L ++A + + LG G FG V+ + +
Sbjct: 1 MALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKE 60
Query: 481 -----------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL 529
L + EI + ++++H N++++L QG L+ E + LD F
Sbjct: 61 KVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGS-GLDLFA 119
Query: 530 FDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589
F L A I + + YL +IHRD+K NI++ + K+ DFG
Sbjct: 120 FIDRHPRLDEPLAS-YIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFG 175
Query: 590 LARMFGGDELQSNTKRIVGTYGYMSPE-YAIHGFFSIKSDVFSFGVLL 636
A +L GT Y +PE + + + +++S GV L
Sbjct: 176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 42/208 (20%), Positives = 75/208 (36%), Gaps = 57/208 (27%)
Query: 464 ENKLGEGGFGPVYK-----SGQGL--------EEFKNEIKLTAKLQ-HRNLVRLLGCCVE 509
+ LG G G V + +GQ + + E+ + ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYEN 93
Query: 510 QGENV----LIYEYLPNKSLDSFLFDTTKEGLLGWGARI--------------RIIEGIA 551
+I E + L F RI I+ I
Sbjct: 94 MHHGKRCLLIIMECMEGGEL----FS-----------RIQERGDQAFTEREAAEIMRDIG 138
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGGDELQSNTKRIVG 608
+ +LH + HRD+KP N+L + + + K++DFG A+ + LQ+
Sbjct: 139 TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCY 191
Query: 609 TYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
T Y++PE + D++S GV++
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 47/218 (21%), Positives = 77/218 (35%), Gaps = 64/218 (29%)
Query: 464 ENKLGEGGFGPVYK-----SGQ-------------GLEEFKNEIKLTAKLQ-HRNLVRLL 504
E+ LGEG V + Q E+++ + Q HRN++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 505 GCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARI------------RIIEGIA 551
E+ + L++E + S+ I +++ +A
Sbjct: 78 EFF-EEEDRFYLVFEKMRGGSI----LS-----------HIHKRRHFNELEASVVVQDVA 121
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGGDELQSNTKR--- 605
L +LH + HRDLKP NIL + KI DF L + S
Sbjct: 122 SALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 606 --IVGTYGYMSPE-----YAIHGFFSIKSDVFSFGVLL 636
G+ YM+PE + + D++S GV+L
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 53/238 (22%), Positives = 92/238 (38%), Gaps = 50/238 (21%)
Query: 442 METKTQGKSLASVSAATNNFGVENKLGEGGFGPVYK-----SGQG------LEE--FKN- 487
M + + F VE G+G FG V +G +++ F+N
Sbjct: 6 MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR 65
Query: 488 ---EIKLTAKLQHRNLVRLLGCCVEQGEN-------VLIYEYLP---NKSLDSFLFDTTK 534
++ A L H N+V+L GE ++ EY+P ++ ++
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQV- 124
Query: 535 EGLLGWGARIRIIEG------IAQGLLYLHQYSRLRVIHRDLKPSNILLD-SNMIPKISD 587
I + + + LH S + V HRD+KP N+L++ ++ K+ D
Sbjct: 125 --------APPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCD 175
Query: 588 FGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF--FSIKSDVFSFGVLLLETLSSK 643
FG A+ E N I Y Y +PE I G ++ D++S G + E + +
Sbjct: 176 FGSAKKLSPSE--PNVAYICSRY-YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 45/206 (21%), Positives = 74/206 (35%), Gaps = 53/206 (25%)
Query: 463 VENKLGEGGFGPVYK-----SGQ---------GLEEFKNEIK-LTAKLQHRNLVRLLGCC 507
V+ +G G + + + + EI+ L QH N++ L
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY 85
Query: 508 VEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI------------RIIEGIAQGLL 555
+ ++ E + L D +I ++ I + +
Sbjct: 86 DDGKYVYVVTELMKGGEL----LD-----------KILRQKFFSEREASAVLFTITKTVE 130
Query: 556 YLHQYSRLRVIHRDLKPSNILL-----DSNMIPKISDFGLARMFGGDELQSNTKRIVGTY 610
YLH V+HRDLKPSNIL + I +I DFG A+ + T T
Sbjct: 131 YLHA---QGVVHRDLKPSNILYVDESGNPESI-RICDFGFAKQLRAENGLLMT--PCYTA 184
Query: 611 GYMSPEYAIHGFFSIKSDVFSFGVLL 636
+++PE + D++S GVLL
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 57/195 (29%), Positives = 84/195 (43%), Gaps = 36/195 (18%)
Query: 467 LGEGGFGPVY-------------------KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCC 507
LGEG +G V ++ E K EI + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 508 VEQGENVLIYEYLPNKSLDSFLFD--TTKEGLLGWGARI---RIIEGIAQGLLYLHQYSR 562
E L EY L FD G+ A+ +++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE-YAIHG 621
+ + HRD+KP N+LLD KISDFGLA +F + + ++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 622 FFSIKSDVFSFGVLL 636
F + DV+S G++L
Sbjct: 184 FHAEPVDVWSCGIVL 198
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 57/195 (29%), Positives = 84/195 (43%), Gaps = 36/195 (18%)
Query: 467 LGEGGFGPVY-----KSGQG--------------LEEFKNEIKLTAKLQHRNLVRLLGCC 507
LGEG +G V + + E K EI + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 508 VEQGENVLIYEYLPNKSLDSFLFD--TTKEGLLGWGARI---RIIEGIAQGLLYLHQYSR 562
E L EY L FD G+ A+ +++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE-YAIHG 621
+ + HRD+KP N+LLD KISDFGLA +F + + ++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 622 FFSIKSDVFSFGVLL 636
F + DV+S G++L
Sbjct: 184 FHAEPVDVWSCGIVL 198
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 44/209 (21%), Positives = 80/209 (38%), Gaps = 58/209 (27%)
Query: 464 ENKLGEGGFGPVYK-----SGQGL--------EEFKNEIKLTAKLQ-HRNLVRLLGCC-- 507
LG G G V + + + + + E++L + ++VR++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYEN 126
Query: 508 -VEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARI--------------RIIEGIA 551
+ + ++ E L L F RI I++ I
Sbjct: 127 LYAGRKCLLIVMECLDGGEL----FS-----------RIQDRGDQAFTEREASEIMKSIG 171
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMF-GGDELQSNTKRIV 607
+ + YLH + + HRD+KP N+L S N I K++DFG A+ + L +
Sbjct: 172 EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT----PC 224
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLL 636
T Y++PE + D++S GV++
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 50/213 (23%), Positives = 79/213 (37%), Gaps = 51/213 (23%)
Query: 460 NFGVENKLGEGGFGPVY-----KSGQ-------------------GLEEFKNEIKLTAKL 495
+ + LG+GGFG V+ E+ L K+
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 496 ----QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFD------TTKEGLLGWGARIR 545
H ++RLL Q +L+ E P + D LFD EG +R
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGP----SR-C 143
Query: 546 IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIP-KISDFGLARMFGGDELQSNTK 604
+ + + H V+HRD+K NIL+D K+ DFG + +
Sbjct: 144 FFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----T 196
Query: 605 RIVGTYGYMSPEY-AIHGFFSIKSDVFSFGVLL 636
GT Y PE+ + H + ++ + V+S G+LL
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILL 229
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 41/203 (20%)
Query: 467 LGEGGFGPVY--KSGQGLEEF------------KNEIKLT-------AKLQHRNLVRLLG 505
LGEG F V + E+ +N++ ++L H V+L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 506 CCVEQGENVL--IYEYLPNKSLDSFL-----FDTTKEGLLGWGARIRIIEGIAQGLLYLH 558
Q + L Y N L ++ FD T R E I L YLH
Sbjct: 98 TF--QDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-------TRFYTAE-IVSALEYLH 147
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA 618
+IHRDLKP NILL+ +M +I+DFG A++ + Q+ VGT Y+SPE
Sbjct: 148 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204
Query: 619 IHGFFSIKSDVFSFGVLLLETLS 641
SD+++ G ++ + ++
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVA 227
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 54/211 (25%), Positives = 74/211 (35%), Gaps = 49/211 (23%)
Query: 460 NFGVENKLGEGGFGPVY-----KSGQ-------------------GLEEFKNEIKLTAKL 495
+ V LG GGFG VY E+ L K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 496 QHR--NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFD------TTKEGLLGWGARIRII 547
++RLL VLI E P D LFD +E L AR
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEEL----AR-SFF 155
Query: 548 EGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGLARMFGGDELQSNTKRI 606
+ + + + H V+HRD+K NIL+D N K+ DFG +
Sbjct: 156 WQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDF 208
Query: 607 VGTYGYMSPEY-AIHGFFSIKSDVFSFGVLL 636
GT Y PE+ H + + V+S G+LL
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-17
Identities = 65/241 (26%), Positives = 93/241 (38%), Gaps = 36/241 (14%)
Query: 425 PSFSSGGASYYFMHILSMETKTQGKSLASVSAATNNFGVENKLGEGGFGPVY-------- 476
+ S ++ + Q K L N F LG+GGFG V
Sbjct: 150 HEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATG 209
Query: 477 -------------KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV-LIYEYLPN 522
K +G NE ++ K+ R +V L E + + L+ +
Sbjct: 210 KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNG 268
Query: 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI 582
L ++ + G A E I GL LH R R+++RDLKP NILLD +
Sbjct: 269 GDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RERIVYRDLKPENILLDDHGH 324
Query: 583 PKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE---YAIHGFFSIKSDVFSFGVLLLET 639
+ISD GLA + K VGT GYM+PE + F D ++ G LL E
Sbjct: 325 IRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTF---SPDWWALGCLLYEM 378
Query: 640 L 640
+
Sbjct: 379 I 379
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 25/199 (12%), Positives = 50/199 (25%), Gaps = 58/199 (29%)
Query: 463 VENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+ G ++ L+E + +++ +
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
R+L + +++ E++ SL GA IR ++ +A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA-IRAMQSLAAAADAAH--- 146
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG 621
R V PS + +S G + M
Sbjct: 147 RAGVALSIDHPSRVR--------VSIDGDVV--------------LAYPATMPDA----- 179
Query: 622 FFSIKSDVFSFGVLLLETL 640
+ + D+ G L L
Sbjct: 180 --NPQDDIRGIGASLYALL 196
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 33/193 (17%)
Query: 467 LGEGGFGPVY---------------------KSGQGLEEFKNEIKLTAKLQHRNLVRLLG 505
LG G FG V +S + + K EI+ +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFD-TTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLR 564
+ ++ EY+ L FD K G + R+ + I + Y H R
Sbjct: 79 VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCH---RHM 131
Query: 565 VIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE-YAIHGFF 623
V+HRDLKP N+LLD++M KI+DFGL+ M E + G+ Y +PE + +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGRLYA 188
Query: 624 SIKSDVFSFGVLL 636
+ D++S GV+L
Sbjct: 189 GPEVDIWSCGVIL 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 36/92 (39%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
+A+G+ +L + + IHRDL NILL + KI DFGLAR D
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641
+M+PE ++I+SDV+SFGVLL E S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 29/160 (18%), Positives = 52/160 (32%), Gaps = 36/160 (22%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAK 494
+ + LG G FG V + + +E+K+
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 495 L-QHRNLVRLLGCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQ 552
+ H N+V LLG C + G + +I E+ +L ++L R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592
G + + I DLK + S+ S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 8e-17
Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 33/193 (17%)
Query: 467 LGEGGFGPVY---------------------KSGQGLEEFKNEIKLTAKLQHRNLVRLLG 505
LG G FG V +S + + + EI+ +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFD-TTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLR 564
+ ++ EY+ L FD K G L R+ + I G+ Y H R
Sbjct: 84 VISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCH---RHM 136
Query: 565 VIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE-YAIHGFF 623
V+HRDLKP N+LLD++M KI+DFGL+ M E + G+ Y +PE + +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGRLYA 193
Query: 624 SIKSDVFSFGVLL 636
+ D++S GV+L
Sbjct: 194 GPEVDIWSSGVIL 206
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 38/92 (41%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I GL ++H V++RDLKP+NILLD + +ISD GLA F + VGT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353
Query: 610 YGYMSPEYAIHGFFSIKS-DVFSFGVLLLETL 640
+GYM+PE G S D FS G +L + L
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 63/239 (26%), Positives = 93/239 (38%), Gaps = 51/239 (21%)
Query: 436 FMHILSMETKTQGKSLASVSAATNNFGVENKLGEGGFGPVY------------------- 476
F+ L Q K L + + F LG GGFG V+
Sbjct: 162 FLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKK 221
Query: 477 --KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV-LIYEY---------LPNKS 524
K +G + E K+ AK+ R +V L E ++ L+ + N
Sbjct: 222 RLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVD 280
Query: 525 LDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPK 584
D+ F + A + I GL +LHQ +I+RDLKP N+LLD + +
Sbjct: 281 EDNPGFQEPR-------AIFYTAQ-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVR 329
Query: 585 ISDFGLARMFGGDELQSNTKRIVGTYGYMSPE---YAIHGFFSIKSDVFSFGVLLLETL 640
ISD GLA + ++ GT G+M+PE + F D F+ GV L E +
Sbjct: 330 ISDLGLAVELKAGQTKTKG--YAGTPGFMAPELLLGEEYDF---SVDYFALGVTLYEMI 383
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 50/193 (25%), Positives = 81/193 (41%), Gaps = 34/193 (17%)
Query: 467 LGEGGFGPVY---------------------KSGQGLEEFKNEIKLTAKLQHRNLVRLLG 505
LGEG FG V K + EI L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 506 CCVEQGENVLIYEYLPNKSLDSFLFD-TTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLR 564
+ V++ EY + LFD ++ + R + I + Y H R +
Sbjct: 77 VITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RHK 128
Query: 565 VIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE-YAIHGFF 623
++HRDLKP N+LLD N+ KI+DFGL+ + + G+ Y +PE +
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEVINGKLYA 185
Query: 624 SIKSDVFSFGVLL 636
+ DV+S G++L
Sbjct: 186 GPEVDVWSCGIVL 198
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 45/216 (20%), Positives = 84/216 (38%), Gaps = 50/216 (23%)
Query: 458 TNNFGVENKLGEGGFGPVY-----KSGQ----------GLEEFKNEIKLTAKLQ-HRNLV 501
+++ + KLG G + V+ + + ++ K EIK+ L+ N++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 94
Query: 502 RLLGCCVEQGEN--VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIR-IIEGIAQGLLYLH 558
L + L++E++ N T IR + I + L Y H
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY-------DIRFYMYEILKALDYCH 147
Query: 559 QYSRLRVIHRDLKPSNILLDS-NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE- 616
S ++HRD+KP N+++D + ++ D+GLA Q R+ Y + PE
Sbjct: 148 --SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGPEL 201
Query: 617 --------YAIHGFFSIKSDVFSFGVLLLETLSSKR 644
Y++ D++S G +L + K
Sbjct: 202 LVDYQMYDYSL--------DMWSLGCMLASMIFRKE 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 49/192 (25%), Positives = 73/192 (38%), Gaps = 33/192 (17%)
Query: 467 LGEGGFGPVY-----------------KSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509
+G G FG + E + EI L+H N+VR +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 510 QGENVLIYEYLPNKSLDSFLFD--TTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIH 567
+I EY L++ AR + + G+ Y H +++ H
Sbjct: 88 PTHLAIIMEYASGGE----LYERICNAGRFSEDEAR-FFFQQLLSGVSYCH---SMQICH 139
Query: 568 RDLKPSNILLDSNMIP--KISDFGLARMFGGDELQSNTKRIVGTYGYMSPE-YAIHGFFS 624
RDLK N LLD + P KI DFG ++ +T VGT Y++PE +
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRQEYDG 196
Query: 625 IKSDVFSFGVLL 636
+DV+S GV L
Sbjct: 197 KIADVWSCGVTL 208
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 8e-16
Identities = 42/241 (17%), Positives = 84/241 (34%), Gaps = 62/241 (25%)
Query: 458 TNNFGVENKLGEGGFGPVYK-----SGQGL--------EEFKN-EIKLTAKLQHRNLVRL 503
+ + + LG G FG V + SG+ +KN E+ + L H N+++L
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKL 65
Query: 504 LGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI------------------- 544
+ G+ P+ +
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH 125
Query: 545 RIIEG-------------------IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM-IPK 584
++++ + + + ++H L + HRD+KP N+L++S K
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLK 182
Query: 585 ISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF--FSIKSDVFSFGVLLLETLSS 642
+ DFG A+ + + I + Y +PE + G ++ D++S G + E +
Sbjct: 183 LCDFGSAKKL--IPSEPSVAYICSRF-YRAPEL-MLGATEYTPSIDLWSIGCVFGELILG 238
Query: 643 K 643
K
Sbjct: 239 K 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 41/223 (18%), Positives = 81/223 (36%), Gaps = 66/223 (29%)
Query: 443 ETKTQGKSLASVSAATNNFGVENK------LGEGGFGPVYK-----SGQGL------EEF 485
+ K AS+ +++ + ++ +G G +G V + + + F
Sbjct: 31 KQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF 90
Query: 486 KN---------EIKLTAKLQHRNLVRLLG-CCVEQGENV----LIYEYLP---NKSLDS- 527
++ EI + +L H ++V++L + E ++ E K +
Sbjct: 91 EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP 150
Query: 528 ----------FLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL 577
L++ + G+ Y+H S ++HRDLKP+N L+
Sbjct: 151 VYLTELHIKTLLYN------------------LLVGVKYVH--SA-GILHRDLKPANCLV 189
Query: 578 DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH 620
+ + K+ DFGLAR E ++ I M+ H
Sbjct: 190 NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 15/101 (14%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
+ L YL R+IHRD+KP NILLD + I+DF +A M + + GT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177
Query: 610 YGYMSPE------YAIHGFFSIKSDVFSFGVLLLETLSSKR 644
YM+PE A + F++ D +S GV E L +R
Sbjct: 178 KPYMAPEMFSSRKGAGYS-FAV--DWWSLGVTAYELLRGRR 215
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 34/170 (20%)
Query: 488 EIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSF--------LFDTT-----K 534
E+ L + H+N++ LL NV P KSL+ F L D +
Sbjct: 74 ELVLMKCVNHKNIIGLL--------NVFT----PQKSLEEFQDVYIVMELMDANLCQVIQ 121
Query: 535 EGLLGWGARIR-IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593
L R+ ++ + G+ +LH +IHRDLKPSNI++ S+ KI DFGLAR
Sbjct: 122 MEL--DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
G + + V T Y +PE + + D++S G ++ E +
Sbjct: 177 AGTSFMMTPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 34/170 (20%)
Query: 488 EIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSF--------LFDT-----TK 534
E+ L + H+N++ LL NV P K+L+ F L D +
Sbjct: 111 ELVLMKCVNHKNIISLL--------NVFT----PQKTLEEFQDVYLVMELMDANLCQVIQ 158
Query: 535 EGLLGWGARIR-IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593
L R+ ++ + G+ +LH +IHRDLKPSNI++ S+ KI DFGLAR
Sbjct: 159 MEL--DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
Query: 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
G + + V T Y +PE + + D++S G ++ E + K
Sbjct: 214 AGTSFMMTPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 50/218 (22%), Positives = 84/218 (38%), Gaps = 52/218 (23%)
Query: 459 NNFGVENKLGEGGFGPVY----KSGQGL-----------------EEFKNEIKLTAKLQH 497
+F + +G G FG V K+ + F+ E +
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 498 RNLVRLLGCCVEQGENV-LIYEYLP--------NKSLDSFLFDTTKEGLLGWGARIRIIE 548
+ + L + N+ L+ +Y +K D + AR + E
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM---------ARFYLAE 183
Query: 549 GIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA-RMFGGDELQSNTKRIV 607
+ + +HQ L +HRD+KP NIL+D N +++DFG ++ +QS+ V
Sbjct: 184 -MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AV 237
Query: 608 GTYGYMSPE-----YAIHGFFSIKSDVFSFGVLLLETL 640
GT Y+SPE G + + D +S GV + E L
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 14/107 (13%)
Query: 542 ARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA-RMFGGDELQ 600
AR + E I + +H+ L +HRD+KP NILLD +++DFG ++ ++
Sbjct: 164 ARFYLAE-IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219
Query: 601 SNTKRIVGTYGYMSPE-------YAIHGFFSIKSDVFSFGVLLLETL 640
S VGT Y+SPE G + + D ++ GV E
Sbjct: 220 SLV--AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 37/171 (21%)
Query: 488 EIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSF--------LFDTT-----K 534
E+ L +QH N++ LL +V P SL +F T
Sbjct: 73 ELLLLKHMQHENVIGLL--------DVFT----PASSLRNFYDFYLVMPFMQTDLQKIMG 120
Query: 535 EGLLGWGARIR-IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593
+I+ ++ + +GL Y+H V+HRDLKP N+ ++ + KI DFGLAR
Sbjct: 121 LKFSE--EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 175
Query: 594 FGGDELQSNTKRIVGTYGYMSPEYAI-HGFFSIKSDVFSFGVLLLETLSSK 643
+ V T Y +PE + ++ D++S G ++ E L+ K
Sbjct: 176 ADAEMTGY-----VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 34/170 (20%)
Query: 488 EIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSF--------LFDTT-----K 534
E++L ++H N++ LL +V P+++LD F T K
Sbjct: 74 ELRLLKHMRHENVIGLL--------DVFT----PDETLDDFTDFYLVMPFMGTDLGKLMK 121
Query: 535 EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594
LG ++ + +GL Y+H +IHRDLKP N+ ++ + KI DFGLAR
Sbjct: 122 HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178
Query: 595 GGDELQSNTKRIVGTYGYMSPEYAI-HGFFSIKSDVFSFGVLLLETLSSK 643
S V T Y +PE + ++ D++S G ++ E ++ K
Sbjct: 179 -----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 47/214 (21%)
Query: 459 NNFGVENKLGEGGFGPVY----KSGQGL-----------------EEFKNEIKLTAKLQH 497
++ V +G G FG V KS + + F E + A
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 498 RNLVRLLGCCVEQGENVL--IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLL 555
+V+L Q + L + EY+P L + + + + AR E + L
Sbjct: 129 PWVVQLFYAF--QDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAE-VVLALD 182
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA-RMFGGDELQSNTKRIVGTYGYMS 614
+H + IHRD+KP N+LLD + K++DFG +M ++ +T VGT Y+S
Sbjct: 183 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVGTPDYIS 237
Query: 615 PE-------YAIHGFFSIKS-DVFSFGVLLLETL 640
PE +G + D +S GV L E L
Sbjct: 238 PEVLKSQGGDGYYG----RECDWWSVGVFLYEML 267
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 52/179 (29%)
Query: 488 EIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSF--------LFDTTKEGLLG 539
E++L ++H N++ LL +V P +SL+ F L L
Sbjct: 78 ELRLLKHMKHENVIGLL--------DVFT----PARSLEEFNDVYLVTHLMGAD----LN 121
Query: 540 WGARIRIIEG--------------IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKI 585
I++ I +GL Y+H +IHRDLKPSN+ ++ + KI
Sbjct: 122 -----NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 173
Query: 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI-HGFFSIKSDVFSFGVLLLETLSSK 643
DFGLAR + V T Y +PE + ++ D++S G ++ E L+ +
Sbjct: 174 LDFGLARHTADEMTGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 19/70 (27%), Positives = 31/70 (44%), Gaps = 3/70 (4%)
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
G ++H +IHRDLKP+N LL+ + K+ DFGLAR ++ + +
Sbjct: 141 GENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 613 MSPEYAIHGF 622
+
Sbjct: 198 GPHNKNLKKQ 207
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 50/201 (24%), Positives = 80/201 (39%), Gaps = 69/201 (34%)
Query: 458 TNNFGVENKLGEGGFGPVYK-----SGQG-----LEEFKN---------EIKLTAKLQHR 498
+++F +++ LGEG +G V +G+ +E F EIK+ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSF--------LFDTTKEGLLGWGARIRIIEG- 549
N++ + N+ S ++F L T L R+I
Sbjct: 70 NIITIF--------NIQ-----RPDSFENFNEVYIIQELMQTD----LH-----RVISTQ 107
Query: 550 -------------IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596
+ + LH + VIHRDLKPSN+L++SN K+ DFGLAR+
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII-- 162
Query: 597 DELQSNTKRIVGTYGYMSPEY 617
DE ++ G M E+
Sbjct: 163 DESAADNSEPTGQQSGMV-EF 182
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 38/95 (40%), Positives = 53/95 (55%), Gaps = 13/95 (13%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
+A L +LH L +I+RDLKP NILLD K++DFGL++ E ++ + GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 610 YGYMSPE---YAIHGFFSIKS-DVFSFGVLLLETL 640
YM+PE H +S D +SFGVL+ E L
Sbjct: 190 VEYMAPEVVNRRGHT----QSADWWSFGVLMFEML 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 36/156 (23%), Positives = 66/156 (42%), Gaps = 43/156 (27%)
Query: 466 KLGEGGFGPVYK-----SGQGL--------EEFKNEIKLTAKL-QHRNLVRLLGCC---V 508
LG G G V + + + + + E++L + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY 84
Query: 509 EQGENV-LIYEYLP---------NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH 558
+ + ++ E L ++ +F T +E A I++ I + + YLH
Sbjct: 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAF---TERE------AS-EIMKSIGEAIQYLH 134
Query: 559 QYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLA 591
+ + HRD+KP N+L S N I K++DFG A
Sbjct: 135 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I L YLH S V++RDLK N++LD + KI+DFGL + D T GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 312
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETL 640
Y++PE + D + GV++ E +
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 4e-12
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I+ L +LHQ +I+RDLKP NI+L+ K++DFGL + D ++T GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 610 YGYMSPE---YAIHGFFSIKS-DVFSFGVLLLETL 640
YM+PE + H ++ D +S G L+ + L
Sbjct: 185 IEYMAPEILMRSGHN----RAVDWWSLGALMYDML 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 43/170 (25%), Positives = 66/170 (38%), Gaps = 31/170 (18%)
Query: 488 EIKLTAKLQHRNLVRLLGC-CVEQGENV----LIYEYLPN------KSLDSFLFDTTKEG 536
EI+L H N++ L + + L+ E + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP----- 133
Query: 537 LLGWGARIR-IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595
I+ + I GL LH+ V+HRDL P NILL N I DF LAR
Sbjct: 134 -----QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 596 GDELQSNTKRIVGTYGYMSPEYAIHGF--FSIKSDVFSFGVLLLETLSSK 643
D +++ V Y +PE + F F+ D++S G ++ E + K
Sbjct: 186 ADANKTHY---VTHRWYRAPE-LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 68/229 (29%)
Query: 458 TNNFGVENKLGEGGFGPVYK-----SGQG-----LEEFKN---------EIKLTAKLQHR 498
+ + +GEG +G V + + F++ EIK+ + +H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSF--------LFDTTKEGLLGWG----ARIR- 545
N++ + +++ +++ L +T LL I
Sbjct: 86 NIIGIN--------DII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 132
Query: 546 IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN--T 603
+ I +GL Y+H S V+HRDLKPSN+LL++ KI DFGLAR+ D + T
Sbjct: 133 FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 604 KRIVGTYGYMSPE-------Y--AIHGFFSIKSDVFSFGVLLLETLSSK 643
+ V T Y +PE Y +I D++S G +L E LS++
Sbjct: 190 EY-VATRWYRAPEIMLNSKGYTKSI--------DIWSVGCILAEMLSNR 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 17/97 (17%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
I L YLH V++RD+K N++LD + KI+DFGL + + G K
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFC 166
Query: 608 GTYGYMSPE---YAIHGFFSIKS-DVFSFGVLLLETL 640
GT Y++PE +G ++ D + GV++ E +
Sbjct: 167 GTPEYLAPEVLEDNDYG----RAVDWWGLGVVMYEMM 199
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 15/97 (15%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
I+ L YLH+ +I+RDLK N+LLDS K++D+G+ + + GD T
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFC 171
Query: 608 GTYGYMSPE---YAIHGFFSIKSDVFSFGVLLLETLS 641
GT Y++PE +G FS+ D ++ GVL+ E ++
Sbjct: 172 GTPNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMA 205
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-12
Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 17/97 (17%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
IA GL +L +I+RDLK N++LDS KI+DFG+ + ++ G TK
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFC 182
Query: 608 GTYGYMSPE---YAIHGFFSIKS-DVFSFGVLLLETL 640
GT Y++PE Y +G KS D ++FGVLL E L
Sbjct: 183 GTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEML 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-12
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 17/97 (17%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA--RMFGGDELQSNTKRIV 607
I L++LH +I+RDLK N+LLD K++DFG+ + G T
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFC 185
Query: 608 GTYGYMSPE---YAIHGFFSIKS-DVFSFGVLLLETL 640
GT Y++PE ++G + D ++ GVLL E L
Sbjct: 186 GTPDYIAPEILQEMLYG----PAVDWWAMGVLLYEML 218
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 22/64 (34%), Positives = 35/64 (54%), Gaps = 3/64 (4%)
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
+ YLH S ++HRD+KPSNILL++ K++DFGL+R F +N +
Sbjct: 121 VIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 613 MSPE 616
+ +
Sbjct: 178 ENFD 181
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 50/214 (23%), Positives = 82/214 (38%), Gaps = 52/214 (24%)
Query: 459 NNFGVENKLGEGGFGPVY----------------------KSGQGLEEFKNEIKLTAKLQ 496
+ F LG G FG V K Q +E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 497 HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL-----FDTTKEGLLGWGARIRIIEGIA 551
LV+L + ++ EY+ + S L F AR + I
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-------ARFYAAQ-IV 151
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG 611
YLH +I+RDLKP N+L+D +++DFG A+ ++ T + GT
Sbjct: 152 LTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPE 203
Query: 612 YMSPEYAI---HGFFSIKS-DVFSFGVLLLETLS 641
++PE + + K+ D ++ GVL+ E +
Sbjct: 204 ALAPEIILSKGYN----KAVDWWALGVLIYEMAA 233
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 15/97 (15%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
I+ L YLH+ +I+RDLK N+LLDS K++D+G+ + + GD T
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFC 214
Query: 608 GTYGYMSPE---YAIHGFFSIKSDVFSFGVLLLETLS 641
GT Y++PE +G FS+ D ++ GVL+ E ++
Sbjct: 215 GTPNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMA 248
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 17/97 (17%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
IA L YLH L +++RDLKP NILLDS ++DFGL + + T
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFC 200
Query: 608 GTYGYMSPE---YAIHGFFSIKS-DVFSFGVLLLETL 640
GT Y++PE + ++ D + G +L E L
Sbjct: 201 GTPEYLAPEVLHKQPYD----RTVDWWCLGAVLYEML 233
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 37/97 (38%), Positives = 49/97 (50%), Gaps = 17/97 (17%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
I GL +LH +++RDLK NILLD + KI+DFG+ + M G T
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFC 179
Query: 608 GTYGYMSPE---YAIHGFFSIKS-DVFSFGVLLLETL 640
GT Y++PE + S D +SFGVLL E L
Sbjct: 180 GTPDYIAPEILLGQKYN----HSVDWWSFGVLLYEML 212
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 15/96 (15%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR--MFGGDELQSNTKRIV 607
IA GL +L +I+RDLK N++LDS KI+DFG+ + ++ G TK
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFC 503
Query: 608 GTYGYMSPE---YAIHGFFSIKSDVFSFGVLLLETL 640
GT Y++PE Y +G S+ D ++FGVLL E L
Sbjct: 504 GTPDYIAPEIIAYQPYG-KSV--DWWAFGVLLYEML 536
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
I L +LH+ L +I+RD+K NILLDSN ++DFGL++ F DE + GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
Query: 610 YGYMSPE---YAIHGFFSIKS-DVFSFGVLLLETL 640
YM+P+ G K+ D +S GVL+ E L
Sbjct: 224 IEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELL 256
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 45/181 (24%), Positives = 85/181 (46%), Gaps = 41/181 (22%)
Query: 488 EIKLTAKLQHRNLVRLL-------------GCCVEQGENV-LIYEYLPNKSLDSFLFDTT 533
EIK+ +L H N+V++ + + +V ++ EY+ ++ L +
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVL 112
Query: 534 KEGLLGWGARIR-IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS-NMIPKISDFGLA 591
++G L R + + +GL Y+H + V+HRDLKP+N+ +++ +++ KI DFGLA
Sbjct: 113 EQGPLL-EEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLA 168
Query: 592 RMFGGDELQSN--TKRIVGTYGYMSPE-------YAIHGFFSIKSDVFSFGVLLLETLSS 642
R+ ++ +V T Y SP Y + D+++ G + E L+
Sbjct: 169 RIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTG 221
Query: 643 K 643
K
Sbjct: 222 K 222
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 37/98 (37%), Positives = 52/98 (53%), Gaps = 20/98 (20%)
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
+ L YLH +I+RDLKP NILLD N KI+DFG A+ + T + GT
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 166
Query: 610 YGYMSPEYAI-----HGFFSIKS-DVFSFGVLLLETLS 641
Y++PE + + KS D +SFG+L+ E L+
Sbjct: 167 PDYIAPE--VVSTKPYN----KSIDWWSFGILIYEMLA 198
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 48/218 (22%), Positives = 89/218 (40%), Gaps = 55/218 (25%)
Query: 463 VENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQ--------- 496
+ KLG G F V+ E ++EIKL ++
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 497 --HRNLVRLLGCCVEQGEN----VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGI 550
++++LL +G N V+++E L ++L + + G+ + ++ I
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI-----PLIYVKQI 136
Query: 551 AQ----GLLYLHQYSRLRVIHRDLKPSNILLDSNMIP------KISDFGLARMFGGDELQ 600
++ GL Y+H R +IH D+KP N+L++ P KI+D G A + +
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHYT 193
Query: 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLE 638
+ + T Y SPE + + +D++S L+ E
Sbjct: 194 N----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 4e-10
Identities = 18/83 (21%), Positives = 36/83 (43%), Gaps = 10/83 (12%)
Query: 71 PDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGN 130
T VW +N + + ++GN V+ + ++W+S++ R N V L + GN
Sbjct: 36 HSTSVWASNTGILG-KKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGN 94
Query: 131 LIVRDNFSRSASEGSCLWQSFDY 153
+++ S +W + Y
Sbjct: 95 VVIYG---------SDIWSTGTY 108
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-06
Identities = 18/73 (24%), Positives = 29/73 (39%), Gaps = 8/73 (10%)
Query: 79 NRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPV-AQLLDTGNLIVRDNF 137
+ + + NLV+ + + ++W+SNT + A L GN +V D
Sbjct: 11 YAGQSLDVEPYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA- 68
Query: 138 SRSASEGSCLWQS 150
EG LW S
Sbjct: 69 -----EGRSLWAS 76
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 7e-10
Identities = 31/198 (15%), Positives = 51/198 (25%), Gaps = 61/198 (30%)
Query: 457 ATNNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLT 492
T K+GEG FG V++ + EE EI ++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 493 AKLQ---------HRNLVRLLGCCVEQG-------------------ENVLIYEYLPNKS 524
+L + L QG N + ++
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 525 LDSFLFDTTKEGLLGWGARIR-------IIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL 577
F+ L ++ I+ + L LR HRDL N+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLL 195
Query: 578 DSNMIPKISDFGLARMFG 595
+ K+ +
Sbjct: 196 KKTSLKKLHYTLNGKSST 213
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 1e-09
Identities = 25/125 (20%), Positives = 47/125 (37%), Gaps = 21/125 (16%)
Query: 26 DTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPII 85
++++ + + G + + L + Y VW +N
Sbjct: 2 NSLSS-PNSLFTGH-SLEVGPSYRLIMQGDCNF------VLYDS--GKPVWASNTGGL-- 49
Query: 86 EPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGS 145
LT+ NNGNLVI + +N IW + T+ K ++ V L N+++ G
Sbjct: 50 GSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIY---------GP 100
Query: 146 CLWQS 150
+W +
Sbjct: 101 VVWAT 105
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-09
Identities = 16/79 (20%), Positives = 29/79 (36%), Gaps = 11/79 (13%)
Query: 72 DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNL 131
+ +W N + +G LV++ N +W S + KA + V L N+
Sbjct: 48 NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNV 105
Query: 132 IVRDNFSRSASEGSCLWQS 150
++ G LW +
Sbjct: 106 VIY---------GDALWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-07
Identities = 19/89 (21%), Positives = 30/89 (33%), Gaps = 7/89 (7%)
Query: 62 YLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENP 121
+ P + + + + NLV+ + N IW++NT
Sbjct: 5 FSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYD-NNNPIWATNTGGLGNGC 63
Query: 122 VAQLLDTGNLIVRDNFSRSASEGSCLWQS 150
A L G L+V N E +WQS
Sbjct: 64 RAVLQPDGVLVVITN------ENVTVWQS 86
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 43/211 (20%)
Query: 458 TNNFGVENKLGEGGFGPVYK-----SGQGL--------EEF----KNEIKLTAKLQHR-- 498
+ + +++ +G+G FG V K + + + F + E++L +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 499 ----NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQ-- 552
+V L + + L++E L + +L L +T G+ + + AQ
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGV-----SLNLTRKFAQQM 166
Query: 553 --GLLYLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGGDELQSNTKRIV 607
LL+L L +IH DLKP NILL + I KI DFG + G + +
Sbjct: 167 CTALLFLAT-PELSIIHCDLKPENILLCNPKRSAI-KIVDFGSS-CQLGQRIYQ----YI 219
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLE 638
+ Y SPE + + + D++S G +L+E
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 52/188 (27%), Positives = 76/188 (40%), Gaps = 45/188 (23%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQG----LEEFKN-------EIKLTAKLQH-RNLV 501
N + + K+G G FG +Y +G+ LE K E K+ +Q +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFD------TTKEGLLGWGARIRIIEGIAQGLL 555
+ C E NV++ E L SL+ LF+ + K LL I IE
Sbjct: 69 TIRWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKFSLKTVLLLADQMISRIE------- 119
Query: 556 YLHQYSRLRVIHRDLKPSNILL----DSNMIPKISDFGLARMFGGDE-----LQSNTKRI 606
Y+H + IHRD+KP N L+ N++ I DFGLA+ + K +
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYRENKNL 175
Query: 607 VGTYGYMS 614
GT Y S
Sbjct: 176 TGTARYAS 183
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 31/200 (15%), Positives = 65/200 (32%), Gaps = 49/200 (24%)
Query: 459 NNFGVENKLGEGGFGPVY-------------------------KSGQGLEEFK------- 486
+ +++ G +Y K G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 487 -NEIKLTAKLQHRNLV---RLLGCCVEQGE-NVLIYEYLPNKSLDSFLFDTTKEGLLGWG 541
++ KL L+ +G V Q + L+ L +SL S D + + +L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSER 159
Query: 542 ARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKI--SDFGLARMF---GG 596
+ +++ + L +LH+ +H ++ NI +D ++ + +G A + G
Sbjct: 160 SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 597 DELQSNTKR--IVGTYGYMS 614
R G ++S
Sbjct: 217 HVAYVEGSRSPHEGDLEFIS 236
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 40/190 (21%), Positives = 75/190 (39%), Gaps = 47/190 (24%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQG----LEEFKN-------EIKLTAKLQH-RNLV 501
++ V ++GEG FG +++ + Q E ++ E + L +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFD------TTKEGLLGWGARIRIIEGIAQGLL 555
+ E NVL+ + L SL+ L D + K + + ++
Sbjct: 70 NVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCGRKFSVKTVAMAAKQMLARVQ------- 120
Query: 556 YLHQYSRLRVIHRDLKPSNILL------DSNMIPKISDFGLARMFGGDE-----LQSNTK 604
+H+ S +++RD+KP N L+ ++NMI + DFG+ + + K
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVKFYRDPVTKQHIPYREKK 176
Query: 605 RIVGTYGYMS 614
+ GT YMS
Sbjct: 177 NLSGTARYMS 186
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 2e-08
Identities = 25/126 (19%), Positives = 48/126 (38%), Gaps = 20/126 (15%)
Query: 25 ADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPI 84
+D + + G + + L ++ + VW + N
Sbjct: 1 SDRLNSGHQ-LDTGGSLAE--GGYLFIIQNDCN-----LVLYDN---NRAVWASGTNGKA 49
Query: 85 IEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEG 144
L + N+GNLVI + + AIW+SNT+R+ N L N+++ D +
Sbjct: 50 --SGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYD------NSN 100
Query: 145 SCLWQS 150
+ +W +
Sbjct: 101 NAIWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-05
Identities = 13/46 (28%), Positives = 24/46 (52%), Gaps = 2/46 (4%)
Query: 71 PDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSR 116
+W +N N N L + + N+VI + +N AIW+++T+
Sbjct: 67 GSRAIWASNTNRQ--NGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 3e-08
Identities = 20/79 (25%), Positives = 35/79 (44%), Gaps = 11/79 (13%)
Query: 72 DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNL 131
D +W N + L++ ++GNLV+ + N IW+SNT + N V L N+
Sbjct: 37 DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNV 94
Query: 132 IVRDNFSRSASEGSCLWQS 150
++ G+ W +
Sbjct: 95 VIY---------GTARWAT 104
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-05
Identities = 13/63 (20%), Positives = 24/63 (38%), Gaps = 7/63 (11%)
Query: 88 NAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCL 147
+ + NLV+ + + IW++NT + GNL+V + +
Sbjct: 20 RYVFIMQEDCNLVLYD-VDKPIWATNTGGLDRRCHLSMQSDGNLVVYSP------RNNPI 72
Query: 148 WQS 150
W S
Sbjct: 73 WAS 75
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 50/193 (25%), Positives = 73/193 (37%), Gaps = 53/193 (27%)
Query: 459 NNFGVENKLGEGGFGPVYKSGQGLEEFKNE---IKL-TAKLQHRNLV------------- 501
NF V K+G G FG + G + NE IKL K + L
Sbjct: 9 PNFRVGKKIGCGNFGELR---LGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 502 ---RLLGCCVEQGENVLIYEYLPNKSLDSFLFD------TTKEGLLGWGARIRIIEGIAQ 552
++ N ++ E L SL+ LFD + K L+ I +E
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRTFSLKTVLMIAIQLISRME---- 119
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILL------DSNMIPKISDFGLARMFGGDELQS----- 601
Y+H + +I+RD+KP N L+ +I I DF LA+ + E +
Sbjct: 120 ---YVHSKN---LIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAKEYIDPETKKHIPYR 172
Query: 602 NTKRIVGTYGYMS 614
K + GT YMS
Sbjct: 173 EHKSLTGTARYMS 185
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 45/206 (21%), Positives = 82/206 (39%), Gaps = 45/206 (21%)
Query: 463 VENKLGEGGFGPVYK-----SGQG------------LEEFKNEIKLTAKLQHR------N 499
V +G+G FG V K Q + EI++ L+ + N
Sbjct: 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQ----GLL 555
++ +L + + +E L + +L + +G + ++ A L
Sbjct: 161 VIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGF-----SLPLVRKFAHSILQCLD 214
Query: 556 YLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
LH + R+IH DLKP NILL + I K+ DFG + + + + + + Y
Sbjct: 215 ALH---KNRIIHCDLKPENILLKQQGRSGI-KVIDFGSS-CYEHQRVYT----YIQSRFY 265
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLE 638
+PE + + + D++S G +L E
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAE 291
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 56/256 (21%), Positives = 90/256 (35%), Gaps = 44/256 (17%)
Query: 458 TNNFGVENKLGEGGFGP----------------VYKSGQ-GLEEFKNEIKLTAKLQ---- 496
+ V KLG G F V KS + E +EI+L ++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDP 95
Query: 497 ----HRNLVRLLGCCVEQGEN----VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIE 548
+V+LL G N +++E L L ++ + +GL + +II+
Sbjct: 96 NDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK-KIIQ 153
Query: 549 GIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVG 608
+ QGL YLH ++ R+IH D+KP NILL N A + + V
Sbjct: 154 QVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 609 TYGYMSPEYAIHGFFSIKSDVFS--FGVLLLETLSSKRSTRFFNTNSL----TLLGHAWN 662
T + + ++ ++ L K T T L+G +N
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYN 271
Query: 663 LWKDDRS-----WELM 673
D S +EL
Sbjct: 272 TPADIWSTACMAFELA 287
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 50/188 (26%), Positives = 75/188 (39%), Gaps = 45/188 (23%)
Query: 459 NNFGVENKLGEGGFGPVYK-----SGQG----LEEFKN-------EIKLTAKLQHRNLV- 501
N F + K+G G FG +Y + + LE K E K+ LQ +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFD------TTKEGLLGWGARIRIIEGIAQGLL 555
+ VE NVL+ + L SL+ LF+ + K L+ I +E
Sbjct: 67 NVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVE------- 117
Query: 556 YLHQYSRLRVIHRDLKPSNILL----DSNMIPKISDFGLARMFGGDELQS-----NTKRI 606
++H S +HRD+KP N L+ +N + I DFGLA+ + K +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYII-DFGLAKKYRDTSTHQHIPYRENKNL 173
Query: 607 VGTYGYMS 614
GT Y S
Sbjct: 174 TGTARYAS 181
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 9e-08
Identities = 16/79 (20%), Positives = 26/79 (32%), Gaps = 11/79 (13%)
Query: 72 DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNL 131
+W +N + LT+ ++GNLVI + N +W S L G
Sbjct: 38 GRQIWASNTDRR--GSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRF 95
Query: 132 IVRDNFSRSASEGSCLWQS 150
++ LW
Sbjct: 96 VIYGPV---------LWSL 105
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-05
Identities = 21/75 (28%), Positives = 32/75 (42%), Gaps = 1/75 (1%)
Query: 79 NRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFS 138
+ + + LTI N NLV IW+SNT R+ LL GNL++ D+ +
Sbjct: 12 HADHSLQAGAYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNN 70
Query: 139 RSASEGSCLWQSFDY 153
+C + Y
Sbjct: 71 NDVWGSACWGDNGKY 85
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-07
Identities = 17/72 (23%), Positives = 28/72 (38%), Gaps = 8/72 (11%)
Query: 79 NRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFS 138
+ + N L + + NLV+ W SNT E+ +L G LI++D
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYG--GKYGWQSNTHGNGEHCFLRLNHKGELIIKD--- 70
Query: 139 RSASEGSCLWQS 150
+ +W S
Sbjct: 71 ---DDFKTIWSS 79
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 5e-07
Identities = 16/63 (25%), Positives = 27/63 (42%), Gaps = 2/63 (3%)
Query: 71 PDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGN 130
W +N + + L +++ G L+I + IWSS +S K V L D G
Sbjct: 40 GGKYGWQSNTHGN--GEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGF 97
Query: 131 LIV 133
++
Sbjct: 98 GVI 100
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-07
Identities = 15/86 (17%), Positives = 32/86 (37%), Gaps = 11/86 (12%)
Query: 65 IWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQ 124
+ K +VW + + + + + ++G L I + ++ SNT + + V
Sbjct: 37 VLTKGSKTNIVWESGTSGR--GQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLI 94
Query: 125 LLDTGNLIVRDNFSRSASEGSCLWQS 150
L G +V G +W +
Sbjct: 95 LQINGQAVVY---------GPAVWST 111
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 9e-07
Identities = 14/73 (19%), Positives = 33/73 (45%), Gaps = 7/73 (9%)
Query: 79 NRNSPIIEPNAALTISNNGNLVI-LNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNF 137
N+ + + +L + ++ NLV+ +W S TS + ++ +L +G L + D+
Sbjct: 16 YDNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD- 74
Query: 138 SRSASEGSCLWQS 150
+ ++ S
Sbjct: 75 -----RLNTVFVS 82
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-07
Identities = 15/63 (23%), Positives = 25/63 (39%), Gaps = 9/63 (14%)
Query: 88 NAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCL 147
+ LT+++ G LVI N +W S N A + G L+V G +
Sbjct: 50 DCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVV---------FGPSV 100
Query: 148 WQS 150
++
Sbjct: 101 FKI 103
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 3e-04
Identities = 17/63 (26%), Positives = 31/63 (49%), Gaps = 10/63 (15%)
Query: 88 NAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCL 147
+ L + ++ NLV+ N W SNT+ + L D G L++++ +GS +
Sbjct: 22 DFDLVMQDDCNLVLYN----GNWQSNTANNGRDCKLTLTDYGELVIKN------GDGSTV 71
Query: 148 WQS 150
W+S
Sbjct: 72 WKS 74
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 49/229 (21%), Positives = 82/229 (35%), Gaps = 63/229 (27%)
Query: 458 TNNFGVENKLGEGGFGPVYK---SGQGLEEF-----KN----------EIKLTAKLQHR- 498
+ + LGEG FG V + +G + +N EI + K++ +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKD 77
Query: 499 -----NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQG 553
V + G + +E L K+ FL + + + + +A
Sbjct: 78 KENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPY-----PLPHVRHMAYQ 131
Query: 554 LL----YLHQYSRLRVIHRDLKPSNILLDSNMIP-------------------KISDFGL 590
L +LH ++ H DLKP NIL ++ +++DFG
Sbjct: 132 LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF-FSIKSDVFSFGVLLLE 638
A F + + IV T Y PE I ++ DV+S G +L E
Sbjct: 189 A-TFDHEHHTT----IVATRHYRPPE-VILELGWAQPCDVWSIGCILFE 231
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.3 bits (116), Expect = 2e-06
Identities = 17/85 (20%), Positives = 28/85 (32%), Gaps = 12/85 (14%)
Query: 72 DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNL 131
W A +GNLV+ N +W S+T A + V +L G++
Sbjct: 183 GAATWNAGTQGK---GAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHA-SAVLRLQANGSI 238
Query: 132 IVRDNFSRSASEGSCLWQSFDYPSD 156
+ D +W F +
Sbjct: 239 AILD--------EKPVWARFGFQPT 255
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.7 bits (104), Expect = 6e-05
Identities = 43/293 (14%), Positives = 86/293 (29%), Gaps = 49/293 (16%)
Query: 19 IQLSKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVA 78
I + ++ PA + G+ +S ++RF+L L I VWVA
Sbjct: 7 IPFNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQDNGAT---VWVA 58
Query: 79 NRNSPII------EPNAALTISNNGNLVILNLTNGAIWSSNTSR-----KAENPVAQLLD 127
N P A L + + + +W ++ S + L D
Sbjct: 59 NEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQD 118
Query: 128 TGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPSP 187
GN+++ D+ + + S L G +L +
Sbjct: 119 DGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQG------VVYGAGA------- 165
Query: 188 GNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSYASILSEPILV--DNEDEIY 245
++L L Y + WN G A + LV + +
Sbjct: 166 ----SKLVFQGDGNLVAYGPNGA----ATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVL 217
Query: 246 YSYESYNNPIIAILTVNPSGTV----QRLIWHERSNGWAAVHLAPTLFCQFYG 294
+ + + A+L + +G++ ++ +W G+ +
Sbjct: 218 WHSHTGGHA-SAVLRLQANGSIAILDEKPVW--ARFGFQPTYRHIRKINPDQK 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 38/204 (18%), Positives = 71/204 (34%), Gaps = 60/204 (29%)
Query: 459 NNFGVENKLGEGGFGPVY---------------------KSGQGLEEFKNEIKL-----T 492
N + + K+G GGFG +Y ++G E K ++
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 493 AKLQHRNLVRLLG----------CCVEQGENVLIYEYLPNKSLDSFLFDT----TKEGLL 538
K R + LG + ++ E L L + K +L
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKKSTVL 154
Query: 539 GWGAR-IRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKI--SDFGLARMFG 595
G R + ++E Y+H+ +H D+K +N+LL ++ +D+GL+ +
Sbjct: 155 QLGIRMLDVLE-------YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
Query: 596 GDEL-----QSNTKRIVGTYGYMS 614
+ ++ K GT + S
Sbjct: 205 PNGNHKQYQENPRKGHNGTIEFTS 228
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 3e-06
Identities = 96/650 (14%), Positives = 172/650 (26%), Gaps = 168/650 (25%)
Query: 167 DLKNGVERYLTSWRSADD----PSPGNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFF 222
D+++ + L+ D + T RL L L + + + F
Sbjct: 37 DVQDMPKSILSK-EEIDHIIMSKDAVSGTLRL-FWTL----LSKQEEMVQK-------FV 83
Query: 223 GAA--PSYASILSEPILVDNEDE--IYYSYESYNNPIIAILTVNPSGTVQR--LIWHERS 276
+Y L PI + + Y + + V V R R
Sbjct: 84 EEVLRINY-KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ 142
Query: 277 NGWAAVHLAPTLFCQFYGHCG-G-----NRVCSYEKTPNCECLKGFKPK--SQHNQTRPG 328
A + L P G G G VC K +C FK + N P
Sbjct: 143 ---ALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKV---QCKMDFKIFWLNLKNCNSPE 196
Query: 329 S--------CVRSESADCKSGDRF----IMVDDIK--LPDLLNVSLNKSMNLKEC----- 369
+ + + D + + I+ L LL KS + C
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL-----KSKPYENCLLVLL 251
Query: 370 ---EAECLK--NRTCRAYANSEVTGRGSGCLMWYGDLIDTTKAKFHNGQPMAREAILVIC 424
A+ N +C+ +T R F + ++
Sbjct: 252 NVQNAKAWNAFNLSCKIL----LTTR------------FKQVTDFLSAATTTHISLDHHS 295
Query: 425 PSFSSGGASYYFMHILSMETKTQGKSLASVSAATNNFGVENKLGEGGFGPVYKS--GQGL 482
+ + + L + L TN P S + +
Sbjct: 296 MTLTPDEVKSLLLKYLDCRP----QDLPREVLTTN--------------PRRLSIIAESI 337
Query: 483 EEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLF-DTTK--EGLLG 539
+ + L ++ + E + L +F + LL
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF--DRL--SVFPPSAHIPTILLS 393
Query: 540 --WGARIRI-IEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596
W I+ + + LH+YS ++ + K S I I L
Sbjct: 394 LIWFDVIKSDVMVVVNK---LHKYS---LVEKQPKESTI--------SIPSIYLELKVKL 439
Query: 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSD--VFSF-GVLLLETLSSKRSTRF----- 648
+ + + IV Y + D +S G L +R T F
Sbjct: 440 ENEYALHRSIVDHYNIPK-TFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL 498
Query: 649 ---FNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADR- 704
F + AWN + L K Y K YI C + +R
Sbjct: 499 DFRFLEQKIRHDSTAWNASGSILN-TLQQLKF-----Y---KPYI-----CDNDPKYERL 544
Query: 705 --------PTMSEVISMLTNEFVNLPSPQQPGFSSLKKSV-ETVARSMNR 745
P + E + + +++ +L + + +++ E + + R
Sbjct: 545 VNAILDFLPKIEENL--ICSKYTDL---LRIALMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 5e-06
Identities = 74/495 (14%), Positives = 139/495 (28%), Gaps = 149/495 (30%)
Query: 68 KQIPDTVVW--VANRNSP--IIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVA 123
++ + W + N NSP ++E L + N T+ + SSN + + A
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKLL-----YQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 124 QLLD-------TGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYL 176
+L L+V N + W +F+ L L
Sbjct: 233 ELRRLLKSKPYENCLLVLLNVQNAK-----AWNAFNLSCKIL-----------------L 270
Query: 177 TSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSYA-SILSEP 235
T+ R +T+ L + L + S L+ P S+L +
Sbjct: 271 TT-RFK------QVTDFLSAATTTHISLDHHSMTLT-------------PDEVKSLLLKY 310
Query: 236 ILVDNEDEIYYSYESYNNPIIAILTVNPSGTVQRLIW---HERSNGWAAVHLAPTLFCQF 292
+ +D P LT NP +I + W
Sbjct: 311 LDCRPQDL----------PREV-LTTNP--RRLSIIAESIRDGLATW-----------DN 346
Query: 293 YGHCGGNRVCSYEKTPNCECLKGFKPKSQHNQTRPGSCVRSESADCKSGDRFIMVDDIKL 352
+ H +++ + ++ L +P R + +
Sbjct: 347 WKHVNCDKLTTIIES----SLNVLEPAEY----------RKMFDRL-----SVFPPSAHI 387
Query: 353 P-DLL-----NVSLNKSMN-LKECEAECL-----KNRTCRAYANSEVTGRGSGCLMWYGD 400
P LL +V + M + + L K T
Sbjct: 388 PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP-----------------S 430
Query: 401 LIDTTKAKFHNGQPMAREAI--LVICPSFSSGGAS------YYFMHILS-METKTQGKSL 451
+ K K N + R + I +F S Y++ HI ++ + +
Sbjct: 431 IYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERM 490
Query: 452 ASVSAATNNFG-VENKL-----GEGGFGPVYKSGQGLEEFKNEIKLTAKLQHRNLVRLLG 505
+F +E K+ G + + Q L+ +K I R + +L
Sbjct: 491 TLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILD 550
Query: 506 CCVEQGENVLIYEYL 520
+ EN++ +Y
Sbjct: 551 FLPKIEENLICSKYT 565
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 2e-05
Identities = 43/332 (12%), Positives = 98/332 (29%), Gaps = 90/332 (27%)
Query: 474 PVYKSGQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI----------YEYLPNK 523
+ EE + I + +RL + + E ++ Y++L +
Sbjct: 44 SILSK----EEIDHIIMSKDAVSG--TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSP 97
Query: 524 --------SLDSFLFDTTKEGLLGWG----------ARIRIIEGIAQGLLYLHQYSRLRV 565
S+ + ++ ++ L + +R++ + Q LL L + +
Sbjct: 98 IKTEQRQPSMMTRMYIEQRDRL--YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV-L 154
Query: 566 IHRDL---KPSNILLDSNMIPKISDFGLARMFGG----------DELQSNTKRIVGTYGY 612
I L K + + LD + + + ++ + +
Sbjct: 155 IDGVLGSGK-TWVALDV-----CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ 208
Query: 613 MSPEYA--IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670
+ P + +IK + S L L SK N L +L + N +W
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-----YENCLLVLLNVQNAK----AW 259
Query: 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE--------FVNLP 722
+ L C+ + R+ V + ++ LT + +++
Sbjct: 260 NAFN--LSCKIL--LTTRFKQVTDF-LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 723 SPQQPGFSSLKKSVETVARSMNRLTLSVMDAR 754
L + + N LS++
Sbjct: 315 ------PQDLPRE----VLTTNPRRLSIIAES 336
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 5e-04
Identities = 43/417 (10%), Positives = 113/417 (27%), Gaps = 87/417 (20%)
Query: 400 DLIDTTKAKFHN-------GQPMAREAILVICPSFSSGGASYYFMHILSMETKTQGKSLA 452
D+ D K+ A L + + S + + ++
Sbjct: 37 DVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS 96
Query: 453 SVSAATNNFGVENKLGEGGFGPVYKSGQGLEEF-----KNEIKLTAKLQ----HRNLVR- 502
+ + ++ +Y Q ++ + +KL L +N++
Sbjct: 97 PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID 156
Query: 503 -LLGCCVEQGENVLIYEYLPNKSLDSFLFD----------TTKEGLL------------G 539
+LG G+ + + + + + + E +L
Sbjct: 157 GVLGS----GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPN 212
Query: 540 WGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG--- 596
W +R I + + R + + + ++L + + + F
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN-----VQNAKAWNAFNLSCK 267
Query: 597 ------DELQSNTKRIVG-TYGYMSPEYAIHGFFSIKS-DVFSFGVLLLETLSSKRSTRF 648
+ T + T ++S ++ + + L R
Sbjct: 268 ILLTTRF--KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL-KYLDCRPQDLPREVLT 324
Query: 649 FNTNSLTLLG-------HAWNLWKDDRSWEL---MDPKLQCEASYPIVKRYINVALLCVQ 698
N L+++ W+ WK +L ++ L K + +++
Sbjct: 325 TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF--P 382
Query: 699 ENAADRPTMSEVISMLTNEFVNLPSPQQPGF---SSLKKSVETVARSMNRLTLSVMD 752
+A + ++S++ + K S+ V + T+S+
Sbjct: 383 PSA---HIPTILLSLIWFD----VIKSDVMVVVNKLHKYSL--VEKQPKESTISIPS 430
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 3e-06
Identities = 20/79 (25%), Positives = 29/79 (36%), Gaps = 9/79 (11%)
Query: 72 DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNL 131
D V + N+ + NG + +L N A+W+S SR A V L NL
Sbjct: 166 DRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNL 225
Query: 132 IVRDNFSRSASEGSCLWQS 150
+ G LW +
Sbjct: 226 AIY---------GGALWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 2e-05
Identities = 29/198 (14%), Positives = 56/198 (28%), Gaps = 18/198 (9%)
Query: 72 DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNL 131
D VW +N + ++G LVIL N WSS T N V L +
Sbjct: 44 DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100
Query: 132 IVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPSPGNIT 191
+ LW S +++ L + S
Sbjct: 101 TIYG---------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSP 151
Query: 192 NRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSYASILSEPILV--DNEDEIYYSYE 249
RL + L L++ ++ + A + + N++ ++
Sbjct: 152 YRLSMETDCNLVLFDRDDRVWSTNTAG----KGTGCRAVLQPNGRMDVLTNQNIAVWTSG 207
Query: 250 SYNNPIIAILTVNPSGTV 267
+ + + + P +
Sbjct: 208 NSRSAGRYVFVLQPDRNL 225
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 37/208 (17%), Positives = 72/208 (34%), Gaps = 65/208 (31%)
Query: 459 NNFGVENKLGEGGFGPVY-----------------------KSGQGLEEFKNEIKLTAKL 495
+ V +G+GGFG +Y +G E K +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 496 QHRNLVRLL-------------GCCVEQGE--NVLIYEYLPNKSLDSFLFD------TTK 534
Q + +R G + G+ +I + L +++ + K
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRFSRK 152
Query: 535 EGL-LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKI--SDFGLA 591
L L +RI++ + Y+H++ +H D+K SN+LL+ ++ D+GLA
Sbjct: 153 TVLQLS----LRILDILE----YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
Query: 592 RMFGGDEL-----QSNTKRIVGTYGYMS 614
+ + + + GT + S
Sbjct: 202 YRYCPEGVHKAYAADPKRCHDGTIEFTS 229
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 9e-06
Identities = 11/51 (21%), Positives = 21/51 (41%), Gaps = 2/51 (3%)
Query: 91 LTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSA 141
+ + NLV+ N + SNT + + +L + G L + S +
Sbjct: 24 FVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTP 72
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 5e-04
Identities = 13/48 (27%), Positives = 22/48 (45%), Gaps = 3/48 (6%)
Query: 67 YKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNT 114
+ +T VWV R+ + N A T+ + ++ I AIWS+
Sbjct: 65 HSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIY---GPAIWSTPA 109
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 58/233 (24%), Positives = 87/233 (37%), Gaps = 67/233 (28%)
Query: 458 TNNFGVENKLGEGGFGPVYK-----SGQ--------GLEEFKN----EIKLTAKLQHR-- 498
N F V K+G+G FG V + + ++++ E + K+Q+
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 499 ---NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLL 555
N+V+ G + LI+E L SL + G I I+ +L
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGF-----HIEDIKLYCIEIL 147
Query: 556 ----YLHQYSRLRVIHRDLKPSNILLDSNMIP-------------------------KIS 586
YL ++ + H DLKP NILLD K+
Sbjct: 148 KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 587 DFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF-FSIKSDVFSFGVLLLE 638
DFG A F D S I+ T Y +PE I + + SD++SFG +L E
Sbjct: 205 DFGCA-TFKSDYHGS----IINTRQYRAPE-VILNLGWDVSSDMWSFGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 51/224 (22%), Positives = 80/224 (35%), Gaps = 63/224 (28%)
Query: 463 VENKLGEGGFGPVYK---SGQGLEEF-----KN----------EIKLTAKLQHR------ 498
+ + LGEG FG V + G KN EI++ L
Sbjct: 18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTF 77
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLL--- 555
V++L G +++E L S F+ + R+ I +A +
Sbjct: 78 RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPF-----RLDHIRKMAYQICKSV 131
Query: 556 -YLHQYSRLRVIHRDLKPSNILLDSNMIP-------------------KISDFGLARMFG 595
+LH ++ H DLKP NIL + K+ DFG A +
Sbjct: 132 NFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-TYD 187
Query: 596 GDELQSNTKRIVGTYGYMSPEYAIHGF-FSIKSDVFSFGVLLLE 638
+ + +V T Y +PE I +S DV+S G +L+E
Sbjct: 188 DEHHST----LVSTRHYRAPE-VILALGWSQPCDVWSIGCILIE 226
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 754 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.84 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.83 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.82 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.8 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.78 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.78 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.75 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.69 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.67 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.66 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.62 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.61 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.58 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.58 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.56 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.45 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.4 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.29 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.24 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.18 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.04 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.03 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.02 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.99 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.72 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.72 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.7 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.69 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.6 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.17 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.95 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.86 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.58 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.4 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.29 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.11 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.82 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.46 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.23 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.07 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.98 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.8 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.45 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.29 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.17 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.04 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.77 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.57 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.11 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 93.72 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 86.41 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.86 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 84.24 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.48 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=422.40 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=196.1
Q ss_pred hhhhcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
+...+++++.++||+|+||+||++. ...++|.+|++++++++|||||++++++.+ +..+|||
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3455788999999999999999821 235789999999999999999999998865 5689999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
|||++|+|.++|.. ....+++.++..|+.||++||.|||+++ ||||||||+||||++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999964 3356999999999999999999999987 999999999999999999999999999977544
Q ss_pred cccccccccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIH---GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.........+||+.|||||++.. ..|+.|+|||||||+||||++|+.||........ +.... ..+ ...
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~----~~~----~~~ 256 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMV----GRG----YAS 256 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHH----HTT----CCC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHH----hcC----CCC
Confidence 43344556789999999999864 3699999999999999999999999865433221 11111 111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLP 722 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 722 (754)
+.+. ......++.+.+++.+||+.||++||||.||+++|+.+...+|
T Consensus 257 p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 257 PDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp CCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 1111 1122345678999999999999999999999999987644443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=424.69 Aligned_cols=244 Identities=27% Similarity=0.452 Sum_probs=201.3
Q ss_pred hcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
.++|.+.++||+|+||+||++. ...++|.+|+++|++++|||||+++++|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 4678899999999999999842 12467999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceE
Q 036419 515 LIYEYLPNKSLDSFLFDTT----------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPK 584 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~k 584 (754)
||||||++|+|.++|.... ....+++.+++.|+.||++||.|||+++ ||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997532 2356999999999999999999999988 99999999999999999999
Q ss_pred EeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhh
Q 036419 585 ISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNL 663 (754)
Q Consensus 585 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 663 (754)
|+|||+|+...............||+.|||||++.+..|+.|+|||||||++|||+| |+.||......+ +.....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~-- 244 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECIT-- 244 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHH--
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH--
Confidence 999999997765544444455679999999999999999999999999999999998 899986543222 211111
Q ss_pred hccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 664 WKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 664 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
. +... ..+...++++.+|+.+||+.||++|||+++|+++|+....
T Consensus 245 -~-~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 -Q-GRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp -H-TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -c-CCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 1110 1112245678999999999999999999999999987643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=423.63 Aligned_cols=242 Identities=28% Similarity=0.405 Sum_probs=201.5
Q ss_pred hcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~ 513 (754)
..++++.++||+|+||+|||+. ...++|++|++++++++|||||+++++|.+++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 3567788999999999999832 1247899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC
Q 036419 514 VLIYEYLPNKSLDSFLFDTTK-------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN 580 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~ 580 (754)
+||||||++|+|.++|..... ...+++.++++|+.||++||+|||+++ ||||||||+||||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCC
Confidence 999999999999999965322 246999999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHh
Q 036419 581 MIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGH 659 (754)
Q Consensus 581 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 659 (754)
+.+||+|||+|+.+............+||+.|||||++.++.|+.++|||||||+||||++ |+.||...... .+...
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~ 259 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEM 259 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHH
Confidence 9999999999997765544444556789999999999999999999999999999999998 88898654322 22211
Q ss_pred hhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 660 AWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 660 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
. ..+.. .+.+...++.+.+|+.+||+.||++||||+||+++|+..
T Consensus 260 i----~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 I----RNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp H----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H----HcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 11111 011223456788999999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=426.20 Aligned_cols=244 Identities=26% Similarity=0.455 Sum_probs=193.4
Q ss_pred hcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
.++|.+.++||+|+||+||++. ...++|.+|+++|++++|||||+++++|.++...+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4678889999999999999842 12467999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc
Q 036419 515 LIYEYLPNKSLDSFLFDTTK------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI 582 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~ 582 (754)
||||||++|+|.++|..... .+.+++.+++.|+.||++||.|||+.+ ||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999976432 246999999999999999999999987 999999999999999999
Q ss_pred eEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhh
Q 036419 583 PKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAW 661 (754)
Q Consensus 583 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 661 (754)
+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||++ |+.||......+ +.....
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~ 274 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDCIT 274 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHHHH
Confidence 99999999997765544444556789999999999999999999999999999999999 899986543221 111111
Q ss_pred hhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 662 NLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 662 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
...+. ..+...++.+.+|+.+||+.||++|||++||+++|+.+..
T Consensus 275 ---~g~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 275 ---QGREL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp ---HTCCC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---cCCCC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11110 1112235678999999999999999999999999998743
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=417.48 Aligned_cols=234 Identities=23% Similarity=0.350 Sum_probs=189.5
Q ss_pred cCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
++|++.++||+|+||+||++. ...+.+.+|++++++|+|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 689999999999999999721 235678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|++||+|.++|... ....+++.+++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999642 3456899999999999999999999998 9999999999999999999999999999764321
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||....... +... ..... . +
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~---i~~~~-~-----~--- 243 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--LVLK---IISGS-F-----P--- 243 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH---HHHTC-C-----C---
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHH---HHcCC-C-----C---
Confidence 12345689999999999999999999999999999999999999987543222 1111 11111 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
......++.+.+|+.+||+.||++|||+.|+++|
T Consensus 244 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 -PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122345678999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=411.60 Aligned_cols=231 Identities=24% Similarity=0.326 Sum_probs=195.4
Q ss_pred cCccccceeccCCCcceeec---------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~---------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||+||++ ....+.+.+|++++++|+|||||++++++++++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999972 223567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|+|.++|.. .+.+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999954 356999999999999999999999998 999999999999999999999999999987655
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.........+||+.|||||++.+..|+.++||||+||++|||++|+.||...... .+..... .. .. .+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~---~~-~~------~~ 253 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--LIFAKII---KL-EY------DF 253 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH---HT-CC------CC
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH---cC-CC------CC
Confidence 4444556789999999999999999999999999999999999999998654322 1111111 11 00 01
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVI 711 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 711 (754)
+...++++.+++.+||+.||++|||++|++
T Consensus 254 ----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 ----PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 112346788999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=418.78 Aligned_cols=250 Identities=28% Similarity=0.400 Sum_probs=204.4
Q ss_pred hhhHhhhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhcc-CCeeeeee
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQH-RNLVRLLG 505 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~h-pniv~l~~ 505 (754)
..+++...++|++.++||+|+||+||++. ...++|.+|+++|.+++| ||||++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34566777899999999999999999731 124678999999999976 89999999
Q ss_pred eeeec-CeeEEEEEecCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 036419 506 CCVEQ-GENVLIYEYLPNKSLDSFLFDTTK-------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLK 571 (754)
Q Consensus 506 ~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlk 571 (754)
+|.+. +..++|||||++|+|.++|..... ...+++..+..++.||++||.|||+++ |||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence 99764 568999999999999999975322 345899999999999999999999998 9999999
Q ss_pred CCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCccc
Q 036419 572 PSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFN 650 (754)
Q Consensus 572 p~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~ 650 (754)
|+|||+++++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||+||||++ |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999998765544444556789999999999999999999999999999999998 899987544
Q ss_pred CCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 651 TNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.... +.... ..+.. + ..+...++++.+++.+||+.||++|||+++|+++|+..
T Consensus 293 ~~~~-~~~~i----~~g~~-----~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 293 IDEE-FCRRL----KEGTR-----M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CSHH-HHHHH----HHTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH-HHHHH----HcCCC-----C----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 3321 11111 11110 0 11112346788999999999999999999999999865
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=411.90 Aligned_cols=235 Identities=23% Similarity=0.301 Sum_probs=196.1
Q ss_pred hcCccccceeccCCCcceeec------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
.+.|++.++||+|+||+||++ ....+.+.+|+++|++++|||||++++++.+++.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 357999999999999999982 22346689999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++|+|.+++.. +.+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 999999999954 45999999999999999999999998 9999999999999999999999999999775432
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...... ........ . ..+.+
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~----~-----~~~~~-- 290 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRD----N-----LPPRL-- 290 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHH----S-----SCCCC--
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHc----C-----CCCCC--
Confidence 2234578999999999999999999999999999999999999998643321 11111110 0 01111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......++.+.+++.+||+.||++|||+.|+++|-
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp 325 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 325 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 11123457789999999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=403.40 Aligned_cols=232 Identities=24% Similarity=0.378 Sum_probs=185.0
Q ss_pred ccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee----cCeeEEE
Q 036419 461 FGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE----QGENVLI 516 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~----~~~~~lV 516 (754)
|++.++||+|+||+||++. ...+.|.+|++++++|+|||||++++++.. +..++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3677889999999999821 234678999999999999999999999865 3568999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc-CCCceEEeeccCccccC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD-SNMIPKISDFGLARMFG 595 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld-~~~~~kl~DFgla~~~~ 595 (754)
||||++|+|.++|.+ .+.+++..+..++.||+.||.|||+++ .+||||||||+||||+ .++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999964 356999999999999999999999875 4599999999999998 47999999999998654
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||....... .+.... ..... .+
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~~i----~~~~~----~~ 249 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRV----TSGVK----PA 249 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHH----TTTCC----CG
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHHHHH----HcCCC----CC
Confidence 32 2345789999999998764 69999999999999999999999986433211 111111 11100 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. +...++++.+++.+||+.||++|||++|+++|-
T Consensus 250 ~~----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp 284 (290)
T 3fpq_A 250 SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp GG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 11 111235688999999999999999999998863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=414.13 Aligned_cols=243 Identities=21% Similarity=0.235 Sum_probs=194.9
Q ss_pred hcCccccceeccCCCcceeecccc-------------HHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCC
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQG-------------LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKS 524 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~~-------------~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gs 524 (754)
.+.|++.++||+|+||+||++.+. .....+|++++++|+|||||++++++.+++..+|||||++||+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 457889999999999999984321 1223579999999999999999999999999999999999999
Q ss_pred hhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC-ceEEeeccCccccCCCccc---
Q 036419 525 LDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM-IPKISDFGLARMFGGDELQ--- 600 (754)
Q Consensus 525 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~-~~kl~DFgla~~~~~~~~~--- 600 (754)
|.++|.. .+.+++.++..++.||+.||.|||+++ ||||||||+||||+.++ .+||+|||+|+.+......
T Consensus 137 L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 137 LGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp HHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred HHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 9999954 356999999999999999999999998 99999999999999987 6999999999987543221
Q ss_pred ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.......... .. ...... ...
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~i---~~~~~~--------~~~ 277 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL--KI---ASEPPP--------IRE 277 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH--HH---HHSCCG--------GGG
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH--HH---HcCCCC--------chh
Confidence 12234689999999999999999999999999999999999999997554433211 11 011100 001
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
.....++.+.+++.+||+.||++|||+.||+++|.....
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 122345678899999999999999999999999875433
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=414.83 Aligned_cols=235 Identities=23% Similarity=0.298 Sum_probs=196.1
Q ss_pred hcCccccceeccCCCcceeec------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
.+.|++.++||+|+||.||++ ....+.+.+|+++|++++|||||++++++.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 467999999999999999972 22356789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
|++|+|.+++.. +.+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 999999999953 35999999999999999999999998 9999999999999999999999999999775432
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...... ....... . . ..+.+
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~---~-~-----~~~~~-- 367 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIR---D-N-----LPPRL-- 367 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHH---H-S-----CCCCC--
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHH---c-C-----CCCCC--
Confidence 2234678999999999999999999999999999999999999998643321 1111111 0 1 01111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......++.+.+|+.+||+.||++|||+.|+++|-
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 11123456789999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=392.33 Aligned_cols=230 Identities=23% Similarity=0.350 Sum_probs=178.5
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||+||++. ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 589999999999999999721 23467899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+ +|+|.++|.+ .+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6799998854 456999999999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
. .....+||+.|||||++.+..| +.++||||+||++|||++|+.||..... ..+..... .... .
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~~i~----~~~~------~ 230 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFKNIS----NGVY------T 230 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH----HTCC------C
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHH----cCCC------C
Confidence 2 2335789999999999998876 5899999999999999999999864322 11111111 0100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.+...++.+.+++.+||+.||++|||++|+++|-
T Consensus 231 ----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 231 ----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred ----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 1112346788999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=400.78 Aligned_cols=231 Identities=26% Similarity=0.316 Sum_probs=185.4
Q ss_pred cCccccceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
++|++.+.||+|+||+||++.+ ...++.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999997321 23468899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||++||+|.++|.+ .+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999954 356999999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+ +..... ... .
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~---~~~-~------ 243 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--TMTMIL---KAK-L------ 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH---HCC-C------
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--HHHHHH---cCC-C------
Confidence 322 22345789999999999999999999999999999999999999987543222 111111 110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPT-----MSEVISM 713 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 713 (754)
..+...++.+.+++.+||+.||++||| ++|+++|
T Consensus 244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 011124567899999999999999998 5788775
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=397.04 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=189.1
Q ss_pred cCccccceeccCCCcceeecc-------------ccHHHH--HHHHHHHHhhccCCeeeeeeeeeecC----eeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------QGLEEF--KNEIKLTAKLQHRNLVRLLGCCVEQG----ENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------~~~~~~--~~Ev~il~~l~hpniv~l~~~~~~~~----~~~lV~E~ 519 (754)
++|.+.++||+|+||+||++. ...+++ +.|+.++.+++|||||+++++|.+++ .++|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 468889999999999999832 223333 45666677899999999999998764 57999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS-----RLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
|++|+|.++|.. ..++++.+.+++.|+++||+|||+++ ..+|+||||||+||||+.++.+||+|||+|+..
T Consensus 83 ~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 83 HEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999954 35899999999999999999999872 235999999999999999999999999999876
Q ss_pred CCCcc--cccccccccccCcccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHh---------
Q 036419 595 GGDEL--QSNTKRIVGTYGYMSPEYAIHG------FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLL--------- 657 (754)
Q Consensus 595 ~~~~~--~~~~~~~~gt~~y~APE~~~~~------~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~--------- 657 (754)
..... .......+||+.|||||++.+. .++.|+|||||||+||||++|..|+...........
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 54322 1223356899999999998754 478899999999999999999887654332221110
Q ss_pred HhhhhhhccCccccccCcccCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 658 GHAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 658 ~~~~~~~~~~~~~~l~d~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
........ .+.+++.+.. ....+..+.+.+|+.+||+.||++||||.||+++|+.+
T Consensus 239 ~~~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 239 EEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 01111111 1112222221 12235667899999999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=390.01 Aligned_cols=236 Identities=26% Similarity=0.357 Sum_probs=176.4
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC--------
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG-------- 511 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~-------- 511 (754)
++|++.+.||+|+||+||++. ...+.+.+|++++++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 469999999999999999721 13467899999999999999999999997655
Q ss_pred ----eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEee
Q 036419 512 ----ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISD 587 (754)
Q Consensus 512 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~D 587 (754)
..++||||+++|+|.+++..........+..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976544445677888999999999999999998 99999999999999999999999
Q ss_pred ccCccccCCCccc----------ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHh
Q 036419 588 FGLARMFGGDELQ----------SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLL 657 (754)
Q Consensus 588 Fgla~~~~~~~~~----------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~ 657 (754)
||+|+.+...... ......+||+.|||||++.+..|+.++|||||||++|||++ ||.... + ..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~--~~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--E--RV 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--H--HH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--H--HH
Confidence 9999987543221 11234689999999999999999999999999999999996 543211 1 00
Q ss_pred HhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 658 GHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 658 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
..... ...... + +......+.+.+++.+||+.||++|||+.|+++|-
T Consensus 235 ~~~~~-~~~~~~-----p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~ 281 (299)
T 4g31_A 235 RTLTD-VRNLKF-----P----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA 281 (299)
T ss_dssp HHHHH-HHTTCC-----C----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHH-HhcCCC-----C----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 00100 001100 0 01122335567899999999999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=383.84 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=192.4
Q ss_pred hhhHhhhhcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeec
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQ 510 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~ 510 (754)
+..+....++|++.++||+|+||+||++. ....++.+|+++|+++ +|||||++++++.++
T Consensus 13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 34455677899999999999999999742 1346788999999998 699999999999999
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC-CceEEeecc
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFG 589 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-~~~kl~DFg 589 (754)
++.++||||+++++|.+++. .+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999982 4899999999999999999999998 9999999999999877 799999999
Q ss_pred CccccCCCccc--------------------------ccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhC
Q 036419 590 LARMFGGDELQ--------------------------SNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSS 642 (754)
Q Consensus 590 la~~~~~~~~~--------------------------~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg 642 (754)
+|+........ ......+||+.|||||++.+. .|+.++||||+|||+|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99865432110 112345799999999999876 589999999999999999999
Q ss_pred CCCCCcccCCchhHhHhhhhhh------------c-----cCc-----cc---------cccCcc---------cCCCCC
Q 036419 643 KRSTRFFNTNSLTLLGHAWNLW------------K-----DDR-----SW---------ELMDPK---------LQCEAS 682 (754)
Q Consensus 643 ~~p~~~~~~~~~~~~~~~~~~~------------~-----~~~-----~~---------~l~d~~---------~~~~~~ 682 (754)
+.||.........+. ...... . ... .. ....+. ......
T Consensus 244 ~~Pf~~~~~~~~~l~-~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (361)
T 4f9c_A 244 RYPFYKASDDLTALA-QIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW 322 (361)
T ss_dssp CSSSSCCSSHHHHHH-HHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred CCCCCCCCCHHHHHH-HHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence 999854332211111 000000 0 000 00 000000 000111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...++.+.+|+.+||+.||++|||++|+++|-
T Consensus 323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp 354 (361)
T 4f9c_A 323 NEVPDEAYDLLDKLLDLNPASRITAEEALLHP 354 (361)
T ss_dssp TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 22346788999999999999999999999874
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=367.37 Aligned_cols=231 Identities=18% Similarity=0.208 Sum_probs=179.5
Q ss_pred hccccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCC----CceEEEecCc
Q 036419 22 SKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEP----NAALTISNNG 97 (754)
Q Consensus 22 ~~~~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~----~~~l~~~~~g 97 (754)
+++.|+|++|++| +++++|+|++|.|+||||.++ ++|| |+ ..+ |||+|||++|+.++ +++|+|+.||
T Consensus 11 ~~~~~~l~~g~~l-~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 11 GVGTSVLPAYQTL-SAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CTTSSEECTTEEB-CTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred cccCCEecCCCEe-cCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 5678999999999 899999999999999999432 5777 77 236 99999999999875 7899999999
Q ss_pred cEEE--EcCCCCeEEeecCCCC-----CCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccccCcccceecC
Q 036419 98 NLVI--LNLTNGAIWSSNTSRK-----AENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLKN 170 (754)
Q Consensus 98 ~l~l--~~~~~~~~ws~~~~~~-----~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~~ 170 (754)
+|+| .|++|.+||+|+++.. ..++.|+|+|+|||||++ +.+|||| |||||||||||||.++++
T Consensus 82 ~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--------~~~lWqS--~ptdtlLpg~~~~~~l~~ 151 (276)
T 3m7h_A 82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--------SLALWNG--TPAIPLVPGAIDSLLLAP 151 (276)
T ss_dssp SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--------EEEEEES--CTTSCCCCSCTTCEEECS
T ss_pred cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--------CceeeCc--cccccccccccccccccc
Confidence 9999 7888999999997642 224679999999999996 5689999 999999999999999998
Q ss_pred CCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEc-CCeeeEecCCCCcccccccCccccccccceE-eeCCC-ceEEE
Q 036419 171 GVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYN-GSQKLSRSGPWNGIFFGAAPSYASILSEPIL-VDNED-EIYYS 247 (754)
Q Consensus 171 g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~-~~~~~~~~g~w~~~~~~~~p~~~~~~~~~~~-~~~~~-~~~~~ 247 (754)
|.. | ++.+||++|.|++++++++. +++|+ +..+||++|+|++.. ..+.....-.++ .++.+ .++.+
T Consensus 152 g~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~----~~l~l~~dGnLvl~d~~~~~vWsS 220 (276)
T 3m7h_A 152 GSE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGA----VRAVFQGDGNLVVYGAGNAVLWHS 220 (276)
T ss_dssp SEE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTC----CEEEECTTSCEEEECTTSCEEEEC
T ss_pred Ccc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCcc----EEEEEcCCCeEEEEeCCCcEEEEe
Confidence 866 5 67899999999999999984 45665 458999999997532 111111111222 33333 33333
Q ss_pred EeecCCCeEEEEEEccCCcEEEEEEeecCCceEEEEeccc
Q 036419 248 YESYNNPIIAILTVNPSGTVQRLIWHERSNGWAAVHLAPT 287 (754)
Q Consensus 248 ~~~~~~~~~~rl~Ld~~G~l~~~~w~~~~~~W~~~~~~p~ 287 (754)
++. ....+|++|+.||++++|.| ...|...+..|+
T Consensus 221 ~t~--~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 221 HTG--GHASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp SCT--TCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred cCC--CCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 332 22348999999999999998 234666555554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=386.65 Aligned_cols=248 Identities=19% Similarity=0.264 Sum_probs=189.0
Q ss_pred hcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee------cC
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE------QG 511 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~------~~ 511 (754)
.++|++.++||+|+||+||++. ...+.+.+|+++|++|+|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4689999999999999999822 124568899999999999999999998753 36
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
.+|||||||+ |+|.++|. ..+.+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 67999984 3467999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCc--ccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc
Q 036419 592 RMFGGDE--LQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 592 ~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
+.+.... ........+||+.|||||++.+. .++.++||||+|||+|||++|+.||....... .............
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--~l~~I~~~~g~p~ 283 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--QLQLIMMVLGTPS 283 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhcCCCC
Confidence 9764432 12234467999999999998875 57999999999999999999999997544322 1111111000000
Q ss_pred -----------cccc---cCcccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 669 -----------SWEL---MDPKLQC---EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 669 -----------~~~l---~d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.... +.+.... .......+.+.+|+.+||+.||++|||+.|+++|-
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 0000 0000000 00011346788999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=362.61 Aligned_cols=265 Identities=36% Similarity=0.609 Sum_probs=224.0
Q ss_pred chhhHhhhhcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 450 SLASVSAATNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 450 ~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
.+.++...+++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+++.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 344566788999999999999999999732 235789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTK-EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
.++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999965432 235899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhhhhhhccCccc
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHAWNLWKDDRSW 670 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 670 (754)
+...............||+.|+|||++.+..++.++||||||+++|||++|+.||....+.. .....+...........
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 87654333233345679999999999999999999999999999999999999987654433 33333443444455566
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 671 ~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+.+++...........+.+.+++.+||+.||++|||+.+|+++|+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 67777776677788899999999999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=392.39 Aligned_cols=233 Identities=26% Similarity=0.311 Sum_probs=189.3
Q ss_pred hcCccccceeccCCCcceeeccc---------------------cHHHHHH---HHHHHHhhccCCeeeeeeeeeecCee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKN---EIKLTAKLQHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~---Ev~il~~l~hpniv~l~~~~~~~~~~ 513 (754)
-++|++.+.||+|+||+||++.+ ....+.+ ++++++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 47899999999999999997321 2223334 45667778999999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
||||||++||+|.++|.. .+.+++..+..++.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999954 456999999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCch-hHhHhhhhhhccCcccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-TLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 671 (754)
+.... ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||........ .+.... ....
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---~~~~---- 410 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTMA---- 410 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---HHCC----
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---cCCC----
Confidence 75432 345789999999999975 5799999999999999999999999975443331 111111 0000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPT-----MSEVISML 714 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 714 (754)
. ......++.+.+|+.+||+.||.+|++ ++||++|-
T Consensus 411 ---~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 411 ---V----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp ---C----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred ---C----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 0 111224567899999999999999998 78988764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=359.84 Aligned_cols=269 Identities=39% Similarity=0.632 Sum_probs=228.9
Q ss_pred CCchhhHhhhhcCccccceeccCCCcceeeccc------------------cHHHHHHHHHHHHhhccCCeeeeeeeeee
Q 036419 448 GKSLASVSAATNNFGVENKLGEGGFGPVYKSGQ------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509 (754)
Q Consensus 448 ~~~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~~------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~ 509 (754)
.+++.++....++|++.+.||+|+||.||++.. ....+.+|++++++++||||+++++++.+
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 367788999999999999999999999998321 12368999999999999999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeec
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTK-EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDF 588 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DF 588 (754)
....++||||+++++|.+++..... ...+++..+..++.||+.||.|||+....+|+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 9999999999999999999976543 345999999999999999999999982223999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCchhHhHhhhhhhc
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFN---TNSLTLLGHAWNLWK 665 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~---~~~~~~~~~~~~~~~ 665 (754)
|+++....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ........+......
T Consensus 179 g~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 179 GLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp SSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred ccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99987654322 22334569999999999999999999999999999999999999986332 222344455555666
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 666 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
......+.+............+.+.+++.+||+.||.+|||+.+|+++|++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 6677777888777778888999999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=392.54 Aligned_cols=237 Identities=24% Similarity=0.319 Sum_probs=195.0
Q ss_pred hcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
.++|++.+.||+|+||.||++. ...+.+++|+++|++|+|||||++++++.++..++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 3689999999999999999732 1346788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC--CceEEeeccCccccCCC
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN--MIPKISDFGLARMFGGD 597 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~--~~~kl~DFgla~~~~~~ 597 (754)
|+||+|.++|.. ..+.+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999953 3356999999999999999999999998 9999999999999854 89999999999987544
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.. ....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ ...... ... ..+
T Consensus 311 ~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--~~~~i~---~~~-------~~~ 375 (573)
T 3uto_A 311 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRNVK---SCD-------WNM 375 (573)
T ss_dssp SE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHH---TTC-------CCC
T ss_pred Cc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHH---hCC-------CCC
Confidence 32 335689999999999999999999999999999999999999986543322 111111 000 001
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
........++.+.+|+.+||+.||++|||+.|+++|-
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 1111122456788999999999999999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=343.65 Aligned_cols=264 Identities=38% Similarity=0.547 Sum_probs=213.7
Q ss_pred CCchhhHhhhhcCcccc------ceeccCCCcceeec--------------------cccHHHHHHHHHHHHhhccCCee
Q 036419 448 GKSLASVSAATNNFGVE------NKLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKLQHRNLV 501 (754)
Q Consensus 448 ~~~~~~~~~~~~~y~~~------~~lG~G~fg~Vyk~--------------------~~~~~~~~~Ev~il~~l~hpniv 501 (754)
.+++.++..++++|... ++||+|+||.||++ ....+.+.+|++++++++||||+
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 93 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeE
Confidence 36777888888888766 89999999999972 12357789999999999999999
Q ss_pred eeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC
Q 036419 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM 581 (754)
Q Consensus 502 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~ 581 (754)
++++++.+.+..++||||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~ 170 (307)
T 2nru_A 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAF 170 (307)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTC
T ss_pred EEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCC
Confidence 999999999999999999999999999976555667999999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhh
Q 036419 582 IPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW 661 (754)
Q Consensus 582 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 661 (754)
.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|+|++|..||......... .....
T Consensus 171 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~ 248 (307)
T 2nru_A 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LDIKE 248 (307)
T ss_dssp CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT-THHHH
T ss_pred cEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH-HHHHH
Confidence 999999999987654333333445679999999998764 5899999999999999999999998765433311 11111
Q ss_pred hhh-ccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 662 NLW-KDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 662 ~~~-~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
... ........+++.+ .......++.+.+++.+||+.||.+|||+.+|+++|+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 249 EIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred Hhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111 1112223333333 234556788899999999999999999999999999876
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=353.22 Aligned_cols=254 Identities=25% Similarity=0.424 Sum_probs=192.9
Q ss_pred HhhhhcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
+....++|++.++||+|+||.||++. ...+++.+|++++++++||||+++++++.+....++
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34456789999999999999999732 224678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++........+++..+..++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999999965443345899999999999999999999875 349999999999999999999999999998654
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..... .... .
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~--~~~~-~------ 257 (309)
T 3p86_A 191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVG--FKCK-R------ 257 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHH--HSCC-C------
T ss_pred ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH--hcCC-C------
Confidence 332 123346799999999999999999999999999999999999999865432221 11110 0000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCC
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSP 724 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p 724 (754)
.......+..+.+++.+||+.||++|||+.+|++.|+.......+|
T Consensus 258 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 258 ---LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 0111223467889999999999999999999999999775544433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.00 Aligned_cols=244 Identities=25% Similarity=0.432 Sum_probs=200.7
Q ss_pred hhcCccccceeccCCCcceeecc--------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeee
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVE 509 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~ 509 (754)
..++|++.+.||+|+||.||++. ...+++.+|+++++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 45789999999999999999632 1245789999999999 89999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceE
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTK-------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNIL 576 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIl 576 (754)
++..++||||+++|+|.+++..... ...+++.++..++.||++||.|||+.+ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999976432 245899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchh
Q 036419 577 LDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLT 655 (754)
Q Consensus 577 ld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~ 655 (754)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||........
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~- 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence 99999999999999997765443333445567889999999999999999999999999999999 8998865433221
Q ss_pred HhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 656 LLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 656 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.... ..... .......+..+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 315 -~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 315 -FKLL----KEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp -HHHH----HTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHH----hcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 11100 0111234467899999999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=354.47 Aligned_cols=239 Identities=24% Similarity=0.395 Sum_probs=193.7
Q ss_pred hcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
.++|++.++||+|+||.||++. ...+++.+|++++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 4679999999999999999732 23467899999999999999999999998764 78
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+|+||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999999653 346999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.............+|..|+|||++.+..++.++|||||||++|||++ |+.||........ .... ....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~----~~~~----- 236 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSIL----EKGE----- 236 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHH----HTTC-----
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--HHHH----HcCC-----
Confidence 65444333445567889999999999999999999999999999999 9999865443321 1111 0010
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
...........+.+++.+||+.||++||++.+|+++|+..
T Consensus 237 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111222446788999999999999999999999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=341.90 Aligned_cols=237 Identities=23% Similarity=0.340 Sum_probs=195.7
Q ss_pred hhcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
..++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 45789999999999999999731 235678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999954 35899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . ..... ...+
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~---~~~~~-~~~~------ 236 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--L---IATNG-TPEL------ 236 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--H---HHHHC-SCCC------
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H---HHhCC-CCCC------
Confidence 2 2334679999999999999999999999999999999999999986443221110 0 00000 0000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
......+..+.+++.+||+.||++|||++|+++|--
T Consensus 237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 237 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred -CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 111234567889999999999999999999998753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.32 Aligned_cols=246 Identities=24% Similarity=0.432 Sum_probs=197.5
Q ss_pred hcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 4689999999999999999832 2356789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++... ...+++.++..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999653 346999999999999999999999998 99999999999999999999999999987644322
Q ss_pred cc------------cccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC
Q 036419 600 QS------------NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD 667 (754)
Q Consensus 600 ~~------------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 667 (754)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..|+................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~----- 238 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG----- 238 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH-----
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc-----
Confidence 11 1114679999999999999999999999999999999999999876543332111000000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 036419 668 RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNL 721 (754)
Q Consensus 668 ~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 721 (754)
..+.. .....++.+.+++.+||+.||++|||+.+|+++|+.....+
T Consensus 239 ----~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 239 ----FLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ----HHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----ccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00000 01122346889999999999999999999999998764433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=357.19 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=206.2
Q ss_pred hhhhcCccccceeccCCCcceeecc--------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeee
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSG--------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCC 507 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~--------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~ 507 (754)
....++|++.++||+|+||.||++. ...+++.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 4456799999999999999999742 1236788999999999 899999999999
Q ss_pred eecCeeEEEEEecCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 036419 508 VEQGENVLIYEYLPNKSLDSFLFDTTK-------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSN 574 (754)
Q Consensus 508 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~N 574 (754)
.+++..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999976432 245999999999999999999999998 9999999999
Q ss_pred eEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCc
Q 036419 575 ILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNS 653 (754)
Q Consensus 575 Illd~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~ 653 (754)
||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..|+.......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999997765443344445678899999999999999999999999999999999 898876443221
Q ss_pred hhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCCCCCC
Q 036419 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPG 728 (754)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~ 728 (754)
+.... ..... .......++.+.+++.+||+.||++|||+.+|+++|+......+..+.+.
T Consensus 302 --~~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 361 (382)
T 3tt0_A 302 --LFKLL----KEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY 361 (382)
T ss_dssp --HHHHH----HTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred --HHHHH----HcCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence 11111 11100 01112234678899999999999999999999999998755444444333
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.97 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=196.5
Q ss_pred hhhcCccccceeccCCCcceeecc---------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC----eeEEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG---------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG----ENVLI 516 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~---------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~----~~~lV 516 (754)
...++|++.++||+|+||.||++. .......+|++++++++||||+++++++.+.. ..++|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 345789999999999999999832 12345667899999999999999999998754 36999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCceeeCCCCCCceEEcCCCceEEe
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY----------SRLRVIHRDLKPSNILLDSNMIPKIS 586 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~----------~~~~iiH~Dlkp~NIlld~~~~~kl~ 586 (754)
|||+++++|.+++.. ..+++..+..++.||++||.|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999954 3489999999999999999999997 6 9999999999999999999999
Q ss_pred eccCccccCCCcccccccccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHh-
Q 036419 587 DFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH-----GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGH- 659 (754)
Q Consensus 587 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~- 659 (754)
|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999987765444334445689999999999886 356778999999999999999999987543322 111100
Q ss_pred --------hhhhhccCccccccCcccCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 660 --------AWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 660 --------~~~~~~~~~~~~l~d~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
........ ...+.+.. .......+.+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 254 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHK----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcc----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00000011 11111111 11224567799999999999999999999999999865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=351.15 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=203.1
Q ss_pred CchhhHhhhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhh-ccCCeeee
Q 036419 449 KSLASVSAATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKL-QHRNLVRL 503 (754)
Q Consensus 449 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l-~hpniv~l 503 (754)
.....+....++|++.++||+|+||.||++. ...+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4455667788999999999999999999842 1235689999999999 78999999
Q ss_pred eeeeeecCe-eEEEEEecCCCChhhHhhccCC------------------------------------------------
Q 036419 504 LGCCVEQGE-NVLIYEYLPNKSLDSFLFDTTK------------------------------------------------ 534 (754)
Q Consensus 504 ~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 534 (754)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999976432
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 535 ---------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 535 ---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122899999999999999999999998 99999999999999999999999999987654433
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.......... ... .....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~~~----~~~~~--------- 314 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-RRL----KEGTR--------- 314 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-HHH----HHTCC---------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH-HHH----HcCCC---------
Confidence 334445678999999999999999999999999999999998 999986544332111 111 11100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.......++.+.+++.+||+.||.+|||+.+|+++|+..
T Consensus 315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 011112346788999999999999999999999999865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=345.07 Aligned_cols=239 Identities=25% Similarity=0.347 Sum_probs=194.9
Q ss_pred hcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 4689999999999999999731 123568899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999994 3445999999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............+. .... ..
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-----~~~~--~~---- 228 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKKT--YL---- 228 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH-----TTCT--TS----
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-----cccc--cC----
Confidence 3333446789999999999987765 7899999999999999999999876544332222111 1100 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.........+.+++.+||+.||++|||+.|++++.-
T Consensus 229 --~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred --CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 111234567889999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=346.09 Aligned_cols=233 Identities=24% Similarity=0.348 Sum_probs=193.4
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
..++|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++......++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 45689999999999999999722 1245688999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999999543 45999999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccccccccccccCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFS-IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.. .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||....... +.... .... .
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i---~~~~-~------ 231 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--LRERV---LRGK-Y------ 231 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---HHCC-C------
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--HHHHH---HhCC-C------
Confidence 32 23456899999999999888765 89999999999999999999986543222 11111 1100 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
..+...+..+.+++.+||+.||.+|||++|+++|-
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 01112346788999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.50 Aligned_cols=243 Identities=27% Similarity=0.401 Sum_probs=196.6
Q ss_pred hhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
..++|++.++||+|+||.||++. ....++.+|++++++++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 34789999999999999999743 123468899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC---ceEE
Q 036419 513 NVLIYEYLPNKSLDSFLFDTT----KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM---IPKI 585 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~---~~kl 585 (754)
.++||||+++++|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999997643 2245899999999999999999999998 99999999999999555 5999
Q ss_pred eeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhh
Q 036419 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLW 664 (754)
Q Consensus 586 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 664 (754)
+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |..||....... ......
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~~~i~--- 300 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVT--- 300 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH---
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---
Confidence 99999986543322233345678999999999999999999999999999999998 888876443221 111111
Q ss_pred ccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 665 KDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 665 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.... .......+..+.+++.+||+.||++|||+.+|+++|+..
T Consensus 301 ~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCC----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1110 011122346688999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=346.43 Aligned_cols=243 Identities=27% Similarity=0.455 Sum_probs=195.7
Q ss_pred hhcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 35689999999999999999732 12457899999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 127 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999999542 346999999999999999999999998 999999999999999999999999999977
Q ss_pred CCCcc-cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 595 GGDEL-QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 595 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
..... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||....... ...... ..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~----~~----- 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVE----EG----- 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHH----TT-----
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHH----cC-----
Confidence 54321 112223456788999999999999999999999999999999 999975433222 111111 00
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
.........++.+.+++.+||+.||++|||+.+|+++|+....
T Consensus 271 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 271 ----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0011122345678999999999999999999999999998643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=342.87 Aligned_cols=247 Identities=28% Similarity=0.429 Sum_probs=202.4
Q ss_pred HhhhhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeee
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~ 509 (754)
+....++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 344567899999999999999997421 23678899999999999999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeC
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTK---------------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHR 568 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~ 568 (754)
....++||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence 9999999999999999999976432 234899999999999999999999998 9999
Q ss_pred CCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 036419 569 DLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTR 647 (754)
Q Consensus 569 Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~ 647 (754)
||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987755443333445567889999999999999999999999999999999 999986
Q ss_pred cccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 648 FFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
....... .... ..... .......++.+.+++.+||+.||++|||+.+|+++|+...
T Consensus 255 ~~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 255 GIPPERL--FNLL----KTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp TCCGGGH--HHHH----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHHHH--HHHh----hcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 5443221 1111 11100 1111234567899999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=335.76 Aligned_cols=256 Identities=20% Similarity=0.299 Sum_probs=202.3
Q ss_pred hhcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC--eeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG--ENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~--~~~l 515 (754)
..++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.+.. ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 35689999999999999999721 23577889999999999999999999998765 7799
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE----cCCCceEEeeccCc
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL----DSNMIPKISDFGLA 591 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll----d~~~~~kl~DFgla 591 (754)
||||+++++|.+++........+++..+..++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999977655556999999999999999999999998 9999999999999 78888999999999
Q ss_pred cccCCCcccccccccccccCcccccccc--------cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc--hhHhHhhh
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAI--------HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS--LTLLGHAW 661 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~--~~~~~~~~ 661 (754)
+....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||....... ........
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 87654332 23457999999999886 4678999999999999999999999986443322 11111111
Q ss_pred hhhccCccccc---c--------CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 662 NLWKDDRSWEL---M--------DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 662 ~~~~~~~~~~l---~--------d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
..........+ . +..............+.+++.+||+.||++|||++|++++.....
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 10000000000 0 011122344567888999999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=338.87 Aligned_cols=244 Identities=28% Similarity=0.470 Sum_probs=193.4
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 34689999999999999999731 124678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999999543 46899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ....... . +
T Consensus 163 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~~-~-----~ 230 (294)
T 4eqm_A 163 ETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-----IKHIQDS-V-----P 230 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-----HHHHSSC-C-----C
T ss_pred cccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhhcc-C-----C
Confidence 4322 2233467999999999999999999999999999999999999998654322111 0001100 0 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhccc
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRP-TMSEVISMLTNEF 718 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~ 718 (754)
..........++.+.+++.+||+.||++|| +++++.+.|+...
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 011111223456789999999999999999 9999999998763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.99 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=194.5
Q ss_pred hcCccccceeccCCCcceeec--------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCC
Q 036419 458 TNNFGVENKLGEGGFGPVYKS--------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNK 523 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~--------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 523 (754)
.++|++.+.||+|+||.||++ ....+.+.+|++++++++||||+++++++. +..++||||++++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~ 84 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGG 84 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTC
T ss_pred HhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCC
Confidence 367899999999999999973 234577899999999999999999999887 4589999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc-eEEeeccCccccCCCccccc
Q 036419 524 SLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI-PKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 524 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~-~kl~DFgla~~~~~~~~~~~ 602 (754)
+|.+++........+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----- 159 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----- 159 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----
Confidence 99999976554446889999999999999999999943234999999999999998886 799999999865432
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.............. .... . + ...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~-~-----~----~~~ 226 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV---HNGT-R-----P----PLI 226 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH---HTTC-C-----C----CCB
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH---hcCC-C-----C----Ccc
Confidence 2235689999999999999999999999999999999999999865433322111111 1110 0 0 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCCCCCCc
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGF 729 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~ 729 (754)
...++.+.+++.+||+.||++|||+++|+++|+......+.+..|..
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~ 273 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence 12346788999999999999999999999999987665655555443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=346.78 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=201.5
Q ss_pred HhhhhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhh-ccCCeeeeeeeee
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKL-QHRNLVRLLGCCV 508 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l-~hpniv~l~~~~~ 508 (754)
.....++|++.+.||+|+||.||++.. ..+.+.+|+++++++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 345668999999999999999997321 236789999999999 8999999999999
Q ss_pred ecCeeEEEEEecCCCChhhHhhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeC
Q 036419 509 EQGENVLIYEYLPNKSLDSFLFDTTKE--------------------GLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHR 568 (754)
Q Consensus 509 ~~~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~ 568 (754)
..+..++||||+++++|.+++...... ..+++..+..++.||+.||.|||+.+ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 999999999999999999999754321 34899999999999999999999998 9999
Q ss_pred CCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 036419 569 DLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTR 647 (754)
Q Consensus 569 Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~ 647 (754)
||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999987654433333445667889999999999999999999999999999998 999986
Q ss_pred cccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 036419 648 FFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVN 720 (754)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 720 (754)
........ .... ... .........++.+.+++.+||+.||.+|||+.+|+++|+.....
T Consensus 277 ~~~~~~~~-~~~~----~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVDANF-YKLI----QNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCSHHH-HHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcHHHH-HHHH----hcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 55433211 1111 111 00111122356789999999999999999999999999987443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=346.54 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=202.9
Q ss_pred hhhHhhhhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeeeeeee
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVRLLGC 506 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~l~~~ 506 (754)
+..+....++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 344556778999999999999999997321 14678999999999999999999999
Q ss_pred eeecCeeEEEEEecCCCChhhHhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 036419 507 CVEQGENVLIYEYLPNKSLDSFLFDTTK---------------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565 (754)
Q Consensus 507 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i 565 (754)
+.++...++||||+++++|.+++..... ...+++.+++.++.||++||.|||+++ |
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 9999999999999999999999976422 256999999999999999999999998 9
Q ss_pred eeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCC
Q 036419 566 IHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKR 644 (754)
Q Consensus 566 iH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~ 644 (754)
+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999987654433333345678999999999999999999999999999999999 888
Q ss_pred CCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 645 STRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 645 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
||....... ..... ...... ......+..+.+++.+||+.||++|||+.+|+++|+....
T Consensus 276 p~~~~~~~~--~~~~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 276 PYYGMAHEE--VIYYV----RDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTTTSCHHH--HHHHH----HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCCCCChHH--HHHHH----hCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 876433221 11111 111110 1112234678999999999999999999999999998744
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.70 Aligned_cols=240 Identities=28% Similarity=0.449 Sum_probs=197.3
Q ss_pred hhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
..++|++.+.||+|+||.||++ ....+++.+|++++++++||||+++++++.++...++||||+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 3468999999999999999972 224578999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++++|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 99999999954 3346899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ...... ... ..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~---~~~---~~------- 226 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIS---TGF---RL------- 226 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH---TTC---CC-------
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHh---cCc---cC-------
Confidence 22234567888999999999999999999999999999999 888876433221 111110 000 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
......++.+.+++.+||+.||++|||+.+++++|+..
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11112346688999999999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.38 Aligned_cols=237 Identities=24% Similarity=0.292 Sum_probs=193.8
Q ss_pred hhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 45789999999999999999721 124789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC----ceEEeec
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM----IPKISDF 588 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~----~~kl~DF 588 (754)
.++||||+++++|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999994 3456999999999999999999999998 99999999999998877 7999999
Q ss_pred cCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...... . ..
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--~~~~i~---~-~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANIT---A-VS 234 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHH---T-TC
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH---h-cC
Confidence 9998765432 2335679999999999999999999999999999999999999986543221 111110 0 00
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
. ..++. .....++.+.+++.+||+.||++|||+.|+++|-
T Consensus 235 ~--~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 235 Y--DFDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp C--CCCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred C--CCCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 00000 0012346788999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=341.47 Aligned_cols=233 Identities=21% Similarity=0.256 Sum_probs=192.8
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 3689999999999999999721 2345788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999954 346899999999999999999999998 99999999999999999999999999986432
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.... .... . .
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i---~~~~-~------~ 223 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELI---LMEE-I------R 223 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---HHCC-C------C
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--HHHHH---HcCC-C------C
Confidence 22 22345789999999999999999999999999999999999999986433221 11111 1000 0 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 714 (754)
.....++.+.+++.+||+.||++|| ++++|++|-
T Consensus 224 ----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 1112346788999999999999999 999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=333.31 Aligned_cols=249 Identities=26% Similarity=0.316 Sum_probs=191.7
Q ss_pred hhcCccccceeccCCCcceeec-------------cccHHHHHHHHHHHHh--hccCCeeeeeeeeeec----CeeEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS-------------GQGLEEFKNEIKLTAK--LQHRNLVRLLGCCVEQ----GENVLIY 517 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~-------------~~~~~~~~~Ev~il~~--l~hpniv~l~~~~~~~----~~~~lV~ 517 (754)
..++|++.++||+|+||.||++ ....+.+.+|.+++.. ++||||+++++++... ...++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 4578999999999999999983 2345667778887777 7899999999987543 4589999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH--------QYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
||+++++|.+++. ...+++..+..++.||+.||.||| +.+ |+||||||+|||++.++.+||+|||
T Consensus 86 e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 86 HYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp CCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCT
T ss_pred hhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCC
Confidence 9999999999993 346999999999999999999999 665 9999999999999999999999999
Q ss_pred CccccCCCccc--ccccccccccCcccccccccC------CCCcccchhhHHHHHHHHHhC----------CCCCCcccC
Q 036419 590 LARMFGGDELQ--SNTKRIVGTYGYMSPEYAIHG------FFSIKSDVFSFGVLLLETLSS----------KRSTRFFNT 651 (754)
Q Consensus 590 la~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~------~~s~ksDVwSlGvil~elltg----------~~p~~~~~~ 651 (754)
+++........ .......||+.|+|||++.+. .++.++|||||||++|||++| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 99876443221 112345799999999999876 456799999999999999999 677654333
Q ss_pred CchhHhHhhhhhhccCccccccCcccC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 652 NSLTLLGHAWNLWKDDRSWELMDPKLQ-CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~l~d~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
................ ..+... .......++.+.+++.+||+.||++|||+.+|+++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCCHHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcchhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2211111111111111 011111 112234678899999999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.77 Aligned_cols=238 Identities=21% Similarity=0.291 Sum_probs=194.4
Q ss_pred hcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 5789999999999999999731 23466889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC--CCceEEeeccCccccCCCc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS--NMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~--~~~~kl~DFgla~~~~~~~ 598 (754)
++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+....
T Consensus 84 ~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999953 2346999999999999999999999998 999999999999987 7899999999999775432
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...... ..... .+.
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~---~~~~~---~~~--- 224 (321)
T 1tki_A 159 N---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIENIM---NAEYT---FDE--- 224 (321)
T ss_dssp E---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHH---HTCCC---CCH---
T ss_pred c---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH--HHHHHH---cCCCC---CCh---
Confidence 2 234678999999999998889999999999999999999999986543221 111111 00000 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
......++.+.+++.+||+.||++|||+.|+++|--
T Consensus 225 -~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 225 -EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp -HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 000123467899999999999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.08 Aligned_cols=249 Identities=26% Similarity=0.396 Sum_probs=203.0
Q ss_pred HhhhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeee
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCV 508 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~ 508 (754)
.....++|++.+.||+|+||.||++. ...+.+.+|+++++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 34556789999999999999999742 1246789999999999 8999999999999
Q ss_pred ecCeeEEEEEecCCCChhhHhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCC
Q 036419 509 EQGENVLIYEYLPNKSLDSFLFDTTK---------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPS 573 (754)
Q Consensus 509 ~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~ 573 (754)
+++..++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 99999999999999999999976432 225899999999999999999999998 999999999
Q ss_pred ceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCC
Q 036419 574 NILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTN 652 (754)
Q Consensus 574 NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~ 652 (754)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |+.||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999997765443333445667889999999999999999999999999999998 99888654433
Q ss_pred chhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 653 SLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
... ..... .. . ........+..+.+++.+||+.||.+|||+.+|+++|+....
T Consensus 255 ~~~-~~~~~----~~-----~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 255 SKF-YKMIK----EG-----F----RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHH-HHHHH----HT-----C----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHH-HHHhc----cC-----C----CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 211 11111 00 0 001112234678999999999999999999999999987643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=344.87 Aligned_cols=240 Identities=25% Similarity=0.354 Sum_probs=192.2
Q ss_pred hcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 4689999999999999999732 12245678999999999999999999886 56789
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++++|.+++... .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999999643 346889999999999999999999998 999999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.............||..|+|||++.+..++.++||||||+++|+|++ |+.||......... ... ..... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~----~~~~~--~~ 237 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP--DLL----EKGER--LA 237 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH--HHH----HTTCB--CC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH--HHH----HcCCC--CC
Confidence 65544344455678889999999999999999999999999999999 99998754433211 111 01100 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.....+..+.+++.+||+.||.+|||+.+|+++|+...
T Consensus 238 -------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 238 -------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112335778999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.44 Aligned_cols=242 Identities=25% Similarity=0.373 Sum_probs=198.3
Q ss_pred hhhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 456 AATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
...++|++.+.||+|+||.||++ ....+++.+|++++.+++||||+++++++.++...++||||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 34578999999999999999972 22467899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999999653 235899999999999999999999998 99999999999999999999999999987655433
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
.. .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......... ... .... ....
T Consensus 160 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~~---~~~~---~~~~---- 226 (268)
T 3sxs_A 160 VS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV--LKV---SQGH---RLYR---- 226 (268)
T ss_dssp EE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--HHH---HTTC---CCCC----
T ss_pred hc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH--HHH---HcCC---CCCC----
Confidence 22 233456778999999999899999999999999999999 99887644322211 111 0000 0011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
....++.+.+++.+||+.||++|||+.+|+++|+...
T Consensus 227 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 ---PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp ---CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred ---CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1112456889999999999999999999999998763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=353.60 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=196.4
Q ss_pred hhhcCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
...++|++.++||+|+||.||++.. ..+++.+|++++++++||||+++++++.+++..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 4457899999999999999997321 124678999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999999643 235899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
...........++..|+|||++....++.++|||||||++|||++ |..|+....... ...... ...+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~~---~~~~------- 333 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFVE---KGGR------- 333 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHHH---TTCC-------
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---cCCC-------
Confidence 433222233456788999999999999999999999999999998 888876543221 111110 1110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.......++.+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 334 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 ---LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 011112346788999999999999999999999999865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=350.51 Aligned_cols=242 Identities=27% Similarity=0.466 Sum_probs=185.1
Q ss_pred hhcCccccceeccCCCcceeeccc----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
..++|++.+.||+|+||.||++.. ..+++.+|++++++++||||+++++++.++...+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 346899999999999999997321 2357899999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++++|.+++... ...+++.++..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999642 346999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 595 GGDELQ-SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 595 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
...... .......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ...... ..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~i~----~~----- 266 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKAVD----EG----- 266 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHHHH----TT-----
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH----cC-----
Confidence 543211 11222345778999999999999999999999999999998 999975433221 111110 00
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.........+..+.+++.+||+.||++||++.+|+++|+...
T Consensus 267 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 267 ----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 011112234567899999999999999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=353.63 Aligned_cols=239 Identities=23% Similarity=0.327 Sum_probs=192.8
Q ss_pred hhhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
...++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 456789999999999999999721 134678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc---CCCceEEeeccCcc
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD---SNMIPKISDFGLAR 592 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld---~~~~~kl~DFgla~ 592 (754)
||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999999854 356999999999999999999999998 99999999999998 56789999999998
Q ss_pred ccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... +..... .+.. .
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--~~~~i~----~~~~-~- 231 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--LYQQIK----AGAY-D- 231 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH----HTCC-C-
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--HHHHHH----hCCC-C-
Confidence 7654322 2234689999999999999999999999999999999999999986433221 111111 0000 0
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.........++.+.+++.+||+.||++|||+.|+++|-
T Consensus 232 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 232 ----FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp ----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred ----CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 00111123356788999999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=342.71 Aligned_cols=251 Identities=22% Similarity=0.371 Sum_probs=188.4
Q ss_pred hhhHhhhhcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeee
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCC 507 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~ 507 (754)
+.++....++|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 34455667899999999999999999732 1246788999999999999999999999
Q ss_pred eecCee------EEEEEecCCCChhhHhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc
Q 036419 508 VEQGEN------VLIYEYLPNKSLDSFLFDTTK---EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD 578 (754)
Q Consensus 508 ~~~~~~------~lV~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld 578 (754)
...... ++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~ 171 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLA 171 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEc
Confidence 877665 999999999999999965432 225899999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHh
Q 036419 579 SNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLL 657 (754)
Q Consensus 579 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~ 657 (754)
+++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||........ .
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~ 249 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--Y 249 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--H
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--H
Confidence 999999999999987755443333344567889999999999999999999999999999999 8888765433221 1
Q ss_pred HhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 658 GHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 658 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
... ..... .......++.+.+++.+||+.||++|||+.++++.|+....
T Consensus 250 ~~~---~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 250 NYL---IGGNR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHH---HTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH---hcCCC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111 11110 01112344678999999999999999999999999987644
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=344.04 Aligned_cols=240 Identities=24% Similarity=0.390 Sum_probs=189.1
Q ss_pred hcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
.++|++.++||+|+||.||++. ...+++.+|++++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 4689999999999999999722 24578999999999999999999999998764 88
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+|+||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999999653 346999999999999999999999998 999999999999999999999999999977
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.............+|+.|+|||++.+..++.++|||||||++|||++ |..||......... ... ....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~--~~~----~~~~----- 236 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--SIL----EKGE----- 236 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--HHH----HTTC-----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH--HHH----HcCC-----
Confidence 55443333444567889999999999999999999999999999999 99998654433211 111 0010
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
........+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 237 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 ----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01112224457889999999999999999999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.69 Aligned_cols=237 Identities=31% Similarity=0.500 Sum_probs=186.7
Q ss_pred hcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 4689999999999999999731 23467899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC--------CCceEEeecc
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS--------NMIPKISDFG 589 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~--------~~~~kl~DFg 589 (754)
||+++++|.+++. ...+++..+..++.||++||.|||+++..+|+||||||+|||++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999994 346899999999999999999999987556999999999999986 6789999999
Q ss_pred CccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcc
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
+++...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... .......
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~-- 230 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA-----YGVAMNK-- 230 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-----HHHHTSC--
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HhhhcCC--
Confidence 998664332 22457899999999999999999999999999999999999998654322111 0000011
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
.........++.+.+++.+||+.||++|||+.+++++|+.
T Consensus 231 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 -------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0111122334678999999999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=333.79 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=186.8
Q ss_pred HhhhhcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
.+...++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++ .....++|
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34566889999999999999999721 2346789999999999999999999965 55678999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999954 2356999999999999999999999998 99999999999999999999999999986654
Q ss_pred CcccccccccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAI---HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
...........||+.|+|||++. ...++.++||||||+++|+|++|+.||........ +..... ....
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~----~~~~---- 243 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEMVG----RGSL---- 243 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHHHHH----HTSC----
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHHHhc----cccc----
Confidence 33233344567999999999986 56789999999999999999999999865433221 111111 1111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.+.. .......++.+.+++.+||+.||++|||+.+|+++|+...
T Consensus 244 ~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred Ccch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0100 0111234577899999999999999999999999998763
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=338.51 Aligned_cols=237 Identities=23% Similarity=0.306 Sum_probs=193.4
Q ss_pred hhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.++..
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 44679999999999999999721 135789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC----ceEEeec
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM----IPKISDF 588 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~----~~kl~DF 588 (754)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999943 456999999999999999999999998 99999999999999887 8999999
Q ss_pred cCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....... ..
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~---~~- 233 (326)
T 2y0a_A 163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANVSA---VN- 233 (326)
T ss_dssp TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHH---TC-
T ss_pred CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHHh---cC-
Confidence 9998765332 2334679999999999998999999999999999999999999986433221 1111100 00
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...........+..+.+++.+||+.||++|||+.++++|-
T Consensus 234 ------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 234 ------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp ------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred ------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 0000000012346688999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=333.70 Aligned_cols=244 Identities=27% Similarity=0.399 Sum_probs=196.7
Q ss_pred hHhhhhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
......++|++.++||+|+||.||++ ....+++.+|++++++++||||+++++++.++...++|
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 34456678999999999999999972 22467899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 98 TEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp ECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9999999999999653 345999999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ..... .... ..
T Consensus 173 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~---~~~~------~~ 240 (283)
T 3gen_A 173 DEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHI---AQGL------RL 240 (283)
T ss_dssp HHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHH---HTTC------CC
T ss_pred ccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHHHH---hccc------CC
Confidence 322 12233457788999999999999999999999999999998 999986543222 11111 0000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
......++.+.+++.+||+.||++|||+.+++++|+..
T Consensus 241 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 241 ----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11112246788999999999999999999999999865
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=357.06 Aligned_cols=254 Identities=28% Similarity=0.455 Sum_probs=199.4
Q ss_pred HhhhhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++...++|++.++||+|+||.||++ ....+++.+|++++++++||||+++++++.+ +..++||
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 4456678999999999999999972 1245789999999999999999999999876 6789999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999642 2245899999999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
... ......++..|+|||++....++.++||||||+++|||++ |+.|+......+ ...... ...+
T Consensus 334 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~---~~~~-------- 399 (452)
T 1fmk_A 334 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVE---RGYR-------- 399 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHH---TTCC--------
T ss_pred cee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---cCCC--------
Confidence 221 1223456789999999999999999999999999999999 888876443221 111111 1100
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCCCCCC
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPG 728 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~ 728 (754)
.......++.+.+++.+||+.||++|||+++|+++|+.......+..+|+
T Consensus 400 --~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~ 449 (452)
T 1fmk_A 400 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449 (452)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccccc
Confidence 11122345678999999999999999999999999998877666665554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.87 Aligned_cols=246 Identities=18% Similarity=0.224 Sum_probs=196.3
Q ss_pred hhcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
..++|++.+.||+|+||.||++. ...+.+.+|+++++++ +||||+++++++..+...++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 34789999999999999999732 2235689999999999 999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc-----eEEeeccCcccc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI-----PKISDFGLARMF 594 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~-----~kl~DFgla~~~ 594 (754)
+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.+
T Consensus 87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 87 L-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred C-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9 99999999653 356999999999999999999999998 999999999999998887 999999999976
Q ss_pred CCCcccc-----cccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch-hHhHhhhhhhccCc
Q 036419 595 GGDELQS-----NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-TLLGHAWNLWKDDR 668 (754)
Q Consensus 595 ~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~ 668 (754)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .........-...
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~- 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT- 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS-
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC-
Confidence 4432211 12457899999999999999999999999999999999999999976543331 1111110000000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
..... ....+ .+.+++..||+.||.+||++++|++.|+...
T Consensus 240 -----~~~~~---~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 240 -----PIEVL---CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp -----CHHHH---TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -----CHHHH---hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 00000 00112 7899999999999999999999999997543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=331.08 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=188.6
Q ss_pred cCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
++|++.++||+|+||+||++. ...+.+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 579999999999999999721 124678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|++++ +.+++.. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~-l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQD-LKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEE-HHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCC-HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99874 4444432 2356999999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc------ccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGF-FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR------SWE 671 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~ 671 (754)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..|+.........+ ........... ...
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH-HHHHHHHCCCCTTTCTTGGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHHhCCCChhhhhhhcc
Confidence 2233467899999999998765 8999999999999999999998863322221111 11111110000 000
Q ss_pred ccC---------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 672 LMD---------PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 672 l~d---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
..+ ............+.+.+++.+||+.||++|||++|+++|-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 000 0000111123457788999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=340.20 Aligned_cols=251 Identities=26% Similarity=0.392 Sum_probs=192.4
Q ss_pred hhcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee--cCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE--QGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~--~~~ 512 (754)
..++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 45789999999999999998743 123678899999999999999999999864 456
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 899999999999999996532 35899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccc-ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch----------hHhHhhh
Q 036419 593 MFGGDELQ-SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL----------TLLGHAW 661 (754)
Q Consensus 593 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~----------~~~~~~~ 661 (754)
........ .......++..|+|||++.+..++.++||||||+++|||++|..|+........ .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 76543221 222334577889999999999999999999999999999999988753321100 0000011
Q ss_pred hhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 036419 662 NLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNL 721 (754)
Q Consensus 662 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 721 (754)
..... ..........++.+.+++.+||+.||++|||+.+|+++|+.+...+
T Consensus 243 ~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 243 ELLKN---------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHT---------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHhc---------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11111 1111112234577899999999999999999999999998765444
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=359.13 Aligned_cols=244 Identities=27% Similarity=0.432 Sum_probs=200.8
Q ss_pred hhhhcCccccceeccCCCcceeec-----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKS-----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~-----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
+....+|++.++||+|+||.||++ ....+++.+|++++++++||||+++++++.+....++||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 345578999999999999999972 224678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 296 E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 296 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999999653 2345899999999999999999999998 999999999999999999999999999977544
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
... ......++..|+|||++....++.++|||||||++|||++ |..|+....... ...... ..
T Consensus 372 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~~~----~~--------- 435 (495)
T 1opk_A 372 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLE----KD--------- 435 (495)
T ss_dssp CEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHH----TT---------
T ss_pred cee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH----cC---------
Confidence 322 2233456789999999999999999999999999999999 888876544322 111111 10
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.........++.+.+++.+||+.||++|||+.+|++.|+...
T Consensus 436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 011112234567889999999999999999999999998864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.72 Aligned_cols=248 Identities=29% Similarity=0.417 Sum_probs=200.6
Q ss_pred hHhhhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeee
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCC 507 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~ 507 (754)
......++|++.+.||+|+||.||++. ...+.+.+|+++++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345567899999999999999999732 1246788999999999 899999999999
Q ss_pred eecCeeEEEEEecCCCChhhHhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceE
Q 036419 508 VEQGENVLIYEYLPNKSLDSFLFDTTK-----------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNIL 576 (754)
Q Consensus 508 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIl 576 (754)
.+++..++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 999999999999999999999965321 346899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchh
Q 036419 577 LDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLT 655 (754)
Q Consensus 577 ld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~ 655 (754)
++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..|+.........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999987654333233344567889999999999999999999999999999998 88887654333211
Q ss_pred HhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 656 LLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 656 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.... .... ........++.+.+++.+||+.||.+|||+.+|+++|+..
T Consensus 277 -~~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 -YKLV----KDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -HHHH----HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHH----hcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111 0100 0011112246788999999999999999999999999865
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=342.90 Aligned_cols=234 Identities=23% Similarity=0.325 Sum_probs=192.5
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3689999999999999999721 2346788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999953 456999999999999999999999998 99999999999999999999999999997654
Q ss_pred CcccccccccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchh-HhHhhhhhhccCccccc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIH---GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLT-LLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~l 672 (754)
.. .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||......... ...... ...
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~~~---- 236 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TTV---- 236 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----HCC----
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----hcc----
Confidence 32 2345789999999999874 45899999999999999999999998755443321 111110 000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPT-MSEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L 714 (754)
.......+..+.+++.+||+.||.+||+ +++|++|-
T Consensus 237 ------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp 273 (384)
T 4fr4_A 237 ------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP 273 (384)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSG
T ss_pred ------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcCh
Confidence 0111223467899999999999999998 88887643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=334.34 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=191.8
Q ss_pred hhhcCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
...++|++.++||+|+||.||++.. ..+.+.+|++++++++||||+++++++.++...++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 4457899999999999999997321 235688999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999986 77777754 3345899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC---c----
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD---R---- 668 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~---- 668 (754)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .......... .
T Consensus 172 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 172 PV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PKIFSILGTPNPREWPQV 247 (311)
T ss_dssp CC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HHHHHHHCCCCTTTSGGG
T ss_pred Cc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHHCCCChHHhhhh
Confidence 22 12334578999999999876 56899999999999999999999998765443311 1111100000 0
Q ss_pred ---------cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 669 ---------SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 669 ---------~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.....+............+++.+++.+||+.||++|||++|+++|-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 302 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 0000110000001112346788999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.67 Aligned_cols=234 Identities=25% Similarity=0.335 Sum_probs=192.4
Q ss_pred ccccceeccCCCcceeec------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 461 FGVENKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
|...++||+|+||.||++ ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 777889999999999973 22357789999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 127 ~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 197 (321)
T 2c30_A 127 GALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 197 (321)
T ss_dssp CBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence 999999843 45899999999999999999999988 99999999999999999999999999987654322 2
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ....... .. ..+.. ...
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~~~~----~~-----~~~~~--~~~ 264 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLR----DS-----PPPKL--KNS 264 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHH----HS-----SCCCC--TTG
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh----cC-----CCCCc--Ccc
Confidence 33567999999999999999999999999999999999999998643221 1111111 00 01111 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
...++.+.+++.+||+.||++|||+.+++++.--
T Consensus 265 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 298 (321)
T 2c30_A 265 HKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298 (321)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 2234678899999999999999999999997643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=342.77 Aligned_cols=238 Identities=24% Similarity=0.351 Sum_probs=193.1
Q ss_pred hhhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
...++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 345789999999999999999721 124678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC---ceEEeeccCcc
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM---IPKISDFGLAR 592 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~---~~kl~DFgla~ 592 (754)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999999843 456899999999999999999999998 99999999999998654 59999999998
Q ss_pred ccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... +..... .... ..
T Consensus 180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~~i~----~~~~-~~ 249 (362)
T 2bdw_A 180 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQIK----AGAY-DY 249 (362)
T ss_dssp CCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH----HTCC-CC
T ss_pred EecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH----hCCC-CC
Confidence 765432 2334679999999999999999999999999999999999999986433211 111111 0000 00
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
........++.+.+++.+||+.||++|||+.++++|-
T Consensus 250 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 250 -----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp -----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred -----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 0011123456789999999999999999999999873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=345.23 Aligned_cols=240 Identities=19% Similarity=0.283 Sum_probs=190.5
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~ 514 (754)
..++|++.++||+|+||+||++. ...+.+.+|..++.++ +||||+++++++.++...+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 34689999999999999999721 1224578999999887 8999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++|+|..++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999999964 346999999999999999999999998 999999999999999999999999999863
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchh---HhHhhhhhhccCcccc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLT---LLGHAWNLWKDDRSWE 671 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 671 (754)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .............
T Consensus 204 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 278 (396)
T 4dc2_A 204 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 278 (396)
T ss_dssp CCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred ccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence 3221 2244578999999999999999999999999999999999999999644322110 0011111100110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHH
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTM------SEVISML 714 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~L 714 (754)
. ..+...+..+.+++.+||+.||++||++ .+|++|-
T Consensus 279 -----~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 279 -----I--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp -----C--CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred -----c--CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 0 1112245678899999999999999985 6777664
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=339.01 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=202.0
Q ss_pred hhhHhhhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeee
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGC 506 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~ 506 (754)
..++....++|++.+.||+|+||.||++. ....++.+|++++++++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 34556677899999999999999999731 123568899999999999999999999
Q ss_pred eeecCeeEEEEEecCCCChhhHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC
Q 036419 507 CVEQGENVLIYEYLPNKSLDSFLFDTTK-------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS 579 (754)
Q Consensus 507 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~ 579 (754)
+.++...++||||+++++|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcC
Confidence 9999999999999999999999965321 245789999999999999999999998 999999999999999
Q ss_pred CCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhH
Q 036419 580 NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLG 658 (754)
Q Consensus 580 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 658 (754)
++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..|+....... ...
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~ 251 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLR 251 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--HHH
Confidence 99999999999987654433333444567889999999999999999999999999999999 788875433211 111
Q ss_pred hhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 659 HAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 659 ~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.. ...... ......+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus 252 ~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 252 FV----MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HH----HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HH----HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 11 111110 11123446788999999999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=342.57 Aligned_cols=240 Identities=23% Similarity=0.307 Sum_probs=193.1
Q ss_pred hhcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~ 513 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34679999999999999999721 1356789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc---eEEeecc
Q 036419 514 VLIYEYLPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI---PKISDFG 589 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~---~kl~DFg 589 (754)
++||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999988886543 2345899999999999999999999998 999999999999986654 9999999
Q ss_pred CccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcc
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+.... .... .
T Consensus 179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~i---~~~~-~ 249 (351)
T 3c0i_A 179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RLFEGI---IKGK-Y 249 (351)
T ss_dssp TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HHHHHH---HHTC-C
T ss_pred ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HHHHHH---HcCC-C
Confidence 9987754322 23346799999999999999999999999999999999999999865321 111111 0000 0
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...+.. ....++.+.+++.+||+.||++|||+.++++|-
T Consensus 250 --~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 250 --KMNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp --CCCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --CCCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 000000 012346789999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=331.58 Aligned_cols=247 Identities=27% Similarity=0.426 Sum_probs=202.8
Q ss_pred hhHhhhhcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 452 ASVSAATNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 452 ~~~~~~~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
...+...++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...+
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 3455667899999999999999999732 23578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 86 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999999653 3356899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..|+........ ..... ..
T Consensus 162 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--~~~~~----~~------ 228 (288)
T 3kfa_A 162 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELLE----KD------ 228 (288)
T ss_dssp CSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHHH----TT------
T ss_pred cCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHh----cc------
Confidence 54432 22234567889999999999999999999999999999999 8888765433221 11110 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.........++.+.+++.+||+.||.+|||+.+|+++|+...
T Consensus 229 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 229 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 011111233467899999999999999999999999998653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=356.54 Aligned_cols=247 Identities=28% Similarity=0.438 Sum_probs=199.9
Q ss_pred HhhhhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
+....++|++.++||+|+||.||++ ....+++.+|++++++++||||+++++++. .+..++||
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 4556678999999999999999973 224678999999999999999999999986 66789999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 262 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred eecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999996432 235889999999999999999999998 999999999999999999999999999976543
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
... ......++..|+|||++....++.++|||||||++|||++ |+.||......+ ...... ...+
T Consensus 338 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~---~~~~-------- 403 (454)
T 1qcf_A 338 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALE---RGYR-------- 403 (454)
T ss_dssp HHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH---HTCC--------
T ss_pred cee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---cCCC--------
Confidence 221 1223456789999999999999999999999999999999 999986443221 111111 1110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNL 721 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 721 (754)
.......++.+.+++.+||+.||++|||+++|+++|+......
T Consensus 404 --~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 404 --MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 0111234567899999999999999999999999999875543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.11 Aligned_cols=239 Identities=25% Similarity=0.363 Sum_probs=185.2
Q ss_pred hhhcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhcc--CCeeeeeeeeeecCeeE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQH--RNLVRLLGCCVEQGENV 514 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~h--pniv~l~~~~~~~~~~~ 514 (754)
...++|++.++||+|+||.||++. ...+.+.+|++++.+++| |||+++++++.++...+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 446789999999999999999721 124678999999999987 99999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||| +.+++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+
T Consensus 86 lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999 568899999964 356899999999999999999999998 99999999999997 578999999999977
Q ss_pred CCCcccccccccccccCccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIH-----------GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL 663 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 663 (754)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+ ..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----~~- 232 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----HA- 232 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH----HH-
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH----HH-
Confidence 55443333445689999999999865 678999999999999999999999986432211111 11
Q ss_pred hccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 664 WKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 664 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.+++...........+.+.+++.+||+.||++|||+.++++|.-
T Consensus 233 --------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 233 --------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp --------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 11111111111122356889999999999999999999998864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=336.12 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=192.7
Q ss_pred chhhHhhhhcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeee
Q 036419 450 SLASVSAATNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGC 506 (754)
Q Consensus 450 ~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~ 506 (754)
.+.++....++|++.+.||+|+||.||++. ...+.+.+|++++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 345556677899999999999999999621 123568899999999999999999999
Q ss_pred eeecCe-----eEEEEEecCCCChhhHhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc
Q 036419 507 CVEQGE-----NVLIYEYLPNKSLDSFLFDT---TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD 578 (754)
Q Consensus 507 ~~~~~~-----~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld 578 (754)
+.+... .++||||+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+|||++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~ 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEEC
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEc
Confidence 987653 49999999999999998543 23356999999999999999999999988 99999999999999
Q ss_pred CCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHh
Q 036419 579 SNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLL 657 (754)
Q Consensus 579 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~ 657 (754)
.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..|+........ .
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~ 259 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--Y 259 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--H
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--H
Confidence 999999999999987654433333344567889999999999999999999999999999999 8888765433221 1
Q ss_pred HhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 036419 658 GHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLP 722 (754)
Q Consensus 658 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 722 (754)
... ..... + ......++.+.+++.+||+.||.+|||+.+|+++|+.....+|
T Consensus 260 ~~~---~~~~~------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 260 DYL---LHGHR------L----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHH---HTTCC------C----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHH---HcCCC------C----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 111 11100 0 1112234678999999999999999999999999998755444
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=332.37 Aligned_cols=241 Identities=24% Similarity=0.328 Sum_probs=184.4
Q ss_pred hhhhcCccccceeccCCCcceeeccc----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSGQ----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~~----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
....++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++. ++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 44567899999999999999997321 2457889999999999999999999984 567
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 89999999999999999643 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
........ ......+|+.|+|||++....++.++||||||+++|||++ |..||........ ..... ....
T Consensus 165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~~i~---~~~~--- 235 (281)
T 1mp8_A 165 YMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIE---NGER--- 235 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHH---TTCC---
T ss_pred ccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HHHHH---cCCC---
Confidence 76543221 1233456789999999999999999999999999999996 8888865433221 11110 0000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.......++.+.+++.+||+.||++|||+.+|+++|+..
T Consensus 236 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011123456788999999999999999999999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=343.65 Aligned_cols=234 Identities=22% Similarity=0.293 Sum_probs=187.7
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~ 514 (754)
..++|++.+.||+|+||.||++. ...+.+.+|+++++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 34789999999999999999732 1235678899999988 6999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999999543 45999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.... ....
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~~i---~~~~------- 240 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEAI---LNDE------- 240 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---HHCC-------
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--HHHHH---HcCC-------
Confidence 3222 22345689999999999999999999999999999999999999986543322 11111 1110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHH
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTM------SEVISML 714 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~L 714 (754)
. .......+.+.+++.+||+.||.+||++ .++++|-
T Consensus 241 --~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 241 --V--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp --C--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred --C--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 0 0111234678899999999999999998 8888764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.96 Aligned_cols=256 Identities=29% Similarity=0.395 Sum_probs=195.0
Q ss_pred cCc-cccceeccCCCcceeec-----------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeec--Ce
Q 036419 459 NNF-GVENKLGEGGFGPVYKS-----------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GE 512 (754)
Q Consensus 459 ~~y-~~~~~lG~G~fg~Vyk~-----------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~ 512 (754)
++| ++.++||+|+||.||+. ....+.+.+|++++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 99999999999999641 12246789999999999999999999999874 67
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 8999999999999999954 24899999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCccc-ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 593 MFGGDELQ-SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 593 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
........ .......||..|+|||++.+..++.++||||||+++|+|++|+.|+........................+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 87543221 22334568889999999999999999999999999999999999976432211100000000000000111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNL 721 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 721 (754)
.++...........+..+.+++.+||+.||++|||+.+|++.|+......
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11111111222334577999999999999999999999999998764433
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=338.80 Aligned_cols=237 Identities=26% Similarity=0.364 Sum_probs=187.2
Q ss_pred hcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC-------
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG------- 511 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~------- 511 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4679999999999999999721 23577999999999999999999999986543
Q ss_pred --------------------------------------------------eeEEEEEecCCCChhhHhhccCCCCCCCHH
Q 036419 512 --------------------------------------------------ENVLIYEYLPNKSLDSFLFDTTKEGLLGWG 541 (754)
Q Consensus 512 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 541 (754)
..++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999876555567788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc----------ccccccccccC
Q 036419 542 ARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ----------SNTKRIVGTYG 611 (754)
Q Consensus 542 ~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~----------~~~~~~~gt~~ 611 (754)
.+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 999999999999999999999999999987543211 12234579999
Q ss_pred cccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHH
Q 036419 612 YMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYIN 691 (754)
Q Consensus 612 y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~ 691 (754)
|+|||++.+..++.++|||||||++|||++|..|+... ...... ...... ..........+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~~~~~~----~~~~~~---------~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----VRIITD----VRNLKF---------PLLFTQKYPQEHM 304 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----HHHHHH----HHTTCC---------CHHHHHHCHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----HHHHHH----hhccCC---------CcccccCChhHHH
Confidence 99999999999999999999999999999987663210 000000 000000 0011233466789
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 036419 692 VALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 692 li~~cl~~dP~~RPt~~evl~~L 714 (754)
++.+||+.||++|||+.+++++-
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHST
T ss_pred HHHHHccCCCCcCCCHHHHhhch
Confidence 99999999999999999999863
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=326.06 Aligned_cols=253 Identities=16% Similarity=0.216 Sum_probs=201.6
Q ss_pred hhcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
..++|++.+.||+|+||.||++. ...+.+.+|+++++++ +|+|++++++++.++...++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 45789999999999999999832 2345688999999999 799999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc-----eEEeeccCcccc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI-----PKISDFGLARMF 594 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~-----~kl~DFgla~~~ 594 (754)
+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 88 ~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 88 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 9 99999999653 345999999999999999999999988 999999999999987776 999999999977
Q ss_pred CCCccc-----ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhhhhhhccCc
Q 036419 595 GGDELQ-----SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHAWNLWKDDR 668 (754)
Q Consensus 595 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~ 668 (754)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ...............
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 543221 12345679999999999999999999999999999999999999987654332 111111111000000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCC
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSP 724 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p 724 (754)
..+ . ....++.+.+++.+||+.||++||++++|++.|+........+
T Consensus 242 ~~~-----~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 242 LRE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp HHH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHH-----H----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 000 0 1123467899999999999999999999999999765544443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=340.03 Aligned_cols=247 Identities=25% Similarity=0.416 Sum_probs=200.8
Q ss_pred hhhhcCccccceeccCCCcceeeccc--------------------------cHHHHHHHHHHHHhh-ccCCeeeeeeee
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSGQ--------------------------GLEEFKNEIKLTAKL-QHRNLVRLLGCC 507 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~~--------------------------~~~~~~~Ev~il~~l-~hpniv~l~~~~ 507 (754)
....++|++.+.||+|+||.||++.. ..+.+.+|+++++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 44568999999999999999997421 235688999999999 899999999999
Q ss_pred eecCeeEEEEEecCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 036419 508 VEQGENVLIYEYLPNKSLDSFLFDTTK-------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSN 574 (754)
Q Consensus 508 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~N 574 (754)
.+.+..++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 999999999999999999999976432 234899999999999999999999998 9999999999
Q ss_pred eEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCc
Q 036419 575 ILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNS 653 (754)
Q Consensus 575 Illd~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~ 653 (754)
||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+.......
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 9999999999999999997765443333445567889999999999999999999999999999999 998876443221
Q ss_pred hhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
+..... .... .......+..+.+++.+||+.||.+|||+.+|+++|+.+..
T Consensus 268 --~~~~~~----~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 268 --LFKLLK----EGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp --HHHHHH----HTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHh----cCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111 1100 01112234678899999999999999999999999987643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=333.00 Aligned_cols=233 Identities=22% Similarity=0.314 Sum_probs=184.8
Q ss_pred hcCccccceeccCCCcceeeccc--------------------------------------------cHHHHHHHHHHHH
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ--------------------------------------------GLEEFKNEIKLTA 493 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~--------------------------------------------~~~~~~~Ev~il~ 493 (754)
.++|++.+.||+|+||.||++.. ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999997311 1246889999999
Q ss_pred hhccCCeeeeeeeeee--cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 036419 494 KLQHRNLVRLLGCCVE--QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLK 571 (754)
Q Consensus 494 ~l~hpniv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlk 571 (754)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||++||.|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 56889999999999998865 2356999999999999999999999998 9999999
Q ss_pred CCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCc
Q 036419 572 PSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF---FSIKSDVFSFGVLLLETLSSKRSTRF 648 (754)
Q Consensus 572 p~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~ksDVwSlGvil~elltg~~p~~~ 648 (754)
|+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654322 123457999999999987765 47899999999999999999999864
Q ss_pred ccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 649 FNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.... .+..... .... ........++.+.+++.+||+.||++|||+.|+++|
T Consensus 243 ~~~~--~~~~~~~----~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ERIM--CLHSKIK----SQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSHH--HHHHHHH----HCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ccHH--HHHHHHh----cccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 3221 1111110 0000 001112234678999999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=349.59 Aligned_cols=245 Identities=21% Similarity=0.261 Sum_probs=197.0
Q ss_pred hhhHhhhhcCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeee
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~ 509 (754)
+.++....++|++.++||+|+||.||++.. ..+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 345566778999999999999999997321 12347799999999999999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
+...++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999954 35899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCcccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhc
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF----FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWK 665 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 665 (754)
+++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ..... ..
T Consensus 214 ~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~i---~~ 287 (410)
T 3v8s_A 214 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--TYSKI---MN 287 (410)
T ss_dssp TCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHH---HT
T ss_pred eeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh--HHHHH---Hh
Confidence 9987654332 1233578999999999998765 8899999999999999999999986443222 11111 00
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHh
Q 036419 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAAD--RPTMSEVISMLT 715 (754)
Q Consensus 666 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L~ 715 (754)
... .+..+.....++.+.+++.+||+.+|.+ ||+++||++|--
T Consensus 288 ~~~-------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 288 HKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp HHH-------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred ccc-------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 000 0000111123567889999999999998 999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=333.92 Aligned_cols=252 Identities=27% Similarity=0.393 Sum_probs=202.1
Q ss_pred CchhhHhhhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhh-ccCCeeee
Q 036419 449 KSLASVSAATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKL-QHRNLVRL 503 (754)
Q Consensus 449 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l-~hpniv~l 503 (754)
..........++|++.+.||+|+||.||++. ...+.+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 3445566677899999999999999999742 1235688999999999 68999999
Q ss_pred eeeeeecC-eeEEEEEecCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCC
Q 036419 504 LGCCVEQG-ENVLIYEYLPNKSLDSFLFDTTK-------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRD 569 (754)
Q Consensus 504 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~D 569 (754)
++++.+.+ ..++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987754 58999999999999999975432 223889999999999999999999998 99999
Q ss_pred CCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCc
Q 036419 570 LKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRF 648 (754)
Q Consensus 570 lkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~ 648 (754)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654433333445678899999999999999999999999999999998 9999865
Q ss_pred ccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 649 FNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
....... .... ..... . ......++.+.+++.+||+.||.+|||+.+|+++|+..
T Consensus 254 ~~~~~~~-~~~~----~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKIDEEF-CRRL----KEGTR-----M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCSHHH-HHHH----HHTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhHHH-HHHh----ccCcc-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 4433211 1111 01100 0 01112346788999999999999999999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.41 Aligned_cols=239 Identities=23% Similarity=0.273 Sum_probs=182.8
Q ss_pred hhcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
..++|++.++||+|+||.||++. ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 35789999999999999999722 2346789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc--eEEeeccCccccCCC
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI--PKISDFGLARMFGGD 597 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~--~kl~DFgla~~~~~~ 597 (754)
+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999954 345999999999999999999999998 999999999999987765 999999999854322
Q ss_pred cccccccccccccCcccccccccCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIK-SDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k-sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
.......||+.|+|||++.+..+..+ +|||||||++|+|++|+.||......... ......... ..
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~~~~~~~~---------~~ 238 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-RKTIQRILS---------VK 238 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-HHHHHHHHT---------TC
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-HHHHHHHhc---------CC
Confidence 12334579999999999988887655 89999999999999999998754432211 111111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...+.....++.+.+++.+||+.||++|||+.++++|-
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 11111112346788999999999999999999999974
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.93 Aligned_cols=230 Identities=25% Similarity=0.326 Sum_probs=191.8
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
.++|++.+.||+|+||.||++. ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 3679999999999999999721 2345678899999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++++|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999954 346899999999999999999999988 99999999999999999999999999987643
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ......
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~---~i~~~~--------- 219 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TYE---KILNAE--------- 219 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH---HHHHCC---------
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHH---HHHhCC---------
Confidence 2 234689999999999999999999999999999999999999986433211 111 111110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 714 (754)
. .......+.+.+++.+||+.||++|| ++++|++|-
T Consensus 220 ~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 220 L--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp C--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred C--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 0 01112346788999999999999999 899999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.99 Aligned_cols=238 Identities=25% Similarity=0.353 Sum_probs=194.5
Q ss_pred hcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 4689999999999999999731 224778999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999984 3346899999999999999999999998 9999999999999999999999999998764333
Q ss_pred ccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||............+. .... ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~--~~---- 228 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKKT--YL---- 228 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-----TTCT--TS----
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-----hccc--cc----
Confidence 2233445679999999999987765 7899999999999999999999876544332221111 1100 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......+..+.+++.+||+.||++|||+.+++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred --CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 01123356788999999999999999999998864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.40 Aligned_cols=239 Identities=21% Similarity=0.303 Sum_probs=179.5
Q ss_pred hhhcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
...++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 456789999999999999999732 2346688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC---CCceEEeeccCccccCC
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFGG 596 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~---~~~~kl~DFgla~~~~~ 596 (754)
+++++|.+++.. .+.+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999943 456899999999999999999999998 999999999999975 88999999999987643
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ... .... . ...
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~i---~~~~-~-~~~--- 271 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF-RRI---LNCE-Y-YFI--- 271 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH-HHH---HTTC-C-CCC---
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH-HHH---HhCC-C-ccC---
Confidence 32 2234679999999999999999999999999999999999999986433222111 111 1100 0 000
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.......+..+.+++.+||+.||++|||+.+++++-
T Consensus 272 --~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 307 (349)
T 2w4o_A 272 --SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307 (349)
T ss_dssp --TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred --CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 111123456788999999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=331.02 Aligned_cols=235 Identities=23% Similarity=0.342 Sum_probs=189.6
Q ss_pred hcCccccceeccCCCcceeecc-------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4689999999999999999731 234778999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc--------eE
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI--------PK 584 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~--------~k 584 (754)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999653 234899999999999999999999998 999999999999998887 99
Q ss_pred EeeccCccccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh
Q 036419 585 ISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL 663 (754)
Q Consensus 585 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 663 (754)
|+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+......... ....
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~--- 231 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFY--- 231 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHH---
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHh---
Confidence 9999999765322 23568899999999987 67999999999999999999976554322111111 1000
Q ss_pred hccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 664 WKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 664 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
..... . ....++.+.+++.+||+.||++|||+.+++++|+....
T Consensus 232 ~~~~~--------~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDRHQ--------L----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTTCC--------C----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hccCC--------C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00000 0 01113457899999999999999999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=337.88 Aligned_cols=232 Identities=23% Similarity=0.328 Sum_probs=190.8
Q ss_pred hcCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
-++|++.+.||+|+||.||++.. ..+.+.+|+++++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999997321 235788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+ +|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6788888854 345999999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... . .+...
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------~-----~i~~~ 223 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------K-----KVNSC 223 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------C-----CCCSS
T ss_pred Ccc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------H-----HHHcC
Confidence 432 334679999999999988776 78999999999999999999998643222110 0 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
. ...+...+..+.+++.+||+.||.+|||++|++++--
T Consensus 224 ~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 224 V--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp C--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred C--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 0 0111223567889999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.78 Aligned_cols=259 Identities=26% Similarity=0.352 Sum_probs=196.5
Q ss_pred hcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeee--ecCee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCV--EQGEN 513 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~--~~~~~ 513 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4689999999999999999743 12356899999999999999999999886 45668
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999996532 35899999999999999999999988 99999999999999999999999999997
Q ss_pred cCCCcc-cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 594 FGGDEL-QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 594 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
...... ........||..|+|||++.+..++.++||||||+++|+|++|+.|+........................+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 754322 1223345688899999999999999999999999999999999999754322110000000000000000011
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNL 721 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 721 (754)
+............++.+.+++.+||+.||++|||+.+|+++|+......
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111111222344577899999999999999999999999999765443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=328.98 Aligned_cols=254 Identities=29% Similarity=0.430 Sum_probs=199.4
Q ss_pred hHhhhhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
+.....++|++.+.||+|+||.||++ ....+.+.+|++++++++||||+++++++. .+..++|
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 34556688999999999999999972 224678999999999999999999999986 4568999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 99999999999995421 125899999999999999999999998 99999999999999999999999999997754
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.... ......++..|+|||++.+..++.++||||||+++|||++ |+.|+....... ...... ... .
T Consensus 162 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~---~~~------~- 228 (279)
T 1qpc_A 162 NEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLE---RGY------R- 228 (279)
T ss_dssp SCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHH---TTC------C-
T ss_pred cccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHh---ccc------C-
Confidence 4322 2234457889999999998899999999999999999999 888876433211 111111 000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCCCCC
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQP 727 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p 727 (754)
.......++.+.+++.+||+.||++|||+.+|++.|+..........+|
T Consensus 229 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 277 (279)
T 1qpc_A 229 ---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277 (279)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC------
T ss_pred ---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCCC
Confidence 0111223467899999999999999999999999999876554444433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=334.37 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=194.8
Q ss_pred hcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec--Ce
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GE 512 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~ 512 (754)
.+.|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4568999999999999998743 1346789999999999999999999999876 66
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 89999999999999999543 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc-cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCC---------chhHhHhhhh
Q 036419 593 MFGGDEL-QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN---------SLTLLGHAWN 662 (754)
Q Consensus 593 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~---------~~~~~~~~~~ 662 (754)
....... ........||..|+|||++.+..++.++||||||+++|+|++|..|+...... ..........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 7754332 12234567888999999999999999999999999999999999875322100 0000000000
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.... ..........++.+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 255 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 255 TLKE---------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhc---------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111 111112223457789999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.49 Aligned_cols=243 Identities=25% Similarity=0.372 Sum_probs=182.4
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee--
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN-- 513 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~-- 513 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 45789999999999999999722 1235688999999999999999999998776543
Q ss_pred --EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 514 --VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 514 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
++||||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 999999999999999954 346899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcc-cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccc
Q 036419 592 RMFGGDEL-QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670 (754)
Q Consensus 592 ~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (754)
+.+..... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||......... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~~~~- 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-----YQHVREDPI- 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----HHHHHCCCC-
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhcCCCC-
Confidence 87654322 12233467999999999999999999999999999999999999998654322211 111111100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH-HHHhcc
Q 036419 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVI-SMLTNE 717 (754)
Q Consensus 671 ~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl-~~L~~~ 717 (754)
.+ .......++.+.+++.+||+.||++||++.+++ +.|...
T Consensus 238 ---~~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 238 ---PP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ---CH---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---Cc---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00 000112346788999999999999999665555 445443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.12 Aligned_cols=246 Identities=24% Similarity=0.329 Sum_probs=187.6
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999732 1236788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++ +|.+++.. ..+.+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 986 88888854 2356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc--------Cccc
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD--------DRSW 670 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~ 670 (754)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .......... ....
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHHCCCChhhchhhhcc
Confidence 122345789999999998764 689999999999999999999999865432221 1111111000 0000
Q ss_pred cccCcccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 671 ELMDPKLQ-------CEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 671 ~l~d~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...++... .......++.+.+++.+||+.||++|||+.|+++|-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00111110 011122456788999999999999999999998864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=351.80 Aligned_cols=248 Identities=19% Similarity=0.239 Sum_probs=197.3
Q ss_pred hhhHhhhhcCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeee
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~ 509 (754)
+.++....++|++.++||+|+||+||++.. ..+.+.+|+.++.+++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 445566778999999999999999998321 11237899999999999999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
+...++||||+++|+|.+++... .+.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999642 356999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW 664 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 664 (754)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+ ......
T Consensus 221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--~~~~i~--- 294 (437)
T 4aw2_A 221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TYGKIM--- 294 (437)
T ss_dssp TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHH---
T ss_pred hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH--HHHhhh---
Confidence 9987654332 1233468999999999987 5678999999999999999999999986543222 111110
Q ss_pred ccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHh
Q 036419 665 KDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAAD--RPTMSEVISMLT 715 (754)
Q Consensus 665 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L~ 715 (754)
.... .+.-+. .....++.+.+++.+||+.+|++ ||+++|+++|--
T Consensus 295 ~~~~--~~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 295 NHKE--RFQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp THHH--HCCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred hccc--cccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 0000 000010 01123567889999999988888 999999999853
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.66 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=178.2
Q ss_pred hcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4689999999999999999721 124678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 519 YLPNKSLDSFLFDTT---KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|++ ++|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58998886532 2245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh--------hcc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL--------WKD 666 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~ 666 (754)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ....... |..
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ--LKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCTTTCGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChhHhhh
Confidence 322 122345789999999998764 689999999999999999999999875443221 1111110 000
Q ss_pred CccccccCccc------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 667 DRSWELMDPKL------------QCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 667 ~~~~~l~d~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
........+.. ...........+.+++.+||+.||++|||+.|+++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 295 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence 00000000000 0001112346789999999999999999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.07 Aligned_cols=258 Identities=17% Similarity=0.227 Sum_probs=194.6
Q ss_pred hHhhhhcCccccceeccC--CCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec
Q 036419 453 SVSAATNNFGVENKLGEG--GFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ 510 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G--~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~ 510 (754)
.+....++|++.++||+| +||.||++. ...+.+.+|++++++++||||+++++++.++
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 344556789999999999 999999722 1246778899999999999999999999999
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
+..++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGG
T ss_pred CEEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccc
Confidence 99999999999999999996532 345899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCc-----ccccccccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh-
Q 036419 591 ARMFGGDE-----LQSNTKRIVGTYGYMSPEYAIH--GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN- 662 (754)
Q Consensus 591 a~~~~~~~-----~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~- 662 (754)
+....... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||................
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 87543211 1111233578999999999987 579999999999999999999999987544333211100000
Q ss_pred --hhccCc------------------ccccc---Cc------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 663 --LWKDDR------------------SWELM---DP------KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 663 --~~~~~~------------------~~~l~---d~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
...... ....+ .+ ..........++.+.+++.+||+.||++|||+.|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000 00000 00 00001112235678999999999999999999999987
Q ss_pred H
Q 036419 714 L 714 (754)
Q Consensus 714 L 714 (754)
-
T Consensus 335 p 335 (389)
T 3gni_B 335 S 335 (389)
T ss_dssp G
T ss_pred H
Confidence 3
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=336.87 Aligned_cols=231 Identities=21% Similarity=0.258 Sum_probs=193.0
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 3689999999999999999732 2345788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999999643 45899999999999999999999998 99999999999999999999999999997643
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .. ...
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i---~~-~~~------- 255 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--IYEKI---VS-GKV------- 255 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---HH-CCC-------
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--HHHHH---Hc-CCC-------
Confidence 2 234689999999999999999999999999999999999999986433211 11111 11 100
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHh
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPT-----MSEVISMLT 715 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~ 715 (754)
......+..+.+++.+||+.||.+||+ +++|++|--
T Consensus 256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 011123467889999999999999998 899988753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.86 Aligned_cols=264 Identities=16% Similarity=0.177 Sum_probs=196.5
Q ss_pred hhcCccccceeccCCCcceeeccc-------------------cHHHHHH---------------HHHHHHhhccCCeee
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKN---------------EIKLTAKLQHRNLVR 502 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~---------------Ev~il~~l~hpniv~ 502 (754)
..++|++.++||+|+||.||++.. ....+.+ |+..+.+++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 456899999999999999998421 1122333 444555667999999
Q ss_pred eeeeeeec----CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc
Q 036419 503 LLGCCVEQ----GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD 578 (754)
Q Consensus 503 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld 578 (754)
+++++.+. ...++||||+ +++|.+++... .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999775 4589999999 99999999652 356999999999999999999999998 99999999999999
Q ss_pred --CCCceEEeeccCccccCCCccc-----ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccC
Q 036419 579 --SNMIPKISDFGLARMFGGDELQ-----SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNT 651 (754)
Q Consensus 579 --~~~~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~ 651 (754)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876533211 112345699999999999999999999999999999999999999875433
Q ss_pred CchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCCCCCCccc
Q 036419 652 NSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSS 731 (754)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~ 731 (754)
.... ........ .....+++++.+.. ...++.+.+++..||+.||++||++.+|+++|+........+....+.+
T Consensus 267 ~~~~-~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 341 (364)
T 3op5_A 267 DPKY-VRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL 341 (364)
T ss_dssp CHHH-HHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred CHHH-HHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence 3211 11111101 01112222222111 1224678899999999999999999999999987665555544444433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.29 Aligned_cols=236 Identities=23% Similarity=0.304 Sum_probs=191.8
Q ss_pred hhhhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCe
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~ 512 (754)
....++|++.+.||+|+||.||++. ...+.+..|.+++.++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 3455789999999999999999732 2345678899999987 89999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999954 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.... ....
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i---~~~~----- 234 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSI---RMDN----- 234 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---HHCC-----
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH---HhCC-----
Confidence 643222 22345789999999999999999999999999999999999999986443221 11111 0000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMS-EVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~L 714 (754)
+.. ....++.+.+++.+||+.||++||++. +|++|-
T Consensus 235 --~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 235 --PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp --CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred --CCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 011 112346788999999999999999998 777653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.41 Aligned_cols=239 Identities=19% Similarity=0.275 Sum_probs=190.3
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~l 515 (754)
.++|++.+.||+|+||.||++. ...+.+.+|+++++++ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 3679999999999999999721 1235678999999998 89999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999999543 45899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch---hHhHhhhhhhccCccccc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL---TLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~l 672 (754)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...............
T Consensus 162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 236 (345)
T 3a8x_A 162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 236 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---
T ss_pred CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---
Confidence 221 223456899999999999999999999999999999999999999864322110 000011111101100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTM------SEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~L 714 (754)
..+...+..+.+++.+||+.||++||++ .++++|-
T Consensus 237 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 237 -------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred -------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 0112234678899999999999999995 6777764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=340.37 Aligned_cols=237 Identities=24% Similarity=0.302 Sum_probs=193.0
Q ss_pred hcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
.++|++.+.||+|+||.||++. .....+.+|++++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4689999999999999999731 1345789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC--CCceEEeeccCccccCCC
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS--NMIPKISDFGLARMFGGD 597 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~--~~~~kl~DFgla~~~~~~ 597 (754)
+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999953 2346899999999999999999999998 999999999999974 578999999999977543
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||....... ....... .. . ..
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~i~~---~~-~------~~ 269 (387)
T 1kob_A 205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVKR---CD-W------EF 269 (387)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHH---CC-C------CC
T ss_pred cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--HHHHHHh---CC-C------CC
Confidence 22 234579999999999999999999999999999999999999986533211 1111110 00 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
........+..+.+++.+||+.||++|||+.++++|-
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 1111123456789999999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=325.86 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=188.8
Q ss_pred hhhcCccccceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhc---cCCeeeeeeeeee
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQ---HRNLVRLLGCCVE 509 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~---hpniv~l~~~~~~ 509 (754)
...++|++.++||+|+||.||++.+ ....+.+|++++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467999999999999999997321 1347788888888776 9999999999987
Q ss_pred cC-----eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceE
Q 036419 510 QG-----ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPK 584 (754)
Q Consensus 510 ~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~k 584 (754)
.. ..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 65 5799999998 49999986533 234899999999999999999999998 99999999999999999999
Q ss_pred EeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh
Q 036419 585 ISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW 664 (754)
Q Consensus 585 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 664 (754)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .........
T Consensus 161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~ 235 (308)
T 3g33_A 161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLI 235 (308)
T ss_dssp ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHHHH
T ss_pred EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence 99999998764332 2345679999999999999999999999999999999999999986543322 111111111
Q ss_pred c---cCcccc---c----cCcc---cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 665 K---DDRSWE---L----MDPK---LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 665 ~---~~~~~~---l----~d~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
. ...... + +.+. ..........+.+.+++.+||+.||++|||+.|+++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 0 000000 0 0000 00000112446789999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=348.60 Aligned_cols=239 Identities=26% Similarity=0.390 Sum_probs=194.7
Q ss_pred hhhhcCccccceeccCCCcceeec--------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecC-eeEEEEEe
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKS--------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG-ENVLIYEY 519 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~--------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~-~~~lV~E~ 519 (754)
....++|++.++||+|+||.||++ ....+.+.+|++++++++||||+++++++.+.. ..++||||
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 345578999999999999999972 224578999999999999999999999987765 78999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++|+|.+++.... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 99999999997532 234799999999999999999999998 999999999999999999999999999864322
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
.....++..|+|||++.+..++.++|||||||++|||++ |+.|+......+. ..... ...+
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i~---~~~~---------- 404 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVE---KGYK---------- 404 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HHHHH---TTCC----------
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHH---cCCC----------
Confidence 122357889999999999999999999999999999998 9999875543321 11111 1100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.......++.+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011123456788999999999999999999999999865
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=314.57 Aligned_cols=217 Identities=15% Similarity=0.199 Sum_probs=169.5
Q ss_pred ccccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEE
Q 036419 23 KAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVIL 102 (754)
Q Consensus 23 ~~~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~ 102 (754)
++.|+|++|++| .+|++| ++|.|+|||+.+++ +.+ |.. +|+||+|||+.| .+++|+|+.||||||+
T Consensus 6 ~~~~~i~~g~~L-~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~--~~~vW~an~~~~---~~~~l~l~~dGnLvl~ 71 (236)
T 1dlp_A 6 GLSHEGSHPQTL-HAAQSL--ELSSFRFTMQSDCN-----LVL-FDS--DVRVWASNTAGA---TGCRAVLQSDGLLVIL 71 (236)
T ss_dssp CSSSSSCSCSCC-CTTCEE--CSTTEEEEECTTSC-----EEE-EES--SSEEECCCCCSC---SCCBCCBCSSSCBCCB
T ss_pred eccceeCCCCEE-CCCCEE--EcCCEEEEECCCCc-----EEE-EEC--CEEEEECCCCCC---CCeEEEEcCCCcEEEE
Confidence 678999999999 899999 59999999987654 334 432 799999999998 4789999999999999
Q ss_pred cCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccc-cccCccccee-cCCC-----eee
Q 036419 103 NLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTL-LAGMKLGWDL-KNGV-----ERY 175 (754)
Q Consensus 103 ~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTl-Lpg~~l~~~~-~~g~-----~~~ 175 (754)
|.+|.+||+|++........|+|+|+|||||++ .++||||||||||+ |||| |.|. .+|+ ++.
T Consensus 72 d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~---------~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~ 140 (236)
T 1dlp_A 72 TAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---------PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQT 140 (236)
T ss_dssp CTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---------SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCE
T ss_pred cCCCcEEEeCCccccCCcEEEEEeCCCCEEEec---------CCEEECCCCCCcccccCCc--cceEEecCCcCCCccce
Confidence 999999999998654445679999999999984 27999999999877 6665 5555 5555 567
Q ss_pred EEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecCCCCcccccccCccccccccceEeeCCCceEEEEeecCCCe
Q 036419 176 LTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPWNGIFFGAAPSYASILSEPILVDNEDEIYYSYESYNNPI 255 (754)
Q Consensus 176 l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~w~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (754)
|++ ..||++|.|+++++++| +++++++..+||++++|++. +...+++...-+..+...+.++++.+|...+. .
T Consensus 141 L~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~-~ 213 (236)
T 1dlp_A 141 LHA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA-G 213 (236)
T ss_dssp ECS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCSS-S
T ss_pred EEc---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCCC-C
Confidence 874 78999999999999998 67889988899999999754 55666664322211212233455555554433 4
Q ss_pred EEEEEEccCCcEEEEE
Q 036419 256 IAILTVNPSGTVQRLI 271 (754)
Q Consensus 256 ~~rl~Ld~~G~l~~~~ 271 (754)
.+|++||+||++++|.
T Consensus 214 ~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 214 RYVFVLQPDRNLAIYG 229 (236)
T ss_dssp CCEEEECSSSCEEEEC
T ss_pred CEEEEEcCCCcEEEeC
Confidence 6899999999999984
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=344.54 Aligned_cols=232 Identities=24% Similarity=0.394 Sum_probs=192.2
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
.++|.+.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++......++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4689999999999999999732 1235788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++++|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999994 3456999999999999999999999988 99999999999999999999999999997654
Q ss_pred CcccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... +.... .. .
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--~~~~i---~~-~-------- 231 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--LFKKI---CD-G-------- 231 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--HHHHH---HT-T--------
T ss_pred ccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--HHHHH---hc-C--------
Confidence 322 334679999999999988765 789999999999999999999986433221 11111 11 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
... ........+.+++.+||+.||++|||+.+|++|-
T Consensus 232 ~~~--~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 232 IFY--TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp CCC--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred CcC--CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 000 0112345688999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.96 Aligned_cols=250 Identities=17% Similarity=0.188 Sum_probs=187.2
Q ss_pred hcCccccceeccCCCcceeeccc--------------------------------cHHHHHHHHHHHHhhccCCeeeeee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ--------------------------------GLEEFKNEIKLTAKLQHRNLVRLLG 505 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~--------------------------------~~~~~~~Ev~il~~l~hpniv~l~~ 505 (754)
.++|++.+.||+|+||.||++.. ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 46899999999999999998321 1123557788888899999999999
Q ss_pred eeee----cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC
Q 036419 506 CCVE----QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM 581 (754)
Q Consensus 506 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~ 581 (754)
++.. ....++||||+ +++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 99999999543 36999999999999999999999998 99999999999999887
Q ss_pred --ceEEeeccCccccCCCccc-----ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch
Q 036419 582 --IPKISDFGLARMFGGDELQ-----SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL 654 (754)
Q Consensus 582 --~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~ 654 (754)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876432211 112346799999999999999999999999999999999999999864333222
Q ss_pred hHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 655 TLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 655 ~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
........... . ....+... ......++.+.+++.+||+.||++||++.+|++.|+....
T Consensus 269 ~~~~~~~~~~~-~-~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAKTNLLD-E-LPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHH-T-TTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHhhcc-c-ccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111100 0 00000000 0001234678999999999999999999999999987643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=335.59 Aligned_cols=246 Identities=22% Similarity=0.255 Sum_probs=190.0
Q ss_pred HhhhhcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ 510 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~ 510 (754)
+....++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 45567899999999999999999721 2346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhhHhhccCC-------------------------------------CCCCCHHHHHHHHHHHHHH
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTK-------------------------------------EGLLGWGARIRIIEGIAQG 553 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~qi~~~ 553 (754)
...++||||+++++|.+++..... ...+++..+..++.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999852110 1124677888999999999
Q ss_pred HHHHHhcCCCceeeCCCCCCceEEcCCC--ceEEeeccCccccCCCc--ccccccccccccCccccccccc--CCCCccc
Q 036419 554 LLYLHQYSRLRVIHRDLKPSNILLDSNM--IPKISDFGLARMFGGDE--LQSNTKRIVGTYGYMSPEYAIH--GFFSIKS 627 (754)
Q Consensus 554 L~yLH~~~~~~iiH~Dlkp~NIlld~~~--~~kl~DFgla~~~~~~~--~~~~~~~~~gt~~y~APE~~~~--~~~s~ks 627 (754)
|.|||+.+ |+||||||+|||++.++ .+||+|||+++.+.... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 89999999998653321 1112345679999999999875 6789999
Q ss_pred chhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 036419 628 DVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTM 707 (754)
Q Consensus 628 DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 707 (754)
|||||||++|||++|+.||........ .. ........ ... ......++.+.+++.+||+.||.+|||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~--~~---~~~~~~~~--~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADT--IS---QVLNKKLC--FEN-----PNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHHCCCC--TTS-----GGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHH--HH---HHHhcccc--cCC-----cccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 999999999999999999865432221 11 11111100 000 1111235678899999999999999999
Q ss_pred HHHHHHH
Q 036419 708 SEVISML 714 (754)
Q Consensus 708 ~evl~~L 714 (754)
.+++++-
T Consensus 326 ~~~l~hp 332 (345)
T 3hko_A 326 MRALQHP 332 (345)
T ss_dssp HHHHHSH
T ss_pred HHHhcCh
Confidence 9999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=342.89 Aligned_cols=237 Identities=25% Similarity=0.361 Sum_probs=184.6
Q ss_pred hcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhc--cCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQ--HRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~--hpniv~l~~~~~~~~~~~lV 516 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 4569999999999999999721 13467899999999997 49999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|| +.+++|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 6788999999643 46889999999999999999999988 99999999999995 57999999999997754
Q ss_pred CcccccccccccccCccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIH-----------GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWK 665 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 665 (754)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+ ...
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----~~~-- 280 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----HAI-- 280 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH----HHH--
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH----HHH--
Confidence 433333445689999999999865 468999999999999999999999986432211111 111
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 666 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
+++...........+.+.+++.+||+.||++|||+.+|++|.-
T Consensus 281 -------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 281 -------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp -------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -------hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 1111111111112457889999999999999999999998864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=328.57 Aligned_cols=247 Identities=27% Similarity=0.378 Sum_probs=193.6
Q ss_pred hhcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeee-ecCee
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCV-EQGEN 513 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~-~~~~~ 513 (754)
...+|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++. .+...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34578999999999999999732 12467889999999999999999999864 55678
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999964 3356899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc--ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCC-CCCcccCCchhHhHhhhhhhccCccc
Q 036419 594 FGGDELQ--SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKR-STRFFNTNSLTLLGHAWNLWKDDRSW 670 (754)
Q Consensus 594 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (754)
....... .......||+.|+|||.+.+..++.++||||||+++|+|++|.. |+........ ..... ... .
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~~~~~---~~~-~- 250 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL---QGR-R- 250 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--HHHHH---TTC-C-
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--HHHHh---cCC-C-
Confidence 6543321 12234567889999999999999999999999999999999554 4443322221 11110 000 0
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCC
Q 036419 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPS 723 (754)
Q Consensus 671 ~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 723 (754)
. ......+..+.+++.+||+.||++|||++++++.|+........
T Consensus 251 -~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 251 -L-------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp -C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred -C-------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 00112345788999999999999999999999999987655443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=358.65 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=204.2
Q ss_pred hhHhhhhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 452 ASVSAATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 452 ~~~~~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..++...++|++.++||+|+||.||++ ....++|.+|++++++++||||+++++++.+ +..++
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 344556788999999999999999972 1235789999999999999999999999876 67899
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.++|... ....+++.+++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+++...
T Consensus 339 v~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 99999999999999542 2245899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
..... ......++..|+|||++....++.++|||||||++|||++ |+.||......+ ...... ...+
T Consensus 415 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~---~~~~------ 482 (535)
T 2h8h_A 415 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVE---RGYR------ 482 (535)
T ss_dssp CHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHH---TTCC------
T ss_pred CCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---cCCC------
Confidence 43221 1223456789999999999999999999999999999999 888876433221 111111 1100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCCCCCC
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPG 728 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~ 728 (754)
.......++.+.+|+.+||+.||++|||+++|+++|+..........+|+
T Consensus 483 ----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~ 532 (535)
T 2h8h_A 483 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532 (535)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC-
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccCcc
Confidence 01112345678999999999999999999999999998866655544443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=321.82 Aligned_cols=238 Identities=27% Similarity=0.503 Sum_probs=190.7
Q ss_pred hhcCccccceeccCCCcceeeccc-------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecC
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ-------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG 511 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~-------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~ 511 (754)
..++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 357899999999999999997211 1167899999999999999999999986655
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc-----eEEe
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI-----PKIS 586 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~-----~kl~ 586 (754)
++||||+++++|.+++.. ....+++..+..++.||+.||.|||+++ .+|+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999988864 3346999999999999999999999875 34999999999999988776 9999
Q ss_pred eccCccccCCCcccccccccccccCcccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh
Q 036419 587 DFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI--HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW 664 (754)
Q Consensus 587 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 664 (754)
|||+++..... .....||+.|+|||++. ...++.++||||||+++|+|++|+.||................
T Consensus 172 Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-- 244 (287)
T 4f0f_A 172 DFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-- 244 (287)
T ss_dssp CCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH--
T ss_pred CCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc--
Confidence 99999854332 33467999999999984 4567899999999999999999999987554443222211111
Q ss_pred ccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 665 KDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 665 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
.. ..+ ......++.+.+++.+||+.||++|||+++|++.|+.
T Consensus 245 -~~-----~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 -EG-----LRP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -SC-----CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -cC-----CCC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 00 011 1122335678999999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.53 Aligned_cols=247 Identities=25% Similarity=0.397 Sum_probs=197.6
Q ss_pred hhcCccccc-eeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 457 ATNNFGVEN-KLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 457 ~~~~y~~~~-~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
..++|.+.+ .||+|+||.||++. ...+++.+|++++++++||||+++++++ +.+..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 345677776 99999999999732 1346788999999999999999999999 566799
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++++|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 86 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999999953 3346999999999999999999999998 999999999999999999999999999977
Q ss_pred CCCcc-cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 595 GGDEL-QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 595 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
..... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ...... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~----~~~~--- 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIE----QGKR--- 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHH----TTCC---
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHh----cCCc---
Confidence 54322 122234457889999999998899999999999999999998 999986543322 111111 1100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCC
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSP 724 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p 724 (754)
.......++.+.+++.+||+.||++||++.+|+++|+........+
T Consensus 232 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 232 ------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 1112234567899999999999999999999999998765544444
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.87 Aligned_cols=260 Identities=22% Similarity=0.286 Sum_probs=193.0
Q ss_pred hhhHhhhhcCccccceeccCCCcceeecc-------------ccHHHHHHHHHHHHhh--ccCCeeeeeeeeeec----C
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKSG-------------QGLEEFKNEIKLTAKL--QHRNLVRLLGCCVEQ----G 511 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~-------------~~~~~~~~Ev~il~~l--~hpniv~l~~~~~~~----~ 511 (754)
........++|++.++||+|+||.||++. .....+..|.+++..+ +||||+++++++.+. .
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 34445566899999999999999999732 2345556666666655 899999999999887 7
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeeCCCCCCceEEcCCCceEEe
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS-----RLRVIHRDLKPSNILLDSNMIPKIS 586 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~iiH~Dlkp~NIlld~~~~~kl~ 586 (754)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 89999999999999999954 35899999999999999999999871 1139999999999999999999999
Q ss_pred eccCccccCCCcccc--cccccccccCcccccccccCCCCcc------cchhhHHHHHHHHHhC----------CCCCCc
Q 036419 587 DFGLARMFGGDELQS--NTKRIVGTYGYMSPEYAIHGFFSIK------SDVFSFGVLLLETLSS----------KRSTRF 648 (754)
Q Consensus 587 DFgla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~k------sDVwSlGvil~elltg----------~~p~~~ 648 (754)
|||+++.+....... ......||+.|+|||++.+.....+ +|||||||++|||++| +.|+..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998765432211 1234579999999999987766655 9999999999999999 444433
Q ss_pred ccCCchhHhHhhhhhhccCccccccCcccCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 649 FNTNSLTLLGHAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
........... ....... ...+.... ......++.+.+++.+||+.||++|||+.+|+++|+....
T Consensus 265 ~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 265 LVPSDPSYEDM-REIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TSCSSCCHHHH-HHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCchhhh-HHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 22222111110 0001011 11111111 1122567889999999999999999999999999987643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=329.10 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=186.9
Q ss_pred cCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
++|++.++||+|+||.||++.. ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 6799999999999999997211 24567899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999998843 345899999999999999999999998 9999999999999999999999999998765332
Q ss_pred ccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhH-hHhh--------hhhhccCc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL-LGHA--------WNLWKDDR 668 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~-~~~~--------~~~~~~~~ 668 (754)
. ......||..|+|||++.+ ..++.++||||||+++|+|++|+.||.......... .... ...+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 1 2234578999999999876 578999999999999999999999986544322110 0000 00000000
Q ss_pred cc---cccCcccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 669 SW---ELMDPKLQC---EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 669 ~~---~l~d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. .+.++.... ......++.+.+++.+||+.||++|||++++++|-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 00 000100000 00112456688999999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=335.43 Aligned_cols=234 Identities=24% Similarity=0.304 Sum_probs=191.5
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~ 514 (754)
..++|++.+.||+|+||.||++. ...+.+.+|.+++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34789999999999999999722 2345678899999988 7999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++|+|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999543 45999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.... .... .
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~~i---~~~~-~----- 238 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSI---MEHN-V----- 238 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---HHCC-C-----
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH--HHHHH---HhCC-C-----
Confidence 3222 22345789999999999999999999999999999999999999986443221 11111 1110 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPT-----MSEVISML 714 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 714 (754)
......+..+.+++.+||+.||.+||+ +++|++|-
T Consensus 239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 011224567899999999999999995 68888764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=336.00 Aligned_cols=244 Identities=26% Similarity=0.389 Sum_probs=193.1
Q ss_pred hhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
..++|++.+.||+|+||.||++. ....++.+|++++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 45789999999999999999843 124568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC---CCceEE
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTK----EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKI 585 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~---~~~~kl 585 (754)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976432 245899999999999999999999998 999999999999984 446999
Q ss_pred eeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhh
Q 036419 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLW 664 (754)
Q Consensus 586 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 664 (754)
+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||....... ......
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~--- 259 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVT--- 259 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH---
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HHHHHh---
Confidence 99999986644433333445678899999999999999999999999999999998 888876432211 111111
Q ss_pred ccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 665 KDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 665 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.... . ......+..+.+++.+||+.||.+||++.+|+++|+...
T Consensus 260 -~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 260 -SGGR-----M----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp -TTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cCCC-----C----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 1100 0 111223467889999999999999999999999998653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=332.85 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=197.1
Q ss_pred hhhcCccccc-eeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 456 AATNNFGVEN-KLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 456 ~~~~~y~~~~-~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
...++|++.+ .||+|+||.||++. ...+++.+|++++++++||||+++++++ +.+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456888888 99999999999741 1146789999999999999999999999 6678
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 8999999999999999964 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccc
Q 036419 593 MFGGDELQ-SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670 (754)
Q Consensus 593 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (754)
........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....... ..... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~----~~~~~- 238 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAML----EKGER- 238 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH----HTTCC-
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH----HcCCC-
Confidence 76543221 12223456788999999998899999999999999999999 999986543221 11111 11100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCC
Q 036419 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSP 724 (754)
Q Consensus 671 ~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p 724 (754)
.......++.+.+++.+||+.||++||++.+|++.|+......+.+
T Consensus 239 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 239 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 0111234567899999999999999999999999999876554433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=339.55 Aligned_cols=244 Identities=28% Similarity=0.406 Sum_probs=184.4
Q ss_pred cCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee-cCeeEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE-QGENVL 515 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~-~~~~~l 515 (754)
..|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 457788999999999999621 134678999999999999999999998754 567899
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999954 3345889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccc--cccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 596 GDELQS--NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 596 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..|+......... ... ..... .
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~--~~~---~~~~~---~ 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--VYL---LQGRR---L 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH--HHH---HTTCC---C
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH--HHH---HcCCC---C
Confidence 432211 1234567889999999999999999999999999999999 56666544332211 111 01110 0
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLP 722 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 722 (754)
. .....++.+.+++.+||+.||++|||+.+|+++|+.......
T Consensus 316 ~-------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 316 L-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp C-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred C-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0 111234678899999999999999999999999998755544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.29 Aligned_cols=238 Identities=24% Similarity=0.382 Sum_probs=186.8
Q ss_pred hhcCccccceeccCCCcceeec-------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS-------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~-------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
..++|.+.++||+|+||.||++ ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4468999999999999999972 224578999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE---cCCCceEEeeccCccc
Q 036419 518 EYLPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARM 593 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll---d~~~~~kl~DFgla~~ 593 (754)
||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 9999999999886532 3356999999999999999999999998 9999999999999 4567899999999987
Q ss_pred cCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
..... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......... .... .....
T Consensus 177 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~--~~~~--~~~~~----- 243 (285)
T 3is5_A 177 FKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ--QKAT--YKEPN----- 243 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH--HCCCC-----
T ss_pred cCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH--hhhc--cCCcc-----
Confidence 65432 233467899999999875 57899999999999999999999998654322211 1110 00000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. ......++.+.+++.+||+.||++|||+.||+++-
T Consensus 244 ---~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 280 (285)
T 3is5_A 244 ---YA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280 (285)
T ss_dssp ---CC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred ---cc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 00 00011346788999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=322.59 Aligned_cols=237 Identities=24% Similarity=0.349 Sum_probs=192.4
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
..++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 45789999999999999999721 1246788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc---eEEeeccCccc
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI---PKISDFGLARM 593 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~---~kl~DFgla~~ 593 (754)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999888543 45899999999999999999999998 999999999999986655 99999999987
Q ss_pred cCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ...... .... ..
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~----~~~~-~~- 226 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQIK----AGAY-DY- 226 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH----HTCC-CC-
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--HHHHHH----hccc-cC-
Confidence 654322 234679999999999999999999999999999999999999986433221 111110 0000 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
........++.+.+++.+||+.||++|||+.++++|-
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 227 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred ----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 0011122346788999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.68 Aligned_cols=241 Identities=28% Similarity=0.435 Sum_probs=193.2
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV 516 (754)
++|++.+.||+|+||.||++. ...+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 689999999999999999731 1345688999999999 899999999999999999999
Q ss_pred EEecCCCChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCce
Q 036419 517 YEYLPNKSLDSFLFDTT-------------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIP 583 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~ 583 (754)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996542 2346999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhh
Q 036419 584 KISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 584 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 662 (754)
||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....... .....
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~-- 254 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKL-- 254 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHG--
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HHHHh--
Confidence 99999999853221 12233457889999999998899999999999999999998 999986443221 11111
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVN 720 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 720 (754)
... .........++.+.+++.+||+.||.+|||+.+++++|+.....
T Consensus 255 --~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 255 --PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp --GGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --hcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 010 00011123346789999999999999999999999999875443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.08 Aligned_cols=240 Identities=28% Similarity=0.443 Sum_probs=196.3
Q ss_pred hhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
..++|++.+.||+|+||.||++ ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 3468999999999999999972 124578999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999999643 346899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
.......++..|+|||++.+..++.++||||||+++|+|++ |+.|+....... ...... .... .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~---~~~~---~------- 224 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIS---TGFR---L------- 224 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH---TTCC---C-------
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHh---cCCc---C-------
Confidence 12234567889999999998999999999999999999999 888876433211 111111 1000 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
......++.+.+++.+||+.||++|||+.+++++|+..
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01112346788999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=325.49 Aligned_cols=244 Identities=25% Similarity=0.311 Sum_probs=193.3
Q ss_pred CccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee-EEE
Q 036419 460 NFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN-VLI 516 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~-~lV 516 (754)
.|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 56677999999999999732 1246788999999999999999999999876665 999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+.+++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999965 3456899999999999999999999998 99999999999999999999999999987654
Q ss_pred Ccc--cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 597 DEL--QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 597 ~~~--~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+...... ........ ...
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~----~~~------ 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLA----QGR------ 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHH----TTC------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhh----cCC------
Confidence 321 12233457889999999999999999999999999999999976664322111 11111111 000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLP 722 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 722 (754)
........++.+.+++.+||+.||.+|||+.+++++|+.....+.
T Consensus 246 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 246 ---RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ---CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 001112234678999999999999999999999999987655443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=333.49 Aligned_cols=242 Identities=27% Similarity=0.456 Sum_probs=189.4
Q ss_pred hhcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~ 513 (754)
..++|.+.+.||+|+||.||++. .....+.+|++++++++||||+++++++.+....
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 44688899999999999999731 1235688999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999999642 346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 594 FGGDELQ-SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 594 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
....... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||....... ..... ....+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~---~~~~~--- 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAI---NDGFR--- 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH---HTTCC---
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHHH---HCCCc---
Confidence 6543211 11223456788999999999999999999999999999999 999985433211 11111 11100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.......++.+.+++.+||+.||++||++.+|+++|+...
T Consensus 269 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 269 -------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111234567899999999999999999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=328.02 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=187.8
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
.++|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++.+++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 4579999999999999999721 1246788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 517 YEYLPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999996532 3456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.........+..... ......
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~---- 257 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE----QCDYPP---- 257 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH----TTCSCC----
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh----cccCCC----
Confidence 3321 223457899999999999999999999999999999999999998644332222211111 111100
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCC
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSP 724 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p 724 (754)
......++.+.+++.+||+.||++|||+.+|+++|+.+.+..+.|
T Consensus 258 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 258 ----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp ----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred ----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 011123467889999999999999999999999999875554444
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=336.43 Aligned_cols=253 Identities=25% Similarity=0.272 Sum_probs=195.5
Q ss_pred CchhhHhhhhcCccccceeccCCCcceeeccc-----------------cHHHHHHHHHHHHhhc-----cCCeeeeeee
Q 036419 449 KSLASVSAATNNFGVENKLGEGGFGPVYKSGQ-----------------GLEEFKNEIKLTAKLQ-----HRNLVRLLGC 506 (754)
Q Consensus 449 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~~-----------------~~~~~~~Ev~il~~l~-----hpniv~l~~~ 506 (754)
+++.+.....++|++.++||+|+||.||++.. ..+.+..|++++++++ ||||++++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 45566667788999999999999999997321 2456788999999997 9999999999
Q ss_pred eeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC-------
Q 036419 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS------- 579 (754)
Q Consensus 507 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~------- 579 (754)
+...+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccc
Confidence 99999999999999 999999996533 345899999999999999999999998 999999999999975
Q ss_pred ------------------CCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh
Q 036419 580 ------------------NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS 641 (754)
Q Consensus 580 ------------------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt 641 (754)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999865432 234678999999999999999999999999999999999
Q ss_pred CCCCCCcccCCchhHhHhhhhhhcc-----------CccccccCc-----ccC-CCCC---------------HHHHHHH
Q 036419 642 SKRSTRFFNTNSLTLLGHAWNLWKD-----------DRSWELMDP-----KLQ-CEAS---------------YPIVKRY 689 (754)
Q Consensus 642 g~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~l~d~-----~~~-~~~~---------------~~~~~~l 689 (754)
|+.||....... ........... ......++. ... .... ....+.+
T Consensus 255 g~~pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 255 GSLLFRTHEHME--HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp SSCSCCCSSHHH--HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred CCCCCCCCcHHH--HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 999986543221 11000000000 000000000 000 0000 0012567
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 036419 690 INVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 690 ~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.+++.+||+.||++|||+.|+++|
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHhcCChhhCCCHHHHhcC
Confidence 899999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.94 Aligned_cols=230 Identities=23% Similarity=0.303 Sum_probs=180.7
Q ss_pred hcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV 516 (754)
.++|++.++||+|+||+||++. ....+...|+..+.++ +||||+++++++.++...++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 4689999999999999999721 1223455666666666 899999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 66888888653 346999999999999999999999988 99999999999999999999999999987654
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..++..... +....... ..+.
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~~~~~~----~~~~ 272 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQLRQGY----LPPE 272 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHHHTTTC----CCHH
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHHHhccC----CCcc
Confidence 32 2234569999999998875 799999999999999999999876542211 00011110 0111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.....++.+.+++.+||+.||++|||+.+++++-
T Consensus 273 ----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 273 ----FTAGLSSELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp ----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 1112346789999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=322.86 Aligned_cols=236 Identities=22% Similarity=0.325 Sum_probs=191.4
Q ss_pred hhcCccccceeccCCCcceeec------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
..++|++.++||+|+||.||++ ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4578999999999999999972 2345789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE---cCCCceEEeeccCccccC
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFG 595 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll---d~~~~~kl~DFgla~~~~ 595 (754)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999998854 345899999999999999999999998 9999999999999 788999999999998765
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||........ ..... ....
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~----~~~~------ 224 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV--MLKIR----EGTF------ 224 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH----HCCC------
T ss_pred Ccc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH--HHHHH----hCCC------
Confidence 432 2234579999999998765 499999999999999999999999865432211 11110 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
..........++.+.+++.+||+.||++|||+.++++|-
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 000000002346788999999999999999999998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=323.36 Aligned_cols=240 Identities=27% Similarity=0.392 Sum_probs=191.4
Q ss_pred hhhcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~ 513 (754)
...++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+ +..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 345789999999999999999731 134678899999999999999999999765 457
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 8999999999999999653 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
....... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||........ ..... .....
T Consensus 163 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--~~~~~---~~~~~--- 233 (281)
T 3cc6_A 163 IEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--IGVLE---KGDRL--- 233 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--HHHHH---HTCCC---
T ss_pred ccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--HHHHh---cCCCC---
Confidence 6543221 1233457889999999998999999999999999999998 9999864433321 11110 00000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
......++.+.+++.+||+.||++|||+.+|+++|+..
T Consensus 234 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 -------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 11112346788999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.19 Aligned_cols=237 Identities=23% Similarity=0.238 Sum_probs=169.3
Q ss_pred cceeccCCCcceeecc---------------ccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEEEEEecCCCChhh
Q 036419 464 ENKLGEGGFGPVYKSG---------------QGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVLIYEYLPNKSLDS 527 (754)
Q Consensus 464 ~~~lG~G~fg~Vyk~~---------------~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~ 527 (754)
.++||+|+||.||++. .....+.+|++++++++ ||||+++++++.++...++||||+++++|.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence 3789999999999832 23577889999999997 9999999999999999999999999999999
Q ss_pred HhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC---ceEEeeccCccccCCCccccccc
Q 036419 528 FLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM---IPKISDFGLARMFGGDELQSNTK 604 (754)
Q Consensus 528 ~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~---~~kl~DFgla~~~~~~~~~~~~~ 604 (754)
++.. .+.+++.++..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 96 ~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~ 167 (325)
T 3kn6_A 96 RIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLK 167 (325)
T ss_dssp HHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--ccc
Confidence 9954 356999999999999999999999998 99999999999998765 899999999987644321 233
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc--hhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 605 RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS--LTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 605 ~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ........ ....... .......
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~i~~~~~------~~~~~~~ 240 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK-KIKKGDF------SFEGEAW 240 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH-HHTTTCC------CCCSHHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH-HHHcCCC------CCCcccc
Confidence 4678999999999999999999999999999999999999987544321 01111111 1111100 0000001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
...++.+.+++.+||+.||++|||++++++|--
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 124567899999999999999999999987753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=331.47 Aligned_cols=235 Identities=27% Similarity=0.331 Sum_probs=184.5
Q ss_pred hhcCccccceeccCCCcceeeccc-------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecC
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ-------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG 511 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~-------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~ 511 (754)
..++|++.+.||+|+||.||++.. ....+.+|++++++++||||+++++++.+++
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 357899999999999999996211 2345778999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..++||||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999999954 345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
+...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..... ....
T Consensus 169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i---~~~~---- 237 (327)
T 3a62_A 169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--TIDKI---LKCK---- 237 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHH---HHTC----
T ss_pred cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--HHHHH---HhCC----
Confidence 8643222 12334679999999999999999999999999999999999999986443221 11111 1100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHh
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISMLT 715 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~ 715 (754)
. ......+..+.+++.+||+.||++|| ++.++++|--
T Consensus 238 -----~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 238 -----L--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp -----C--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred -----C--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 0 01112346788999999999999999 8889988753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=335.78 Aligned_cols=244 Identities=16% Similarity=0.166 Sum_probs=198.9
Q ss_pred hHhhhhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhc---cCCeeeeeeeeee
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQ---HRNLVRLLGCCVE 509 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~---hpniv~l~~~~~~ 509 (754)
++....++|++.++||+|+||.||++. ....++..|++++++++ |+||+++++++..
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 344566889999999999999999861 23567889999999887 9999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC--------
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTT--KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS-------- 579 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~-------- 579 (754)
++..++||||+++|+|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999996532 3456999999999999999999999988 999999999999998
Q ss_pred ---CCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhH
Q 036419 580 ---NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL 656 (754)
Q Consensus 580 ---~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~ 656 (754)
++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~- 294 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK- 294 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence 8999999999997654322223344568999999999999999999999999999999999999997533221110
Q ss_pred hHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHhcccc
Q 036419 657 LGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADR-PTMSEVISMLTNEFV 719 (754)
Q Consensus 657 ~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~~~ 719 (754)
+....... ...+.+.+++..||+.+|.+| |++.++.+.|+....
T Consensus 295 ----------------~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 ----------------PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ----------------ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----------------echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 01111111 235667889999999999999 588888888887543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=323.40 Aligned_cols=233 Identities=27% Similarity=0.363 Sum_probs=189.9
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 45789999999999999999731 124568899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999999543 45899999999999999999999988 9999999999999999999999999987543
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....... . ..
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~----~------~~ 224 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRISR----V------EF 224 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHH----T------CC
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--HHHHHHh----C------CC
Confidence 322 234578999999999999999999999999999999999999986433221 1111100 0 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
......++.+.+++.+||+.||++|||+.+|++|--
T Consensus 225 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 225 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred ----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 111123467889999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.26 Aligned_cols=247 Identities=20% Similarity=0.230 Sum_probs=195.1
Q ss_pred hhhHhhhhcCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeee
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~ 509 (754)
+.+.....++|++.+.||+|+||.||++.. ..+.+++|+.++.+++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 445556678999999999999999997321 12347889999999999999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
.+..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999999653 236899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCcccccccc-------cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAI-------HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 662 (754)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+. .....
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~i~- 283 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET--YGKIV- 283 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHH-
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH--HHHHH-
Confidence 9987654322 1223468999999999987 35789999999999999999999999865432221 11110
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHHh
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADR---PTMSEVISMLT 715 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~L~ 715 (754)
.... .+.-+. .....++.+.+++.+||+ +|.+| |+++||++|--
T Consensus 284 --~~~~--~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 284 --HYKE--HLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp --THHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred --hccc--CcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 0000 000010 011235678999999999 99998 69999998853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=329.14 Aligned_cols=237 Identities=24% Similarity=0.302 Sum_probs=193.4
Q ss_pred hhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
..++|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++.++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 45679999999999999999721 135789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC----ceEEeec
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM----IPKISDF 588 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~----~~kl~DF 588 (754)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999954 346899999999999999999999998 99999999999999887 7999999
Q ss_pred cCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
|+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....... ..
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~----~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANITS----VS 234 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHT----TC
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHh----cc
Confidence 9998765432 2234579999999999999999999999999999999999999986433221 1111100 00
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
. ..++.. ....++.+.+++.+||+.||++|||+.++++|-
T Consensus 235 ~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 235 Y--DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp C--CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred c--ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 0 000000 012346688999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=348.71 Aligned_cols=234 Identities=21% Similarity=0.246 Sum_probs=184.0
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..++|++.++||+|+||.||++. .....+.+|++++++++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 34689999999999999999722 123567789999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ-YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999954 3468999999999999999999998 77 999999999999999999999999999864
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.... .... .
T Consensus 300 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i---~~~~-~----- 366 (446)
T 4ejn_A 300 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELI---LMEE-I----- 366 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---HHCC-C-----
T ss_pred cCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHHH---HhCC-C-----
Confidence 3322 22345789999999999999999999999999999999999999986443221 11111 0000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISML 714 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 714 (754)
. ........+.+++.+||+.||++|| +++++++|-
T Consensus 367 -~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 367 -R----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp -C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred -C----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 0 1112346788999999999999999 999999865
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=320.32 Aligned_cols=237 Identities=19% Similarity=0.324 Sum_probs=191.0
Q ss_pred hcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec--CeeEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ--GENVLIY 517 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~--~~~~lV~ 517 (754)
.++|++.++||+|+||.||++. ...+++.+|++++++++||||+++++++.+. ...++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 4689999999999999999721 2346789999999999999999999999877 7889999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++... ....+++..+..++.||++||.|||+.+ ..|+||||||+|||++.++.+||+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999999653 2336899999999999999999999864 3599999999999999999999999998765322
Q ss_pred cccccccccccccCcccccccccCCCC---cccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFS---IKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s---~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
....||+.|+|||++.+..++ .++||||||+++|||++|+.||......... ....... ..
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~-----~~ 229 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-----MKVALEG-----LR 229 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-----HHHHHSC-----CC
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-----HHHHhcC-----CC
Confidence 235689999999999876544 4899999999999999999998644322211 0111111 01
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+ ......+..+.+++.+||+.||++|||++++++.|+..
T Consensus 230 ~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 230 P----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1 11122346789999999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=336.09 Aligned_cols=254 Identities=20% Similarity=0.312 Sum_probs=200.5
Q ss_pred hhcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC--eeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG--ENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~--~~~l 515 (754)
..++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.+.. ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 35689999999999999999721 23577889999999999999999999998765 7799
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE----cCCCceEEeeccCc
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL----DSNMIPKISDFGLA 591 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll----d~~~~~kl~DFgla 591 (754)
||||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999976555556999999999999999999999998 9999999999999 78888999999999
Q ss_pred cccCCCcccccccccccccCccccccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIH--------GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL 663 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 663 (754)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ......
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~~ 239 (396)
T 4eut_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKI 239 (396)
T ss_dssp EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-HHHHHH
T ss_pred eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-HHHHHH
Confidence 8765432 2234679999999999865 567899999999999999999999986443222111 111111
Q ss_pred hccCc---cc---ccc--------CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 664 WKDDR---SW---ELM--------DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 664 ~~~~~---~~---~l~--------d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
..... .. ... +..............+.+++.+||+.||++||++.++++.|+.+
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 11110 00 000 01112234456788899999999999999999999999999765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=334.82 Aligned_cols=231 Identities=30% Similarity=0.372 Sum_probs=182.6
Q ss_pred cceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCCCCh
Q 036419 464 ENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 464 ~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
.+.||+|+||.||++. ...+++.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 5689999999999731 2456789999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE--cCCCceEEeeccCccccCCCcccccc
Q 036419 526 DSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL--DSNMIPKISDFGLARMFGGDELQSNT 603 (754)
Q Consensus 526 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll--d~~~~~kl~DFgla~~~~~~~~~~~~ 603 (754)
.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 9988642 235899999999999999999999998 9999999999999 5678999999999997754322 2
Q ss_pred cccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCH
Q 036419 604 KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASY 683 (754)
Q Consensus 604 ~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~ 683 (754)
....||+.|+|||++....++.++|||||||++|||++|+.||....... ...... ... ..+.. ....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~i~---~~~--~~~~~-----~~~~ 313 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--TLNNIL---ACR--WDLED-----EEFQ 313 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHH---HTC--CCSCS-----GGGT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH---hcc--CCCCh-----hhhc
Confidence 34579999999999998999999999999999999999999986543221 111111 000 00000 0111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 684 PIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 684 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
..++.+.+++.+||+.||.+|||+.|+++|-
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 2356789999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=333.83 Aligned_cols=241 Identities=20% Similarity=0.250 Sum_probs=191.5
Q ss_pred hhcCccccceeccCCCcceeeccc--------------cHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEecC
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ--------------GLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEYLP 521 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~--------------~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~~~ 521 (754)
..++|++.+.||+|+||.||++.. ......+|++++.++ +||||+++++++.++...++||||++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 457899999999999999998322 123456899999998 79999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC----CceEEeeccCccccCCC
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN----MIPKISDFGLARMFGGD 597 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~----~~~kl~DFgla~~~~~~ 597 (754)
+|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||+.++ +.+||+|||+++.....
T Consensus 100 gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 100 GGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp SCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999999954 356999999999999999999999998 9999999999998543 35999999999876543
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhhhhhhccCccccccCcc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ..+..... .+.. .
T Consensus 174 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~------~ 241 (342)
T 2qr7_A 174 NG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKF------S 241 (342)
T ss_dssp TC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCC------C
T ss_pred CC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCc------c
Confidence 21 2334678999999999988889999999999999999999999987543222 11111111 1100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.........++.+.+++.+||+.||++|||+.++++|--
T Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 111112234567899999999999999999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.89 Aligned_cols=257 Identities=21% Similarity=0.268 Sum_probs=198.6
Q ss_pred hhhHhhhhcCccccceeccCCCcceeec-------------cccHHHHHHHHHHHHh--hccCCeeeeeeeeeecC----
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKS-------------GQGLEEFKNEIKLTAK--LQHRNLVRLLGCCVEQG---- 511 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~-------------~~~~~~~~~Ev~il~~--l~hpniv~l~~~~~~~~---- 511 (754)
+.......++|++.+.||+|+||.||++ ....+.+.+|++++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 3344556789999999999999999983 2345678899999988 78999999999998876
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceeeCCCCCCceEEcCCCce
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH--------QYSRLRVIHRDLKPSNILLDSNMIP 583 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~iiH~Dlkp~NIlld~~~~~ 583 (754)
..++||||+++++|.+++.. ..+++..+..++.||+.||.||| +.+ |+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999954 35899999999999999999999 665 9999999999999999999
Q ss_pred EEeeccCccccCCCccc--ccccccccccCcccccccccC------CCCcccchhhHHHHHHHHHhC----------CCC
Q 036419 584 KISDFGLARMFGGDELQ--SNTKRIVGTYGYMSPEYAIHG------FFSIKSDVFSFGVLLLETLSS----------KRS 645 (754)
Q Consensus 584 kl~DFgla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~------~~s~ksDVwSlGvil~elltg----------~~p 645 (754)
||+|||++......... .......||+.|+|||++.+. .++.++|||||||++|||++| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999999876543221 123456799999999998765 334789999999999999999 566
Q ss_pred CCcccCCchhHhHhhhhhhccCccccccCcccCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 646 TRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC-EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
|............... ..... ...+.+.. .......+.+.+++.+||+.||++|||+.+|+++|+.+..
T Consensus 267 ~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRK-VVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTTTSCSSCCHHHHHH-HHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCcCcccHHHHHH-HHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 5443322211111111 11111 11111111 1223567789999999999999999999999999987643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=322.33 Aligned_cols=237 Identities=28% Similarity=0.395 Sum_probs=193.3
Q ss_pred hhcCccccceeccCCCcceeeccc--------------cHHHHHHHHHHHHhhccCCeeeeeeeeee-------------
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ--------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE------------- 509 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~--------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~------------- 509 (754)
..++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 456899999999999999998422 23578899999999999999999998864
Q ss_pred ---cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEe
Q 036419 510 ---QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKIS 586 (754)
Q Consensus 510 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~ 586 (754)
....++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEEC
Confidence 455899999999999999996532 356899999999999999999999998 9999999999999999999999
Q ss_pred eccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc
Q 036419 587 DFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD 666 (754)
Q Consensus 587 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 666 (754)
|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..|+.... .. ......
T Consensus 165 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~----~~~~~~ 233 (284)
T 2a19_B 165 DFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----KF----FTDLRD 233 (284)
T ss_dssp CCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----HH----HHHHHT
T ss_pred cchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----HH----HHHhhc
Confidence 9999987754321 234578999999999999999999999999999999999998753110 00 000111
Q ss_pred CccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 036419 667 DRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVN 720 (754)
Q Consensus 667 ~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 720 (754)
. ... ...+..+.+++.+||+.||++|||+.+++++|+.....
T Consensus 234 ~--------~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 234 G--------IIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp T--------CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred c--------ccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1 111 12335688999999999999999999999999876443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=347.22 Aligned_cols=238 Identities=25% Similarity=0.298 Sum_probs=196.1
Q ss_pred hhhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
...++|++.+.||+|+||.||++. .....+.+|++++++++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 455789999999999999999721 23456789999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++|+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 261 lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999996532 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc--hhHhHhhhhhhccCccccc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS--LTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~l 672 (754)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..... ...
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~----~~~---- 405 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK----EVP---- 405 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH----HCC----
T ss_pred ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh----ccc----
Confidence 54322 234589999999999999999999999999999999999999987654322 11111110 000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 714 (754)
.......+..+.+++.+||+.||.+|| +++||++|-
T Consensus 406 ------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 406 ------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred ------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 011122456789999999999999999 789998874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=332.51 Aligned_cols=228 Identities=21% Similarity=0.340 Sum_probs=190.1
Q ss_pred hhhcCccccceeccCCCcceeeccc--------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeee
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ--------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~--------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~ 509 (754)
...++|++.++||+|+||.||++.. ..+.+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3457899999999999999997321 22356789999999999999999999999
Q ss_pred cCeeEEEEEecCCC-ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeec
Q 036419 510 QGENVLIYEYLPNK-SLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDF 588 (754)
Q Consensus 510 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DF 588 (754)
....++||||+.+| +|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999777 99999953 346999999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD 667 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 667 (754)
|+++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......
T Consensus 175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 99987754322 234679999999999988876 89999999999999999999998532110
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 668 RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 668 ~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...... .....++.+.+++.+||+.||++|||+.+++++-
T Consensus 237 -----~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 237 -----VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp -----TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred -----HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000000 0111346788999999999999999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=340.31 Aligned_cols=249 Identities=23% Similarity=0.313 Sum_probs=179.9
Q ss_pred hhhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecC--e
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQG--E 512 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~--~ 512 (754)
...++|++.++||+|+||.||++. ...+++.+|++++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 345789999999999999999731 13456789999999998 999999999997544 6
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 589888854 46899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCc-------------------ccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCC
Q 036419 593 MFGGDE-------------------LQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTN 652 (754)
Q Consensus 593 ~~~~~~-------------------~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~ 652 (754)
.+.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 763211 1112334689999999999986 67999999999999999999999998754322
Q ss_pred chhHhHhhhhhhccCccc---ccc------------------CcccCC------------CCCHHHHHHHHHHHHHcccc
Q 036419 653 SLTLLGHAWNLWKDDRSW---ELM------------------DPKLQC------------EASYPIVKRYINVALLCVQE 699 (754)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~---~l~------------------d~~~~~------------~~~~~~~~~l~~li~~cl~~ 699 (754)
.. .............. .+. ...... .......+.+.+++.+||+.
T Consensus 238 ~~--~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 238 NQ--LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HH--HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HH--HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 21 11110000000000 000 000000 00002245788999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 036419 700 NAADRPTMSEVISML 714 (754)
Q Consensus 700 dP~~RPt~~evl~~L 714 (754)
||++|||++|+++|-
T Consensus 316 dP~~R~t~~e~l~Hp 330 (388)
T 3oz6_A 316 NPNKRISANDALKHP 330 (388)
T ss_dssp SGGGSCCHHHHTTST
T ss_pred CcccCCCHHHHhCCH
Confidence 999999999999983
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=326.83 Aligned_cols=246 Identities=22% Similarity=0.273 Sum_probs=191.4
Q ss_pred hhcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee----cCeeE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE----QGENV 514 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~----~~~~~ 514 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 45789999999999999999732 235678899999999999999999999873 45789
Q ss_pred EEEEecCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 515 LIYEYLPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
+||||+++++|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999996532 3456999999999999999999999998 99999999999999999999999999886
Q ss_pred cCCCccc-------ccccccccccCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh
Q 036419 594 FGGDELQ-------SNTKRIVGTYGYMSPEYAIHGF---FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL 663 (754)
Q Consensus 594 ~~~~~~~-------~~~~~~~gt~~y~APE~~~~~~---~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 663 (754)
....... .......||+.|+|||++.... ++.++||||||+++|+|++|+.||...............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-- 261 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-- 261 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh--
Confidence 5321110 0112345799999999987553 789999999999999999999998542211111111000
Q ss_pred hccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 664 WKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 664 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
. ..........+..+.+++.+||+.||++|||+.+|+++|+...
T Consensus 262 --~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 262 --N---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp --C---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred --c---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0 0001111233467899999999999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=331.59 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=181.5
Q ss_pred hhhhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
....++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 3445789999999999999999731 12345779999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE-----cCCCceEEeecc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL-----DSNMIPKISDFG 589 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll-----d~~~~~kl~DFg 589 (754)
+||||+++ +|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999985 99999854 345899999999999999999999998 9999999999999 455569999999
Q ss_pred CccccCCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhc--c
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWK--D 666 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~ 666 (754)
+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ......... .
T Consensus 183 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~ 258 (329)
T 3gbz_A 183 LARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPD 258 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCC
T ss_pred CccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCc
Confidence 998764332 123345789999999999875 589999999999999999999999865433221 111100000 0
Q ss_pred Cccc--------------cccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 667 DRSW--------------ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 667 ~~~~--------------~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.... ......+.........+.+.+++.+||+.||++|||+.|+++|-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 0000 00000000000111346788999999999999999999999865
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=334.02 Aligned_cols=241 Identities=20% Similarity=0.251 Sum_probs=183.5
Q ss_pred hcCcccc-ceeccCCCcceeeccc-------------cHHHHHHHHHHHHh-hccCCeeeeeeeeee----cCeeEEEEE
Q 036419 458 TNNFGVE-NKLGEGGFGPVYKSGQ-------------GLEEFKNEIKLTAK-LQHRNLVRLLGCCVE----QGENVLIYE 518 (754)
Q Consensus 458 ~~~y~~~-~~lG~G~fg~Vyk~~~-------------~~~~~~~Ev~il~~-l~hpniv~l~~~~~~----~~~~~lV~E 518 (754)
.++|.+. +.||+|+||.||++.. ....+.+|++++.+ .+||||+++++++.. ....++|||
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 3567766 6899999999998322 34678899998855 489999999999876 667899999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC---CCceEEeeccCccccC
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFG 595 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~---~~~~kl~DFgla~~~~ 595 (754)
|+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 140 ~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 140 CLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp CCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred eCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 99999999999653 2346999999999999999999999988 999999999999997 7899999999998764
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch--hHhHhhhhhhccCcccccc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL--TLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~l~ 673 (754)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....... .... .
T Consensus 216 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~-~-- 285 (400)
T 1nxk_A 216 SHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY-E-- 285 (400)
T ss_dssp --------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC-C--
T ss_pred CCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc-c--
Confidence 322 23356789999999999999999999999999999999999999865443221 0111110 0000 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.........++.+.+++.+||+.||++|||+.+|++|.-
T Consensus 286 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 286 ---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp ---CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 000111234567899999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=331.49 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=187.7
Q ss_pred hcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
-++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 36799999999999999997211 2355789999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999988743 345999999999999999999999998 999999999999999999999999999876433
Q ss_pred cccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhH--hH-------hhhhhhc--
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL--LG-------HAWNLWK-- 665 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~--~~-------~~~~~~~-- 665 (754)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......... .. .....+.
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 21 22345789999999998875 78999999999999999999999986543322100 00 0000011
Q ss_pred ----cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 666 ----DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 666 ----~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.....++.............++.+.+++.+||+.||++|||+.|+++|-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 1111111111110011113457799999999999999999999998864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.04 Aligned_cols=264 Identities=24% Similarity=0.359 Sum_probs=193.9
Q ss_pred CchhhHhhhhcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC
Q 036419 449 KSLASVSAATNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG 511 (754)
Q Consensus 449 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~ 511 (754)
....+.....++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+..
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 3445556677899999999999999999732 22356788999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ceEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 999999999999999999542 346899999999999999999999998 99999999999998 679999999998
Q ss_pred cccCCCc---ccccccccccccCccccccccc---------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHh
Q 036419 592 RMFGGDE---LQSNTKRIVGTYGYMSPEYAIH---------GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH 659 (754)
Q Consensus 592 ~~~~~~~---~~~~~~~~~gt~~y~APE~~~~---------~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~ 659 (754)
+...... .........||+.|+|||++.. ..++.++||||||+++|||++|+.||........ ...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~ 254 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--IWQ 254 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH--HHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH
Confidence 7653211 1122234568999999999874 4579999999999999999999999864432211 111
Q ss_pred hhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCCCCCCcccc
Q 036419 660 AWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSL 732 (754)
Q Consensus 660 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~~ 732 (754)
. . .... +... ....+..+.+++.+||+.||++|||+.+|+++|+...........|+.++.
T Consensus 255 ~---~-~~~~-----~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 255 M---G-TGMK-----PNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp H---H-TTCC-----CCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred h---c-cCCC-----CCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence 1 0 1101 1110 111234588999999999999999999999999988766666666666553
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.04 Aligned_cols=235 Identities=26% Similarity=0.399 Sum_probs=172.1
Q ss_pred hhcCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++.+....++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999997321 23678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999999642 356899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... . .....
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~-------------~~~~~ 227 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-N-------------KVVLA 227 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSS
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-H-------------HHhhc
Confidence 3221 122457899999999999989999999999999999999999998654322210 0 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. ......+..+.+++.+||+.||++|||+++++++-
T Consensus 228 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 228 DY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp CC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred cc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 00 11122346788999999999999999999998864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=344.33 Aligned_cols=178 Identities=24% Similarity=0.403 Sum_probs=141.5
Q ss_pred hcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec-----Ce
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ-----GE 512 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~-----~~ 512 (754)
.++|++.++||+|+||.||++. ...+++.+|++++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4789999999999999999731 1246788999999999999999999998443 57
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 689888843 456999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc-------------------------cccccccccccCccccccc-ccCCCCcccchhhHHHHHHHHHhC
Q 036419 593 MFGGDEL-------------------------QSNTKRIVGTYGYMSPEYA-IHGFFSIKSDVFSFGVLLLETLSS 642 (754)
Q Consensus 593 ~~~~~~~-------------------------~~~~~~~~gt~~y~APE~~-~~~~~s~ksDVwSlGvil~elltg 642 (754)
....... .......+||+.|+|||++ ....++.++||||||||+|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643211 0123456789999999976 456799999999999999999994
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=331.25 Aligned_cols=248 Identities=23% Similarity=0.257 Sum_probs=178.9
Q ss_pred HhhhhcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhc-cCCeeeeeeeee------
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQ-HRNLVRLLGCCV------ 508 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~-hpniv~l~~~~~------ 508 (754)
+.....+|++.++||+|+||.||++. ...+.+.+|+++++++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 44456789999999999999999732 12467889999999996 999999999984
Q ss_pred --ecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEe
Q 036419 509 --EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKIS 586 (754)
Q Consensus 509 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~ 586 (754)
.....++||||+. |+|.+++......+.+++..+..++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEe
Confidence 3445789999996 689998876555667999999999999999999999874 349999999999999999999999
Q ss_pred eccCccccCCCcccc----------cccccccccCccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc
Q 036419 587 DFGLARMFGGDELQS----------NTKRIVGTYGYMSPEYA---IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS 653 (754)
Q Consensus 587 DFgla~~~~~~~~~~----------~~~~~~gt~~y~APE~~---~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~ 653 (754)
|||+++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 999998765432111 11245689999999998 56678999999999999999999999985432211
Q ss_pred hhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 036419 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNL 721 (754)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 721 (754)
. +...............+.+++.+||+.||++|||+.+++++|+......
T Consensus 261 ~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 261 I------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred h------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 0000011111112244788999999999999999999999998765433
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=339.57 Aligned_cols=238 Identities=22% Similarity=0.317 Sum_probs=180.9
Q ss_pred hhhcCccccceeccCCCcceeeccc--------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeee
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ--------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~--------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~ 509 (754)
...++|++.++||+|+||.||++.. ....+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4568999999999999999997311 1124789999999999999999999975
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC---ceEEe
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM---IPKIS 586 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~---~~kl~ 586 (754)
.+..++||||+++++|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 456899999999999999884 3456999999999999999999999998 99999999999997544 59999
Q ss_pred eccCccccCCCcccccccccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh
Q 036419 587 DFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH---GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL 663 (754)
Q Consensus 587 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 663 (754)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +.....
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~i~-- 358 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQIT-- 358 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHHHH--
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHHHh--
Confidence 999999765432 2335679999999999863 5788999999999999999999999865433221 111110
Q ss_pred hccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 664 WKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 664 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.... .. .+. .....++.+.+++.+||+.||++|||+.++++|-
T Consensus 359 --~~~~-~~-~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 359 --SGKY-NF-IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp --TTCC-CC-CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred --cCCC-CC-Cch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 0000 00 000 0012346789999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=318.44 Aligned_cols=250 Identities=20% Similarity=0.276 Sum_probs=192.2
Q ss_pred hhcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhccCCeeeeeeee-eecCeeEEEEEe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCC-VEQGENVLIYEY 519 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~-~~~~~~~lV~E~ 519 (754)
..++|++.+.||+|+||.||++. ...+++.+|++++++++|++++..+..+ .++...++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 45789999999999999999843 1234688999999999988777666655 667788999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE---cCCCceEEeeccCccccCC
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll---d~~~~~kl~DFgla~~~~~ 596 (754)
+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 87 L-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp C-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred c-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9 99999999642 345999999999999999999999998 9999999999999 7889999999999997754
Q ss_pred Cccc-----ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhhhhhhccCccc
Q 036419 597 DELQ-----SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHAWNLWKDDRSW 670 (754)
Q Consensus 597 ~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 670 (754)
.... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||....... ................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-
Confidence 3221 12335679999999999999999999999999999999999999997654332 1111111000000000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 036419 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNL 721 (754)
Q Consensus 671 ~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 721 (754)
+.. ....++.+.+++.+||+.||++|||+++|++.|+......
T Consensus 240 ----~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 240 ----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ----HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----hhh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 000 0112467899999999999999999999999998765433
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=341.52 Aligned_cols=244 Identities=22% Similarity=0.208 Sum_probs=182.0
Q ss_pred hcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec------C
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ------G 511 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~------~ 511 (754)
.++|++.++||+|+||.||++. ...+++.+|++++++++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4789999999999999999731 1246788999999999999999999999654 4
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..++||||++++ |.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999875 555552 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhh----------
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW---------- 661 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---------- 661 (754)
+...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.... +.....
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFM 287 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHH
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHH
Confidence 8765432 23456899999999999999999999999999999999999999875442211 000000
Q ss_pred --------hhhccC------ccccccCcccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 662 --------NLWKDD------RSWELMDPKLQCE---ASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 662 --------~~~~~~------~~~~l~d~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...... ............. ......+.+.+++.+||+.||++|||++|+++|-
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 000000 0000000000000 0111356799999999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=343.99 Aligned_cols=239 Identities=24% Similarity=0.322 Sum_probs=195.2
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+....++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 44789999999999999999722 234568899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 516 IYEYLPNKSLDSFLFDTTK-EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999975432 346999999999999999999999998 999999999999999999999999999976
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc--hhHhHhhhhhhccCccccc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS--LTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~l 672 (754)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.... ....
T Consensus 340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i---~~~~----- 409 (543)
T 3c4z_A 340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV---LEQA----- 409 (543)
T ss_dssp CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH---HHCC-----
T ss_pred cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH---hhcc-----
Confidence 54322 2334689999999999999999999999999999999999999987553321 1111111 1100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTM-----SEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~L 714 (754)
. ..+...+..+.+++.+||+.||.+||++ ++|++|-
T Consensus 410 ----~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp 450 (543)
T 3c4z_A 410 ----V--TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450 (543)
T ss_dssp ----C--CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred ----c--CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence 0 1112345678899999999999999964 7787653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.63 Aligned_cols=244 Identities=21% Similarity=0.298 Sum_probs=185.7
Q ss_pred hhcCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.-++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++.+++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 347899999999999999997321 13678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999643 45899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .+..... .... .+
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~---~~~~-----~~ 254 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHIN---QAIP-----RP 254 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHH---SCCC-----CG
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhc---cCCC-----Cc
Confidence 4322 1223457899999999999999999999999999999999999998643321 1111110 0000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhccccC
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRP-TMSEVISMLTNEFVN 720 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~ 720 (754)
.......+..+.+++.+||+.||++|| +++++++.|+.....
T Consensus 255 ---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 255 ---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 011122345688999999999999999 999999999876443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.68 Aligned_cols=235 Identities=23% Similarity=0.355 Sum_probs=186.2
Q ss_pred hcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee----cCee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE----QGEN 513 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~----~~~~ 513 (754)
.+.|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.. +...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3458889999999999999721 134668899999999999999999999875 3568
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc-CCCceEEeeccCcc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD-SNMIPKISDFGLAR 592 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld-~~~~~kl~DFgla~ 592 (754)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999999543 45899999999999999999999874 3599999999999998 78999999999997
Q ss_pred ccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
...... .....||+.|+|||++. ..++.++||||||+++|+|++|+.||.......... ... .....
T Consensus 181 ~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~----~~~~~--- 247 (290)
T 1t4h_A 181 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-RRV----TSGVK--- 247 (290)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-HHH----TTTCC---
T ss_pred cccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH-HHH----hccCC---
Confidence 654332 23457899999999776 569999999999999999999999986433222111 110 11100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. .......+.+.+++.+||+.||++|||+.+|++|-
T Consensus 248 -~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 248 -PA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp -CG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred -cc----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 00 01111235688999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=324.93 Aligned_cols=251 Identities=24% Similarity=0.303 Sum_probs=197.9
Q ss_pred cCCCchhhHhhhhcCcccc-ceeccCCCcceeec--------------------cccHHHHHHHHHHHHhhc-cCCeeee
Q 036419 446 TQGKSLASVSAATNNFGVE-NKLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKLQ-HRNLVRL 503 (754)
Q Consensus 446 ~~~~~~~~~~~~~~~y~~~-~~lG~G~fg~Vyk~--------------------~~~~~~~~~Ev~il~~l~-hpniv~l 503 (754)
..+..+.......++|.+. +.||+|+||.||++ .....++.+|++++++++ ||||+++
T Consensus 15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 3445566667778889887 89999999999972 123578999999999995 6999999
Q ss_pred eeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC---C
Q 036419 504 LGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---N 580 (754)
Q Consensus 504 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~---~ 580 (754)
++++.+....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. +
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTB
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCC
Confidence 99999999999999999999999998542 3356999999999999999999999998 999999999999987 7
Q ss_pred CceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhh
Q 036419 581 MIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA 660 (754)
Q Consensus 581 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 660 (754)
+.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ...
T Consensus 171 ~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i 245 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY--LNI 245 (327)
T ss_dssp CCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHH
T ss_pred CcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH--HHH
Confidence 899999999999765432 123467999999999999999999999999999999999999998654322211 111
Q ss_pred hhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 661 WNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 661 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
... .............+.+.+++.+||+.||++|||+++++++--
T Consensus 246 ~~~----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 246 SQV----------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp HHT----------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred Hhc----------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 000 000111111234567889999999999999999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=317.29 Aligned_cols=239 Identities=25% Similarity=0.394 Sum_probs=188.6
Q ss_pred cCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 459 NNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
++|.....||+|+||.||++. ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 345555699999999999732 23577899999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC-CCceEEeeccCccccCCCcc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS-NMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~-~~~~kl~DFgla~~~~~~~~ 599 (754)
++++|.+++........+++..+..++.||+.||.|||+.+ |+|+||||+||+++. ++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999976544456789999999999999999999998 999999999999987 8999999999998765322
Q ss_pred cccccccccccCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGF--FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.............. .. ...+.
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~-------~~~~~- 246 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG--MF-------KVHPE- 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH--HH-------CCCCC-
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc--cc-------ccccc-
Confidence 1223457899999999987653 89999999999999999999999864332221111100 00 00111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.....++.+.+++.+||+.||++||++.+++++--
T Consensus 247 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 247 ---IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp ---CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred ---ccccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 11233467889999999999999999999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=321.87 Aligned_cols=235 Identities=26% Similarity=0.395 Sum_probs=194.7
Q ss_pred hhcCccccceeccCCCcceeec-------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS-------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~-------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
..+.|++.++||+|+||.||++ ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3467999999999999999972 224578999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. +.+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 100 e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999999943 46899999999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+....... ...... . .. .+..
T Consensus 173 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~---~-~~-----~~~~ 239 (303)
T 3a7i_A 173 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIP---K-NN-----PPTL 239 (303)
T ss_dssp BC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHH---H-SC-----CCCC
T ss_pred cc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhh---c-CC-----CCCC
Confidence 22 2234678999999999999999999999999999999999999986433221 111110 0 00 0111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
....++.+.+++.+||+.||++|||+.+|+++.-
T Consensus 240 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 240 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp ----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred ----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 1123466889999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.73 Aligned_cols=236 Identities=23% Similarity=0.308 Sum_probs=189.3
Q ss_pred hcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~ 513 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 4679999999999999999721 1367899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC----ceEEeecc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM----IPKISDFG 589 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~----~~kl~DFg 589 (754)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999954 345899999999999999999999998 99999999999998877 89999999
Q ss_pred CccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcc
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ...... ....
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~----~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--TLTNIS----AVNY 228 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHH----TTCC
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--HHHHhH----hccc
Confidence 998765432 1234568999999999999999999999999999999999999986543221 111110 0000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
..... .....++.+.+++.+||+.||++|||+.+++++-
T Consensus 229 --~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 229 --DFDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp --CCCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred --CCcch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 00000 0012346788999999999999999999999853
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=331.76 Aligned_cols=255 Identities=15% Similarity=0.146 Sum_probs=198.6
Q ss_pred hcCccccceeccCCCcceeecccc---------------------HHHHHHHHHHHHhhccCCeee--------------
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQG---------------------LEEFKNEIKLTAKLQHRNLVR-------------- 502 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~~---------------------~~~~~~Ev~il~~l~hpniv~-------------- 502 (754)
.++|++.+.||+|+||.||++... .+.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 468999999999999999985321 135889999999999999988
Q ss_pred -eeeeeee-cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC
Q 036419 503 -LLGCCVE-QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN 580 (754)
Q Consensus 503 -l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~ 580 (754)
+++++.. +...++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPE 195 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETT
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCC
Confidence 5667665 67889999999 99999999653 2356999999999999999999999998 9999999999999999
Q ss_pred C--ceEEeeccCccccCCCccc-----ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc
Q 036419 581 M--IPKISDFGLARMFGGDELQ-----SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS 653 (754)
Q Consensus 581 ~--~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~ 653 (754)
+ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 8 9999999999876533211 11234579999999999999999999999999999999999999987654333
Q ss_pred hhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 036419 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLP 722 (754)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 722 (754)
..+.......... ...+.+... .....++.+.+++.+||+.||++|||+++|+++|+.......
T Consensus 276 ~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 276 EDIMKQKQKFVDK--PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp HHHHHHHHHHHHS--CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhccCC--hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 2222221111111 111111110 011234678999999999999999999999999987654443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=332.63 Aligned_cols=234 Identities=29% Similarity=0.435 Sum_probs=188.8
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..+.|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++.++...++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 34569999999999999999722 123568899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||++ |+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 132 v~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EEECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 999998 5777777532 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAI---HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
.. ....||+.|+|||++. ...++.++|||||||++|||++|+.||........ ........ .
T Consensus 206 ~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----~~~~~~~~-~--- 270 (348)
T 1u5q_A 206 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNE-S--- 270 (348)
T ss_dssp SB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSC-C---
T ss_pred CC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcC-C---
Confidence 32 2457999999999985 56789999999999999999999999754332111 11111111 0
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
+.. .....++.+.+++.+||+.||++|||+++++++.--
T Consensus 271 --~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 271 --PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp --CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred --CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 101 111234668899999999999999999999988654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=322.06 Aligned_cols=245 Identities=19% Similarity=0.280 Sum_probs=190.7
Q ss_pred hcCccccceeccCCCcceeec---------------cccHHHHHHHHHHHHhhc-cCCeeeeeeeeee--cCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKS---------------GQGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVE--QGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~---------------~~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~--~~~~~lV~E~ 519 (754)
.++|++.++||+|+||.||++ ....+.+.+|++++++++ ||||+++++++.+ ....++||||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 368999999999999999973 234678999999999997 9999999999987 6678999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC-ceEEeeccCccccCCCc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM-IPKISDFGLARMFGGDE 598 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~-~~kl~DFgla~~~~~~~ 598 (754)
+++++|.+++. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++......
T Consensus 115 ~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 115 VNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred cCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999883 2889999999999999999999998 99999999999999776 89999999998765432
Q ss_pred ccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhh--------hhhccCc-
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW--------NLWKDDR- 668 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~- 668 (754)
. .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.........+..... .......
T Consensus 186 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 186 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred c---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 2 334578999999999887 67999999999999999999999998543322111111000 0000000
Q ss_pred -------------cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 669 -------------SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 669 -------------~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.................++.+.+++.+||+.||++|||++|+++|-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence 0000000111111222467899999999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=327.20 Aligned_cols=253 Identities=21% Similarity=0.321 Sum_probs=188.4
Q ss_pred hcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee--------
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE-------- 509 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~-------- 509 (754)
.++|++.++||+|+||.||++. .....+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 3689999999999999999732 124578899999999999999999999987
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
....++||||+++ +|.+.+.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 4568999999986 66666643 2345999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcc--cccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCch-hHhHhhhh---
Q 036419 590 LARMFGGDEL--QSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-TLLGHAWN--- 662 (754)
Q Consensus 590 la~~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~--- 662 (754)
+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9987653221 122345678999999998876 4689999999999999999999999875433221 11100000
Q ss_pred --hhccC---ccccccCcccCCCCCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 663 --LWKDD---RSWELMDPKLQCEASYP-------IVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 663 --~~~~~---~~~~l~d~~~~~~~~~~-------~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
.+... ...+.+........... ..+.+.+++.+||+.||++|||+.|+++|---
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 00000 00000000000000110 13458899999999999999999999998643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=326.97 Aligned_cols=246 Identities=20% Similarity=0.255 Sum_probs=185.4
Q ss_pred hcCcccc-ceeccCCCcceeec------------------cccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEE
Q 036419 458 TNNFGVE-NKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 458 ~~~y~~~-~~lG~G~fg~Vyk~------------------~~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~ 517 (754)
.+.|++. +.||+|+||.||++ ....+.+.+|++++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678884 78999999999972 12357899999999995 7999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc---eEEeeccCcccc
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI---PKISDFGLARMF 594 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~---~kl~DFgla~~~ 594 (754)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999653 45899999999999999999999998 999999999999998776 999999999865
Q ss_pred CCCcc-----cccccccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhH--------
Q 036419 595 GGDEL-----QSNTKRIVGTYGYMSPEYAIH-----GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL-------- 656 (754)
Q Consensus 595 ~~~~~-----~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~-------- 656 (754)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 111224569999999999875 568999999999999999999999987554322100
Q ss_pred -hHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 657 -LGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 657 -~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
............. ..........+..+.+++.+||+.||++|||+.|+++|--
T Consensus 245 ~~~~~~~~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 245 CQNMLFESIQEGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp HHHHHHHHHHHCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred HHHHHHHHHhccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 0000000000000 0000000113467899999999999999999999999753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.59 Aligned_cols=240 Identities=28% Similarity=0.413 Sum_probs=188.0
Q ss_pred hcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~ 513 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4689999999999999999732 12357889999999999999999999988765 8
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999999653 245899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 594 FGGDELQ-SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 594 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
....... .......+|..|+|||++.+..++.++||||||+++|+|++ |+.||....... ..... .....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~---~~~~~--- 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKI---DKEGE--- 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH---HTSCC---
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--HHHHH---HccCC---
Confidence 7543221 22334567889999999998899999999999999999999 999986443221 11111 11110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
........++.+.+++.+||+.||++|||+.+|+++|+..
T Consensus 243 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 243 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 0011123456789999999999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=323.17 Aligned_cols=243 Identities=26% Similarity=0.383 Sum_probs=191.2
Q ss_pred hcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee--cCeeEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE--QGENVL 515 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~--~~~~~l 515 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+ +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4689999999999999999721 134678899999999999999999998854 568899
Q ss_pred EEEecCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 516 IYEYLPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYS--RLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997543 2345999999999999999999999976 2349999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... +..... .....
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~i~----~~~~~-- 234 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKIR----EGKFR-- 234 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH----HTCCC--
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HHHHHh----hcccc--
Confidence 7643321 1223578999999999999999999999999999999999999986543221 111111 11110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
......++.+.+++.+||+.||++||++.+|++++...
T Consensus 235 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 235 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred -------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 11122346789999999999999999999999987654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=316.20 Aligned_cols=252 Identities=20% Similarity=0.268 Sum_probs=195.9
Q ss_pred hhcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhccCCeeeeeeee-eecCeeEEEEEe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCC-VEQGENVLIYEY 519 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~-~~~~~~~lV~E~ 519 (754)
..++|++.+.||+|+||.||++. ...+++.+|++++++++|++++..+..+ .++...++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 45789999999999999999832 2345789999999999998866666555 667788999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE---cCCCceEEeeccCccccCC
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll---d~~~~~kl~DFgla~~~~~ 596 (754)
+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 87 L-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred c-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 9 99999999642 346999999999999999999999998 9999999999999 5888999999999997754
Q ss_pred Cccc-----ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhhhhhhccCccc
Q 036419 597 DELQ-----SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHAWNLWKDDRSW 670 (754)
Q Consensus 597 ~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 670 (754)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-
Confidence 3321 11245679999999999999999999999999999999999999987644322 1111111100000000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCC
Q 036419 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPS 723 (754)
Q Consensus 671 ~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 723 (754)
+.. ....++.+.+++.+||+.||++|||+++|++.|+........
T Consensus 240 ----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 240 ----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ----HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ----HHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 000 012346789999999999999999999999999876554433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=324.56 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=180.1
Q ss_pred HhhhhcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
.....++|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++..++..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 44556899999999999999999732 22456789999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 515 LIYEYLPNKSLDSFLFDT-----TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
+||||+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999998642 13456899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcc---cccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhc
Q 036419 590 LARMFGGDEL---QSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWK 665 (754)
Q Consensus 590 la~~~~~~~~---~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 665 (754)
++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~ 241 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----TLQ 241 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-----HHT
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-----Hhc
Confidence 9987643221 111234578999999999876 5789999999999999999999999875543321110 001
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 666 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. ...+.............++.+.+++.+||+.||.+|||+.+++++-
T Consensus 242 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 242 ND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp SS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred cC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 10 0000000000111112346788999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=334.01 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=191.6
Q ss_pred hcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 4689999999999999999722 124678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY-SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
|+++++|.+++... +.+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999543 4589999999999999999999985 7 999999999999999999999999999765321
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhh----------hh----
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW----------NL---- 663 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~----------~~---- 663 (754)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ..
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 233467999999999999999999999999999999999999998654332211000000 00
Q ss_pred ----------hccCccccccC----cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 664 ----------WKDDRSWELMD----PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 664 ----------~~~~~~~~l~d----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.......+.++ ...........+..+.+++.+||+.||++|||+.++++|--
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 00000000000 00000111123567899999999999999999999998763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.91 Aligned_cols=231 Identities=23% Similarity=0.333 Sum_probs=191.8
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.++...++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 3689999999999999999731 1245788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++++|.+++... +.+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999999643 45899999999999999999999988 99999999999999999999999999976543
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|..||....... .... .... +.
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~---~~~~-------~~- 229 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--THRR---IVNV-------DL- 229 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH---HHTT-------CC-
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--HHHH---Hhcc-------cc-
Confidence 22 234578999999999999999999999999999999999999986433221 1111 1100 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......+..+.+++.+||+.||.+|||++++++|-
T Consensus 230 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 230 ---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 11122346788999999999999999999999865
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=326.81 Aligned_cols=251 Identities=25% Similarity=0.308 Sum_probs=188.3
Q ss_pred hhhcCccccceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
...++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999997311 02357899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+++ +|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999987 88888854 2346889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC---c
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD---R 668 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 668 (754)
.+.... .......||+.|+|||++.+. .++.++|||||||++|||++|..|+....... ............ .
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTT
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHcCCCChhh
Confidence 764332 123346789999999998764 58999999999999999999999876543221 111111110000 0
Q ss_pred c------ccccCcccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 669 S------WELMDPKLQCEA-----SYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 669 ~------~~l~d~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
. .+.+........ ....++.+.+++.+||+.||++|||+.|+++|.--
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 0 000000000000 01234678999999999999999999999998753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=330.18 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=185.9
Q ss_pred hhcCccccceeccCCCcceeecc-------------ccHHHHHHHHHH--HHhhccCCeeeeeeeeee-----cCeeEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG-------------QGLEEFKNEIKL--TAKLQHRNLVRLLGCCVE-----QGENVLI 516 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~-------------~~~~~~~~Ev~i--l~~l~hpniv~l~~~~~~-----~~~~~lV 516 (754)
..++|++.+.||+|+||.||++. ...+.+..|.++ +..++||||+++++.+.. ....++|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 34789999999999999999832 233455555555 445899999999986542 3367899
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCceeeCCCCCCceEEcCCCceEEee
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY---------SRLRVIHRDLKPSNILLDSNMIPKISD 587 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---------~~~~iiH~Dlkp~NIlld~~~~~kl~D 587 (754)
|||+++++|.+++.. ...++..+..++.||++||.|||+. + |+||||||+|||++.++.+||+|
T Consensus 91 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp ECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECC
T ss_pred EecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEee
Confidence 999999999999954 2358999999999999999999998 6 99999999999999999999999
Q ss_pred ccCccccCCCcc------cccccccccccCccccccccc-------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCch
Q 036419 588 FGLARMFGGDEL------QSNTKRIVGTYGYMSPEYAIH-------GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL 654 (754)
Q Consensus 588 Fgla~~~~~~~~------~~~~~~~~gt~~y~APE~~~~-------~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~ 654 (754)
||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987654321 112234579999999999876 4567899999999999999999877543222110
Q ss_pred -h--Hh---------HhhhhhhccCccccccCcccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 655 -T--LL---------GHAWNLWKDDRSWELMDPKLQ--CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 655 -~--~~---------~~~~~~~~~~~~~~l~d~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
. .. .......... ...+.+. .......++.+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSRE----KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTS----CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhccc----ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 0 00 0000000000 0111111 11223467789999999999999999999999999987543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=352.97 Aligned_cols=241 Identities=24% Similarity=0.404 Sum_probs=189.3
Q ss_pred hcCccccc-eeccCCCcceeec---------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 458 TNNFGVEN-KLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 458 ~~~y~~~~-~lG~G~fg~Vyk~---------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.+++.+.+ +||+|+||.||++ ....+++.+|++++++++|||||++++++.. +..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34455555 8999999999962 1245789999999999999999999999876 56999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 413 v~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999954 2456999999999999999999999998 9999999999999999999999999999765
Q ss_pred CCccc-ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 596 GDELQ-SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 596 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ ..... ..+.
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i----~~~~----- 556 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFI----EQGK----- 556 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHH----HTTC-----
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HcCC-----
Confidence 43211 11223345689999999999999999999999999999998 999987544322 11111 1110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
........++.+.+++.+||+.||++||++.+|++.|+....
T Consensus 557 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 557 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 011122345678999999999999999999999999987543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=320.69 Aligned_cols=238 Identities=26% Similarity=0.399 Sum_probs=186.2
Q ss_pred hhhcCccccceeccCCCcceeec--------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeec-CeeEEEEEec
Q 036419 456 AATNNFGVENKLGEGGFGPVYKS--------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ-GENVLIYEYL 520 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~--------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~-~~~~lV~E~~ 520 (754)
...++|++.+.||+|+||.||++ ....+.+.+|++++++++||||+++++++.+. ...++||||+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred CChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 34578999999999999999972 22457899999999999999999999997554 5789999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 9999999996432 223789999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 601 SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.|+........ .... ... ...
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~~----~~~---------~~~ 233 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRV----EKG---------YKM 233 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHHH----TTT---------CCC
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH----hcC---------CCC
Confidence 123457889999999999999999999999999999998 9998765433221 1111 000 001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
......++.+.+++.+||+.||++|||+.++++.|+..
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 11123356788999999999999999999999999865
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=334.89 Aligned_cols=233 Identities=24% Similarity=0.263 Sum_probs=181.0
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHH-HHhhccCCeeeeeeeeeecCeeE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKL-TAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~i-l~~l~hpniv~l~~~~~~~~~~~ 514 (754)
..++|++.+.||+|+||.||++. ...+.+.+|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 34689999999999999999721 123445667666 56789999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999999954 345899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||....... ..... ... ..
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~~i---~~~-~~----- 256 (373)
T 2r5t_A 190 IEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYDNI---LNK-PL----- 256 (373)
T ss_dssp BCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH--HHHHH---HHS-CC-----
T ss_pred ccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--HHHHH---Hhc-cc-----
Confidence 3221 22445789999999999999999999999999999999999999986433221 11111 110 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH----HHHHH
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMS----EVISM 713 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~----evl~~ 713 (754)
.........+.+++.+||+.||.+||++. ++++|
T Consensus 257 -----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 257 -----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp -----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 01112346788999999999999999874 55554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=341.60 Aligned_cols=238 Identities=25% Similarity=0.337 Sum_probs=191.4
Q ss_pred hhhcCccccceeccCCCcceeec--------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~--------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
...++|++.++||+|+||.||++ ....+.+.+|++++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 34578999999999999999972 2245678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc---CCCceEEeeccCcc
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD---SNMIPKISDFGLAR 592 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld---~~~~~kl~DFgla~ 592 (754)
||||+++++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999988543 45899999999999999999999998 99999999999995 45679999999998
Q ss_pred ccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+ ...... ....
T Consensus 173 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~----~~~~--- 239 (486)
T 3mwu_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRVE----TGKY--- 239 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH----HTCC---
T ss_pred ECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH----hCCC---
Confidence 765432 2334679999999998865 59999999999999999999999986543222 111111 0000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
....+.....++.+.+++.+||+.||.+|||+.++++|--
T Consensus 240 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 240 ---AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp ---CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred ---CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 0000111234567899999999999999999999999753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.95 Aligned_cols=235 Identities=25% Similarity=0.323 Sum_probs=193.2
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34689999999999999999721 134678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++.. ...+++.++..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999998854 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+. ... . .....
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~---~-~~~~~------ 232 (294)
T 2rku_A 167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET--YLR---I-KKNEY------ 232 (294)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHH---H-HTTCC------
T ss_pred cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH---H-hhccC------
Confidence 3221 22346789999999999998999999999999999999999999865432211 000 0 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.........+.+++.+||+.||++|||+++++++.-
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 233 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred ----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 011123456889999999999999999999998754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.28 Aligned_cols=231 Identities=20% Similarity=0.349 Sum_probs=186.6
Q ss_pred hhcCccccceeccCCCcceeec--------------------cccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~--------------------~~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~l 515 (754)
..++|++.+.||+|+||.||++ .....++.+|+.++.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999972 12356788999999999 89999999999999999999
Q ss_pred EEEecCCCChhhHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC--------------
Q 036419 516 IYEYLPNKSLDSFLFDTTK-EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-------------- 580 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-------------- 580 (754)
||||+++++|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999965422 256899999999999999999999998 9999999999999844
Q ss_pred -----CceEEeeccCccccCCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCch
Q 036419 581 -----MIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL 654 (754)
Q Consensus 581 -----~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~ 654 (754)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 479999999998765432 24589999999999876 67789999999999999999987653211
Q ss_pred hHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 655 TLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 655 ~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
... . ...... +.. ....++.+.+++.+||+.||++|||+.++++|-
T Consensus 236 ~~~-~----~~~~~~-----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 236 QWH-E----IRQGRL-----PRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp HHH-H----HHTTCC-----CCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred HHH-H----HHcCCC-----CCC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 110 0 011111 111 112346788999999999999999999998864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.61 Aligned_cols=240 Identities=23% Similarity=0.270 Sum_probs=191.5
Q ss_pred hcCccccceeccCCCcceeeccc-------------------------cHHHHHHHHHHHHhh-ccCCeeeeeeeeeecC
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ-------------------------GLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQG 511 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~-------------------------~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~ 511 (754)
.++|++.++||+|+||.||++.. ..+.+.+|+++++++ +||||+++++++..+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999996321 235577899999999 5999999999999999
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..++||||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999999643 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcc
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIH--GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
+.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...........
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~-- 282 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRILKSE-- 282 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHHHHCC--
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-HHHHHHHhccC--
Confidence 87643322 22334679999999999985 35789999999999999999999998754433211 11111111000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhc
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISMLTN 716 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~ 716 (754)
.......+..+.+++.+||+.||++|| +++++++++--
T Consensus 283 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 283 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred ---------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 011223446788999999999999999 99999998743
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.95 Aligned_cols=237 Identities=22% Similarity=0.261 Sum_probs=186.5
Q ss_pred hcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeee--eecCee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCC--VEQGEN 513 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~--~~~~~~ 513 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4689999999999999999721 2346789999999999999999999998 455688
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||++++ |.+++... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 66666543 3456999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGF--FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
..............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ...... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~i~----~~~~-- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--LFENIG----KGSY-- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH----HCCC--
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHHh----cCCC--
Confidence 65433223334567999999999987654 4789999999999999999999986432211 111110 0100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
. ......+.+.+++.+||+.||++|||+.+++++.-
T Consensus 231 ----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 231 ----A----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp ----C----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred ----C----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 0 11123467889999999999999999999998753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.76 Aligned_cols=234 Identities=25% Similarity=0.319 Sum_probs=192.8
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34689999999999999999721 134678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++.. ...+++.++..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999999854 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.... ......||..|+|||++.+..++.++||||||+++|+|++|+.||......... ... .. ...
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~---~~-~~~------ 258 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--LRI---KK-NEY------ 258 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHH---HH-TCC------
T ss_pred cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH--HHH---hc-CCC------
Confidence 3321 223467999999999999999999999999999999999999998644322110 000 00 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. .......+.+++.+||+.||++|||+.+++++-
T Consensus 259 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 259 SI----PKHINPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 01 112345688999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=336.30 Aligned_cols=183 Identities=25% Similarity=0.404 Sum_probs=153.2
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec-----C
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ-----G 511 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~-----~ 511 (754)
..++|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 45789999999999999999731 1246788999999999999999999999766 5
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..++||||+++ +|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIADS-DLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCSE-EHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCCc-CHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 78999999874 99999943 456999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccc--------------------ccccccccccCccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCC
Q 036419 592 RMFGGDELQ--------------------SNTKRIVGTYGYMSPEYA-IHGFFSIKSDVFSFGVLLLETLSSKRST 646 (754)
Q Consensus 592 ~~~~~~~~~--------------------~~~~~~~gt~~y~APE~~-~~~~~s~ksDVwSlGvil~elltg~~p~ 646 (754)
+........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 976543211 123567899999999986 5567999999999999999999865544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=342.56 Aligned_cols=236 Identities=23% Similarity=0.345 Sum_probs=187.1
Q ss_pred hhcCccccceeccCCCcceeec--------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~--------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
..++|++.++||+|+||.||++ ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999972 12356789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC---CceEEeeccCccc
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN---MIPKISDFGLARM 593 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~---~~~kl~DFgla~~ 593 (754)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999988543 45899999999999999999999998 9999999999999764 4599999999987
Q ss_pred cCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||....... +...... ... ...
T Consensus 189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~----~~~-~~~ 257 (494)
T 3lij_A 189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--ILRKVEK----GKY-TFD 257 (494)
T ss_dssp CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH----TCC-CCC
T ss_pred CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh----CCC-CCC
Confidence 65432 233467999999999875 569999999999999999999999986543322 1111110 000 000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.+ .....++.+.+++.+||+.||.+|||+.++++|-
T Consensus 258 ~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 258 SP-----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp SG-----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred ch-----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 01 1112346788999999999999999999999763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=328.36 Aligned_cols=247 Identities=22% Similarity=0.315 Sum_probs=184.0
Q ss_pred cCccccceeccCCCcceeecccc-------------------HHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQG-------------------LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~~-------------------~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|++.++||+|+||.||++... ...+.+|++++++++||||+++++++.++...++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999983211 11345799999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++ +|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 985 888888643 346899999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc---CccccccC-
Q 036419 600 QSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD---DRSWELMD- 674 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~l~d- 674 (754)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ........... ........
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGC
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHhchhhhcc
Confidence 12234578999999999876 578999999999999999999999986543322 11111111100 00000000
Q ss_pred --------cccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 675 --------PKLQC----EASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 675 --------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
+.... .......+.+.+++.+||+.||++|||++|+++|--
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 00000 001123467889999999999999999999999754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=353.79 Aligned_cols=232 Identities=26% Similarity=0.397 Sum_probs=184.4
Q ss_pred ceeccCCCcceeec----------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKS----------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~----------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
++||+|+||.||++ ....+++.+|++++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999973 112478999999999999999999999986 4568999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc-cc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL-QS 601 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~-~~ 601 (754)
++|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999953 356899999999999999999999998 99999999999999999999999999997754322 12
Q ss_pred cccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ..... ..+.. ..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i----~~~~~---------~~ 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAML----EKGER---------MG 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH----HTTCC---------CC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----HcCCC---------CC
Confidence 2233457889999999999999999999999999999998 999986543322 11111 11100 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.....++.+.+++.+||+.||++||++.+|+++|+...
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11234567899999999999999999999999998653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.60 Aligned_cols=237 Identities=23% Similarity=0.307 Sum_probs=191.3
Q ss_pred hhcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 45689999999999999999721 124568899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE---cCCCceEEeeccCccccC
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFG 595 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll---d~~~~~kl~DFgla~~~~ 595 (754)
|+++++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999998543 45899999999999999999999998 9999999999999 788999999999998654
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... +..... .... .
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~----~~~~-~---- 225 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LFEKIK----EGYY-E---- 225 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHH----HCCC-C----
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH----cCCC-C----
Confidence 32 1234568999999999999999999999999999999999999986433211 111111 0000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.........++.+.+++.+||+.||++|||+.+++++--
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 226 -FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred -CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 001111234567899999999999999999999998653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=329.09 Aligned_cols=243 Identities=21% Similarity=0.288 Sum_probs=183.6
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC-----
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG----- 511 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~----- 511 (754)
..++|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 35789999999999999999731 12467889999999999999999999997653
Q ss_pred -eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 512 -ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 512 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8899999854 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC--
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD-- 667 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 667 (754)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPA 247 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCH
Confidence 9875432 334678999999999887 689999999999999999999999987543221 111100000000
Q ss_pred ---------c-------cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 668 ---------R-------SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 668 ---------~-------~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
. ......... ..........+.+++.+||+.||++|||+.++++|--
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 0 000000000 0111223567899999999999999999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=332.82 Aligned_cols=250 Identities=18% Similarity=0.231 Sum_probs=187.1
Q ss_pred hcCccccceeccCCCcceeeccc-------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCe------eEEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ-------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE------NVLIYE 518 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~-------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~------~~lV~E 518 (754)
..+|++.++||+|+||.||++.. ......+|++++++++||||+++++++..... .++|||
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 45799999999999999997432 12234579999999999999999999965543 789999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc-CCCceEEeeccCccccCCC
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD-SNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld-~~~~~kl~DFgla~~~~~~ 597 (754)
|++++.+............+++..+..++.||++||.|||+.+ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 9998665554433334567999999999999999999999998 99999999999999 7899999999999876443
Q ss_pred cccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh----------h---
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN----------L--- 663 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----------~--- 663 (754)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +...... .
T Consensus 196 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 196 EP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp CC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCG
T ss_pred CC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhhCh
Confidence 22 2345789999999998765 599999999999999999999999875442221 1100000 0
Q ss_pred -hccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 664 -WKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 664 -~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+.....................++.+.+++.+||+.||.+|||+.|+++|-
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 000000000000000111122446799999999999999999999999984
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=323.14 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=187.5
Q ss_pred CCCchhhHhhhhcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhcc--CCeeeeee
Q 036419 447 QGKSLASVSAATNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQH--RNLVRLLG 505 (754)
Q Consensus 447 ~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~h--pniv~l~~ 505 (754)
....+..+....++|++.+.||+|+||.||++. ...+.+.+|++++.+++| |||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 334555566677899999999999999999721 134678999999999984 99999999
Q ss_pred eeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEE
Q 036419 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKI 585 (754)
Q Consensus 506 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl 585 (754)
++.++...++||| +.+++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++ +.+||
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEE
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEE
Confidence 9999999999999 678899999964 346899999999999999999999998 999999999999975 89999
Q ss_pred eeccCccccCCCcccccccccccccCccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCch
Q 036419 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH-----------GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL 654 (754)
Q Consensus 586 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~ 654 (754)
+|||+++...............||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 99999987754433233345679999999999875 4788999999999999999999999864322111
Q ss_pred hHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 655 TLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 655 ~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.+ .... ++...........+.+.+++.+||+.||++||++.+++++.-
T Consensus 248 ~~----~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 248 KL----HAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HH----HHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HH----HHHH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 11 1111 111111111122467889999999999999999999998764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=342.74 Aligned_cols=237 Identities=24% Similarity=0.331 Sum_probs=193.3
Q ss_pred hhcCccccceeccCCCcceeec---------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~---------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..++|++.++||+|+||.||++ ....+.+.+|++++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4568999999999999999961 2346789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE---cCCCceEEeeccCcc
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLAR 592 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll---d~~~~~kl~DFgla~ 592 (754)
||||+++++|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999998854 356999999999999999999999998 9999999999999 567899999999998
Q ss_pred ccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ...... . ...
T Consensus 178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~---~-~~~--- 244 (484)
T 3nyv_A 178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--ILKKVE---K-GKY--- 244 (484)
T ss_dssp HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH---H-CCC---
T ss_pred Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH---c-CCC---
Confidence 765432 2234579999999998865 69999999999999999999999986543222 111111 0 000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
....+.....++.+.+++.+||+.||.+|||+.++++|--
T Consensus 245 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 245 ---TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp ---CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred ---CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 0000111234567899999999999999999999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.07 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=193.9
Q ss_pred hhcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC--e
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG--E 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~--~ 512 (754)
..++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 34679999999999999999743 12467899999999999999999999987654 7
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 89999999999999999653 245899999999999999999999988 9999999999999999999999999999
Q ss_pred ccCCCccc-ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc----------hhHhHhhh
Q 036419 593 MFGGDELQ-SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS----------LTLLGHAW 661 (754)
Q Consensus 593 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~----------~~~~~~~~ 661 (754)
........ .......++..|+|||++.+..++.++||||||+++|||++|..|+......- ........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 77543221 12233457788999999999899999999999999999999998865321100 00000000
Q ss_pred hhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 662 NLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 662 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
..... ..........++.+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 274 ~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 274 ELLKN---------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHT---------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhc---------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 0011112234567899999999999999999999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=352.47 Aligned_cols=234 Identities=24% Similarity=0.307 Sum_probs=192.5
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~ 514 (754)
..++|++.+.||+|+||.||++. ...+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34689999999999999999722 2345678899999988 6999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
|||||+++|+|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999643 45999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......+ +.... ...
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~--~~~~i---~~~-------- 557 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSI---MEH-------- 557 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---HSS--------
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH--HHHHH---HhC--------
Confidence 3322 22445789999999999999999999999999999999999999987543221 11111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHH
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTM-----SEVISML 714 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~L 714 (754)
.. ......++.+.+|+.+||+.||++||++ ++|++|-
T Consensus 558 -~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ 599 (674)
T 3pfq_A 558 -NV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599 (674)
T ss_dssp -CC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred -CC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence 01 1112345678999999999999999997 8888753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=312.58 Aligned_cols=233 Identities=23% Similarity=0.365 Sum_probs=183.3
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+....++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 34689999999999999999732 123578899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++... +.+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999999643 45899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.... .....|++.|+|||++.+..+ +.++||||||+++|+|++|+.||...... ....... ....
T Consensus 163 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~----~~~~----- 228 (276)
T 2h6d_A 163 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIR----GGVF----- 228 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH----HCCC-----
T ss_pred CCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhh----cCcc-----
Confidence 4322 234578999999999988765 68999999999999999999998643221 1111110 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.........+.+++.+||+.||++|||+.+|++|-
T Consensus 229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 01112345688999999999999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=331.88 Aligned_cols=239 Identities=11% Similarity=0.087 Sum_probs=170.6
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh--ccCCeeeee-------eee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL--QHRNLVRLL-------GCC 507 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l--~hpniv~l~-------~~~ 507 (754)
..+|++.++||+|+||.||++. ...+.+++|+++++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4569999999999999999732 1245677886666655 599988755 444
Q ss_pred eec-----------------CeeEEEEEecCCCChhhHhhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCc
Q 036419 508 VEQ-----------------GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGAR------IRIIEGIAQGLLYLHQYSRLR 564 (754)
Q Consensus 508 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~~L~yLH~~~~~~ 564 (754)
... ...++||||++ ++|.+++.... ..+.+..+ ..++.||++||.|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 332 34799999999 89999997542 23455555 778899999999999998
Q ss_pred eeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCccccccccc--CCCCcccchhhHHHHHHHHHhC
Q 036419 565 VIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH--GFFSIKSDVFSFGVLLLETLSS 642 (754)
Q Consensus 565 iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSlGvil~elltg 642 (754)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999764321 13457799999999987 6899999999999999999999
Q ss_pred CCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 643 KRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 643 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+.||.......... +.....................++.+.+++.+||+.||++|||+.++++|-
T Consensus 290 ~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 290 FLPFGLVTPGIKGS-------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp SCSTTBCCTTCTTC-------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred CCCCCCcCcccccc-------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 99987553322110 010000111111111111123457789999999999999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.56 Aligned_cols=239 Identities=23% Similarity=0.386 Sum_probs=189.0
Q ss_pred hhhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 456 AATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
...++|++.+.||+|+||.||++ ....+++.+|++++++++||||+++++++.+....++||||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 35678999999999999999973 22357899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 106 CGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999953 2356899999999999999999999998 99999999999999999999999999987654321
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ . .... .... +..
T Consensus 181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~---~~~~-~~~~-----~~~-- 245 (314)
T 3com_A 181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--I---FMIP-TNPP-----PTF-- 245 (314)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H---HHHH-HSCC-----CCC--
T ss_pred --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--H---HHHh-cCCC-----ccc--
Confidence 22345789999999999999999999999999999999999999864332111 0 0000 0000 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......+..+.+++.+||+.||.+|||+.+++++-
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 01112346788999999999999999999998865
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.53 Aligned_cols=247 Identities=23% Similarity=0.260 Sum_probs=189.2
Q ss_pred hcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhhc--------cCCeeeeeeeee----
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKLQ--------HRNLVRLLGCCV---- 508 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l~--------hpniv~l~~~~~---- 508 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 4789999999999999999832 12467889999999996 788999999987
Q ss_pred ecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCceEEcCCC------
Q 036419 509 EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY-SRLRVIHRDLKPSNILLDSNM------ 581 (754)
Q Consensus 509 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NIlld~~~------ 581 (754)
.....++||||+ +++|.+++... ....+++..+..++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence 566899999999 45555555432 234699999999999999999999998 7 99999999999999775
Q ss_pred -------------------------------------------ceEEeeccCccccCCCcccccccccccccCccccccc
Q 036419 582 -------------------------------------------IPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA 618 (754)
Q Consensus 582 -------------------------------------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~ 618 (754)
.+||+|||++...... .....||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 7999999999876432 2345789999999999
Q ss_pred ccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch----hHhHhhhhhhcc-------------------CccccccCc
Q 036419 619 IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL----TLLGHAWNLWKD-------------------DRSWELMDP 675 (754)
Q Consensus 619 ~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~----~~~~~~~~~~~~-------------------~~~~~l~d~ 675 (754)
.+..++.++|||||||++|||++|+.||........ ............ .....+.+.
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999975543321 011111000000 000000000
Q ss_pred cc---------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 676 KL---------QCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 676 ~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. ...........+.+++.+||+.||++|||+.||++|-
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 00 0122455678899999999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.98 Aligned_cols=239 Identities=24% Similarity=0.331 Sum_probs=176.6
Q ss_pred hhhcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
...++|++.++||+|+||.||++.. ..+.+..+..+++.++||||+++++++.+++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3457899999999999999997321 11233445555788899999999999999999999
Q ss_pred EEEecCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 516 IYEYLPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQGLLYLHQY-SRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
||||+++ +|.+++... .....+++..+..++.||+.||.|||++ + |+||||||+|||++.++.+||+|||+++.
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999985 887777542 2345799999999999999999999998 7 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYA----IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~----~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
...... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||.........+.... ....
T Consensus 160 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~- 231 (290)
T 3fme_A 160 LVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV----EEPS- 231 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH----HSCC-
T ss_pred cccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh----ccCC-
Confidence 654322 2234789999999996 456789999999999999999999999864332222111111 1110
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+ .......++.+.+++.+||+.||++|||+.++++|-
T Consensus 232 -----~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp 268 (290)
T 3fme_A 232 -----P---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP 268 (290)
T ss_dssp -----C---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred -----C---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence 0 001112346789999999999999999999999854
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=318.61 Aligned_cols=238 Identities=24% Similarity=0.410 Sum_probs=187.8
Q ss_pred hhcCccccceeccCCCcceeec------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
..++|++.+.||+|+||.||++ ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999972 2245788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999998643 345899999999999999999999998 9999999999999999999999999976432111
Q ss_pred ccccccccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.......||+.|+|||++. ...++.++||||||+++|+|++|..|+........ ... ..... ....
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~---~~~~~-~~~~- 242 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLK---IAKSD-PPTL- 242 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHH---HHHSC-CCCC-
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHH---HhccC-Cccc-
Confidence 1123457899999999984 56789999999999999999999999865432211 111 11111 0000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......+..+.+++.+||+.||++|||+.++++|-
T Consensus 243 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 243 ------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp ------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred ------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 11122346788999999999999999999998764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=321.50 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=188.7
Q ss_pred chhhHhhhhcCccccceeccCCCcceeec-----------------cccHHHHHHHHHHHHhh-ccCCeeeeeeeeee--
Q 036419 450 SLASVSAATNNFGVENKLGEGGFGPVYKS-----------------GQGLEEFKNEIKLTAKL-QHRNLVRLLGCCVE-- 509 (754)
Q Consensus 450 ~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~-----------------~~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~-- 509 (754)
.+.++....++|++.+.||+|+||.||++ ....+.+.+|+++++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 34455667889999999999999999973 22457899999999999 79999999999987
Q ss_pred ----cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEE
Q 036419 510 ----QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKI 585 (754)
Q Consensus 510 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl 585 (754)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEE
Confidence 56789999999999999999653 2346899999999999999999999998 999999999999999999999
Q ss_pred eeccCccccCCCcccccccccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhh
Q 036419 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA 660 (754)
Q Consensus 586 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 660 (754)
+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|+.||........ .
T Consensus 171 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~--- 243 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--L--- 243 (326)
T ss_dssp CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H---
T ss_pred eeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--H---
Confidence 99999987643221 223457899999999987 56789999999999999999999999854332111 1
Q ss_pred hhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 661 WNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 661 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.... ......+ .....++.+.+++.+||+.||.+||++.++++|-
T Consensus 244 ~~~~-~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 244 FLIP-RNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp HHHH-HSCCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred HHhh-cCccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 0000 0101011 1112346788999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=338.79 Aligned_cols=237 Identities=26% Similarity=0.352 Sum_probs=190.0
Q ss_pred hhcCccccceeccCCCcceeecc-------------------------------ccHHHHHHHHHHHHhhccCCeeeeee
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG-------------------------------QGLEEFKNEIKLTAKLQHRNLVRLLG 505 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~-------------------------------~~~~~~~~Ev~il~~l~hpniv~l~~ 505 (754)
..++|++.++||+|+||+||++. ...+++.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 46789999999999999999621 22467889999999999999999999
Q ss_pred eeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC---c
Q 036419 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM---I 582 (754)
Q Consensus 506 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~---~ 582 (754)
++.++...++||||+++++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999998543 45999999999999999999999998 99999999999998776 6
Q ss_pred eEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh
Q 036419 583 PKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 583 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 662 (754)
+||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||....... +.....
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~- 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--IIKKVE- 260 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-
Confidence 9999999998775432 233467999999999876 569999999999999999999999987543322 111111
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
..... .+. ......++.+.+++.+||+.||.+|||++++++|--
T Consensus 261 ---~~~~~--~~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 261 ---KGKYY--FDF----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp ---HCCCC--CCH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ---cCCCC--CCc----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 00000 000 000123467899999999999999999999998753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.89 Aligned_cols=256 Identities=20% Similarity=0.215 Sum_probs=180.3
Q ss_pred hHhhhhcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe---
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE--- 512 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~--- 512 (754)
......++|++.++||+|+||.||++. .....+.+|++.+.+++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 445667899999999999999999732 123467788889999999999999999976443
Q ss_pred ----eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCceeeCCCCCCceEEcC-CCceEE
Q 036419 513 ----NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH--QYSRLRVIHRDLKPSNILLDS-NMIPKI 585 (754)
Q Consensus 513 ----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--~~~~~~iiH~Dlkp~NIlld~-~~~~kl 585 (754)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+||
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence 7899999997544333322345567899999999999999999999 776 999999999999997 899999
Q ss_pred eeccCccccCCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhh---
Q 036419 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW--- 661 (754)
Q Consensus 586 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--- 661 (754)
+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ +.....
T Consensus 174 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~ 249 (360)
T 3e3p_A 174 CDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVRVLG 249 (360)
T ss_dssp CCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHC
T ss_pred eeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHHHcC
Confidence 99999987654322 2345789999999998665 589999999999999999999999875433221 110000
Q ss_pred -------hhhcc-CccccccCc------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 662 -------NLWKD-DRSWELMDP------KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 662 -------~~~~~-~~~~~l~d~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
..... .......+. ..........++.+.+++.+||+.||.+|||+.|+++|--
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 00000 000000000 0001112224678999999999999999999999999854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=332.65 Aligned_cols=246 Identities=21% Similarity=0.263 Sum_probs=194.1
Q ss_pred hhcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhcc-CCeeeeeeeeeecCeeEEEEEe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQH-RNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~h-pniv~l~~~~~~~~~~~lV~E~ 519 (754)
..++|++.++||+|+||.||++. ...+++.+|+++++.|+| +++..+..++.+....++||||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 35789999999999999999832 123568899999999987 5666667777888889999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE---cCCCceEEeeccCccccCC
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll---d~~~~~kl~DFgla~~~~~ 596 (754)
+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.+..
T Consensus 85 ~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 85 L-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred C-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9 99999999642 346999999999999999999999998 9999999999999 6889999999999997754
Q ss_pred Cccc-----ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-hhHhHhhhhhhccCccc
Q 036419 597 DELQ-----SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-LTLLGHAWNLWKDDRSW 670 (754)
Q Consensus 597 ~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 670 (754)
.... .......||..|+|||++.+..++.++|||||||+||||++|+.||....... .................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 3321 12235689999999999999999999999999999999999999997654433 11111111000000000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 671 ~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.+. ...++++.+++..||+.||++||++.+|+++|+..
T Consensus 239 ~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 239 ALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 000 11246789999999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.69 Aligned_cols=184 Identities=23% Similarity=0.292 Sum_probs=159.9
Q ss_pred hhcCccccceeccCCCcceeeccc-----------------cHHHHHHHHHHHHhh------ccCCeeeeeeeeeecCee
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ-----------------GLEEFKNEIKLTAKL------QHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~-----------------~~~~~~~Ev~il~~l------~hpniv~l~~~~~~~~~~ 513 (754)
...+|++.++||+|+||.||++.. ..+.+.+|+++++.+ +|+||+++++++......
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 456899999999999999998321 236678899999988 467999999999999999
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc--eEEeeccCc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI--PKISDFGLA 591 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~--~kl~DFgla 591 (754)
++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 58988886533 345899999999999999999999998 999999999999999887 999999999
Q ss_pred cccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFN 650 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~ 650 (754)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 865432 234678999999999999999999999999999999999999987554
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=330.98 Aligned_cols=251 Identities=18% Similarity=0.227 Sum_probs=186.1
Q ss_pred hhhhcCccccceeccCCCcceeeccc--------------cHHHHHHHHHHHHhhccCCeeeeeeeeee-----------
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSGQ--------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE----------- 509 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~~--------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~----------- 509 (754)
+...++|++.++||+|+||.||++.. ......+|++++++++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 45568999999999999999998422 22344589999999999999999999844
Q ss_pred ---------------------------cCeeEEEEEecCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 036419 510 ---------------------------QGENVLIYEYLPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQGLLYLHQYS 561 (754)
Q Consensus 510 ---------------------------~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 561 (754)
....++||||+++ +|.+.+... .....+++..+..++.||++||.|||+.+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 3347899999995 777777542 23457999999999999999999999988
Q ss_pred CCceeeCCCCCCceEEc-CCCceEEeeccCccccCCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHH
Q 036419 562 RLRVIHRDLKPSNILLD-SNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLET 639 (754)
Q Consensus 562 ~~~iiH~Dlkp~NIlld-~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~el 639 (754)
|+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||
T Consensus 162 ---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 162 ---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp ---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred ---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 99999999999998 688999999999997654322 2345789999999998775 599999999999999999
Q ss_pred HhCCCCCCcccCCchhHhHhhhhhhc---------------cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCC
Q 036419 640 LSSKRSTRFFNTNSLTLLGHAWNLWK---------------DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADR 704 (754)
Q Consensus 640 ltg~~p~~~~~~~~~~~~~~~~~~~~---------------~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 704 (754)
++|+.||......+. +. ....... ......+.............++.+.+++.+||+.||++|
T Consensus 236 l~g~~pf~~~~~~~~-~~-~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQ-LV-RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHSSCSSCCSSHHHH-HH-HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HhCCCCCCCCChHHH-HH-HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999875432221 11 1100000 000000001111111112245678999999999999999
Q ss_pred CCHHHHHHHH
Q 036419 705 PTMSEVISML 714 (754)
Q Consensus 705 Pt~~evl~~L 714 (754)
||+.|+++|-
T Consensus 314 ~t~~e~l~hp 323 (383)
T 3eb0_A 314 INPYEAMAHP 323 (383)
T ss_dssp CCHHHHHTSG
T ss_pred CCHHHHhcCH
Confidence 9999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.26 Aligned_cols=236 Identities=22% Similarity=0.324 Sum_probs=185.2
Q ss_pred hhcCccccceeccCCCcceeeccc--------------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeec
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ--------------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ 510 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~--------------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~ 510 (754)
..++|++.+.||+|+||.||++.. ....+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 456899999999999999997311 113478999999999999999999998765
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc---eEEee
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI---PKISD 587 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~---~kl~D 587 (754)
. .++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999984 3456999999999999999999999998 999999999999987664 99999
Q ss_pred ccCccccCCCcccccccccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh
Q 036419 588 FGLARMFGGDELQSNTKRIVGTYGYMSPEYAI---HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW 664 (754)
Q Consensus 588 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 664 (754)
||+++....... .....||+.|+|||++. ...++.++|||||||++|+|++|..||........ +.....
T Consensus 161 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~--- 233 (322)
T 2ycf_A 161 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQIT--- 233 (322)
T ss_dssp CTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHH---
T ss_pred Cccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHH---
Confidence 999987654321 23457899999999874 46789999999999999999999999865433221 111110
Q ss_pred ccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 665 KDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 665 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.... . ..+.. ....++.+.+++.+||+.||++|||+.++++|
T Consensus 234 -~~~~-~-~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 -SGKY-N-FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -HTCC-C-CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -hCcc-c-cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0000 0 00000 01234678999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=332.90 Aligned_cols=250 Identities=22% Similarity=0.248 Sum_probs=184.1
Q ss_pred hcCccccceeccCCCcceeeccc--------------cHHHHHHHHHHHHhhccCCeeeeeeeeeec------CeeEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ--------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ------GENVLIY 517 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~--------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~------~~~~lV~ 517 (754)
..+|++.+.||+|+||.||++.. ......+|++++++++||||+++++++... ...++||
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 34689999999999999998322 123345799999999999999999998542 2367999
Q ss_pred EecCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC-CceEEeeccCccccC
Q 036419 518 EYLPNKSLDSFLFDT-TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGLARMFG 595 (754)
Q Consensus 518 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-~~~kl~DFgla~~~~ 595 (754)
||+++ +|.+++... .....+++..+..++.||++||.|||+.+ |+||||||+||||+.+ +.+||+|||+++.+.
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99987 555555331 23457999999999999999999999988 9999999999999965 578999999999764
Q ss_pred CCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh-------hc--
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL-------WK-- 665 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~-- 665 (754)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+......+ +.
T Consensus 209 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 209 RGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp TTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHHHH
T ss_pred cCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhh
Confidence 4321 2345789999999998765 79999999999999999999999987543221 111111100 00
Q ss_pred cCccccccCcccCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 666 DDRSWELMDPKLQC-----EASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 666 ~~~~~~l~d~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
.....+..-+.... ......+..+.+|+.+||+.||++|||+.|+++|--
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 00000111111100 011223467899999999999999999999998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=335.38 Aligned_cols=228 Identities=14% Similarity=0.174 Sum_probs=177.4
Q ss_pred hhhcCccccceeccCCCcceeecc---------------------ccHHHHHHHH---HHHHhhccCCeeeee-------
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEI---KLTAKLQHRNLVRLL------- 504 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev---~il~~l~hpniv~l~------- 504 (754)
...++|++.+.||+|+||.||++. ...+.+.+|+ +++++++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 345789999999999999999722 1347789999 556666899999998
Q ss_pred eeeeecC-----------------eeEEEEEecCCCChhhHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 036419 505 GCCVEQG-----------------ENVLIYEYLPNKSLDSFLFDTTK----EGLLGWGARIRIIEGIAQGLLYLHQYSRL 563 (754)
Q Consensus 505 ~~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~ 563 (754)
+++...+ ..++||||+ +|+|.+++..... ...+++..+..|+.||++||.|||+++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5555443 378999999 6799999965321 112345888899999999999999998
Q ss_pred ceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccC-----------CCCcccchhhH
Q 036419 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG-----------FFSIKSDVFSF 632 (754)
Q Consensus 564 ~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~ksDVwSl 632 (754)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||
T Consensus 227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred -eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 99999999999999999999999999986432 2234567 999999999887 89999999999
Q ss_pred HHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036419 633 GVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVIS 712 (754)
Q Consensus 633 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 712 (754)
||++|||++|+.||......... ..+... ....++.+.+++.+||+.||++|||+.++++
T Consensus 300 G~il~elltg~~Pf~~~~~~~~~--------------~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGGS--------------EWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHSSCCC------CCS--------------GGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHCCCCCcccccccch--------------hhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999998643322110 000000 0123467889999999999999999999997
Q ss_pred H
Q 036419 713 M 713 (754)
Q Consensus 713 ~ 713 (754)
+
T Consensus 360 h 360 (377)
T 3byv_A 360 T 360 (377)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.21 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=191.8
Q ss_pred hhcCccccceeccCCCcceeeccc------------------cHHHHHHHHHHHHhhccCC------eeeeeeeeeecCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ------------------GLEEFKNEIKLTAKLQHRN------LVRLLGCCVEQGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~------------------~~~~~~~Ev~il~~l~hpn------iv~l~~~~~~~~~ 512 (754)
..++|++.++||+|+||.||++.. ..+.+.+|++++++++|++ ++++++++.+.+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 457899999999999999997421 2367889999999998765 9999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC-------------
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS------------- 579 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~------------- 579 (754)
.++||||+ +++|.+++... ....+++..+..++.||++||.|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999998653 2246899999999999999999999998 999999999999987
Q ss_pred ------CCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc
Q 036419 580 ------NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS 653 (754)
Q Consensus 580 ------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~ 653 (754)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 668999999999865432 234678999999999999999999999999999999999999987544322
Q ss_pred h-hHhHhhhh-----hhccCcccc---------------------ccCcc-cCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 036419 654 L-TLLGHAWN-----LWKDDRSWE---------------------LMDPK-LQCEASYPIVKRYINVALLCVQENAADRP 705 (754)
Q Consensus 654 ~-~~~~~~~~-----~~~~~~~~~---------------------l~d~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RP 705 (754)
. ........ .+....... ...+. ..........+.+.+++.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 1 10000000 000000000 00000 00112334678899999999999999999
Q ss_pred CHHHHHHH
Q 036419 706 TMSEVISM 713 (754)
Q Consensus 706 t~~evl~~ 713 (754)
|+.||++|
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999876
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.56 Aligned_cols=244 Identities=24% Similarity=0.372 Sum_probs=192.5
Q ss_pred hcCccccceeccCCCcceeeccc-------------------c--------------HHHHHHHHHHHHhhccCCeeeee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ-------------------G--------------LEEFKNEIKLTAKLQHRNLVRLL 504 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~-------------------~--------------~~~~~~Ev~il~~l~hpniv~l~ 504 (754)
.++|++.+.||+|+||.||++.. . .+.+.+|++++++++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 47899999999999999997321 0 18899999999999999999999
Q ss_pred eeeeecCeeEEEEEecCCCChhhH------hhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCceEE
Q 036419 505 GCCVEQGENVLIYEYLPNKSLDSF------LFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ-YSRLRVIHRDLKPSNILL 577 (754)
Q Consensus 505 ~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NIll 577 (754)
+++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ .+ |+||||||+|||+
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 999999999999999999999998 532 224679999999999999999999999 77 9999999999999
Q ss_pred cCCCceEEeeccCccccCCCcccccccccccccCcccccccccC-CCCc-ccchhhHHHHHHHHHhCCCCCCcccCCchh
Q 036419 578 DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG-FFSI-KSDVFSFGVLLLETLSSKRSTRFFNTNSLT 655 (754)
Q Consensus 578 d~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~-ksDVwSlGvil~elltg~~p~~~~~~~~~~ 655 (754)
+.++.+||+|||++...... ......||..|+|||++.+. .++. ++||||||+++|+|++|+.||........
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE- 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-
Confidence 99999999999999876443 23346789999999999887 6766 99999999999999999999875543211
Q ss_pred HhHhhhhhhccCcccc------ccCc---ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 656 LLGHAWNLWKDDRSWE------LMDP---KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 656 ~~~~~~~~~~~~~~~~------l~d~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...... ...... ...+ ..........+..+.+++.+||+.||.+|||+.++++|-
T Consensus 261 ~~~~i~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 261 LFNNIR----TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp HHHHHT----SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred HHHHHh----ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 111110 110000 0000 000001123456789999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=325.35 Aligned_cols=249 Identities=22% Similarity=0.271 Sum_probs=189.6
Q ss_pred hhcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec-----Ce
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ-----GE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~-----~~ 512 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 35789999999999999999731 1236788999999999999999999998755 46
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 8999999985 89888853 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-ccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcc-
Q 036419 593 MFGGDELQ-SNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS- 669 (754)
Q Consensus 593 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 669 (754)
........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ .............
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQE 254 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHHHHHHHCSCCHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHHHHhCCCCHH
Confidence 76543221 123456899999999987654 589999999999999999999999865543321 1111000000000
Q ss_pred --------------ccccCcccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 670 --------------WELMDPKLQ--CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 670 --------------~~l~d~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
..+..+... ..........+.+++.+||+.||++|||+.++++|--
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 000000000 0001123467899999999999999999999999763
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=322.68 Aligned_cols=243 Identities=21% Similarity=0.218 Sum_probs=179.2
Q ss_pred hcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC------
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG------ 511 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~------ 511 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4689999999999999999731 12356889999999999999999999997654
Q ss_pred eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 512 ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 512 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999986 6777773 24889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh---------
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN--------- 662 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------- 662 (754)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ......
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEF 249 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 8764332 22346799999999999999999999999999999999999999865432210 000000
Q ss_pred ----------hhccCc------cccccCcccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 663 ----------LWKDDR------SWELMDPKLQCE---ASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 663 ----------~~~~~~------~~~l~d~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
...... ...+........ ........+.+++.+||+.||++|||++|+++|-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000000 000000000000 0112367899999999999999999999999976
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=331.84 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=174.0
Q ss_pred hcCccc-cceeccCCCcceeeccc------------------cHHHHHHHHHHHHhhccCCeeeeeeeeee--cCeeEEE
Q 036419 458 TNNFGV-ENKLGEGGFGPVYKSGQ------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVE--QGENVLI 516 (754)
Q Consensus 458 ~~~y~~-~~~lG~G~fg~Vyk~~~------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~--~~~~~lV 516 (754)
.+.|++ .++||+|+||.||++.. ..+.+.+|++++++++||||+++++++.. +...++|
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 345766 55899999999998431 23578899999999999999999999954 6789999
Q ss_pred EEecCCCChhhHhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE----cCCCceEEe
Q 036419 517 YEYLPNKSLDSFLFDTT------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL----DSNMIPKIS 586 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll----d~~~~~kl~ 586 (754)
|||+++ +|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 7777764321 2235999999999999999999999998 9999999999999 778899999
Q ss_pred eccCccccCCCcc-cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCc-------hhHh
Q 036419 587 DFGLARMFGGDEL-QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-------LTLL 657 (754)
Q Consensus 587 DFgla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-------~~~~ 657 (754)
|||+++.+..... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987653221 1223456899999999999874 59999999999999999999999996543321 0111
Q ss_pred Hhhhhhhcc--Ccccccc-------------CcccCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 658 GHAWNLWKD--DRSWELM-------------DPKLQCEAS---------YPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 658 ~~~~~~~~~--~~~~~l~-------------d~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
......... ...+..+ ......... ....+.+.+|+.+||+.||.+|||++|+++|
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111000 0000000 000000000 0114568899999999999999999999998
Q ss_pred Hhc
Q 036419 714 LTN 716 (754)
Q Consensus 714 L~~ 716 (754)
---
T Consensus 335 p~f 337 (405)
T 3rgf_A 335 PYF 337 (405)
T ss_dssp GGG
T ss_pred hhh
Confidence 753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=324.87 Aligned_cols=255 Identities=22% Similarity=0.262 Sum_probs=186.8
Q ss_pred chhhHhhhhcCccccceeccCCCcceeeccc----------------------------cHHHHHHHHHHHHhhccCCee
Q 036419 450 SLASVSAATNNFGVENKLGEGGFGPVYKSGQ----------------------------GLEEFKNEIKLTAKLQHRNLV 501 (754)
Q Consensus 450 ~~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~~----------------------------~~~~~~~Ev~il~~l~hpniv 501 (754)
.+.++....++|++.+.||+|+||.||++.. ..+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3556778889999999999999999997311 127889999999999999999
Q ss_pred eeeeeeee-----cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceE
Q 036419 502 RLLGCCVE-----QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNIL 576 (754)
Q Consensus 502 ~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIl 576 (754)
++++++.. ....++||||++ ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 99999854 336799999998 578777753 3346999999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCccccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchh
Q 036419 577 LDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLT 655 (754)
Q Consensus 577 ld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~ 655 (754)
++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-- 241 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence 9999999999999998654332 2334678999999999877 679999999999999999999999986543221
Q ss_pred HhHhhhhhhccCc-----------cccccCcccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 656 LLGHAWNLWKDDR-----------SWELMDPKLQ-------CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 656 ~~~~~~~~~~~~~-----------~~~l~d~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
............. ....+..... ........+.+.+++.+||+.||++|||+.++++|--
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 1111100000000 0000000000 0011123466889999999999999999999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.84 Aligned_cols=240 Identities=20% Similarity=0.322 Sum_probs=191.7
Q ss_pred HhhhhcCccccceeccCCCcceeeccc--------------------------cHHHHHHHHHHHHhh-ccCCeeeeeee
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSGQ--------------------------GLEEFKNEIKLTAKL-QHRNLVRLLGC 506 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~~--------------------------~~~~~~~Ev~il~~l-~hpniv~l~~~ 506 (754)
.....++|++.+.||+|+||.||++.. ..+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 344567899999999999999997211 135678999999999 79999999999
Q ss_pred eeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEe
Q 036419 507 CVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKIS 586 (754)
Q Consensus 507 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~ 586 (754)
+......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999643 45899999999999999999999998 9999999999999999999999
Q ss_pred eccCccccCCCcccccccccccccCccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhh
Q 036419 587 DFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH------GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA 660 (754)
Q Consensus 587 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 660 (754)
|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ......
T Consensus 243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~i 317 (365)
T 2y7j_A 243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLRMI 317 (365)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HHHHHH
Confidence 999998775432 2334679999999998863 35889999999999999999999998643221 111111
Q ss_pred hhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 661 WNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 661 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. ... ....+.. ...+..+.+++.+||+.||++|||+.++++|-
T Consensus 318 ~~----~~~-~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 318 ME----GQY-QFSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp HH----TCC-CCCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred Hh----CCC-CCCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 00 000 0000000 01245688999999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.39 Aligned_cols=237 Identities=21% Similarity=0.299 Sum_probs=191.2
Q ss_pred hhcCccccceeccCCCcceeeccc---------------------------cHHHHHHHHHHHHhhc-cCCeeeeeeeee
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ---------------------------GLEEFKNEIKLTAKLQ-HRNLVRLLGCCV 508 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~---------------------------~~~~~~~Ev~il~~l~-hpniv~l~~~~~ 508 (754)
..++|++.+.||+|+||.||++.. ..+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 457899999999999999997211 1356789999999996 999999999999
Q ss_pred ecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeec
Q 036419 509 EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDF 588 (754)
Q Consensus 509 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DF 588 (754)
++...++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999964 345899999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCcccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAI------HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 662 (754)
|++....... ......|++.|+|||++. ...++.++||||||+++|+|++|+.|+....... ......
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~- 242 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--MLRMIM- 242 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--HHHHHh-
Confidence 9998765432 223457899999999885 4568899999999999999999999986433211 111110
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
... . . .........++.+.+++.+||+.||++|||+.++++|-
T Consensus 243 --~~~-~-~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 243 --SGN-Y-Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp --HTC-C-C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred --cCC-c-c-----cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 000 0 0 00111123456789999999999999999999998754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=347.59 Aligned_cols=243 Identities=23% Similarity=0.322 Sum_probs=192.4
Q ss_pred hHhhhhcCccccceeccCCCcceeeccc----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeec
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKSGQ----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ 510 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~~~----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~ 510 (754)
......++|++.+.||+|+||.||++.. ..+.+.+|+.++++++||||+++++++. +
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 3445567899999999999999997321 1367899999999999999999999985 4
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
+..++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 5689999999999999999643 345899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcc
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ...... .....
T Consensus 538 a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~---~~~~~ 611 (656)
T 2j0j_A 538 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIE---NGERL 611 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH---HTCCC
T ss_pred CeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH---cCCCC
Confidence 9976543221 2233467789999999999999999999999999999997 888876443221 111111 11100
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
......+..+.+++.+||+.||++|||+.+|+++|+..
T Consensus 612 ----------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 ----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11123346788999999999999999999999999865
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=326.35 Aligned_cols=244 Identities=20% Similarity=0.276 Sum_probs=171.4
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeec------
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ------ 510 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~------ 510 (754)
..++|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 34789999999999999999731 1246778999999999999999999998654
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
...++|+|++ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 6899988843 46999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC--
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD-- 667 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 667 (754)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGA 251 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence 9875432 334679999999999887 689999999999999999999999987544321 111111100000
Q ss_pred ------c---cccccCccc-CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 668 ------R---SWELMDPKL-QCEAS-----YPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 668 ------~---~~~l~d~~~-~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
. ....+.... ..... ......+.+|+.+||+.||++|||+.++++|--
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 0 000000000 00000 112466889999999999999999999999853
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=311.90 Aligned_cols=238 Identities=24% Similarity=0.357 Sum_probs=179.8
Q ss_pred hcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee-----------
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE----------- 509 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~----------- 509 (754)
.++|++.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 4679999999999999999832 134678899999999999999999998865
Q ss_pred --cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEee
Q 036419 510 --QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISD 587 (754)
Q Consensus 510 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~D 587 (754)
....++||||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 45789999999999999999643 235788999999999999999999998 99999999999999999999999
Q ss_pred ccCccccCCCcc------------cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCch
Q 036419 588 FGLARMFGGDEL------------QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL 654 (754)
Q Consensus 588 Fgla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~ 654 (754)
||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ |+..... ..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-~~ 235 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-RV 235 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-HH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-HH
Confidence 999987643210 1122345789999999998764 78999999999999999998 3321110 01
Q ss_pred hHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 655 TLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 655 ~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
..... .... ............++.+.+++.+||+.||.+|||+.+++++-
T Consensus 236 ~~~~~----~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 236 NILKK----LRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp HHHHH----HHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred HHHHh----cccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 11111 1110 01111122233456788999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.32 Aligned_cols=248 Identities=20% Similarity=0.265 Sum_probs=188.6
Q ss_pred hcCccccceeccCCCcceeeccc-----------------cHHHHHHHHHHHHhhc-----------cCCeeeeeeeeee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ-----------------GLEEFKNEIKLTAKLQ-----------HRNLVRLLGCCVE 509 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~-----------------~~~~~~~Ev~il~~l~-----------hpniv~l~~~~~~ 509 (754)
.++|++.+.||+|+||.||++.. ..+.+.+|++++++++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 46899999999999999998431 2467889999999987 8999999999986
Q ss_pred cC----eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCceEEc------
Q 036419 510 QG----ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY-SRLRVIHRDLKPSNILLD------ 578 (754)
Q Consensus 510 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NIlld------ 578 (754)
.. ..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++ + |+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 54 789999999 889999996533 34589999999999999999999998 7 99999999999994
Q ss_pred CCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc----h
Q 036419 579 SNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS----L 654 (754)
Q Consensus 579 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~----~ 654 (754)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999876432 234578999999999999999999999999999999999999987544221 0
Q ss_pred hHhHhhhhhh------------------ccCccccccCc----------ccCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 036419 655 TLLGHAWNLW------------------KDDRSWELMDP----------KLQCEASYPIVKRYINVALLCVQENAADRPT 706 (754)
Q Consensus 655 ~~~~~~~~~~------------------~~~~~~~l~d~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 706 (754)
.......... ........+.. ...........+.+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 1111110000 00000000000 0011233567788999999999999999999
Q ss_pred HHHHHHHHh
Q 036419 707 MSEVISMLT 715 (754)
Q Consensus 707 ~~evl~~L~ 715 (754)
+.||++|--
T Consensus 328 ~~ell~hp~ 336 (373)
T 1q8y_A 328 AGGLVNHPW 336 (373)
T ss_dssp HHHHHTCGG
T ss_pred HHHHhhChh
Confidence 999999753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=314.29 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=190.8
Q ss_pred hhhcCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhh---ccCCeeeeeeeee---
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKL---QHRNLVRLLGCCV--- 508 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l---~hpniv~l~~~~~--- 508 (754)
...++|++.+.||+|+||.||++.. ....+.+|+++++++ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4568999999999999999998421 123567888888877 7999999999987
Q ss_pred --ecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEe
Q 036419 509 --EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKIS 586 (754)
Q Consensus 509 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~ 586 (754)
.....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5677899999998 59999986533 345899999999999999999999998 9999999999999999999999
Q ss_pred eccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh---
Q 036419 587 DFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL--- 663 (754)
Q Consensus 587 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--- 663 (754)
|||+++...... ......||..|+|||++.+..++.++||||||+++|+|++|+.||....... ........
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCC
Confidence 999998764322 2334678999999999999999999999999999999999999986543222 11111100
Q ss_pred -----hccCc-c-ccccC---cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 664 -----WKDDR-S-WELMD---PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 664 -----~~~~~-~-~~l~d---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
|.... . ..... ...........++.+.+++.+||+.||++|||+.++++|-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 298 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00000 0 00000 0000111123456788999999999999999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.38 Aligned_cols=249 Identities=23% Similarity=0.310 Sum_probs=181.0
Q ss_pred hhcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeee----------
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCV---------- 508 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~---------- 508 (754)
..++|++.+.||+|+||.||++. ...+++.+|++++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 35789999999999999999732 23467889999999999999999999873
Q ss_pred ----ecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc-CCCce
Q 036419 509 ----EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD-SNMIP 583 (754)
Q Consensus 509 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld-~~~~~ 583 (754)
+....++||||++ ++|.+++. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 4467899999998 59999984 356899999999999999999999998 99999999999997 56799
Q ss_pred EEeeccCccccCCCcc-cccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhh
Q 036419 584 KISDFGLARMFGGDEL-QSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW 661 (754)
Q Consensus 584 kl~DFgla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 661 (754)
||+|||+++....... ........+|..|+|||++.+ ..++.++||||||+++|||++|+.||........ .....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~ 238 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLIL 238 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence 9999999987643221 122334567999999998876 6799999999999999999999999875432211 10000
Q ss_pred hhhcc---Cccccc-------cCcccC-C-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 662 NLWKD---DRSWEL-------MDPKLQ-C-----EASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 662 ~~~~~---~~~~~l-------~d~~~~-~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
..... ....++ +..... . ......+..+.+++.+||+.||++|||+.++++|--
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 00000 000000 000000 0 001123567899999999999999999999998753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=326.86 Aligned_cols=241 Identities=24% Similarity=0.296 Sum_probs=177.2
Q ss_pred cCccccceeccCCCcceeec--------------cccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEecCCC
Q 036419 459 NNFGVENKLGEGGFGPVYKS--------------GQGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEYLPNK 523 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~--------------~~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~g 523 (754)
+.|.+.+.||+|+||+||.. ....+.+.+|++++.++ +||||+++++++.++...++||||++ +
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 45666789999999999741 12346788999999987 89999999999999999999999996 5
Q ss_pred ChhhHhhccCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC-------------CceEEe
Q 036419 524 SLDSFLFDTTKEG----LLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN-------------MIPKIS 586 (754)
Q Consensus 524 sL~~~l~~~~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~-------------~~~kl~ 586 (754)
+|.+++....... ..++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 9999996543211 1133346789999999999999998 9999999999999754 489999
Q ss_pred eccCccccCCCccc--ccccccccccCccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhH
Q 036419 587 DFGLARMFGGDELQ--SNTKRIVGTYGYMSPEYAIH-------GFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTL 656 (754)
Q Consensus 587 DFgla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~-------~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~ 656 (754)
|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||..........
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i 250 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHH
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHH
Confidence 99999987543221 12334679999999999875 578999999999999999999 888875432221111
Q ss_pred hHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 657 LGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 657 ~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
. ..... .+..........+..+.+++.+||+.||.+|||+.+|++|-
T Consensus 251 ~-------~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 251 I-------RGIFS----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp H-------HTCCC----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred h-------cCCCC----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 1 00000 01111222345678899999999999999999999998753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=316.42 Aligned_cols=249 Identities=23% Similarity=0.282 Sum_probs=187.4
Q ss_pred hhcCccccceeccCCCcceeeccc-------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeec-----Ce
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ-------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ-----GE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~-------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~-----~~ 512 (754)
..++|++.+.||+|+||.||++.. ...++.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 457899999999999999997321 235678999999999999999999988754 67
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999998 589988854 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccc--------cccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh
Q 036419 593 MFGGDELQS--------NTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL 663 (754)
Q Consensus 593 ~~~~~~~~~--------~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 663 (754)
......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||......... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~ 238 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL--LLIFGI 238 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHHH
Confidence 765322111 1223578999999998765 67999999999999999999999998754322110 001100
Q ss_pred hccCc----cc--------cccCc--ccC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 664 WKDDR----SW--------ELMDP--KLQ----CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 664 ~~~~~----~~--------~l~d~--~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
..... .. +.... ... .......+..+.+++.+||+.||++|||+.++++|--
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 00000 00 00000 000 0001123567889999999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=322.14 Aligned_cols=243 Identities=19% Similarity=0.253 Sum_probs=183.8
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee---
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN--- 513 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~--- 513 (754)
..++|.+.+.||+|+||.||++. ...+.+.+|++++++++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 34789999999999999999731 1246788999999999999999999999877665
Q ss_pred ---EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 514 ---VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 514 ---~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 58887772 23899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC--
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD-- 667 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 667 (754)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ ............
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGT 263 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCcH
Confidence 9865432 234678999999999887 689999999999999999999999986543221 111110000000
Q ss_pred ---------ccccc---cCcccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 668 ---------RSWEL---MDPKLQ---CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 668 ---------~~~~l---~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
..... +..... ........+.+.+++.+||+.||++|||+.++++|--
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 00000 000000 0001123567899999999999999999999999853
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=307.37 Aligned_cols=238 Identities=26% Similarity=0.344 Sum_probs=190.4
Q ss_pred hhhhcCccccceeccCCCcceeec--------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~--------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
....++|++.++||+|+||.||++ ....+.+.+|++++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345578999999999999999972 124578899999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC---CceEEeeccCc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN---MIPKISDFGLA 591 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~---~~~kl~DFgla 591 (754)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999988543 35899999999999999999999998 9999999999999764 46999999999
Q ss_pred cccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ...... .....
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~----~~~~~- 240 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRVE----TGKYA- 240 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH----HCCCC-
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHH----cCCCC-
Confidence 8765432 1233468999999998765 58999999999999999999999986543221 111111 01000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.+ .......++.+.+++.+||+.||++|||+.+++++-
T Consensus 241 -~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 241 -FD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp -CC----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred -CC----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 00 000112346788999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=316.05 Aligned_cols=190 Identities=25% Similarity=0.357 Sum_probs=160.1
Q ss_pred hHhhhhcCccccceeccCCCcceeeccc-----------------cHHHHHHHHHHHHhhc-cC-----Ceeeeeeeeee
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKSGQ-----------------GLEEFKNEIKLTAKLQ-HR-----NLVRLLGCCVE 509 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~~~-----------------~~~~~~~Ev~il~~l~-hp-----niv~l~~~~~~ 509 (754)
......++|++.++||+|+||.||++.. ..+++..|+++++.++ |+ +|+++++++..
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3344568999999999999999998321 2466788999999886 44 49999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc--CCCceEEee
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD--SNMIPKISD 587 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld--~~~~~kl~D 587 (754)
....++||||+++ +|.+++.... ...+++..+..++.||+.||.|||.+. .+|+||||||+|||++ .++.+||+|
T Consensus 128 ~~~~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CCceEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999999975 9999986543 245899999999999999999999531 2499999999999994 578899999
Q ss_pred ccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 036419 588 FGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFN 650 (754)
Q Consensus 588 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~ 650 (754)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999876432 234678999999999999999999999999999999999999987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.69 Aligned_cols=246 Identities=22% Similarity=0.263 Sum_probs=189.2
Q ss_pred hhcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCC------eeeeeeeeeecCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRN------LVRLLGCCVEQGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpn------iv~l~~~~~~~~~ 512 (754)
..++|++.+.||+|+||.||++. ...+.+.+|++++++++|++ ++.+++++.....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 35789999999999999999731 12467889999999998876 9999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE---------------
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL--------------- 577 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll--------------- 577 (754)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55666666442 2346899999999999999999999988 9999999999999
Q ss_pred ----cCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc
Q 036419 578 ----DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS 653 (754)
Q Consensus 578 ----d~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~ 653 (754)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 66789999999999865432 234679999999999999999999999999999999999999987543322
Q ss_pred hhHhHhhhhhhcc--------Ccccc-c--------------------cCc-ccCCCCCHHHHHHHHHHHHHccccCCCC
Q 036419 654 LTLLGHAWNLWKD--------DRSWE-L--------------------MDP-KLQCEASYPIVKRYINVALLCVQENAAD 703 (754)
Q Consensus 654 ~~~~~~~~~~~~~--------~~~~~-l--------------------~d~-~~~~~~~~~~~~~l~~li~~cl~~dP~~ 703 (754)
. .......... ..... . ..+ .............+.+++.+||+.||++
T Consensus 247 ~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 247 H--LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp H--HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred H--HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 1 1011000000 00000 0 000 0001122345678999999999999999
Q ss_pred CCCHHHHHHHH
Q 036419 704 RPTMSEVISML 714 (754)
Q Consensus 704 RPt~~evl~~L 714 (754)
|||+.++++|-
T Consensus 325 Rpt~~e~l~hp 335 (355)
T 2eu9_A 325 RITLAEALLHP 335 (355)
T ss_dssp SCCHHHHTTSG
T ss_pred CcCHHHHhcCh
Confidence 99999998764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=312.80 Aligned_cols=241 Identities=23% Similarity=0.356 Sum_probs=166.6
Q ss_pred hhcCccccceeccCCCcceeecc-------------------ccHHHHHHHHH-HHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIK-LTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~-il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
..++|++.+.||+|+||.||++. ....++..|+. +++.++||||+++++++.+++..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 34789999999999999999721 12345556665 67778999999999999999999999
Q ss_pred EEecCCCChhhHhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 517 YEYLPNKSLDSFLFDT--TKEGLLGWGARIRIIEGIAQGLLYLHQY-SRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
|||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999986 777776431 2245789999999999999999999998 7 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYA----IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~----~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
...... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||.........+. ...
T Consensus 176 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~----- 243 (327)
T 3aln_A 176 LVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT----QVV----- 243 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C----CCC-----
T ss_pred cccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH----HHh-----
Confidence 643321 2234789999999998 456789999999999999999999999864332111100 000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
....+.+...........+.+++.+||+.||++|||+.+|+++.
T Consensus 244 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 287 (327)
T 3aln_A 244 -KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP 287 (327)
T ss_dssp -CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred -cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence 00011111111123456789999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.50 Aligned_cols=243 Identities=18% Similarity=0.218 Sum_probs=164.6
Q ss_pred hhcCccccc-eeccCCCcceeeccc-------------cHHHHHHHH-HHHHhhccCCeeeeeeeeee----cCeeEEEE
Q 036419 457 ATNNFGVEN-KLGEGGFGPVYKSGQ-------------GLEEFKNEI-KLTAKLQHRNLVRLLGCCVE----QGENVLIY 517 (754)
Q Consensus 457 ~~~~y~~~~-~lG~G~fg~Vyk~~~-------------~~~~~~~Ev-~il~~l~hpniv~l~~~~~~----~~~~~lV~ 517 (754)
..++|++.+ .||+|+||.||++.. ......+|+ ..++.++||||+++++++.. +...++||
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 457899865 699999999998321 122333444 44667789999999999976 45689999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC---CCceEEeeccCcccc
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMF 594 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~---~~~~kl~DFgla~~~ 594 (754)
||+++++|.+++... ....+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 106 e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 106 ECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp ECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred eccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999999999999653 2346999999999999999999999998 999999999999976 455999999999866
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........... ...... ...
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~------~~~ 249 (336)
T 3fhr_A 182 TQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIR------LGQ 249 (336)
T ss_dssp --------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred cccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhh------ccc
Confidence 4322 2345789999999999888999999999999999999999999864433221000 000000 000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
...........++.+.+++.+||+.||++|||+.++++|--
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 00111111234567899999999999999999999999664
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.96 Aligned_cols=241 Identities=20% Similarity=0.253 Sum_probs=183.6
Q ss_pred hcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCe-----
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE----- 512 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~----- 512 (754)
.++|.+.+.||+|+||.||++.. ..+++.+|++++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999997311 24678899999999999999999999987654
Q ss_pred -eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 513 -NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 513 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
.++||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 58887773 24899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc----
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD---- 666 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 666 (754)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ...........
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTE 246 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCBCCHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 865432 234578999999999887 688999999999999999999999987543221 11111000000
Q ss_pred -------C-------ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 667 -------D-------RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 667 -------~-------~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
. .......+.. .......+..+.+++.+||+.||++|||+.++++|--
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0 0000000000 0111234577899999999999999999999998753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=314.86 Aligned_cols=230 Identities=23% Similarity=0.331 Sum_probs=188.0
Q ss_pred HhhhhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhc--cCCeeeeeeee
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQ--HRNLVRLLGCC 507 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~--hpniv~l~~~~ 507 (754)
.....++|++.+.||+|+||.||++.. ..+.+.+|++++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 345568899999999999999997321 1245678999999997 59999999999
Q ss_pred eecCeeEEEEEecCC-CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc-CCCceEE
Q 036419 508 VEQGENVLIYEYLPN-KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD-SNMIPKI 585 (754)
Q Consensus 508 ~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld-~~~~~kl 585 (754)
.+++..++|||++.+ ++|.+++.. .+.+++..+..++.||++||.|||+.+ |+||||||+|||++ +++.+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence 999999999999986 899999954 346899999999999999999999998 99999999999999 7899999
Q ss_pred eeccCccccCCCcccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh
Q 036419 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW 664 (754)
Q Consensus 586 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 664 (754)
+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... . .
T Consensus 192 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~-------~ 256 (320)
T 3a99_A 192 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----I-------I 256 (320)
T ss_dssp CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----H-------H
T ss_pred eeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----h-------h
Confidence 9999998765432 234579999999999987765 7899999999999999999999753210 0 0
Q ss_pred ccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 665 KDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 665 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
... . . .....++.+.+++.+||+.||++|||+++|+++--
T Consensus 257 ~~~-~--~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 257 RGQ-V--F--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp HCC-C--C--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ccc-c--c--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 000 0 0 01123467889999999999999999999998753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=311.37 Aligned_cols=230 Identities=23% Similarity=0.383 Sum_probs=179.4
Q ss_pred HhhhhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhh----ccCCeeeeee
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKL----QHRNLVRLLG 505 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l----~hpniv~l~~ 505 (754)
.....++|++.+.||+|+||.||++.. ....+.+|++++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 345568899999999999999997311 123356799999999 8999999999
Q ss_pred eeeecCeeEEEEEe-cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc-CCCce
Q 036419 506 CCVEQGENVLIYEY-LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD-SNMIP 583 (754)
Q Consensus 506 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld-~~~~~ 583 (754)
++.+.+..++|||| +++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 799999999965 345899999999999999999999998 99999999999999 88999
Q ss_pred EEeeccCccccCCCcccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhh
Q 036419 584 KISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 584 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 662 (754)
||+|||++....... .....||..|+|||++.+..+ +.++||||||+++|+|++|+.||.... ...
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~----- 246 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----EIL----- 246 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHH-----
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----HHh-----
Confidence 999999998765432 234568999999999887766 469999999999999999999975321 000
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
. ... .........+.+++.+||+.||++|||+.+++++--
T Consensus 247 --~-~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 247 --E-AEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp --H-TCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred --h-hcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0 000 011123467889999999999999999999999653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.60 Aligned_cols=240 Identities=20% Similarity=0.261 Sum_probs=177.1
Q ss_pred hhhhcCccccceeccCCCcceee-c-------------cccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEe
Q 036419 455 SAATNNFGVENKLGEGGFGPVYK-S-------------GQGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk-~-------------~~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
.....+|.+.+.||+|+||+||. . ....+.+.+|+++++++ +|||||++++++.+....++||||
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 34556799999999999999653 1 11223467899999999 799999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC-----CCceEEeeccCcccc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS-----NMIPKISDFGLARMF 594 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~-----~~~~kl~DFgla~~~ 594 (754)
++ ++|.+++.... ....+..+..++.||++||.|||+.+ |+||||||+|||++. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 97 59999996533 23445566789999999999999998 999999999999953 336889999999877
Q ss_pred CCCcc-cccccccccccCcccccccc---cCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcc
Q 036419 595 GGDEL-QSNTKRIVGTYGYMSPEYAI---HGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRS 669 (754)
Q Consensus 595 ~~~~~-~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 669 (754)
..... ........||+.|+|||++. ...++.++|||||||++|||++ |..||.......... ..... .
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~------~~~~~-~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI------LLGAC-S 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH------HTTCC-C
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH------HhccC-C
Confidence 54321 12234567999999999997 4567889999999999999999 888874322211110 00000 0
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.... .........+.+++.+||+.||++|||+.+|++|
T Consensus 247 ~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 LDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0000 1122345668899999999999999999999965
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=333.14 Aligned_cols=242 Identities=25% Similarity=0.319 Sum_probs=184.6
Q ss_pred hcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee------cCe
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE------QGE 512 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~------~~~ 512 (754)
.++|++.++||+|+||.||++. ...+.+.+|++++++++||||+++++++.. +..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 3789999999999999999732 124678899999999999999999998765 677
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc---eEEeecc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI---PKISDFG 589 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~---~kl~DFg 589 (754)
.++||||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999977655557999999999999999999999988 999999999999997765 8999999
Q ss_pred CccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC--
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD-- 667 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 667 (754)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..+........
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC-----
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccch
Confidence 9997654332 23467999999999999999999999999999999999999998542110 00000000000
Q ss_pred --ccccc------cCcc--cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 036419 668 --RSWEL------MDPK--LQCEASYPIVKRYINVALLCVQENAADRPTMSE 709 (754)
Q Consensus 668 --~~~~l------~d~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 709 (754)
..... .... .........++.+.+++.+||+.||++|||+.+
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00000 0000 112233457788999999999999999999966
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=304.71 Aligned_cols=236 Identities=22% Similarity=0.347 Sum_probs=166.5
Q ss_pred hcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
.++|++.+.||+|+||.||++.. ..+.+..+..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 46899999999999999997321 1123444556788889999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY-SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
||+ ++.+..+... ....+++..+..++.||++||.|||+. + |+|+||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4555555532 235689999999999999999999995 7 99999999999999999999999999986644
Q ss_pred CcccccccccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
.. ......||+.|+|||++. ...++.++||||||+++|+|++|+.||.........+. .. .....
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~---~~~~~--- 247 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT-KV---LQEEP--- 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH-HH---HHSCC---
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH-HH---hccCC---
Confidence 32 123457899999999984 45789999999999999999999999864332211111 11 11110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
+.. ......+..+.+++.+||+.||.+||++.+|+++-
T Consensus 248 ---~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 248 ---PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp ---CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred ---CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 001 01112346788999999999999999999998864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=329.09 Aligned_cols=222 Identities=21% Similarity=0.298 Sum_probs=178.8
Q ss_pred hhcCccccceeccCCCcceeeccc--------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCe----
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ--------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE---- 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~--------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~---- 512 (754)
..++|++.++||+|+||.||++.+ ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 347899999999999999997321 23567899999999999999999999988766
Q ss_pred -eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCc
Q 036419 513 -NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLA 591 (754)
Q Consensus 513 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla 591 (754)
.++||||+++++|.+++.. .+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987732 5899999999999999999999998 9999999999999986 8999999999
Q ss_pred cccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 592 RMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 592 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
+..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..|+.......
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------ 283 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------ 283 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------
T ss_pred hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------------
Confidence 876432 3467999999999887654 899999999999999999988764321110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhc
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRP-TMSEVISMLTN 716 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~ 716 (754)
+. .........+.+.+++.+||+.||++|| +++++.+.|..
T Consensus 284 ~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 LP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 0011122346788999999999999999 56666666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=289.19 Aligned_cols=213 Identities=14% Similarity=0.067 Sum_probs=169.6
Q ss_pred hhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
..++|++.+.||+|+||.||++. ...+++.+|++++.+++||||+++++++.+++..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 44789999999999999999721 123678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++++|.+++.. + ....++.+++.||+.||.|||+++ |+||||||+|||++.++.+||+++
T Consensus 109 v~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~------- 173 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP------- 173 (286)
T ss_dssp EEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC-------
T ss_pred EEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec-------
Confidence 9999999999999942 2 356678899999999999999998 999999999999999999999744
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
+|++| ++.++|||||||++|||++|+.||........... . ...+..
T Consensus 174 ---------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--~---------~~~~~~ 220 (286)
T 3uqc_A 174 ---------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--A---------ERDTAG 220 (286)
T ss_dssp ---------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--C---------CBCTTS
T ss_pred ---------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--H---------HHHhcc
Confidence 34443 68999999999999999999999875443221000 0 000000
Q ss_pred ccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 676 KLQ--CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 676 ~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
... .......++.+.+++.+||+.||++| |+.++++.|+...
T Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 000 01112244678999999999999999 9999999998643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=289.48 Aligned_cols=220 Identities=20% Similarity=0.263 Sum_probs=169.9
Q ss_pred hcCcccc-ceeccCCCcceeeccc-------------cHHHHHHHHHHH-HhhccCCeeeeeeeeee----cCeeEEEEE
Q 036419 458 TNNFGVE-NKLGEGGFGPVYKSGQ-------------GLEEFKNEIKLT-AKLQHRNLVRLLGCCVE----QGENVLIYE 518 (754)
Q Consensus 458 ~~~y~~~-~~lG~G~fg~Vyk~~~-------------~~~~~~~Ev~il-~~l~hpniv~l~~~~~~----~~~~~lV~E 518 (754)
.++|.+. +.||+|+||.||++.. ....+.+|++++ +.++||||+++++++.. +...++|||
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 3567776 7899999999997322 346788999988 55689999999999987 778899999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC---CCceEEeeccCccccC
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFG 595 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~---~~~~kl~DFgla~~~~ 595 (754)
|+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++....
T Consensus 96 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 96 CLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp CCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred ecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 99999999999763 2346999999999999999999999998 999999999999998 7889999999997542
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
+..++.++|||||||++|||++|+.||......... ......+...
T Consensus 172 ------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----------~~~~~~~~~~ 217 (299)
T 3m2w_A 172 ------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------PGMKTRIRMG 217 (299)
T ss_dssp ------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCSCCSSCTT
T ss_pred ------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----------HHHHHHHhhc
Confidence 234678999999999999999999998644322110 0000000000
Q ss_pred ccCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 676 KLQCE--ASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 676 ~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
..... .....++.+.+++.+||+.||++|||+.++++|.-
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 00000 00123567899999999999999999999999753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=295.71 Aligned_cols=229 Identities=16% Similarity=0.140 Sum_probs=171.9
Q ss_pred hhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhc---------cCCeeee
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQ---------HRNLVRL 503 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~---------hpniv~l 503 (754)
..++|++.++||+|+||.||++.. ..+.+.+|++++++++ ||||+++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 357899999999999999997211 1278999999999997 6666666
Q ss_pred eee-----------------eee-------------cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 036419 504 LGC-----------------CVE-------------QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQG 553 (754)
Q Consensus 504 ~~~-----------------~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~ 553 (754)
.++ +.+ ....++||||+++|++.+.+.+ ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 554 333 6789999999999976666632 458999999999999999
Q ss_pred HHHHH-hcCCCceeeCCCCCCceEEcCCC--------------------ceEEeeccCccccCCCcccccccccccccCc
Q 036419 554 LLYLH-QYSRLRVIHRDLKPSNILLDSNM--------------------IPKISDFGLARMFGGDELQSNTKRIVGTYGY 612 (754)
Q Consensus 554 L~yLH-~~~~~~iiH~Dlkp~NIlld~~~--------------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y 612 (754)
|.||| +.+ |+||||||+||||+.++ .+||+|||+|+..... ..+||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 888 99999999999999887 8999999999976432 35799999
Q ss_pred ccccccccCCCCcccchhhHHHH-HHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHH
Q 036419 613 MSPEYAIHGFFSIKSDVFSFGVL-LLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYIN 691 (754)
Q Consensus 613 ~APE~~~~~~~s~ksDVwSlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~ 691 (754)
+|||++.+.. +.++||||++++ .+++++|..||....... ... ........ .............++.+.+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~-~~~---~~~~~~~~----~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH-YLT---DKMLKQMT----FKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH-HHH---HHHHHTCC----CSSCCCSHHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh-HHH---Hhhhhhhc----cCcccchhhhhhcCHHHHH
Confidence 9999998766 899999998777 788888988864210000 000 00010000 0011111122346788999
Q ss_pred HHHHccccCCCCCCCHHHHH-HH
Q 036419 692 VALLCVQENAADRPTMSEVI-SM 713 (754)
Q Consensus 692 li~~cl~~dP~~RPt~~evl-~~ 713 (754)
++.+||+.| |++|++ +|
T Consensus 315 li~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHhccC-----CHHHHHhcC
Confidence 999999976 999998 65
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=296.97 Aligned_cols=227 Identities=15% Similarity=0.148 Sum_probs=167.7
Q ss_pred hhhcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhcc-CCeeeee---------
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQH-RNLVRLL--------- 504 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~h-pniv~l~--------- 504 (754)
.....|+..+.||+|+||.||++. ...+.+++|+.+++.++| +|...+.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 344568888999999999999832 125778999999999987 3221111
Q ss_pred ------------eeeee-----cCeeEEEEEecCCCChhhHhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 036419 505 ------------GCCVE-----QGENVLIYEYLPNKSLDSFLFDT----TKEGLLGWGARIRIIEGIAQGLLYLHQYSRL 563 (754)
Q Consensus 505 ------------~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~ 563 (754)
.++.. ....+++|+++ +++|.+++... .....+++..++.++.||++||.|||+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 11111 12356666654 67999888421 22345788899999999999999999998
Q ss_pred ceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCccccccc----------ccCCCCcccchhhHH
Q 036419 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA----------IHGFFSIKSDVFSFG 633 (754)
Q Consensus 564 ~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~s~ksDVwSlG 633 (754)
|+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....++.++||||||
T Consensus 232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred -cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 999999999999999999999999999875432 334567 999999999 555688999999999
Q ss_pred HHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036419 634 VLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVIS 712 (754)
Q Consensus 634 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 712 (754)
|++|||++|+.||......... ..++... ...++.+.+++.+||+.||++||++.++++
T Consensus 305 vil~elltg~~Pf~~~~~~~~~--------------~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGGS--------------EWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSCS--------------GGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHCCCCCCCcchhhhH--------------HHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999998644322110 0011100 022367899999999999999999777654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=275.28 Aligned_cols=153 Identities=20% Similarity=0.183 Sum_probs=116.9
Q ss_pred ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 036419 480 QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH 558 (754)
Q Consensus 480 ~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH 558 (754)
...++|.+|+++|+++ +|+||++++++++++...||||||++|++|.++|.. .+.++.. +|+.||+.||.|||
T Consensus 283 ~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH 356 (569)
T 4azs_A 283 RNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALE 356 (569)
T ss_dssp HHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHH
Confidence 3457899999999999 699999999999999999999999999999999954 3456654 58899999999999
Q ss_pred hcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHH
Q 036419 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLE 638 (754)
Q Consensus 559 ~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~e 638 (754)
+++ ||||||||+||||++++.+||+|||+|+...... ......+||++|||||++.+ .+..++|+||+|+++++
T Consensus 357 ~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~ 430 (569)
T 4azs_A 357 KQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFN 430 (569)
T ss_dssp HTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CC
T ss_pred HCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhh
Confidence 998 9999999999999999999999999999765432 22345789999999998865 46788999999999988
Q ss_pred HHhCCC
Q 036419 639 TLSSKR 644 (754)
Q Consensus 639 lltg~~ 644 (754)
+.++..
T Consensus 431 l~~~~~ 436 (569)
T 4azs_A 431 LPQPWS 436 (569)
T ss_dssp CCTTHH
T ss_pred hccccc
Confidence 766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-24 Score=248.31 Aligned_cols=169 Identities=20% Similarity=0.194 Sum_probs=134.2
Q ss_pred cccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 462 GVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 462 ~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
...++||+|+||.||++. ...+++.+|++++++++||||+++..++...+..++||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 446789999999999510 01345799999999999999997666667888889999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++++|.+++.. +..++.||++||.|||+++ |+||||||+|||++. .+||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999953 4689999999999999998 999999999999999 9999999999987543
Q ss_pred cccc-----cccccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 036419 598 ELQS-----NTKRIVGTYGYMSPEYAIH--GFFSIKSDVFSFGVLLLETLSSKRST 646 (754)
Q Consensus 598 ~~~~-----~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSlGvil~elltg~~p~ 646 (754)
.... ......||+.|||||++.. ..|+.++|+|+..+-.++.+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 1235789999999999987 57889999999999888888776553
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-20 Score=165.31 Aligned_cols=104 Identities=19% Similarity=0.413 Sum_probs=90.5
Q ss_pred cccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEcCC
Q 036419 26 DTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNLT 105 (754)
Q Consensus 26 ~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~ 105 (754)
|+|.+||.| ..|++|+| |.|.|.|...++ |.++. ..++||+|||+.|... .++|+|+.||||||+|++
T Consensus 2 n~L~~g~~L-~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 2 NILDNNEGL-YAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CEECTTEEE-CTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECTT
T ss_pred CCcCCCCEE-cCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECCC
Confidence 789999999 89999998 889999987654 66764 3699999999999764 689999999999999999
Q ss_pred CCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccc
Q 036419 106 NGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQS 150 (754)
Q Consensus 106 ~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQS 150 (754)
+.+||+|++........|+|+|+|||||++ ..||||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~---------~~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYG---------SDIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEE---------SEEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEEC---------CcEecC
Confidence 999999998766666789999999999995 359998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=4.1e-20 Score=166.92 Aligned_cols=108 Identities=17% Similarity=0.326 Sum_probs=93.6
Q ss_pred ccccccCCCCccccCCCeEE--eCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEE
Q 036419 23 KAADTITPASSFIRDGEKFV--SSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLV 100 (754)
Q Consensus 23 ~~~~~~~~~~~l~~~~~~lv--S~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~ 100 (754)
++.++|.+|++| .+|++|+ |++|.|+|+|+.+++ | +||++ .++||+||++.| +.++.|+|..|||||
T Consensus 6 ~~~~~l~~g~~L-~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 6 SKQPDDNHPQIL-HATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLV 74 (119)
T ss_dssp CSCSSSCCCCEE-ETTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred ecCcccCCCCEE-cCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEE
Confidence 578999999999 9999999 999999999998665 2 57876 899999999877 346899999999999
Q ss_pred EEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccc
Q 036419 101 ILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQS 150 (754)
Q Consensus 101 l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQS 150 (754)
|+|.++.++|++++........++|+|+|||||++ .++|||
T Consensus 75 l~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---------~~~W~S 115 (119)
T 1b2p_A 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---------DALWAT 115 (119)
T ss_dssp EECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---------SEEEEC
T ss_pred EEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---------ccEeCC
Confidence 99999999999987654445678999999999985 279997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=7.8e-20 Score=162.92 Aligned_cols=110 Identities=24% Similarity=0.446 Sum_probs=94.1
Q ss_pred ccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEcC
Q 036419 25 ADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNL 104 (754)
Q Consensus 25 ~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~ 104 (754)
+|+|.+|+.| ..|++|+ ++|.|+|+|+..++ | ++|+ ..++||.||++.|. .+++|+|..||||||+|.
T Consensus 1 ~d~l~~g~~L-~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 1 VNSLSSPNSL-FTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp CCEEETTCEE-CTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEE-CCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECC
Confidence 4789999999 9999999 99999999987665 2 6676 47999999998773 468999999999999999
Q ss_pred CCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCc
Q 036419 105 TNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPS 155 (754)
Q Consensus 105 ~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~Pt 155 (754)
+|.++|++++........++|+|+|||||++ + ++||||+||.
T Consensus 69 ~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~--------~-~~W~S~~~~~ 110 (110)
T 3a0c_A 69 SNRVIWQTKTNGKEDHYVLVLQQDRNVVIYG--------P-VVWATGSGPA 110 (110)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEEC--------S-EEEECSCCC-
T ss_pred CCcEEEecCCCCCCCCEEEEEeCCccEEEEC--------C-CEecCCCcCC
Confidence 9999999997755445578999999999985 2 7999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.7e-19 Score=160.96 Aligned_cols=110 Identities=17% Similarity=0.322 Sum_probs=92.7
Q ss_pred ccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEcC
Q 036419 25 ADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNL 104 (754)
Q Consensus 25 ~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~ 104 (754)
.|+|.+||+| ..|++|+ +|.|+|+|+..++ |. +|+ ..++||+||++.|. .+++|+|..+|||||+|.
T Consensus 2 ~dtl~~gq~L-~~g~~L~--~g~~~L~~~~dgn-----lv-ly~--~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 2 DNVLLSGQTL-HADHSLQ--AGAYTLTIQNKCN-----LV-KYQ--NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp CCEEETTCEE-ETTEEEE--ETTEEEEECTTSC-----EE-EEE--TTEEEEECSCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEE-CCCCEEE--CCCEEEEEcCCCc-----EE-EEe--CCEEEEeCCCCCCC--CceEEEECCCCcEEEECC
Confidence 5899999999 8999998 7999999987654 22 355 47999999999883 468999999999999999
Q ss_pred CCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcc
Q 036419 105 TNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSD 156 (754)
Q Consensus 105 ~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtD 156 (754)
++.++|++++........++|+|+|||||++ . ++||||.+++.
T Consensus 69 ~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~--------~-~~W~S~~~~~~ 111 (115)
T 2dpf_A 69 NNNDVWGSACWGDNGKYALVLQKDGRFVIYG--------P-VLWSLGPNGCR 111 (115)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEEC--------S-EEECSSTTCBC
T ss_pred CceEEEEcCCCCCCCCEEEEEeCCCeEEEEC--------C-CEEECCCCCCc
Confidence 8999999988654445678999999999985 2 79999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.8e-19 Score=157.59 Aligned_cols=110 Identities=25% Similarity=0.480 Sum_probs=92.2
Q ss_pred ccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEcC
Q 036419 25 ADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNL 104 (754)
Q Consensus 25 ~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~ 104 (754)
+|+|.+||.| .+|++| ++|.|+|+|+.+++ | ++|++ .++||+||++.+ +.+++|+|..+|||||+|
T Consensus 1 tdtl~~gq~L-~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQL-DTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEE-CTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEE-CCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-
Confidence 4899999999 999999 57999999998765 2 35665 799999999864 346899999999999999
Q ss_pred CCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCC
Q 036419 105 TNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYP 154 (754)
Q Consensus 105 ~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~P 154 (754)
++.++|++.+........++|+++|||||++.. +.++||||++.
T Consensus 67 ~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~------~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS------NNAIWATHTNV 110 (112)
T ss_dssp TTEEEEECCCCCSCCCCEEEECTTSCEEEECTT------SCEEEECCCCC
T ss_pred CCEEEEECCccCCCCCEEEEEeCCCcEEEECCC------CceEEECCCcc
Confidence 888999998765444567899999999999743 67999999974
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-19 Score=190.20 Aligned_cols=135 Identities=17% Similarity=0.149 Sum_probs=108.9
Q ss_pred hHhhhhcCccccceeccCCCcceeeccc-----------------------------------cHHHHHHHHHHHHhhcc
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKSGQ-----------------------------------GLEEFKNEIKLTAKLQH 497 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~~~-----------------------------------~~~~~~~Ev~il~~l~h 497 (754)
.+......|.+.+.||+|+||.||++.. ....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 4445566788889999999999997321 2346889999999999
Q ss_pred CCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEE
Q 036419 498 RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILL 577 (754)
Q Consensus 498 pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIll 577 (754)
| +++.+++.. +..++||||+++++|.+ +.. .....++.||++||.|||+.+ |+||||||+|||+
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 4 666665543 56799999999999988 411 224579999999999999998 9999999999999
Q ss_pred cCCCceEEeeccCccccCCCcccccccccccccCccccccccc
Q 036419 578 DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH 620 (754)
Q Consensus 578 d~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 620 (754)
+ ++.+||+|||+++. +..++|||++..
T Consensus 227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 9 99999999999973 345789998753
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=6.3e-18 Score=150.38 Aligned_cols=104 Identities=23% Similarity=0.460 Sum_probs=87.3
Q ss_pred ccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEcC
Q 036419 25 ADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNL 104 (754)
Q Consensus 25 ~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~ 104 (754)
.++|.+||.| .+|++|+ +|.|.|+|+..++ |.+ |+. .++||+||++.+ +.++.|.|..||||||+|.
T Consensus 1 ~ntL~~gq~L-~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~ 67 (109)
T 3dzw_A 1 DNILYSGETL-SPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSP 67 (109)
T ss_dssp CCEEETTEEE-CTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECT
T ss_pred CCCcCCCCEe-CCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECC
Confidence 3689999999 9999997 7999999987664 333 554 699999999876 3468999999999999999
Q ss_pred CCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccc
Q 036419 105 TNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQS 150 (754)
Q Consensus 105 ~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQS 150 (754)
++.++|++++........|+|+|+|||||++ .++|||
T Consensus 68 ~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~---------~~~W~s 104 (109)
T 3dzw_A 68 RNNPIWASNTGGENGNYVCVLQKDRNVVIYG---------TARWAT 104 (109)
T ss_dssp TSCEEEECCCCCSSSCEEEEECTTSCEEEEE---------SCCCCC
T ss_pred CCCEEEECCCCCCCCCEEEEEeCCCEEEEEC---------CCEEeC
Confidence 9999999998765545679999999999995 269997
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.69 E-value=8.6e-17 Score=143.02 Aligned_cols=106 Identities=18% Similarity=0.297 Sum_probs=86.0
Q ss_pred hccccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEE
Q 036419 22 SKAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVI 101 (754)
Q Consensus 22 ~~~~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l 101 (754)
.++.|+|.+||.| ..|++|+|. .|.|-|...++ |.+ |.. .+||.+|++.. +.++.|.|..||||||
T Consensus 3 ~~~~dtL~~gq~L-~~g~~L~sg--~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl 68 (110)
T 3r0e_B 3 PFTNNLLFSGQVL-YGDGRLTAK--NHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELII 68 (110)
T ss_dssp CCBTTEEETTCEE-ETTEEEECS--SCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEE
T ss_pred ccccCEECCCCEe-cCCCEEEeC--CEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEE
Confidence 4688999999999 899999984 58886654433 555 553 58999999863 3457999999999999
Q ss_pred EcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccc
Q 036419 102 LNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQS 150 (754)
Q Consensus 102 ~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQS 150 (754)
+|.++.++|++++........|+|+|+|||||++ ..+|+|
T Consensus 69 ~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---------~~~W~t 108 (110)
T 3r0e_B 69 KDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---------PAIFET 108 (110)
T ss_dssp ECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---------SEEEES
T ss_pred EeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---------CCEecC
Confidence 9999999999998654445689999999999995 369986
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.3e-16 Score=141.02 Aligned_cols=96 Identities=25% Similarity=0.374 Sum_probs=80.0
Q ss_pred CCCCCCceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccccC
Q 036419 83 PIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGM 162 (754)
Q Consensus 83 p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg~ 162 (754)
|+.+...+|.|..||+|+|++. +.+||++++.+.+..+.|+|+|+|||||++ + +.++||||+
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~------~~~~W~S~~---------- 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G------SRAIWASNT---------- 76 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T------TEEEEECCC----------
T ss_pred EEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C------CEEEEECCc----------
Confidence 4444568899999999999987 789999998765555789999999999997 5 679999993
Q ss_pred cccceecCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEc-CCeeeEecCCCCc
Q 036419 163 KLGWDLKNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYN-GSQKLSRSGPWNG 219 (754)
Q Consensus 163 ~l~~~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~-~~~~~~~~g~w~~ 219 (754)
+|++|.|++.++++|. +++|. +..+||++++|+|
T Consensus 77 ---------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ---------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ---------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ---------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567899999999987 55675 5679999999986
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.66 E-value=7.1e-16 Score=137.88 Aligned_cols=108 Identities=15% Similarity=0.275 Sum_probs=88.7
Q ss_pred ccccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEE
Q 036419 23 KAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVIL 102 (754)
Q Consensus 23 ~~~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~ 102 (754)
.+.|+|.+||.| ..|+.|.+ |.|.|-|...++ |.++.. -..++||.+|+..+ +.++.|.|..||||||+
T Consensus 4 ~~~~tL~~gq~L-~~g~~L~~--g~~~L~~q~dGN-----LvL~~~-~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~ 72 (113)
T 3mez_B 4 RVRNVLFSSQVM-YDNAQLAT--RDYSLVMRDDCN-----LVLTKG-SKTNIVWESGTSGR--GQHCFMRLGHSGELDIT 72 (113)
T ss_dssp CCSSEEETTCEE-ETTCEEEE--TTEEEEECTTSC-----EEEEET-TTTEEEEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred ccCCEeCCCCEE-CCCCEeEc--CCEEEEEcCCCE-----EEEEEC-CCCEEEEECCcccC--CcCEEEEEeCCCcEEEE
Confidence 467999999999 89999975 889999876554 666432 24689999999876 34689999999999999
Q ss_pred cCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccc
Q 036419 103 NLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQS 150 (754)
Q Consensus 103 ~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQS 150 (754)
|.++.++|++++........|+|+|+|||||++ ..||+|
T Consensus 73 d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---------~~~W~s 111 (113)
T 3mez_B 73 DDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---------PAVWST 111 (113)
T ss_dssp CTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---------SEEEES
T ss_pred CCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---------CCEecC
Confidence 999999999998654445689999999999994 479997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=2e-15 Score=134.35 Aligned_cols=89 Identities=20% Similarity=0.353 Sum_probs=75.3
Q ss_pred CCceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccccCcccc
Q 036419 87 PNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGW 166 (754)
Q Consensus 87 ~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg~~l~~ 166 (754)
...+|.|..||||||++ .+.+||++++...+....++|+|+|||||++.+ +.+|||||
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~------~~~~W~S~--------------- 77 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS------NRVIWQTK--------------- 77 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT------CCEEEECC---------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC------CcEEEecC---------------
Confidence 36889999999999998 578999999876655678999999999999854 78999999
Q ss_pred eecCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecCCC
Q 036419 167 DLKNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPW 217 (754)
Q Consensus 167 ~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~w 217 (754)
++|++|.|+++++++|. +++|++ +||+++++
T Consensus 78 ----------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ----------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ----------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ----------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 35667999999999987 566775 89999875
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.1e-15 Score=133.82 Aligned_cols=109 Identities=20% Similarity=0.368 Sum_probs=87.8
Q ss_pred ccccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEE
Q 036419 23 KAADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVIL 102 (754)
Q Consensus 23 ~~~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~ 102 (754)
+|.|+|.+||.| ..|+.| .+|.|.|.|...++ |.+ |.. +|.+|+..+ +.+++|+|..||||||+
T Consensus 1 ~~~dtL~~gq~L-~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~ 64 (109)
T 3r0e_A 1 LGTNYLLSGQTL-DTEGHL--KNGDFDLVMQDDCN-----LVL-YNG-----NWQSNTANN--GRDCKLTLTDYGELVIK 64 (109)
T ss_dssp CCCSEEETTCEE-CTTCEE--EETTEEEEECTTSC-----EEE-ETT-----TEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred CccCCcCCCCCc-CCCCEe--ECCCEEEEEecCCe-----EEE-EeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEE
Confidence 478999999999 899999 57999999976554 333 331 699998865 34689999999999999
Q ss_pred cCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCccccccc
Q 036419 103 NLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAG 161 (754)
Q Consensus 103 ~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg 161 (754)
|.++.++|++++........|+|+|+|||||++ ..+|+| .|.+||
T Consensus 65 d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---------~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 65 NGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---------PSVFKI-----DPWVRG 109 (109)
T ss_dssp CTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---------SEEEEE-----CTTSCC
T ss_pred eCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---------cCEECC-----CCccCC
Confidence 999999999998654445679999999999994 469996 666654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.5e-15 Score=157.20 Aligned_cols=120 Identities=16% Similarity=0.156 Sum_probs=94.1
Q ss_pred CccccceeccCCCcceeeccc-----c---------------------------------------HHHHHHHHHHHHhh
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ-----G---------------------------------------LEEFKNEIKLTAKL 495 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~-----~---------------------------------------~~~~~~Ev~il~~l 495 (754)
-|++.+.||+|+||.||++.. . ...+.+|++++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999997321 0 02578899999999
Q ss_pred ccCCe--eeeeeeeeecCeeEEEEEecCC-C----ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceee
Q 036419 496 QHRNL--VRLLGCCVEQGENVLIYEYLPN-K----SLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH-QYSRLRVIH 567 (754)
Q Consensus 496 ~hpni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~iiH 567 (754)
+|+++ +++++. ...+|||||+.+ | +|.+++.. .++..+..++.||+.+|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 98864 444432 367899999942 3 66666532 224466889999999999999 877 999
Q ss_pred CCCCCCceEEcCCCceEEeeccCcccc
Q 036419 568 RDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 568 ~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
|||||+|||+++ .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999864
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.58 E-value=8e-15 Score=132.15 Aligned_cols=87 Identities=24% Similarity=0.292 Sum_probs=73.6
Q ss_pred CceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccccCcccce
Q 036419 88 NAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWD 167 (754)
Q Consensus 88 ~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg~~l~~~ 167 (754)
..+|.|..||+|+|++. +++||++++...+..+.|+|+|+|||||++.+ +.+|||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~------~~~lW~S~---------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE------NVTVWQSP---------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT------CCEEEECS----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC------CcEEEcCC----------------
Confidence 46789999999999987 89999999876555678999999999999854 78999999
Q ss_pred ecCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecCC
Q 036419 168 LKNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGP 216 (754)
Q Consensus 168 ~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~ 216 (754)
++|++|.|++.++++|. ++++. .+||++|+
T Consensus 88 ---------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 ---------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp ---------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred ---------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 35678999999999987 55666 38999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.4e-14 Score=130.05 Aligned_cols=90 Identities=30% Similarity=0.398 Sum_probs=75.7
Q ss_pred CceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccccCcccce
Q 036419 88 NAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWD 167 (754)
Q Consensus 88 ~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg~~l~~~ 167 (754)
..+|.|..||+|+|++ .+++||++++......+.++|+++|||||++.+ +.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~------~~~vW~S~~~-------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN------NNDVWGSACW-------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT------CCEEEECCCC--------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC------ceEEEEcCCC--------------
Confidence 5789999999999998 578999999876555578899999999999854 7799999997
Q ss_pred ecCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecCCCCc
Q 036419 168 LKNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPWNG 219 (754)
Q Consensus 168 ~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~w~~ 219 (754)
|++|.|++.++++|. +++|++ +||++++|..
T Consensus 80 -----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~ 110 (115)
T 2dpf_A 80 -----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGC 110 (115)
T ss_dssp -----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCB
T ss_pred -----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCC
Confidence 356789999999997 566765 8999999964
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.45 E-value=3.3e-13 Score=119.99 Aligned_cols=103 Identities=16% Similarity=0.274 Sum_probs=81.2
Q ss_pred ccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEcC
Q 036419 25 ADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNL 104 (754)
Q Consensus 25 ~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~ 104 (754)
.|+|.+||.| ..|+.| .+|.|.|-|...++ |.+ |.. .. ||.+|+..+ ...+.|.|..||||||+|.
T Consensus 2 ~~~l~~gq~L-~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVI-HTDNQL--SYESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEE-CTTCEE--EETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTS--CSSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEe-CCCCEE--ecCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccC--CcCEEEEEcCCCcEEEEeC
Confidence 5899999999 899999 36889999976554 444 432 23 999999876 3358999999999999998
Q ss_pred CCC-eEEeecCCC--CCCCceEEEccCCCEEEEecCCCCCCcCceeccc
Q 036419 105 TNG-AIWSSNTSR--KAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQS 150 (754)
Q Consensus 105 ~~~-~~ws~~~~~--~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQS 150 (754)
++. ++|++++.. ......++|+|+|||||++ ..+|+|
T Consensus 68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s 107 (111)
T 3mez_A 68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---------PAIWST 107 (111)
T ss_dssp SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---------SEEEEC
T ss_pred CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---------cCEEcc
Confidence 876 599999642 2234578999999999994 569986
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.40 E-value=9.7e-14 Score=149.96 Aligned_cols=126 Identities=13% Similarity=0.188 Sum_probs=86.9
Q ss_pred hhhhcCccccceeccCCCcceeeccc-------------------------------cHHHH--------HHHHHHHHhh
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSGQ-------------------------------GLEEF--------KNEIKLTAKL 495 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~~-------------------------------~~~~~--------~~Ev~il~~l 495 (754)
.....-|++.++||+|+||.||++.. ..... .+|...|.++
T Consensus 91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 91 AARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 33334599999999999999997210 01112 2355555555
Q ss_pred ccCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCce
Q 036419 496 QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNI 575 (754)
Q Consensus 496 ~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 575 (754)
.+.++.-. ..+.. ...+|||||+++++|..+.. ......++.||+.+|.|||..+ ||||||||.||
T Consensus 171 ~~~gv~vp-~p~~~-~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NI 236 (397)
T 4gyi_A 171 YEEGFPVP-EPIAQ-SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNI 236 (397)
T ss_dssp HHTTCSCC-CEEEE-ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred HhcCCCCC-eeeec-cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHE
Confidence 44332211 11111 23379999999998866541 1134578899999999999988 99999999999
Q ss_pred EEcCCC----------ceEEeeccCcccc
Q 036419 576 LLDSNM----------IPKISDFGLARMF 594 (754)
Q Consensus 576 lld~~~----------~~kl~DFgla~~~ 594 (754)
|+++++ .+.|+||+.+...
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEeCCCCcccccccccceEEEEeCCcccC
Confidence 998776 3899999988753
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.29 E-value=1.2e-11 Score=110.34 Aligned_cols=96 Identities=19% Similarity=0.280 Sum_probs=73.4
Q ss_pred CCCCCCCCCceEEEecCccEEEEcC-CCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccc
Q 036419 80 RNSPIIEPNAALTISNNGNLVILNL-TNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTL 158 (754)
Q Consensus 80 r~~p~~~~~~~l~~~~~g~l~l~~~-~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTl 158 (754)
.+.|+.+...+|.+..||||||++. .+.++|++++...+....++|+++|||||++.+ +.++|||=.+
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~------~~~iW~S~t~----- 85 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR------LNTVFVSNTV----- 85 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT------SCEEEECSCC-----
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC------CCEEEECCCc-----
Confidence 3455555678999999999999998 488999999876555678899999999999854 6789996210
Q ss_pred cccCcccceecCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecCC
Q 036419 159 LAGMKLGWDLKNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGP 216 (754)
Q Consensus 159 Lpg~~l~~~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~ 216 (754)
-..|.|.+.++.+|... +|. .+.|.+|+
T Consensus 86 --------------------------~~~~~~~~~L~~dGnlv--ly~--~~~W~s~~ 113 (113)
T 3mez_B 86 --------------------------GQEGDYVLILQINGQAV--VYG--PAVWSTAA 113 (113)
T ss_dssp --------------------------CSSSCCEEEECTTSCEE--EEC--SEEEESCC
T ss_pred --------------------------CCCCCEEEEEcCCceEE--Eec--CCEecCCC
Confidence 01355888999998765 454 57898875
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.5e-11 Score=127.48 Aligned_cols=112 Identities=20% Similarity=0.380 Sum_probs=87.4
Q ss_pred cccccCCCCc----cccCCCeEEeCCCeEEEEeeCCC--CCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCc
Q 036419 24 AADTITPASS----FIRDGEKFVSSSERFELGFFSPR--KSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNG 97 (754)
Q Consensus 24 ~~~~~~~~~~----l~~~~~~lvS~~g~F~lGF~~~~--~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g 97 (754)
.+|++.||+. | ..|++|+| ..+++-|+|+.. .....+ +| ++ ..+++|.+++..+ + ...|.+..+|
T Consensus 135 ptdtlLpg~~~~~~l-~~g~~L~S-~~dps~G~fsl~l~~dGnlv--Ly-~~-~~~~yW~Sgt~~~--~-~~~l~l~~dG 205 (276)
T 3m7h_A 135 PAIPLVPGAIDSLLL-APGSELVQ-GVVYGAGASKLVFQGDGNLV--AY-GP-NGAATWNAGTQGK--G-AVRAVFQGDG 205 (276)
T ss_dssp TTSCCCCSCTTCEEE-CSSEEECT-TCEEEETTEEEEECTTSCEE--EE-CT-TSSEEEECCCTTT--T-CCEEEECTTS
T ss_pred ccccccccccccccc-ccCccccc-CCCCCCceEEEeecCCceEE--EE-eC-CCeEEEECCCCCC--c-cEEEEEcCCC
Confidence 5699999999 6 78888865 467888877642 223333 33 32 2589999999876 2 2789999999
Q ss_pred cEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCC
Q 036419 98 NLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDY 153 (754)
Q Consensus 98 ~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~ 153 (754)
+|+++|.++.++|++++.... ...|+|+++|||||++ .+++|||||+
T Consensus 206 nLvl~d~~~~~vWsS~t~~~~-~~rl~Ld~dGnLvly~--------~~~~Wqsf~~ 252 (276)
T 3m7h_A 206 NLVVYGAGNAVLWHSHTGGHA-SAVLRLQANGSIAILD--------EKPVWARFGF 252 (276)
T ss_dssp CEEEECTTSCEEEECSCTTCT-TCEEEECTTSCEEEEE--------EEEEEESSSC
T ss_pred eEEEEeCCCcEEEEecCCCCC-CEEEEEcCCccEEEEc--------CCCeEEccCc
Confidence 999999988999999976543 4789999999999996 2579999997
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.18 E-value=7.1e-11 Score=104.87 Aligned_cols=94 Identities=18% Similarity=0.228 Sum_probs=70.8
Q ss_pred CCCCCCCceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCc-eeccccCCCcccccc
Q 036419 82 SPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGS-CLWQSFDYPSDTLLA 160 (754)
Q Consensus 82 ~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~-~lWQSFd~PtDTlLp 160 (754)
.++.....+|.+..||||||++.++ +|++++.+.+....++|+++|||||++.+ +. ++|||.-+
T Consensus 15 ~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~------~~~~vW~S~t~------- 79 (111)
T 3mez_A 15 NQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSAN------SNTPVWVYPRS------- 79 (111)
T ss_dssp CEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSS------CSSCSEEESSS-------
T ss_pred CEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCC------CCEEEEEeccc-------
Confidence 3344446889999999999999876 99999876655578899999999999754 44 59998621
Q ss_pred cCcccceecCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecCC
Q 036419 161 GMKLGWDLKNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGP 216 (754)
Q Consensus 161 g~~l~~~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~ 216 (754)
.....|.|.+.++.+|...+ |. .++|.++.
T Consensus 80 ----------------------~~~~~~~~~l~Lq~dGNlvl--y~--~~~W~s~t 109 (111)
T 3mez_A 80 ----------------------VNTVRGNYAATLGPDQHVTI--YG--PAIWSTPA 109 (111)
T ss_dssp ----------------------CCCCSSCCEEEECTTSCEEE--EC--SEEEECCC
T ss_pred ----------------------cCCCCcCEEEEECCCCeEEE--ec--cCEEccCC
Confidence 01134788999999987654 54 67898764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.04 E-value=6.8e-10 Score=98.33 Aligned_cols=86 Identities=23% Similarity=0.320 Sum_probs=66.0
Q ss_pred CCceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccccCcccc
Q 036419 87 PNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGW 166 (754)
Q Consensus 87 ~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg~~l~~ 166 (754)
...+|.+..||||||++. .++|++++...+....++|+++|||||++.+ +.++|||-.+
T Consensus 24 g~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~------~~~iW~S~t~------------- 82 (110)
T 3r0e_B 24 KNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD------FKTIWSSRSS------------- 82 (110)
T ss_dssp SSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT------CCEEEECCCC-------------
T ss_pred CCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC------CCEEEEcCCc-------------
Confidence 357899999999999876 5899999876555568899999999999854 6789997421
Q ss_pred eecCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecC
Q 036419 167 DLKNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSG 215 (754)
Q Consensus 167 ~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g 215 (754)
-..|.|.+.++.+|... +|. .+.|.+|
T Consensus 83 ------------------~~~~~~~~~L~~dGNlv--ly~--~~~W~t~ 109 (110)
T 3r0e_B 83 ------------------SKQGEYVLILQDDGFGV--IYG--PAIFETS 109 (110)
T ss_dssp ------------------CSSSCCEEEECTTSCEE--EEC--SEEEESC
T ss_pred ------------------CCCCCEEEEEcCCccEE--Eec--CCEecCC
Confidence 01345788999988765 454 4788876
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.03 E-value=9.2e-10 Score=97.33 Aligned_cols=92 Identities=23% Similarity=0.422 Sum_probs=69.8
Q ss_pred CCCCCCCCceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccc
Q 036419 81 NSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLA 160 (754)
Q Consensus 81 ~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLp 160 (754)
+.|+.....+|.+..||||||+++ +|++++...+....++|+++|||||++.+ +.++|+|= |
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~------~~~vWss~-----t--- 76 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD------GSTVWKSG-----A--- 76 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT------SCEEEECC-----C---
T ss_pred CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC------CCEEEcCC-----C---
Confidence 344445578899999999999984 79999876655678899999999999854 67899751 1
Q ss_pred cCcccceecCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecCCC
Q 036419 161 GMKLGWDLKNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGPW 217 (754)
Q Consensus 161 g~~l~~~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~w 217 (754)
....+.|.+.++.+|... +|. .+.|.+++|
T Consensus 77 -----------------------~~~~~~~~~~L~~dGNlv--ly~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 -----------------------QSVKGNYAAVVHPDGRLV--VFG--PSVFKIDPW 106 (109)
T ss_dssp -----------------------CCSSSCCEEEEETTTEEE--EEC--SEEEEECTT
T ss_pred -----------------------cCCCcCEEEEEcCCCeEE--EEe--cCEECCCCc
Confidence 012356788999988654 454 688999987
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=1.1e-09 Score=96.89 Aligned_cols=87 Identities=21% Similarity=0.302 Sum_probs=66.2
Q ss_pred CceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccccCcccce
Q 036419 88 NAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWD 167 (754)
Q Consensus 88 ~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg~~l~~~ 167 (754)
..+|.|..||||||++. +.++|++++...+....++|+++|||||++.+ +.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~------~~~~W~S~t~~------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR------NNPIWASNTGG------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT------SCEEEECCCCC-------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC------CCEEEECCCCC-------------
Confidence 57899999999999987 78999999876555578899999999999854 67899974211
Q ss_pred ecCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecCC
Q 036419 168 LKNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGP 216 (754)
Q Consensus 168 ~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~ 216 (754)
..+.|.+.++.+|... +|.. +.|.++.
T Consensus 80 ------------------~~~~~~~~L~ddGNlv--ly~~--~~W~s~t 106 (109)
T 3dzw_A 80 ------------------ENGNYVCVLQKDRNVV--IYGT--ARWATGT 106 (109)
T ss_dssp ------------------SSSCEEEEECTTSCEE--EEES--CCCCCCC
T ss_pred ------------------CCCCEEEEEeCCCEEE--EECC--CEEeCCC
Confidence 1256788899888765 4442 6676653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=1e-09 Score=113.15 Aligned_cols=128 Identities=17% Similarity=0.127 Sum_probs=100.6
Q ss_pred hcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEEEEEec
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
-..|++...++.|+.+.||+.. .....+.+|+++++.+. |..+.++++++.+....++||||+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 3568777788888888888621 22346899999999995 677889999999888999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS--------------------------------------- 561 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--------------------------------------- 561 (754)
+|.+|.+.+. +......++.+++++|..||+..
T Consensus 93 ~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 93 DGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp SSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred CCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 9999987641 11223578899999999999811
Q ss_pred -----------------CCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 562 -----------------RLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 562 -----------------~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13499999999999998766677999998763
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.72 E-value=5.8e-08 Score=85.02 Aligned_cols=55 Identities=31% Similarity=0.522 Sum_probs=45.4
Q ss_pred ceEEEecCccEEEEcCCCCeEEeecCCCCC-CCceEEEccCCCEEEEecCCCCCCcCceeccc
Q 036419 89 AALTISNNGNLVILNLTNGAIWSSNTSRKA-ENPVAQLLDTGNLIVRDNFSRSASEGSCLWQS 150 (754)
Q Consensus 89 ~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQS 150 (754)
-+|.+..||||||++. +.+||++++..+. ..+.+.|.++|||||+|.+ +++||+|
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~------~~~vWss 76 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS------GRSLWAS 76 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT------CCEEEEC
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC------cEEEEEe
Confidence 5688999999999985 5799999986544 3457899999999999865 7889985
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.72 E-value=2.1e-08 Score=102.55 Aligned_cols=100 Identities=21% Similarity=0.270 Sum_probs=78.1
Q ss_pred HHHHHHHHHHHhhccCC--eeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 036419 483 EEFKNEIKLTAKLQHRN--LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560 (754)
Q Consensus 483 ~~~~~Ev~il~~l~hpn--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 560 (754)
..+.+|+++++.+.+.+ +.+++++...++..++||||++|.+|. ... .+ ...++.++++.|..||..
T Consensus 58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~ 126 (264)
T 1nd4_A 58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTL 126 (264)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTS
T ss_pred hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCC
Confidence 56789999999997654 567888888888899999999998884 211 11 235778888888888874
Q ss_pred C-------------------------------------------------------CCceeeCCCCCCceEEcCCCceEE
Q 036419 561 S-------------------------------------------------------RLRVIHRDLKPSNILLDSNMIPKI 585 (754)
Q Consensus 561 ~-------------------------------------------------------~~~iiH~Dlkp~NIlld~~~~~kl 585 (754)
. ...++|+|++|.|||++++..++|
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~l 206 (264)
T 1nd4_A 127 DPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGF 206 (264)
T ss_dssp CGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEE
T ss_pred CCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEE
Confidence 3 123999999999999988776789
Q ss_pred eeccCccc
Q 036419 586 SDFGLARM 593 (754)
Q Consensus 586 ~DFgla~~ 593 (754)
+||+.+..
T Consensus 207 iD~~~a~~ 214 (264)
T 1nd4_A 207 IDCGRLGV 214 (264)
T ss_dssp CCCTTCEE
T ss_pred Ecchhccc
Confidence 99999864
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.70 E-value=4.6e-08 Score=99.21 Aligned_cols=58 Identities=24% Similarity=0.363 Sum_probs=48.3
Q ss_pred CceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCC
Q 036419 88 NAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDY 153 (754)
Q Consensus 88 ~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~ 153 (754)
.-+|.|..+|+|+|+++ +++||++|+... ..+.++|.++|||||+|.+ +.+||+|+.+
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~-~~~~l~l~~dGnLvl~d~~------~~~vW~s~~~ 84 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRAVLQSDGLLVILTAQ------NTIRWSSGTK 84 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSC-SCCBCCBCSSSCBCCBCTT------TCCSCCCCCC
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCC-CCeEEEEcCCCcEEEEcCC------CcEEEeCCcc
Confidence 46688888999999886 789999997655 4566789999999999854 7899999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.69 E-value=5.7e-08 Score=104.92 Aligned_cols=125 Identities=14% Similarity=0.282 Sum_probs=95.1
Q ss_pred cceeccCCCcceeec------------c-------ccHHHHHHHHHHHHhhc--cCCeeeeeeeeeec---CeeEEEEEe
Q 036419 464 ENKLGEGGFGPVYKS------------G-------QGLEEFKNEIKLTAKLQ--HRNLVRLLGCCVEQ---GENVLIYEY 519 (754)
Q Consensus 464 ~~~lG~G~fg~Vyk~------------~-------~~~~~~~~Ev~il~~l~--hpniv~l~~~~~~~---~~~~lV~E~ 519 (754)
.+.|+.|.++.||+. . .....+.+|+++++.|. +..+++++.++.+. ...++||||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 456777777777751 1 11346788999999997 45688899888776 458999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS-------------------------------------- 561 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-------------------------------------- 561 (754)
++|..+.+.. ...++...+..++.++++.|..||...
T Consensus 123 v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 123 VSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred cCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9998875422 123678888999999999999999731
Q ss_pred -----------------CCceeeCCCCCCceEEcCCCc--eEEeeccCccc
Q 036419 562 -----------------RLRVIHRDLKPSNILLDSNMI--PKISDFGLARM 593 (754)
Q Consensus 562 -----------------~~~iiH~Dlkp~NIlld~~~~--~kl~DFgla~~ 593 (754)
...++|+|++|.|||+++++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.60 E-value=3.5e-08 Score=104.08 Aligned_cols=175 Identities=19% Similarity=0.218 Sum_probs=113.8
Q ss_pred ceeccCCCcceeecc-----------ccHHHHHHHHHHHHhhc-cCC--eeeeeeeeeecC---eeEEEEEecCCCChhh
Q 036419 465 NKLGEGGFGPVYKSG-----------QGLEEFKNEIKLTAKLQ-HRN--LVRLLGCCVEQG---ENVLIYEYLPNKSLDS 527 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~-----------~~~~~~~~Ev~il~~l~-hpn--iv~l~~~~~~~~---~~~lV~E~~~~gsL~~ 527 (754)
+.++.|....||+.. .....+.+|+++++.+. +.. +.+++....... ..++|||+++|.+|..
T Consensus 26 ~~~~~G~~n~v~~v~~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~ 105 (304)
T 3sg8_A 26 EISGEGNDCIAYEINRDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTP 105 (304)
T ss_dssp CEEEECSSEEEEESTTSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCH
T ss_pred EecCCCCcceEEEECCEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCc
Confidence 457777777777521 23467899999999984 322 445555443333 3478999999998875
Q ss_pred HhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 036419 528 FLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS---------------------------------------------- 561 (754)
Q Consensus 528 ~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------------- 561 (754)
... ..++.+++..++.++++.++.||...
T Consensus 106 ~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 180 (304)
T 3sg8_A 106 LLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI 180 (304)
T ss_dssp HHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred ccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence 432 23677888889999999999999621
Q ss_pred ---------CCceeeCCCCCCceEEcC--CCceEEeeccCccccCCCcccccccc------------cccccCccc-ccc
Q 036419 562 ---------RLRVIHRDLKPSNILLDS--NMIPKISDFGLARMFGGDELQSNTKR------------IVGTYGYMS-PEY 617 (754)
Q Consensus 562 ---------~~~iiH~Dlkp~NIlld~--~~~~kl~DFgla~~~~~~~~~~~~~~------------~~gt~~y~A-PE~ 617 (754)
...++|+|++|.||++++ ...+.|+||+.+..-........... .....+... |+.
T Consensus 181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~ 260 (304)
T 3sg8_A 181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTV 260 (304)
T ss_dssp HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHH
T ss_pred HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHH
Confidence 135899999999999998 55678999999876432110000000 000111112 222
Q ss_pred cccCCCCcccchhhHHHHHHHHHhCCCCC
Q 036419 618 AIHGFFSIKSDVFSFGVLLLETLSSKRST 646 (754)
Q Consensus 618 ~~~~~~s~ksDVwSlGvil~elltg~~p~ 646 (754)
.... ....+.|+++.+++.+.+|..++
T Consensus 261 ~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 261 LEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 1111 22358999999999999998653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=3.8e-05 Score=80.74 Aligned_cols=107 Identities=24% Similarity=0.282 Sum_probs=77.9
Q ss_pred HHHHHHHHHHHHhhccC---Ceeeeeeeee-ecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 036419 482 LEEFKNEIKLTAKLQHR---NLVRLLGCCV-EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557 (754)
Q Consensus 482 ~~~~~~Ev~il~~l~hp---niv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yL 557 (754)
...+.+|.++|+.|.+. .+.+.+.+.. ..+..++|||+++|..+...... .++...+..++.++++.|..|
T Consensus 53 ~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~L 127 (306)
T 3tdw_A 53 ADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNEL 127 (306)
T ss_dssp HHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHH
Confidence 46789999999999753 3566666664 34567899999999988764311 245566666777777777777
Q ss_pred HhcC---------------------------------------------------------CCceeeCCCCCCceEEcC-
Q 036419 558 HQYS---------------------------------------------------------RLRVIHRDLKPSNILLDS- 579 (754)
Q Consensus 558 H~~~---------------------------------------------------------~~~iiH~Dlkp~NIlld~- 579 (754)
|+.. ...++|+|++|.||+++.
T Consensus 128 H~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~ 207 (306)
T 3tdw_A 128 SAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLN 207 (306)
T ss_dssp HHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTT
T ss_pred hcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecC
Confidence 7532 234799999999999987
Q ss_pred --CCc-eEEeeccCccc
Q 036419 580 --NMI-PKISDFGLARM 593 (754)
Q Consensus 580 --~~~-~kl~DFgla~~ 593 (754)
++. +.|+||+.+..
T Consensus 208 ~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 208 SRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CSSCCEEEECCCTTCEE
T ss_pred CCCCceEEEEehhhcCC
Confidence 455 48999998875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=4.4e-05 Score=78.39 Aligned_cols=105 Identities=18% Similarity=0.180 Sum_probs=80.3
Q ss_pred HHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 036419 482 LEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560 (754)
Q Consensus 482 ~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 560 (754)
...+.+|..+|+.|. +--+.+++.++.+.+..++|||+++|.++.+..... ......+..++++.|.-||..
T Consensus 63 ~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~ 135 (272)
T 4gkh_A 63 ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSI 135 (272)
T ss_dssp HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTS
T ss_pred HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC-------HHHHHHHHHHHHHHHHHhcCC
Confidence 456889999999886 334778889999999999999999999887765321 122345667777777777752
Q ss_pred C-------------------------------------------------------CCceeeCCCCCCceEEcCCCceEE
Q 036419 561 S-------------------------------------------------------RLRVIHRDLKPSNILLDSNMIPKI 585 (754)
Q Consensus 561 ~-------------------------------------------------------~~~iiH~Dlkp~NIlld~~~~~kl 585 (754)
. ...++|+|+.+.|||+++++.+-|
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~v 215 (272)
T 4gkh_A 136 PVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGC 215 (272)
T ss_dssp CGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEE
T ss_pred CcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEE
Confidence 1 023799999999999998877789
Q ss_pred eeccCccc
Q 036419 586 SDFGLARM 593 (754)
Q Consensus 586 ~DFgla~~ 593 (754)
+||+.+..
T Consensus 216 iDwe~a~~ 223 (272)
T 4gkh_A 216 IDVGRVGI 223 (272)
T ss_dssp CCCTTCEE
T ss_pred EECccccc
Confidence 99998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00035 Score=74.85 Aligned_cols=45 Identities=7% Similarity=0.110 Sum_probs=33.6
Q ss_pred HHHHHHHHHHHhhcc---CCeeeeeeeeeec---CeeEEEEEecCCCChhh
Q 036419 483 EEFKNEIKLTAKLQH---RNLVRLLGCCVEQ---GENVLIYEYLPNKSLDS 527 (754)
Q Consensus 483 ~~~~~Ev~il~~l~h---pniv~l~~~~~~~---~~~~lV~E~~~~gsL~~ 527 (754)
..+.+|+.+++.|.. -.+.+++.++.+. ...++||||++|..+.+
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 457889999988853 3577888877655 35689999999977654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0012 Score=69.72 Aligned_cols=44 Identities=20% Similarity=0.077 Sum_probs=34.3
Q ss_pred HHHHHHHHHh----------cCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 550 IAQGLLYLHQ----------YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 550 i~~~L~yLH~----------~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
+.+++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4446667763 1235699999999999998888999999998763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.005 Score=64.61 Aligned_cols=125 Identities=20% Similarity=0.213 Sum_probs=78.6
Q ss_pred cceeccCCCcceeec-------------cccHHHHHHHHHHHHhhcc---CCeeeeeeeeeecCeeEEEEEecCCCChhh
Q 036419 464 ENKLGEGGFGPVYKS-------------GQGLEEFKNEIKLTAKLQH---RNLVRLLGCCVEQGENVLIYEYLPNKSLDS 527 (754)
Q Consensus 464 ~~~lG~G~fg~Vyk~-------------~~~~~~~~~Ev~il~~l~h---pniv~l~~~~~~~~~~~lV~E~~~~gsL~~ 527 (754)
.+.|+.|....+|+. ......+..|...|+.|.. ..+++++.+....+..++||||+++..+..
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~ 120 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQ 120 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCT
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCc
Confidence 346677777777651 1235678999999999853 568888888887888999999999986521
Q ss_pred -----------HhhccCC-C----------C--------CCCHHHHH---HHH----------------HHHHHHH-HHH
Q 036419 528 -----------FLFDTTK-E----------G--------LLGWGARI---RII----------------EGIAQGL-LYL 557 (754)
Q Consensus 528 -----------~l~~~~~-~----------~--------~l~~~~~~---~i~----------------~qi~~~L-~yL 557 (754)
-|+.... . + .-+|.... ++. ..++..+ ..|
T Consensus 121 ~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L 200 (312)
T 3jr1_A 121 SSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTL 200 (312)
T ss_dssp THHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHh
Confidence 1111111 0 0 12454322 111 1112112 233
Q ss_pred Hh-cCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 558 HQ-YSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 558 H~-~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus 201 ~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 201 SKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp TTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred ccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 22 2245799999999999999887 8899973
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0051 Score=66.78 Aligned_cols=30 Identities=27% Similarity=0.315 Sum_probs=26.0
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
..++|+|+.+.|||++++ .++|+||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 469999999999999876 489999988774
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.23 E-value=0.011 Score=57.85 Aligned_cols=101 Identities=11% Similarity=0.018 Sum_probs=64.6
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcccc
Q 036419 522 NKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601 (754)
Q Consensus 522 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~ 601 (754)
..+|.++|.. ...++++++++.++.|.++.|.-+-.... -..+=+-|..|+|..+|.|.+.+ ..+.
T Consensus 32 ~vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 3478888854 45679999999999999999877622110 11233456899999999887754 1110
Q ss_pred cccccccccCcccccccccCCCCcccchhhHHHHHHHHHhC
Q 036419 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSS 642 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg 642 (754)
.....+.|||... ...+.+.=|||||+++|..+-=
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1123467888653 3556888999999999988743
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.07 E-value=0.016 Score=60.70 Aligned_cols=112 Identities=20% Similarity=0.226 Sum_probs=64.4
Q ss_pred HHHHHHHHHHHHhhccCC--eeeeeee------eeecCeeEEEEEecCCCChhh----H----------hhccCC----C
Q 036419 482 LEEFKNEIKLTAKLQHRN--LVRLLGC------CVEQGENVLIYEYLPNKSLDS----F----------LFDTTK----E 535 (754)
Q Consensus 482 ~~~~~~Ev~il~~l~hpn--iv~l~~~------~~~~~~~~lV~E~~~~gsL~~----~----------l~~~~~----~ 535 (754)
.+++..|+.++..|.... +.+++.. ....+..++||||++|..+.. . ++.... .
T Consensus 59 ~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~ 138 (322)
T 2ppq_A 59 KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIK 138 (322)
T ss_dssp CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCC
T ss_pred HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCc
Confidence 456788999998886332 3444422 123356789999999875421 0 111000 0
Q ss_pred --CCC---CHHHHHH------------HHHHHHHHHHHHHhc----CCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 536 --GLL---GWGARIR------------IIEGIAQGLLYLHQY----SRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 536 --~~l---~~~~~~~------------i~~qi~~~L~yLH~~----~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
... .|..... +...+.+.+..++.. ....++|+|+++.|||++++..+.|+||+.+..
T Consensus 139 ~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 139 RPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001 1222110 001244455556532 134699999999999999876668999998763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.98 E-value=0.02 Score=62.56 Aligned_cols=78 Identities=9% Similarity=0.042 Sum_probs=46.7
Q ss_pred CCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccccccccc--ccCcccccccccCC---CCcccchhhHHHHH
Q 036419 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVG--TYGYMSPEYAIHGF---FSIKSDVFSFGVLL 636 (754)
Q Consensus 562 ~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~---~s~ksDVwSlGvil 636 (754)
...++|+|++|.|||+++++ ++|+||+.+..-..... ...... ...|++|+...... -....++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 35699999999999998876 99999999875321110 001111 12456665443111 11224455677777
Q ss_pred HHHHhCC
Q 036419 637 LETLSSK 643 (754)
Q Consensus 637 ~elltg~ 643 (754)
++.+.+.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7776653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.022 Score=59.14 Aligned_cols=31 Identities=29% Similarity=0.222 Sum_probs=26.2
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
..++|+|+.+.||+ ..++.+.|+||..+..-
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 45899999999999 56677899999988753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.45 E-value=0.044 Score=56.42 Aligned_cols=62 Identities=13% Similarity=0.115 Sum_probs=39.7
Q ss_pred CccccceeccCCCcceeec-----------------cccHHHHHHHHHHHHhhccC---CeeeeeeeeeecCeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKS-----------------GQGLEEFKNEIKLTAKLQHR---NLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~-----------------~~~~~~~~~Ev~il~~l~hp---niv~l~~~~~~~~~~~lV~E~ 519 (754)
...-.+.+|.|..+.||+. ......|..|...|+.|... -+++++.+ +.-++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 3444567777777777761 11234688999999998532 34555543 234789999
Q ss_pred cCCCCh
Q 036419 520 LPNKSL 525 (754)
Q Consensus 520 ~~~gsL 525 (754)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.29 E-value=0.031 Score=58.79 Aligned_cols=33 Identities=24% Similarity=0.346 Sum_probs=28.2
Q ss_pred CCceeeCCCCCCceEEcCC----CceEEeeccCcccc
Q 036419 562 RLRVIHRDLKPSNILLDSN----MIPKISDFGLARMF 594 (754)
Q Consensus 562 ~~~iiH~Dlkp~NIlld~~----~~~kl~DFgla~~~ 594 (754)
...++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3469999999999999874 67899999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.17 E-value=0.041 Score=59.19 Aligned_cols=109 Identities=23% Similarity=0.266 Sum_probs=67.1
Q ss_pred cHHHHHHHHHHHHhhcc-CCeeeeeeeeeecCeeEEEEEecCCCChhhH-h----------------hcc--CCCCCCC-
Q 036419 481 GLEEFKNEIKLTAKLQH-RNLVRLLGCCVEQGENVLIYEYLPNKSLDSF-L----------------FDT--TKEGLLG- 539 (754)
Q Consensus 481 ~~~~~~~Ev~il~~l~h-pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~-l----------------~~~--~~~~~l~- 539 (754)
......+|.++++.|.. .-..++++++.++ +||||++|..|..- + +.. ...+...
T Consensus 96 ~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~ 171 (379)
T 3feg_A 96 GVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHW 171 (379)
T ss_dssp CHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 34566789999988863 2336667665442 99999998665421 0 000 0011122
Q ss_pred -HHHHHHHHHHHHH-------------------HHHHHH----hc-CCCceeeCCCCCCceEEcCC----CceEEeeccC
Q 036419 540 -WGARIRIIEGIAQ-------------------GLLYLH----QY-SRLRVIHRDLKPSNILLDSN----MIPKISDFGL 590 (754)
Q Consensus 540 -~~~~~~i~~qi~~-------------------~L~yLH----~~-~~~~iiH~Dlkp~NIlld~~----~~~kl~DFgl 590 (754)
+.++.++..++.. .+..|. .. ....++|+|+.+.|||++++ +.+.|+||..
T Consensus 172 l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~ 251 (379)
T 3feg_A 172 LFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEY 251 (379)
T ss_dssp HHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTT
T ss_pred HHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEeccc
Confidence 3455555544322 233332 21 23469999999999999876 7899999998
Q ss_pred ccc
Q 036419 591 ARM 593 (754)
Q Consensus 591 a~~ 593 (754)
+..
T Consensus 252 a~~ 254 (379)
T 3feg_A 252 SSY 254 (379)
T ss_dssp CEE
T ss_pred CCc
Confidence 864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.04 E-value=0.025 Score=62.02 Aligned_cols=39 Identities=26% Similarity=0.399 Sum_probs=27.4
Q ss_pred HHHHHHHHHHHhhccCCe-eeeeeeeeecCeeEEEEEecCCCCh
Q 036419 483 EEFKNEIKLTAKLQHRNL-VRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 483 ~~~~~Ev~il~~l~hpni-v~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
+.+.+|..+++.|...++ +++++.+.+ .+|+||++|.+|
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 566789999998864444 566665542 389999987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.77 E-value=0.089 Score=55.01 Aligned_cols=29 Identities=31% Similarity=0.373 Sum_probs=25.5
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4589999999999999 4 899999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.57 E-value=0.092 Score=57.99 Aligned_cols=36 Identities=19% Similarity=0.289 Sum_probs=25.8
Q ss_pred HHHHHHHHhhccCCe-eeeeeeeeecCeeEEEEEecCCCCh
Q 036419 486 KNEIKLTAKLQHRNL-VRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 486 ~~Ev~il~~l~hpni-v~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
.+|.++++.|...++ .++++.+. + .+||||++|..|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 589999999975444 56777663 2 259999998655
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=93.72 E-value=0.11 Score=55.47 Aligned_cols=30 Identities=23% Similarity=0.435 Sum_probs=25.2
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
..++|+|+++.|||++++. +.|+||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 4599999999999998655 89999998864
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=86.41 E-value=28 Score=34.71 Aligned_cols=86 Identities=15% Similarity=0.211 Sum_probs=49.8
Q ss_pred EEEEEeecCCeEEEeecCCCC--CCC----CCceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEec
Q 036419 63 LGIWYKQIPDTVVWVANRNSP--IIE----PNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDN 136 (754)
Q Consensus 63 l~iw~~~~~~tvVW~ANr~~p--~~~----~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~ 136 (754)
+.|| +.-...++|...+..+ +.+ +.+.+-++.++.+..+|.+|..+|............++.+.+||+++.+.
T Consensus 17 v~~~-d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 17 IAII-NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp EEEE-ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred EEEE-ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 4555 2223678899887642 111 23445555555566667789999998764222223456788899888753
Q ss_pred C-CC----CCCcCceecc
Q 036419 137 F-SR----SASEGSCLWQ 149 (754)
Q Consensus 137 ~-~~----~~~~~~~lWQ 149 (754)
. .. ...+++.+|+
T Consensus 96 ~~~~~v~~vd~~Gk~l~~ 113 (276)
T 3no2_A 96 GHPSTILEVNMKGEVLSK 113 (276)
T ss_dssp STTEEEEEECTTSCEEEE
T ss_pred CCCCEEEEEeCCCCEEEE
Confidence 2 00 0134667776
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.86 E-value=0.31 Score=52.73 Aligned_cols=30 Identities=27% Similarity=0.346 Sum_probs=25.5
Q ss_pred ceeeCCCCCCceEE------cCCCceEEeeccCccc
Q 036419 564 RVIHRDLKPSNILL------DSNMIPKISDFGLARM 593 (754)
Q Consensus 564 ~iiH~Dlkp~NIll------d~~~~~kl~DFgla~~ 593 (754)
.++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999999874
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=84.24 E-value=0.66 Score=37.64 Aligned_cols=35 Identities=26% Similarity=0.617 Sum_probs=28.4
Q ss_pred ccCChhHHHHHhhccceeeeeeecccCCCCcceecccc
Q 036419 362 KSMNLKECEAECLKNRTCRAYANSEVTGRGSGCLMWYG 399 (754)
Q Consensus 362 ~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~g 399 (754)
...++++|++.|+.+=.|.+|.|.. +...|.+..+
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~---~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNV---KSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEET---TTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEecc---CCCceEcccC
Confidence 3578999999999999999999953 3457987654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.48 E-value=2.2 Score=41.43 Aligned_cols=115 Identities=13% Similarity=0.141 Sum_probs=77.2
Q ss_pred ccCCeeeeeeeeeecCeeEEEEEecCC-CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 036419 496 QHRNLVRLLGCCVEQGENVLIYEYLPN-KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSN 574 (754)
Q Consensus 496 ~hpniv~l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~N 574 (754)
.||+++.. .+-.+.+.+.+.++.-+. .++.. | ..++...+++++.+|+....+++. -+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 57888766 455666676676765442 23322 3 237788999999999998866654 5788999999
Q ss_pred eEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 036419 575 ILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTR 647 (754)
Q Consensus 575 Illd~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~ 647 (754)
|+++.++.+++.=.|+-..+ +|. .++...=.-.+=+++..+++++..|.
T Consensus 110 L~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999776654432 221 01111112356678888898887764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 754 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-20 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 7e-20 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 5e-07 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-12 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 4e-12 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 5e-10 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 5e-09 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 5e-07 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 3e-65
Identities = 69/284 (24%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 459 NNFGVENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLV 501
V ++G G FG VYK + Q L+ FKNE+ + K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
+G + ++ ++ SL L E I I AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA--- 618
+IHRDLK +NI L ++ KI DFGLA + +++ G+ +M+PE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 619 IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678
+S +SDV++FG++L E ++ + + N N+ + + + + S +L +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQI--IFMVGRGYLSPDLSKVRSN 237
Query: 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLP 722
C K + C+++ +RP ++++ + +LP
Sbjct: 238 C------PKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-59
Identities = 70/272 (25%), Positives = 113/272 (41%), Gaps = 36/272 (13%)
Query: 459 NNFGVENKLGEGGFGPVYK----------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
+ ++G G FG V+ E+F E ++ KL H LV+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
L G C+EQ L++E++ + L +L + GL + + + +G+ YL +
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE--- 119
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF 622
VIHRDL N L+ N + K+SDFG+ R D+ +++ + SPE
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSR 178
Query: 623 FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682
+S KSDV+SFGVL+ E S + +NS + + L P+L
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGFRLYKPRL----- 226
Query: 683 YPIVKRYINVALLCVQENAADRPTMSEVISML 714
+ C +E DRP S ++ L
Sbjct: 227 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-58
Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 36/286 (12%)
Query: 459 NNFGVENKLGEGGFGPVYK----------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
+ +E KLG+G FG V+ E F E ++ KL+H LV+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
L + ++ EY+ SL FL L + + IA G+ Y+ +
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM-- 132
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF 622
+HRDL+ +NIL+ N++ K++DFGLAR+ +E + + +PE A++G
Sbjct: 133 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYGR 190
Query: 623 FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682
F+IKSDV+SFG+LL E + R N L + ++ +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL--------------DQVERGYRMPCP 236
Query: 683 YPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPG 728
+ ++ C ++ +RPT + + L + F + QPG
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-58
Identities = 74/276 (26%), Positives = 120/276 (43%), Gaps = 36/276 (13%)
Query: 459 NNFGVENKLGEGGFGPVYK----------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
+ +LG G FG V+ + F E L +LQH+ LVR
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
L Q +I EY+ N SL FL + L + + IA+G+ ++ +
Sbjct: 73 LYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE--- 127
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF 622
IHRDL+ +NIL+ + KI+DFGLAR+ +E + + +PE +G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGT 186
Query: 623 FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682
F+IKSDV+SFG+LL E ++ R + + + + +R + ++ P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEV-----IQNLERGYRMVRPD------ 233
Query: 683 YPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718
+ + LC +E DRPT + S+L + F
Sbjct: 234 -NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 5e-57
Identities = 64/274 (23%), Positives = 112/274 (40%), Gaps = 36/274 (13%)
Query: 459 NNFGVENKLGEGGFGPVYK----------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
+ +LG G FG V +EF E K+ L H LV+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
L G C +Q +I EY+ N L ++L + + + + + + + YL
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGF 622
+ +HRDL N L++ + K+SDFGL+R DE S+ + PE ++
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSK 177
Query: 623 FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682
FS KSD+++FGVL+ E S + + + + + E + L+
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYRP 223
Query: 683 YPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
+ ++ + C E A +RPT ++S + +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 1e-56
Identities = 68/273 (24%), Positives = 122/273 (44%), Gaps = 36/273 (13%)
Query: 459 NNFGVENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+ +++KLG G +G VY+ +EEF E + +++H NLV
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
+LLG C + +I E++ +L +L + + + + + I+ + YL
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE--- 132
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG 621
+ IHRDL N L+ N + K++DFGL+R+ GD ++ + +PE +
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYN 191
Query: 622 FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681
FSIKSDV++FGVLL E + + L+ + +EL++ + E
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGM--SPYPGIDLSQV------------YELLEKDYRMER 237
Query: 682 SYPIVKRYINVALLCVQENAADRPTMSEVISML 714
++ + C Q N +DRP+ +E+
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-56
Identities = 57/292 (19%), Positives = 101/292 (34%), Gaps = 42/292 (14%)
Query: 463 VENKLGEGGFGPVYK---------------SGQGLEEFKNEIKLTAKLQHRNLVRLLGCC 507
++ +G+G FG V++ + + EI T L+H N++ +
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 508 VEQGENV----LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ---- 559
+ L+ +Y + SL +L + I++ A GL +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 560 -YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF--GGDELQSNTKRIVGTYGYMSPE 616
+ + HRDLK NIL+ N I+D GLA D + VGT YM+PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 617 Y------AIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-----LTLLGHAWNLWK 665
H ++D+++ G++ E L + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 666 DDRSWELMDPKL-QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
+ + P + S ++ + C N A R T + L+
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-56
Identities = 62/303 (20%), Positives = 113/303 (37%), Gaps = 56/303 (18%)
Query: 457 ATNNFGVENKLGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKLQH 497
++F ++LG G G V+K + E+++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 498 RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557
+V G GE + E++ SLD L K G + ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
+ +++HRD+KPSNIL++S K+ DFG++ S VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPER 174
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677
+S++SD++S G+ L+E + + L L+ +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 678 QCEASYPIVKRY----------------------------INVALLCVQENAADRPTMSE 709
+ +SY + R + C+ +N A+R + +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 710 VIS 712
++
Sbjct: 295 LMV 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-56
Identities = 63/294 (21%), Positives = 107/294 (36%), Gaps = 43/294 (14%)
Query: 457 ATNNFGVEN-KLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAK 494
+N + + +LG G FG V + EE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 495 LQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGL 554
L + +VRL+G C + +L+ E L FL K + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 555 LYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR-IVGTYGYM 613
YL + +HRDL N+LL + KISDFGL++ G D+ + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 614 SPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673
+PE FS +SDV+S+GV + E LS + + K +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ--------------KPYKKMKGPEVMAFI 225
Query: 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQP 727
+ + E + C DRP V + + +L S +
Sbjct: 226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 5e-56
Identities = 65/308 (21%), Positives = 121/308 (39%), Gaps = 54/308 (17%)
Query: 450 SLASVSAATNNFG---------VENKLGEGGFGPVYK----------------------S 478
+ + A F +E +G G FG V +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 479 GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLL 538
+ +F +E + + H N++ L G + ++I E++ N SLDSFL +G
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQF 125
Query: 539 GWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598
+ ++ GIA G+ YL +HRDL NIL++SN++ K+SDFGL+R D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 599 LQSNTKRIVG---TYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLT 655
+G + +PE + F+ SDV+S+G+++ E +S
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE----------- 231
Query: 656 LLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715
+ + ++ + + L C Q++ RP ++++ L
Sbjct: 232 ---RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL- 287
Query: 716 NEFVNLPS 723
++ + P+
Sbjct: 288 DKMIRNPN 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-55
Identities = 65/271 (23%), Positives = 106/271 (39%), Gaps = 38/271 (14%)
Query: 459 NNFGVENKLGEGGFGPVYK--------------SGQGLEEFKNEIKLTAKLQHRNLVRLL 504
+ +G+G FG V + + F E + +L+H NLV+LL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 66
Query: 505 GCCVEQGENV-LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRL 563
G VE+ + ++ EY+ SL +L +LG ++ + + + YL
Sbjct: 67 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GN 122
Query: 564 RVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFF 623
+HRDL N+L+ + + K+SDFGL + E S + +PE F
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKF 177
Query: 624 SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASY 683
S KSDV+SFG+LL E S R + L + + + P +
Sbjct: 178 STKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV------ 229
Query: 684 PIVKRYINVALLCVQENAADRPTMSEVISML 714
V C +AA RP+ ++ L
Sbjct: 230 ------YEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (477), Expect = 1e-54
Identities = 68/301 (22%), Positives = 116/301 (38%), Gaps = 62/301 (20%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAK 494
NN +GEG FG V++ S +F+ E L A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 495 LQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL----------------- 537
+ N+V+LLG C L++EY+ L+ FL + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 538 ----LGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593
L ++ I +A G+ YL + + +HRDL N L+ NM+ KI+DFGL+R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS 653
+ +M PE + ++ +SDV+++GV+L E S ++
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL-QPYYGMAH 248
Query: 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713
++ + + L C + P N+ LC + ADRP+ + +
Sbjct: 249 EEVIYYVRD-----------GNILACPENCP--LELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 714 L 714
L
Sbjct: 296 L 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-54
Identities = 61/281 (21%), Positives = 107/281 (38%), Gaps = 44/281 (15%)
Query: 464 ENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+ +LG G FG V K +E E + +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
R++G C E +L+ E L+ +L + + I ++ ++ G+ YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD-ELQSNTKRIVGTYGYMSPEYAIH 620
+HRDL N+LL + KISDFGL++ D + +PE +
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 621 GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680
FS KSDV+SFGVL+ E S + + K +++ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGSEVTAMLEKGERMG 230
Query: 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNL 721
+ ++ LC + +RP + V L N + ++
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 2e-54
Identities = 75/315 (23%), Positives = 119/315 (37%), Gaps = 54/315 (17%)
Query: 461 FGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQHRN 499
F ++G G FG VY S + ++ E++ KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
++ GC + + L+ EY + D + L + G QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI 619
+IHRD+K NILL + K+ DFG A + + VGT +M+PE +
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184
Query: 620 ---HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676
G + K DV+S G+ +E K FN N+++ L H
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 677 LQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGFSSLKKSV 736
+ N C+Q+ DRPT + L + FV P ++++
Sbjct: 243 FR------------NFVDSCLQKIPQDRPTSEVL---LKHRFVLRERPPTVIMDLIQRTK 287
Query: 737 ETVARSMNRLTLSVM 751
+ V R ++ L M
Sbjct: 288 DAV-RELDNLQYRKM 301
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 5e-54
Identities = 64/287 (22%), Positives = 110/287 (38%), Gaps = 42/287 (14%)
Query: 459 NNFGVENKLGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKLQHRN 499
++ + LGEG +G V + E K EI + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
+V+ G E L EY L + + + R + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI 619
+ + HRD+KP N+LLD KISDFGLA +F + + ++ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 620 HG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678
F + DV+S G++L L+ + ++S W+ +D
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGEL-PWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQ 725
++ + + EN + R T+ ++ + + N P +
Sbjct: 238 A-----LLHK-------ILVENPSARITIPDI---KKDRWYNKPLKK 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 9e-54
Identities = 65/304 (21%), Positives = 106/304 (34%), Gaps = 61/304 (20%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAK 494
N LG G FG V E +E+K+ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 495 L-QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTK------------------- 534
L H N+V LLG C G LI+EY L ++L +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 535 -EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593
+L + + +A+G+ +L +HRDL N+L+ + KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS 653
D +M+PE G ++IKSDV+S+G+LL E S +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272
Query: 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713
++L+ + + + + + C ++ RP+ + S
Sbjct: 273 DANF------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 714 LTNE 717
L +
Sbjct: 321 LGCQ 324
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-53
Identities = 66/308 (21%), Positives = 122/308 (39%), Gaps = 57/308 (18%)
Query: 461 FGVENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQH 497
F LG G FG VYK S + +E +E + A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 498 RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557
++ RLLG C+ LI + +P L ++ + + +G + IA+G+ YL
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
R++HRDL N+L+ + KI+DFGLA++ G +E + + + +M+ E
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677
+H ++ +SDV+S+GV + E ++ ++ +++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEKGE 230
Query: 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT--------------NEFVNLPS 723
+ + + C +A RP E+I + +E ++LPS
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPS 290
Query: 724 PQQPGFSS 731
P F
Sbjct: 291 PTDSNFYR 298
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-53
Identities = 65/281 (23%), Positives = 109/281 (38%), Gaps = 46/281 (16%)
Query: 460 NFGVENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQH 497
+F +G G FG VY + +F E + H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 498 RNLVRLLGCCVE-QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLY 556
N++ LLG C+ +G +++ Y+ + L +F+ + + I +A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGM-- 143
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR--IVGTYGYMS 614
+ + +HRDL N +LD K++DFGLAR E S + +M+
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 615 PEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674
E F+ KSDV+SFGVLL E ++ + + L + R L+
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGA--PPY--PDVNTFDITVYLLQGRR---LLQ 255
Query: 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715
P+ V L C A RP+ SE++S ++
Sbjct: 256 PEY-------CPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 4e-53
Identities = 70/277 (25%), Positives = 108/277 (38%), Gaps = 42/277 (15%)
Query: 460 NFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRN 499
++ V +G G +G K + + +E+ L +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 500 LVRLLGCCVEQGENVL--IYEYLPNKSLDSFLFDTTKE-GLLGWGARIRIIEGIAQGLLY 556
+VR +++ L + EY L S + TKE L +R++ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 557 LHQYSR--LRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMS 614
H+ S V+HRDLKP+N+ LD K+ DFGLAR+ D S K VGT YMS
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMS 182
Query: 615 PEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674
PE ++ KSD++S G LL E + F S L K R
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM---PPFTAFSQKELAGKIREGKFRRIPYRYS 239
Query: 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVI 711
+L + + RP++ E++
Sbjct: 240 DELN------------EIITRMLNLKDYHRPSVEEIL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 6e-53
Identities = 66/299 (22%), Positives = 106/299 (35%), Gaps = 56/299 (18%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAK 494
N LG G FG V + E +E+K+ +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 495 L-QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFD---------------TTKEGLL 538
L H N+V LLG C G ++I EY L +FL E L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 539 GWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598
+ +A+G+ +L IHRDL NILL I KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLG 658
+M+PE + ++ +SDV+S+G+ L E S S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 659 HAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717
+ D + ++++ + + ++ C + RPT +++ ++ +
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 9e-53
Identities = 59/275 (21%), Positives = 114/275 (41%), Gaps = 49/275 (17%)
Query: 464 ENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRNLVRL 503
+ ++G G F VYK + + FK E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 504 LGCCVEQGEN----VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
+ VL+ E + + +L ++L + ++ I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 560 YSRLRVIHRDLKPSNILLDS-NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA 618
+ +IHRDLK NI + KI D GLA + S K ++GT +M+PE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEM- 184
Query: 619 IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNT-NSLTLLGHAWNLWKDDRSWELMDPKL 677
+ DV++FG+ +LE +S+ + N+ + + K ++ P++
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVIS 712
+ + C+++N +R ++ ++++
Sbjct: 243 K------------EIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 74/320 (23%), Positives = 128/320 (40%), Gaps = 61/320 (19%)
Query: 459 NNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKL-Q 496
N+ ++ +GEG FG V K S +F E+++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 497 HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFL-------------FDTTKEGLLGWGAR 543
H N++ LLG C +G L EY P+ +L FL + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 544 IRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT 603
+ +A+G+ YL Q + IHRDL NIL+ N + KI+DFGL+R E+
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 604 KRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL 663
+M+ E + ++ SDV+S+GVLL E +S T + L
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-TPYCGMTCAELYEKLPQG 242
Query: 664 WKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT------NE 717
++ ++ D ++ ++ C +E +RP+ ++++ L
Sbjct: 243 YRLEK-PLNCDDEV------------YDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 718 FVNLPSPQQPGFSSLKKSVE 737
+VN ++ ++ + S E
Sbjct: 290 YVNTTLYEKFTYAGIDCSAE 309
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-52
Identities = 67/289 (23%), Positives = 126/289 (43%), Gaps = 44/289 (15%)
Query: 459 NNFGVENKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKL 495
+ + +G G FG VYK + + +F E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 496 QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLL 555
H N++RL G + ++I EY+ N +LD FL + K+G + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 556 YLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT-KRIVGTYGYMS 614
YL + +HRDL NIL++SN++ K+SDFGL+R+ D + T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 615 PEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674
PE + F+ SDV+SFG+++ E ++ + +N + + ++
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM--------------KAIN 227
Query: 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPS 723
+ + + C Q+ A RP ++++S+L ++ + P
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL-DKLIRAPD 275
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 7e-52
Identities = 68/282 (24%), Positives = 103/282 (36%), Gaps = 44/282 (15%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAK 494
+ + KLG+G FG V + + +++F E+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 495 LQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGL 554
L HRNL+RL G ++ E P SL L +G G R +A+G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124
Query: 555 LYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG-GDELQSNTKRIVGTYGYM 613
YL R IHRDL N+LL + + KI DFGL R D+ + + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 614 SPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673
+PE FS SD + FGV L E + + + N +L + K+
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQIL---HKIDKEGERLPRP 237
Query: 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715
+ + NV + C DRPT + L
Sbjct: 238 E---------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-51
Identities = 66/291 (22%), Positives = 124/291 (42%), Gaps = 46/291 (15%)
Query: 458 TNNFGVENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRN 499
+ + + +LG+G FG VYK S + LE++ EI + A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
+V+LL + ++ E+ ++D+ + + E L + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI 619
++IHRDLK NIL + K++DFG++ + ++ +GT +M+PE +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 620 -----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674
+ K+DV+S G+ L+E + N + +L + K +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVL---LKIAKSEP------ 232
Query: 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQ 725
P L + + + + C+++N R T S++ L + FV + S +
Sbjct: 233 PTLAQPSRWS--SNFKDFLKKCLEKNVDARWTTSQL---LQHPFVTVDSNK 278
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 5e-51
Identities = 66/277 (23%), Positives = 105/277 (37%), Gaps = 51/277 (18%)
Query: 459 NNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQH 497
+F + LG+G FG VY + + E+++ + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 498 RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557
N++RL G + LI EY P ++ L K I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
H RVIHRD+KP N+LL S KI+DFG + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677
K D++S GVL E L K ++ + E
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP------------------PFEANTYQETYKRIS 217
Query: 678 QCEASYP--IVKRYINVALLCVQENAADRPTMSEVIS 712
+ E ++P + + ++ ++ N + RP + EV+
Sbjct: 218 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-50
Identities = 71/300 (23%), Positives = 121/300 (40%), Gaps = 43/300 (14%)
Query: 443 ETKTQGKSLASVSAATNNFGVENKLGEGGFGPVYK------------------SGQGLEE 484
E + +S+ SV + K+G+G G VY E
Sbjct: 4 EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63
Query: 485 FKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARI 544
NEI + + ++ N+V L + E ++ EYL SL + +T + G
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIA 119
Query: 545 RIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTK 604
+ Q L +LH +VIHRD+K NILL + K++DFG + QS
Sbjct: 120 AVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRS 174
Query: 605 RIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW 664
+VGT +M+PE + K D++S G++ +E + + + N N L L L
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRAL----YLI 228
Query: 665 KDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSP 724
+ + EL +P+ + R C+ + R + E+ L ++F+ + P
Sbjct: 229 ATNGTPELQNPEKLSAIFRDFLNR-------CLDMDVEKRGSAKEL---LQHQFLKIAKP 278
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 5e-48
Identities = 65/303 (21%), Positives = 111/303 (36%), Gaps = 50/303 (16%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAK 494
+ +LG+G FG VY+ S + EF NE + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 495 LQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLF-------DTTKEGLLGWGARIRII 547
++VRLLG + ++I E + L S+L + I++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 548 EGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIV 607
IA G+ YL+ + +HRDL N ++ + KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 608 GTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD 667
+MSPE G F+ SDV+SFGV+L E + + ++
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--------------QPYQGLSNE 242
Query: 668 RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQP 727
+ + + + +C Q N RP+ E+IS + E P ++
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM--EPGFREV 300
Query: 728 GFS 730
F
Sbjct: 301 SFY 303
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 61/282 (21%), Positives = 102/282 (36%), Gaps = 47/282 (16%)
Query: 459 NNFGVENKLGEGGFGPVYK----------------------SGQGLEEFKNEIKLTAKLQ 496
+ +GEG FG V++ S E+F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 497 HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLY 556
H ++V+L+G E +I E L SFL ++ L + I ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 123
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
L R +HRD+ N+L+ SN K+ DFGL+R + + +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPE 179
Query: 617 YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR--SWELMD 674
F+ SDV+ FGV + E L N+ + + +R
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----GRIENGERLPMPPNCP 235
Query: 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
P L ++ C + + RP +E+ + L+
Sbjct: 236 PTLY------------SLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-45
Identities = 64/296 (21%), Positives = 112/296 (37%), Gaps = 57/296 (19%)
Query: 459 NNFGVENKLGEGGFGPVYK--------------------------SGQGLEEFKNEIKLT 492
+ + LGEG FG V + + L + +E+++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 493 AKL-QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGL-------------L 538
+ +H+N++ LLG C + G +I EY +L +L GL L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 539 GWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598
+ +A+G+ YL + IHRDL N+L+ + + KI+DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLG 658
T +M+PE ++ +SDV+SFGVLL E + + + L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEEL- 246
Query: 659 HAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714
++L+ + + + C + RPT +++ L
Sbjct: 247 -----------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 7e-45
Identities = 55/276 (19%), Positives = 96/276 (34%), Gaps = 47/276 (17%)
Query: 460 NFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQHR 498
+F LGEG F V + E + ++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH 558
V+L + + Y N L ++ K G I L YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA 618
+IHRDLKP NILL+ +M +I+DFG A++ + Q+ VGT Y+SPE
Sbjct: 126 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 619 IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678
SD+++ G ++ + ++ ++ + + ++
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLP------------------PFRAGNEYLIFQKIIK 224
Query: 679 CEASYP--IVKRYINVALLCVQENAADRPTMSEVIS 712
E +P + ++ + +A R E+
Sbjct: 225 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 7e-45
Identities = 71/297 (23%), Positives = 104/297 (35%), Gaps = 55/297 (18%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIK-LTA 493
+ + LG G FG V + + +E+K L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 494 KLQHRNLVRLLGCCVEQGENVLI-YEYLPNKSLDSFLFDTTKE-------------GLLG 539
H N+V LLG C + G +++ E+ +L ++L E L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 540 WGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599
I +A+G+ +L + IHRDL NILL + KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGH 659
+M+PE ++I+SDV+SFGVLL E S S + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEE 245
Query: 660 AWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716
K+ D L C + RPT SE++ L N
Sbjct: 246 FCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 161 bits (409), Expect = 1e-44
Identities = 58/307 (18%), Positives = 114/307 (37%), Gaps = 53/307 (17%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNL 500
+++ + +LG G FG V++ E + EI+ + L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
V L + E V+IYE++ L + D + + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 561 SRLRVIHRDLKPSNILLDS--NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA 618
+H DLKP NI+ + + K+ DFGL + + K GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 619 IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678
+D++S GVL LS N + + + DD ++ + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVN----------LPSPQQPG 728
+++ + + R T+ + L + ++ +PS +
Sbjct: 258 -----DFIRK-------LLLADPNTRMTIHQA---LEHPWLTPGNAPGRDSQIPSSRYTK 302
Query: 729 FSSLKKS 735
K+
Sbjct: 303 IRDSIKT 309
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (391), Expect = 4e-42
Identities = 59/294 (20%), Positives = 106/294 (36%), Gaps = 54/294 (18%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------SGQGLEEFKNEIKLTAKLQHRNL 500
+ + + +LG G FG V++ KNEI + +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 501 VRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
+ L ++ E VLI E+L L + ++ + I + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 561 SRLRVIHRDLKPSNILLDSNMIP--KISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA 618
++H D+KP NI+ ++ KI DFGLA DE+ K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 619 IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678
+D+++ GVL LS + + E + +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS------------------PFAGEDDLETLQNVKR 242
Query: 679 CEASYP------IVKRYINVALLCVQENAADRPTMSEVISM--LTNEFVNLPSP 724
C+ + + + +Q+ R T+ + + L + NL S
Sbjct: 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 9e-41
Identities = 60/316 (18%), Positives = 116/316 (36%), Gaps = 49/316 (15%)
Query: 460 NFGVENKLGEGGFGPVYK-----------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
+ + LG G FG V++ G K EI + +HRN++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
L E V+I+E++ + + T L + + + + L +LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS--- 120
Query: 563 LRVIHRDLKPSNILLDS--NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIH 620
+ H D++P NI+ + + KI +FG AR + N + + Y +PE H
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQH 177
Query: 621 GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680
S +D++S G L+ LS F + ++ N+ + +++ K
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQII---ENIMNAEYTFDEEAFKEISI 232
Query: 681 ASYPIVKRYINVALLCVQENAADRPTMSEV---------ISMLTNEFVNLPSPQQPGFSS 731
+ V R + + R T SE I ++ + + ++ + +
Sbjct: 233 EAMDFVDR-------LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRY-YHT 284
Query: 732 LKKSVETVARSMNRLT 747
L K + S R++
Sbjct: 285 LIKKDLNMVVSAARIS 300
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 146 bits (369), Expect = 5e-40
Identities = 59/284 (20%), Positives = 111/284 (39%), Gaps = 45/284 (15%)
Query: 458 TNNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQ 496
++ + + LG GG V+ F+ E + A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 497 HRNLVRLLGCCVEQGEN----VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQ 552
H +V + + ++ EY+ +L + EG + I +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG-GDELQSNTKRIVGTYG 611
L + H + +IHRD+KP+NI++ + K+ DFG+AR + T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 612 YMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671
Y+SPE A +SDV+S G +L E L+ + F + +++ + ++D
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVA---YQHVREDPIPP 234
Query: 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRP-TMSEVISML 714
+ +V + + +N +R T +E+ + L
Sbjct: 235 SARHEGLSADLDAVVLK-------ALAKNPENRYQTAAEMRADL 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 6e-40
Identities = 63/293 (21%), Positives = 110/293 (37%), Gaps = 43/293 (14%)
Query: 458 TNNFGVENKLGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKLQHR 498
+ + +GEG +G V + EIK+ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH 558
N++ + + YL + + L+ K L + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNT-KRIVGTYGYMSPEY 617
V+HRDLKPSN+LL++ KI DFGLAR+ D + V T Y +PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 618 AIHGFFSIKS-DVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW----KDDRSWEL 672
++ KS D++S G +L E LS++ F + L L H + ++D + +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR--PIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 673 MDPKLQCEASYPIVKRY-------------INVALLCVQENAADRPTMSEVIS 712
S P + +++ + N R + + ++
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 8e-40
Identities = 50/287 (17%), Positives = 89/287 (31%), Gaps = 37/287 (12%)
Query: 459 NNFGVENKLGEGGFGPVYK----------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
N + + K+G G FG +Y + E K+ +Q +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
+ C +G+ ++ L SL+ + + + + + Y+H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 121
Query: 563 LRVIHRDLKPSNIL---LDSNMIPKISDFGLARMFGGDELQSN-----TKRIVGTYGYMS 614
IHRD+KP N L + I DFGLA+ + + K + GT Y S
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 615 PEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674
+ S + D+ S G +L+ + + + K E++
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNL 721
E C D+P S + + N F
Sbjct: 242 KGYPSEF--------ATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 147 bits (373), Expect = 1e-39
Identities = 64/276 (23%), Positives = 98/276 (35%), Gaps = 48/276 (17%)
Query: 459 NNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNE---IKLTAK 494
N+F V +G GGFG VY QG NE + L +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 495 LQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGL 554
+V + + I + + L L + G+ I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 555 LYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMS 614
++H V++RDLKP+NILLD + +ISD GLA F + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 615 PEYAIHGF-FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673
PE G + +D FS G +L + L R T + L +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSF 232
Query: 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSE 709
P+L+ +++ +Q + R
Sbjct: 233 SPELR-----SLLEG-------LLQRDVNRRLGCLG 256
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (368), Expect = 2e-39
Identities = 60/301 (19%), Positives = 111/301 (36%), Gaps = 45/301 (14%)
Query: 458 TNNFGVENKLGEGGFGPVYK-----SGQ--------------GLEEFKNEIKLTAKLQHR 498
+ + + LG G F V + + +NEI + K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH 558
N+V L G LI + + L + ++G R+I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 559 QYSRLRVIHRDLKPSNILL---DSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSP 615
++HRDLKP N+L D + ISDFGL++M + GT GY++P
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAP 178
Query: 616 EYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675
E +S D +S GV+ L F++ N L + K + ++
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKLF---EQILKAEYEFDSPYW 233
Query: 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM--LTNEFVNLPSPQQPGFSSLK 733
+++ ++ ++++ R T + + + + + Q +K
Sbjct: 234 DDISDSAKDFIRH-------LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIK 286
Query: 734 K 734
K
Sbjct: 287 K 287
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 143 bits (361), Expect = 8e-39
Identities = 53/287 (18%), Positives = 105/287 (36%), Gaps = 55/287 (19%)
Query: 460 NFGVENKLGEGGFGPVYK---------------------------SGQGLEEFKNEIKLT 492
N+ + LG G V + + E E+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 493 AKLQ-HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIA 551
K+ H N+++L L+++ + L +L T++ L +I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 552 QGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYG 611
+ + LH +L ++HRDLKP NILLD +M K++DFG + E + + GT
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174
Query: 612 YMSPEYA------IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWK 665
Y++PE H + + D++S GV++ L+ F++ + +L +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLRMIMS--- 229
Query: 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVIS 712
+ + ++ + R T E ++
Sbjct: 230 -------GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 142 bits (359), Expect = 2e-38
Identities = 37/289 (12%), Positives = 91/289 (31%), Gaps = 39/289 (13%)
Query: 459 NNFGVENKLGEGGFGPVYK----------------SGQGLEEFKNEIKLTAKLQHRNLVR 502
++ V ++GEG FG +++ + ++E + L +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 503 LLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSR 562
+ ++G + ++ L SL+ L + + + +H+
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE--- 119
Query: 563 LRVIHRDLKPSNILLDSNMIP-----KISDFGLARMFGGDELQSN-----TKRIVGTYGY 612
+++RD+KP N L+ + DFG+ + + + + K + GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672
MS + S + D+ + G + + L + + + + +
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQKYERIGEKKQS 234
Query: 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNL 721
+ C +Y++ P + + + L
Sbjct: 235 TPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-38
Identities = 58/277 (20%), Positives = 94/277 (33%), Gaps = 50/277 (18%)
Query: 459 NNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIK-LTAKLQ 496
+F + LG+G FG V+ +E E + L+ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 497 HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLY 556
H L + + + EYL L + I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
LH +++RDLK NILLD + KI+DFG+ + + ++NT GT Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 617 YAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676
+ ++ D +SFGVLL E L + + EL
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEEELFHSI 215
Query: 677 LQCEASYP--IVKRYINVALLCVQENAADRPTMSEVI 711
YP + K ++ + R + I
Sbjct: 216 RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 140 bits (354), Expect = 1e-37
Identities = 57/271 (21%), Positives = 102/271 (37%), Gaps = 52/271 (19%)
Query: 459 NNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQH 497
+F + LG G FG V+ + +E +E + + + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 498 RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557
++R+ G + + +I +Y+ L S L + + + L YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYL 120
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
H +I+RDLKP NILLD N KI+DFG A+ + T + GT Y++PE
Sbjct: 121 H---SKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677
++ D +SFG+L+ E L+ + D + + + L
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT------------------PFYDSNTMKTYEKIL 214
Query: 678 QCEASYP--IVKRYINVALLCVQENAADRPT 706
E +P + ++ + + + R
Sbjct: 215 NAELRFPPFFNEDVKDLLSRLITRDLSQRLG 245
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-37
Identities = 66/319 (20%), Positives = 115/319 (36%), Gaps = 53/319 (16%)
Query: 460 NFGVENKLGEGGFGPVYK-----SGQ---------GLEEFKNEIKLTAKLQHRNLVRLLG 505
++ +G G FG VY+ SG+ E+++ KL H N+VRL
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 506 CCVEQGEN------VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
GE L+ +Y+P + + L + + + L Y+H
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 560 YSRLRVIHRDLKPSNILLDSN-MIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA 618
+ HRD+KP N+LLD + + K+ DFG A+ E + + + Y +PE
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELI 194
Query: 619 IHGF-FSIKSDVFSFGVLLLETLSSKRSTRFFNTNS--------LTLLGHAWNLWKDDRS 669
++ DV+S G +L E L + F +S + +LG + +
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ---PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 670 WELMDPKLQCEASYPIVKRY--------INVALLCVQENAADRPTMSEV-----ISMLTN 716
+ K ++P K + I + ++ R T E L +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311
Query: 717 EFVNLPS-PQQPGFSSLKK 734
V LP+ P +
Sbjct: 312 PNVKLPNGRDTPALFNFTT 330
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-36
Identities = 67/296 (22%), Positives = 113/296 (38%), Gaps = 48/296 (16%)
Query: 457 ATNNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKL 495
A + ++GEG +G V+K E+ + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 496 ---QHRNLVRLLGCCVEQGENVLIYEYLPNKSLDS---FLFDTTKEGLLGWGARIRIIEG 549
+H N+VRL C + L + +D D E + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 550 IAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGT 609
+ +GL +LH RV+HRDLKP NIL+ S+ K++DFGLAR++ Q +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 610 YGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD--- 666
Y +PE + ++ D++S G + E K F ++ + LG ++
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL--FRGSSDVDQLGKILDVIGLPGE 236
Query: 667 ---DRSWELMDPKLQCEASYPIVKRYINVALL-------CVQENAADRPTMSEVIS 712
R L +++ PI K ++ L C+ N A R + +S
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 70/304 (23%), Positives = 107/304 (35%), Gaps = 52/304 (17%)
Query: 465 NKLGEGGFGPVYK-----------------------SGQGLEEFKNEIKLTAKLQHRNLV 501
+ LGEG F VYK EIKL +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 502 RLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS 561
LL + L+++++ +L + QGL YLHQ+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 562 RLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI-H 620
++HRDLKP+N+LLD N + K++DFGLA+ FG V T Y +PE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGA 175
Query: 621 GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS--------LTLLGHAWNLWKDDRSWEL 672
+ + D+++ G +L E L F +S LG D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV---PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 673 MDPKLQCEASYPIVKRYINVA-----LL--CVQENAADRPTMSEVISM--LTNEFVNLPS 723
+ P+ + L+ N R T ++ + M +N P
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
Query: 724 PQQP 727
Q P
Sbjct: 293 CQLP 296
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 4e-36
Identities = 68/305 (22%), Positives = 111/305 (36%), Gaps = 51/305 (16%)
Query: 460 NFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHRN 499
NF K+GEG +G VYK + EI L +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
+V+LL + + L++E+L D + + + + QGL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE-YA 618
+ RV+HRDLKP N+L+++ K++DFGLAR FG V T Y +PE
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175
Query: 619 IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLL-----------GHAWNLWKDD 667
++S D++S G + E ++ + F + + L W
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL--FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 668 RSWELMDPKLQCEASYPIVKRYINVAL----LCVQENAADRPTMSEVISMLTNEF---VN 720
++ PK + +V + + R + L + F V
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA---LAHPFFQDVT 290
Query: 721 LPSPQ 725
P P
Sbjct: 291 KPVPH 295
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 9e-36
Identities = 59/298 (19%), Positives = 99/298 (33%), Gaps = 63/298 (21%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAK 494
+ + V LG GGFG VY E+ L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 495 LQ--HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQ 552
+ ++RLL VLI E T+ G L + +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGLARMFGGDELQSNTKRIVGTYG 611
+ + H V+HRD+K NIL+D N K+ DFG + + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRV 174
Query: 612 YMSPEY-AIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670
Y PE+ H + + V+S G+LL + + F + + ++ S
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEII---RGQVFFRQRVSS 229
Query: 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV-NLPSPQQP 727
E +++ C+ +DRPT E+ + ++ ++ PQ+
Sbjct: 230 ECQH----------LIRW-------CLALRPSDRPTFEEI---QNHPWMQDVLLPQET 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 134 bits (338), Expect = 1e-35
Identities = 63/287 (21%), Positives = 109/287 (37%), Gaps = 41/287 (14%)
Query: 459 NNFGVENKLGEGGFGPVYK-------------------SGQGLEEFKNEIKLTAKLQHRN 499
+ K+GEG +G VYK EI + +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 500 LVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ 559
+V+L + VL++E+L EG L + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 560 YSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI 619
RV+HRDLKP N+L++ KI+DFGLAR FG + + T Y +P+ +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 620 -HGFFSIKSDVFSFGVLLLETLSSK-------------RSTRFFNTNSLTLLGHAWNLWK 665
+S D++S G + E ++ R R T + + L K
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 666 DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVIS 712
D ++ + +P + + I++ ++ + R T + +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-35
Identities = 58/282 (20%), Positives = 105/282 (37%), Gaps = 49/282 (17%)
Query: 459 NNFGVENKLGEGGFGPVYK------------------------SGQGLEEFKNEIKLTAK 494
+ + +LG G F V K G E+ + E+ + +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 495 LQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGL 554
+QH N++ L + + +LI E + L FL ++ L ++ I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG- 125
Query: 555 LYLHQYSRLRVIHRDLKPSNILLDSNMIP----KISDFGLARMFGGDELQSNTKRIVGTY 610
++ L++ H DLKP NI+L +P KI DFGLA K I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 611 GYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670
+++PE + +++D++S GV+ LS F L N+ + +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETL---ANVSAVNYEF 235
Query: 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVIS 712
E + ++R + ++ R T+ + +
Sbjct: 236 EDEYFSNTSALAKDFIRR-------LLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 1e-34
Identities = 63/317 (19%), Positives = 121/317 (38%), Gaps = 43/317 (13%)
Query: 463 VENKLGEGGFGPVYK-----SGQ--------GLEEFKNEIKLTAKL-QHRNLVRLLGCC- 507
LG G G V + + + + + E++L + Q ++VR++
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 508 ---VEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLR 564
+ +++ E L L S + D + I++ I + + YLH +
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHS---IN 131
Query: 565 VIHRDLKPSNILLDS---NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHG 621
+ HRD+KP N+L S N I K++DFG A+ + T Y++PE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPE 188
Query: 622 FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681
+ D++S GV++ L F++ + L + + R + P +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAIS---PGMKTRIRMGQYEFPNPEWSE 243
Query: 682 SYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV--NLPSPQQPGFSS--LKKSVE 737
VK I ++ R T++E + + ++ + PQ P +S LK+ E
Sbjct: 244 VSEEVKMLIR---NLLKTEPTQRMTITEF---MNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 738 TVARSMNRLTLSVMDAR 754
+T ++ R
Sbjct: 298 RWEDVKEEMTSALATMR 314
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 60/289 (20%), Positives = 101/289 (34%), Gaps = 43/289 (14%)
Query: 459 NNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHR 498
+ K+GEG +G V+K EI L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 499 NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLH 558
N+VRL + L++E+ F G + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 559 QYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYA 618
V+HRDLKP N+L++ N K+++FGLAR F G ++ + +V +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 619 IHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL--------WKDDRSW 670
+S D++S G + E ++ R F + L + L W
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 671 ELMDPKLQCEASYPIVKRYINVA-----LL--CVQENAADRPTMSEVIS 712
P A+ +V + LL ++ N R + E +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 4e-33
Identities = 53/301 (17%), Positives = 107/301 (35%), Gaps = 53/301 (17%)
Query: 459 NNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHR 498
+ + K+G+G FG V+K EIK+ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 499 NLVRLLGCCVEQGENV--------LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGI 550
N+V L+ C + L++++ + K R+++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 551 AQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKR--IVG 608
GL Y+H+ +++HRD+K +N+L+ + + K++DFGLAR F + + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 609 TYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLS------SKRSTRFFNTNSLTLLGHAW 661
T Y PE + + D++ G ++ E + S
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 662 NLWKDDRSWELMDPKLQCEASYPIVKRYINVALL----------CVQENAADRPTMSEVI 711
+W + ++EL + + VK + + + + A R + +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 712 S 712
+
Sbjct: 304 N 304
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 5e-32
Identities = 44/207 (21%), Positives = 72/207 (34%), Gaps = 29/207 (14%)
Query: 459 NNFGVENKLGEGGFGPVYK---------------------SGQGLEEFKNEIKLTAKLQH 497
N+F LG+G FG V + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 498 RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557
L L + EY L L + R R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFY--GAEIVSAL 118
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
V++RD+K N++LD + KI+DFGL + D + K GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 618 AIHGFFSIKSDVFSFGVLLLETLSSKR 644
+ D + GV++ E + +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-30
Identities = 65/327 (19%), Positives = 120/327 (36%), Gaps = 50/327 (15%)
Query: 459 NNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHR 498
+ +G G +G V S + E++L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 499 NLVRLLGCCVEQGENVLIYE-YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYL 557
N++ LL + YL + + L K LG ++ + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 558 HQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEY 617
H +IHRDLKP N+ ++ + KI DFGLAR + S V T Y +PE
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189
Query: 618 AI-HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL---------TLLGHAWNLWKDD 667
+ ++ D++S G ++ E ++ K + + T + D
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
Query: 668 RSWELMD--PKLQCEASYPIVKRYINVAL----LCVQENAADRPTMSEVISMLTNEFV-N 720
+ M P+L+ + I+ +A+ + +A R T E L + + +
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA---LAHPYFES 306
Query: 721 LPSPQ-QPGFSSLKKSVETVARSMNRL 746
L + +P S + V R+++
Sbjct: 307 LHDTEDEPQVQKYDDSFDDVDRTLDEW 333
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (299), Expect = 6e-30
Identities = 52/261 (19%), Positives = 95/261 (36%), Gaps = 37/261 (14%)
Query: 443 ETKTQGKSLASVSAATNNFGVENKLGEGGFGPVYK---------------------SGQG 481
+ + ++ + +A + F LG G FG V +
Sbjct: 25 DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ 84
Query: 482 LEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWG 541
+E NE ++ + LV+L + ++ EY+ + S L + G
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEP 141
Query: 542 ARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQS 601
I YLH L +I+RDLKP N+L+D +++DFG A+ +
Sbjct: 142 HARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KG 193
Query: 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAW 661
T + GT ++PE + ++ D ++ GVL+ E + FF + +
Sbjct: 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP--FFADQPIQIYEKIV 251
Query: 662 NL---WKDDRSWELMDPKLQC 679
+ + S +L D
Sbjct: 252 SGKVRFPSHFSSDLKDLLRNL 272
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (297), Expect = 7e-30
Identities = 51/296 (17%), Positives = 103/296 (34%), Gaps = 54/296 (18%)
Query: 459 NNFGVENKLGEGGFGPVYK---------------SGQGLEEFKNEIKLTAKLQ-HRNLVR 502
+++ + KLG G + V++ ++ K EIK+ L+ N++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 503 LLGCCVEQGEN--VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560
L + L++E++ N L + I + L Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS- 147
Query: 561 SRLRVIHRDLKPSNILLDS-NMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAI 619
+ ++HRD+KP N+++D + ++ D+GLA + + + V + + PE +
Sbjct: 148 --MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV---RVASRYFKGPELLV 202
Query: 620 -HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL------LGHAWNLWKDDRSWEL 672
+ + D++S G +L + K + N L LG D+
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 673 MDPKLQCEASYPIVKRYINVALL----------------CVQENAADRPTMSEVIS 712
+DP+ KR+ ++ + R T E +
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-27
Identities = 56/279 (20%), Positives = 98/279 (35%), Gaps = 47/279 (16%)
Query: 459 NNFGVENKLGEGGFGPVYK-------------------------SGQGLEEFKNEIKLTA 493
NF + LG G +G V+ + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 494 KLQHR-NLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQ 552
++ LV L + + LI +Y+ L + L + + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH------EVQIYVGE 137
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
+L L +L +I+RD+K NILLDSN ++DFGL++ F DE GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEY 196
Query: 613 MSPEYAIHGF--FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670
M+P+ G D +S GVL+ E L+ F + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS--PFTVDGEKNSQ---AEISRRILKS 251
Query: 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSE 709
E P+ + +++R + ++ R
Sbjct: 252 EPPYPQEMSALAKDLIQR-------LLMKDPKKRLGCGP 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-25
Identities = 63/327 (19%), Positives = 110/327 (33%), Gaps = 48/327 (14%)
Query: 458 TNNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQH 497
+ + +G G +G V S + E++L ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 498 RNLVRLLGCCVEQGENVLI-YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLY 556
N++ LL YL + + L + K L +I I +GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 557 LHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPE 616
+H +IHRDLKPSN+ ++ + KI DFGLAR T + +
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEI 189
Query: 617 YAIHGFFSIKSDVFSFGVLLLETLSSK-------------RSTRFFNTNSLTLLGHAWNL 663
++ D++S G ++ E L+ + R T LL +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 664 WKDDRSWELMDPKLQCEASYPIVKRYINVALL--CVQENAADRPTMSEVISMLTNE-FVN 720
+ L A+ I + V LL + ++ R T ++ L + F
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA---LAHAYFAQ 306
Query: 721 LPSP-QQPGFSSLKKSVETVARSMNRL 746
P +P +S E+ ++
Sbjct: 307 YHDPDDEPVADPYDQSFESRDLLIDEW 333
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-25
Identities = 46/211 (21%), Positives = 77/211 (36%), Gaps = 38/211 (18%)
Query: 459 NNFGVENKLGEGGFGPVYK--------------------SGQGLEEFKNEIKLTAKLQHR 498
+ +G G G V + + E+ L + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 499 NLVRLLGCCVEQG------ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQ 552
N++ LL Q + L+ E + + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGY 612
G+ +LH +IHRDLKPSNI++ S+ KI DFGLAR G + V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 613 MSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
+PE + + D++S G ++ E + K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.8 bits (242), Expect = 2e-22
Identities = 36/212 (16%), Positives = 72/212 (33%), Gaps = 33/212 (15%)
Query: 463 VENKLGEGGFGPVY-----------------KSGQGLEEFKNEIKLTAKLQHRNLVRLLG 505
+ KLG G F V+ E ++EIKL ++ + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 506 CCVEQGENVLIYEYLPNKSL-------------DSFLFDTTKEGLLGWGARIRIIEGIAQ 552
+L + + L + + +I + +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 553 GLLYLHQYSRLRVIHRDLKPSNILLDSN-MIPKISDFGLARMFGGDELQSNTKRIVGTYG 611
GL Y+H+ R +IH D+KP N+L++ + +A + + + T
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 612 YMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK 643
Y SPE + + +D++S L+ E ++
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.0 bits (212), Expect = 7e-20
Identities = 33/212 (15%), Positives = 62/212 (29%), Gaps = 58/212 (27%)
Query: 462 GVENKLGEGGFGPVYK---------------------------SGQGLEEFKNEIKLTAK 494
+ +GEG V+ G F +A+
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 495 LQHRNLVRLLGCCV----EQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGI 550
+ R L +L G V N ++ E + K L +++ I
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV----------RVENPDEVLDMI 112
Query: 551 AQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTY 610
+ + + ++H DL N+L+ I DF + G + + +R V
Sbjct: 113 LEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV--- 165
Query: 611 GYMSPEYAIHGFF----SIKSDVFSFGVLLLE 638
I +F + D+ S +L+
Sbjct: 166 ------RNIITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 83.1 bits (205), Expect = 7e-20
Identities = 20/119 (16%), Positives = 48/119 (40%), Gaps = 14/119 (11%)
Query: 35 IRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTIS 94
+ +GE + + ++ + L ++ T VW +N + +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGILG-KKGCKAVLQ 58
Query: 95 NNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDY 153
++GN V+ + ++W+S++ R N V L + GN+++ + +W + Y
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---------DIWSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 68.4 bits (167), Expect = 2e-14
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 65 IWYKQIP-DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVA 123
I Y D + + L++ + NLV+ + + +WS+NT+ K A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD-RDDRVWSTNTAGKGTGCRA 70
Query: 124 QLLDTGNLIVRDNFSRSASEGSCLWQSFD--YPSDTLL 159
L G + V N + +W S + +
Sbjct: 71 VLQPNGRMDVLTN------QNIAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 46.8 bits (111), Expect = 5e-07
Identities = 18/65 (27%), Positives = 24/65 (36%), Gaps = 2/65 (3%)
Query: 71 PDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGN 130
D VW N + NG + +L N A+W+S SR A V L N
Sbjct: 52 RDDRVWSTNTAGKG--TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 109
Query: 131 LIVRD 135
L +
Sbjct: 110 LAIYG 114
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 62.7 bits (152), Expect = 1e-12
Identities = 16/83 (19%), Positives = 29/83 (34%), Gaps = 11/83 (13%)
Query: 71 PDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGN 130
+ +W N + +G LV++ N +W S + KA + V L N
Sbjct: 47 NNNPIWATNTGGLG--NGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRN 104
Query: 131 LIVRDNFSRSASEGSCLWQSFDY 153
+++ G LW +
Sbjct: 105 VVIY---------GDALWATQTV 118
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 61.2 bits (148), Expect = 4e-12
Identities = 22/110 (20%), Positives = 40/110 (36%), Gaps = 19/110 (17%)
Query: 44 SSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILN 103
+ F L ++ D +W N + L++ +GNLV+ N
Sbjct: 17 NYGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGLS--RSCFLSMQTDGNLVVYN 66
Query: 104 LTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDY 153
+N IW+SNT + N V L N+++ + W + +
Sbjct: 67 PSNKPIWASNTGGQNGNYVCILQKDRNVVIYG---------TDRWATGTH 107
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 55.6 bits (133), Expect = 5e-10
Identities = 25/132 (18%), Positives = 48/132 (36%), Gaps = 20/132 (15%)
Query: 25 ADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPI 84
+D + + G + + + Y + VW + N
Sbjct: 1 SDRLNSGHQ-LDTGGSLAEG--GYLFIIQNDCNL------VLYD--NNRAVWASGTNGKA 49
Query: 85 IEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEG 144
L + N+GNLVI + + AIW+SNT+R+ N L N+++ D +
Sbjct: 50 --SGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYD------NSN 100
Query: 145 SCLWQSFDYPSD 156
+ +W + +
Sbjct: 101 NAIWATHTNVGN 112
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 52.6 bits (126), Expect = 5e-09
Identities = 15/88 (17%), Positives = 35/88 (39%), Gaps = 9/88 (10%)
Query: 65 IWY-KQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVA 123
I + + + + + T+ ++ NLV+ + ++ +W+SNT+ A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGAT-GCRA 60
Query: 124 QLLDTGNLIVRDNFSRSASEGSCLWQSF 151
L G L++ ++ + W S
Sbjct: 61 VLQSDGLLVILT------AQNTIRWSSG 82
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 46.9 bits (111), Expect = 5e-07
Identities = 17/66 (25%), Positives = 23/66 (34%), Gaps = 3/66 (4%)
Query: 71 PDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGN 130
D VW +N + ++G LVIL N WSS T N V L
Sbjct: 43 SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRT 99
Query: 131 LIVRDN 136
+ +
Sbjct: 100 VTIYGP 105
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 36.5 bits (84), Expect = 0.002
Identities = 10/56 (17%), Positives = 18/56 (32%), Gaps = 5/56 (8%)
Query: 62 YLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRK 117
+ +T+ W + N L + + + I +W S TS K
Sbjct: 65 DGLLVILTAQNTIRWSSGTKGS--IGNYVLVLQPDRTVTIYG---PGLWDSGTSNK 115
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 754 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.82 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.81 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.8 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.75 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.67 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.56 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.49 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.35 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.07 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.9 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.86 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.67 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.48 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.99 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.12 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.25 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.14 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.58 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 90.91 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=402.60 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=196.2
Q ss_pred hhhcCccccceeccCCCcceeec-----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKS-----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~-----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
...++|++.++||+|+||+||++ ....++|++|++++++++|||||++++++.+ ...++|||
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 34578999999999999999972 2345789999999999999999999998754 56899999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++|+|.++|.. ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999964 3346999999999999999999999988 9999999999999999999999999998876544
Q ss_pred ccccccccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIH---GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.........||+.|||||++.. ..|+.++|||||||++|||++|+.||......... ..... .+. ..+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~-~~~~~----~~~----~~p 229 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-IFMVG----RGY----LSP 229 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHHHH----HTS----CCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH-HHHHh----cCC----CCC
Confidence 4344556789999999999864 35899999999999999999999998754332211 11111 110 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLP 722 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 722 (754)
.. .......++.+.+++.+||+.||++|||+++|+++|+.+...+|
T Consensus 230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11 11122345678999999999999999999999999998765554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=400.13 Aligned_cols=237 Identities=25% Similarity=0.349 Sum_probs=194.3
Q ss_pred hcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
.++|++.++||+|+||+||++. ...+++.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 3579999999999999999721 224568999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++|+|.++|. ..+.+++.++..++.||++||.|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999994 3456999999999999999999999998 9999999999999999999999999999875444
Q ss_pred ccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
........+||+.|||||++.+..+ +.++|||||||++|||++|+.||.............. ....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-----~~~~-------- 224 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKKT-------- 224 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH-----TTCT--------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh-----cCCC--------
Confidence 3344556789999999999988775 6889999999999999999999875543332211111 0000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
........++.+.+++.+||+.||++|||++|+++|
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011112335678899999999999999999999775
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-46 Score=395.24 Aligned_cols=247 Identities=28% Similarity=0.415 Sum_probs=202.4
Q ss_pred hHhhhhcCccccceeccCCCcceeec-----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 453 SVSAATNNFGVENKLGEGGFGPVYKS-----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 453 ~~~~~~~~y~~~~~lG~G~fg~Vyk~-----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
+++...++|++.++||+|+||+||++ ....+++.+|++++++++|||||+++++|.+++..++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 44556678999999999999999982 2346789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++|+|.+++... ....+++..+..++.||++||.|||+++ |+||||||+||||++++.+||+|||+|+...
T Consensus 91 v~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999999653 3457999999999999999999999988 9999999999999999999999999999875
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
..... ......|++.|||||++.+..|+.|+|||||||++|||++|..|+...... ..+... ...+
T Consensus 167 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~~~~----i~~~-------- 232 (287)
T d1opja_ 167 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYEL----LEKD-------- 232 (287)
T ss_dssp SSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHH----HHTT--------
T ss_pred CCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HHHHHH----HhcC--------
Confidence 54332 223456899999999999999999999999999999999987775422221 111111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.........++++.+++.+||+.||++|||+++|+++|+...
T Consensus 233 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 233 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111112234567899999999999999999999999998763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=389.54 Aligned_cols=229 Identities=27% Similarity=0.374 Sum_probs=192.8
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||+||++. ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999721 23467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|+|.+++.. .+.+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999954 345999999999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||....... ...... . .. .
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~i~---~-~~------~-- 221 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRIS---R-VE------F-- 221 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHH---T-TC------C--
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--HHHHHH---c-CC------C--
Confidence 2 335689999999999999999999999999999999999999986433221 111111 1 10 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..+...++.+.+++.+||+.||++|||++|+++|
T Consensus 222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 0111234678899999999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-47 Score=403.36 Aligned_cols=243 Identities=27% Similarity=0.433 Sum_probs=198.5
Q ss_pred hhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeec
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQ 510 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~ 510 (754)
...++|++.++||+|+||+||++. ...+.+.+|++++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 445789999999999999999732 1235688999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChhhHhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCC
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTK--------------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDL 570 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dl 570 (754)
+..++||||+++|+|.++|..... ...+++..++.++.||++||+|||+++ |+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 999999999999999999975432 235899999999999999999999988 999999
Q ss_pred CCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcc
Q 036419 571 KPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFF 649 (754)
Q Consensus 571 kp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~ 649 (754)
||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++ |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987655443333445678999999999999999999999999999999997 89998654
Q ss_pred cCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 650 NTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
..... +.... ..+ .....+...++.+.+|+.+||+.||++|||++||+++|.
T Consensus 271 ~~~~~-~~~~~----~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDAN-FYKLI----QNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHH-HHHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHH-HHHHH----hcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 43321 11111 111 011112234567899999999999999999999999995
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=390.89 Aligned_cols=235 Identities=24% Similarity=0.348 Sum_probs=195.2
Q ss_pred hcCccccceeccCCCcceeec------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
.++|++.++||+|+||+||++ ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 458999999999999999982 22457799999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++|+|.+++.+ +.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999998853 35999999999999999999999998 99999999999999999999999999998754332
Q ss_pred cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQC 679 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 679 (754)
.....+||+.|||||++.+..|+.++|||||||++|+|++|+.||........ ... ...... .. .
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~---~~~~~~-~~-----~-- 236 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYL---IATNGT-PE-----L-- 236 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHH---HHHHCS-CC-----C--
T ss_pred --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--HHH---HHhCCC-CC-----C--
Confidence 23456899999999999999999999999999999999999999864332211 111 111110 00 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 680 EASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 680 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......++.+.+++.+||+.||++|||+.|+++|-
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp 271 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 11123457789999999999999999999998763
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-46 Score=397.33 Aligned_cols=240 Identities=26% Similarity=0.448 Sum_probs=186.8
Q ss_pred hcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.++|++.++||+|+||+||++. ...++|.+|++++++++|||||++++++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3578889999999999999721 124678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++|+|.+++.. ..+.+++.++..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 105 v~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998854 3456999999999999999999999988 9999999999999999999999999999775
Q ss_pred CCccccc---ccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 596 GDELQSN---TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 596 ~~~~~~~---~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
....... .....||+.|||||.+.+..++.++|||||||++|||++ |+.||...... .+..... ...
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~---~~~---- 250 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIE---QDY---- 250 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH---TTC----
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHH---cCC----
Confidence 4332211 223467899999999999999999999999999999998 88887644322 1111111 111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
..+.....++.+.+++.+||+.||++|||+.+|+++|+..
T Consensus 251 ------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 251 ------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112223457789999999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=385.72 Aligned_cols=239 Identities=28% Similarity=0.458 Sum_probs=185.8
Q ss_pred cCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 459 NNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
++|++.++||+|+||+||++ ....++|.+|++++++++|||||+++++|.+++..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 57999999999999999982 23467899999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
|+|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++........ .
T Consensus 85 g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~ 158 (263)
T d1sm2a_ 85 GCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-S 158 (263)
T ss_dssp CBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-e
Confidence 999999864 3356899999999999999999999988 999999999999999999999999999877543322 2
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEAS 682 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 682 (754)
.....||+.|+|||++.+..|+.|+|||||||++|||+++..|+..... ...+...... .. ....+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~---~~---~~~~p------- 224 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDIST---GF---RLYKP------- 224 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-HHHHHHHHHH---TC---CCCCC-------
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-HHHHHHHHHh---cC---CCCCc-------
Confidence 3346789999999999999999999999999999999996555432211 1122211111 10 11111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 683 YPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 683 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
...++++.+++.+||+.||++|||+++|+++|+.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 12346788999999999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=400.84 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=193.3
Q ss_pred hhhcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
...++|++.++||+|+||+||++. ...+++.+|+++|++++|||||+++++|.++.+.++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 346789999999999999999821 2346789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY-SRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
|||+++|+|.+++.+ .+.+++..+..++.||++||.|||+. + |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 83 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999964 34699999999999999999999974 6 9999999999999999999999999999753
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc---------
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD--------- 666 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 666 (754)
.. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||....................
T Consensus 157 ~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 157 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred CC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 22 23456899999999999999999999999999999999999999976543321111000000000
Q ss_pred ---------------Ccccccc----CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 667 ---------------DRSWELM----DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 667 ---------------~~~~~l~----d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
....+.. ............+.++.+++.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000 0000000011134678899999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=388.08 Aligned_cols=255 Identities=29% Similarity=0.451 Sum_probs=200.2
Q ss_pred hhhhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
+...++|++.++||+|+||.||++ ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 344578999999999999999982 2345789999999999999999999999854 56899999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+++|+|..++.... ...+++.+++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 92 y~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 92 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred ecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999999986532 345999999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
. .......||+.|+|||++.++.++.++|||||||++|||++|..|+....... ....... .+ ..
T Consensus 168 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~i~----~~---------~~ 232 (285)
T d1fmka3 168 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVE----RG---------YR 232 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHH----TT---------CC
T ss_pred c-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHH----hc---------CC
Confidence 2 22334678999999999999999999999999999999999877654332211 1111111 11 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCCCCCCc
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVNLPSPQQPGF 729 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~ 729 (754)
.+.....++++.+++.+||+.||++|||+++|+++|+..+...+++.+|+.
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~~ 283 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCCC
Confidence 112223456789999999999999999999999999988777777777753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=391.49 Aligned_cols=238 Identities=27% Similarity=0.416 Sum_probs=182.0
Q ss_pred cCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee--cCeeEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE--QGENVLI 516 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~--~~~~~lV 516 (754)
++|++.+.||+|+||+||++. ...+.+.+|++++++++|||||++++++.+ +...++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 679999999999999999821 234668899999999999999999999865 4568999
Q ss_pred EEecCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 517 YEYLPNKSLDSFLFDTT-KEGLLGWGARIRIIEGIAQGLLYLHQYSR--LRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~--~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
|||+++|+|.+++.+.. ....+++..++.++.||+.||.|||+.+. .+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999996543 34579999999999999999999998652 3599999999999999999999999999998
Q ss_pred cCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
+.... .......||+.|||||++.+..|+.++|||||||++|||++|+.||......+ +.... ......
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~~i----~~~~~~--- 232 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKI----REGKFR--- 232 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHH----HHTCCC---
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HHHHH----HcCCCC---
Confidence 75432 22345789999999999999999999999999999999999999986543221 11111 111110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..+...++.+.+++.+||+.||++|||++|+++|
T Consensus 233 ------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 233 ------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1112245678999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-46 Score=385.72 Aligned_cols=245 Identities=30% Similarity=0.429 Sum_probs=196.8
Q ss_pred HhhhhcCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++...++|++.++||+|+||+||++ ....++|.+|++++++++|||||++++++.+ +..++||
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 3445678999999999999999982 2346789999999999999999999998754 5679999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|+|.+++.... ...+++..++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 87 Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence 9999999999885432 235899999999999999999999988 999999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
... ......||+.|||||++.+..++.++|||||||++|||++|..|+...... ........ .+ ..+
T Consensus 163 ~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~i~----~~-----~~~-- 229 (272)
T d1qpca_ 163 EYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLE----RG-----YRM-- 229 (272)
T ss_dssp CEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHH----TT-----CCC--
T ss_pred ccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHHHHH----hc-----CCC--
Confidence 332 233467899999999999999999999999999999999977664322211 11111111 11 000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
..+...++.+.+++.+||+.||++||||++|+++|+..+
T Consensus 230 --~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 230 --VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 111223467899999999999999999999999998654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=383.45 Aligned_cols=231 Identities=24% Similarity=0.381 Sum_probs=183.6
Q ss_pred ccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee----cCeeEEE
Q 036419 461 FGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE----QGENVLI 516 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~----~~~~~lV 516 (754)
|++.++||+|+||+||++. ...+.+.+|++++++++|||||++++++.+ +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3677899999999999821 134678999999999999999999999865 3467999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc-CCCceEEeeccCccccC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD-SNMIPKISDFGLARMFG 595 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld-~~~~~kl~DFgla~~~~ 595 (754)
|||+++|+|.+++.. ...+++..+..++.||++||.|||+++ .+|+||||||+||||+ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999954 346999999999999999999999875 4599999999999996 57899999999998654
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
... ....+||+.|||||++.+ .++.++|||||||++|||++|+.||....... .+.... ..+.. .+
T Consensus 167 ~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~~~i----~~~~~----~~ 232 (270)
T d1t4ha_ 167 ASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRV----TSGVK----PA 232 (270)
T ss_dssp TTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHH----TTTCC----CG
T ss_pred CCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HHHHHH----HcCCC----Cc
Confidence 332 335689999999998765 69999999999999999999999986433221 111111 11100 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.. +...++++.+++.+||+.||++|||++|+++|
T Consensus 233 ~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11 11223568899999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=389.71 Aligned_cols=232 Identities=24% Similarity=0.313 Sum_probs=189.7
Q ss_pred cCccccceeccCCCcceeec---------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~---------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||+||++ ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999972 123467899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999999854 356999999999999999999999998 999999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.........+||+.|||||++.+..|+.++|||||||++|||++|+.||...+... +.... .. ... .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i---~~-~~~------~- 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--IFQKI---IK-LEY------D- 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---HT-TCC------C-
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--HHHHH---Hc-CCC------C-
Confidence 44444456789999999999999999999999999999999999999987543221 11111 11 100 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVIS 712 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 712 (754)
.+...++.+.+++.+||+.||++|||++|+++
T Consensus 229 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11123467889999999999999999998644
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=387.98 Aligned_cols=236 Identities=25% Similarity=0.407 Sum_probs=193.2
Q ss_pred hcCccccceeccCCCcceeec------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKS------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
.+.|++.++||+|+||+||++ ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 457999999999999999982 23457789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+++|+|.+++.+. .+.+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 91 ~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 91 CAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 9999999998543 346999999999999999999999998 9999999999999999999999999998653221
Q ss_pred cccccccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 600 QSNTKRIVGTYGYMSPEYAI-----HGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
......+||+.|||||++. +..|+.++|||||||++|||++|+.||......+. .... .... .
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~i---~~~~-~----- 232 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLKI---AKSE-P----- 232 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHH---HHSC-C-----
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHHH---HcCC-C-----
Confidence 1233568999999999984 45689999999999999999999999865443321 1111 1111 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
+. .......++.+.+++.+||+.||++|||++|+++|
T Consensus 233 ~~--~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 PT--LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CC--CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CC--CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 01112345678999999999999999999999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=376.64 Aligned_cols=237 Identities=28% Similarity=0.433 Sum_probs=197.8
Q ss_pred cCccccceeccCCCcceeec----------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 459 NNFGVENKLGEGGFGPVYKS----------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~----------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
++|++.++||+|+||+||++ ....++|++|++++++++||||++++++|.+++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 68999999999999999982 23568899999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
|+|.+++... ...+++..+.+++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 84 g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~ 157 (258)
T d1k2pa_ 84 GCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-S 157 (258)
T ss_dssp EEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-C
T ss_pred CcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-e
Confidence 9999998543 346899999999999999999999988 999999999999999999999999999877554332 2
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
.....||+.|+|||++.+..++.|+|||||||++|||++ |+.||......+ +.... ....+ +..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i---~~~~~---~~~------- 222 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHI---AQGLR---LYR------- 222 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHH---HTTCC---CCC-------
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHH---HhCCC---CCC-------
Confidence 334679999999999999999999999999999999998 788876543322 11111 11111 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 682 SYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
+...++.+.+++.+||+.||++|||+++|+++|..
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11234678999999999999999999999999964
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=384.19 Aligned_cols=242 Identities=27% Similarity=0.462 Sum_probs=189.0
Q ss_pred hcCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
...|++.+.||+|+||+||++. ...++|.+|++++++++|||||++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4578899999999999999731 12357899999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||++++++.+++... ...+++.++..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 86 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999999988543 356999999999999999999999988 999999999999999999999999999976
Q ss_pred CCCccc-ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 595 GGDELQ-SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 595 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
...... .......||+.|||||++.+..++.++|||||||++|||+++..|+...... ..+.... ..+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i----~~~------ 229 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAI----NDG------ 229 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHH----HTT------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHH----hcc------
Confidence 543221 2233457899999999999999999999999999999999977665432221 1111111 111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
...+.....++.+.+|+.+||+.||++||||.+|+++|+...
T Consensus 230 ---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 230 ---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp ---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 111122234567899999999999999999999999998753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-45 Score=388.53 Aligned_cols=236 Identities=24% Similarity=0.315 Sum_probs=179.9
Q ss_pred hhcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
..+.|++.+.||+|+||+||++. ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45779999999999999999821 12356789999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc---CCCceEEeeccCcccc
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD---SNMIPKISDFGLARMF 594 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld---~~~~~kl~DFgla~~~ 594 (754)
||+++|+|.++|.. .+.+++.++..++.||+.||.|||+.+ |+||||||+|||+. +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999953 456999999999999999999999998 99999999999994 5789999999999876
Q ss_pred CCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....... ..... ....
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i---~~~~------- 225 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFEQI---LKAE------- 225 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHH---HTTC-------
T ss_pred cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHH---hccC-------
Confidence 5432 2335689999999999999999999999999999999999999986433221 11111 1110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
...........++.+.+++.+||+.||++|||++|+++|
T Consensus 226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 011111222345778999999999999999999999997
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=382.75 Aligned_cols=231 Identities=27% Similarity=0.395 Sum_probs=186.6
Q ss_pred ceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEecCC
Q 036419 465 NKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYLPN 522 (754)
Q Consensus 465 ~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 522 (754)
++||+|+||+||++. ...+++.+|++++++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999731 123578999999999999999999999854 567899999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc-cc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL-QS 601 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~-~~ 601 (754)
|+|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999954 346999999999999999999999988 99999999999999999999999999997754332 22
Q ss_pred cccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCC
Q 036419 602 NTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCE 680 (754)
Q Consensus 602 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 680 (754)
......||+.|||||.+.+..++.++|||||||++|||++ |+.||......+ +.... ....+ ..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~~~i---~~~~~----------~~ 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAML---EKGER----------MG 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH---HTTCC----------CC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HHHHH---HcCCC----------CC
Confidence 2345678999999999999999999999999999999998 899986543221 11111 11111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 681 ASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 681 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.+...++.+.+|+.+||+.||++|||+++|+++|+..
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1122356788999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=382.51 Aligned_cols=240 Identities=25% Similarity=0.405 Sum_probs=194.6
Q ss_pred hcCccccc-eeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 458 TNNFGVEN-KLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 458 ~~~y~~~~-~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.++|.+.+ +||+|+||+||++. ...++|.+|++++++++|||||++++++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 35677777 59999999999831 124678999999999999999999999864 56899
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
||||+++|+|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999999843 3356999999999999999999999988 9999999999999999999999999999876
Q ss_pred CCcc-cccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 596 GDEL-QSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 596 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.... ........||+.|||||++.+..++.++|||||||++|||++ |+.||......+ +.... ..+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i----~~~~~---- 230 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFI----EQGKR---- 230 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHH----HTTCC----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHH----HcCCC----
Confidence 5332 223345678999999999999999999999999999999998 899987543221 11111 11111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
...+...++.+.+|+.+||+.||++|||+.+|++.|+..+
T Consensus 231 -----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 231 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 0111234567889999999999999999999999998644
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-45 Score=389.38 Aligned_cols=230 Identities=30% Similarity=0.462 Sum_probs=188.8
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV 516 (754)
.+.|++.++||+|+||+||++. ...+.+.+|++++++++|||||++++++.+++..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 3469999999999999999721 1235688999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++|+|..++.. .+.+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 94 ~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999999877643 356999999999999999999999998 99999999999999999999999999986543
Q ss_pred CcccccccccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIH---GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||....... .. ....... .
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--~~---~~i~~~~-~---- 231 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL---YHIAQNE-S---- 231 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH---HHHHHSC-C----
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--HH---HHHHhCC-C----
Confidence 234679999999999864 468999999999999999999999986433221 11 1111111 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
+.+ .....++.+.+++.+||+.||++|||++|+++|
T Consensus 232 -~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 -PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 011 112234678999999999999999999999886
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.9e-44 Score=386.82 Aligned_cols=236 Identities=24% Similarity=0.322 Sum_probs=194.3
Q ss_pred hcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
-++|++.+.||+|+||.||++. ...+.+++|++++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3589999999999999999822 2346788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc--CCCceEEeeccCccccCCC
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD--SNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld--~~~~~kl~DFgla~~~~~~ 597 (754)
+++|+|.++|.. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999854 3356999999999999999999999998 99999999999995 4678999999999987544
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||......+ ....... .. ...
T Consensus 180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~i~~---~~-------~~~ 244 (350)
T d1koaa2 180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRNVKS---CD-------WNM 244 (350)
T ss_dssp SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH---TC-------CCS
T ss_pred cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHh---CC-------CCC
Confidence 32 334689999999999999999999999999999999999999986443221 1111110 00 000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
........++.+.+++.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112345678999999999999999999999997
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-45 Score=383.56 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=201.5
Q ss_pred hhhHhhhhcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhccCCeeeeeee
Q 036419 451 LASVSAATNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQHRNLVRLLGC 506 (754)
Q Consensus 451 ~~~~~~~~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~hpniv~l~~~ 506 (754)
+.+++...++|++.++||+|+||+||++.. ..++|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 345566778999999999999999997421 24679999999999999999999999
Q ss_pred eeecCeeEEEEEecCCCChhhHhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 036419 507 CVEQGENVLIYEYLPNKSLDSFLFDTTK---------------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRV 565 (754)
Q Consensus 507 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i 565 (754)
+......++||||+++|+|.++|..... ...+++..++.|+.||+.||+|||+.+ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 9999999999999999999999964321 234899999999999999999999988 9
Q ss_pred eeCCCCCCceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCC-
Q 036419 566 IHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKR- 644 (754)
Q Consensus 566 iH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~- 644 (754)
+||||||+|||||.++.+||+|||+++...............||+.|+|||.+.+..|+.|+|||||||++|||++|..
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999987755444444456778999999999999999999999999999999999964
Q ss_pred CCCcccCCchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 645 STRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 645 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
|+......+ ....+ ..+... ..+...++++.+|+.+||+.||++||||.||+++|+.+
T Consensus 242 p~~~~~~~e--~~~~v----~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAHEE--VIYYV----RDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCHHH--HHHHH----HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCHHH--HHHHH----HcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 554332221 11111 111111 11122346789999999999999999999999999876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=380.08 Aligned_cols=249 Identities=28% Similarity=0.405 Sum_probs=191.8
Q ss_pred hhHhhhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeee
Q 036419 452 ASVSAATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGC 506 (754)
Q Consensus 452 ~~~~~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~ 506 (754)
.+++...++|++.++||+|+||.||++. ...+++.+|++++.++ +|+||++++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3445556789999999999999999732 1235677888888887 58899999999
Q ss_pred eeec-CeeEEEEEecCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCC
Q 036419 507 CVEQ-GENVLIYEYLPNKSLDSFLFDTTK-------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKP 572 (754)
Q Consensus 507 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp 572 (754)
+.+. ...++||||+++|+|.++|..... ...+++..+..++.||++||.|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 8654 568999999999999999975322 245899999999999999999999998 99999999
Q ss_pred CceEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCC-CCCcccC
Q 036419 573 SNILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKR-STRFFNT 651 (754)
Q Consensus 573 ~NIlld~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~-p~~~~~~ 651 (754)
+||||++++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+++.. |+.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997765544444556789999999999999999999999999999999999754 5554332
Q ss_pred CchhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 652 NSLTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.. .+.... ..+.. + ......++++.+++.+||+.||++|||++||++||+.+
T Consensus 243 ~~-~~~~~~----~~~~~-----~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 243 DE-EFCRRL----KEGTR-----M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp SH-HHHHHH----HHTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH-HHHHHH----hcCCC-----C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22 111111 11111 1 11122346789999999999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=382.88 Aligned_cols=238 Identities=25% Similarity=0.402 Sum_probs=191.6
Q ss_pred cCccccceeccCCCcceeecc-----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVL 515 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~l 515 (754)
.+|++.++||+|+||+||++. ...+++.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999721 2356799999999999999999999999865 5678
Q ss_pred EEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccC
Q 036419 516 IYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFG 595 (754)
Q Consensus 516 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~ 595 (754)
++||+.+++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999999988653 456999999999999999999999988 9999999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccC
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMD 674 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 674 (754)
............||+.|||||++.++.|+.++|||||||++|||++ |..|+....... +..... ...+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~---~~~~------ 231 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILE---KGER------ 231 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHH---HTCC------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHH---cCCC------
Confidence 5544444455679999999999999999999999999999999998 677776543322 111111 1110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 675 PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 675 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
...+...++.+.+++.+||+.||++|||+.+|+++|+..
T Consensus 232 ----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 111223446789999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=377.56 Aligned_cols=236 Identities=23% Similarity=0.302 Sum_probs=193.5
Q ss_pred hhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE 512 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~ 512 (754)
..++|++.+.||+|+||+||++. ...+.+++|++++++++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34789999999999999999821 135789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC----ceEEeec
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM----IPKISDF 588 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~----~~kl~DF 588 (754)
.++||||+++|+|.++|.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999954 346999999999999999999999998 99999999999998776 4999999
Q ss_pred cCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
|+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ...... . ..
T Consensus 162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~---~-~~ 232 (293)
T d1jksa_ 162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANVS---A-VN 232 (293)
T ss_dssp TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH---T-TC
T ss_pred hhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--HHHHHH---h-cC
Confidence 99998754332 334678999999999999999999999999999999999999986543221 111110 0 00
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
...........+..+.+++.+||+.||++|||++|+++|
T Consensus 233 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 ------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000011234678899999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.1e-44 Score=384.64 Aligned_cols=236 Identities=24% Similarity=0.306 Sum_probs=194.3
Q ss_pred hcCccccceeccCCCcceeecc------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
.++|++.++||+|+||.||++. ...+.+++|++++++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3579999999999999999832 1345788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc--CCCceEEeeccCccccCCC
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD--SNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld--~~~~~kl~DFgla~~~~~~ 597 (754)
+++|+|.+++.. ....+++.++..|+.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999888743 3346999999999999999999999998 99999999999998 6789999999999987654
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||....... ...... ... ...
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~i~---~~~-------~~~ 247 (352)
T d1koba_ 183 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVK---RCD-------WEF 247 (352)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHH---HCC-------CCC
T ss_pred Cc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH---hCC-------CCC
Confidence 32 334679999999999999999999999999999999999999986443222 111111 000 011
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
........++.+.+++.+||+.||.+|||+.|+++|
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122345678999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=376.19 Aligned_cols=240 Identities=24% Similarity=0.334 Sum_probs=185.0
Q ss_pred hhhcCccccceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee
Q 036419 456 AATNNFGVENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 456 ~~~~~y~~~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~ 513 (754)
...++|++.+.||+|+||.||++. ...+.+.+|++++++++|||||++++++. ++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345789999999999999999731 12467899999999999999999999986 4678
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999998754 3456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccc
Q 036419 594 FGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWEL 672 (754)
Q Consensus 594 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 672 (754)
+..... .......||+.|+|||++.+..++.++|||||||++|||++ |..|+......+ +.... ....+.
T Consensus 158 ~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i---~~~~~~--- 228 (273)
T d1mp8a_ 158 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRI---ENGERL--- 228 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH---HTTCCC---
T ss_pred ccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHH---HcCCCC---
Confidence 654332 22345678999999999999999999999999999999998 788876544332 11111 111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 673 MDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 673 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+.+...++.+.+++.+||+.||++|||+++|+++|+.+
T Consensus 229 -------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11223456789999999999999999999999999764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-44 Score=381.00 Aligned_cols=231 Identities=22% Similarity=0.252 Sum_probs=193.7
Q ss_pred cCccccceeccCCCcceeec---------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKS---------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~---------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.+.||+|+||.||++ ....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999972 223567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999954 356899999999999999999999998 999999999999999999999999999976433
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||....... +.... . ....
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~i---~-~~~~-------- 222 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELI---L-MEEI-------- 222 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---H-HCCC--------
T ss_pred C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--HHHHH---h-cCCC--------
Confidence 2 22345789999999999999999999999999999999999999987544322 11111 0 1100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRPT-----MSEVISM 713 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 713 (754)
..+...++++.+++.+||+.||.+||+ ++++++|
T Consensus 223 --~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 111223467889999999999999994 8899886
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-44 Score=376.46 Aligned_cols=246 Identities=26% Similarity=0.424 Sum_probs=197.6
Q ss_pred hhhhcCccccceeccCCCcceeecc--------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeee
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSG--------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCC 507 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~--------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~ 507 (754)
....++|++.+.||+|+||.||++. ....++.+|+..+.++ +|||||+++++|
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3455789999999999999999732 1246788899999999 799999999999
Q ss_pred eecCeeEEEEEecCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 036419 508 VEQGENVLIYEYLPNKSLDSFLFDTTK-------------EGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSN 574 (754)
Q Consensus 508 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~N 574 (754)
.++...++||||+++|+|.++|..... ...+++.+++.++.||+.||+|||+.+ |+||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence 999999999999999999999975432 246899999999999999999999998 9999999999
Q ss_pred eEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCc
Q 036419 575 ILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNS 653 (754)
Q Consensus 575 Illd~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~ 653 (754)
||++.++.+||+|||+++...............||+.|+|||.+.++.|+.|+|||||||++|||++ |..|+......
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~- 244 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 244 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-
Confidence 9999999999999999998766554445566789999999999999999999999999999999998 57776533321
Q ss_pred hhHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 654 LTLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.+. ..+..+... ..+...++++.+++.+||+.||++|||+.||+++|+.+.
T Consensus 245 -~~~----~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 -ELF----KLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -HHH----HHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHH----HHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 111 111111110 111223467899999999999999999999999998763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-43 Score=374.49 Aligned_cols=228 Identities=25% Similarity=0.320 Sum_probs=191.6
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|++.++||+|+||+||++. ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 579999999999999999832 23467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999998854 445889999999999999999999998 999999999999999999999999999976533
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||....... ..... .... .
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i---~~~~-~-------- 218 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TYEKI---LNAE-L-------- 218 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHH---HHCC-C--------
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH--HHHHH---HcCC-C--------
Confidence 235789999999999999999999999999999999999999986543221 11111 1110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISM 713 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 713 (754)
..+...++.+.+++.+||+.||.+|| |++++++|
T Consensus 219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11122346788999999999999996 99999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=369.23 Aligned_cols=239 Identities=28% Similarity=0.414 Sum_probs=187.5
Q ss_pred hcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGEN 513 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~ 513 (754)
.++|++.+.||+|+||.||++. ...++|.+|++++++++|||||++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3679999999999999999731 124678999999999999999999999965 467
Q ss_pred EEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 514 VLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 514 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
++||||++++++.+++... .+.+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 8999999999999988653 345999999999999999999999988 99999999999999999999999999998
Q ss_pred cCCCccc-ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 594 FGGDELQ-SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 594 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
+...... .......|+..|+|||++.+..++.++|||||||++|||++ |+.||......+ ..... ...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~i---~~~~~--- 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKI---DKEGE--- 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH---HTSCC---
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHHHH---HhCCC---
Confidence 7554322 22334568889999999999999999999999999999998 899976443222 11111 11110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTN 716 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 716 (754)
..+.....+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus 233 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111112334678899999999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-44 Score=367.97 Aligned_cols=236 Identities=26% Similarity=0.397 Sum_probs=184.5
Q ss_pred hcCccccceeccCCCcceeec--------------cccHHHHHHHHHHHHhhccCCeeeeeeeeee-cCeeEEEEEecCC
Q 036419 458 TNNFGVENKLGEGGFGPVYKS--------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVE-QGENVLIYEYLPN 522 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~--------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~-~~~~~lV~E~~~~ 522 (754)
-++|++.++||+|+||.||++ ....+++.+|++++++++||||++++++|.+ .+..++||||+++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 457899999999999999972 2345789999999999999999999999865 4668999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccccc
Q 036419 523 KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQSN 602 (754)
Q Consensus 523 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~~~ 602 (754)
|+|.++|.... ...+++..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----- 156 (262)
T d1byga_ 86 GSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 156 (262)
T ss_dssp EEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-----
Confidence 99999996532 234899999999999999999999987 999999999999999999999999999865432
Q ss_pred ccccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCchhHhHhhhhhhccCccccccCcccCCCC
Q 036419 603 TKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLS-SKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQCEA 681 (754)
Q Consensus 603 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 681 (754)
.....+|..|+|||++.+..+++++|||||||++|||++ |+.|+....... +..... .+ ...+.
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i~----~~---------~~~~~ 221 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVE----KG---------YKMDA 221 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHT----TT---------CCCCC
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHH----cC---------CCCCC
Confidence 234568899999999999999999999999999999998 566655433222 211111 11 01111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 682 SYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 682 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
....++++.+++.+||+.||++|||+.+|+++|+.+
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 223346788999999999999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=373.93 Aligned_cols=240 Identities=28% Similarity=0.422 Sum_probs=193.6
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeeecCeeEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~~~~~~lV 516 (754)
++|++.++||+|+||+||++. ...+++.+|++++.++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 688999999999999999721 1345789999999999 799999999999999999999
Q ss_pred EEecCCCChhhHhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCce
Q 036419 517 YEYLPNKSLDSFLFDT-------------TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIP 583 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~ 583 (754)
|||+++|+|.++|+.. .....+++..+.+++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999653 23467999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCC-CCCcccCCchhHhHhhhh
Q 036419 584 KISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKR-STRFFNTNSLTLLGHAWN 662 (754)
Q Consensus 584 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~ 662 (754)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. |+..... ..+...+.
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--~~~~~~i~- 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLP- 240 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHGG-
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--HHHHHHHH-
Confidence 999999998654321 2234578999999999999999999999999999999999875 4543221 11111111
Q ss_pred hhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 036419 663 LWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFV 719 (754)
Q Consensus 663 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 719 (754)
... ........++++.+++.+||+.||++||||++|+++|+....
T Consensus 241 --~~~----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 241 --QGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp --GTC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hcC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111 011122345679999999999999999999999999987644
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=373.99 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=200.7
Q ss_pred hhhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhh-ccCCeeeeeeeeee
Q 036419 455 SAATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKL-QHRNLVRLLGCCVE 509 (754)
Q Consensus 455 ~~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l-~hpniv~l~~~~~~ 509 (754)
+...++|++.++||+|+||.||++. ....++.+|+.+++++ +|||||++++++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 3455789999999999999999732 1245688999999999 69999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTT---------------KEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSN 574 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~N 574 (754)
+...++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccc
Confidence 999999999999999999997543 2236899999999999999999999998 9999999999
Q ss_pred eEEcCCCceEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch
Q 036419 575 ILLDSNMIPKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL 654 (754)
Q Consensus 575 Illd~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~ 654 (754)
||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++++.|+........
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999987655444445567899999999999999999999999999999999996555432222221
Q ss_pred hHhHhhhhhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 655 TLLGHAWNLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 655 ~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.+.... ..+ .........++.+.+|+.+||+.||++|||+++|+++|+..
T Consensus 256 ~~~~~i----~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 256 KFYKMI----KEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHH----HHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH----hcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111111 111 11111122346789999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.7e-43 Score=366.24 Aligned_cols=242 Identities=26% Similarity=0.371 Sum_probs=187.5
Q ss_pred hcCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCe----
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGE---- 512 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~---- 512 (754)
.++|++.+.||+|+||+||++. ...+.+.+|++++++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4789999999999999999821 124578999999999999999999999987643
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+++++|.+++.. .+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999998854 346999999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCc-ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccc
Q 036419 593 MFGGDE-LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWE 671 (754)
Q Consensus 593 ~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (754)
...... ........+||+.|||||++.+..++.++|||||||++|||++|+.||......+. ..........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~~~~~~~~-- 232 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----AYQHVREDPI-- 232 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHCCCC--
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-----HHHHHhcCCC--
Confidence 654322 22234456899999999999999999999999999999999999999864432221 1111111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcc
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRP-TMSEVISMLTNE 717 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 717 (754)
.........++.+.+++.+||+.||++|| |++++++.|...
T Consensus 233 -----~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 -----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -----CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 01111123456789999999999999999 899999888653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-42 Score=373.17 Aligned_cols=228 Identities=21% Similarity=0.268 Sum_probs=192.1
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIY 517 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~ 517 (754)
++|+++++||+|+||.||++. ...+.+.+|++++++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 579999999999999999832 23456889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCC
Q 036419 518 EYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 518 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~ 597 (754)
||+.+|+|..++... +.+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999999543 46999999999999999999999998 999999999999999999999999999977532
Q ss_pred cccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCccc
Q 036419 598 ELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKL 677 (754)
Q Consensus 598 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 677 (754)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...... .+..... ... .
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~---~~~-~-------- 255 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYEKIV---SGK-V-------- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH---HCC-C--------
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--HHHHHHh---cCC-C--------
Confidence 23568999999999999999999999999999999999999998643321 1111111 110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036419 678 QCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISM 713 (754)
Q Consensus 678 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 713 (754)
......++.+.+++.+||+.||.+|+ |++++++|
T Consensus 256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 01122456788999999999999994 99999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.4e-43 Score=363.45 Aligned_cols=235 Identities=21% Similarity=0.297 Sum_probs=192.4
Q ss_pred hcCccccceeccCCCcceeeccc---------------------------cHHHHHHHHHHHHhhc-cCCeeeeeeeeee
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ---------------------------GLEEFKNEIKLTAKLQ-HRNLVRLLGCCVE 509 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~---------------------------~~~~~~~Ev~il~~l~-hpniv~l~~~~~~ 509 (754)
.++|++.+.||+|+||+||++.+ ..+.+.+|++++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999998211 1245889999999997 9999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeecc
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFG 589 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFg 589 (754)
++..++||||+++|+|.++|.. .+.+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999954 346999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIH------GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL 663 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 663 (754)
+++.+.... .....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .....
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--~~~~i--- 227 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--MLRMI--- 227 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---
T ss_pred heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--HHHHH---
Confidence 999875432 2334689999999999863 357889999999999999999999987543222 11111
Q ss_pred hccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 664 WKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 664 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.... . ..........++++.+++.+||+.||++|||++||++|
T Consensus 228 ~~~~-~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGN-Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTC-C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCC-C------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1110 0 01111122355789999999999999999999999876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-42 Score=376.30 Aligned_cols=232 Identities=27% Similarity=0.324 Sum_probs=187.2
Q ss_pred cCccccceeccCCCcceeeccc---------------------cHHHHHHH---HHHHHhhccCCeeeeeeeeeecCeeE
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNE---IKLTAKLQHRNLVRLLGCCVEQGENV 514 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~E---v~il~~l~hpniv~l~~~~~~~~~~~ 514 (754)
++|++.+.||+|+||.||++.+ ....+.+| +++++.++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5899999999999999997321 12234444 66677778999999999999999999
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+||||+++|+|.++|.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999954 356899999999999999999999998 999999999999999999999999999977
Q ss_pred CCCcccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCcccccc
Q 036419 595 GGDELQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELM 673 (754)
Q Consensus 595 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 673 (754)
.... ....+||+.|||||++.. ..|+.++|||||||++|||++|+.||........... .....
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--~~~~~--------- 222 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMTL--------- 222 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH--HHHSS---------
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhcc---------
Confidence 5432 345689999999999875 5789999999999999999999999876544332111 00000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 036419 674 DPKLQCEASYPIVKRYINVALLCVQENAADRPT-----MSEVISM 713 (754)
Q Consensus 674 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 713 (754)
... .......++.+.+++.+||+.||++||| ++|+++|
T Consensus 223 ~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 TMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SCC--CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred cCC--CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 000 0111123467899999999999999999 7999876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-43 Score=369.90 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=200.4
Q ss_pred HhhhhcCccccceeccCCCcceeecc------------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee
Q 036419 454 VSAATNNFGVENKLGEGGFGPVYKSG------------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE 509 (754)
Q Consensus 454 ~~~~~~~y~~~~~lG~G~fg~Vyk~~------------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~ 509 (754)
++...++|++.++||+|+||+||++. .....+.+|++++++++|||||++++++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 34456889999999999999999621 123468999999999999999999999999
Q ss_pred cCeeEEEEEecCCCChhhHhhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCc
Q 036419 510 QGENVLIYEYLPNKSLDSFLFDT-------TKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMI 582 (754)
Q Consensus 510 ~~~~~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~ 582 (754)
++..++||||+++|+|.+++... .....+++..+..++.||++||.|||+++ |+||||||+||||+++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence 99999999999999999998643 12235789999999999999999999987 999999999999999999
Q ss_pred eEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCcccCCchhHhHhhh
Q 036419 583 PKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSK-RSTRFFNTNSLTLLGHAW 661 (754)
Q Consensus 583 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~ 661 (754)
+||+|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||++|. .|+...... ......
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~--~~~~~i- 248 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRFV- 248 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHHHHH-
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-
Confidence 9999999999876554444455667999999999999999999999999999999999996 555432221 111111
Q ss_pred hhhccCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 662 NLWKDDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 662 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
.+.. .. ......++.+.+++.+||+.||++|||+++|+++|+..
T Consensus 249 --~~~~-~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 249 --MEGG-LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp --HTTC-CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --HhCC-CC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111 10 11112346799999999999999999999999999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=370.25 Aligned_cols=236 Identities=21% Similarity=0.290 Sum_probs=191.9
Q ss_pred hcCccccceeccCCCcceeecc-----------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-----------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-----------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
.++|++.+.||+|+||+||++. .....+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 4689999999999999999822 13456889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCC--CceEEeeccCccccCCCc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSN--MIPKISDFGLARMFGGDE 598 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~--~~~kl~DFgla~~~~~~~ 598 (754)
++|+|.++|.. ....+++.++..++.||++||.|||+.+ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 84 ~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999953 2346999999999999999999999998 9999999999999854 589999999999765433
Q ss_pred ccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
. .....||+.|+|||.+.+..|+.++|||||||++|+|++|..||....... ..... .... . ...
T Consensus 159 ~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--~~~~i---~~~~-~------~~~ 223 (321)
T d1tkia_ 159 N---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIENI---MNAE-Y------TFD 223 (321)
T ss_dssp E---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHH---HHTC-C------CCC
T ss_pred c---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--HHHHH---HhCC-C------CCC
Confidence 2 234678999999999999999999999999999999999999986543221 11111 1000 0 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.......++++.+++.+||+.||++|||+.|+++|
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001234678999999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=370.25 Aligned_cols=241 Identities=20% Similarity=0.245 Sum_probs=189.7
Q ss_pred hcCccccc-eeccCCCcceeeccc-------------cHHHHHHHHHHHHhh-ccCCeeeeeeeeee----cCeeEEEEE
Q 036419 458 TNNFGVEN-KLGEGGFGPVYKSGQ-------------GLEEFKNEIKLTAKL-QHRNLVRLLGCCVE----QGENVLIYE 518 (754)
Q Consensus 458 ~~~y~~~~-~lG~G~fg~Vyk~~~-------------~~~~~~~Ev~il~~l-~hpniv~l~~~~~~----~~~~~lV~E 518 (754)
.++|++.+ .||+|+||.||++.+ ..+.+.+|++++.++ +|||||++++++.+ +...++|||
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 36898875 599999999998432 346789999997765 79999999999875 467899999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC---CCceEEeeccCccccC
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS---NMIPKISDFGLARMFG 595 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~---~~~~kl~DFgla~~~~ 595 (754)
|++||+|.++|... ....+++.++..++.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||+|+...
T Consensus 90 y~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 90 CLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp CCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred CCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceeeecc
Confidence 99999999999653 2346999999999999999999999998 999999999999985 5679999999999765
Q ss_pred CCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCc
Q 036419 596 GDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDP 675 (754)
Q Consensus 596 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 675 (754)
.... .....||+.|||||++.+..|+.++|||||||++|+|++|+.||.......... .... .... ...
T Consensus 166 ~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~--~~~~---~i~~---~~~ 234 (335)
T d2ozaa1 166 SHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKT---RIRM---GQY 234 (335)
T ss_dssp CCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCS---CSS
T ss_pred CCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH--HHHH---HHhc---CCC
Confidence 4332 345689999999999999999999999999999999999999986543322100 0000 0000 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 676 KLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 676 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..........++++.+++.+||+.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01111112346789999999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=366.00 Aligned_cols=241 Identities=26% Similarity=0.295 Sum_probs=185.4
Q ss_pred cceeccCCCcceeeccc-----------------------cHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEec
Q 036419 464 ENKLGEGGFGPVYKSGQ-----------------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 464 ~~~lG~G~fg~Vyk~~~-----------------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~~ 520 (754)
+++||+|+||+||++.+ ..+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999998211 1235789999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
+++++..++ .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 998877666 33456899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccc------ccc
Q 036419 601 SNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW------ELM 673 (754)
Q Consensus 601 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~l~ 673 (754)
.....+||+.|+|||++... .|+.++|||||||++|||++|..||......+ ............... ...
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHHhcCCCChhhccchhccc
Confidence 23346799999999988754 68999999999999999999999986543322 111111111000000 000
Q ss_pred C---cccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 674 D---PKLQCEA-----SYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 674 d---~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
. ....... .....+.+.+++.+||+.||++|||++|+++|-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp 281 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 281 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCH
Confidence 0 0000000 112346789999999999999999999999873
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=364.39 Aligned_cols=238 Identities=27% Similarity=0.420 Sum_probs=190.3
Q ss_pred cceeccCCCcceeecc----------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee-cCeeEEEEEec
Q 036419 464 ENKLGEGGFGPVYKSG----------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE-QGENVLIYEYL 520 (754)
Q Consensus 464 ~~~lG~G~fg~Vyk~~----------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~-~~~~~lV~E~~ 520 (754)
.++||+|+||+||++. ...++|.+|++++++++|||||++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999721 134679999999999999999999999876 45789999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCccc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDELQ 600 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~~ 600 (754)
++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999864 3345788999999999999999999998 999999999999999999999999999977543322
Q ss_pred --ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcccC
Q 036419 601 --SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPKLQ 678 (754)
Q Consensus 601 --~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 678 (754)
.......||+.|+|||.+....++.++||||||+++|||++|+.|+...... ....... ....+ ...+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i---~~g~~---~~~p--- 256 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYL---LQGRR---LLQP--- 256 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH---HTTCC---CCCC---
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHH---HcCCC---CCCc---
Confidence 2233457899999999999999999999999999999999988886533211 1111111 11111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 036419 679 CEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEFVN 720 (754)
Q Consensus 679 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 720 (754)
...++.+.+++.+||+.||++||+|.||+++|+.+...
T Consensus 257 ----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 ----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 12346788999999999999999999999999987543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=363.64 Aligned_cols=246 Identities=24% Similarity=0.325 Sum_probs=188.8
Q ss_pred cCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
++|++.++||+|+||+||++. ...+++.+|++++++++|||||++++++.++.+.++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 589999999999999999821 235678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
|+.++.+.... . ...+.+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~-~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMD-A-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHH-H-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhh-h-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99875554433 2 23456999999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh-ccC--c---ccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGF-FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW-KDD--R---SWE 671 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~--~---~~~ 671 (754)
.......||+.|+|||.+.... ++.++|||||||++|+|++|+.||........ ........ ... . ...
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhcccccc
Confidence 2234568999999999887665 58999999999999999999999875432221 10110000 000 0 000
Q ss_pred ccC--cccC--CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 672 LMD--PKLQ--CE-----ASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 672 l~d--~~~~--~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
..+ .... .. .....++.+.+++.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 0000 00 011234678999999999999999999999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=368.41 Aligned_cols=231 Identities=23% Similarity=0.315 Sum_probs=189.8
Q ss_pred cCccccceeccCCCcceeecc---------------------ccHHHHHHHHHHHH-hhccCCeeeeeeeeeecCeeEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------------QGLEEFKNEIKLTA-KLQHRNLVRLLGCCVEQGENVLI 516 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------------~~~~~~~~Ev~il~-~l~hpniv~l~~~~~~~~~~~lV 516 (754)
++|++.+.||+|+||+||++. ...+.+..|+.++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 579999999999999999721 23456777887766 68999999999999999999999
Q ss_pred EEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCC
Q 036419 517 YEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGG 596 (754)
Q Consensus 517 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~ 596 (754)
|||+++|+|.++|.. ...+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999954 345899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccccccCcc
Q 036419 597 DELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSWELMDPK 676 (754)
Q Consensus 597 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 676 (754)
.. .......||+.|+|||++.+..|+.++|||||||++|||++|+.||....... +..... .. .+.
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~----~~------~~~ 221 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIR----MD------NPF 221 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH----HC------CCC
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHH----cC------CCC
Confidence 32 22345689999999999999999999999999999999999999987543222 111111 00 011
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 036419 677 LQCEASYPIVKRYINVALLCVQENAADRPTMS-EVISM 713 (754)
Q Consensus 677 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~ 713 (754)
.+...++.+.+++.+||+.||++|||+. +|++|
T Consensus 222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 1112356789999999999999999995 78754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-42 Score=362.89 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=188.0
Q ss_pred cCccccceeccCCCcceeecc-------------ccHHHH--HHHHHHHHhhccCCeeeeeeeeeecC----eeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------QGLEEF--KNEIKLTAKLQHRNLVRLLGCCVEQG----ENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------~~~~~~--~~Ev~il~~l~hpniv~l~~~~~~~~----~~~lV~E~ 519 (754)
++|.+.++||+|+||.||++. ...+++ +.|+..+.+++|||||++++++.+++ ..++||||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 567888999999999999732 223344 34555566789999999999998764 57899999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYS-----RLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+++|+|.++|.+ ..+++..++.++.|++.||.|||+.. ..+|+||||||+||||+.++.+||+|||+++..
T Consensus 83 ~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 83 HEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 999999999964 35899999999999999999999741 245999999999999999999999999999977
Q ss_pred CCCcc--cccccccccccCcccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHh---------
Q 036419 595 GGDEL--QSNTKRIVGTYGYMSPEYAIHG------FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLL--------- 657 (754)
Q Consensus 595 ~~~~~--~~~~~~~~gt~~y~APE~~~~~------~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~--------- 657 (754)
..... ........||+.|||||++.+. .++.|+|||||||+||||++|..|+...........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 54322 2233457899999999998764 367899999999999999999887654332221110
Q ss_pred HhhhhhhccCccccccCcccCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 658 GHAWNLWKDDRSWELMDPKLQCE-ASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 658 ~~~~~~~~~~~~~~l~d~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
....... ..+.+++.+... ...+....+.+++.+||+.||++|||+.||+++|+.+
T Consensus 239 ~~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 239 EEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0011111 111122222211 1234567799999999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=358.73 Aligned_cols=225 Identities=24% Similarity=0.353 Sum_probs=184.2
Q ss_pred hcCccccceeccCCCcceeeccc------------------------cHHHHHHHHHHHHhhc--cCCeeeeeeeeeecC
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ------------------------GLEEFKNEIKLTAKLQ--HRNLVRLLGCCVEQG 511 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~------------------------~~~~~~~Ev~il~~l~--hpniv~l~~~~~~~~ 511 (754)
.++|++.+.||+|+||+||++.+ ...++.+|++++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999997221 1133678999999997 899999999999999
Q ss_pred eeEEEEEecCC-CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC-CCceEEeecc
Q 036419 512 ENVLIYEYLPN-KSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS-NMIPKISDFG 589 (754)
Q Consensus 512 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~-~~~~kl~DFg 589 (754)
..++||||+.+ +++.+++.. ...+++.++..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 677777743 356999999999999999999999998 999999999999985 4799999999
Q ss_pred CccccCCCcccccccccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc
Q 036419 590 LARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFF-SIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR 668 (754)
Q Consensus 590 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 668 (754)
+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ... ...
T Consensus 157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i~-------~~~- 220 (273)
T d1xwsa_ 157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EII-------RGQ- 220 (273)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHH-------HCC-
T ss_pred cceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----HHh-------hcc-
Confidence 998764332 335689999999999987765 678999999999999999999986321 000 000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 669 SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 669 ~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
... ....++++.+++.+||+.||++|||++|+++|-
T Consensus 221 --~~~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 256 (273)
T d1xwsa_ 221 --VFF--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 256 (273)
T ss_dssp --CCC--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred --cCC--------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 001 112346789999999999999999999998863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-41 Score=354.15 Aligned_cols=245 Identities=23% Similarity=0.310 Sum_probs=188.3
Q ss_pred cCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEEe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYEY 519 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E~ 519 (754)
++|++.++||+|+||+||++. ...+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 589999999999999999821 2256899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCcc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDEL 599 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~~ 599 (754)
+.++.+..+. ...+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9988877776 34467999999999999999999999988 99999999999999999999999999998754332
Q ss_pred cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhcc--------C---
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKD--------D--- 667 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~--- 667 (754)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+. .......... .
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchhhh
Confidence 23345689999999998764 679999999999999999999999865432221 1111100000 0
Q ss_pred ----ccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 668 ----RSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 668 ----~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.......+...........+.+.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000001111111112234678899999999999999999999876
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=356.49 Aligned_cols=247 Identities=25% Similarity=0.348 Sum_probs=187.9
Q ss_pred hcCccccceeccCCCcceeeccc---------------------cHHHHHHHHHHHHhh---ccCCeeeeeeeeee----
Q 036419 458 TNNFGVENKLGEGGFGPVYKSGQ---------------------GLEEFKNEIKLTAKL---QHRNLVRLLGCCVE---- 509 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~~---------------------~~~~~~~Ev~il~~l---~hpniv~l~~~~~~---- 509 (754)
.++|++.++||+|+||+||++.+ ....+.+|+++++.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999998321 123466888887776 79999999999853
Q ss_pred -cCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeec
Q 036419 510 -QGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDF 588 (754)
Q Consensus 510 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DF 588 (754)
....+++|||++++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 356899999999987765543 34456899999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhh-----
Q 036419 589 GLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNL----- 663 (754)
Q Consensus 589 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----- 663 (754)
|+++..... .......||+.|||||++.+..|+.++||||+||++|||++|+.||......+ ........
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPG 235 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCc
Confidence 999865433 23345789999999999999999999999999999999999999987543322 11111100
Q ss_pred ---hccCc-cc-ccc---CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 664 ---WKDDR-SW-ELM---DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 664 ---~~~~~-~~-~l~---d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
|.... .. ... ............++.+.+|+.+||+.||++|||++|+++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp 294 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 00000 00 000 00000111122456788999999999999999999999873
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=357.02 Aligned_cols=247 Identities=21% Similarity=0.221 Sum_probs=185.3
Q ss_pred CccccceeccCCCcceeeccc--------------cHHHHHHHHHHHHhhccCCeeeeeeeeeec------CeeEEEEEe
Q 036419 460 NFGVENKLGEGGFGPVYKSGQ--------------GLEEFKNEIKLTAKLQHRNLVRLLGCCVEQ------GENVLIYEY 519 (754)
Q Consensus 460 ~y~~~~~lG~G~fg~Vyk~~~--------------~~~~~~~Ev~il~~l~hpniv~l~~~~~~~------~~~~lV~E~ 519 (754)
+|+..++||+|+||+||++.+ ......+|+++|++++||||+++++++... .+.++||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 688899999999999998332 123356899999999999999999998543 347899999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC-ceEEeeccCccccCCCc
Q 036419 520 LPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM-IPKISDFGLARMFGGDE 598 (754)
Q Consensus 520 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~-~~kl~DFgla~~~~~~~ 598 (754)
++++.+..+.........+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++.+....
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 998765555443345567999999999999999999999988 99999999999999775 89999999999775443
Q ss_pred ccccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhh----------hhhhc--
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA----------WNLWK-- 665 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~----------~~~~~-- 665 (754)
. .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||........ +.... +....
T Consensus 178 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 178 P---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp C---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCC-
T ss_pred c---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhhhccc
Confidence 2 234679999999998875 4789999999999999999999999865432221 10000 00000
Q ss_pred --cCccccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 666 --DDRSWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 666 --~~~~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.....................+.+.+|+.+||+.||++|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000001100011111122345678999999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=345.62 Aligned_cols=251 Identities=20% Similarity=0.288 Sum_probs=186.2
Q ss_pred cCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee--------c
Q 036419 459 NNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE--------Q 510 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~--------~ 510 (754)
++|++.++||+|+||+||++. ...+++.+|+++|++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 689999999999999999832 234668899999999999999999999854 4
Q ss_pred CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 511 GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 511 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
.+.++||||++++.+..+. .....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 5689999999988777655 34456899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccc--ccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCch-hHhHhhhhhhcc
Q 036419 591 ARMFGGDELQ--SNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-TLLGHAWNLWKD 666 (754)
Q Consensus 591 a~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~ 666 (754)
++.+...... ......+||+.|+|||++.+. .++.|+|||||||++|||++|+.||........ ............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9876543221 222345799999999998765 789999999999999999999999865432221 111111000000
Q ss_pred C--------ccccccCcccCCCCCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 036419 667 D--------RSWELMDPKLQCEASYP-------IVKRYINVALLCVQENAADRPTMSEVISMLT 715 (754)
Q Consensus 667 ~--------~~~~l~d~~~~~~~~~~-------~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 715 (754)
. ................. ..+.+++|+.+||+.||++|||++|+++|--
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 0 00000000000011111 1345678999999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-40 Score=352.07 Aligned_cols=241 Identities=22% Similarity=0.294 Sum_probs=180.5
Q ss_pred hhcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC-----
Q 036419 457 ATNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG----- 511 (754)
Q Consensus 457 ~~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~----- 511 (754)
..++|++.++||+|+||+||++. ...+.+.+|+++|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 35789999999999999999821 12457889999999999999999999997654
Q ss_pred -eeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccC
Q 036419 512 -ENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGL 590 (754)
Q Consensus 512 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgl 590 (754)
+.++||||+ +.+|..++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 579999999 557777763 246999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhh-----
Q 036419 591 ARMFGGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLW----- 664 (754)
Q Consensus 591 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----- 664 (754)
|+..... .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||........ +. ......
T Consensus 168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~-~~~~~~~~~~~ 240 (346)
T d1cm8a_ 168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LK-EIMKVTGTPPA 240 (346)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH-HHHHHHCCCCH
T ss_pred eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HH-HHHhccCCCcH
Confidence 9876432 3456799999999998764 579999999999999999999999865432211 00 000000
Q ss_pred ---ccCc----------cccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 665 ---KDDR----------SWELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 665 ---~~~~----------~~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.... ..+...... ........+.+.+|+.+||+.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 000000000 01111234568899999999999999999999998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=350.99 Aligned_cols=247 Identities=23% Similarity=0.271 Sum_probs=183.2
Q ss_pred hcCccccceeccCCCcceeecc-------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeeecC----eeE
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG-------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQG----ENV 514 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~-------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~----~~~ 514 (754)
+.+|+++++||+|+||+||++. ...+++.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4679999999999999999821 12457889999999999999999999987543 335
Q ss_pred EEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcccc
Q 036419 515 LIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMF 594 (754)
Q Consensus 515 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~ 594 (754)
+++||+.+++|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55667789999999953 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-ccccccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc----
Q 036419 595 GGDELQ-SNTKRIVGTYGYMSPEYAIH-GFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR---- 668 (754)
Q Consensus 595 ~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 668 (754)
...... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||......... ...........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL--NHILGILGSPSQEDL 237 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH--HHHhhhccCCChhhh
Confidence 543221 22345679999999999855 46799999999999999999999998654322110 00000000000
Q ss_pred -------cc--cccCcccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036419 669 -------SW--ELMDPKLQC----EASYPIVKRYINVALLCVQENAADRPTMSEVISM 713 (754)
Q Consensus 669 -------~~--~l~d~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 713 (754)
.. ....+.... ........++.+++.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000000000 0011223568899999999999999999999997
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.7e-39 Score=344.11 Aligned_cols=244 Identities=19% Similarity=0.295 Sum_probs=187.6
Q ss_pred cCccccceeccCCCcceeecc---------------ccHHHHHHHHHHHHhhc-cCCeeeeeeeeee--cCeeEEEEEec
Q 036419 459 NNFGVENKLGEGGFGPVYKSG---------------QGLEEFKNEIKLTAKLQ-HRNLVRLLGCCVE--QGENVLIYEYL 520 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~---------------~~~~~~~~Ev~il~~l~-hpniv~l~~~~~~--~~~~~lV~E~~ 520 (754)
++|++.++||+|+||+||++. ...+++.+|+++|++++ ||||+++++++.. ....++||||+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 579999999999999999832 24578999999999996 9999999999974 35689999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCC-ceEEeeccCccccCCCcc
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNM-IPKISDFGLARMFGGDEL 599 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~-~~kl~DFgla~~~~~~~~ 599 (754)
++++|..+. +.+++..+..++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+|+......
T Consensus 115 ~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 115 NNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp CSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred CCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 999997764 35899999999999999999999998 99999999999998655 68999999999775443
Q ss_pred cccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhh-----------hhhhccC
Q 036419 600 QSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHA-----------WNLWKDD 667 (754)
Q Consensus 600 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~-----------~~~~~~~ 667 (754)
......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.............. .......
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 23456789999999998765 579999999999999999999999865443221110000 0000000
Q ss_pred cc---cccc--------CcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 668 RS---WELM--------DPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 668 ~~---~~l~--------d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
.. .... ............++++.+|+.+||+.||++|||++|+++|-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp 320 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 00 0000 00111111223456789999999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=338.93 Aligned_cols=247 Identities=24% Similarity=0.281 Sum_probs=191.9
Q ss_pred cCccccceeccCCCcceeec--------------------cccHHHHHHHHHHHHhhccCCeeeeeeeeeecCeeEEEEE
Q 036419 459 NNFGVENKLGEGGFGPVYKS--------------------GQGLEEFKNEIKLTAKLQHRNLVRLLGCCVEQGENVLIYE 518 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~--------------------~~~~~~~~~Ev~il~~l~hpniv~l~~~~~~~~~~~lV~E 518 (754)
++|++.++||+|+||+||++ ....+++.+|++++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999972 1235788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCccccCCCc
Q 036419 519 YLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLARMFGGDE 598 (754)
Q Consensus 519 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~~~~~~ 598 (754)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988884 3456899999999999999999999988 9999999999999999999999999999875433
Q ss_pred ccccccccccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCc------ccc
Q 036419 599 LQSNTKRIVGTYGYMSPEYAIHGF-FSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDR------SWE 671 (754)
Q Consensus 599 ~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~ 671 (754)
. ......++..|+|||.+.... ++.++|||||||++|||++|+.|+.........+ ........... ..+
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH-HHHHHHHCCCCTTTCTTGGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH-HHHHhhcCCCChhhhhhhhh
Confidence 2 223346788999999887664 6999999999999999999999974332222111 11111111000 000
Q ss_pred ccC---------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 672 LMD---------PKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 672 l~d---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
..+ ............+.+.+++.+||+.||++|||++||++|-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp 284 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence 000 0001111223456788999999999999999999999863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.6e-39 Score=337.16 Aligned_cols=245 Identities=20% Similarity=0.257 Sum_probs=184.7
Q ss_pred hcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhccCCe-eeeeeeeeecCeeEEEEEec
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQHRNL-VRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~hpni-v~l~~~~~~~~~~~lV~E~~ 520 (754)
.++|++.++||+|+||+||++. ...+++..|++++++++|+|+ +.+..+..++...++||||+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4679999999999999999832 233568899999999987765 55556667888899999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEc---CCCceEEeeccCccccCCC
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLD---SNMIPKISDFGLARMFGGD 597 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld---~~~~~kl~DFgla~~~~~~ 597 (754)
.+ +|.+.+.. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+...
T Consensus 86 ~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 86 GP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred CC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 55 55555533 3356999999999999999999999998 99999999999985 4557999999999987543
Q ss_pred ccc-----ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchhH-hHhhhhhhccCcccc
Q 036419 598 ELQ-----SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTL-LGHAWNLWKDDRSWE 671 (754)
Q Consensus 598 ~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 671 (754)
... .......||+.|||||.+.+..++.++|||||||++|||++|+.||.......... .............
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-- 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH--
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh--
Confidence 221 22345689999999999999999999999999999999999999987654333111 1000000000000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 036419 672 LMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNE 717 (754)
Q Consensus 672 l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 717 (754)
+.. ....++++.+++.+||+.||++||+++++.+.|+..
T Consensus 238 ---~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 238 ---EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ---HHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ---hHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 000 112346788999999999999999999998888764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-39 Score=341.67 Aligned_cols=236 Identities=23% Similarity=0.285 Sum_probs=189.7
Q ss_pred cCccccceeccCCCcceeeccc-------------------------cHHHHHHHHHHHHhhcc-CCeeeeeeeeeecCe
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ-------------------------GLEEFKNEIKLTAKLQH-RNLVRLLGCCVEQGE 512 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~-------------------------~~~~~~~Ev~il~~l~h-pniv~l~~~~~~~~~ 512 (754)
++|++.++||+|+||+||++.. ..+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999998311 23567899999999987 899999999999999
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+.+++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999999543 45789999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccCccc
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHG--FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDDRSW 670 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (754)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||........... ........
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~-i~~~~~~~---- 251 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE-ISRRILKS---- 251 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-HHHHHHHC----
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcccC----
Confidence 76543322 23456799999999998764 578899999999999999999999876544331111 00000000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036419 671 ELMDPKLQCEASYPIVKRYINVALLCVQENAADRP-----TMSEVISM 713 (754)
Q Consensus 671 ~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 713 (754)
........++++.+++.+||+.||++|| |++|+++|
T Consensus 252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0011223457889999999999999999 58999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.1e-38 Score=331.12 Aligned_cols=246 Identities=16% Similarity=0.224 Sum_probs=194.2
Q ss_pred hcCccccceeccCCCcceeecc----------------ccHHHHHHHHHHHHhhcc-CCeeeeeeeeeecCeeEEEEEec
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG----------------QGLEEFKNEIKLTAKLQH-RNLVRLLGCCVEQGENVLIYEYL 520 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~----------------~~~~~~~~Ev~il~~l~h-pniv~l~~~~~~~~~~~lV~E~~ 520 (754)
.++|++.++||+|+||+||++. ...+.+++|+++++.|+| +|++.+++++.++...++||||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 5789999999999999999832 233567899999999986 89999999999999999999998
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcC-----CCceEEeeccCccccC
Q 036419 521 PNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDS-----NMIPKISDFGLARMFG 595 (754)
Q Consensus 521 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~-----~~~~kl~DFgla~~~~ 595 (754)
+++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 84 -~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 -GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 68999888542 346999999999999999999999998 999999999999974 5789999999999765
Q ss_pred CCccc-----ccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCch-hHhHhhhhhhccCcc
Q 036419 596 GDELQ-----SNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSL-TLLGHAWNLWKDDRS 669 (754)
Q Consensus 596 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 669 (754)
..... ......+||+.|||||++.+..++.++|||||||++|||++|..||........ .........-.....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 32211 123356899999999999999999999999999999999999999976544432 111111100000001
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 036419 670 WELMDPKLQCEASYPIVKRYINVALLCVQENAADRPTMSEVISMLTNEF 718 (754)
Q Consensus 670 ~~l~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 718 (754)
.++ ....++++.+++..|+..+|++||+++.+.+.|+...
T Consensus 238 ~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 238 REL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 011 0112356889999999999999999999998887643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-38 Score=338.48 Aligned_cols=244 Identities=21% Similarity=0.209 Sum_probs=177.6
Q ss_pred cCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee------cCe
Q 036419 459 NNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE------QGE 512 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~------~~~ 512 (754)
++|++.++||+|+||+||++. ...+++.+|++++++++|||||++++++.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 689999999999999999832 223568899999999999999999999963 368
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++||||+.++.+..+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999876655442 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCchh--HhH------------
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLT--LLG------------ 658 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~--~~~------------ 658 (754)
...... ......||+.|+|||++.+..++.++||||+||++++|++|+.||......... ...
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 765432 234567999999999999999999999999999999999999998654322110 000
Q ss_pred ---hhhhhhccC------ccccccCcccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 659 ---HAWNLWKDD------RSWELMDPKLQCE---ASYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 659 ---~~~~~~~~~------~~~~l~d~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
......... ............. .....++.+.+|+.+||+.||++|||++||++|-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 000000000 0001111111111 1123567899999999999999999999999884
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-38 Score=340.69 Aligned_cols=243 Identities=21% Similarity=0.270 Sum_probs=181.6
Q ss_pred hcCccccceeccCCCcceeecc--------------------ccHHHHHHHHHHHHhhccCCeeeeeeeeee-----cCe
Q 036419 458 TNNFGVENKLGEGGFGPVYKSG--------------------QGLEEFKNEIKLTAKLQHRNLVRLLGCCVE-----QGE 512 (754)
Q Consensus 458 ~~~y~~~~~lG~G~fg~Vyk~~--------------------~~~~~~~~Ev~il~~l~hpniv~l~~~~~~-----~~~ 512 (754)
.++|++.++||+|+||+||++. ...+++.+|++++++++|||+|++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5789999999999999999831 123568899999999999999999999863 334
Q ss_pred eEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEEeeccCcc
Q 036419 513 NVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKISDFGLAR 592 (754)
Q Consensus 513 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl~DFgla~ 592 (754)
.++|+||+.+++|.+++.. +.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5677888899999999943 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCchhHhHhhhhhhccC----
Q 036419 593 MFGGDELQSNTKRIVGTYGYMSPEYAIHG-FFSIKSDVFSFGVLLLETLSSKRSTRFFNTNSLTLLGHAWNLWKDD---- 667 (754)
Q Consensus 593 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 667 (754)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ ...........
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~--~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGAEL 242 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChHH
Confidence 6532 23346799999999987765 568999999999999999999999865432211 00000000000
Q ss_pred -------ccccccCcccC-CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036419 668 -------RSWELMDPKLQ-CEA-----SYPIVKRYINVALLCVQENAADRPTMSEVISML 714 (754)
Q Consensus 668 -------~~~~l~d~~~~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 714 (754)
........... ... .....+.+.+|+.+||+.||.+|||++|+++|-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp 302 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCH
Confidence 00000000000 000 012346688999999999999999999999963
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-33 Score=303.13 Aligned_cols=248 Identities=18% Similarity=0.195 Sum_probs=181.8
Q ss_pred cCccccceeccCCCcceeeccc-----------------cHHHHHHHHHHHHhhc-----------cCCeeeeeeeeeec
Q 036419 459 NNFGVENKLGEGGFGPVYKSGQ-----------------GLEEFKNEIKLTAKLQ-----------HRNLVRLLGCCVEQ 510 (754)
Q Consensus 459 ~~y~~~~~lG~G~fg~Vyk~~~-----------------~~~~~~~Ev~il~~l~-----------hpniv~l~~~~~~~ 510 (754)
++|+++++||+|+||+||++.+ ..+.+.+|++++++++ |+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4699999999999999998421 2366788999999886 57899999988654
Q ss_pred --CeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCceEEcCCCc-----
Q 036419 511 --GENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQ-YSRLRVIHRDLKPSNILLDSNMI----- 582 (754)
Q Consensus 511 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NIlld~~~~----- 582 (754)
...+++|+++..+..............+++..+..++.||++||.|||+ .+ |+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 5667778777666555544445566779999999999999999999998 55 999999999999986653
Q ss_pred -eEEeeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcccCCc-----hhH
Q 036419 583 -PKISDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLLLETLSSKRSTRFFNTNS-----LTL 656 (754)
Q Consensus 583 -~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltg~~p~~~~~~~~-----~~~ 656 (754)
+|++|||.+...... ....+||+.|+|||++....++.++||||+||++++|++|+.||....... ..+
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 899999999865322 235679999999999999999999999999999999999999986443221 001
Q ss_pred hHhhhh-----------------hhccCccccccCc----------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 036419 657 LGHAWN-----------------LWKDDRSWELMDP----------KLQCEASYPIVKRYINVALLCVQENAADRPTMSE 709 (754)
Q Consensus 657 ~~~~~~-----------------~~~~~~~~~l~d~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 709 (754)
...... .+........+.. ...........+.+.+++.+||+.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 000000 0000000000000 0011223456788999999999999999999999
Q ss_pred HHHHH
Q 036419 710 VISML 714 (754)
Q Consensus 710 vl~~L 714 (754)
+++|-
T Consensus 325 ~L~Hp 329 (362)
T d1q8ya_ 325 LVNHP 329 (362)
T ss_dssp HHTCG
T ss_pred HhcCc
Confidence 99973
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.82 E-value=2.7e-20 Score=164.47 Aligned_cols=112 Identities=23% Similarity=0.423 Sum_probs=95.1
Q ss_pred ccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEcC
Q 036419 25 ADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNL 104 (754)
Q Consensus 25 ~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~ 104 (754)
+|+|.|||.| ..|++|+| |.|.|+|...++ |.|+. +.++||.||++.|.. .+.|.|+.||+|+|+|.
T Consensus 1 tDtL~~gq~L-~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQL-DTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEE-CTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET
T ss_pred CCEecCCCEe-cCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccCCC--CcEEEEeccccEEEEec
Confidence 5899999999 99999985 999999997765 66664 479999999998843 57899999999999996
Q ss_pred CCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcc
Q 036419 105 TNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSD 156 (754)
Q Consensus 105 ~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtD 156 (754)
+.++|++++........|+|+|+|||||++.+ +.++|||+.+|+|
T Consensus 68 -~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~------~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 -SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS------NNAIWATHTNVGN 112 (112)
T ss_dssp -TEEEEECCCCCSCCCCEEEECTTSCEEEECTT------SCEEEECCCCCCC
T ss_pred -CCeEEEEeeccCCCceEEEEcCCCCEEEECCC------CcEEecCCCccCC
Confidence 56788887766655668899999999999854 7899999999985
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.81 E-value=3.9e-20 Score=161.88 Aligned_cols=107 Identities=22% Similarity=0.365 Sum_probs=92.5
Q ss_pred ccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEcC
Q 036419 25 ADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNL 104 (754)
Q Consensus 25 ~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~ 104 (754)
+|+|.+||.| ..|++|. +|.|.|.|...++ |.||. ..++||.||++.|- +.+.|.|+.+|+|+|.++
T Consensus 1 ~~~L~~g~~L-~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 1 DNILYSGETL-STGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGLS--RSCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CCEEETTEEE-CTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCCccCCCEe-cCCCEEE--cCCEEEEECCCCe-----EEEEe---CCceeeEeCCCCCC--CccEEEEeccceEEEECC
Confidence 4789999999 9999995 6999999998776 67765 36899999999883 457899999999999999
Q ss_pred CCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCC
Q 036419 105 TNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDY 153 (754)
Q Consensus 105 ~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~ 153 (754)
+|.+||++++.......+|+|+|+|||||++ ..+||||+|
T Consensus 68 ~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~---------~~~W~S~t~ 107 (108)
T d1jpca_ 68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYG---------TDRWATGTH 107 (108)
T ss_dssp TCCEEEECCCCCSCSCEEEEECTTSCEEEEE---------CCCCCCCCC
T ss_pred CccceEEccccCCCCcEEEEEcCCCCEEEeC---------CCcccCCCC
Confidence 9999999998766666678999999999995 348999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.80 E-value=1.4e-19 Score=158.32 Aligned_cols=108 Identities=20% Similarity=0.395 Sum_probs=91.1
Q ss_pred ccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEcC
Q 036419 25 ADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNL 104 (754)
Q Consensus 25 ~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~ 104 (754)
.|+|.+|+.| ..|++|++ |.|.|+|...++ |.++. ..++||+||++.|... .++|.|+.||+|||+|.
T Consensus 1 ~~~L~~g~~L-~~g~~l~~--g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~ 68 (109)
T d1kj1a_ 1 RNLLTNGEGL-YAGQSLDV--EPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDA 68 (109)
T ss_dssp CCEEETTCEE-ETTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECS
T ss_pred CCCccCCCEE-eCCCEEEe--CCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeC
Confidence 3789999999 89999974 889999987654 55553 3689999999999864 68899999999999999
Q ss_pred CCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCC
Q 036419 105 TNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDY 153 (754)
Q Consensus 105 ~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~ 153 (754)
+|.+||+++++......+|+|+|+|||||++ ..+|||+-|
T Consensus 69 ~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~---------~~~W~S~t~ 108 (109)
T d1kj1a_ 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIYG---------SDIWSTGTY 108 (109)
T ss_dssp SSCEEEECCCCCCSSCCEEEECTTSCEEEEC---------CEEEECCCC
T ss_pred CCcEEEEEeeECCCCCEEEEEeCCCcEEEEC---------CCEecCCCc
Confidence 9999999998755556678999999999994 359999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.75 E-value=1.7e-19 Score=175.77 Aligned_cols=153 Identities=18% Similarity=0.194 Sum_probs=107.7
Q ss_pred ccccceeccCCCcceeeccc-----------------------------------cHHHHHHHHHHHHhhccCCeeeeee
Q 036419 461 FGVENKLGEGGFGPVYKSGQ-----------------------------------GLEEFKNEIKLTAKLQHRNLVRLLG 505 (754)
Q Consensus 461 y~~~~~lG~G~fg~Vyk~~~-----------------------------------~~~~~~~Ev~il~~l~hpniv~l~~ 505 (754)
+.+.++||+|+||.||++.. ......+|...+.++.|+++++.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 34678999999999997211 0123456888999999999998876
Q ss_pred eeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCceEEcCCCceEE
Q 036419 506 CCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQYSRLRVIHRDLKPSNILLDSNMIPKI 585 (754)
Q Consensus 506 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIlld~~~~~kl 585 (754)
+. ..++||||+++..+.+ ++...+..++.||+++|.|||+.+ |+||||||+|||++++ .++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 53 2379999999866543 333445789999999999999998 9999999999999976 4899
Q ss_pred eeccCccccCCCcccccccccccccCcccccccccCCCCcccchhhHHHHH
Q 036419 586 SDFGLARMFGGDELQSNTKRIVGTYGYMSPEYAIHGFFSIKSDVFSFGVLL 636 (754)
Q Consensus 586 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil 636 (754)
+|||+|.............+.+.. -.| +....|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHH
Confidence 999999865432211100000000 011 1235688999999975433
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.67 E-value=4.8e-17 Score=144.40 Aligned_cols=101 Identities=22% Similarity=0.273 Sum_probs=85.8
Q ss_pred EEEEeecC-CeEEEeecCCCCCCCCCceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCC
Q 036419 64 GIWYKQIP-DTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSAS 142 (754)
Q Consensus 64 ~iw~~~~~-~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~ 142 (754)
-|||.+++ ++.+|++|++.|+.....+|.+..||||+|++. +.++|++++.+.+....|.|+++|||||++.+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~----- 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ----- 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT-----
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCC-----
Confidence 58998887 799999999999988778999999999999986 67899999887777778999999999999855
Q ss_pred cCceeccccCCCcccccccCcccceecCCCeeeEEecCCCCCCCCCceEEEeecCCCceE
Q 036419 143 EGSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPSPGNITNRLDIHVLPEL 202 (754)
Q Consensus 143 ~~~~lWQSFd~PtDTlLpg~~l~~~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~ 202 (754)
+++|||||. +.++|.|.+.++++|...+
T Consensus 85 -~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvl 112 (120)
T d1dlpa2 85 -NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAI 112 (120)
T ss_dssp -TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEE
T ss_pred -CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEE
Confidence 789999973 3456889999999997654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.56 E-value=1e-14 Score=128.78 Aligned_cols=103 Identities=17% Similarity=0.340 Sum_probs=82.6
Q ss_pred cccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEcCC
Q 036419 26 DTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNLT 105 (754)
Q Consensus 26 ~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~ 105 (754)
++|.++|+| ...+..|.|.|.|...++ |.++ . +.++||.||+..|. ..+.|.|..||+|+|.|++
T Consensus 15 ~~l~~~q~l-----~~~~~~~~y~l~mQ~DGN-----LVLy-~--~~~~vWssnt~~~~--~~~~l~l~~dGnLvL~d~~ 79 (119)
T d1b2pa_ 15 QILHATESL-----EILFGTHVYRFIMQTDCN-----LVLY-D--NNNPIWATNTGGLG--NGCRAVLQPDGVLVVITNE 79 (119)
T ss_dssp CEEETTCEE-----EEEETTEEEEEEECTTSC-----EEEE-E--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CEEeCCCeE-----EEecCCceEEEEECCCCc-----EEEE-E--CCeEEEEecCCCCC--cceEEEEEeCCCEEEECCC
Confidence 455555555 346779999999998776 5553 3 47899999998774 3578999999999999999
Q ss_pred CCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccC
Q 036419 106 NGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFD 152 (754)
Q Consensus 106 ~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd 152 (754)
|.+||++++.+.....+|+|+|+|||||++ .++|||-.
T Consensus 80 g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---------~~~W~S~T 117 (119)
T d1b2pa_ 80 NVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---------DALWATQT 117 (119)
T ss_dssp CCEEEECSCCCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred CcEEEECCCcCCCCceEEEEcCCCCEEEEC---------CCEeccCC
Confidence 999999998766656678999999999984 46999853
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.49 E-value=7.6e-15 Score=128.65 Aligned_cols=109 Identities=21% Similarity=0.250 Sum_probs=87.5
Q ss_pred EEEeec-CCeEEEeecCCCCCCCCCceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCc
Q 036419 65 IWYKQI-PDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASE 143 (754)
Q Consensus 65 iw~~~~-~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~ 143 (754)
|||.-. +.+..|+.+.+.++.....+|.+..||||||+++ +.++|++++.+.. .+.|.|+|+|||||++.+
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~~~-~~~l~l~~dGNLvl~d~~------ 74 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGAT-GCRAVLQSDGLLVILTAQ------ 74 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCSCS-CCBCCBCSSSCBCCBCTT------
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCCCC-ceEEEEeccCCEEEEccC------
Confidence 566533 3577799999999988778999999999999884 6889999987544 567899999999999855
Q ss_pred CceeccccCCCcccccccCcccceecCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecCC
Q 036419 144 GSCLWQSFDYPSDTLLAGMKLGWDLKNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGP 216 (754)
Q Consensus 144 ~~~lWQSFd~PtDTlLpg~~l~~~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~ 216 (754)
+.+||||+- +.++|.|.+.++++|... +|. .++|.+|.
T Consensus 75 ~~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlv--lY~--~~~Wssgt 112 (115)
T d1dlpa1 75 NTIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVT--IYG--PGLWDSGT 112 (115)
T ss_dssp TCCSCCCCC-------------------------------CCCSSCCEEEECSSSCEE--EEC--SEEEECSC
T ss_pred CCEEEEcCC-------------------------------CCCCCCEEEEECCCCcEE--EeC--CCeecCCC
Confidence 789999762 346799999999999754 453 47898774
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.35 E-value=1.9e-13 Score=119.62 Aligned_cols=99 Identities=26% Similarity=0.372 Sum_probs=78.0
Q ss_pred cccccCCCCccccCCCeEEeCCCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEc
Q 036419 24 AADTITPASSFIRDGEKFVSSSERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILN 103 (754)
Q Consensus 24 ~~~~~~~~~~l~~~~~~lvS~~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~ 103 (754)
+..+|.++++| .+|.|.|.|...++ |.++. +.++||.+|...+ ..+++.|..+|||||.|
T Consensus 13 ~~~tl~~~~~l---------~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d 72 (115)
T d1dlpa1 13 HPQTLHAAQSL---------ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (115)
T ss_dssp SCSCCCTTCEE---------CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred CcceecCCCcE---------EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCCC---CceEEEEeccCCEEEEc
Confidence 44555555555 36779999998776 66754 4688999997543 36789999999999999
Q ss_pred CCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceecccc
Q 036419 104 LTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSF 151 (754)
Q Consensus 104 ~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSF 151 (754)
.++.+||++.+.......+++|+++|||||++ ..+|+|-
T Consensus 73 ~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~---------~~~Wssg 111 (115)
T d1dlpa1 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---------PGLWDSG 111 (115)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---------SEEEECS
T ss_pred cCCCEEEEcCCCCCCCCEEEEECCCCcEEEeC---------CCeecCC
Confidence 99999999998766656678999999999983 4699974
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.07 E-value=1.7e-10 Score=101.55 Aligned_cols=87 Identities=25% Similarity=0.398 Sum_probs=66.6
Q ss_pred CCeEEEEeeCCCCCCcEEEEEEEeecCCeEEEeecCCCCCCCCCceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEE
Q 036419 45 SERFELGFFSPRKSRYRYLGIWYKQIPDTVVWVANRNSPIIEPNAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQ 124 (754)
Q Consensus 45 ~g~F~lGF~~~~~~~~~~l~iw~~~~~~tvVW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~ 124 (754)
.|.|.|.|-..++ |.|+. +..+||.+|-.. .+..+++.|..+|||||.|.++.++|++++.......++.
T Consensus 34 ~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l~ 103 (120)
T d1dlpa2 34 LSPYRLSMETDCN-----LVLFD---RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFV 103 (120)
T ss_dssp CSSCEEEEETTTE-----EEEEB---TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEEE
T ss_pred cCCEEEEEcCCCc-----EEEec---CCcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcEEEE
Confidence 4567777765443 55542 357789988543 3446789999999999999999999999987655566789
Q ss_pred EccCCCEEEEecCCCCCCcCceeccc
Q 036419 125 LLDTGNLIVRDNFSRSASEGSCLWQS 150 (754)
Q Consensus 125 l~d~GNlvl~~~~~~~~~~~~~lWQS 150 (754)
|+++|||||++ ..+|.|
T Consensus 104 Lq~DGnlvlY~---------~~~W~t 120 (120)
T d1dlpa2 104 LQPDRNLAIYG---------GALWTT 120 (120)
T ss_dssp ECSSSCEEEEC---------CCCCBC
T ss_pred ECCCCcEEEeC---------CCcccC
Confidence 99999999993 458976
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.90 E-value=3e-09 Score=93.07 Aligned_cols=85 Identities=25% Similarity=0.307 Sum_probs=66.1
Q ss_pred eEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccccCcccceec
Q 036419 90 ALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWDLK 169 (754)
Q Consensus 90 ~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~ 169 (754)
+|.+..||||||+++ +.++|++++.+.+..+.+.|.++|||||++.. +.+||+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~------g~~vWsS~------------------ 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE------NVTVWQSP------------------ 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT------CCEEEECS------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCC------CcEEEECC------------------
Confidence 578889999999875 57899999887766678999999999999855 78899852
Q ss_pred CCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecCC
Q 036419 170 NGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGP 216 (754)
Q Consensus 170 ~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~ 216 (754)
..-+.|.|.+.++.+|...+ |. .+.|.++.
T Consensus 88 -------------t~~~~~~~~l~Lq~DGNlvl--Yg--~~~W~S~T 117 (119)
T d1b2pa_ 88 -------------VAGKAGHYVLVLQPDRNVVI--YG--DALWATQT 117 (119)
T ss_dssp -------------CCCCSSCEEEEECTTSCEEE--EE--SEEEECCC
T ss_pred -------------CcCCCCceEEEEcCCCCEEE--EC--CCEeccCC
Confidence 11245778899999987654 42 46888764
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.86 E-value=4e-09 Score=90.85 Aligned_cols=86 Identities=21% Similarity=0.359 Sum_probs=65.6
Q ss_pred CceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccccCcccce
Q 036419 88 NAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWD 167 (754)
Q Consensus 88 ~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg~~l~~~ 167 (754)
.-+|.+..||||||++. +.+||++++.+++..+.+.|.++|||||++.+ +.+||+|
T Consensus 20 ~~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~------g~~vWsS----------------- 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS------NKPIWAS----------------- 75 (108)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT------CCEEEEC-----------------
T ss_pred CEEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECCC------ccceEEc-----------------
Confidence 35688999999999874 57899999887776778999999999999855 8899985
Q ss_pred ecCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecC
Q 036419 168 LKNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSG 215 (754)
Q Consensus 168 ~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g 215 (754)
......+.|.+.++.+|...+ |. .+.|.++
T Consensus 76 --------------~t~~~~~~~~l~L~ddGNlVl--y~--~~~W~S~ 105 (108)
T d1jpca_ 76 --------------NTGGQNGNYVCILQKDRNVVI--YG--TDRWATG 105 (108)
T ss_dssp --------------CCCCSCSCEEEEECTTSCEEE--EE--CCCCCCC
T ss_pred --------------cccCCCCcEEEEEcCCCCEEE--eC--CCcccCC
Confidence 112245678889999887644 43 2456654
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.67 E-value=6.4e-08 Score=83.18 Aligned_cols=87 Identities=25% Similarity=0.377 Sum_probs=64.5
Q ss_pred CceEEEecCccEEEEcCCCCeEEeecCCCCC-CCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccccCcccc
Q 036419 88 NAALTISNNGNLVILNLTNGAIWSSNTSRKA-ENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGW 166 (754)
Q Consensus 88 ~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg~~l~~ 166 (754)
.-+|.|..||||||+. .+.+||++++..+. ....+.|.++|||||++.+ +.++|+|
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~------g~~vW~s---------------- 76 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE------GRSLWAS---------------- 76 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS------SCEEEEC----------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC------CcEEEEE----------------
Confidence 3568888999999986 56899999987544 3456899999999999855 7889986
Q ss_pred eecCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcCCeeeEecCC
Q 036419 167 DLKNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNGSQKLSRSGP 216 (754)
Q Consensus 167 ~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~ 216 (754)
....+.|.|.+.++++|... +|. .+.|.++.
T Consensus 77 ---------------~t~~~~~~~~l~L~ddGNlv--ly~--~~~W~S~t 107 (109)
T d1kj1a_ 77 ---------------HSVRGNGNYVLVLQEDGNVV--IYG--SDIWSTGT 107 (109)
T ss_dssp ---------------CCCCCSSCCEEEECTTSCEE--EEC--CEEEECCC
T ss_pred ---------------eeECCCCCEEEEEeCCCcEE--EEC--CCEecCCC
Confidence 11123467889999998764 453 35787664
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.48 E-value=4e-07 Score=78.63 Aligned_cols=88 Identities=25% Similarity=0.425 Sum_probs=65.2
Q ss_pred CceEEEecCccEEEEcCCCCeEEeecCCCCCCCceEEEccCCCEEEEecCCCCCCcCceeccccCCCcccccccCcccce
Q 036419 88 NAALTISNNGNLVILNLTNGAIWSSNTSRKAENPVAQLLDTGNLIVRDNFSRSASEGSCLWQSFDYPSDTLLAGMKLGWD 167 (754)
Q Consensus 88 ~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~lWQSFd~PtDTlLpg~~l~~~ 167 (754)
.-.|.|..||||||++ .+.+||++++......+.++|..+|||||++. ++.+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-------~~~~w~s----------------- 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-------SRAIWAS----------------- 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET-------TEEEEEC-----------------
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec-------CCeEEEE-----------------
Confidence 4678999999999987 46899999987666667889999999999973 3455543
Q ss_pred ecCCCeeeEEecCCCCCCCCCceEEEeecCCCceEEEEcC-CeeeEecCC
Q 036419 168 LKNGVERYLTSWRSADDPSPGNITNRLDIHVLPELGLYNG-SQKLSRSGP 216 (754)
Q Consensus 168 ~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~~~~~~~~~~~-~~~~~~~g~ 216 (754)
...-..|.|.+.++.+|... +++. ..+.|.++.
T Consensus 75 --------------~t~~~~~~~~l~L~ddGNlv--ly~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 --------------NTNRQNGNYYLILQRDRNVV--IYDNSNNAIWATHT 108 (112)
T ss_dssp --------------CCCCSCCCCEEEECTTSCEE--EECTTSCEEEECCC
T ss_pred --------------eeccCCCceEEEEcCCCCEE--EECCCCcEEecCCC
Confidence 12223467889999998764 4554 356888763
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.99 E-value=8.4e-06 Score=80.92 Aligned_cols=104 Identities=19% Similarity=0.179 Sum_probs=76.4
Q ss_pred HHHHHHHHHHHHhhc-cCCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 036419 482 LEEFKNEIKLTAKLQ-HRNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560 (754)
Q Consensus 482 ~~~~~~Ev~il~~l~-hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 560 (754)
...+.+|.+.+..+. +--+.+++.+..+++..++|||+++|.++.+..... .....++.++++.++.||+.
T Consensus 53 ~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~ 124 (263)
T d1j7la_ 53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSI 124 (263)
T ss_dssp TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTS
T ss_pred hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhcc
Confidence 345788999988885 334678888888888999999999998886654211 11234566667777777742
Q ss_pred C--------------------------------------------------------CCceeeCCCCCCceEEcCCCceE
Q 036419 561 S--------------------------------------------------------RLRVIHRDLKPSNILLDSNMIPK 584 (754)
Q Consensus 561 ~--------------------------------------------------------~~~iiH~Dlkp~NIlld~~~~~k 584 (754)
. ...++|+|+.|.|||+++++.+.
T Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~ 204 (263)
T d1j7la_ 125 DISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSG 204 (263)
T ss_dssp CCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEE
T ss_pred CccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEE
Confidence 1 02378999999999999877778
Q ss_pred EeeccCccc
Q 036419 585 ISDFGLARM 593 (754)
Q Consensus 585 l~DFgla~~ 593 (754)
|+||+.+..
T Consensus 205 lIDwe~a~~ 213 (263)
T d1j7la_ 205 FIDLGRSGR 213 (263)
T ss_dssp ECCCTTCEE
T ss_pred Eeechhccc
Confidence 999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.12 E-value=0.0004 Score=67.88 Aligned_cols=100 Identities=22% Similarity=0.252 Sum_probs=68.2
Q ss_pred HHHHHHHHHHHhhcc--CCeeeeeeeeeecCeeEEEEEecCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 036419 483 EEFKNEIKLTAKLQH--RNLVRLLGCCVEQGENVLIYEYLPNKSLDSFLFDTTKEGLLGWGARIRIIEGIAQGLLYLHQY 560 (754)
Q Consensus 483 ~~~~~Ev~il~~l~h--pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 560 (754)
..+..|...++.|.. -.+.+++.+..+++..++|||+++|.++.+.. ... ...+.++.+.|.-||..
T Consensus 49 ~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~--------~~~---~~~~~~l~~~la~LH~~ 117 (255)
T d1nd4a_ 49 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH--------LAP---AEKVSIMADAMRRLHTL 117 (255)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC--------CCH---HHHHHHHHHHHHHHTTS
T ss_pred hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc--------ccH---HHHHHHHHHHHHHHccC
Confidence 357888888888764 33677888888888899999999987664321 111 11223344444444421
Q ss_pred -------------------------------------------------------CCCceeeCCCCCCceEEcCCCceEE
Q 036419 561 -------------------------------------------------------SRLRVIHRDLKPSNILLDSNMIPKI 585 (754)
Q Consensus 561 -------------------------------------------------------~~~~iiH~Dlkp~NIlld~~~~~kl 585 (754)
....++|+|+.|.|||++++..+-|
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~i 197 (255)
T d1nd4a_ 118 DPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGF 197 (255)
T ss_dssp CGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEE
T ss_pred ChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEE
Confidence 1123899999999999998877789
Q ss_pred eeccCccc
Q 036419 586 SDFGLARM 593 (754)
Q Consensus 586 ~DFgla~~ 593 (754)
+||+.+..
T Consensus 198 ID~~~~~~ 205 (255)
T d1nd4a_ 198 IDCGRLGV 205 (255)
T ss_dssp CCCTTCEE
T ss_pred EEchhccc
Confidence 99998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.25 E-value=0.0034 Score=65.61 Aligned_cols=30 Identities=27% Similarity=0.323 Sum_probs=26.1
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
..++|+|+.|.|||++++. ++|+||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 3599999999999998764 89999998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.88 E-value=0.022 Score=59.09 Aligned_cols=40 Identities=25% Similarity=0.365 Sum_probs=28.1
Q ss_pred HHHHHHHHHHHHhhccCCe-eeeeeeeeecCeeEEEEEecCCCCh
Q 036419 482 LEEFKNEIKLTAKLQHRNL-VRLLGCCVEQGENVLIYEYLPNKSL 525 (754)
Q Consensus 482 ~~~~~~Ev~il~~l~hpni-v~l~~~~~~~~~~~lV~E~~~~gsL 525 (754)
.....+|.++++.+.-.++ .++++++.. .+|+||+++..+
T Consensus 88 ~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 88 ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 3456689999988864444 577777643 689999988654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.14 E-value=0.064 Score=53.79 Aligned_cols=114 Identities=12% Similarity=0.163 Sum_probs=63.1
Q ss_pred ccccHHHHHHHHHHHHhhccCCe--eeee-----eeeeecCeeEEEEEecCCCChhh----Hhh--------------c-
Q 036419 478 SGQGLEEFKNEIKLTAKLQHRNL--VRLL-----GCCVEQGENVLIYEYLPNKSLDS----FLF--------------D- 531 (754)
Q Consensus 478 ~~~~~~~~~~Ev~il~~l~hpni--v~l~-----~~~~~~~~~~lV~E~~~~gsL~~----~l~--------------~- 531 (754)
+....+++..|.+.+..|....+ +..+ ..+..+...+.++++++|..+.. .+. .
T Consensus 57 ~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~ 136 (325)
T d1zyla1 57 ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQ 136 (325)
T ss_dssp TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSS
T ss_pred CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccC
Confidence 34567889999999999864332 1111 12345566788999988754321 110 0
Q ss_pred -cCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCceeeCCCCCCceEEcCCCceEEee
Q 036419 532 -TTKEGLLGWG-------------------ARIRIIEGIAQGLLYLHQ----YSRLRVIHRDLKPSNILLDSNMIPKISD 587 (754)
Q Consensus 532 -~~~~~~l~~~-------------------~~~~i~~qi~~~L~yLH~----~~~~~iiH~Dlkp~NIlld~~~~~kl~D 587 (754)
.......+.. .+..+...+.+.+..+.. .....+||+|+.+.|||++++ ..++|
T Consensus 137 ~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~ID 214 (325)
T d1zyla1 137 LFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVD 214 (325)
T ss_dssp CCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECC
T ss_pred CccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEe
Confidence 0001111111 111222223333333332 223468999999999999754 45899
Q ss_pred ccCccc
Q 036419 588 FGLARM 593 (754)
Q Consensus 588 Fgla~~ 593 (754)
|+-+..
T Consensus 215 Fdd~~~ 220 (325)
T d1zyla1 215 LDDARN 220 (325)
T ss_dssp CTTCCE
T ss_pred chhccc
Confidence 998874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.58 E-value=0.14 Score=50.64 Aligned_cols=31 Identities=29% Similarity=0.373 Sum_probs=27.5
Q ss_pred CceeeCCCCCCceEEcCCCceEEeeccCccc
Q 036419 563 LRVIHRDLKPSNILLDSNMIPKISDFGLARM 593 (754)
Q Consensus 563 ~~iiH~Dlkp~NIlld~~~~~kl~DFgla~~ 593 (754)
.++||+|+.++||+++.+...-|.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4599999999999999988778999998863
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.91 E-value=0.054 Score=34.04 Aligned_cols=32 Identities=31% Similarity=0.691 Sum_probs=25.3
Q ss_pred cccccccCCCCCccccCC-CCCcCCcCCCCCCCC
Q 036419 288 LFCQFYGHCGGNRVCSYE-KTPNCECLKGFKPKS 320 (754)
Q Consensus 288 ~~C~~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 320 (754)
|+|.+-..|| ||.|+.- ..-.|.|-.||+|-.
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 6899999998 6889753 344599999999764
|